results.N	results.drug	results.ROR	results.CI_low	results.CI_up	results.pval	results.DrugReac	results.DrugNoReac	results.NoDrugReac	results.NoDrugNoReac	results_indication.N	results_indication.drug	results_indication.indication	results_indication.ROR	results_indication.CI_low	results_indication.CI_up	results_indication.pval	results_indication.DrugReac	results_indication.DrugNoReac	results_indication.NoDrugReac	results_indication.NoDrugNoReac	results_age.N	results_age.drug	results_age.indication	results_age.min_age	results_age.max_age	results_age.ROR	results_age.CI_low	results_age.CI_up	results_age.pval	results_age.DrugReac	results_age.DrugNoReac	results_age.NoDrugReac	results_age.NoDrugNoReac	results_male.N	results_male.drug	results_male.indication	results_male.ROR	results_male.CI_low	results_male.CI_up	results_male.pval	results_male.DrugReac	results_male.DrugNoReac	results_male.NoDrugReac	results_male.NoDrugNoReac	results_female.N	results_female.drug	results_female.indication	results_female.ROR	results_female.CI_low	results_female.CI_up	results_female.pval	results_female.DrugReac	results_female.DrugNoReac	results_female.NoDrugReac	results_female.NoDrugNoReac	results_logReg.N	results_logReg.drug	results_logReg.indication	results_logReg.logOR_Drug	results_logReg.OR_Drug	results_logReg.SE_Drug	results_logReg.pval_Drug	results_logReg.logOR_Age	results_logReg.SE_Age	results_logReg.pval_Age	results_logReg.logOR_Sex	results_logReg.SE_Sex	results_logReg.pval_Sex
1	hydroxyamphetamine	0	0	8.51	1	0	23	177549	8686767	1	hydroxyamphetamine	ophthalmological examination	0	0	118.98	1	0	4	4	237	1	hydroxyamphetamine	ophthalmological examination	NA	NA	0	0	Inf	1	0	0	0	0	1	hydroxyamphetamine	ophthalmological examination	0	0	Inf	1	0	0	0	21	1	hydroxyamphetamine	ophthalmological examination	0	0	Inf	1	0	2	0	38	1	hydroxyamphetamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2	sulfapyridine	0	0	53.4	1	0	5	177549	8686785	2	sulfapyridine	disseminated tuberculosis	0	0	Inf	1	0	2	0	313	2	sulfapyridine	disseminated tuberculosis	NA	NA	0	0	Inf	1	0	0	0	0	2	sulfapyridine	disseminated tuberculosis	0	0	Inf	1	0	0	0	47	2	sulfapyridine	disseminated tuberculosis	0	0	Inf	1	0	0	0	46	2	sulfapyridine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
3	heparin sodium	1.29	1.16	1.42	1.5e-06	400	15197	177149	8671593	3	heparin sodium	prophylaxis	1.05	0.65	1.62	0.82	21	1618	1258	101933	3	heparin sodium	prophylaxis	23.9	79.7	0	0	3.52	0.63	0	122	207	23538	3	heparin sodium	prophylaxis	0	0	6.88	1	0	93	82	13635	3	heparin sodium	prophylaxis	0	0	5.64	1	0	66	148	14346	3	heparin sodium	prophylaxis	-12.77	2.84485061407025e-06	311.81	0.97	-0.01	0	0.02	-0.52	0.14	0
4	histamine phosphate	0	0	24.79	1	0	9	177549	8686781	4	histamine phosphate	colon cancer	0	0	7024.26	1	0	1	74	14970	4	histamine phosphate	colon cancer	44.6	81.9	0	0	Inf	1	0	0	23	3205	4	histamine phosphate	colon cancer	0	0	Inf	1	0	0	12	2040	4	histamine phosphate	colon cancer	0	0	Inf	1	0	0	15	1686	4	histamine phosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
5	butabarbital sodium	8.51	2.14	24.91	0.002	4	23	177545	8686767	5	butabarbital sodium	anal fissure	0	0	165.3	1	0	3	4	220	5	butabarbital sodium	anal fissure	42	60	0	0	Inf	1	0	1	0	9	5	butabarbital sodium	anal fissure	0	0	Inf	1	0	0	0	20	5	butabarbital sodium	anal fissure	0	0	477.42	1	0	1	3	36	5	butabarbital sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
6	desoxycorticosterone acetate	0	0	53.4	1	0	5	177549	8686785	6	desoxycorticosterone acetate	adrenal insufficiency	0	0	1980.73	1	0	1	22	1152	6	desoxycorticosterone acetate	adrenal insufficiency	10.6	47.7	0	0	1373.88	1	0	1	2	71	6	desoxycorticosterone acetate	adrenal insufficiency	0	0	Inf	1	0	0	0	128	6	desoxycorticosterone acetate	adrenal insufficiency	0	0	1661.97	1	0	1	4	174	6	desoxycorticosterone acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
7	guanidine	0	0	13.64	1	0	15	177549	8686775	7	guanidine	renal transplant	0	0	394.15	1	0	4	84	21635	7	guanidine	renal transplant	34	58.8	0	0	Inf	1	0	0	9	1675	7	guanidine	renal transplant	0	0	Inf	1	0	0	4	2281	7	guanidine	renal transplant	0	0	Inf	1	0	0	8	1506	7	guanidine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
8	menadione	0	0	3.46	0.63	0	54	177549	8686736	8	menadione	acute lymphocytic leukaemia	0	0	103.17	1	0	8	70	12075	8	menadione	acute lymphocytic leukaemia	6.4	64.6	0	0	Inf	1	0	0	11	1954	8	menadione	acute lymphocytic leukaemia	0	0	Inf	1	0	0	11	1502	8	menadione	acute lymphocytic leukaemia	0	0	Inf	1	0	0	2	1241	8	menadione	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
9	thyroglobulin	0	0	17.61	1	0	12	177549	8686778	9	thyroglobulin	prophylaxis against transplant rejection	0	0	216.06	1	0	4	70	9844	9	thyroglobulin	prophylaxis against transplant rejection	14.5	68.6	0	0	Inf	1	0	0	5	1179	9	thyroglobulin	prophylaxis against transplant rejection	0	0	Inf	1	0	0	5	864	9	thyroglobulin	prophylaxis against transplant rejection	0	0	Inf	1	0	0	2	572	9	thyroglobulin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
10	inulin	0	0	4.61	1	0	41	177549	8686749	10	inulin	oesophageal carcinoma	0	0	779.97	1	0	3	10	3020	10	inulin	oesophageal carcinoma	52.4	77.1	0	0	Inf	1	0	0	1	347	10	inulin	oesophageal carcinoma	0	0	Inf	1	0	0	3	348	10	inulin	oesophageal carcinoma	0	0	Inf	1	0	0	0	108	10	inulin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
11	aminophylline	1.06	0.74	1.47	0.73	36	1668	177513	8685122	11	aminophylline	asthma	0.84	0.38	1.61	0.75	9	354	3035	100020	11	aminophylline	asthma	9	76	3.34	0.86	9.31	0.039	4	39	536	17477	11	aminophylline	asthma	6.7	1.68	19.67	0.0046	4	26	143	6232	11	aminophylline	asthma	0	0	6.12	1	0	21	458	14541	11	aminophylline	asthma	1.13	3.09565650012471	0.53	0.03	-0.02	0	0	-0.41	0.1	0
12	sulfur	1.55	0.86	2.57	0.1	15	475	177534	8686315	12	sulfur	acne	0.6	0.16	1.65	0.4	4	46	4372	30358	12	sulfur	acne	14.8	44.4	0	0	11.39	1	0	7	173	2817	12	sulfur	acne	0	0	100.33	1	0	3	28	1128	12	sulfur	acne	0	0	12.47	1	0	6	164	2388	12	sulfur	acne	-12.62	3.3052448588734e-06	479.02	0.98	0	0.01	0.66	-1.03	0.21	0
13	methyltestosterone	3.07	1.82	4.88	3.6e-05	19	303	177530	8686487	13	methyltestosterone	hormone replacement therapy	1.58	0.19	6	0.37	2	54	934	39815	13	methyltestosterone	hormone replacement therapy	34.3	74	0	0	19.59	1	0	8	91	2998	13	methyltestosterone	hormone replacement therapy	0	0	38.29	1	0	4	48	1188	13	methyltestosterone	hormone replacement therapy	0	0	34.07	1	0	6	56	2198	13	methyltestosterone	hormone replacement therapy	-12.08	5.67182285902797e-06	454.51	0.98	-0.03	0.01	0	0.43	0.2	0.03
14	vasopressin tannate	0	0	28.67	1	0	8	177549	8686782	14	vasopressin tannate	systemic candida	0	0	Inf	1	0	4	0	713	14	vasopressin tannate	systemic candida	NA	NA	0	0	Inf	1	0	0	0	0	14	vasopressin tannate	systemic candida	0	0	Inf	1	0	0	0	60	14	vasopressin tannate	systemic candida	0	0	Inf	1	0	0	0	47	14	vasopressin tannate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
15	ergocalciferol	1.77	1.72	1.82	2e-279	4908	137360	172641	8549430	15	ergocalciferol	osteoporosis	1.32	1.24	1.41	2.6e-16	1116	15600	7686	142086	15	ergocalciferol	osteoporosis	53.1	85	1.09	0.83	1.39	0.51	70	1975	738	22593	15	ergocalciferol	osteoporosis	2.34	0.69	6.27	0.085	5	223	26	2712	15	ergocalciferol	osteoporosis	1.17	0.91	1.48	0.2	78	2097	790	24790	15	ergocalciferol	osteoporosis	0.17	1.18530485132037	0.12	0.14	-0.01	0	0	-1.15	0.18	0
16	menadiol sodium diphosphate	0	0	260.7	1	0	2	177549	8686788	16	menadiol sodium diphosphate	cystic fibrosis	0	0	6166.28	1	0	1	57	9972	16	menadiol sodium diphosphate	cystic fibrosis	14.3	57.2	0	0	Inf	1	0	0	18	3379	16	menadiol sodium diphosphate	cystic fibrosis	0	0	Inf	1	0	0	7	2062	16	menadiol sodium diphosphate	cystic fibrosis	0	0	Inf	1	0	0	13	2425	16	menadiol sodium diphosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
17	estrone	1.35	0.85	2.05	0.14	23	831	177526	8685959	17	estrone	hormone replacement therapy	0.23	0.01	1.32	0.14	1	182	935	39687	17	estrone	hormone replacement therapy	34.3	74	0	0	80.56	1	0	3	91	3003	17	estrone	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	17	estrone	hormone replacement therapy	0	0	96.53	1	0	3	56	2201	17	estrone	hormone replacement therapy	-10.75	2.14454083165892e-05	508.08	0.98	-0.03	0.01	0	0.43	0.2	0.03
18	diethylstilbestrol	2.74	1.08	5.82	0.017	7	125	177542	8686665	18	diethylstilbestrol	prostate cancer	8.48	2.21	23.29	0.0017	4	49	440	45702	18	diethylstilbestrol	prostate cancer	56.9	87.4	0	0	4547.83	1	0	1	102	12803	18	diethylstilbestrol	prostate cancer	0	0	4655.58	1	0	1	114	14675	18	diethylstilbestrol	prostate cancer	0	0	Inf	1	0	0	0	51	18	diethylstilbestrol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
19	sulfadiazine	3.4	2.68	4.27	2.3e-19	80	1150	177469	8685640	19	sulfadiazine	hiv infection	0	0	3.39	0.63	0	129	500	58262	19	sulfadiazine	hiv infection	25	64	0	0	44.62	1	0	7	120	7634	19	sulfadiazine	hiv infection	0	0	35.4	1	0	8	96	5720	19	sulfadiazine	hiv infection	0	0	210.88	1	0	3	40	3436	19	sulfadiazine	hiv infection	-11.4	1.11954848425909e-05	438.11	0.98	0	0.01	0.8	0.38	0.2	0.05
20	sulfadiazine sodium	0	0	118.34	1	0	3	177549	8686787	20	sulfadiazine sodium	anaemia	0	0	1577.65	1	0	1	468	19409	20	sulfadiazine sodium	anaemia	22.2	83.9	0	0	Inf	1	0	0	57	4050	20	sulfadiazine sodium	anaemia	0	0	Inf	1	0	0	6	1866	20	sulfadiazine sodium	anaemia	0	0	1755.74	1	0	1	59	2730	20	sulfadiazine sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
21	alcohol	1.96	1.76	2.17	1.5e-31	385	9641	177164	8677149	21	alcohol	depression	1.76	1.41	2.18	1.1e-06	97	742	14274	192043	21	alcohol	depression	21	73.3	3.65	1.54	7.78	0.002	9	34	2053	28308	21	alcohol	depression	4.58	1.33	12.86	0.0087	5	18	632	10429	21	alcohol	depression	4.34	1.7	9.84	0.0014	8	27	1663	24357	21	alcohol	depression	1.36	3.89619330179521	0.32	0	-0.01	0	0	-0.14	0.05	0
22	dextrose	0.13	0.12	0.15	0	199	71775	177350	8615015	22	dextrose	peritoneal dialysis	0.56	0.38	0.82	0.0019	43	55729	85	61863	22	dextrose	peritoneal dialysis	29.7	77.4	0.33	0.07	3.05	0.16	12	14922	2	823	22	dextrose	peritoneal dialysis	0.23	0.04	2.3	0.11	7	9494	2	632	22	dextrose	peritoneal dialysis	0.29	0.04	13.47	0.28	6	8525	1	415	22	dextrose	peritoneal dialysis	-1.39	0.249075304631668	0.64	0.03	-0.02	0.01	0.27	0.13	0.51	0.8
23	estrogens	2.01	1.94	2.09	8.9e-269	3240	79439	174309	8607351	23	estrogens	hormone replacement therapy	0.48	0.42	0.55	3.1e-27	500	28085	436	11784	23	estrogens	hormone replacement therapy	34.3	74	0.52	0.23	1.05	0.066	9	521	82	2485	23	estrogens	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	23	estrogens	hormone replacement therapy	1.06	0.56	1.93	0.88	17	643	39	1561	23	estrogens	hormone replacement therapy	0.19	1.20924959765725	0.3	0.51	-0.03	0.01	0	0.48	0.22	0.03
24	meperidine	6.41	5.95	6.91	0	785	6011	176764	8680779	24	meperidine	pain	3.75	3.16	4.42	7.6e-42	169	1018	8300	187466	24	meperidine	pain	23	79	1.98	0.84	4.04	0.073	8	134	1080	35883	24	meperidine	pain	3.8	1.18	9.47	0.013	5	56	359	15261	24	meperidine	pain	2.57	1	5.55	0.025	7	85	850	26505	24	meperidine	pain	1	2.71828182845905	0.3	0	-0.02	0	0	-0.28	0.06	0
25	homatropine methylbromide	2.99	1.98	4.35	6.4e-07	29	475	177520	8686315	25	homatropine methylbromide	cough	2.7	1.13	5.56	0.013	8	113	370	14100	25	homatropine methylbromide	cough	13.7	78	3.47	0.39	14.52	0.13	2	22	81	3096	25	homatropine methylbromide	cough	0	0	17.44	1	0	16	25	1576	25	homatropine methylbromide	cough	7.16	0.75	34.59	0.042	2	10	67	2404	25	homatropine methylbromide	cough	1.48	4.39294568091876	0.75	0.05	-0.01	0	0	-0.65	0.24	0.01
26	hydrocodone bitartrate	4.37	4.27	4.47	0	8517	99104	169032	8587686	26	hydrocodone bitartrate	pain	2.63	2.5	2.78	3.4e-250	2034	20194	6435	168290	26	hydrocodone bitartrate	pain	23	79	1.66	1.4	1.95	5.5e-09	186	3981	902	32036	26	hydrocodone bitartrate	pain	1.09	0.76	1.53	0.59	39	1519	325	13798	26	hydrocodone bitartrate	pain	1.97	1.65	2.35	1e-12	164	2850	693	23740	26	hydrocodone bitartrate	pain	0.54	1.71600686218486	0.08	0	-0.02	0	0	-0.27	0.06	0
27	ethinyl estradiol	7.04	6.92	7.16	0	16080	121144	161469	8565646	27	ethinyl estradiol	contraception	3.37	3.22	3.54	0	4897	47346	3104	101288	27	ethinyl estradiol	contraception	19	43	1.14	0.99	1.31	0.065	253	3170	1462	20911	27	ethinyl estradiol	contraception	0	0	Inf	1	0	5	0	17	27	ethinyl estradiol	contraception	1.22	1.07	1.39	0.0025	300	3762	1639	25143	27	ethinyl estradiol	contraception	0.2	1.22140275816017	0.07	0	0	0	0.95	-10.88	114.08	0.92
28	iophendylate	8.15	0.18	67.33	0.13	1	6	177548	8686784	28	iophendylate	nuclear magnetic resonance imaging	0	0	30.33	1	0	2	1146	6521	28	iophendylate	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	28	iophendylate	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	28	iophendylate	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	28	iophendylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
29	methamphetamine	1.85	1.49	2.26	4.8e-08	99	2625	177450	8684165	29	methamphetamine	drug abuse	1.26	0.03	7.53	0.56	1	63	59	4670	29	methamphetamine	drug abuse	21	60.4	0	0	27.09	1	0	9	19	942	29	methamphetamine	drug abuse	0	0	21.68	1	0	8	17	579	29	methamphetamine	drug abuse	0	0	105.62	1	0	5	8	670	29	methamphetamine	drug abuse	-13.78	1.03614858769009e-06	1087.54	0.99	-0.01	0.01	0.56	0.87	0.43	0.04
30	dicumarol	0	0	6.18	1	0	31	177549	8686759	30	dicumarol	pulmonary hypertension	0	0	108.8	1	0	7	273	42502	30	dicumarol	pulmonary hypertension	23.5	83	0	0	Inf	1	0	0	140	17188	30	dicumarol	pulmonary hypertension	0	0	Inf	1	0	0	21	4825	30	dicumarol	pulmonary hypertension	0	0	Inf	1	0	0	135	14395	30	dicumarol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
31	aminohippurate sodium	0	0	24.79	1	0	9	177549	8686781	31	aminohippurate sodium	renal transplant	0	0	1383.52	1	0	2	84	21637	31	aminohippurate sodium	renal transplant	34	58.8	0	0	Inf	1	0	0	9	1675	31	aminohippurate sodium	renal transplant	0	0	Inf	1	0	0	4	2281	31	aminohippurate sodium	renal transplant	0	0	Inf	1	0	0	8	1506	31	aminohippurate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
32	mannitol	14.82	13.65	16.08	0	771	2556	176778	8684234	32	mannitol	prophylaxis	2.02	0.86	4.04	0.069	8	322	1271	103229	32	mannitol	prophylaxis	23.9	79.7	1.24	0.03	7.18	0.56	1	92	206	23568	32	mannitol	prophylaxis	2.52	0.06	14.91	0.33	1	67	81	13661	32	mannitol	prophylaxis	0	0	10.02	1	0	38	148	14374	32	mannitol	prophylaxis	0.17	1.18530485132037	1.01	0.87	-0.01	0	0.03	-0.52	0.14	0
33	tubocurarine chloride	0	0	74.11	1	0	4	177549	8686786	33	tubocurarine chloride	anaesthesia	0	0	169.9	1	0	4	60	6600	33	tubocurarine chloride	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	33	tubocurarine chloride	anaesthesia	0	0	Inf	1	0	0	1	387	33	tubocurarine chloride	anaesthesia	0	0	Inf	1	0	0	10	485	33	tubocurarine chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
35	triple sulfa\>	0	0	14.75	1	0	14	177549	8686776	35	triple sulfa\>	antibacterial prophylaxis	0	0	664.7	1	0	1	9	154	35	triple sulfa\>	antibacterial prophylaxis	NA	NA	0	0	Inf	1	0	0	0	0	35	triple sulfa\>	antibacterial prophylaxis	0	0	Inf	1	0	0	0	0	35	triple sulfa\>	antibacterial prophylaxis	0	0	Inf	1	0	0	0	0	35	triple sulfa\>	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
36	sulfacetamide	3.73	2.61	5.2	4.2e-11	38	498	177511	8686292	36	sulfacetamide	acne	0.69	0.24	1.6	0.58	6	60	4370	30344	36	sulfacetamide	acne	14.8	44.4	2.53	0.27	11.3	0.21	2	13	171	2811	36	sulfacetamide	acne	0	0	45.68	1	0	5	28	1126	36	sulfacetamide	acne	2.45	0.26	11.14	0.23	2	12	162	2382	36	sulfacetamide	acne	0.75	2.11700001661267	0.76	0.32	0	0.01	0.65	-1.03	0.21	0
38	nitrofurazone	0	0	14.75	1	0	14	177549	8686776	38	nitrofurazone	pain	0	0	33.72	1	0	4	8469	188480	38	nitrofurazone	pain	23	79	0	0	Inf	1	0	0	1088	36017	38	nitrofurazone	pain	0	0	Inf	1	0	0	364	15317	38	nitrofurazone	pain	0	0	Inf	1	0	0	857	26590	38	nitrofurazone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
39	diphenhydramine	2.13	2.05	2.21	2.1e-294	3092	71665	174457	8615125	39	diphenhydramine	premedication	1.6	1.34	1.92	2.4e-07	241	10499	256	17863	39	diphenhydramine	premedication	13.8	73.2	2.85	1.97	4.2	3.7e-09	100	2515	43	3086	39	diphenhydramine	premedication	2.21	1.14	4.34	0.015	24	1057	18	1750	39	diphenhydramine	premedication	2.96	1.93	4.64	8.5e-08	86	1932	31	2059	39	diphenhydramine	premedication	0.99	2.69123447234926	0.17	0	0	0	0.54	-0.57	0.18	0
40	trimethadione	7.65	2.33	19.76	0.00082	5	32	177544	8686758	40	trimethadione	epilepsy	0	0	23.34	1	0	13	640	45413	40	trimethadione	epilepsy	13.6	68.1	0	0	148.78	1	0	3	87	5311	40	trimethadione	epilepsy	0	0	3209.35	1	0	1	41	3551	40	trimethadione	epilepsy	0	0	114.88	1	0	4	56	4180	40	trimethadione	epilepsy	-10.17	3.83023234165555e-05	394.65	0.98	0	0	0.57	-0.15	0.21	0.47
41	folic acid	0.98	0.94	1.02	0.3	2688	134181	174861	8552609	41	folic acid	rheumatoid arthritis	1.45	1.32	1.6	2.7e-13	495	48211	2915	412166	41	folic acid	rheumatoid arthritis	33	75	1.7	1.42	2.03	1.5e-08	151	10127	909	103811	41	folic acid	rheumatoid arthritis	1.57	0.96	2.44	0.06	23	2171	157	23220	41	folic acid	rheumatoid arthritis	1.7	1.41	2.03	3.6e-08	144	9618	867	98346	41	folic acid	rheumatoid arthritis	0.53	1.69893230861855	0.08	0	-0.01	0	0	-0.26	0.08	0
42	tripelennamine	0	0	17.61	1	0	12	177549	8686778	42	tripelennamine	drug abuse	0	0	121.11	1	0	4	60	4729	42	tripelennamine	drug abuse	21	60.4	0	0	Inf	1	0	0	19	951	42	tripelennamine	drug abuse	0	0	Inf	1	0	0	17	587	42	tripelennamine	drug abuse	0	0	Inf	1	0	0	8	675	42	tripelennamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
43	tripelennamine citrate	0	0	1852.91	1	0	1	177549	8686789	43	tripelennamine citrate	NA	0	0	Inf	1	0	0	0	0	43	tripelennamine citrate	NA	NA	NA	0	0	Inf	1	0	0	0	0	43	tripelennamine citrate	NA	0	0	Inf	1	0	0	0	0	43	tripelennamine citrate	NA	0	0	Inf	1	0	0	0	0	43	tripelennamine citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
44	dihydroergotamine mesylate	1.32	0.86	1.93	0.15	27	1002	177522	8685788	44	dihydroergotamine mesylate	migraine	0.77	0.28	1.72	0.71	6	175	1781	40070	44	dihydroergotamine mesylate	migraine	20.7	70.1	1.16	0.03	7.14	0.59	1	24	266	7376	44	dihydroergotamine mesylate	migraine	0	0	51.02	1	0	4	32	1045	44	dihydroergotamine mesylate	migraine	1.18	0.03	7.34	0.58	1	23	264	7178	44	dihydroergotamine mesylate	migraine	-0.04	0.960789439152323	1.02	0.97	-0.02	0	0	-0.21	0.19	0.27
45	protein hydrolysate	0	0	21.83	1	0	10	177549	8686780	45	protein hydrolysate	rheumatoid arthritis	0	0	710.39	1	0	2	3410	460375	45	protein hydrolysate	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	45	protein hydrolysate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	45	protein hydrolysate	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	45	protein hydrolysate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
46	dimercaprol	0	0	53.4	1	0	5	177549	8686785	46	dimercaprol	status epilepticus	0	0	11738.85	1	0	1	5	1842	46	dimercaprol	status epilepticus	73.8	73.8	0	0	Inf	1	0	0	0	0	46	dimercaprol	status epilepticus	0	0	Inf	1	0	1	0	204	46	dimercaprol	status epilepticus	0	0	Inf	1	0	0	1	245	46	dimercaprol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
47	sulfacetamide sodium	3.66	2.66	4.93	4.4e-13	47	628	177502	8686162	47	sulfacetamide sodium	acne	0.52	0.14	1.42	0.31	4	53	4372	30351	47	sulfacetamide sodium	acne	14.8	44.4	2.99	0.32	13.86	0.17	2	11	171	2813	47	sulfacetamide sodium	acne	0	0	35.69	1	0	6	28	1125	47	sulfacetamide sodium	acne	2.94	0.31	13.97	0.18	2	10	162	2384	47	sulfacetamide sodium	acne	0.89	2.43512965128987	0.76	0.24	0	0.01	0.63	-1.04	0.21	0
48	sodium tetradecyl	0	0	1.9	0.27	0	97	177549	8686693	48	sodium tetradecyl	spider vein	0	0	Inf	1	0	18	0	20	48	sodium tetradecyl	spider vein	NA	NA	0	0	Inf	1	0	0	0	0	48	sodium tetradecyl	spider vein	0	0	Inf	1	0	0	0	1	48	sodium tetradecyl	spider vein	0	0	Inf	1	0	0	0	1	48	sodium tetradecyl	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
49	chloroquine phosphate	0.71	0.35	1.28	0.3	11	757	177538	8686033	49	chloroquine phosphate	rheumatoid arthritis	1.73	0.47	4.47	0.3	4	313	3406	460064	49	chloroquine phosphate	rheumatoid arthritis	33	75	8.96	0.21	60.79	0.11	1	12	1059	113926	49	chloroquine phosphate	rheumatoid arthritis	0	0	737.25	1	0	2	180	25389	49	chloroquine phosphate	rheumatoid arthritis	8.91	0.21	60.2	0.11	1	12	1010	107952	49	chloroquine phosphate	rheumatoid arthritis	1.98	7.24274298516101	1.04	0.06	-0.01	0	0	-0.26	0.08	0
50	chloroquine	0.76	0.51	1.09	0.15	30	1930	177519	8684860	50	chloroquine	rheumatoid arthritis	2.22	1.24	3.69	0.0054	15	913	3395	459464	50	chloroquine	rheumatoid arthritis	33	75	1.34	0.16	4.92	0.66	2	161	1058	113777	50	chloroquine	rheumatoid arthritis	0	0	23.62	1	0	24	180	25367	50	chloroquine	rheumatoid arthritis	1.9	0.39	5.66	0.21	3	169	1008	107795	50	chloroquine	rheumatoid arthritis	0.49	1.63231621995538	0.58	0.4	-0.01	0	0	-0.26	0.08	0
51	mephenytoin	0	0	5.79	1	0	33	177549	8686757	51	mephenytoin	epilepsy	0	0	19.83	1	0	15	640	45411	51	mephenytoin	epilepsy	13.6	68.1	0	0	2296.69	1	0	1	87	5313	51	mephenytoin	epilepsy	0	0	Inf	1	0	0	41	3552	51	mephenytoin	epilepsy	0	0	2787.01	1	0	1	56	4183	51	mephenytoin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
52	ferrous	1.55	1.46	1.64	1.7e-43	1185	37542	176364	8649248	52	ferrous	hypertension	1.36	1.09	1.67	0.0052	94	3206	6801	314407	52	ferrous	hypertension	38	82.9	1.13	0.63	1.89	0.58	15	844	966	61565	52	ferrous	hypertension	0.23	0.01	1.3	0.14	1	398	340	31241	52	ferrous	hypertension	1.22	0.66	2.08	0.45	14	601	748	39329	52	ferrous	hypertension	-0.05	0.951229424500714	0.26	0.86	-0.02	0	0	-0.59	0.07	0
53	methylergonovine maleate	1.32	0.79	2.08	0.23	19	704	177530	8686086	53	methylergonovine maleate	foetal exposure during pregnancy	0	0	9	1	0	4	411	2435	53	methylergonovine maleate	foetal exposure during pregnancy	0	5.3	0	0	Inf	1	0	0	5	95	53	methylergonovine maleate	foetal exposure during pregnancy	0	0	Inf	1	0	0	4	61	53	methylergonovine maleate	foetal exposure during pregnancy	0	0	Inf	1	0	0	2	37	53	methylergonovine maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
55	ascorbic acid	2.63	2.49	2.78	1.1e-194	1319	24660	176230	8662130	55	ascorbic acid	hypertension	1.28	0.96	1.68	0.086	54	1949	6841	315664	55	ascorbic acid	hypertension	38	82.9	1.24	0.25	3.7	0.53	3	154	978	62255	55	ascorbic acid	hypertension	0	0	4.23	1	0	83	341	31556	55	ascorbic acid	hypertension	2.17	0.58	5.75	0.12	4	97	758	39833	55	ascorbic acid	hypertension	0.45	1.56831218549017	0.51	0.37	-0.02	0	0	-0.59	0.07	0
56	biotin	1.57	1.39	1.76	1.5e-12	294	9187	177255	8677603	56	biotin	rheumatoid arthritis	1.24	0.49	2.56	0.52	7	765	3403	459612	56	biotin	rheumatoid arthritis	33	75	1.03	0.21	3.06	0.77	3	312	1057	113626	56	biotin	rheumatoid arthritis	0	0	63.3	1	0	10	180	25381	56	biotin	rheumatoid arthritis	0.88	0.18	2.59	1	3	365	1008	107599	56	biotin	rheumatoid arthritis	-0.12	0.886920436717157	0.58	0.83	-0.01	0	0	-0.26	0.08	0
57	cyanocobalamin	1.9	1.73	2.07	7.9e-38	507	13105	177042	8673685	57	cyanocobalamin	hypertension	1.41	1	1.94	0.043	39	1276	6856	316337	57	cyanocobalamin	hypertension	38	82.9	0	0	1.03	0.055	0	229	981	62180	57	cyanocobalamin	hypertension	0	0	3.49	0.63	0	100	341	31539	57	cyanocobalamin	hypertension	0.35	0.01	1.96	0.54	1	151	761	39779	57	cyanocobalamin	hypertension	-1.32	0.26713530196585	1	0.19	-0.02	0	0	-0.59	0.07	0
58	dexpanthenol	0.27	0.03	0.99	0.057	2	361	177547	8686429	58	dexpanthenol	prophylaxis	0	0	4.97	1	0	62	1279	103489	58	dexpanthenol	prophylaxis	23.9	79.7	0	0	32.08	1	0	15	207	23645	58	dexpanthenol	prophylaxis	0	0	117.57	1	0	7	82	13721	58	dexpanthenol	prophylaxis	0	0	57.55	1	0	8	148	14404	58	dexpanthenol	prophylaxis	-9.74	5.88805348414794e-05	226.86	0.97	-0.01	0	0.03	-0.52	0.14	0
59	niacinamide	0.85	0.61	1.14	0.32	43	2485	177506	8684305	59	niacinamide	crohn s disease	0	0	1.04	0.056	0	355	1477	146957	59	niacinamide	crohn s disease	15.6	67	0	0	20.95	1	0	16	406	32678	59	niacinamide	crohn s disease	0	0	48.34	1	0	9	148	13989	59	niacinamide	crohn s disease	0	0	28.33	1	0	12	305	23885	59	niacinamide	crohn s disease	-10.12	4.02661255318714e-05	192.32	0.96	-0.01	0	0	-0.21	0.1	0.04
60	pyridoxine	1.57	1.39	1.78	7e-12	270	8395	177279	8678395	60	pyridoxine	prophylaxis	1.16	0.46	2.4	0.68	7	491	1272	103060	60	pyridoxine	prophylaxis	23.9	79.7	0	0	5.22	1	0	83	207	23577	60	pyridoxine	prophylaxis	0	0	10.99	1	0	59	82	13669	60	pyridoxine	prophylaxis	0	0	8.39	1	0	45	148	14367	60	pyridoxine	prophylaxis	-11.74	7.96861385989486e-06	233.74	0.96	-0.01	0	0.02	-0.52	0.14	0
61	riboflavin 5-phosphate sodium	1.25	0.03	7.41	0.55	1	39	177548	8686751	61	riboflavin 5-phosphate sodium	parenteral nutrition	0	0	109.63	1	0	11	4	728	61	riboflavin 5-phosphate sodium	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	61	riboflavin 5-phosphate sodium	parenteral nutrition	0	0	Inf	1	0	1	0	63	61	riboflavin 5-phosphate sodium	parenteral nutrition	0	0	Inf	1	0	0	0	78	61	riboflavin 5-phosphate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
62	thiamine	1.55	1.35	1.76	7.2e-10	233	7373	177316	8679417	62	thiamine	hypertension	0.78	0.37	1.45	0.57	10	589	6885	317024	62	thiamine	hypertension	38	82.9	0.97	0.12	3.59	1	2	131	979	62278	62	thiamine	hypertension	0	0	4.51	1	0	78	341	31561	62	thiamine	hypertension	1.67	0.2	6.29	0.34	2	63	760	39867	62	thiamine	hypertension	-0.09	0.913931185271228	0.71	0.9	-0.02	0	0	-0.59	0.07	0
63	vitamin a palmitate	1.56	1.3	1.86	2.1e-06	131	4097	177418	8682693	63	vitamin a palmitate	hypertension	1.83	0.9	3.33	0.061	11	277	6884	317336	63	vitamin a palmitate	hypertension	38	82.9	0	0	4.5	1	0	54	981	62355	63	vitamin a palmitate	hypertension	0	0	30.57	1	0	13	341	31626	63	vitamin a palmitate	hypertension	0	0	4.02	1	0	50	762	39880	63	vitamin a palmitate	hypertension	-10.46	2.86602331662198e-05	110.21	0.92	-0.02	0	0	-0.59	0.07	0
64	vitamin e	3.01	2.85	3.18	2.8e-247	1344	21955	176205	8664835	64	vitamin e	hypertension	2.74	2.22	3.35	5.6e-18	103	1747	6792	315866	64	vitamin e	hypertension	38	82.9	1.97	1.04	3.43	0.028	13	422	968	61987	64	vitamin e	hypertension	1.24	0.15	4.59	0.68	2	150	339	31489	64	vitamin e	hypertension	1.85	0.91	3.38	0.059	11	313	751	39617	64	vitamin e	hypertension	0.6	1.82211880039051	0.28	0.03	-0.02	0	0	-0.59	0.07	0
65	dienestrol	9.79	1.04	45.91	0.023	2	10	177547	8686780	65	dienestrol	hormone replacement therapy	0	0	64.55	1	0	4	936	39865	65	dienestrol	hormone replacement therapy	34.3	74	0	0	Inf	1	0	0	91	3006	65	dienestrol	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	65	dienestrol	hormone replacement therapy	0	0	Inf	1	0	0	56	2204	65	dienestrol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
66	methadone	2.24	2.11	2.37	1.3e-134	1244	27290	176305	8659500	66	methadone	pain	2.23	1.97	2.5	5.6e-34	321	3279	8148	185205	66	methadone	pain	23	79	1	0.6	1.56	1	20	663	1068	35354	66	methadone	pain	1.87	1.02	3.16	0.031	15	345	349	14972	66	methadone	pain	0.59	0.24	1.24	0.23	7	364	850	26226	66	methadone	pain	0.01	1.01005016708417	0.22	0.95	-0.02	0	0	-0.28	0.06	0
67	propylthiouracil	0.92	0.55	1.44	0.82	19	1011	177530	8685779	67	propylthiouracil	hyperthyroidism	0.15	0	0.88	0.03	1	270	88	3609	67	propylthiouracil	hyperthyroidism	30.1	74.3	0	0	5.69	1	0	29	16	600	67	propylthiouracil	hyperthyroidism	0	0	120.19	1	0	11	2	237	67	propylthiouracil	hyperthyroidism	0	0	4.28	0.62	0	40	16	632	67	propylthiouracil	hyperthyroidism	-15.1	2.76791865854081e-07	893.3	0.99	-0.02	0.01	0.08	-1.07	0.75	0.15
68	dibucaine	1.27	0.15	4.75	0.67	2	77	177547	8686713	68	dibucaine	prophylaxis	0	0	24.43	1	0	14	1279	103537	68	dibucaine	prophylaxis	23.9	79.7	0	0	4167.48	1	0	1	207	23659	68	dibucaine	prophylaxis	0	0	899.37	1	0	2	82	13726	68	dibucaine	prophylaxis	0	0	3585.07	1	0	1	148	14411	68	dibucaine	prophylaxis	-8.7	0.000166585810987634	307.84	0.98	-0.01	0	0.03	-0.52	0.14	0
69	hexachlorophene	3.68	1.72	6.98	0.00066	10	133	177539	8686657	69	hexachlorophene	peritoneal dialysis	0	0	418.55	1	0	10	128	117582	69	hexachlorophene	peritoneal dialysis	29.7	77.4	0	0	1902.08	1	0	4	14	15741	69	hexachlorophene	peritoneal dialysis	0	0	3157.22	1	0	3	9	10123	69	hexachlorophene	peritoneal dialysis	0	0	7322.29	1	0	2	7	8938	69	hexachlorophene	peritoneal dialysis	-9.49	7.56041032846277e-05	1069.42	0.99	-0.01	0.01	0.29	0.17	0.51	0.74
70	lindane	1.38	0.37	3.61	0.54	4	142	177545	8686648	70	lindane	lice infestation	0	0	12.14	1	0	49	6	682	70	lindane	lice infestation	36.2	68.2	0	0	Inf	1	0	1	0	52	70	lindane	lice infestation	0	0	Inf	1	0	0	0	24	70	lindane	lice infestation	0	0	211.14	1	0	3	2	99	70	lindane	lice infestation	-17.65	2.16123700214543e-08	10063.79	1	0.04	0.04	0.25	-17.13	3362.58	1
71	sulfamerazine	0	0	8.13	1	0	24	177549	8686766	71	sulfamerazine	chronic lymphocytic leukaemia	0	0	214.06	1	0	7	72	21852	71	sulfamerazine	chronic lymphocytic leukaemia	50.7	85	0	0	Inf	1	0	0	31	7442	71	sulfamerazine	chronic lymphocytic leukaemia	0	0	Inf	1	0	0	25	5387	71	sulfamerazine	chronic lymphocytic leukaemia	0	0	Inf	1	0	0	10	2999	71	sulfamerazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
72	trisulfapyrimidines\>	3.4	2.67	4.26	2.7e-19	80	1153	177469	8685637	72	trisulfapyrimidines\>	hiv infection	0	0	3.39	0.63	0	129	500	58262	72	trisulfapyrimidines\>	hiv infection	25	64	0	0	44.62	1	0	7	120	7634	72	trisulfapyrimidines\>	hiv infection	0	0	35.4	1	0	8	96	5720	72	trisulfapyrimidines\>	hiv infection	0	0	210.88	1	0	3	40	3436	72	trisulfapyrimidines\>	hiv infection	-11.4	1.11954848425909e-05	438.11	0.98	0	0.01	0.8	0.38	0.2	0.05
74	isoproterenol	4.14	2.36	6.79	2.5e-06	17	201	177532	8686589	74	isoproterenol	ventricular tachycardia	0	0	21.22	1	0	12	30	1680	74	isoproterenol	ventricular tachycardia	35	78	0	0	7626.41	1	0	1	1	221	74	isoproterenol	ventricular tachycardia	0	0	Inf	1	0	0	4	233	74	isoproterenol	ventricular tachycardia	0	0	1411.2	1	0	1	3	110	74	isoproterenol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
75	theophylline sodium glycinate	12.23	0.25	123.27	0.096	1	4	177548	8686786	75	theophylline sodium glycinate	asthma	0	0	49.97	1	0	4	3044	100370	75	theophylline sodium glycinate	asthma	9	76	0	0	Inf	1	0	0	540	17516	75	theophylline sodium glycinate	asthma	0	0	Inf	1	0	0	147	6258	75	theophylline sodium glycinate	asthma	0	0	Inf	1	0	0	458	14562	75	theophylline sodium glycinate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
76	hyaluronidase	0.16	0	0.9	0.037	1	304	177548	8686486	76	hyaluronidase	local anaesthesia	0	0	3.97	1	0	55	51	2815	76	hyaluronidase	local anaesthesia	9	63.2	0	0	Inf	1	0	0	9	379	76	hyaluronidase	local anaesthesia	0	0	Inf	1	0	1	0	222	76	hyaluronidase	local anaesthesia	0	0	Inf	1	0	0	11	352	76	hyaluronidase	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
77	tolazoline	0	0	12.68	1	0	16	177549	8686774	77	tolazoline	patent ductus arteriosus	0	0	Inf	1	0	5	0	1240	77	tolazoline	patent ductus arteriosus	NA	NA	0	0	Inf	1	0	0	0	0	77	tolazoline	patent ductus arteriosus	0	0	Inf	1	0	0	0	19	77	tolazoline	patent ductus arteriosus	0	0	Inf	1	0	0	0	39	77	tolazoline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
78	doxylamine succinate	2.21	1.7	2.83	1.4e-08	66	1461	177483	8685329	78	doxylamine succinate	insomnia	0.73	0.31	1.46	0.53	8	252	2935	67336	78	doxylamine succinate	insomnia	26.9	78.5	0.45	0.01	2.62	0.73	1	50	530	11847	78	doxylamine succinate	insomnia	0.88	0.02	5.38	1	1	29	211	5408	78	doxylamine succinate	insomnia	1.45	0.17	5.73	0.65	2	32	377	8758	78	doxylamine succinate	insomnia	0.28	1.32312981233744	0.6	0.64	-0.02	0	0	-0.08	0.09	0.38
79	amodiaquine	0	0	4.09	1	0	46	177549	8686744	79	amodiaquine	malaria	0	0	6.94	1	0	17	25	669	79	amodiaquine	malaria	25	45.3	0	0	Inf	1	0	0	1	51	79	amodiaquine	malaria	0	0	Inf	1	0	0	1	45	79	amodiaquine	malaria	0	0	Inf	1	0	0	3	45	79	amodiaquine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
80	diethylcarbamazine citrate	0	0	2.54	0.41	0	73	177549	8686717	80	diethylcarbamazine citrate	filariasis lymphatic	0	0	Inf	1	0	35	0	107	80	diethylcarbamazine citrate	filariasis lymphatic	NA	NA	0	0	Inf	1	0	0	0	0	80	diethylcarbamazine citrate	filariasis lymphatic	0	0	Inf	1	0	0	0	5	80	diethylcarbamazine citrate	filariasis lymphatic	0	0	Inf	1	0	0	0	7	80	diethylcarbamazine citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
81	protamine	60.11	55.98	64.39	0	1713	1409	175836	8685381	81	protamine	coronary artery bypass	5.01	4.28	5.88	9.1e-111	1139	236	1713	1778	81	protamine	coronary artery bypass	69.7	83	0	0	2166.62	1	0	2	1	114	81	protamine	coronary artery bypass	0	0	2378.25	1	0	3	1	189	81	protamine	coronary artery bypass	0	0	Inf	1	0	0	3	35	81	protamine	coronary artery bypass	-11.86	7.06752648464835e-06	2269.09	1	0.12	0.08	0.14	-2.91	1.19	0.01
82	calcium gluceptate	0	0	11.12	1	0	18	177549	8686772	82	calcium gluceptate	multiple myeloma	0	0	93.64	1	0	3	1483	57294	82	calcium gluceptate	multiple myeloma	NA	NA	0	0	Inf	1	0	0	0	0	82	calcium gluceptate	multiple myeloma	0	0	Inf	1	0	0	0	0	82	calcium gluceptate	multiple myeloma	0	0	Inf	1	0	0	0	0	82	calcium gluceptate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
83	lidocaine	3.11	2.98	3.25	0	2149	34078	175400	8652712	83	lidocaine	pain	1.53	1.35	1.73	7.9e-11	289	4252	8180	184232	83	lidocaine	pain	23	79	0.97	0.67	1.38	1	34	1154	1054	34863	83	lidocaine	pain	0.71	0.28	1.48	0.51	7	414	357	14903	83	lidocaine	pain	1	0.66	1.44	1	30	934	827	25656	83	lidocaine	pain	-0.08	0.923116346386636	0.17	0.66	-0.02	0	0	-0.28	0.06	0
84	epinephrine	2.8	2.63	2.97	2.7e-188	1147	20157	176402	8666633	84	epinephrine	immunodeficiency common variable	0.31	0.12	0.69	0.0018	8	2893	31	3461	84	epinephrine	immunodeficiency common variable	23.1	62.5	0	0	2.6	0.3	0	400	4	684	84	epinephrine	immunodeficiency common variable	0.77	0.01	14.86	1	1	170	2	261	84	epinephrine	immunodeficiency common variable	0	0	3.27	0.27	0	634	3	855	84	epinephrine	immunodeficiency common variable	-1.18	0.307278738601131	1.1	0.29	-0.02	0.02	0.43	1.08	0.85	0.2
85	sulfisoxazole	0	0	3.67	0.63	0	51	177549	8686739	85	sulfisoxazole	pyuria	0	0	Inf	1	0	2	0	24	85	sulfisoxazole	pyuria	NA	NA	0	0	Inf	1	0	0	0	0	85	sulfisoxazole	pyuria	0	0	Inf	1	0	0	0	1	85	sulfisoxazole	pyuria	0	0	Inf	1	0	1	0	4	85	sulfisoxazole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
86	sulfanilamide	1.48	0.04	8.85	0.5	1	33	177548	8686757	86	sulfanilamide	bipolar disorder	0	0	776.66	1	0	1	2577	51948	86	sulfanilamide	bipolar disorder	19.9	69	0	0	622.7	1	0	1	365	5884	86	sulfanilamide	bipolar disorder	0	0	Inf	1	0	0	123	2777	86	sulfanilamide	bipolar disorder	0	0	610.33	1	0	1	285	4502	86	sulfanilamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
87	bethanechol chloride	3.38	2.36	4.72	9.4e-10	37	535	177512	8686255	87	bethanechol chloride	multiple sclerosis	0.58	0.01	3.31	1	1	89	8344	430268	87	bethanechol chloride	multiple sclerosis	26.5	67	0	0	9.03	1	0	20	1304	58022	87	bethanechol chloride	multiple sclerosis	0	0	90.71	1	0	4	235	14045	87	bethanechol chloride	multiple sclerosis	0	0	8.18	1	0	21	1218	51828	87	bethanechol chloride	multiple sclerosis	-9.64	6.50730547475429e-05	106.95	0.93	-0.01	0	0	-0.34	0.07	0
88	ammonium chloride	2.8	1.47	4.89	0.0013	13	227	177536	8686563	88	ammonium chloride	premedication	0	0	62.31	1	0	5	497	28357	88	ammonium chloride	premedication	13.8	73.2	0	0	Inf	1	0	0	143	5601	88	ammonium chloride	premedication	0	0	Inf	1	0	0	42	2807	88	ammonium chloride	premedication	0	0	Inf	1	0	0	117	3991	88	ammonium chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
89	caffeine	2.3	2.11	2.52	4.8e-62	529	11250	177020	8675540	89	caffeine	migraine	1.05	0.83	1.32	0.68	82	1764	1705	38481	89	caffeine	migraine	20.7	70.1	2.13	1.35	3.22	0.001	27	372	240	7028	89	caffeine	migraine	0.46	0.01	2.84	0.72	1	69	31	980	89	caffeine	migraine	2.22	1.42	3.35	0.00036	28	364	237	6837	89	caffeine	migraine	0.77	2.15976625378492	0.2	0	-0.02	0	0	-0.22	0.19	0.24
90	ergotamine tartrate	2.01	1.16	3.26	0.0085	17	413	177532	8686377	90	ergotamine tartrate	migraine	0.44	0.09	1.32	0.23	3	152	1784	40093	90	ergotamine tartrate	migraine	20.7	70.1	0	0	12.41	1	0	10	267	7390	90	ergotamine tartrate	migraine	0	0	176.88	1	0	2	32	1047	90	ergotamine tartrate	migraine	0	0	8.95	1	0	13	265	7188	90	ergotamine tartrate	migraine	-10.95	1.75580153011059e-05	227.32	0.96	-0.02	0	0	-0.21	0.19	0.28
92	mechlorethamine	0.05	0	0.26	2.9e-08	1	1054	177548	8685736	92	mechlorethamine	hodgkin s disease	0	0	5.01	1	0	168	22	4567	92	mechlorethamine	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	7	0	118	92	mechlorethamine	hodgkin s disease	0	0	Inf	1	0	13	0	505	92	mechlorethamine	hodgkin s disease	0	0	201.82	1	0	11	2	399	92	mechlorethamine	hodgkin s disease	-17.33	2.97629948096469e-08	14637.38	1	-0.01	0.04	0.69	-18.19	3461.95	1
93	methoxamine	7.19	2.2	18.5	0.0011	5	34	177544	8686756	93	methoxamine	general anaesthesia	0	0	153.35	1	0	5	21	2794	93	methoxamine	general anaesthesia	19.4	52.5	0	0	Inf	1	0	0	3	245	93	methoxamine	general anaesthesia	0	0	Inf	1	0	0	1	248	93	methoxamine	general anaesthesia	0	0	Inf	1	0	0	4	358	93	methoxamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
94	trihexyphenidyl	1.57	1.29	1.9	8.1e-06	113	3516	177436	8683274	94	trihexyphenidyl	schizophrenia	1.13	0.69	1.74	0.56	21	733	1494	58791	94	trihexyphenidyl	schizophrenia	20.1	64.1	1.18	0.37	2.89	0.62	5	101	289	6913	94	trihexyphenidyl	schizophrenia	1.83	0.57	4.53	0.21	5	80	177	5182	94	trihexyphenidyl	schizophrenia	0	0	2.27	0.41	0	38	148	3257	94	trihexyphenidyl	schizophrenia	0.21	1.23367805995674	0.46	0.65	-0.02	0	0	-0.31	0.11	0.01
95	paramethadione	0	0	260.7	1	0	2	177549	8686788	95	paramethadione	epilepsy	0	0	2653.42	1	0	1	640	45425	95	paramethadione	epilepsy	13.6	68.1	0	0	Inf	1	0	0	87	5314	95	paramethadione	epilepsy	0	0	Inf	1	0	0	41	3552	95	paramethadione	epilepsy	0	0	Inf	1	0	0	56	4184	95	paramethadione	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
96	aminosalicylic acid	0.17	0.02	0.61	0.0015	2	578	177547	8686212	96	aminosalicylic acid	tuberculosis	1.87	0.21	7.54	0.31	2	156	27	3932	96	aminosalicylic acid	tuberculosis	23.8	59	4.84	0.45	30.47	0.098	2	51	5	620	96	aminosalicylic acid	tuberculosis	0	0	13.44	1	0	48	5	576	96	aminosalicylic acid	tuberculosis	16.9	1.19	240.62	0.018	2	28	2	481	96	aminosalicylic acid	tuberculosis	1.31	3.7061737122102	0.84	0.12	-0.01	0.02	0.73	0.02	0.69	0.98
97	aminosalicylate sodium	0	0	6.18	1	0	31	177549	8686759	97	aminosalicylate sodium	tuberculosis	0	0	74.73	1	0	9	29	4079	97	aminosalicylate sodium	tuberculosis	23.8	59	0	0	96.95	1	0	6	7	665	97	aminosalicylate sodium	tuberculosis	0	0	171.77	1	0	5	5	619	97	aminosalicylate sodium	tuberculosis	0	0	4605.68	1	0	1	4	508	97	aminosalicylate sodium	tuberculosis	-12.82	2.70610561241254e-06	1614.11	0.99	-0.01	0.02	0.53	0.09	0.68	0.9
98	sulfisoxazole diolamine	0	0	11.85	1	0	17	177549	8686773	98	sulfisoxazole diolamine	pyuria	0	0	Inf	1	0	2	0	24	98	sulfisoxazole diolamine	pyuria	NA	NA	0	0	Inf	1	0	0	0	0	98	sulfisoxazole diolamine	pyuria	0	0	Inf	1	0	0	0	1	98	sulfisoxazole diolamine	pyuria	0	0	Inf	1	0	1	0	4	98	sulfisoxazole diolamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
99	chlorpheniramine maleate	0.71	0.54	0.92	0.0091	57	3921	177492	8682869	99	chlorpheniramine maleate	prophylaxis	0.34	0.04	1.24	0.14	2	472	1277	103079	99	chlorpheniramine maleate	prophylaxis	23.9	79.7	0	0	7.42	1	0	59	207	23601	99	chlorpheniramine maleate	prophylaxis	0	0	16.05	1	0	41	82	13687	99	chlorpheniramine maleate	prophylaxis	0	0	9.02	1	0	42	148	14370	99	chlorpheniramine maleate	prophylaxis	-11.8	7.50455791507686e-06	261.71	0.96	-0.01	0	0.02	-0.52	0.14	0
100	crotamiton	0.16	0.02	0.57	0.00052	2	625	177547	8686165	100	crotamiton	prophylaxis	0	0	3.01	0.64	0	101	1279	103450	100	crotamiton	prophylaxis	23.9	79.7	0	0	37.76	1	0	13	207	23647	100	crotamiton	prophylaxis	0	0	86.22	1	0	9	82	13719	100	crotamiton	prophylaxis	0	0	83.35	1	0	6	148	14406	100	crotamiton	prophylaxis	-9.73	5.94722940546415e-05	225.83	0.97	-0.01	0	0.03	-0.52	0.14	0
102	sulfasalazine	0.74	0.66	0.83	2.3e-08	330	21713	177219	8665077	102	sulfasalazine	rheumatoid arthritis	1.3	1.07	1.57	0.0075	117	12240	3293	448137	102	sulfasalazine	rheumatoid arthritis	33	75	1.54	1.1	2.12	0.01	41	2892	1019	111046	102	sulfasalazine	rheumatoid arthritis	2.37	1.23	4.18	0.0083	13	809	167	24582	102	sulfasalazine	rheumatoid arthritis	1.52	1.06	2.11	0.018	37	2635	974	105329	102	sulfasalazine	rheumatoid arthritis	0.52	1.68202764969889	0.15	0	-0.01	0	0	-0.26	0.08	0
103	cortisone acetate	1.26	1	1.57	0.044	81	3146	177468	8683644	103	cortisone acetate	rheumatoid arthritis	0	0	1.04	0.056	0	480	3410	459897	103	cortisone acetate	rheumatoid arthritis	33	75	0	0	17.89	1	0	24	1060	113914	103	cortisone acetate	rheumatoid arthritis	0	0	120.17	1	0	6	180	25385	103	cortisone acetate	rheumatoid arthritis	0	0	22.92	1	0	19	1011	107945	103	cortisone acetate	rheumatoid arthritis	-8.84	0.000144822746682688	106.93	0.93	-0.01	0	0	-0.26	0.08	0
104	procainamide	6.69	4.56	9.55	4.7e-17	35	256	177514	8686534	104	procainamide	ventricular tachycardia	0	0	8.27	1	0	28	30	1664	104	procainamide	ventricular tachycardia	35	78	0	0	1380.11	1	0	6	1	216	104	procainamide	ventricular tachycardia	0	0	85.83	1	0	5	4	228	104	procainamide	ventricular tachycardia	0	0	119.57	1	0	3	3	108	104	procainamide	ventricular tachycardia	-13.66	1.16825427038899e-06	1395.25	0.99	0	0.02	0.81	-0.49	0.78	0.53
106	aspirin	1.4	1.38	1.43	6.6e-210	9925	351489	167624	8335301	106	aspirin	hypertension	1.12	1.04	1.2	0.0017	984	41196	5911	276417	106	aspirin	hypertension	38	82.9	1.22	1.02	1.46	0.023	156	8351	825	54058	106	aspirin	hypertension	1.33	0.99	1.75	0.046	64	4690	277	26949	106	aspirin	hypertension	1.2	0.97	1.48	0.088	105	4680	657	35250	106	aspirin	hypertension	0.32	1.37712776433596	0.09	0	-0.02	0	0	-0.6	0.07	0
107	oxycodone	3.16	3.09	3.22	0	9253	148780	168296	8538010	107	oxycodone	pain	2.48	2.36	2.59	7.1e-282	2795	31282	5674	157202	107	oxycodone	pain	23	79	1.16	0.99	1.35	0.06	220	6469	868	29548	107	oxycodone	pain	1.48	1.16	1.88	0.0017	96	2985	268	12332	107	oxycodone	pain	1.16	0.96	1.39	0.1	150	4107	707	22483	107	oxycodone	pain	0.21	1.23367805995674	0.07	0	-0.02	0	0	-0.29	0.06	0
108	oxycodone terephthalate	6.65	5.74	7.68	7.1e-96	216	1590	177333	8685200	108	oxycodone terephthalate	pain	5.83	4.55	7.41	4e-34	87	335	8382	188149	108	oxycodone terephthalate	pain	23	79	3.91	1	10.98	0.025	4	34	1084	35983	108	oxycodone terephthalate	pain	0	0	13.85	1	0	13	364	15304	108	oxycodone terephthalate	pain	6.78	2.01	18.28	0.0016	5	23	852	26567	108	oxycodone terephthalate	pain	1.37	3.93535069547047	0.48	0	-0.02	0	0	-0.28	0.06	0
109	methantheline bromide	2.22	0.26	8.52	0.24	2	44	177547	8686746	109	methantheline bromide	depression	0	0	4.04	0.62	0	14	14371	192771	109	methantheline bromide	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	109	methantheline bromide	depression	0	0	Inf	1	0	0	637	10447	109	methantheline bromide	depression	0	0	Inf	1	0	0	1671	24384	109	methantheline bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
110	secobarbital sodium	0	0	6.4	1	0	30	177549	8686760	110	secobarbital sodium	insomnia	0	0	25.07	1	0	5	2943	67583	110	secobarbital sodium	insomnia	26.9	78.5	0	0	Inf	1	0	0	531	11897	110	secobarbital sodium	insomnia	0	0	Inf	1	0	0	212	5437	110	secobarbital sodium	insomnia	0	0	Inf	1	0	0	379	8790	110	secobarbital sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
111	dicyclomine	3.74	3.47	4.02	1.7e-193	779	10236	176770	8676554	111	dicyclomine	crohn s disease	2.87	2.08	3.89	2.1e-09	45	1593	1432	145719	111	dicyclomine	crohn s disease	15.6	67	3.54	1.98	5.89	3.2e-05	16	375	390	32319	111	dicyclomine	crohn s disease	3.06	0.61	9.4	0.081	3	94	145	13904	111	dicyclomine	crohn s disease	3.5	1.87	6.05	0.00011	14	324	291	23573	111	dicyclomine	crohn s disease	1.25	3.49034295746184	0.25	0	-0.01	0	0	-0.2	0.1	0.05
112	corticotropin	0.93	0.73	1.16	0.55	79	4169	177470	8682621	112	corticotropin	infantile spasms	0	0	457.29	1	0	315	1	3719	112	corticotropin	infantile spasms	NA	NA	0	0	Inf	1	0	0	0	0	112	corticotropin	infantile spasms	0	0	Inf	1	0	37	0	539	112	corticotropin	infantile spasms	0	0	Inf	1	0	32	0	478	112	corticotropin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
113	norepinephrine bitartrate	17.69	16.08	19.44	0	594	1648	176955	8685142	113	norepinephrine bitartrate	coronary artery bypass	4.07	3.14	5.35	1.8e-33	379	73	2473	1941	113	norepinephrine bitartrate	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	113	norepinephrine bitartrate	coronary artery bypass	0	0	Inf	1	0	0	1	192	113	norepinephrine bitartrate	coronary artery bypass	0	0	Inf	1	0	0	3	35	113	norepinephrine bitartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
114	methimazole	1.32	1.05	1.64	0.014	85	3140	177464	8683650	114	methimazole	hyperthyroidism	1.31	0.74	2.21	0.32	19	667	70	3212	114	methimazole	hyperthyroidism	30.1	74.3	0.63	0.07	2.81	0.75	2	116	14	513	114	methimazole	hyperthyroidism	0	0	20.39	1	0	52	2	196	114	methimazole	hyperthyroidism	0.71	0.08	3.18	1	2	112	14	560	114	methimazole	hyperthyroidism	-0.56	0.571209063848815	0.76	0.46	-0.02	0.01	0.13	-1.06	0.75	0.16
115	quinidine gluconate	7.07	3.51	13.03	4.9e-07	12	83	177537	8686707	115	quinidine gluconate	ventricular tachycardia	0	0	63.61	1	0	5	30	1687	115	quinidine gluconate	ventricular tachycardia	35	78	0	0	Inf	1	0	0	1	222	115	quinidine gluconate	ventricular tachycardia	0	0	Inf	1	0	0	4	233	115	quinidine gluconate	ventricular tachycardia	0	0	Inf	1	0	0	3	111	115	quinidine gluconate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
116	thiamylal sodium	0	0	1.3	0.12	0	141	177549	8686649	116	thiamylal sodium	anaesthesia	0	0	9.4	1	0	46	60	6558	116	thiamylal sodium	anaesthesia	23	71.2	0	0	2374.23	1	0	1	9	568	116	thiamylal sodium	anaesthesia	0	0	Inf	1	0	0	1	387	116	thiamylal sodium	anaesthesia	0	0	1837.23	1	0	1	10	484	116	thiamylal sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
117	phenacemide	0	0	53.4	1	0	5	177549	8686785	117	phenacemide	epilepsy	0	0	2653.42	1	0	1	640	45425	117	phenacemide	epilepsy	13.6	68.1	0	0	Inf	1	0	0	87	5314	117	phenacemide	epilepsy	0	0	Inf	1	0	0	41	3552	117	phenacemide	epilepsy	0	0	Inf	1	0	0	56	4184	117	phenacemide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
118	dyphylline	8.97	4.25	17.23	1.8e-07	11	60	177538	8686730	118	dyphylline	asthma	0	0	16.71	1	0	9	3044	100365	118	dyphylline	asthma	9	76	0	0	1240.54	1	0	1	540	17515	118	dyphylline	asthma	0	0	227.46	1	0	2	147	6256	118	dyphylline	asthma	0	0	Inf	1	0	0	458	14562	118	dyphylline	asthma	-8.3	0.000248516827107952	229.5	0.97	-0.02	0	0	-0.41	0.1	0
119	gallamine triethiodide	0	0	118.34	1	0	3	177549	8686787	119	gallamine triethiodide	fibromyalgia	0	0	768.89	1	0	1	1648	32884	119	gallamine triethiodide	fibromyalgia	28.6	70.9	0	0	Inf	1	0	0	387	7504	119	gallamine triethiodide	fibromyalgia	0	0	Inf	1	0	0	40	702	119	gallamine triethiodide	fibromyalgia	0	0	Inf	1	0	0	391	7907	119	gallamine triethiodide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
120	potassium chloride	2.16	2.09	2.24	5.5e-306	3097	70655	174452	8616135	120	potassium chloride	hypertension	2.11	1.88	2.36	6.6e-32	332	7440	6563	310173	120	potassium chloride	hypertension	38	82.9	0.91	0.56	1.39	0.76	22	1541	959	60868	120	potassium chloride	hypertension	0.43	0.09	1.26	0.17	3	644	338	30995	120	potassium chloride	hypertension	1.08	0.68	1.64	0.66	23	1119	739	38811	120	potassium chloride	hypertension	-0.03	0.970445533548508	0.2	0.87	-0.02	0	0	-0.59	0.07	0
121	disulfiram	2.67	2	3.51	4.5e-10	55	1007	177494	8685783	121	disulfiram	alcoholism	0.89	0.27	2.22	1	5	218	58	2239	121	disulfiram	alcoholism	23	63	1.01	0.02	7.84	1	1	43	8	347	121	disulfiram	alcoholism	0	0	6.27	1	0	38	6	270	121	disulfiram	alcoholism	1.65	0.03	15.2	0.51	1	10	7	116	121	disulfiram	alcoholism	-0.45	0.637628151621773	1.06	0.67	-0.03	0.02	0.15	-1.22	0.56	0.03
122	probenecid	2.04	1.45	2.8	5.9e-05	40	960	177509	8685830	122	probenecid	gout	0.67	0.08	2.47	0.77	2	178	247	14650	122	probenecid	gout	41	78.7	0	0	7.17	1	0	40	46	3286	122	probenecid	gout	0	0	10.18	1	0	36	34	3045	122	probenecid	gout	0	0	35.73	1	0	11	17	1395	122	probenecid	gout	-13.14	1.96503598467308e-06	575.14	0.98	-0.01	0.01	0.06	-0.15	0.3	0.61
123	promethazine	4.67	4.51	4.85	0	3188	33845	174361	8652945	123	promethazine	pain	3.19	2.93	3.48	1.6e-119	632	4641	7837	183843	123	promethazine	pain	23	79	1.65	1.19	2.24	0.0021	46	938	1042	35079	123	promethazine	pain	1.35	0.57	2.74	0.4	8	250	356	15067	123	promethazine	pain	2.19	1.6	2.94	1.4e-06	51	746	806	25844	123	promethazine	pain	0.59	1.80398841539786	0.14	0	-0.02	0	0	-0.27	0.06	0
124	selenium sulfide	1.39	0.74	2.41	0.24	13	456	177536	8686334	124	selenium sulfide	hypertension	0	0	4.97	1	0	36	6895	317577	124	selenium sulfide	hypertension	38	82.9	0	0	54.1	1	0	6	981	62403	124	selenium sulfide	hypertension	0	0	223.89	1	0	3	341	31636	124	selenium sulfide	hypertension	0	0	126.83	1	0	3	762	39927	124	selenium sulfide	hypertension	-8.44	0.000216050150281479	130.52	0.95	-0.02	0	0	-0.59	0.07	0
125	phenylephrine	5.59	5.07	6.16	7.6e-176	463	4059	177086	8682731	125	phenylephrine	cataract operation	0	0	11.76	1	0	121	6	1657	125	phenylephrine	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	125	phenylephrine	cataract operation	0	0	Inf	1	0	8	0	93	125	phenylephrine	cataract operation	0	0	Inf	1	0	26	0	214	125	phenylephrine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
126	pyrilamine maleate	12.23	1.27	61.4	0.016	2	8	177547	8686782	126	pyrilamine maleate	intentional overdose	Inf	3.64	Inf	0.007	1	0	10	1560	126	pyrilamine maleate	intentional overdose	13	13	0	0	Inf	1	0	0	0	0	126	pyrilamine maleate	intentional overdose	0	0	Inf	1	0	0	0	82	126	pyrilamine maleate	intentional overdose	0	0	Inf	1	0	0	1	93	126	pyrilamine maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
127	edrophonium chloride	0	0	7.46	1	0	26	177549	8686764	127	edrophonium chloride	anaesthesia	0	0	121.9	1	0	5	60	6599	127	edrophonium chloride	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	127	edrophonium chloride	anaesthesia	0	0	Inf	1	0	0	1	387	127	edrophonium chloride	anaesthesia	0	0	Inf	1	0	0	10	485	127	edrophonium chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
129	iopanoic acid	0	0	41.55	1	0	6	177549	8686784	129	iopanoic acid	anxiety	0	0	282.13	1	0	1	11351	82476	129	iopanoic acid	anxiety	20	75	0	0	349.79	1	0	1	1918	17296	129	iopanoic acid	anxiety	0	0	367.08	1	0	1	654	6190	129	iopanoic acid	anxiety	0	0	Inf	1	0	0	1484	14290	129	iopanoic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
130	evans blue	0	0	260.7	1	0	2	177549	8686788	130	evans blue	cardiovascular disorder	0	0	2945.76	1	0	1	57	4512	130	evans blue	cardiovascular disorder	51.8	78.2	0	0	Inf	1	0	0	17	846	130	evans blue	cardiovascular disorder	0	0	Inf	1	0	0	5	590	130	evans blue	cardiovascular disorder	0	0	Inf	1	0	0	15	594	130	evans blue	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
131	methotrexate sodium	0.49	0.47	0.52	2.7e-278	2053	201315	175496	8485475	131	methotrexate sodium	rheumatoid arthritis	1.21	1.12	1.3	8.8e-07	994	116990	2416	343387	131	methotrexate sodium	rheumatoid arthritis	33	75	1.66	1.45	1.9	4.3e-13	315	23080	745	90858	131	methotrexate sodium	rheumatoid arthritis	1.58	1.12	2.19	0.0075	53	5318	127	20073	131	methotrexate sodium	rheumatoid arthritis	1.59	1.38	1.82	1.9e-10	288	21666	723	86298	131	methotrexate sodium	rheumatoid arthritis	0.47	1.59999419321736	0.06	0	-0.01	0	0	-0.26	0.08	0
132	chlorotrianisene	2.72	0.07	17.21	0.32	1	18	177548	8686772	132	chlorotrianisene	hepatic neoplasm malignant	0	0	333.52	1	0	10	13	8711	132	chlorotrianisene	hepatic neoplasm malignant	NA	NA	0	0	Inf	1	0	0	0	0	132	chlorotrianisene	hepatic neoplasm malignant	0	0	Inf	1	0	0	0	0	132	chlorotrianisene	hepatic neoplasm malignant	0	0	Inf	1	0	0	0	0	132	chlorotrianisene	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
133	leucovorin calcium	0.39	0.32	0.48	4.4e-27	98	12190	177451	8674600	133	leucovorin calcium	colorectal cancer metastatic	0.63	0.19	1.6	0.42	5	1958	42	10384	133	leucovorin calcium	colorectal cancer metastatic	38.8	74.6	0	0	15.36	1	0	24	21	1790	133	leucovorin calcium	colorectal cancer metastatic	0	0	27.61	1	0	16	14	1327	133	leucovorin calcium	colorectal cancer metastatic	0	0	43.25	1	0	10	11	931	133	leucovorin calcium	colorectal cancer metastatic	-13.14	1.96503598467308e-06	772.22	0.99	-0.02	0.01	0.08	-0.04	0.41	0.93
134	diphemanil methylsulfate	0	0	28.67	1	0	8	177549	8686782	134	diphemanil methylsulfate	atrial fibrillation	0	0	150.85	1	0	5	808	111404	134	diphemanil methylsulfate	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	134	diphemanil methylsulfate	atrial fibrillation	0	0	Inf	1	0	0	56	22073	134	diphemanil methylsulfate	atrial fibrillation	0	0	Inf	1	0	0	94	17933	134	diphemanil methylsulfate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
135	monobenzone	48.93	0.62	3699.96	0.04	1	1	177548	8686789	135	monobenzone	skin hyperpigmentation	49.14	0.44	5127.14	0.055	1	1	1	69	135	monobenzone	skin hyperpigmentation	NA	NA	0	0	Inf	1	0	0	0	0	135	monobenzone	skin hyperpigmentation	0	0	Inf	1	0	0	0	9	135	monobenzone	skin hyperpigmentation	0	0	Inf	1	0	0	0	18	135	monobenzone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
136	hydrocortisone acetate	1.4	1.13	1.73	0.0022	92	3205	177457	8683585	136	hydrocortisone acetate	prophylaxis	0.38	0.01	2.13	0.53	1	214	1278	103337	136	hydrocortisone acetate	prophylaxis	23.9	79.7	0	0	10.84	1	0	41	207	23619	136	hydrocortisone acetate	prophylaxis	0	0	22.32	1	0	30	82	13698	136	hydrocortisone acetate	prophylaxis	0	0	14.99	1	0	26	148	14386	136	hydrocortisone acetate	prophylaxis	-11.75	7.88932482720022e-06	318.81	0.97	-0.01	0	0.03	-0.52	0.14	0
137	mephentermine	0	0	118.34	1	0	3	177549	8686787	137	mephentermine	resuscitation	0	0	2975.01	1	0	1	1	79	137	mephentermine	resuscitation	21	21	0	0	Inf	1	0	0	0	0	137	mephentermine	resuscitation	0	0	Inf	1	0	0	0	2	137	mephentermine	resuscitation	0	0	Inf	1	0	0	1	7	137	mephentermine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
138	phentolamine mesylate	6.12	3.05	11.19	2e-06	12	96	177537	8686694	138	phentolamine mesylate	prophylaxis	81.17	18.67	352.81	6.4e-08	5	5	1274	103546	138	phentolamine mesylate	prophylaxis	23.9	79.7	0	0	275.81	1	0	3	207	23657	138	phentolamine mesylate	prophylaxis	0	0	406.52	1	0	3	82	13725	138	phentolamine mesylate	prophylaxis	0	0	Inf	1	0	0	148	14412	138	phentolamine mesylate	prophylaxis	-8.58	0.000187824977406354	309.02	0.98	-0.01	0	0.03	-0.52	0.14	0
139	hydralazine	2.43	2.25	2.63	1e-87	678	13680	176871	8673110	139	hydralazine	hypertension	1.57	1.26	1.93	5.5e-05	95	2802	6800	314811	139	hydralazine	hypertension	38	82.9	1.05	0.55	1.81	0.77	13	789	968	61620	139	hydralazine	hypertension	0.66	0.13	1.96	0.64	3	420	338	31219	139	hydralazine	hypertension	1.18	0.61	2.1	0.52	12	532	750	39398	139	hydralazine	hypertension	-0.03	0.970445533548508	0.26	0.89	-0.02	0	0	-0.59	0.07	0
140	codeine phosphate	1.15	1	1.31	0.04	226	9603	177323	8677187	140	codeine phosphate	pain	0.77	0.53	1.07	0.13	36	1042	8433	187442	140	codeine phosphate	pain	23	79	5.75	3.32	9.45	9e-09	19	111	1069	35906	140	codeine phosphate	pain	12.02	5.91	22.85	8.9e-10	13	47	351	15270	140	codeine phosphate	pain	2.6	1.01	5.62	0.024	7	84	850	26506	140	codeine phosphate	pain	1.82	6.17185844988355	0.24	0	-0.02	0	0	-0.28	0.06	0
141	primaquine phosphate	6.68	4.22	10.19	1.3e-12	25	183	177524	8686607	141	primaquine phosphate	pneumocystis jiroveci pneumonia	0	0	405.28	1	0	13	2	945	141	primaquine phosphate	pneumocystis jiroveci pneumonia	NA	NA	0	0	Inf	1	0	0	0	0	141	primaquine phosphate	pneumocystis jiroveci pneumonia	0	0	Inf	1	0	0	0	0	141	primaquine phosphate	pneumocystis jiroveci pneumonia	0	0	Inf	1	0	0	0	0	141	primaquine phosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
142	phenylbutazone	1.53	0.49	3.64	0.39	5	160	177544	8686630	142	phenylbutazone	ankylosing spondylitis	0	0	8.79	1	0	52	389	46270	142	phenylbutazone	ankylosing spondylitis	21.7	64	0	0	4170.4	1	0	1	109	12467	142	phenylbutazone	ankylosing spondylitis	0	0	4566.11	1	0	1	55	6933	142	phenylbutazone	ankylosing spondylitis	0	0	Inf	1	0	0	73	7839	142	phenylbutazone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
143	metharbital	0	0	260.7	1	0	2	177549	8686788	143	metharbital	epilepsy	0	0	2653.42	1	0	1	640	45425	143	metharbital	epilepsy	13.6	68.1	0	0	Inf	1	0	0	87	5314	143	metharbital	epilepsy	0	0	Inf	1	0	0	41	3552	143	metharbital	epilepsy	0	0	Inf	1	0	0	56	4184	143	metharbital	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
144	tyrosine	1.1	0.83	1.44	0.44	56	2481	177493	8684309	144	tyrosine	crohn s disease	0	0	1.03	0.056	0	357	1477	146955	144	tyrosine	crohn s disease	15.6	67	0	0	20.95	1	0	16	406	32678	144	tyrosine	crohn s disease	0	0	48.34	1	0	9	148	13989	144	tyrosine	crohn s disease	0	0	28.33	1	0	12	305	23885	144	tyrosine	crohn s disease	-10.12	4.02661255318714e-05	192.32	0.96	-0.01	0	0	-0.21	0.1	0.04
145	isoniazid	0.48	0.4	0.58	8.6e-18	111	11241	177438	8675549	145	isoniazid	tuberculosis	0.82	0.37	1.85	0.58	16	2458	13	1630	145	isoniazid	tuberculosis	23.8	59	0.63	0.09	3.73	0.71	3	366	4	305	145	isoniazid	tuberculosis	0.17	0	1.68	0.16	1	376	4	248	145	isoniazid	tuberculosis	2.26	0.18	119.4	0.64	3	290	1	219	145	isoniazid	tuberculosis	-0.54	0.58274825237399	0.68	0.43	-0.01	0.02	0.6	0.08	0.68	0.9
146	succinylcholine chloride	8.57	7.28	10.04	4.4e-97	182	1040	177367	8685750	146	succinylcholine chloride	anaesthesia	1.2	0.14	4.61	0.68	2	184	58	6420	146	succinylcholine chloride	anaesthesia	23	71.2	0	0	19.19	1	0	16	9	553	146	succinylcholine chloride	anaesthesia	0	0	1199.12	1	0	12	1	375	146	succinylcholine chloride	anaesthesia	0	0	38	1	0	7	10	478	146	succinylcholine chloride	anaesthesia	-13.79	1.02583873698201e-06	1423	0.99	0	0.01	0.91	-2.06	1.05	0.05
148	oxyphenonium bromide	48.93	0.62	3699.96	0.04	1	1	177548	8686789	148	oxyphenonium bromide	pain	Inf	0.57	Inf	0.043	1	0	8468	188484	148	oxyphenonium bromide	pain	23	79	0	0	Inf	1	0	0	1088	36017	148	oxyphenonium bromide	pain	0	0	Inf	1	0	0	364	15317	148	oxyphenonium bromide	pain	0	0	Inf	1	0	0	857	26590	148	oxyphenonium bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
149	hydrocortisone	1.58	1.48	1.68	3.2e-41	1039	32322	176510	8654468	149	hydrocortisone	premedication	1.17	0.87	1.53	0.27	60	2988	437	25374	149	hydrocortisone	premedication	13.8	73.2	0.43	0.17	0.91	0.026	7	601	136	5000	149	hydrocortisone	premedication	0.8	0.21	2.25	1	4	326	38	2481	149	hydrocortisone	premedication	0.56	0.22	1.21	0.16	7	405	110	3586	149	hydrocortisone	premedication	-0.5	0.606530659712633	0.32	0.12	0	0	0.24	-0.67	0.18	0
150	sulfamethizole	6.9	3.31	13.04	1.8e-06	11	78	177538	8686712	150	sulfamethizole	diffuse large b-cell lymphoma	0	0	3377.43	1	0	2	16	9452	150	sulfamethizole	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	0	0	1214	150	sulfamethizole	diffuse large b-cell lymphoma	0	0	Inf	1	0	0	2	1258	150	sulfamethizole	diffuse large b-cell lymphoma	0	0	Inf	1	0	0	0	1037	150	sulfamethizole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
151	pyrimethamine	0.19	0.05	0.5	2.5e-05	4	1011	177545	8685779	151	pyrimethamine	hiv infection	0	0	1.27	0.13	0	341	500	58050	151	pyrimethamine	hiv infection	25	64	0	0	16.7	1	0	16	120	7625	151	pyrimethamine	hiv infection	0	0	21.77	1	0	12	96	5716	151	pyrimethamine	hiv infection	0	0	45	1	0	9	40	3430	151	pyrimethamine	hiv infection	-11.34	1.18877749621577e-05	316.95	0.97	0	0.01	0.8	0.38	0.2	0.05
152	procaine	1.92	1.27	2.81	0.0015	28	712	177521	8686078	152	procaine	acne	1.46	0.36	4.41	0.52	4	19	4372	30385	152	procaine	acne	14.8	44.4	0	0	Inf	1	0	0	173	2824	152	procaine	acne	0	0	Inf	1	0	0	28	1131	152	procaine	acne	0	0	Inf	1	0	0	164	2394	152	procaine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
153	propoxycaine	0	0	118.34	1	0	3	177549	8686787	153	propoxycaine	gastrooesophageal reflux disease	0	0	996.42	1	0	1	2968	77027	153	propoxycaine	gastrooesophageal reflux disease	22.4	77.2	0	0	Inf	1	0	0	478	18697	153	propoxycaine	gastrooesophageal reflux disease	0	0	Inf	1	0	0	152	8083	153	propoxycaine	gastrooesophageal reflux disease	0	0	Inf	1	0	0	380	14389	153	propoxycaine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
154	levonordefrin	0	0	16.05	1	0	13	177549	8686777	154	levonordefrin	local anaesthesia	0	0	39.99	1	0	7	51	2863	154	levonordefrin	local anaesthesia	9	63.2	0	0	Inf	1	0	0	9	379	154	levonordefrin	local anaesthesia	0	0	Inf	1	0	0	0	223	154	levonordefrin	local anaesthesia	0	0	Inf	1	0	0	11	352	154	levonordefrin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
155	thyrotropin	0	0	3.16	0.63	0	59	177549	8686731	155	thyrotropin	diagnostic procedure	0	0	48.17	1	0	19	21	4365	155	thyrotropin	diagnostic procedure	43.1	71	0	0	Inf	1	0	0	6	1089	155	thyrotropin	diagnostic procedure	0	0	Inf	1	0	0	4	836	155	thyrotropin	diagnostic procedure	0	0	Inf	1	0	0	4	1172	155	thyrotropin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
156	nitrofurantoin	3.33	3.08	3.59	7.8e-150	699	10307	176850	8676483	156	nitrofurantoin	urinary tract infection	0.82	0.63	1.06	0.14	70	2163	679	17271	156	nitrofurantoin	urinary tract infection	22.2	73.2	0.44	0.24	0.77	0.0021	14	488	169	2610	156	nitrofurantoin	urinary tract infection	0.51	0.01	3.16	1	1	76	30	1164	156	nitrofurantoin	urinary tract infection	0.45	0.23	0.8	0.0042	13	551	161	3085	156	nitrofurantoin	urinary tract infection	-0.8	0.449328964117222	0.28	0	-0.03	0	0	-0.44	0.2	0.03
157	phenoxybenzamine	3.42	1.34	7.32	0.0059	7	100	177542	8686690	157	phenoxybenzamine	hypertension	4.61	0.52	18.97	0.079	2	20	6893	317593	157	phenoxybenzamine	hypertension	38	82.9	0	0	339.78	1	0	2	981	62407	157	phenoxybenzamine	hypertension	0	0	3424.95	1	0	1	341	31638	157	phenoxybenzamine	hypertension	0	0	1980.45	1	0	1	762	39929	157	phenoxybenzamine	hypertension	-7.48	0.000564257415572674	136.48	0.96	-0.02	0	0	-0.59	0.07	0
158	levorphanol tartrate	0	0	5.28	1	0	36	177549	8686754	158	levorphanol tartrate	nasopharyngitis	0	0	89.3	1	0	4	206	12117	158	levorphanol tartrate	nasopharyngitis	19.3	78	0	0	Inf	1	0	0	38	1655	158	levorphanol tartrate	nasopharyngitis	0	0	Inf	1	0	0	15	843	158	levorphanol tartrate	nasopharyngitis	0	0	Inf	1	0	0	29	1371	158	levorphanol tartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
159	propantheline bromide	1.36	0.28	4.08	0.49	3	108	177546	8686682	159	propantheline bromide	gastrooesophageal reflux disease	3.71	0.08	28.86	0.26	1	7	2967	77021	159	propantheline bromide	gastrooesophageal reflux disease	22.4	77.2	0	0	Inf	1	0	0	478	18697	159	propantheline bromide	gastrooesophageal reflux disease	0	0	Inf	1	0	0	152	8083	159	propantheline bromide	gastrooesophageal reflux disease	0	0	Inf	1	0	0	380	14389	159	propantheline bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
160	phenytoin	1.16	1.07	1.24	0.00013	750	31774	176799	8655016	160	phenytoin	convulsion	0.85	0.71	1.01	0.068	178	7093	516	17474	160	phenytoin	convulsion	25	66	1.63	0.16	9.41	0.63	2	56	6	274	160	phenytoin	convulsion	0.83	0.02	6.75	1	1	35	7	202	160	phenytoin	convulsion	1.09	0.02	11.3	1	1	66	4	289	160	phenytoin	convulsion	-0.15	0.860707976425058	0.78	0.85	0.01	0.01	0.35	0.9	0.58	0.12
161	phenindione	34.25	11.07	99.61	2.1e-08	7	10	177542	8686780	161	phenindione	acute coronary syndrome	Inf	121.17	Inf	3.5e-14	7	0	97	8358	161	phenindione	acute coronary syndrome	51.9	87.2	Inf	88.24	Inf	7.5e-12	6	0	20	1653	161	phenindione	acute coronary syndrome	0	0	Inf	1	0	0	9	1273	161	phenindione	acute coronary syndrome	Inf	44.45	Inf	4.5e-10	6	0	15	646	161	phenindione	acute coronary syndrome	20.43	745823846.807472	979.61	0.98	-0.01	0.02	0.68	-1.2	0.43	0
162	vitamin a	1.55	1.29	1.85	3.7e-06	130	4104	177419	8682686	162	vitamin a	hypertension	1.83	0.9	3.33	0.061	11	277	6884	317336	162	vitamin a	hypertension	38	82.9	0	0	4.5	1	0	54	981	62355	162	vitamin a	hypertension	0	0	30.57	1	0	13	341	31626	162	vitamin a	hypertension	0	0	4.02	1	0	50	762	39880	162	vitamin a	hypertension	-10.46	2.86602331662198e-05	110.21	0.92	-0.02	0	0	-0.59	0.07	0
163	riboflavin	1.56	1.22	1.96	3e-04	76	2385	177473	8684405	163	riboflavin	multiple sclerosis	1.84	0.79	3.7	0.089	8	224	8337	430133	163	riboflavin	multiple sclerosis	26.5	67	2.88	0.76	7.76	0.057	4	62	1300	57980	163	riboflavin	multiple sclerosis	0	0	30.43	1	0	9	235	14040	163	riboflavin	multiple sclerosis	2.51	0.66	6.74	0.084	4	68	1214	51781	163	riboflavin	multiple sclerosis	0.88	2.41089970641721	0.51	0.09	-0.01	0	0	-0.34	0.07	0
164	cryptenamine acetates	0	0	1852.91	1	0	1	177549	8686789	164	cryptenamine acetates	hypertension	0	0	1747.48	1	0	1	6895	317612	164	cryptenamine acetates	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	164	cryptenamine acetates	hypertension	0	0	Inf	1	0	0	341	31639	164	cryptenamine acetates	hypertension	0	0	Inf	1	0	0	762	39930	164	cryptenamine acetates	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
165	desoxycorticosterone pivalate	0	0	1852.91	1	0	1	177549	8686789	165	desoxycorticosterone pivalate		0	0	Inf	1	0	0	0	0	165	desoxycorticosterone pivalate		NA	NA	0	0	Inf	1	0	0	0	0	165	desoxycorticosterone pivalate		0	0	Inf	1	0	0	0	0	165	desoxycorticosterone pivalate		0	0	Inf	1	0	0	0	0	165	desoxycorticosterone pivalate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
166	rauwolfia serpentina root	0	0	74.11	1	0	4	177549	8686786	166	rauwolfia serpentina root	back pain	0	0	835	1	0	1	2401	52084	166	rauwolfia serpentina root	back pain	26	81	0	0	Inf	1	0	0	235	8850	166	rauwolfia serpentina root	back pain	0	0	Inf	1	0	0	87	4117	166	rauwolfia serpentina root	back pain	0	0	Inf	1	0	0	177	6068	166	rauwolfia serpentina root	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
167	methscopolamine bromide	7.88	5.13	11.71	4.7e-16	29	180	177520	8686610	167	methscopolamine bromide	acne	8.37	3.98	17.85	9.5e-09	18	15	4358	30389	167	methscopolamine bromide	acne	14.8	44.4	Inf	0.42	Inf	0.058	1	0	172	2824	167	methscopolamine bromide	acne	Inf	1.04	Inf	0.024	1	0	27	1131	167	methscopolamine bromide	acne	0	0	Inf	1	0	0	164	2394	167	methscopolamine bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
168	phensuximide	0	0	33.97	1	0	7	177549	8686783	168	phensuximide	convulsion	0	0	188.7	1	0	2	694	24565	168	phensuximide	convulsion	25	66	0	0	Inf	1	0	0	8	330	168	phensuximide	convulsion	0	0	Inf	1	0	0	8	237	168	phensuximide	convulsion	0	0	Inf	1	0	0	5	355	168	phensuximide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
169	alseroxylon	0	0	260.7	1	0	2	177549	8686788	169	alseroxylon	anxiety disorder	0	0	323.06	1	0	1	464	3862	169	alseroxylon	anxiety disorder	20.9	66.6	0	0	Inf	1	0	0	60	535	169	alseroxylon	anxiety disorder	0	0	Inf	1	0	0	13	315	169	alseroxylon	anxiety disorder	0	0	Inf	1	0	0	55	527	169	alseroxylon	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
171	theophylline	1.45	1.3	1.61	9.6e-11	352	11895	177197	8674895	171	theophylline	asthma	0.91	0.72	1.13	0.42	85	3084	2959	97290	171	theophylline	asthma	9	76	1.16	0.59	2.06	0.63	12	338	528	17178	171	theophylline	asthma	1.76	0.55	4.31	0.22	5	123	142	6135	171	theophylline	asthma	0.92	0.41	1.79	1	9	310	449	14252	171	theophylline	asthma	0.19	1.20924959765725	0.28	0.5	-0.02	0	0	-0.41	0.1	0
172	proparacaine	0.7	0.28	1.45	0.42	7	489	177542	8686301	172	proparacaine	diabetic retinal oedema	5.58	0.12	42.92	0.18	1	54	8	2415	172	proparacaine	diabetic retinal oedema	47.2	82.4	0	0	Inf	1	0	19	0	519	172	proparacaine	diabetic retinal oedema	0	0	987.4	1	0	14	1	359	172	proparacaine	diabetic retinal oedema	0	0	1013.31	1	0	10	1	263	172	proparacaine	diabetic retinal oedema	-13.78	1.03614858769009e-06	2187.59	0.99	0.01	0.05	0.84	-0.3	1.42	0.83
173	carbinoxamine maleate	3.42	1.61	6.48	0.0011	10	143	177539	8686647	173	carbinoxamine maleate	cough	3.77	0.09	26.61	0.25	1	10	377	14203	173	carbinoxamine maleate	cough	13.7	78	0	0	1432.32	1	0	1	83	3117	173	carbinoxamine maleate	cough	0	0	Inf	1	0	0	25	1592	173	carbinoxamine maleate	cough	0	0	187.49	1	0	2	69	2412	173	carbinoxamine maleate	cough	-11.33	1.20072490867864e-05	615.65	0.99	-0.01	0	0	-0.64	0.24	0.01
174	edetate calcium disodium	0	0	28.67	1	0	8	177549	8686782	174	edetate calcium disodium	status epilepticus	0	0	11738.85	1	0	1	5	1842	174	edetate calcium disodium	status epilepticus	73.8	73.8	0	0	Inf	1	0	0	0	0	174	edetate calcium disodium	status epilepticus	0	0	Inf	1	0	1	0	204	174	edetate calcium disodium	status epilepticus	0	0	Inf	1	0	0	1	245	174	edetate calcium disodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
175	acetazolamide	1.76	1.47	2.1	6.2e-09	128	3554	177421	8683236	175	acetazolamide	prophylaxis	0.5	0.01	2.83	0.73	1	162	1278	103389	175	acetazolamide	prophylaxis	23.9	79.7	0	0	17.55	1	0	26	207	23634	175	acetazolamide	prophylaxis	0	0	31.14	1	0	22	82	13706	175	acetazolamide	prophylaxis	0	0	19.92	1	0	20	148	14392	175	acetazolamide	prophylaxis	-10.79	2.06045218288883e-05	223.16	0.96	-0.01	0	0.02	-0.52	0.14	0
177	trimethaphan camsylate	0	0	260.7	1	0	2	177549	8686788	177	trimethaphan camsylate	dyspepsia	0	0	435.29	1	0	1	2308	25935	177	trimethaphan camsylate	dyspepsia	26	77.8	0	0	1329.19	1	0	1	143	4976	177	trimethaphan camsylate	dyspepsia	0	0	Inf	1	0	0	66	2315	177	trimethaphan camsylate	dyspepsia	0	0	1556.18	1	0	1	96	3925	177	trimethaphan camsylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
179	methoxsalen	2.34	1.11	4.39	0.014	10	209	177539	8686581	179	methoxsalen	psoriasis	0	0	23.66	1	0	23	1190	161668	179	methoxsalen	psoriasis	25	74.8	0	0	608.91	1	0	2	379	43523	179	methoxsalen	psoriasis	0	0	772.81	1	0	2	149	21342	179	methoxsalen	psoriasis	0	0	3668.84	1	0	1	274	27342	179	methoxsalen	psoriasis	-7.75	0.000430742540575688	187.13	0.97	0	0	0.71	-0.36	0.1	0
181	mercaptopurine	0.4	0.32	0.5	3.5e-21	81	9790	177468	8677000	181	mercaptopurine	crohn s disease	1.09	0.79	1.47	0.58	45	4132	1432	143180	181	mercaptopurine	crohn s disease	15.6	67	1.39	0.63	2.69	0.32	9	524	397	32170	181	mercaptopurine	crohn s disease	0.69	0.08	2.57	1	2	272	146	13726	181	mercaptopurine	crohn s disease	1.67	0.71	3.36	0.16	8	380	297	23517	181	mercaptopurine	crohn s disease	0.24	1.2712491503214	0.32	0.45	-0.01	0	0	-0.21	0.1	0.03
182	ethopropazine	24.45	2.21	170.65	0.0057	2	4	177547	8686786	182	ethopropazine	parkinson s disease	0	0	48.56	1	0	4	872	27920	182	ethopropazine	parkinson s disease	50.1	85.7	0	0	Inf	1	0	0	163	6498	182	ethopropazine	parkinson s disease	0	0	Inf	1	0	0	98	4132	182	ethopropazine	parkinson s disease	0	0	Inf	1	0	0	85	2997	182	ethopropazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
183	ergoloid mesylates	0.9	0.24	2.33	1	4	218	177545	8686572	183	ergoloid mesylates	hypertension	0.78	0.02	4.52	1	1	59	6894	317554	183	ergoloid mesylates	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	183	ergoloid mesylates	hypertension	0	0	3424.95	1	0	1	341	31638	183	ergoloid mesylates	hypertension	0	0	Inf	1	0	0	762	39930	183	ergoloid mesylates	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
184	piperazine citrate	0	0	118.34	1	0	3	177549	8686787	184	piperazine citrate	prophylaxis	0	0	3009.12	1	0	1	1279	103550	184	piperazine citrate	prophylaxis	23.9	79.7	0	0	Inf	1	0	0	207	23660	184	piperazine citrate	prophylaxis	0	0	Inf	1	0	0	82	13728	184	piperazine citrate	prophylaxis	0	0	Inf	1	0	0	148	14412	184	piperazine citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
185	reserpine	2.93	1.38	5.52	0.0032	10	167	177539	8686623	185	reserpine	hypertension	0	0	3.46	0.63	0	51	6895	317562	185	reserpine	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	185	reserpine	hypertension	0	0	3424.95	1	0	1	341	31638	185	reserpine	hypertension	0	0	Inf	1	0	0	762	39930	185	reserpine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
186	chlorpromazine	1.84	1.6	2.1	1.4e-16	230	6131	177319	8680659	186	chlorpromazine	schizophrenia	0.99	0.65	1.43	1	29	1156	1486	58368	186	chlorpromazine	schizophrenia	20.1	64.1	0.92	0.18	2.81	1	3	78	291	6936	186	chlorpromazine	schizophrenia	1.56	0.31	4.87	0.45	3	56	179	5206	186	chlorpromazine	schizophrenia	0	0	2.64	0.4	0	33	148	3262	186	chlorpromazine	schizophrenia	-0.1	0.90483741803596	0.59	0.87	-0.02	0	0	-0.31	0.11	0.01
187	testosterone enanthate	9.15	7.69	10.83	6.5e-91	163	872	177386	8685918	187	testosterone enanthate	androgen replacement therapy	25.91	19.16	35.27	3.6e-100	141	263	88	4263	187	testosterone enanthate	androgen replacement therapy	43	73.3	1.21	0.37	3.12	0.61	5	72	57	991	187	testosterone enanthate	androgen replacement therapy	1.51	0.57	3.45	0.33	7	82	63	1118	187	testosterone enanthate	androgen replacement therapy	0	0	Inf	1	0	0	0	2	187	testosterone enanthate	androgen replacement therapy	0.42	1.52196155561863	0.41	0.31	0.01	0.01	0.5	11.22	624.19	0.99
189	primidone	1.83	1.58	2.11	2.4e-14	196	5233	177353	8681557	189	primidone	epilepsy	0.94	0.38	1.97	1	7	526	633	44900	189	primidone	epilepsy	13.6	68.1	0	0	5.28	1	0	45	87	5269	189	primidone	epilepsy	0	0	14.9	1	0	24	41	3528	189	primidone	epilepsy	0	0	5.84	1	0	50	56	4134	189	primidone	epilepsy	-13.25	1.76034631215617e-06	459.66	0.98	0	0	0.54	-0.15	0.21	0.46
190	sulfisoxazole acetyl	0	0	4.99	1	0	38	177549	8686752	190	sulfisoxazole acetyl	pyrexia	0	0	79.61	1	0	6	182	16959	190	sulfisoxazole acetyl	pyrexia	13.2	74.9	0	0	Inf	1	0	0	22	2373	190	sulfisoxazole acetyl	pyrexia	0	0	16384	1	0	1	3	2079	190	sulfisoxazole acetyl	pyrexia	0	0	Inf	1	0	0	23	1902	190	sulfisoxazole acetyl	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
191	ethiodized oil	0	0	0.27	2.6e-06	0	668	177549	8686122	191	ethiodized oil	therapeutic embolisation	0	0	0.5	0.0032	0	272	5	123	191	ethiodized oil	therapeutic embolisation	77	77	0	0	Inf	1	0	0	0	0	191	ethiodized oil	therapeutic embolisation	0	0	3.6	0.085	0	65	1	5	191	ethiodized oil	therapeutic embolisation	0	0	Inf	1	0	37	0	4	191	ethiodized oil	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
192	benztropine mesylate	3.06	2.74	3.41	1e-68	355	5681	177194	8681109	192	benztropine mesylate	schizophrenia	1.1	0.78	1.51	0.55	40	1436	1475	58088	192	benztropine mesylate	schizophrenia	20.1	64.1	0.66	0.18	1.75	0.53	4	143	290	6871	192	benztropine mesylate	schizophrenia	0.82	0.16	2.49	1	3	106	179	5156	192	benztropine mesylate	schizophrenia	0.44	0.01	2.62	0.72	1	50	147	3245	192	benztropine mesylate	schizophrenia	-0.41	0.663650250136319	0.51	0.42	-0.02	0	0	-0.31	0.11	0.01
193	cryptenamine tannates	0	0	1852.91	1	0	1	177549	8686789	193	cryptenamine tannates	hypertension	0	0	1747.48	1	0	1	6895	317612	193	cryptenamine tannates	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	193	cryptenamine tannates	hypertension	0	0	Inf	1	0	0	341	31639	193	cryptenamine tannates	hypertension	0	0	Inf	1	0	0	762	39930	193	cryptenamine tannates	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
194	warfarin sodium	1.89	1.84	1.95	3.50786608547285e-322	4624	121052	172925	8565738	194	warfarin sodium	atrial fibrillation	2.81	2.41	3.29	2.4e-34	235	14168	573	97241	194	warfarin sodium	atrial fibrillation	49	86.6	0.64	0.2	1.53	0.45	5	2009	127	32617	194	warfarin sodium	atrial fibrillation	1.28	0.34	3.5	0.56	4	1247	52	20826	194	warfarin sodium	atrial fibrillation	0.66	0.18	1.75	0.53	4	1135	90	16798	194	warfarin sodium	atrial fibrillation	-0.11	0.895834135296528	0.36	0.77	-0.01	0	0	-0.76	0.17	0
195	progesterone	2.7	2.46	2.96	3.4e-79	502	9107	177047	8677683	195	progesterone	hormone replacement therapy	2.21	1.69	2.85	2.4e-08	68	1365	868	38504	195	progesterone	hormone replacement therapy	34.3	74	0.98	0.31	2.41	1	5	169	86	2837	195	progesterone	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	195	progesterone	hormone replacement therapy	1.29	0.44	3.06	0.47	6	188	50	2016	195	progesterone	hormone replacement therapy	0.27	1.30996445073325	0.44	0.54	-0.03	0.01	0	0.45	0.21	0.03
196	oxtriphylline	57.09	24.51	135.07	1.3e-17	14	12	177535	8686778	196	oxtriphylline	asthma	459.39	70.51	16384	5.2e-21	14	1	3030	100373	196	oxtriphylline	asthma	9	76	0	0	Inf	1	0	0	540	17516	196	oxtriphylline	asthma	0	0	Inf	1	0	0	147	6258	196	oxtriphylline	asthma	0	0	Inf	1	0	0	458	14562	196	oxtriphylline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
197	deslanoside	0	0	2.86	0.64	0	65	177549	8686725	197	deslanoside	prophylaxis	0	0	47.48	1	0	8	1279	103543	197	deslanoside	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	197	deslanoside	prophylaxis	0	0	5924.82	1	0	1	82	13727	197	deslanoside	prophylaxis	0	0	3585.07	1	0	1	148	14411	197	deslanoside	prophylaxis	-7.91	0.000367054580595098	227.88	0.97	-0.01	0	0.03	-0.52	0.14	0
198	propyliodone	0	0	1852.91	1	0	1	177549	8686789	198	propyliodone	atrial fibrillation	0	0	4960.68	1	0	1	808	111408	198	propyliodone	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	198	propyliodone	atrial fibrillation	0	0	Inf	1	0	0	56	22073	198	propyliodone	atrial fibrillation	0	0	Inf	1	0	0	94	17933	198	propyliodone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
200	iodipamide meglumine	0	0	41.55	1	0	6	177549	8686784	200	iodipamide meglumine	face and mouth x-ray	0	0	Inf	1	0	2	0	1	200	iodipamide meglumine	face and mouth x-ray	NA	NA	0	0	Inf	1	0	0	0	0	200	iodipamide meglumine	face and mouth x-ray	0	0	Inf	1	0	1	0	0	200	iodipamide meglumine	face and mouth x-ray	0	0	Inf	1	0	1	0	0	200	iodipamide meglumine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
201	digoxin	2.66	2.57	2.76	0	3163	58774	174386	8628016	201	digoxin	atrial fibrillation	4.09	3.51	4.76	8.8e-62	254	11221	554	100188	201	digoxin	atrial fibrillation	49	86.6	0.98	0.44	1.92	1	9	2416	123	32210	201	digoxin	atrial fibrillation	0.53	0.06	2.02	0.58	2	1435	54	20638	201	digoxin	atrial fibrillation	0.98	0.38	2.12	1	7	1356	87	16577	201	digoxin	atrial fibrillation	-0.15	0.860707976425058	0.34	0.66	-0.01	0	0	-0.76	0.17	0
202	betazole	0	0	1852.91	1	0	1	177549	8686789	202	betazole	drug abuse	0	0	2935.39	1	0	1	60	4732	202	betazole	drug abuse	21	60.4	0	0	Inf	1	0	0	19	951	202	betazole	drug abuse	0	0	Inf	1	0	0	17	587	202	betazole	drug abuse	0	0	Inf	1	0	0	8	675	202	betazole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
204	busulfan	0.14	0.08	0.21	6.3e-38	20	7092	177529	8679698	204	busulfan	stem cell transplant	0	0	2.43	0.31	0	2338	4	3741	204	busulfan	stem cell transplant	NA	NA	0	0	Inf	1	0	0	0	0	204	busulfan	stem cell transplant	0	0	Inf	1	0	100	0	311	204	busulfan	stem cell transplant	0	0	Inf	1	0	62	0	187	204	busulfan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
205	acetazolamide sodium	2.48	2.01	3.03	5.8e-15	100	1976	177449	8684814	205	acetazolamide sodium	prophylaxis	0.8	0.02	4.58	1	1	101	1278	103450	205	acetazolamide sodium	prophylaxis	23.9	79.7	0	0	26.19	1	0	18	207	23642	205	acetazolamide sodium	prophylaxis	0	0	44.21	1	0	16	82	13712	205	acetazolamide sodium	prophylaxis	0	0	32.24	1	0	13	148	14399	205	acetazolamide sodium	prophylaxis	-10.8	2.03995034111719e-05	268.49	0.97	-0.01	0	0.02	-0.52	0.14	0
207	estradiol valerate	1.08	0.66	1.67	0.72	20	908	177529	8685882	207	estradiol valerate	hormone replacement therapy	5.81	2.67	11.34	2.3e-05	10	74	926	39795	207	estradiol valerate	hormone replacement therapy	34.3	74	0	0	80.56	1	0	3	91	3003	207	estradiol valerate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	207	estradiol valerate	hormone replacement therapy	0	0	96.53	1	0	3	56	2201	207	estradiol valerate	hormone replacement therapy	-11.08	1.54176130119344e-05	509.48	0.98	-0.03	0.01	0	0.43	0.2	0.03
209	chloroprocaine	3.19	0.63	9.93	0.075	3	46	177546	8686744	209	chloroprocaine	anaesthesia	11.16	0.25	80.59	0.095	1	10	59	6594	209	chloroprocaine	anaesthesia	23	71.2	66.96	0.8	5265.68	0.031	1	1	8	568	209	chloroprocaine	anaesthesia	0	0	12213.02	1	0	1	1	386	209	chloroprocaine	anaesthesia	51.07	0.62	4049.23	0.04	1	1	9	484	209	chloroprocaine	anaesthesia	3.86	47.4653513688535	1.36	0	0	0.01	0.73	-2.12	1.07	0.05
210	acetyldigitoxin	0	0	74.11	1	0	4	177549	8686786	210	acetyldigitoxin	colorectal cancer metastatic	0	0	1417.21	1	0	2	47	12340	210	acetyldigitoxin	colorectal cancer metastatic	38.8	74.6	0	0	Inf	1	0	0	21	1814	210	acetyldigitoxin	colorectal cancer metastatic	0	0	Inf	1	0	0	14	1343	210	acetyldigitoxin	colorectal cancer metastatic	0	0	Inf	1	0	0	11	941	210	acetyldigitoxin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
212	cyclizine lactate	0	0	14.75	1	0	14	177549	8686776	212	cyclizine lactate	bone density decreased	0	0	17.1	1	0	3	258	1817	212	cyclizine lactate	bone density decreased	49.6	74.2	0	0	Inf	1	0	0	7	161	212	cyclizine lactate	bone density decreased	0	0	Inf	1	0	0	4	51	212	cyclizine lactate	bone density decreased	0	0	Inf	1	0	0	5	244	212	cyclizine lactate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
213	metaraminol bitartrate	16.74	8.18	32.15	2e-11	13	38	177536	8686752	213	metaraminol bitartrate	hypotension	54.31	6.12	647.67	2e-04	3	2	71	2592	213	metaraminol bitartrate	hypotension	25	69.3	0	0	Inf	1	0	0	3	378	213	metaraminol bitartrate	hypotension	0	0	Inf	1	0	0	2	333	213	metaraminol bitartrate	hypotension	0	0	Inf	1	0	0	3	375	213	metaraminol bitartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
214	glutethimide	0	0	13.64	1	0	15	177549	8686775	214	glutethimide	medication error	0	0	106.37	1	0	4	6	355	214	glutethimide	medication error	9	9	0	0	Inf	1	0	0	0	0	214	glutethimide	medication error	0	0	Inf	1	0	0	1	20	214	glutethimide	medication error	0	0	Inf	1	0	0	0	26	214	glutethimide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
215	diatrizoate sodium	2.65	1.68	4	3.5e-05	24	443	177525	8686347	215	diatrizoate sodium	computerised tomogram abdomen	3.92	0.97	11.7	0.027	4	87	25	2133	215	diatrizoate sodium	computerised tomogram abdomen	53	53	0	0	Inf	1	0	0	0	0	215	diatrizoate sodium	computerised tomogram abdomen	0	0	Inf	1	0	0	0	52	215	diatrizoate sodium	computerised tomogram abdomen	0	0	355.72	1	0	2	2	100	215	diatrizoate sodium	computerised tomogram abdomen	-17.65	2.16123700214543e-08	20670.46	1	0	0.04	0.99	-17.65	4053.81	1
216	methyprylon	0	0	1852.91	1	0	1	177549	8686789	216	methyprylon	NA	0	0	Inf	1	0	0	0	0	216	methyprylon	NA	NA	NA	0	0	Inf	1	0	0	0	0	216	methyprylon	NA	0	0	Inf	1	0	0	0	0	216	methyprylon	NA	0	0	Inf	1	0	0	0	0	216	methyprylon	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
217	meprobamate	1.07	0.79	1.43	0.6	48	2192	177501	8684598	217	meprobamate	ill-defined disorder	2.51	0.5	7.7	0.13	3	64	565	30216	217	meprobamate	ill-defined disorder	33.1	82	0	0	164.77	1	0	2	21	635	217	meprobamate	ill-defined disorder	0	0	Inf	1	0	0	11	272	217	meprobamate	ill-defined disorder	0	0	184.26	1	0	2	14	468	217	meprobamate	ill-defined disorder	-11.86	7.06752648464835e-06	1029.12	0.99	-0.01	0.01	0.37	0.32	0.41	0.43
219	prednisone	1.55	1.51	1.59	2.4e-219	6347	203245	171202	8483545	219	prednisone	rheumatoid arthritis	2.12	1.94	2.31	1.3e-56	654	46379	2756	413998	219	prednisone	rheumatoid arthritis	33	75	2.22	1.89	2.6	1.8e-20	198	10665	862	103273	219	prednisone	rheumatoid arthritis	1.66	1.06	2.51	0.022	27	2444	153	22947	219	prednisone	rheumatoid arthritis	2.22	1.88	2.61	2.4e-19	187	10010	824	97954	219	prednisone	rheumatoid arthritis	0.77	2.15976625378492	0.08	0	-0.01	0	0	-0.26	0.08	0
220	hydroxychloroquine	0.98	0.92	1.05	0.6	864	43070	176685	8643720	220	hydroxychloroquine	rheumatoid arthritis	1.46	1.28	1.65	3.2e-08	261	24796	3149	435581	220	hydroxychloroquine	rheumatoid arthritis	33	75	1.4	1.11	1.75	0.0042	87	6839	973	107099	220	hydroxychloroquine	rheumatoid arthritis	2.13	1.23	3.48	0.0051	18	1260	162	24131	220	hydroxychloroquine	rheumatoid arthritis	1.34	1.05	1.69	0.014	81	6580	930	101384	220	hydroxychloroquine	rheumatoid arthritis	0.37	1.44773461466332	0.11	0	-0.01	0	0	-0.25	0.08	0
222	procyclidine	2.89	2.36	3.5	8.1e-21	110	1863	177439	8684927	222	procyclidine	schizophrenia	1.4	0.9	2.09	0.12	25	705	1490	58819	222	procyclidine	schizophrenia	20.1	64.1	0.63	0.07	2.36	0.77	2	76	292	6938	222	procyclidine	schizophrenia	0.89	0.1	3.39	1	2	65	180	5197	222	procyclidine	schizophrenia	0	0	3.27	0.63	0	27	148	3268	222	procyclidine	schizophrenia	-0.42	0.657046819815057	0.72	0.55	-0.02	0	0	-0.31	0.11	0.01
223	pyridostigmine bromide	1.9	1.51	2.37	1.6e-07	82	2108	177467	8684682	223	pyridostigmine bromide	myasthenia gravis	7.2	3.43	16.9	7e-10	42	788	9	1216	223	pyridostigmine bromide	myasthenia gravis	56	69.5	0	0	84.67	1	0	46	1	99	223	pyridostigmine bromide	myasthenia gravis	0	0	87.32	1	0	62	1	138	223	pyridostigmine bromide	myasthenia gravis	0	0	4.79	0.55	0	95	3	185	223	pyridostigmine bromide	myasthenia gravis	-17.2	3.38949432619692e-08	2293.17	0.99	0.03	0.03	0.41	-0.99	1.18	0.4
225	hydrocortisone sodium succinate	1.32	1.1	1.56	0.003	132	4912	177417	8681878	225	hydrocortisone sodium succinate	premedication	0.75	0.43	1.21	0.28	17	1286	480	27076	225	hydrocortisone sodium succinate	premedication	13.8	73.2	0.17	0	0.99	0.045	1	220	142	5381	225	hydrocortisone sodium succinate	premedication	0.58	0.01	3.46	1	1	114	41	2693	225	hydrocortisone sodium succinate	premedication	0.66	0.13	2.02	0.63	3	153	114	3838	225	hydrocortisone sodium succinate	premedication	-0.5	0.606530659712633	0.51	0.33	0	0	0.29	-0.68	0.18	0
226	hydrocortisone cypionate	1.67	1.43	1.93	3.8e-10	180	5289	177369	8681501	226	hydrocortisone cypionate	premedication	0.95	0.57	1.51	1	19	1134	478	27228	226	hydrocortisone cypionate	premedication	13.8	73.2	0.19	0	1.07	0.064	1	204	142	5397	226	hydrocortisone cypionate	premedication	0.67	0.02	4.06	1	1	98	41	2709	226	hydrocortisone cypionate	premedication	0.69	0.14	2.12	0.8	3	146	114	3845	226	hydrocortisone cypionate	premedication	-0.42	0.657046819815057	0.51	0.41	0	0	0.29	-0.68	0.18	0
227	dyclonine	0	0	3	0.64	0	62	177549	8686728	227	dyclonine	drug abuse	0	0	2935.39	1	0	1	60	4732	227	dyclonine	drug abuse	21	60.4	0	0	Inf	1	0	0	19	951	227	dyclonine	drug abuse	0	0	Inf	1	0	0	17	587	227	dyclonine	drug abuse	0	0	Inf	1	0	0	8	675	227	dyclonine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
228	prednisolone	0.39	0.36	0.42	2.6e-188	714	88582	176835	8598208	228	prednisolone	rheumatoid arthritis	0.5	0.4	0.63	1e-11	82	21498	3328	438879	228	prednisolone	rheumatoid arthritis	33	75	0.93	0.55	1.48	0.91	18	2083	1042	111855	228	prednisolone	rheumatoid arthritis	0.18	0	1.03	0.071	1	755	179	24636	228	prednisolone	rheumatoid arthritis	1.16	0.72	1.77	0.48	22	2032	989	105932	228	prednisolone	rheumatoid arthritis	-0.02	0.980198673306755	0.21	0.93	-0.01	0	0	-0.26	0.08	0
230	ethchlorvynol	0	0	11.12	1	0	18	177549	8686772	230	ethchlorvynol	pain	0	0	18.9	1	0	6	8469	188478	230	ethchlorvynol	pain	23	79	0	0	Inf	1	0	0	1088	36017	230	ethchlorvynol	pain	0	0	Inf	1	0	0	364	15317	230	ethchlorvynol	pain	0	0	Inf	1	0	0	857	26590	230	ethchlorvynol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
231	diatrizoate meglumine	1.99	1.19	3.14	0.0083	19	468	177530	8686322	231	diatrizoate meglumine	computerised tomogram abdomen	5.04	1.47	13.91	0.0059	5	88	24	2132	231	diatrizoate meglumine	computerised tomogram abdomen	53	53	0	0	Inf	1	0	0	0	0	231	diatrizoate meglumine	computerised tomogram abdomen	0	0	Inf	1	0	0	0	52	231	diatrizoate meglumine	computerised tomogram abdomen	0	0	355.72	1	0	2	2	100	231	diatrizoate meglumine	computerised tomogram abdomen	-17.65	2.16123700214543e-08	20670.46	1	0	0.04	0.99	-17.65	4053.81	1
232	fludrocortisone acetate	3.81	3.3	4.38	8.8e-56	213	2736	177336	8684054	232	fludrocortisone acetate	pain	3.85	2.39	5.97	1.6e-07	24	139	8445	188345	232	fludrocortisone acetate	pain	23	79	3.55	0.69	11.53	0.062	3	28	1085	35989	232	fludrocortisone acetate	pain	2.63	0.06	17.04	0.33	1	16	363	15301	232	fludrocortisone acetate	pain	3.27	0.37	13.59	0.14	2	19	855	26571	232	fludrocortisone acetate	pain	1.06	2.88637098926796	0.61	0.08	-0.02	0	0	-0.28	0.06	0
233	amphetamine resin complex	0	0	74.11	1	0	4	177549	8686786	233	amphetamine resin complex	attention deficit/hyperactivity disorder	0	0	117.35	1	0	2	2062	45423	233	amphetamine resin complex	attention deficit/hyperactivity disorder	7	57	0	0	Inf	1	0	0	421	7931	233	amphetamine resin complex	attention deficit/hyperactivity disorder	0	0	Inf	1	0	0	233	6058	233	amphetamine resin complex	attention deficit/hyperactivity disorder	0	0	Inf	1	0	0	257	3542	233	amphetamine resin complex	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
234	dextroamphetamine resin complex	0	0	1852.91	1	0	1	177549	8686789	234	dextroamphetamine resin complex	NA	0	0	Inf	1	0	0	0	0	234	dextroamphetamine resin complex	NA	NA	NA	0	0	Inf	1	0	0	0	0	234	dextroamphetamine resin complex	NA	0	0	Inf	1	0	0	0	0	234	dextroamphetamine resin complex	NA	0	0	Inf	1	0	0	0	0	234	dextroamphetamine resin complex	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
235	phytonadione	1.62	1.27	2.04	0.00014	74	2233	177475	8684557	235	phytonadione	prophylaxis	1.55	0.42	4.04	0.34	4	209	1275	103342	235	phytonadione	prophylaxis	23.9	79.7	0	0	15.61	1	0	29	207	23631	235	phytonadione	prophylaxis	0	0	32.74	1	0	21	82	13707	235	phytonadione	prophylaxis	0	0	25.5	1	0	16	148	14396	235	phytonadione	prophylaxis	-10.73	2.18786343020052e-05	237.88	0.96	-0.01	0	0.03	-0.52	0.14	0
236	phenytoin sodium	1.51	1.39	1.64	4.5e-22	640	20745	176909	8666045	236	phenytoin sodium	convulsion	1.03	0.85	1.23	0.78	155	5369	539	19198	236	phenytoin sodium	convulsion	25	66	2.71	0.26	15.91	0.22	2	36	6	294	236	phenytoin sodium	convulsion	1.73	0.04	14.78	0.48	1	18	7	219	236	phenytoin sodium	convulsion	2.21	0.04	23.12	0.42	1	36	4	319	236	phenytoin sodium	convulsion	0.56	1.7506725002961	0.79	0.48	0.01	0.01	0.42	0.92	0.58	0.11
237	ambenonium chloride	0	0	1.2	0.08	0	152	177549	8686638	237	ambenonium chloride	myasthenia gravis	0	0	2.1	0.42	0	71	51	1933	237	ambenonium chloride	myasthenia gravis	56	69.5	0	0	Inf	1	0	0	1	145	237	ambenonium chloride	myasthenia gravis	0	0	2474.52	1	0	3	1	197	237	ambenonium chloride	myasthenia gravis	0	0	303.41	1	0	3	3	277	237	ambenonium chloride	myasthenia gravis	-13.61	1.22815194767781e-06	2603.64	1	0.02	0.03	0.44	-0.96	1.18	0.42
238	methylphenidate	2.08	1.98	2.18	3.5e-162	1791	42409	175758	8644381	238	methylphenidate	attention deficit/hyperactivity disorder	0.64	0.58	0.71	8.1e-20	604	17771	1458	27654	238	methylphenidate	attention deficit/hyperactivity disorder	7	57	0.75	0.6	0.94	0.012	113	2596	308	5335	238	methylphenidate	attention deficit/hyperactivity disorder	0.92	0.69	1.22	0.58	78	2140	155	3918	238	methylphenidate	attention deficit/hyperactivity disorder	0.63	0.45	0.86	0.0027	53	1037	204	2505	238	methylphenidate	attention deficit/hyperactivity disorder	-0.19	0.826959133943362	0.11	0.08	0.01	0	0	-0.48	0.1	0
239	prednisolone acetate	1.34	1.1	1.61	0.0031	114	4165	177435	8682625	239	prednisolone acetate	cataract operation	0	0	3.51	0.6	0	348	6	1430	239	prednisolone acetate	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	239	prednisolone acetate	cataract operation	0	0	Inf	1	0	12	0	89	239	prednisolone acetate	cataract operation	0	0	Inf	1	0	31	0	209	239	prednisolone acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
240	mecamylamine	0	0	260.7	1	0	2	177549	8686788	240	mecamylamine	autism	0	0	1188.42	1	0	1	62	1924	240	mecamylamine	autism	6	36.2	0	0	Inf	1	0	0	6	379	240	mecamylamine	autism	0	0	Inf	1	0	0	7	383	240	mecamylamine	autism	0	0	Inf	1	0	0	2	57	240	mecamylamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
241	hydroxyprogesterone caproate	0.3	0.16	0.5	4.2e-08	14	2294	177535	8684496	241	hydroxyprogesterone caproate	premature delivery	Inf	0.05	Inf	1	8	970	0	28	241	hydroxyprogesterone caproate	premature delivery	28.3	28.3	0	0	Inf	1	0	0	0	0	241	hydroxyprogesterone caproate	premature delivery	0	0	Inf	1	0	0	0	2	241	hydroxyprogesterone caproate	premature delivery	Inf	0	Inf	1	1	146	0	4	241	hydroxyprogesterone caproate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
242	promazine	1.49	0.84	2.44	0.12	16	527	177533	8686263	242	promazine	schizophrenia	1.46	0.17	5.53	0.41	2	54	1513	59470	242	promazine	schizophrenia	20.1	64.1	0	0	16.6	1	0	7	294	7007	242	promazine	schizophrenia	0	0	20.17	1	0	7	182	5255	242	promazine	schizophrenia	0	0	Inf	1	0	0	148	3295	242	promazine	schizophrenia	-11.17	1.40906373340503e-05	332.51	0.97	-0.02	0	0	-0.31	0.11	0.01
243	clidinium bromide	4.31	3.66	5.04	5.8e-52	172	1955	177377	8684835	243	clidinium bromide	crohn s disease	0	0	1.8	0.28	0	206	1477	147106	243	clidinium bromide	crohn s disease	15.6	67	0	0	5.71	1	0	54	406	32640	243	clidinium bromide	crohn s disease	0	0	66.15	1	0	7	148	13991	243	clidinium bromide	crohn s disease	0	0	6.02	1	0	50	305	23847	243	clidinium bromide	crohn s disease	-11.13	1.4665687152517e-05	192.63	0.95	-0.01	0	0	-0.21	0.1	0.03
244	epinephrine bitartrate	3.44	2.7	4.34	5.8e-19	77	1094	177472	8685696	244	epinephrine bitartrate	musculoskeletal pain	0	0	0.43	0.00038	0	262	208	6285	244	epinephrine bitartrate	musculoskeletal pain	21	75	0	0	Inf	1	0	0	30	986	244	epinephrine bitartrate	musculoskeletal pain	0	0	Inf	1	0	0	11	542	244	epinephrine bitartrate	musculoskeletal pain	0	0	Inf	1	0	0	25	758	244	epinephrine bitartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
245	liothyronine sodium	3.54	3.13	4	6.9e-67	282	3902	177267	8682888	245	liothyronine sodium	hypothyroidism	1.68	1.24	2.23	6e-04	53	845	2032	54446	245	liothyronine sodium	hypothyroidism	28	82.3	1.48	0.58	3.14	0.34	7	178	333	12498	245	liothyronine sodium	hypothyroidism	0	0	6.95	1	0	27	57	2626	245	liothyronine sodium	hypothyroidism	1.6	0.63	3.41	0.22	7	161	316	11613	245	liothyronine sodium	hypothyroidism	0.27	1.30996445073325	0.39	0.49	-0.02	0	0	-0.25	0.15	0.09
246	hydroxyzine	2.6	2.48	2.73	8.1e-244	1688	31923	175861	8654867	246	hydroxyzine	depression	1.6	1.41	1.8	6.4e-13	302	2554	14069	190231	246	hydroxyzine	depression	21	73.3	1.31	0.91	1.82	0.13	39	412	2023	27930	246	hydroxyzine	depression	0.8	0.31	1.7	0.72	7	143	630	10304	246	hydroxyzine	depression	1.49	1.01	2.12	0.034	35	346	1636	24038	246	hydroxyzine	depression	0.26	1.29693008666577	0.16	0.12	-0.01	0	0	-0.14	0.05	0
247	levallorphan tartrate	0	0	28.67	1	0	8	177549	8686782	247	levallorphan tartrate	crohn s disease	0	0	526.65	1	0	2	1477	147310	247	levallorphan tartrate	crohn s disease	15.6	67	0	0	2993.7	1	0	1	406	32693	247	levallorphan tartrate	crohn s disease	0	0	Inf	1	0	0	148	13998	247	levallorphan tartrate	crohn s disease	0	0	2916.48	1	0	1	305	23896	247	levallorphan tartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
248	phenmetrazine	0	0	16.05	1	0	13	177549	8686777	248	phenmetrazine	headache	0	0	56.48	1	0	3	1294	30152	248	phenmetrazine	headache	18	65	0	0	Inf	1	0	0	184	4571	248	phenmetrazine	headache	0	0	Inf	1	0	0	46	1722	248	phenmetrazine	headache	0	0	Inf	1	0	0	162	4626	248	phenmetrazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
249	anileridine phosphate	0	0	1852.91	1	0	1	177549	8686789	249	anileridine phosphate	schizoaffective disorder	0	0	1159.23	1	0	1	298	9020	249	anileridine phosphate	schizoaffective disorder	22.3	64.6	0	0	Inf	1	0	0	67	1303	249	anileridine phosphate	schizoaffective disorder	0	0	Inf	1	0	0	31	839	249	anileridine phosphate	schizoaffective disorder	0	0	Inf	1	0	0	44	684	249	anileridine phosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
251	prednisolone tebutate	0	0	260.7	1	0	2	177549	8686788	251	prednisolone tebutate	rheumatoid arthritis	0	0	4865.13	1	0	1	3410	460376	251	prednisolone tebutate	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	251	prednisolone tebutate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	251	prednisolone tebutate	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	251	prednisolone tebutate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
252	prochlorperazine maleate	3.75	3.58	3.93	0	1959	25775	175590	8661015	252	prochlorperazine maleate	nausea	1	0.85	1.17	1	200	4965	1024	25443	252	prochlorperazine maleate	nausea	17.2	77	0.95	0.64	1.38	0.85	35	1290	183	6402	252	prochlorperazine maleate	nausea	1.82	0.93	3.41	0.053	16	686	34	2655	252	prochlorperazine maleate	nausea	0.77	0.47	1.21	0.29	22	795	173	4799	252	prochlorperazine maleate	nausea	0.2	1.22140275816017	0.18	0.26	-0.03	0	0	-0.78	0.16	0
253	anileridine	0	0	74.11	1	0	4	177549	8686786	253	anileridine	non-small cell lung cancer	0	0	1013.93	1	0	2	173	33925	253	anileridine	non-small cell lung cancer	43.2	79.8	0	0	Inf	1	0	0	26	5358	253	anileridine	non-small cell lung cancer	0	0	Inf	1	0	0	15	3373	253	anileridine	non-small cell lung cancer	0	0	Inf	1	0	0	15	2840	253	anileridine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
254	methsuximide	0.6	0.01	3.42	1	1	82	177548	8686708	254	methsuximide	convulsion	0	0	8.59	1	0	17	694	24550	254	methsuximide	convulsion	25	66	0	0	Inf	1	0	0	8	330	254	methsuximide	convulsion	0	0	Inf	1	0	0	8	237	254	methsuximide	convulsion	0	0	Inf	1	0	0	5	355	254	methsuximide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
256	fluoxymesterone	13.6	7.84	22.57	2.3e-15	20	72	177529	8686718	256	fluoxymesterone	drug abuser	0	0	5256.27	1	0	1	6	880	256	fluoxymesterone	drug abuser	52	52	0	0	Inf	1	0	0	0	0	256	fluoxymesterone	drug abuser	0	0	Inf	1	0	0	1	5	256	fluoxymesterone	drug abuser	0	0	Inf	1	0	0	0	11	256	fluoxymesterone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
257	orphenadrine	5.52	4.55	6.63	4.2e-49	127	1127	177422	8685663	257	orphenadrine	pain	2.85	1.58	4.82	4e-04	16	125	8453	188359	257	orphenadrine	pain	23	79	5.03	1.53	13.01	0.0048	5	33	1083	35984	257	orphenadrine	pain	0	0	21.4	1	0	9	364	15308	257	orphenadrine	pain	5.99	1.79	15.91	0.0025	5	26	852	26564	257	orphenadrine	pain	1.45	4.26311451516882	0.48	0	-0.02	0	0	-0.28	0.06	0
259	chlorambucil	0.47	0.3	0.69	2.7e-05	25	2611	177524	8684179	259	chlorambucil	chronic lymphocytic leukaemia	1.34	0.47	3.07	0.46	6	1393	66	20466	259	chlorambucil	chronic lymphocytic leukaemia	50.7	85	1.8	0.35	5.85	0.25	3	419	28	7023	259	chlorambucil	chronic lymphocytic leukaemia	1.45	0.16	5.91	0.65	2	305	23	5082	259	chlorambucil	chronic lymphocytic leukaemia	2.12	0.05	15.5	0.4	1	149	9	2850	259	chlorambucil	chronic lymphocytic leukaemia	0.56	1.7506725002961	0.61	0.36	-0.02	0.01	0.16	0.31	0.38	0.41
260	tolbutamide	0.31	0.06	0.91	0.031	3	473	177546	8686317	260	tolbutamide	diabetes mellitus	0	0	3.4	0.63	0	115	2327	242783	260	tolbutamide	diabetes mellitus	39.3	82	0	0	211.52	1	0	4	377	52480	260	tolbutamide	diabetes mellitus	0	0	323.68	1	0	4	140	29740	260	tolbutamide	diabetes mellitus	0	0	3688.62	1	0	1	281	28201	260	tolbutamide	diabetes mellitus	-8.46	0.000211772070673631	237.59	0.97	-0.01	0	0	-0.75	0.1	0
261	mepenzolate bromide	3.86	0.76	12.17	0.049	3	38	177546	8686752	261	mepenzolate bromide	prophylaxis	0	0	56.24	1	0	7	1279	103544	261	mepenzolate bromide	prophylaxis	23.9	79.7	0	0	79.7	1	0	7	207	23653	261	mepenzolate bromide	prophylaxis	0	0	406.52	1	0	3	82	13725	261	mepenzolate bromide	prophylaxis	0	0	147.81	1	0	4	148	14408	261	mepenzolate bromide	prophylaxis	-9.94	4.82073046323988e-05	332.21	0.98	-0.01	0	0.03	-0.52	0.14	0
263	meclizine	4.22	3.93	4.53	3.4e-243	851	9903	176698	8676887	263	meclizine	pain	3.12	2.57	3.77	1.8e-25	127	914	8342	187570	263	meclizine	pain	23	79	0.69	0.22	1.63	0.57	5	241	1083	35776	263	meclizine	pain	0.6	0.01	3.48	1	1	70	363	15247	263	meclizine	pain	0.93	0.33	2.06	1	6	201	851	26389	263	meclizine	pain	-0.05	0.951229424500714	0.38	0.89	-0.02	0	0	-0.28	0.06	0
264	prochlorperazine edisylate	3.75	3.58	3.93	0	1959	25775	175590	8661015	264	prochlorperazine edisylate	nausea	1	0.85	1.17	1	200	4965	1024	25443	264	prochlorperazine edisylate	nausea	17.2	77	0.95	0.64	1.38	0.85	35	1290	183	6402	264	prochlorperazine edisylate	nausea	1.82	0.93	3.41	0.053	16	686	34	2655	264	prochlorperazine edisylate	nausea	0.77	0.47	1.21	0.29	22	795	173	4799	264	prochlorperazine edisylate	nausea	0.2	1.22140275816017	0.18	0.26	-0.03	0	0	-0.78	0.16	0
265	isopropamide iodide	0	0	17.61	1	0	12	177549	8686778	265	isopropamide iodide	menopausal symptoms	0	0	46.85	1	0	3	290	5594	265	isopropamide iodide	menopausal symptoms	43	61	0	0	Inf	1	0	0	18	398	265	isopropamide iodide	menopausal symptoms	0	0	Inf	1	0	0	0	4	265	isopropamide iodide	menopausal symptoms	0	0	Inf	1	0	0	22	655	265	isopropamide iodide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
266	polyestradiol phosphate	4.89	0.11	34.41	0.2	1	10	177548	8686780	266	polyestradiol phosphate	prostate cancer	0	0	71.67	1	0	7	444	45744	266	polyestradiol phosphate	prostate cancer	56.9	87.4	0	0	Inf	1	0	0	102	12804	266	polyestradiol phosphate	prostate cancer	0	0	Inf	1	0	0	114	14676	266	polyestradiol phosphate	prostate cancer	0	0	Inf	1	0	0	0	51	266	polyestradiol phosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
267	perphenazine	2.08	1.66	2.58	1.9e-09	86	2021	177463	8684769	267	perphenazine	schizophrenia	0.94	0.4	1.87	1	8	335	1507	59189	267	perphenazine	schizophrenia	20.1	64.1	0	0	4.59	1	0	21	294	6993	267	perphenazine	schizophrenia	0	0	7.54	1	0	16	182	5246	267	perphenazine	schizophrenia	0	0	8.07	1	0	12	148	3283	267	perphenazine	schizophrenia	-12.28	4.64369580069689e-06	273.16	0.96	-0.02	0	0	-0.31	0.11	0.01
268	iron dextran	3.45	2.6	4.51	9.8e-15	58	822	177491	8685968	268	iron dextran	anaemia	5.52	3.34	8.73	1.2e-09	22	172	446	19238	268	iron dextran	anaemia	22.2	83.9	8.01	0.18	59.53	0.13	1	9	56	4041	268	iron dextran	anaemia	0	0	326.52	1	0	6	6	1860	268	iron dextran	anaemia	7.81	0.17	66.08	0.14	1	6	58	2725	268	iron dextran	anaemia	1.77	5.8708533613826	1.08	0.1	-0.01	0.01	0.18	-1.86	0.43	0
269	deserpidine	6.12	0.14	45.61	0.17	1	8	177548	8686782	269	deserpidine	rheumatoid arthritis	0	0	324.65	1	0	3	3410	460374	269	deserpidine	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	269	deserpidine	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	269	deserpidine	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	269	deserpidine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
270	brompheniramine maleate	0.88	0.18	2.61	1	3	167	177546	8686623	270	brompheniramine maleate	hypersensitivity	0	0	6.12	1	0	17	1361	34336	270	brompheniramine maleate	hypersensitivity	15.2	73.8	0	0	1428.87	1	0	1	209	7831	270	brompheniramine maleate	hypersensitivity	0	0	Inf	1	0	0	54	2916	270	brompheniramine maleate	hypersensitivity	0	0	1497.56	1	0	1	179	7037	270	brompheniramine maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
271	ethotoin	1.75	0.04	10.57	0.44	1	28	177548	8686762	271	ethotoin	epilepsy	0	0	41.66	1	0	8	640	45418	271	ethotoin	epilepsy	13.6	68.1	0	0	Inf	1	0	0	87	5314	271	ethotoin	epilepsy	0	0	Inf	1	0	0	41	3552	271	ethotoin	epilepsy	0	0	Inf	1	0	0	56	4184	271	ethotoin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
272	norethindrone	4.38	3.97	4.81	1.9e-138	462	5176	177087	8681614	272	norethindrone	contraception	3.57	3.02	4.19	2.7e-41	180	953	7821	147681	272	norethindrone	contraception	19	43	1.78	0.98	3.01	0.041	16	127	1699	23954	272	norethindrone	contraception	0	0	Inf	1	0	0	0	22	272	norethindrone	contraception	1.37	0.76	2.29	0.23	16	175	1923	28730	272	norethindrone	contraception	0.31	1.36342511413218	0.26	0.24	0	0	0.97	-10.86	114.15	0.92
273	anisindione	0	0	24.79	1	0	9	177549	8686781	273	anisindione	atrial fibrillation	0	0	116.95	1	0	6	808	111403	273	anisindione	atrial fibrillation	49	86.6	0	0	224.53	1	0	6	132	34620	273	anisindione	atrial fibrillation	0	0	437.73	1	0	5	56	22068	273	anisindione	atrial fibrillation	0	0	6665.5	1	0	1	94	17932	273	anisindione	atrial fibrillation	-8.85	0.000143381736276293	357.94	0.98	-0.01	0	0	-0.76	0.17	0
274	buclizine	0	0	3.6	0.63	0	52	177549	8686738	274	buclizine	antiallergic therapy	0	0	1227.15	1	0	1	25	801	274	buclizine	antiallergic therapy	9.6	49.1	0	0	Inf	1	0	0	2	82	274	buclizine	antiallergic therapy	0	0	Inf	1	0	0	2	104	274	buclizine	antiallergic therapy	0	0	Inf	1	0	0	2	167	274	buclizine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
275	sodium phosphate p-32	0	0	1852.91	1	0	1	177549	8686789	275	sodium phosphate p-32	haemophilic arthritis	0	0	Inf	1	0	1	0	3	275	sodium phosphate p-32	haemophilic arthritis	NA	NA	0	0	Inf	1	0	0	0	0	275	sodium phosphate p-32	haemophilic arthritis	0	0	Inf	1	0	0	0	0	275	sodium phosphate p-32	haemophilic arthritis	0	0	Inf	1	0	0	0	0	275	sodium phosphate p-32	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
276	sodium iodide i-131	0.06	0	0.35	4.5e-06	1	778	177548	8686012	276	sodium iodide i-131	basedow s disease	0	0	0.63	0.0063	0	272	34	1495	276	sodium iodide i-131	basedow s disease	31.3	77.1	0	0	1134.9	1	0	1	8	236	276	sodium iodide i-131	basedow s disease	0	0	681.67	1	0	3	1	52	276	sodium iodide i-131	basedow s disease	0	0	Inf	1	0	0	9	255	276	sodium iodide i-131	basedow s disease	-12.78	2.81654387750147e-06	1384.47	0.99	0	0.02	0.8	-0.57	1.08	0.6
277	mestranol	3.53	1.85	6.2	0.00016	13	180	177536	8686610	277	mestranol	hormone replacement therapy	6.09	0.13	47.51	0.17	1	7	935	39862	277	mestranol	hormone replacement therapy	34.3	74	0	0	Inf	1	0	0	91	3006	277	mestranol	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	277	mestranol	hormone replacement therapy	0	0	1499	1	0	1	56	2203	277	mestranol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
278	norethynodrel	0	0	33.97	1	0	7	177549	8686783	278	norethynodrel	asthma	0	0	175.68	1	0	2	3044	100372	278	norethynodrel	asthma	9	76	0	0	Inf	1	0	0	540	17516	278	norethynodrel	asthma	0	0	Inf	1	0	0	147	6258	278	norethynodrel	asthma	0	0	Inf	1	0	0	458	14562	278	norethynodrel	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
279	propoxyphene	5.12	4.91	5.34	0	2454	23701	175095	8663089	279	propoxyphene	pain	1.81	1.64	2	8.8e-29	462	5808	8007	182676	279	propoxyphene	pain	23	79	5.92	2.8	11.38	8.8e-06	11	62	1077	35955	279	propoxyphene	pain	0	0	16.82	1	0	11	364	15306	279	propoxyphene	pain	6.78	3.5	12.26	1.4e-07	14	65	843	26525	279	propoxyphene	pain	1.67	5.31216779718117	0.3	0	-0.02	0	0	-0.27	0.06	0
280	methocarbamol	4.38	4.05	4.73	6.9e-211	708	7941	176841	8678849	280	methocarbamol	pain	2.39	2	2.84	4e-19	147	1382	8322	187102	280	methocarbamol	pain	23	79	2.15	1.39	3.19	0.00056	27	422	1061	35595	280	methocarbamol	pain	2.1	0.66	5.1	0.1	5	101	359	15216	280	methocarbamol	pain	2.22	1.4	3.39	0.00064	24	340	833	26250	280	methocarbamol	pain	0.74	2.09593551449436	0.19	0	-0.02	0	0	-0.28	0.06	0
281	prednisolone sodium phosphate	0.63	0.31	1.14	0.14	11	851	177538	8685939	281	prednisolone sodium phosphate	rheumatoid arthritis	0	0	4.52	1	0	112	3410	460265	281	prednisolone sodium phosphate	rheumatoid arthritis	33	75	0	0	42.88	1	0	11	1060	113927	281	prednisolone sodium phosphate	rheumatoid arthritis	0	0	737.25	1	0	2	180	25389	281	prednisolone sodium phosphate	rheumatoid arthritis	0	0	38.5	1	0	12	1011	107952	281	prednisolone sodium phosphate	rheumatoid arthritis	-8.93	0.000132358024529944	142.84	0.95	-0.01	0	0	-0.26	0.08	0
283	niacin	0.79	0.74	0.85	3.6e-11	761	47010	176788	8639780	283	niacin	blood cholesterol increased	0.31	0.24	0.38	6.9e-34	75	9545	2181	84683	283	niacin	blood cholesterol increased	39.3	79.8	0.77	0.21	2.02	0.82	4	299	289	16679	283	niacin	blood cholesterol increased	0.41	0.01	2.38	0.73	1	172	92	6517	283	niacin	blood cholesterol increased	1.08	0.22	3.25	0.76	3	149	231	12345	283	niacin	blood cholesterol increased	-0.26	0.771051585803566	0.51	0.6	-0.03	0	0	-0.27	0.12	0.03
284	triprolidine	2.64	1.72	3.88	1.3e-05	27	501	177522	8686289	284	triprolidine	pain	0.86	0.1	3.25	1	2	52	8467	188432	284	triprolidine	pain	23	79	0	0	16.79	1	0	9	1088	36008	284	triprolidine	pain	0	0	224.46	1	0	2	364	15315	284	triprolidine	pain	0	0	21.56	1	0	7	857	26583	284	triprolidine	pain	-9.13	0.000108365585099315	107.92	0.93	-0.02	0	0	-0.28	0.06	0
285	triflupromazine	0	0	24.79	1	0	9	177549	8686781	285	triflupromazine	schizophrenia	0	0	209.39	1	0	2	1515	59522	285	triflupromazine	schizophrenia	20.1	64.1	0	0	Inf	1	0	0	294	7014	285	triflupromazine	schizophrenia	0	0	Inf	1	0	0	182	5262	285	triflupromazine	schizophrenia	0	0	Inf	1	0	0	148	3295	285	triflupromazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
286	prochlorperazine	3.77	3.6	3.95	0	1975	25812	175574	8660978	286	prochlorperazine	nausea	1	0.85	1.17	1	200	4966	1024	25442	286	prochlorperazine	nausea	17.2	77	0.95	0.64	1.38	0.85	35	1290	183	6402	286	prochlorperazine	nausea	1.82	0.93	3.41	0.053	16	686	34	2655	286	prochlorperazine	nausea	0.77	0.47	1.21	0.29	22	795	173	4799	286	prochlorperazine	nausea	0.2	1.22140275816017	0.18	0.26	-0.03	0	0	-0.78	0.16	0
287	chlorothiazide	3.35	2.45	4.49	4.8e-12	48	701	177501	8686089	287	chlorothiazide	hypertension	1.15	0.14	4.3	0.69	2	80	6893	317533	287	chlorothiazide	hypertension	38	82.9	12.74	0.27	114.28	0.089	1	5	980	62404	287	chlorothiazide	hypertension	0	0	223.89	1	0	3	341	31636	287	chlorothiazide	hypertension	10.49	0.22	93.95	0.11	1	5	761	39925	287	chlorothiazide	hypertension	1.65	5.20697982717985	1.08	0.12	-0.02	0	0	-0.59	0.07	0
288	chlorothiazide sodium	7.05	4.74	10.19	9.1e-17	33	229	177516	8686561	288	chlorothiazide sodium	nuclear magnetic resonance imaging	0	0	4.84	0.6	0	6	1146	6517	288	chlorothiazide sodium	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	288	chlorothiazide sodium	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	288	chlorothiazide sodium	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	288	chlorothiazide sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
289	methylprednisolone	1.86	1.78	1.94	4.3e-159	2369	62768	175180	8624022	289	methylprednisolone	rheumatoid arthritis	2.4	1.99	2.86	5e-18	132	7612	3278	452765	289	methylprednisolone	rheumatoid arthritis	33	75	3.5	2.66	4.54	5.9e-16	63	2021	997	111917	289	methylprednisolone	rheumatoid arthritis	3.36	1.63	6.21	0.00079	11	483	169	24908	289	methylprednisolone	rheumatoid arthritis	3.76	2.84	4.88	4.7e-17	62	1846	949	106118	289	methylprednisolone	rheumatoid arthritis	1.33	3.78104338756878	0.12	0	-0.01	0	0	-0.26	0.08	0
290	triamcinolone	2.81	2.59	3.04	1.2e-107	644	11243	176905	8675547	290	triamcinolone	psoriasis	1.98	1.12	3.24	0.012	16	1107	1174	160584	290	triamcinolone	psoriasis	25	74.8	0.69	0.08	2.52	1	2	333	377	43192	290	triamcinolone	psoriasis	1.73	0.21	6.44	0.33	2	167	147	21177	290	triamcinolone	psoriasis	0.44	0.01	2.49	0.73	1	226	273	27117	290	triamcinolone	psoriasis	-0.13	0.878095430920561	0.58	0.82	0	0	0.71	-0.36	0.1	0
291	tannic acid	84.01	41.72	175.65	1.3e-31	24	14	177525	8686776	291	tannic acid	migraine	0	0	24.57	1	0	5	1787	40240	291	tannic acid	migraine	20.7	70.1	0	0	Inf	1	0	0	267	7400	291	tannic acid	migraine	0	0	Inf	1	0	0	32	1049	291	tannic acid	migraine	0	0	Inf	1	0	0	265	7201	291	tannic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
292	zinc acetate	1.91	0.76	4.02	0.11	7	179	177542	8686611	292	zinc acetate	hepato-lenticular degeneration	1.32	0.02	25.84	1	1	63	2	167	292	zinc acetate	hepato-lenticular degeneration	12	12	0	0	Inf	1	0	0	0	0	292	zinc acetate	hepato-lenticular degeneration	Inf	0.03	Inf	0.42	1	13	0	19	292	zinc acetate	hepato-lenticular degeneration	0	0	Inf	1	0	19	0	33	292	zinc acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
293	benzonatate	3.63	3.28	4	1.5e-104	432	5835	177117	8680955	293	benzonatate	cough	2.19	1.61	2.94	9.2e-07	56	1044	322	13169	293	benzonatate	cough	13.7	78	1.46	0.75	2.65	0.23	14	380	69	2738	293	benzonatate	cough	3.9	1.36	10	0.0061	7	144	18	1448	293	benzonatate	cough	1.17	0.51	2.41	0.7	9	274	60	2140	293	benzonatate	cough	0.64	1.89648087930495	0.28	0.02	-0.02	0	0	-0.62	0.24	0.01
294	phenprocoumon	0.12	0.03	0.32	9.8e-10	4	1587	177545	8685203	294	phenprocoumon	hypertension	0	0	0.7	0.012	0	243	6895	317370	294	phenprocoumon	hypertension	38	82.9	0	0	8.34	1	0	30	981	62379	294	phenprocoumon	hypertension	0	0	18.87	1	0	20	341	31619	294	phenprocoumon	hypertension	0	0	14.63	1	0	15	762	39915	294	phenprocoumon	hypertension	-10.09	4.14924116190583e-05	148.31	0.95	-0.02	0	0	-0.59	0.07	0
295	dextromethorphan	1.56	1.37	1.76	3.5e-11	261	8195	177288	8678595	295	dextromethorphan	cough	1.29	0.84	1.91	0.22	28	832	350	13381	295	dextromethorphan	cough	13.7	78	0.63	0.17	1.69	0.52	4	233	79	2885	295	dextromethorphan	cough	0.51	0.01	3.16	1	1	121	24	1471	295	dextromethorphan	cough	0.76	0.2	2.09	0.82	4	180	65	2234	295	dextromethorphan	cough	-0.33	0.718923733431926	0.46	0.47	-0.01	0	0	-0.63	0.24	0.01
296	furazolidone	1.44	0.04	8.58	0.51	1	34	177548	8686756	296	furazolidone	helicobacter infection	0	0	13.7	1	0	13	64	2608	296	furazolidone	helicobacter infection	29	65	0	0	20.94	1	0	7	13	353	296	furazolidone	helicobacter infection	0	0	Inf	1	0	0	10	228	296	furazolidone	helicobacter infection	0	0	18.64	1	0	10	11	400	296	furazolidone	helicobacter infection	-13.97	8.56852538712831e-07	1249.91	0.99	0.01	0.01	0.48	0.47	0.44	0.29
297	sodium polystyrene sulfonate	1.45	1.16	1.78	0.00081	92	3111	177457	8683679	297	sodium polystyrene sulfonate	hypertension	0.37	0.08	1.09	0.073	3	374	6892	317239	297	sodium polystyrene sulfonate	hypertension	38	82.9	0	0	2.72	0.65	0	88	981	62321	297	sodium polystyrene sulfonate	hypertension	0	0	5.52	1	0	64	341	31575	297	sodium polystyrene sulfonate	hypertension	0	0	5.5	1	0	37	762	39893	297	sodium polystyrene sulfonate	hypertension	-11.36	1.16523812464762e-05	140.89	0.94	-0.02	0	0	-0.59	0.07	0
298	chlorzoxazone	5.63	4.41	7.1	4e-32	80	696	177469	8686094	298	chlorzoxazone	pain	2.54	1.31	4.52	0.0034	13	114	8456	188370	298	chlorzoxazone	pain	23	79	1.79	0.21	6.96	0.32	2	37	1086	35980	298	chlorzoxazone	pain	3.01	0.07	19.89	0.3	1	14	363	15303	298	chlorzoxazone	pain	1.29	0.03	7.95	0.55	1	24	856	26566	298	chlorzoxazone	pain	0.54	1.71600686218486	0.73	0.46	-0.02	0	0	-0.28	0.06	0
299	trimeprazine tartrate	1.18	0.47	2.46	0.68	7	291	177542	8686499	299	trimeprazine tartrate	depression	0.35	0.01	2.09	0.52	1	38	14370	192747	299	trimeprazine tartrate	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	299	trimeprazine tartrate	depression	0	0	Inf	1	0	0	637	10447	299	trimeprazine tartrate	depression	0	0	Inf	1	0	0	1671	24384	299	trimeprazine tartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
300	halothane	0.37	0.01	2.09	0.53	1	133	177548	8686657	300	halothane	anaesthesia	0	0	11.81	1	0	37	60	6567	300	halothane	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	300	halothane	anaesthesia	0	0	12213.02	1	0	1	1	386	300	halothane	anaesthesia	0	0	126.14	1	0	3	10	482	300	halothane	anaesthesia	-12.35	4.32975326609298e-06	1171.8	0.99	0	0.01	0.93	-2.08	1.05	0.05
301	trolamine polypeptide oleate condensate	12.23	2.98	37.89	6e-04	4	16	177545	8686774	301	trolamine polypeptide oleate condensate	pain	17.81	3.53	82.62	0.00036	4	5	8465	188479	301	trolamine polypeptide oleate condensate	pain	23	79	0	0	1265.54	1	0	1	1088	36016	301	trolamine polypeptide oleate condensate	pain	0	0	1600.1	1	0	1	364	15316	301	trolamine polypeptide oleate condensate	pain	0	0	Inf	1	0	0	857	26590	301	trolamine polypeptide oleate condensate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
302	dichlorphenamide	0.91	0.02	5.27	1	1	54	177548	8686736	302	dichlorphenamide	familial periodic paralysis	0	0	Inf	1	0	24	0	9	302	dichlorphenamide	familial periodic paralysis	NA	NA	0	0	Inf	1	0	0	0	0	302	dichlorphenamide	familial periodic paralysis	0	0	Inf	1	0	9	0	3	302	dichlorphenamide	familial periodic paralysis	0	0	Inf	1	0	8	0	1	302	dichlorphenamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
303	hydroxyzine pamoate	5.26	4.82	5.74	2.9e-203	567	5287	176982	8681503	303	hydroxyzine pamoate	anxiety	0.98	0.8	1.2	0.92	114	841	11237	81636	303	hydroxyzine pamoate	anxiety	20	75	0.98	0.56	1.6	1	18	166	1900	17131	303	hydroxyzine pamoate	anxiety	0.74	0.19	2.03	0.82	4	51	650	6140	303	hydroxyzine pamoate	anxiety	1.24	0.68	2.09	0.39	16	125	1468	14165	303	hydroxyzine pamoate	anxiety	-0.02	0.980198673306755	0.24	0.92	-0.01	0	0	0	0.05	0.94
304	chlormezanone	3.08	1.3	6.26	0.0061	8	127	177541	8686663	304	chlormezanone	pain	0	0	4.77	1	0	19	8469	188465	304	chlormezanone	pain	23	79	0	0	Inf	1	0	0	1088	36017	304	chlormezanone	pain	0	0	Inf	1	0	0	364	15317	304	chlormezanone	pain	0	0	Inf	1	0	0	857	26590	304	chlormezanone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
305	dihydrocodeine bitartrate	0.62	0.37	0.96	0.035	19	1511	177530	8685279	305	dihydrocodeine bitartrate	rheumatoid arthritis	0.48	0.01	2.68	0.73	1	283	3409	460094	305	dihydrocodeine bitartrate	rheumatoid arthritis	33	75	0	0	3934.41	1	0	1	1060	113937	305	dihydrocodeine bitartrate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	305	dihydrocodeine bitartrate	rheumatoid arthritis	0	0	3910.38	1	0	1	1011	107963	305	dihydrocodeine bitartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
306	amphetamine aspartate	4.08	3.7	4.48	3.6e-131	473	5687	177076	8681103	306	amphetamine aspartate	attention deficit/hyperactivity disorder	2	1.69	2.36	1.6e-14	169	1939	1893	43486	306	amphetamine aspartate	attention deficit/hyperactivity disorder	7	57	0	0	4.57	1	0	17	421	7914	306	amphetamine aspartate	attention deficit/hyperactivity disorder	0	0	22.18	1	0	6	233	6052	306	amphetamine aspartate	attention deficit/hyperactivity disorder	0	0	4.17	0.62	0	14	257	3528	306	amphetamine aspartate	attention deficit/hyperactivity disorder	-11.93	6.58971801630773e-06	196.35	0.95	0.01	0	0	-0.48	0.1	0
307	amphetamine	3.48	3.22	3.76	1.5e-162	714	10060	176835	8676730	307	amphetamine	attention deficit/hyperactivity disorder	2.29	2	2.62	4.6e-29	272	2826	1790	42599	307	amphetamine	attention deficit/hyperactivity disorder	7	57	2.29	1.56	3.28	3e-05	37	320	384	7611	307	amphetamine	attention deficit/hyperactivity disorder	1.85	0.86	3.58	0.077	10	143	223	5915	307	amphetamine	attention deficit/hyperactivity disorder	2.12	1.38	3.16	0.00043	32	223	225	3319	307	amphetamine	attention deficit/hyperactivity disorder	0.6	1.82211880039051	0.17	0	0.01	0	0	-0.47	0.1	0
308	dextroamphetamine saccharate	4.12	3.74	4.52	7.9e-133	474	5646	177075	8681144	308	dextroamphetamine saccharate	attention deficit/hyperactivity disorder	2.05	1.73	2.41	2e-15	171	1921	1891	43504	308	dextroamphetamine saccharate	attention deficit/hyperactivity disorder	7	57	0	0	4.57	1	0	17	421	7914	308	dextroamphetamine saccharate	attention deficit/hyperactivity disorder	0	0	22.18	1	0	6	233	6052	308	dextroamphetamine saccharate	attention deficit/hyperactivity disorder	0	0	4.17	0.62	0	14	257	3528	308	dextroamphetamine saccharate	attention deficit/hyperactivity disorder	-11.93	6.58971801630773e-06	196.35	0.95	0.01	0	0	-0.48	0.1	0
309	dextroamphetamine	3.84	3.57	4.13	4.1e-204	794	10139	176755	8676651	309	dextroamphetamine	attention deficit/hyperactivity disorder	2.02	1.74	2.33	2.5e-19	233	2699	1829	42726	309	dextroamphetamine	attention deficit/hyperactivity disorder	7	57	1.68	0.86	2.99	0.097	13	148	408	7783	309	dextroamphetamine	attention deficit/hyperactivity disorder	1.97	0.7	4.56	0.14	6	80	227	5978	309	dextroamphetamine	attention deficit/hyperactivity disorder	1.45	0.67	2.84	0.24	10	96	247	3446	309	dextroamphetamine	attention deficit/hyperactivity disorder	0.35	1.41906754859326	0.27	0.2	0.01	0	0	-0.48	0.1	0
310	indocyanine green	3.34	0.66	10.41	0.068	3	44	177546	8686746	310	indocyanine green	diagnostic procedure	0	0	521.55	1	0	3	21	4381	310	indocyanine green	diagnostic procedure	43.1	71	0	0	6373.66	1	0	1	6	1088	310	indocyanine green	diagnostic procedure	0	0	Inf	1	0	0	4	836	310	indocyanine green	diagnostic procedure	0	0	9695.97	1	0	1	4	1171	310	indocyanine green	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
311	trifluoperazine	2.96	2.34	3.71	2.5e-16	81	1339	177468	8685451	311	trifluoperazine	schizophrenia	0.99	0.42	1.97	1	8	319	1507	59205	311	trifluoperazine	schizophrenia	20.1	64.1	3.42	0.08	26.73	0.28	1	7	293	7007	311	trifluoperazine	schizophrenia	4.15	0.09	32.55	0.24	1	7	181	5255	311	trifluoperazine	schizophrenia	0	0	33.91	1	0	4	148	3291	311	trifluoperazine	schizophrenia	0.92	2.5092903899363	1.05	0.38	-0.02	0	0	-0.31	0.11	0.01
312	sulfinpyrazone	0	0	8.93	1	0	22	177549	8686768	312	sulfinpyrazone	blood cholesterol increased	0	0	222.59	1	0	2	2256	94226	312	sulfinpyrazone	blood cholesterol increased	39.3	79.8	0	0	Inf	1	0	0	293	16978	312	sulfinpyrazone	blood cholesterol increased	0	0	Inf	1	0	0	93	6689	312	sulfinpyrazone	blood cholesterol increased	0	0	Inf	1	0	0	234	12494	312	sulfinpyrazone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
313	methohexital sodium	0.5	0.01	2.88	1	1	97	177548	8686693	313	methohexital sodium	sedative therapy	0	0	8.87	1	0	16	65	2170	313	methohexital sodium	sedative therapy	18	61.7	0	0	Inf	1	0	0	11	269	313	methohexital sodium	sedative therapy	0	0	Inf	1	0	0	2	232	313	methohexital sodium	sedative therapy	0	0	Inf	1	0	0	11	288	313	methohexital sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
314	triamcinolone acetonide	2.8	2.62	2.99	1.8e-154	934	16360	176615	8670430	314	triamcinolone acetonide	asthma	2.13	1.66	2.69	9.2e-09	77	1208	2967	99166	314	triamcinolone acetonide	asthma	9	76	1.85	0.78	3.78	0.09	8	141	532	17375	314	triamcinolone acetonide	asthma	0	0	3.27	0.63	0	50	147	6208	314	triamcinolone acetonide	asthma	2.47	1.03	5.09	0.021	8	104	450	14458	314	triamcinolone acetonide	asthma	0.6	1.82211880039051	0.37	0.1	-0.02	0	0	-0.41	0.1	0
315	oxyphencyclimine	0	0	53.4	1	0	5	177549	8686785	315	oxyphencyclimine	aneurysm repair	0	0	22.3	1	0	2	17	68	315	oxyphencyclimine	aneurysm repair	NA	NA	0	0	Inf	1	0	0	0	0	315	oxyphencyclimine	aneurysm repair	0	0	Inf	1	0	0	0	8	315	oxyphencyclimine	aneurysm repair	0	0	Inf	1	0	0	0	15	315	oxyphencyclimine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
316	phentermine resin complex	5.76	1.48	16.13	0.0069	4	34	177545	8686756	316	phentermine resin complex	resorption bone increased	0	0	1.01	0.039	0	11	88	218	316	phentermine resin complex	resorption bone increased	NA	NA	0	0	Inf	1	0	0	0	0	316	phentermine resin complex	resorption bone increased	0	0	Inf	1	0	0	0	0	316	phentermine resin complex	resorption bone increased	0	0	Inf	1	0	0	0	1	316	phentermine resin complex	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
317	chlorpropamide	3.05	1.75	4.97	9.7e-05	17	273	177532	8686517	317	chlorpropamide	diabetes mellitus	5.03	1.6	12.13	0.004	5	104	2322	242794	317	chlorpropamide	diabetes mellitus	39.3	82	0	0	118.25	1	0	6	377	52478	317	chlorpropamide	diabetes mellitus	0	0	7336.16	1	0	1	140	29743	317	chlorpropamide	diabetes mellitus	0	0	109.79	1	0	5	281	28197	317	chlorpropamide	diabetes mellitus	-8.71	0.000164928254473277	217.67	0.97	-0.01	0	0	-0.75	0.1	0
320	dexamethasone	1.56	1.52	1.61	1.1e-156	4279	135026	173270	8551764	320	dexamethasone	plasma cell myeloma	1.9	1.6	2.27	2.1e-13	264	35587	270	69328	320	dexamethasone	plasma cell myeloma	47.4	82.5	1.41	1.02	1.94	0.031	80	16054	84	23774	320	dexamethasone	plasma cell myeloma	1.67	1.09	2.58	0.015	50	10072	43	14490	320	dexamethasone	plasma cell myeloma	1.29	0.83	1.99	0.23	40	7925	51	13033	320	dexamethasone	plasma cell myeloma	0.36	1.43332941456034	0.15	0.02	-0.03	0.01	0	-0.16	0.15	0.27
321	diethylpropion	6.25	3.54	10.4	1.2e-08	17	133	177532	8686657	321	diethylpropion	weight control	3.08	0.07	21.3	0.3	1	12	78	2885	321	diethylpropion	weight control	32.8	50.3	0	0	617.98	1	0	1	15	239	321	diethylpropion	weight control	0	0	Inf	1	0	1	0	221	321	diethylpropion	weight control	0	0	Inf	1	0	0	17	565	321	diethylpropion	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
322	thiopental sodium	1.99	1.48	2.64	1e-05	51	1252	177498	8685538	322	thiopental sodium	induction of anaesthesia	0	0	4.71	1	0	241	13	3433	322	thiopental sodium	induction of anaesthesia	38.2	60.8	0	0	Inf	1	0	3	0	220	322	thiopental sodium	induction of anaesthesia	0	0	2235.71	1	0	5	1	296	322	thiopental sodium	induction of anaesthesia	0	0	2618.35	1	0	5	1	349	322	thiopental sodium	induction of anaesthesia	-13.81	1.00552576901644e-06	3398.74	1	0	0.03	0.91	0.16	1.42	0.91
323	thiotepa	1.05	0.74	1.45	0.74	38	1772	177511	8685018	323	thiotepa	bone marrow conditioning regimen	0	0	4.83	1	0	254	16	4696	323	thiotepa	bone marrow conditioning regimen	60	61.7	0	0	Inf	1	0	2	0	21	323	thiotepa	bone marrow conditioning regimen	0	0	Inf	1	0	35	0	493	323	thiotepa	bone marrow conditioning regimen	0	0	23.87	1	0	20	4	299	323	thiotepa	bone marrow conditioning regimen	-17.68	2.0973627956718e-08	8408.89	1	0.08	0.04	0.08	-19.06	3120.63	1
324	triamcinolone diacetate	1.43	0.93	2.11	0.076	26	890	177523	8685900	324	triamcinolone diacetate	rheumatoid arthritis	0	0	4.61	1	0	110	3410	460267	324	triamcinolone diacetate	rheumatoid arthritis	33	75	0	0	62.95	1	0	8	1060	113930	324	triamcinolone diacetate	rheumatoid arthritis	0	0	737.25	1	0	2	180	25389	324	triamcinolone diacetate	rheumatoid arthritis	0	0	62.53	1	0	8	1011	107956	324	triamcinolone diacetate	rheumatoid arthritis	-7.75	0.000430742540575688	102.54	0.94	-0.01	0	0	-0.26	0.08	0
326	oxymorphone	1.18	0.99	1.39	0.059	142	5895	177407	8680895	326	oxymorphone	pain	0.82	0.62	1.06	0.15	60	1622	8409	186862	326	oxymorphone	pain	23	79	0.92	0.36	1.92	1	7	253	1081	35764	326	oxymorphone	pain	1.14	0.23	3.44	0.75	3	111	361	15206	326	oxymorphone	pain	0.82	0.22	2.15	1	4	151	853	26439	326	oxymorphone	pain	-0.15	0.860707976425058	0.38	0.7	-0.02	0	0	-0.28	0.06	0
327	methazolamide	0.59	0.07	2.16	0.78	2	166	177547	8686624	327	methazolamide	glaucoma	0	0	8.31	1	0	40	219	18695	327	methazolamide	glaucoma	54.3	87	0	0	42.02	1	0	9	43	3453	327	methazolamide	glaucoma	0	0	78.16	1	0	7	14	1437	327	methazolamide	glaucoma	0	0	123.17	1	0	4	35	2774	327	methazolamide	glaucoma	-12.03	5.96262343546093e-06	722.49	0.99	-0.01	0.01	0.28	-0.26	0.32	0.41
328	fluorometholone	1.13	0.72	1.71	0.5	23	992	177526	8685798	328	fluorometholone	adverse event	0	0	59.99	1	0	6	16	1045	328	fluorometholone	adverse event	48.2	73.4	0	0	2701.95	1	0	3	1	216	328	fluorometholone	adverse event	0	0	2011.51	1	0	4	1	212	328	fluorometholone	adverse event	0	0	Inf	1	0	0	2	159	328	fluorometholone	adverse event	-12.2	5.03045560711145e-06	1978.04	1	0	0.03	0.92	-0.97	1.23	0.43
329	fluphenazine	1.7	1.3	2.18	0.00011	64	1844	177485	8684946	329	fluphenazine	schizophrenia	0.66	0.28	1.31	0.3	8	477	1507	59047	329	fluphenazine	schizophrenia	20.1	64.1	0.41	0.01	2.39	0.73	1	58	293	6956	329	fluphenazine	schizophrenia	0.7	0.02	4.2	1	1	41	181	5221	329	fluphenazine	schizophrenia	0	0	3.27	0.63	0	27	148	3268	329	fluphenazine	schizophrenia	-0.99	0.371576691022046	1.01	0.33	-0.02	0	0	-0.31	0.11	0.01
330	methylprednisolone acetate	2.43	2.3	2.55	4.4e-199	1569	31813	175980	8654977	330	methylprednisolone acetate	rheumatoid arthritis	1.89	1.4	2.51	5.2e-05	50	3588	3360	456789	330	methylprednisolone acetate	rheumatoid arthritis	33	75	1.68	0.86	2.96	0.087	12	773	1048	113165	330	methylprednisolone acetate	rheumatoid arthritis	2.5	0.51	7.55	0.12	3	171	177	25220	330	methylprednisolone acetate	rheumatoid arthritis	1.71	0.88	3.01	0.083	12	754	999	107210	330	methylprednisolone acetate	rheumatoid arthritis	0.61	1.84043139878164	0.26	0.02	-0.01	0	0	-0.26	0.08	0
331	warfarin potassium	0	0	0.09	6e-18	0	1992	177549	8684798	331	warfarin potassium	hypertension	0	0	0.65	0.0081	0	264	6895	317349	331	warfarin potassium	hypertension	38	82.9	0	0	7.3	1	0	34	981	62375	331	warfarin potassium	hypertension	0	0	15.48	1	0	24	341	31615	331	warfarin potassium	hypertension	0	0	9.58	1	0	22	762	39908	331	warfarin potassium	hypertension	-10.2	3.71703186841267e-05	127.65	0.94	-0.02	0	0	-0.59	0.07	0
332	carisoprodol	4.58	4.34	4.83	0	1488	15991	176061	8670799	332	carisoprodol	pain	3.39	3.04	3.76	1.4e-86	414	2819	8055	185665	332	carisoprodol	pain	23	79	1.94	1.27	2.86	0.002	28	483	1060	35534	332	carisoprodol	pain	1.36	0.36	3.6	0.54	4	124	360	15193	332	carisoprodol	pain	2.08	1.31	3.17	0.0016	24	363	833	26227	332	carisoprodol	pain	0.6	1.82211880039051	0.2	0	-0.02	0	0	-0.28	0.06	0
333	hydrochlorothiazide	1.86	1.82	1.91	0	6297	168054	171252	8518736	333	hydrochlorothiazide	hypertension	1.52	1.44	1.61	3.4e-42	1487	48591	5408	269022	333	hydrochlorothiazide	hypertension	38	82.9	1.58	1.33	1.86	2.1e-07	178	7694	803	54715	333	hydrochlorothiazide	hypertension	1.77	1.3	2.38	0.00024	55	3095	286	28544	333	hydrochlorothiazide	hypertension	1.42	1.17	1.71	0.00042	138	5394	624	34536	333	hydrochlorothiazide	hypertension	0.38	1.46228458943422	0.08	0	-0.02	0	0	-0.58	0.07	0
334	thioridazine	5.79	4.8	6.94	4.1e-53	132	1116	177417	8685674	334	thioridazine	depression	3.33	2.2	4.91	3.9e-08	33	133	14338	192652	334	thioridazine	depression	21	73.3	13.77	2.56	73.96	0.0012	4	4	2058	28338	334	thioridazine	depression	32.87	1.71	1912.79	0.0095	2	1	635	10446	334	thioridazine	depression	14.62	2.72	78.54	0.00096	4	4	1667	24380	334	thioridazine	depression	3.05	21.1153444225406	0.61	0	-0.01	0	0	-0.14	0.05	0
335	dexbrompheniramine maleate	3.15	1.41	6.14	0.0033	9	140	177540	8686650	335	dexbrompheniramine maleate	gastrooesophageal reflux disease	0	0	22.05	1	0	6	2968	77022	335	dexbrompheniramine maleate	gastrooesophageal reflux disease	22.4	77.2	0	0	Inf	1	0	0	478	18697	335	dexbrompheniramine maleate	gastrooesophageal reflux disease	0	0	Inf	1	0	0	152	8083	335	dexbrompheniramine maleate	gastrooesophageal reflux disease	0	0	Inf	1	0	0	380	14389	335	dexbrompheniramine maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
336	imipramine	3.73	3.34	4.15	3.3e-91	363	4769	177186	8682021	336	imipramine	depression	1.69	1.36	2.09	4.1e-06	99	786	14272	191999	336	imipramine	depression	21	73.3	1.17	0.46	2.53	0.67	7	82	2055	28260	336	imipramine	depression	0.63	0.02	3.85	1	1	26	636	10421	336	imipramine	depression	2.48	1.22	4.61	0.011	12	71	1659	24313	336	imipramine	depression	0.76	2.13827622049682	0.3	0.01	-0.01	0	0	-0.14	0.05	0
337	chymotrypsin	0	0	4.09	1	0	46	177549	8686744	337	chymotrypsin	her-2 positive gastric cancer	0	0	Inf	1	0	3	0	261	337	chymotrypsin	her-2 positive gastric cancer	NA	NA	0	0	Inf	1	0	0	0	0	337	chymotrypsin	her-2 positive gastric cancer	0	0	Inf	1	0	3	0	136	337	chymotrypsin	her-2 positive gastric cancer	0	0	Inf	1	0	0	0	54	337	chymotrypsin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
338	medroxyprogesterone acetate	1.39	1.32	1.46	6.1e-36	1679	59395	175870	8627395	338	medroxyprogesterone acetate	hormone replacement therapy	0.22	0.19	0.25	8.2e-110	255	25324	681	14545	338	medroxyprogesterone acetate	hormone replacement therapy	34.3	74	1.31	0.34	3.58	0.55	4	102	87	2904	338	medroxyprogesterone acetate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	338	medroxyprogesterone acetate	hormone replacement therapy	1.42	0.37	3.97	0.53	4	113	52	2091	338	medroxyprogesterone acetate	hormone replacement therapy	0.42	1.52196155561863	0.53	0.43	-0.03	0.01	0	0.45	0.2	0.03
339	methylprednisolone sodium succinate	1.64	1.56	1.72	1.9e-74	1650	49438	175899	8637352	339	methylprednisolone sodium succinate	premedication	1.45	1.17	1.79	0.00075	119	5059	378	23303	339	methylprednisolone sodium succinate	premedication	13.8	73.2	2.34	1.65	3.31	9.1e-07	73	1729	70	3872	339	methylprednisolone sodium succinate	premedication	2.63	1.34	5.08	0.003	19	671	23	2136	339	methylprednisolone sodium succinate	premedication	2.05	1.4	3.02	0.00015	60	1352	57	2639	339	methylprednisolone sodium succinate	premedication	0.81	2.24790798667647	0.16	0	-0.01	0	0.15	-0.59	0.18	0
340	demecarium bromide	0	0	1852.91	1	0	1	177549	8686789	340	demecarium bromide		0	0	Inf	1	0	0	0	0	340	demecarium bromide		NA	NA	0	0	Inf	1	0	0	0	0	340	demecarium bromide		0	0	Inf	1	0	0	0	0	340	demecarium bromide		0	0	Inf	1	0	0	0	0	340	demecarium bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
341	nandrolone phenpropionate	0	0	1.86	0.27	0	99	177549	8686691	341	nandrolone phenpropionate	hiv infection	0	0	25.1	1	0	19	500	58372	341	nandrolone phenpropionate	hiv infection	25	64	0	0	2390.6	1	0	1	120	7640	341	nandrolone phenpropionate	hiv infection	0	0	2245.39	1	0	1	96	5727	341	nandrolone phenpropionate	hiv infection	0	0	Inf	1	0	0	40	3439	341	nandrolone phenpropionate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
342	phenelzine	7.46	6.41	8.65	1e-98	204	1339	177345	8685451	342	phenelzine	depression	2.99	2.4	3.7	8.2e-20	107	482	14264	192303	342	phenelzine	depression	21	73.3	0.54	0.06	2.05	0.58	2	51	2060	28291	342	phenelzine	depression	0	0	5.39	1	0	13	637	10434	342	phenelzine	depression	0.56	0.07	2.13	0.58	2	52	1669	24332	342	phenelzine	depression	-0.62	0.537944437594674	0.72	0.39	-0.01	0	0	-0.14	0.05	0
345	diphenylpyraline	2.72	0.07	17.21	0.32	1	18	177548	8686772	345	diphenylpyraline	hodgkin s disease	0	0	1131.73	1	0	2	22	4733	345	diphenylpyraline	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	0	0	125	345	diphenylpyraline	hodgkin s disease	0	0	Inf	1	0	0	0	518	345	diphenylpyraline	hodgkin s disease	0	0	Inf	1	0	0	2	410	345	diphenylpyraline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
346	hydroflumethiazide	0	0	6.89	1	0	28	177549	8686762	346	hydroflumethiazide	glaucoma	0	0	129.84	1	0	4	219	18731	346	hydroflumethiazide	glaucoma	54.3	87	0	0	Inf	1	0	0	43	3462	346	hydroflumethiazide	glaucoma	0	0	Inf	1	0	0	14	1444	346	hydroflumethiazide	glaucoma	0	0	Inf	1	0	0	35	2778	346	hydroflumethiazide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
347	methdilazine	32.63	2.72	284.17	0.0039	2	3	177547	8686787	347	methdilazine	depression	Inf	2.52	Inf	0.0048	2	0	14369	192785	347	methdilazine	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	347	methdilazine	depression	0	0	Inf	1	0	0	637	10447	347	methdilazine	depression	0	0	Inf	1	0	0	1671	24384	347	methdilazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
348	isocarboxazid	0.94	0.02	5.48	1	1	52	177548	8686738	348	isocarboxazid	depression	0.64	0.02	3.97	1	1	21	14370	192764	348	isocarboxazid	depression	21	73.3	0	0	33.28	1	0	3	2062	28339	348	isocarboxazid	depression	0	0	87.15	1	0	2	637	10445	348	isocarboxazid	depression	0	0	35.33	1	0	3	1671	24381	348	isocarboxazid	depression	-8.74	0.000160053887909543	87.72	0.92	-0.01	0	0	-0.14	0.05	0
349	echothiophate iodide	0	0	1.73	0.28	0	106	177549	8686684	349	echothiophate iodide	glaucoma	0	0	6.87	1	0	48	219	18687	349	echothiophate iodide	glaucoma	54.3	87	0	0	197.34	1	0	3	43	3459	349	echothiophate iodide	glaucoma	0	0	261.65	1	0	3	14	1441	349	echothiophate iodide	glaucoma	0	0	433.27	1	0	2	35	2776	349	echothiophate iodide	glaucoma	-11.28	1.26228739119259e-05	647.98	0.99	-0.01	0.01	0.27	-0.26	0.32	0.41
351	dexamethasone sodium phosphate	1.54	1.49	1.58	6.9e-140	4126	132576	173423	8554214	351	dexamethasone sodium phosphate	plasma cell myeloma	1.88	1.58	2.23	8.1e-13	262	35575	272	69340	351	dexamethasone sodium phosphate	plasma cell myeloma	47.4	82.5	1.41	1.02	1.94	0.031	80	16055	84	23773	351	dexamethasone sodium phosphate	plasma cell myeloma	1.67	1.09	2.58	0.015	50	10072	43	14490	351	dexamethasone sodium phosphate	plasma cell myeloma	1.29	0.83	1.99	0.23	40	7925	51	13033	351	dexamethasone sodium phosphate	plasma cell myeloma	0.36	1.43332941456034	0.15	0.02	-0.03	0.01	0	-0.16	0.15	0.27
352	biperiden	1.33	1.13	1.57	0.00081	148	5427	177401	8681363	352	biperiden	schizophrenia	1.16	0.86	1.54	0.28	51	1732	1464	57792	352	biperiden	schizophrenia	20.1	64.1	1.02	0.48	1.94	0.87	10	234	284	6780	352	biperiden	schizophrenia	1.78	0.79	3.56	0.11	9	149	173	5113	352	biperiden	schizophrenia	0.5	0.1	1.52	0.38	3	131	145	3164	352	biperiden	schizophrenia	0.14	1.15027379885723	0.3	0.65	-0.02	0	0	-0.31	0.11	0.01
353	hydrocortisone sodium phosphate	0.22	0.06	0.56	0.00018	4	894	177545	8685896	353	hydrocortisone sodium phosphate	prophylaxis	0	0	3.43	0.63	0	89	1279	103462	353	hydrocortisone sodium phosphate	prophylaxis	23.9	79.7	0	0	26.19	1	0	18	207	23642	353	hydrocortisone sodium phosphate	prophylaxis	0	0	38.8	1	0	18	82	13710	353	hydrocortisone sodium phosphate	prophylaxis	0	0	43.84	1	0	10	148	14402	353	hydrocortisone sodium phosphate	prophylaxis	-10.71	2.2320612032861e-05	273.01	0.97	-0.01	0	0.03	-0.52	0.14	0
354	isosorbide dinitrate	2.32	2.09	2.57	1.2e-45	379	7999	177170	8678791	354	isosorbide dinitrate	hypertension	1.47	1.04	2.04	0.022	38	1190	6857	316423	354	isosorbide dinitrate	hypertension	38	82.9	0.49	0.01	2.76	0.73	1	131	980	62278	354	isosorbide dinitrate	hypertension	0	0	4.03	1	0	87	341	31552	354	isosorbide dinitrate	hypertension	0.9	0.02	5.25	1	1	58	761	39872	354	isosorbide dinitrate	hypertension	-0.65	0.522045776761016	1	0.52	-0.02	0	0	-0.59	0.07	0
355	tolbutamide sodium	0	0	260.7	1	0	2	177549	8686788	355	tolbutamide sodium	type 2 diabetes mellitus	0	0	4207.17	1	0	1	1222	141097	355	tolbutamide sodium	type 2 diabetes mellitus	43	80.7	0	0	Inf	1	0	0	214	33894	355	tolbutamide sodium	type 2 diabetes mellitus	0	0	Inf	1	0	0	85	17936	355	tolbutamide sodium	type 2 diabetes mellitus	0	0	Inf	1	0	0	154	21474	355	tolbutamide sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
356	tropicamide	1.34	0.88	1.97	0.14	27	984	177522	8685806	356	tropicamide	mydriasis	0	0	Inf	1	0	134	0	135	356	tropicamide	mydriasis	NA	NA	0	0	Inf	1	0	0	0	0	356	tropicamide	mydriasis	0	0	Inf	1	0	30	0	18	356	tropicamide	mydriasis	0	0	Inf	1	0	19	0	14	356	tropicamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
357	glucagon	1.83	1.32	2.46	0.00024	45	1206	177504	8685584	357	glucagon	diabetes mellitus	4.25	1.35	10.2	0.0078	5	123	2322	242775	357	glucagon	diabetes mellitus	39.3	82	0	0	20.46	1	0	27	377	52457	357	glucagon	diabetes mellitus	0	0	55.68	1	0	16	140	29728	357	glucagon	diabetes mellitus	0	0	15.38	1	0	26	281	28176	357	glucagon	diabetes mellitus	-10.89	1.86437423315168e-05	220.91	0.96	-0.01	0	0	-0.75	0.1	0
358	mepivacaine	2.89	2.08	3.94	3.8e-09	43	727	177506	8686063	358	mepivacaine	local anaesthesia	1.33	0.34	3.69	0.55	4	173	47	2697	358	mepivacaine	local anaesthesia	9	63.2	0	0	7.99	1	0	24	9	355	358	mepivacaine	local anaesthesia	0	0	Inf	1	0	15	0	208	358	mepivacaine	local anaesthesia	1.07	0.02	8.02	1	1	30	10	322	358	mepivacaine	local anaesthesia	0.06	1.06183654654536	1.07	0.96	-0.01	0.02	0.39	-17.09	1179.89	0.99
359	chlophedianol	0	0	24.79	1	0	9	177549	8686781	359	chlophedianol	lymphoma	0	0	1117.98	1	0	2	39	8090	359	chlophedianol	lymphoma	54.3	80.9	0	0	Inf	1	0	0	6	1268	359	chlophedianol	lymphoma	0	0	Inf	1	0	0	3	1095	359	chlophedianol	lymphoma	0	0	Inf	1	0	0	5	754	359	chlophedianol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
360	benzthiazide	6.61	2.03	16.87	0.0015	5	37	177544	8686753	360	benzthiazide	hypertension	0	0	18.36	1	0	11	6895	317602	360	benzthiazide	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	360	benzthiazide	hypertension	0	0	Inf	1	0	0	341	31639	360	benzthiazide	hypertension	0	0	Inf	1	0	0	762	39930	360	benzthiazide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
361	cyclophosphamide	0.77	0.73	0.82	4.7e-19	1119	70797	176430	8615993	361	cyclophosphamide	diffuse large b-cell lymphoma	0.37	0.11	1.11	0.067	6	5872	10	3582	361	cyclophosphamide	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	653	0	561	361	cyclophosphamide	diffuse large b-cell lymphoma	0.79	0.01	62.25	1	1	702	1	556	361	cyclophosphamide	diffuse large b-cell lymphoma	0	0	Inf	1	0	577	0	460	361	cyclophosphamide	diffuse large b-cell lymphoma	-0.29	0.748263567578565	1.43	0.84	-0.02	0.04	0.72	17.13	2457.17	0.99
362	spironolactone	1.34	1.28	1.41	1.5e-32	1840	67190	175709	8619600	362	spironolactone	hypertension	0.85	0.72	0.99	0.033	171	9271	6724	308342	362	spironolactone	hypertension	38	82.9	1.04	0.71	1.48	0.78	33	2019	948	60390	362	spironolactone	hypertension	0.86	0.41	1.6	0.76	10	1079	331	30560	362	spironolactone	hypertension	1	0.64	1.51	0.92	24	1255	738	38675	362	spironolactone	hypertension	0	1	0.18	0.99	-0.02	0	0	-0.59	0.07	0
363	urea	0.93	0.6	1.36	0.77	26	1375	177523	8685415	363	urea	hypertension	0.3	0.01	1.71	0.39	1	152	6894	317461	363	urea	hypertension	38	82.9	0	0	8.64	1	0	29	981	62380	363	urea	hypertension	0	0	25.98	1	0	15	341	31624	363	urea	hypertension	0	0	15.82	1	0	14	762	39916	363	urea	hypertension	-10.35	3.19927897776892e-05	162.86	0.95	-0.02	0	0	-0.59	0.07	0
364	orphenadrine citrate	6.05	5.11	7.14	8.7e-67	161	1302	177388	8685488	364	orphenadrine citrate	pain	2.51	1.6	3.77	6.8e-05	26	231	8443	188253	364	orphenadrine citrate	pain	23	79	3.24	0.84	8.97	0.042	4	41	1084	35976	364	orphenadrine citrate	pain	4.22	0.1	29.78	0.23	1	10	363	15307	364	orphenadrine citrate	pain	3.01	0.59	9.68	0.089	3	31	854	26559	364	orphenadrine citrate	pain	1.15	3.15819290968977	0.53	0.03	-0.02	0	0	-0.28	0.06	0
365	bendroflumethiazide	0.74	0.61	0.88	0.00033	130	8639	177419	8678151	365	bendroflumethiazide	hypertension	0.64	0.44	0.9	0.0084	33	2367	6862	315246	365	bendroflumethiazide	hypertension	38	82.9	1.43	0.57	2.98	0.36	7	313	974	62096	365	bendroflumethiazide	hypertension	0.65	0.02	3.72	1	1	142	340	31497	365	bendroflumethiazide	hypertension	1.39	0.5	3.1	0.46	6	226	756	39704	365	bendroflumethiazide	hypertension	0.3	1.349858807576	0.38	0.43	-0.02	0	0	-0.59	0.07	0
366	acetic acid, glacial	4.61	3.18	6.5	5.3e-13	36	382	177513	8686408	366	acetic acid, glacial	hypertension	1.34	0.16	5.01	0.66	2	69	6893	317544	366	acetic acid, glacial	hypertension	38	82.9	0	0	96.43	1	0	4	981	62405	366	acetic acid, glacial	hypertension	0	0	223.89	1	0	3	341	31636	366	acetic acid, glacial	hypertension	0	0	279.37	1	0	2	762	39928	366	acetic acid, glacial	hypertension	-8.28	0.00025353720003473	143.3	0.95	-0.02	0	0	-0.59	0.07	0
367	norethindrone acetate	3.41	3.13	3.71	4.1e-132	595	8560	176954	8678230	367	norethindrone acetate	hormone replacement therapy	1.37	1.02	1.82	0.033	54	1700	882	38169	367	norethindrone acetate	hormone replacement therapy	34.3	74	0	0	3.05	0.63	0	42	91	2964	367	norethindrone acetate	hormone replacement therapy	0	0	954.08	1	0	1	48	1191	367	norethindrone acetate	hormone replacement therapy	0	0	2.98	0.64	0	51	56	2153	367	norethindrone acetate	hormone replacement therapy	-14.13	7.30161568924069e-07	543.08	0.98	-0.03	0.01	0	0.4	0.2	0.05
368	fluorouracil	0.36	0.32	0.4	5.2e-106	320	43527	177229	8643263	368	fluorouracil	colorectal cancer metastatic	0.17	0.05	0.44	8.5e-06	5	5036	42	7306	368	fluorouracil	colorectal cancer metastatic	38.8	74.6	0	0	0.5	0.0021	0	504	21	1310	368	fluorouracil	colorectal cancer metastatic	0	0	0.76	0.014	0	383	14	960	368	fluorouracil	colorectal cancer metastatic	0	0	1.09	0.043	0	254	11	687	368	fluorouracil	colorectal cancer metastatic	-17.38	2.83114364241981e-08	1149.38	0.99	-0.03	0.01	0.07	-0.02	0.41	0.97
369	phendimetrazine tartrate	2.31	0.73	5.56	0.073	5	106	177544	8686684	369	phendimetrazine tartrate	gastrooesophageal reflux disease	0	0	138.24	1	0	2	2968	77026	369	phendimetrazine tartrate	gastrooesophageal reflux disease	22.4	77.2	0	0	Inf	1	0	0	478	18697	369	phendimetrazine tartrate	gastrooesophageal reflux disease	0	0	Inf	1	0	0	152	8083	369	phendimetrazine tartrate	gastrooesophageal reflux disease	0	0	Inf	1	0	0	380	14389	369	phendimetrazine tartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
370	chlordiazepoxide	3.81	3.43	4.23	3.2e-100	389	4999	177160	8681791	370	chlordiazepoxide	depression	2.24	1.71	2.89	1.1e-08	70	420	14301	192365	370	chlordiazepoxide	depression	21	73.3	2.96	1.57	5.23	0.00055	15	70	2047	28272	370	chlordiazepoxide	depression	0.86	0.02	5.45	1	1	19	636	10428	370	chlordiazepoxide	depression	3.42	1.76	6.22	0.00023	14	60	1657	24324	370	chlordiazepoxide	depression	1.1	3.00416602394643	0.28	0	-0.01	0	0	-0.14	0.05	0
371	acetophenazine maleate	0	0	118.34	1	0	3	177549	8686787	371	acetophenazine maleate	atrial fibrillation	0	0	4960.68	1	0	1	808	111408	371	acetophenazine maleate	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	371	acetophenazine maleate	atrial fibrillation	0	0	Inf	1	0	0	56	22073	371	acetophenazine maleate	atrial fibrillation	0	0	Inf	1	0	0	94	17933	371	acetophenazine maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
372	fluprednisolone	0	0	74.11	1	0	4	177549	8686786	372	fluprednisolone	rheumatoid arthritis	0	0	204.73	1	0	4	3410	460373	372	fluprednisolone	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	372	fluprednisolone	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	372	fluprednisolone	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	372	fluprednisolone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
373	trichlormethiazide	0.82	0.51	1.26	0.42	21	1249	177528	8685541	373	trichlormethiazide	hypertension	0.11	0	0.6	0.0021	1	432	6894	317181	373	trichlormethiazide	hypertension	38	82.9	0	0	6.68	1	0	37	981	62372	373	trichlormethiazide	hypertension	0	0	14.81	1	0	25	341	31614	373	trichlormethiazide	hypertension	0	0	9.13	1	0	23	762	39907	373	trichlormethiazide	hypertension	-10.39	3.07383345474242e-05	124.67	0.93	-0.02	0	0	-0.59	0.07	0
374	chlorthalidone	1.3	1.09	1.53	0.0028	147	5549	177402	8681241	374	chlorthalidone	hypertension	1.4	1.04	1.84	0.021	52	1718	6843	315895	374	chlorthalidone	hypertension	38	82.9	1.28	0.55	2.55	0.42	8	399	973	62010	374	chlorthalidone	hypertension	2.24	0.71	5.36	0.08	5	209	336	31430	374	chlorthalidone	hypertension	0.86	0.23	2.24	1	4	243	758	39687	374	chlorthalidone	hypertension	0.26	1.29693008666577	0.34	0.44	-0.02	0	0	-0.59	0.07	0
375	oxytocin	1.55	1.19	2	0.0011	63	1983	177486	8684807	375	oxytocin	labour induction	0.68	0.01	6.96	1	1	252	4	690	375	oxytocin	labour induction	37.1	39.9	0	0	Inf	1	0	1	0	11	375	oxytocin	labour induction	0	0	Inf	1	0	1	0	36	375	oxytocin	labour induction	4.06	0.05	326.06	0.36	1	24	1	99	375	oxytocin	labour induction	2.96	19.2979717555028	1.82	0.1	0.4	0.2	0.05	-2.69	4585.23	1
376	dextrothyroxine sodium	0	0	1852.91	1	0	1	177549	8686789	376	dextrothyroxine sodium		0	0	Inf	1	0	0	0	0	376	dextrothyroxine sodium		NA	NA	0	0	Inf	1	0	0	0	0	376	dextrothyroxine sodium		0	0	Inf	1	0	0	0	0	376	dextrothyroxine sodium		0	0	Inf	1	0	0	0	0	376	dextrothyroxine sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
377	guanethidine monosulfate	0	0	24.79	1	0	9	177549	8686781	377	guanethidine monosulfate	hypertension	0	0	111.79	1	0	3	6895	317610	377	guanethidine monosulfate	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	377	guanethidine monosulfate	hypertension	0	0	Inf	1	0	0	341	31639	377	guanethidine monosulfate	hypertension	0	0	Inf	1	0	0	762	39930	377	guanethidine monosulfate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
379	isoetharine	0.66	0.02	3.8	1	1	74	177548	8686716	379	isoetharine	asthma	0	0	3.9	0.63	0	33	3044	100341	379	isoetharine	asthma	9	76	0	0	Inf	1	0	0	540	17516	379	isoetharine	asthma	0	0	Inf	1	0	0	147	6258	379	isoetharine	asthma	0	0	Inf	1	0	0	458	14562	379	isoetharine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
380	tranylcypromine	4.52	3.44	5.86	3.9e-21	63	682	177486	8686108	380	tranylcypromine	depression	1.77	1.21	2.53	0.0028	35	265	14336	192520	380	tranylcypromine	depression	21	73.3	6.9	2.88	15.46	1.7e-05	10	20	2052	28322	380	tranylcypromine	depression	0	0	24.89	1	0	4	637	10443	380	tranylcypromine	depression	8.63	3.52	19.99	3.5e-06	10	17	1661	24367	380	tranylcypromine	depression	1.98	7.24274298516101	0.39	0	-0.01	0	0	-0.14	0.05	0
381	ethosuximide	0.68	0.35	1.19	0.23	12	866	177537	8685924	381	ethosuximide	epilepsy	1.09	0.35	2.57	0.81	5	327	635	45099	381	ethosuximide	epilepsy	13.6	68.1	0	0	15.03	1	0	17	87	5297	381	ethosuximide	epilepsy	0	0	19.22	1	0	19	41	3533	381	ethosuximide	epilepsy	0	0	10.01	1	0	30	56	4154	381	ethosuximide	epilepsy	-13.15	1.94548354993671e-06	564.92	0.98	0	0	0.61	-0.15	0.21	0.47
382	propiomazine	2.06	0.82	4.35	0.091	7	166	177542	8686624	382	propiomazine	depression	4.13	0.98	13.37	0.027	4	13	14367	192772	382	propiomazine	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	382	propiomazine	depression	0	0	Inf	1	0	0	637	10447	382	propiomazine	depression	0	0	Inf	1	0	0	1671	24384	382	propiomazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
383	colchicine	1.5	1.35	1.67	9.2e-13	362	11820	177187	8674970	383	colchicine	gout	0.74	0.51	1.05	0.091	38	2908	211	11920	383	colchicine	gout	41	78.7	0.55	0.17	1.39	0.25	5	606	41	2720	383	colchicine	gout	0.48	0.09	1.54	0.35	3	518	31	2563	383	colchicine	gout	0.89	0.16	3.2	1	3	274	14	1132	383	colchicine	gout	-0.48	0.618783391806141	0.44	0.27	-0.01	0.01	0.06	-0.17	0.3	0.58
384	pseudoephedrine	2.74	2.56	2.93	2.5e-149	938	16803	176611	8669987	384	pseudoephedrine	hypersensitivity	1.16	0.91	1.46	0.21	81	1778	1280	32575	384	pseudoephedrine	hypersensitivity	15.2	73.8	0.84	0.45	1.46	0.69	14	615	195	7217	384	pseudoephedrine	hypersensitivity	1.02	0.2	3.21	1	3	159	51	2757	384	pseudoephedrine	hypersensitivity	0.86	0.42	1.6	0.77	11	497	168	6541	384	pseudoephedrine	hypersensitivity	-0.24	0.786627861066553	0.28	0.4	-0.01	0	0	-0.39	0.16	0.01
385	nitrofurantoin sodium	0	0	9.4	1	0	21	177549	8686769	385	nitrofurantoin sodium	hypertension	0	0	111.79	1	0	3	6895	317610	385	nitrofurantoin sodium	hypertension	38	82.9	0	0	339.78	1	0	2	981	62407	385	nitrofurantoin sodium	hypertension	0	0	Inf	1	0	0	341	31639	385	nitrofurantoin sodium	hypertension	0	0	126.83	1	0	3	762	39927	385	nitrofurantoin sodium	hypertension	-7.41	0.000605170694535053	113.16	0.95	-0.02	0	0	-0.59	0.07	0
386	biperiden lactate	1.17	0.93	1.45	0.17	83	3477	177466	8683313	386	biperiden lactate	schizophrenia	1.13	0.75	1.64	0.48	29	1010	1486	58514	386	biperiden lactate	schizophrenia	20.1	64.1	1.04	0.37	2.35	0.83	6	138	288	6876	386	biperiden lactate	schizophrenia	2.73	1.05	6.02	0.02	7	76	175	5186	386	biperiden lactate	schizophrenia	0.25	0.01	1.42	0.18	1	89	147	3206	386	biperiden lactate	schizophrenia	0.25	1.28402541668774	0.37	0.5	-0.02	0	0	-0.31	0.11	0.01
387	benzphetamine	0	0	3.21	0.63	0	58	177549	8686732	387	benzphetamine	pain	0	0	118.53	1	0	2	8469	188482	387	benzphetamine	pain	23	79	0	0	Inf	1	0	0	1088	36017	387	benzphetamine	pain	0	0	Inf	1	0	0	364	15317	387	benzphetamine	pain	0	0	Inf	1	0	0	857	26590	387	benzphetamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
388	thioguanine	0.23	0.08	0.55	5.8e-05	5	1041	177544	8685749	388	thioguanine	acute lymphocytic leukaemia	0	0	2.67	0.41	0	242	70	11841	388	thioguanine	acute lymphocytic leukaemia	6.4	64.6	0	0	52.94	1	0	16	11	1938	388	thioguanine	acute lymphocytic leukaemia	0	0	90.31	1	0	8	11	1494	388	thioguanine	acute lymphocytic leukaemia	0	0	680.03	1	0	10	2	1231	388	thioguanine	acute lymphocytic leukaemia	-12.04	5.90329434098699e-06	906.96	0.99	0	0.01	0.77	1.51	0.77	0.05
389	atropine	2.59	2.41	2.78	2e-121	839	15899	176710	8670891	389	atropine	crohn s disease	1.71	1.14	2.48	0.0069	29	1702	1448	145610	389	atropine	crohn s disease	15.6	67	1.29	0.41	3.08	0.45	5	312	401	32382	389	atropine	crohn s disease	0.67	0.02	3.87	1	1	140	147	13858	389	atropine	crohn s disease	1.22	0.33	3.19	0.58	4	258	301	23639	389	atropine	crohn s disease	0.15	1.16183424272828	0.45	0.75	-0.01	0	0	-0.21	0.1	0.04
390	diphenoxylate	3.08	2.85	3.34	9.6e-127	657	10446	176892	8676344	390	diphenoxylate	crohn s disease	1.81	1.22	2.58	0.0024	31	1729	1446	145583	390	diphenoxylate	crohn s disease	15.6	67	1.51	0.55	3.35	0.3	6	322	400	32372	390	diphenoxylate	crohn s disease	0.66	0.02	3.79	1	1	143	147	13855	390	diphenoxylate	crohn s disease	1.49	0.48	3.55	0.4	5	265	300	23632	390	diphenoxylate	crohn s disease	0.31	1.36342511413218	0.42	0.46	-0.01	0	0	-0.21	0.1	0.04
392	chlorprothixene	2.11	1.14	3.6	0.01	14	324	177535	8686466	392	chlorprothixene	depression	1.6	0.49	4.03	0.38	5	42	14366	192743	392	chlorprothixene	depression	21	73.3	0	0	20.83	1	0	4	2062	28338	392	chlorprothixene	depression	0	0	633.29	1	0	1	637	10446	392	chlorprothixene	depression	0	0	22.12	1	0	4	1671	24380	392	chlorprothixene	depression	-9.07	0.000115066538646224	87.83	0.92	-0.01	0	0	-0.14	0.05	0
393	methysergide maleate	2.97	0.34	11.59	0.16	2	33	177547	8686757	393	methysergide maleate	migraine	1.41	0.03	9.07	0.52	1	16	1786	40229	393	methysergide maleate	migraine	20.7	70.1	0	0	1062.96	1	0	1	267	7399	393	methysergide maleate	migraine	0	0	Inf	1	0	0	32	1049	393	methysergide maleate	migraine	0	0	1042.52	1	0	1	265	7200	393	methysergide maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
394	methyclothiazide	1.48	0.18	5.57	0.4	2	66	177547	8686724	394	methyclothiazide	hypertension	0	0	13.89	1	0	14	6895	317599	394	methyclothiazide	hypertension	38	82.9	0	0	153.8	1	0	3	981	62406	394	methyclothiazide	hypertension	0	0	489.56	1	0	2	341	31637	394	methyclothiazide	hypertension	0	0	1980.45	1	0	1	762	39929	394	methyclothiazide	hypertension	-7.16	0.000777054553217582	111.79	0.95	-0.02	0	0	-0.59	0.07	0
395	oxyphenbutazone	0	0	53.4	1	0	5	177549	8686785	395	oxyphenbutazone	osteoporosis	0	0	27.14	1	0	4	8802	157682	395	oxyphenbutazone	osteoporosis	53.1	85	0	0	Inf	1	0	0	808	24568	395	oxyphenbutazone	osteoporosis	0	0	Inf	1	0	0	31	2935	395	oxyphenbutazone	osteoporosis	0	0	Inf	1	0	0	868	26887	395	oxyphenbutazone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
396	metronidazole	3.15	3.01	3.29	0	2057	32254	175492	8654536	396	metronidazole	crohn s disease	1.19	0.82	1.68	0.33	33	2773	1444	144539	396	metronidazole	crohn s disease	15.6	67	1.08	0.39	2.4	0.83	6	446	400	32248	396	metronidazole	crohn s disease	0.88	0.11	3.28	1	2	214	146	13784	396	metronidazole	crohn s disease	1.52	0.55	3.39	0.3	6	311	299	23586	396	metronidazole	crohn s disease	0.23	1.25860000992948	0.36	0.52	-0.01	0	0	-0.21	0.1	0.03
397	cyproheptadine	2.57	2.16	3.04	2.7e-22	145	2759	177404	8684031	397	cyproheptadine	pain	4.35	2.84	6.47	3.9e-10	30	154	8439	188330	397	cyproheptadine	pain	23	79	0	0	4.85	1	0	27	1088	35990	397	cyproheptadine	pain	3.01	0.07	19.89	0.3	1	14	363	15303	397	cyproheptadine	pain	0	0	3.92	0.63	0	31	857	26559	397	cyproheptadine	pain	-0.7	0.49658530379141	1.02	0.49	-0.02	0	0	-0.28	0.06	0
398	betamethasone	1.59	1.43	1.78	2.7e-15	341	10468	177208	8676322	398	betamethasone	psoriasis	3.06	1.77	4.95	8.4e-05	17	763	1173	160928	398	betamethasone	psoriasis	25	74.8	1.58	0.32	4.73	0.44	3	218	376	43307	398	betamethasone	psoriasis	1.2	0.03	6.89	0.57	1	120	148	21224	398	betamethasone	psoriasis	3.2	0.85	8.49	0.041	4	126	270	27217	398	betamethasone	psoriasis	0.88	2.41089970641721	0.45	0.05	0	0	0.69	-0.36	0.1	0
399	vinblastine	0.3	0.17	0.48	1.4e-09	17	2795	177532	8683995	399	vinblastine	hodgkin s disease	1.47	0.53	3.77	0.47	8	1325	14	3410	399	vinblastine	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	20	0	105	399	vinblastine	hodgkin s disease	0	0	Inf	1	0	109	0	409	399	vinblastine	hodgkin s disease	0	0	22.18	1	0	80	2	330	399	vinblastine	hodgkin s disease	-17.29	3.09776456701126e-08	5175.61	1	-0.01	0.04	0.77	-18.1	3368.95	1
401	amitriptyline	3.2	3.09	3.31	0	3334	51653	174215	8635137	401	amitriptyline	pain	2.39	2.18	2.61	5.4e-68	581	5640	7888	182844	401	amitriptyline	pain	23	79	1.9	1.45	2.44	4.6e-06	68	1224	1020	34793	401	amitriptyline	pain	3.42	2.19	5.15	2.4e-07	27	351	337	14966	401	amitriptyline	pain	1.41	1.01	1.93	0.035	44	980	813	25610	401	amitriptyline	pain	0.56	1.7506725002961	0.13	0	-0.02	0	0	-0.27	0.06	0
402	sulfamethoxazole	1.58	1.51	1.66	2.1e-75	1919	59588	175630	8627202	402	sulfamethoxazole	prophylaxis	0.7	0.54	0.89	0.0035	67	7608	1212	95943	402	sulfamethoxazole	prophylaxis	23.9	79.7	0.81	0.4	1.49	0.67	11	1532	196	22128	402	sulfamethoxazole	prophylaxis	0.29	0.03	1.07	0.065	2	1106	80	12622	402	sulfamethoxazole	prophylaxis	1.57	0.79	2.86	0.14	12	765	136	13647	402	sulfamethoxazole	prophylaxis	-0.07	0.932393819905948	0.28	0.81	-0.01	0	0.02	-0.52	0.14	0
403	phentermine	3.7	3.33	4.1	4.6e-97	391	5182	177158	8681608	403	phentermine	weight decreased	4.23	3.21	5.58	2e-25	123	1710	104	6121	403	phentermine	weight decreased	27	73.2	3.04	1.72	5.34	8.8e-05	27	531	30	1795	403	phentermine	weight decreased	2.82	0.69	10.63	0.08	5	83	7	329	403	phentermine	weight decreased	3.43	1.93	6.12	1.4e-05	28	490	27	1624	403	phentermine	weight decreased	1.11	3.03435839443568	0.25	0	-0.02	0.01	0.04	0.24	0.33	0.47
404	thiethylperazine maleate	6.42	4.2	9.48	5.4e-14	29	221	177520	8686569	404	thiethylperazine maleate	prophylaxis	0	0	8.04	1	0	39	1279	103512	404	thiethylperazine maleate	prophylaxis	23.9	79.7	0	0	124.98	1	0	5	207	23655	404	thiethylperazine maleate	prophylaxis	0	0	185.18	1	0	5	82	13723	404	thiethylperazine maleate	prophylaxis	0	0	Inf	1	0	0	148	14412	404	thiethylperazine maleate	prophylaxis	-8.48	0.000207578702717718	239.28	0.97	-0.01	0	0.03	-0.52	0.14	0
405	thiethylperazine malate	6.86	4.48	10.14	1.2e-14	29	207	177520	8686583	405	thiethylperazine malate	prophylaxis	0	0	8.5	1	0	37	1279	103514	405	thiethylperazine malate	prophylaxis	23.9	79.7	0	0	275.81	1	0	3	207	23657	405	thiethylperazine malate	prophylaxis	0	0	406.52	1	0	3	82	13725	405	thiethylperazine malate	prophylaxis	0	0	Inf	1	0	0	148	14412	405	thiethylperazine malate	prophylaxis	-8.54	0.000195490260146975	308.97	0.98	-0.01	0	0.03	-0.52	0.14	0
407	paramethasone acetate	0	0	53.4	1	0	5	177549	8686785	407	paramethasone acetate	rheumatoid arthritis	0	0	204.73	1	0	4	3410	460373	407	paramethasone acetate	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	407	paramethasone acetate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	407	paramethasone acetate	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	407	paramethasone acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
408	fluocinolone acetonide	1.88	1.36	2.54	0.00016	44	1147	177505	8685643	408	fluocinolone acetonide	psoriasis	3.61	0.97	9.45	0.028	4	151	1186	161540	408	fluocinolone acetonide	psoriasis	25	74.8	0	0	15.08	1	0	30	379	43495	408	fluocinolone acetonide	psoriasis	0	0	52.05	1	0	12	149	21332	408	fluocinolone acetonide	psoriasis	0	0	13.6	1	0	29	274	27314	408	fluocinolone acetonide	psoriasis	-10.86	1.92115288153726e-05	226.96	0.96	0	0	0.71	-0.36	0.1	0
409	quinidine	1.42	1.07	1.85	0.013	56	1935	177493	8684855	409	quinidine	affect lability	0.45	0.18	1.08	0.062	10	505	15	340	409	quinidine	affect lability	41.5	69.6	Inf	0.04	Inf	1	2	97	0	24	409	quinidine	affect lability	Inf	0.01	Inf	1	1	64	0	19	409	quinidine	affect lability	0.79	0.04	47.37	1	2	127	1	50	409	quinidine	affect lability	0.1	1.10517091807565	1.34	0.94	0	0.03	1	-0.35	1.17	0.77
410	flurandrenolide	1.31	0.35	3.43	0.55	4	149	177545	8686641	410	flurandrenolide	psoriasis	8.78	1.02	34.57	0.024	2	31	1188	161660	410	flurandrenolide	psoriasis	25	74.8	28.82	2.97	144.98	0.0032	2	8	377	43517	410	flurandrenolide	psoriasis	287.92	14.98	14650.47	0.00014	2	1	147	21343	410	flurandrenolide	psoriasis	0	0	69.53	1	0	7	274	27336	410	flurandrenolide	psoriasis	3.33	27.9383417032365	0.79	0	0	0	0.7	-0.36	0.1	0
411	glycopyrrolate	3.22	2.74	3.77	5.2e-36	168	2552	177381	8684238	411	glycopyrrolate	chronic obstructive pulmonary disease	2.72	1.28	5.1	0.0053	10	241	1248	81756	411	glycopyrrolate	chronic obstructive pulmonary disease	48.4	82.8	1.91	0.39	5.8	0.21	3	109	288	20035	411	glycopyrrolate	chronic obstructive pulmonary disease	2.5	0.29	9.59	0.2	2	73	106	9676	411	glycopyrrolate	chronic obstructive pulmonary disease	1.09	0.03	6.4	0.6	1	57	216	13448	411	glycopyrrolate	chronic obstructive pulmonary disease	0.62	1.85892804184634	0.59	0.29	-0.03	0	0	-0.37	0.12	0
412	sutilains	0	0	118.34	1	0	3	177549	8686787	412	sutilains	hypertension	0	0	111.79	1	0	3	6895	317610	412	sutilains	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	412	sutilains	hypertension	0	0	Inf	1	0	0	341	31639	412	sutilains	hypertension	0	0	Inf	1	0	0	762	39930	412	sutilains	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
413	dipyridamole	1.14	0.99	1.3	0.061	224	9638	177325	8677152	413	dipyridamole	hypertension	1.38	0.97	1.91	0.063	37	1237	6858	316376	413	dipyridamole	hypertension	38	82.9	1.35	0.27	4.02	0.49	3	142	978	62267	413	dipyridamole	hypertension	2.24	0.27	8.42	0.23	2	83	339	31556	413	dipyridamole	hypertension	0.58	0.01	3.33	1	1	90	761	39840	413	dipyridamole	hypertension	0.24	1.2712491503214	0.58	0.68	-0.02	0	0	-0.59	0.07	0
414	polythiazide	0	0	24.79	1	0	9	177549	8686781	414	polythiazide	coronary artery disease	0	0	4305.77	1	0	1	112	13256	414	polythiazide	coronary artery disease	55.9	83	0	0	Inf	1	0	0	10	2922	414	polythiazide	coronary artery disease	0	0	Inf	1	0	0	8	2478	414	polythiazide	coronary artery disease	0	0	Inf	1	0	0	6	1278	414	polythiazide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
415	stanozolol	0	0	1.47	0.19	0	125	177549	8686665	415	stanozolol	muscle building therapy	0	0	522.21	1	0	8	1	107	415	stanozolol	muscle building therapy	NA	NA	0	0	Inf	1	0	0	0	0	415	stanozolol	muscle building therapy	0	0	Inf	1	0	3	0	38	415	stanozolol	muscle building therapy	0	0	Inf	1	0	1	0	1	415	stanozolol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
416	uracil mustard	0	0	118.34	1	0	3	177549	8686787	416	uracil mustard	myocardial infarction	0	0	2240.75	1	0	1	167	9942	416	uracil mustard	myocardial infarction	38.2	75.6	0	0	Inf	1	0	0	28	1762	416	uracil mustard	myocardial infarction	0	0	Inf	1	0	0	11	1498	416	uracil mustard	myocardial infarction	0	0	Inf	1	0	0	21	905	416	uracil mustard	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
417	metyrapone	0.39	0.05	1.43	0.25	2	250	177547	8686540	417	metyrapone	cushing s syndrome	0	0	2.76	0.38	0	78	13	642	417	metyrapone	cushing s syndrome	46.6	68.4	0	0	48.45	1	0	4	5	128	417	metyrapone	cushing s syndrome	0	0	76.29	1	0	3	2	35	417	metyrapone	cushing s syndrome	0	0	47.54	1	0	6	5	213	417	metyrapone	cushing s syndrome	-15.38	2.09194791979708e-07	2103.97	0.99	0.03	0.03	0.31	0.87	0.86	0.31
419	dromostanolone propionate	0	0	118.34	1	0	3	177549	8686787	419	dromostanolone propionate	drug abuse	0	0	2935.39	1	0	1	60	4732	419	dromostanolone propionate	drug abuse	21	60.4	0	0	Inf	1	0	0	19	951	419	dromostanolone propionate	drug abuse	0	0	Inf	1	0	0	17	587	419	dromostanolone propionate	drug abuse	0	0	Inf	1	0	0	8	675	419	dromostanolone propionate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
420	ipodate sodium	0	0	1852.91	1	0	1	177549	8686789	420	ipodate sodium	chronic obstructive pulmonary disease	0	0	2444.96	1	0	1	1258	81996	420	ipodate sodium	chronic obstructive pulmonary disease	48.4	82.8	0	0	Inf	1	0	0	291	20144	420	ipodate sodium	chronic obstructive pulmonary disease	0	0	Inf	1	0	0	108	9749	420	ipodate sodium	chronic obstructive pulmonary disease	0	0	Inf	1	0	0	217	13505	420	ipodate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
422	sodium chloride	1.09	1.02	1.16	0.0074	1069	48122	176480	8638668	422	sodium chloride	prophylaxis	0.54	0.34	0.82	0.0024	23	3369	1256	100182	422	sodium chloride	prophylaxis	23.9	79.7	0.67	0.21	1.59	0.57	5	844	202	22816	422	sodium chloride	prophylaxis	0.95	0.19	2.88	1	3	530	79	13198	422	sodium chloride	prophylaxis	0.42	0.05	1.54	0.34	2	459	146	13953	422	sodium chloride	prophylaxis	-0.49	0.612626394184416	0.45	0.28	-0.01	0	0.02	-0.52	0.14	0
423	tromethamine	4.42	3.78	5.14	5.7e-57	184	2038	177365	8684752	423	tromethamine	pain	2.7	1.89	3.76	2.1e-07	40	331	8429	188153	423	tromethamine	pain	23	79	2.16	0.43	6.74	0.17	3	46	1085	35971	423	tromethamine	pain	1.5	0.04	9.15	0.49	1	28	363	15289	423	tromethamine	pain	3.45	0.39	14.46	0.13	2	18	855	26572	423	tromethamine	pain	0.8	2.22554092849247	0.6	0.18	-0.02	0	0	-0.28	0.06	0
424	ethionamide	1.12	0.48	2.24	0.7	8	348	177541	8686442	424	ethionamide	tuberculosis	4.68	1.38	12.72	0.0075	5	174	24	3914	424	ethionamide	tuberculosis	23.8	59	7.93	0.73	50.77	0.044	2	32	5	639	424	ethionamide	tuberculosis	0	0	28.61	1	0	24	5	600	424	ethionamide	tuberculosis	16.29	1.14	231.77	0.02	2	29	2	480	424	ethionamide	tuberculosis	1.73	5.64065390842832	0.87	0.05	0	0.02	0.88	0.12	0.68	0.87
425	methoxyflurane	0	0	53.4	1	0	5	177549	8686785	425	methoxyflurane	hiv infection	0	0	4251.98	1	0	1	500	58390	425	methoxyflurane	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	425	methoxyflurane	hiv infection	0	0	Inf	1	0	0	96	5728	425	methoxyflurane	hiv infection	0	0	Inf	1	0	0	40	3439	425	methoxyflurane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
427	nandrolone decanoate	0.2	0	1.1	0.07	1	250	177548	8686540	427	nandrolone decanoate	hiv infection	0	0	11.32	1	0	40	500	58351	427	nandrolone decanoate	hiv infection	25	64	0	0	2390.6	1	0	1	120	7640	427	nandrolone decanoate	hiv infection	0	0	2245.39	1	0	1	96	5727	427	nandrolone decanoate	hiv infection	0	0	Inf	1	0	0	40	3439	427	nandrolone decanoate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
428	cyclothiazide	0	0	74.11	1	0	4	177549	8686786	428	cyclothiazide	hypertension	0	0	1747.48	1	0	1	6895	317612	428	cyclothiazide	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	428	cyclothiazide	hypertension	0	0	Inf	1	0	0	341	31639	428	cyclothiazide	hypertension	0	0	Inf	1	0	0	762	39930	428	cyclothiazide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
429	triamterene	2.87	2.71	3.03	1.6e-227	1335	22909	176214	8663881	429	triamterene	hypertension	2.07	1.78	2.39	5.1e-19	198	4478	6697	313135	429	triamterene	hypertension	38	82.9	1.58	0.94	2.5	0.057	19	769	962	61640	429	triamterene	hypertension	3.04	1.1	6.83	0.017	6	185	335	31454	429	triamterene	hypertension	1.11	0.6	1.89	0.67	14	662	748	39268	429	triamterene	hypertension	0.32	1.37712776433596	0.23	0.16	-0.02	0	0	-0.59	0.07	0
430	metaxalone	5.3	4.91	5.71	2.6e-276	768	7115	176781	8679675	430	metaxalone	pain	5.02	4.31	5.83	6.2e-72	217	982	8252	187502	430	metaxalone	pain	23	79	2.39	1.21	4.31	0.0068	12	167	1076	35850	430	metaxalone	pain	1.69	0.2	6.46	0.34	2	50	362	15267	430	metaxalone	pain	2.5	1.17	4.77	0.0099	10	125	847	26465	430	metaxalone	pain	0.81	2.24790798667647	0.3	0.01	-0.02	0	0	-0.28	0.06	0
431	diazepam	3.5	3.39	3.61	0	4547	64794	173002	8621996	431	diazepam	pain	2.91	2.69	3.16	3.1e-121	743	6021	7726	182463	431	diazepam	pain	23	79	2.42	1.91	3.04	4.8e-12	87	1250	1001	34767	431	diazepam	pain	4.16	2.91	5.81	4.4e-13	43	478	321	14839	431	diazepam	pain	1.67	1.21	2.27	0.0015	47	891	810	25699	431	diazepam	pain	0.8	2.22554092849247	0.11	0	-0.02	0	0	-0.28	0.06	0
432	quinethazone	0	0	260.7	1	0	2	177549	8686788	432	quinethazone	pain	0	0	856.37	1	0	1	8469	188483	432	quinethazone	pain	23	79	0	0	Inf	1	0	0	1088	36017	432	quinethazone	pain	0	0	Inf	1	0	0	364	15317	432	quinethazone	pain	0	0	Inf	1	0	0	857	26590	432	quinethazone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
433	phenazopyridine	6.43	5.58	7.39	7.3e-99	229	1744	177320	8685046	433	phenazopyridine	pain	2.34	1.42	3.68	0.00069	21	200	8448	188284	433	phenazopyridine	pain	23	79	2.76	0.32	11.15	0.18	2	24	1086	35993	433	phenazopyridine	pain	0	0	46.05	1	0	5	364	15312	433	phenazopyridine	pain	4.91	0.93	16.73	0.03	3	19	854	26571	433	phenazopyridine	pain	1.36	3.89619330179521	0.62	0.03	-0.02	0	0	-0.28	0.06	0
434	iothalamate meglumine	0.83	0.1	3.06	1	2	118	177547	8686672	434	iothalamate meglumine	computerised tomogram	4.26	0.1	27.78	0.22	1	18	64	4906	434	iothalamate meglumine	computerised tomogram	27.5	85	0	0	Inf	1	0	0	1	452	434	iothalamate meglumine	computerised tomogram	0	0	Inf	1	0	0	2	216	434	iothalamate meglumine	computerised tomogram	0	0	Inf	1	0	0	1	302	434	iothalamate meglumine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
435	phenylephrine bitartrate	8.15	0.18	67.33	0.13	1	6	177548	8686784	435	phenylephrine bitartrate	asthma	0	0	175.68	1	0	2	3044	100372	435	phenylephrine bitartrate	asthma	9	76	0	0	Inf	1	0	0	540	17516	435	phenylephrine bitartrate	asthma	0	0	Inf	1	0	0	147	6258	435	phenylephrine bitartrate	asthma	0	0	Inf	1	0	0	458	14562	435	phenylephrine bitartrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
436	iothalamate sodium	0	0	1852.91	1	0	1	177549	8686789	436	iothalamate sodium		0	0	Inf	1	0	0	0	0	436	iothalamate sodium		NA	NA	0	0	Inf	1	0	0	0	0	436	iothalamate sodium		0	0	Inf	1	0	0	0	0	436	iothalamate sodium		0	0	Inf	1	0	0	0	0	436	iothalamate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
437	acetohexamide	3.76	0.09	25.06	0.25	1	13	177548	8686777	437	acetohexamide	hypertension	0	0	111.79	1	0	3	6895	317610	437	acetohexamide	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	437	acetohexamide	hypertension	0	0	Inf	1	0	0	341	31639	437	acetohexamide	hypertension	0	0	Inf	1	0	0	762	39930	437	acetohexamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
438	methyldopa	1	0.78	1.25	1	76	3735	177473	8683055	438	methyldopa	hypertension	0.58	0.35	0.91	0.016	19	1502	6876	316111	438	methyldopa	hypertension	38	82.9	1.31	0.16	4.88	0.67	2	97	979	62312	438	methyldopa	hypertension	0	0	6.34	1	0	56	341	31583	438	methyldopa	hypertension	1.06	0.28	2.77	0.79	4	198	758	39732	438	methyldopa	hypertension	-0.78	0.458406011305224	0.51	0.13	-0.02	0	0	-0.6	0.07	0
439	methyldopate	1.4	1	1.92	0.038	40	1396	177509	8685394	439	methyldopate	hypertension	0.99	0.52	1.71	1	13	604	6882	317009	439	methyldopate	hypertension	38	82.9	3.86	0.45	15.14	0.1	2	33	979	62376	439	methyldopate	hypertension	0	0	24.16	1	0	16	341	31623	439	methyldopate	hypertension	6.38	1.64	17.99	0.0049	4	33	758	39897	439	methyldopate	hypertension	1.17	3.2219926385285	0.53	0.03	-0.02	0	0	-0.59	0.07	0
440	methixene	0	0	260.7	1	0	2	177549	8686788	440	methixene		0	0	Inf	1	0	0	0	0	440	methixene		NA	NA	0	0	Inf	1	0	0	0	0	440	methixene		0	0	Inf	1	0	0	0	0	440	methixene		0	0	Inf	1	0	0	0	0	440	methixene	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
443	acetylcysteine	2.17	1.91	2.47	2.5e-27	255	5741	177294	8681049	443	acetylcysteine	prophylaxis	2.38	1.21	4.21	0.0064	12	411	1267	103140	443	acetylcysteine	prophylaxis	23.9	79.7	1.61	0.04	9.38	0.47	1	71	206	23589	443	acetylcysteine	prophylaxis	0	0	17.39	1	0	38	82	13690	443	acetylcysteine	prophylaxis	4.69	0.54	18.31	0.074	2	42	146	14370	443	acetylcysteine	prophylaxis	1.13	3.09565650012471	0.72	0.12	-0.01	0	0.02	-0.52	0.14	0
444	piperacetazine	0	0	118.34	1	0	3	177549	8686787	444	piperacetazine	bone marrow conditioning regimen	0	0	778.7	1	0	3	16	4947	444	piperacetazine	bone marrow conditioning regimen	60	61.7	0	0	Inf	1	0	0	0	23	444	piperacetazine	bone marrow conditioning regimen	0	0	Inf	1	0	0	0	528	444	piperacetazine	bone marrow conditioning regimen	0	0	Inf	1	0	0	4	319	444	piperacetazine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
445	desipramine	3.51	2.74	4.44	6e-19	75	1045	177474	8685745	445	desipramine	depression	1.45	0.84	2.36	0.15	18	167	14353	192618	445	desipramine	depression	21	73.3	1.06	0.12	4.23	0.71	2	26	2060	28316	445	desipramine	depression	0	0	24.89	1	0	4	637	10443	445	desipramine	depression	1.08	0.12	4.31	0.71	2	27	1669	24357	445	desipramine	depression	0.08	1.08328706767496	0.73	0.92	-0.01	0	0	-0.14	0.05	0
446	oxandrolone	0.6	0.16	1.56	0.43	4	324	177545	8686466	446	oxandrolone	hiv infection	0	0	5.59	1	0	79	500	58312	446	oxandrolone	hiv infection	25	64	0	0	154.71	1	0	3	120	7638	446	oxandrolone	hiv infection	0	0	91.02	1	0	4	96	5724	446	oxandrolone	hiv infection	0	0	Inf	1	0	0	40	3439	446	oxandrolone	hiv infection	-10.46	2.86602331662198e-05	441.37	0.98	0	0.01	0.81	0.38	0.2	0.05
448	idoxuridine	0	0	12.68	1	0	16	177549	8686774	448	idoxuridine	hiv infection	0	0	619.25	1	0	2	500	58389	448	idoxuridine	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	448	idoxuridine	hiv infection	0	0	Inf	1	0	0	96	5728	448	idoxuridine	hiv infection	0	0	Inf	1	0	0	40	3439	448	idoxuridine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
450	ethylestrenol	0	0	17.61	1	0	12	177549	8686778	450	ethylestrenol	prophylaxis	0	0	47.48	1	0	8	1279	103543	450	ethylestrenol	prophylaxis	23.9	79.7	0	0	Inf	1	0	0	207	23660	450	ethylestrenol	prophylaxis	0	0	Inf	1	0	0	82	13728	450	ethylestrenol	prophylaxis	0	0	Inf	1	0	0	148	14412	450	ethylestrenol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
451	vincristine	0.74	0.68	0.8	9.9e-15	596	39528	176953	8647262	451	vincristine	diffuse large b-cell lymphoma	0.39	0.12	1.18	0.065	7	6291	9	3163	451	vincristine	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	658	0	556	451	vincristine	diffuse large b-cell lymphoma	Inf	0.15	Inf	0.5	2	691	0	567	451	vincristine	diffuse large b-cell lymphoma	0	0	Inf	1	0	596	0	441	451	vincristine	diffuse large b-cell lymphoma	17.99	65006641.5283895	3806.34	1	-0.01	0.04	0.73	18.05	3760.66	1
452	pralidoxime chloride	0	0	8.51	1	0	23	177549	8686767	452	pralidoxime chloride	sedative therapy	0	0	180.28	1	0	2	65	2184	452	pralidoxime chloride	sedative therapy	18	61.7	0	0	Inf	1	0	0	11	269	452	pralidoxime chloride	sedative therapy	0	0	Inf	1	0	0	2	232	452	pralidoxime chloride	sedative therapy	0	0	Inf	1	0	0	11	288	452	pralidoxime chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
453	nalidixic acid	0	0	4.85	1	0	39	177549	8686751	453	nalidixic acid	rheumatoid arthritis	0	0	147.64	1	0	5	3410	460372	453	nalidixic acid	rheumatoid arthritis	33	75	0	0	3934.41	1	0	1	1060	113937	453	nalidixic acid	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	453	nalidixic acid	rheumatoid arthritis	0	0	3910.38	1	0	1	1011	107963	453	nalidixic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
454	chlorphenesin carbamate	0	0	4.85	1	0	39	177549	8686751	454	chlorphenesin carbamate	rheumatoid arthritis	0	0	53.81	1	0	11	3410	460366	454	chlorphenesin carbamate	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	454	chlorphenesin carbamate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	454	chlorphenesin carbamate	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	454	chlorphenesin carbamate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
455	nonoxynol-9	0	0	21.83	1	0	10	177549	8686780	455	nonoxynol-9	contraception	0	0	12.89	1	0	7	8001	148627	455	nonoxynol-9	contraception	19	43	0	0	Inf	1	0	0	1715	24081	455	nonoxynol-9	contraception	0	0	Inf	1	0	0	0	22	455	nonoxynol-9	contraception	0	0	Inf	1	0	0	1939	28905	455	nonoxynol-9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
456	betamethasone acetate	2.03	1.07	3.53	0.017	13	313	177536	8686477	456	betamethasone acetate	intervertebral disc protrusion	3.14	0.34	14.29	0.16	2	12	160	3017	456	betamethasone acetate	intervertebral disc protrusion	27.6	64	0	0	Inf	1	0	0	33	470	456	betamethasone acetate	intervertebral disc protrusion	0	0	Inf	1	0	0	6	210	456	betamethasone acetate	intervertebral disc protrusion	0	0	531.49	1	0	1	31	425	456	betamethasone acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
457	betamethasone sodium phosphate	1.92	1.52	2.39	1.1e-07	83	2114	177466	8684676	457	betamethasone sodium phosphate	adverse event	0	0	41.62	1	0	8	16	1043	457	betamethasone sodium phosphate	adverse event	48.2	73.4	0	0	1634.2	1	0	5	1	214	457	betamethasone sodium phosphate	adverse event	0	0	1342.75	1	0	6	1	210	457	betamethasone sodium phosphate	adverse event	0	0	Inf	1	0	0	2	159	457	betamethasone sodium phosphate	adverse event	-13.22	1.81395683868968e-06	2662.77	1	0	0.03	0.92	-0.96	1.23	0.44
458	nortriptyline	3.63	3.38	3.9	5.1e-196	817	11036	176732	8675754	458	nortriptyline	depression	1.16	0.95	1.4	0.13	115	1332	14256	191453	458	nortriptyline	depression	21	73.3	0.64	0.3	1.2	0.18	10	215	2052	28127	458	nortriptyline	depression	0.41	0.05	1.53	0.33	2	80	635	10367	458	nortriptyline	depression	0.79	0.36	1.55	0.64	9	165	1662	24219	458	nortriptyline	depression	-0.36	0.697676326071031	0.31	0.24	-0.01	0	0	-0.14	0.05	0
459	melphalan	2.48	2.31	2.66	6.7e-112	833	16452	176716	8670338	459	melphalan	multiple myeloma	3.62	3.19	4.1	9.1e-76	358	4629	1125	52668	459	melphalan	multiple myeloma	NA	NA	0	0	Inf	1	0	0	0	0	459	melphalan	multiple myeloma	0	0	Inf	1	0	0	0	0	459	melphalan	multiple myeloma	0	0	Inf	1	0	0	0	0	459	melphalan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
460	chlorphentermine	0	0	3.39	0.63	0	55	177549	8686735	460	chlorphentermine	premedication	0	0	86.81	1	0	4	497	28358	460	chlorphentermine	premedication	13.8	73.2	0	0	1491.96	1	0	1	143	5600	460	chlorphentermine	premedication	0	0	Inf	1	0	0	42	2807	460	chlorphentermine	premedication	0	0	1303.26	1	0	1	117	3990	460	chlorphentermine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
461	estrogens, esterified	2.67	2.07	3.39	3.6e-12	70	1284	177479	8685506	461	estrogens, esterified	hormone replacement therapy	2.72	1.85	3.88	7.8e-07	34	545	902	39324	461	estrogens, esterified	hormone replacement therapy	34.3	74	0	0	8.1	1	0	17	91	2989	461	estrogens, esterified	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	461	estrogens, esterified	hormone replacement therapy	0	0	8.61	1	0	19	56	2185	461	estrogens, esterified	hormone replacement therapy	-12.66	3.17564435421807e-06	548.19	0.98	-0.03	0.01	0	0.42	0.2	0.04
462	prilocaine	1.56	1.3	1.85	2.5e-06	132	4149	177417	8682641	462	prilocaine	immunodeficiency common variable	0.15	0	0.92	0.036	1	925	38	5429	462	prilocaine	immunodeficiency common variable	23.1	62.5	0	0	13.28	1	0	112	4	972	462	prilocaine	immunodeficiency common variable	3.27	0.05	63.78	0.35	1	57	2	374	462	prilocaine	immunodeficiency common variable	0	0	15.32	1	0	204	3	1285	462	prilocaine	immunodeficiency common variable	0.3	1.349858807576	1.1	0.78	-0.02	0.02	0.36	1.07	0.85	0.21
463	doxapram	0	0	2.81	0.65	0	66	177549	8686724	463	doxapram	pneumonia	0	0	38.1	1	0	6	395	17659	463	doxapram	pneumonia	28	83	0	0	Inf	1	0	0	49	2600	463	doxapram	pneumonia	0	0	Inf	1	0	0	15	1629	463	doxapram	pneumonia	0	0	Inf	1	0	0	46	1723	463	doxapram	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
464	mefenamic acid	0.92	0.63	1.3	0.73	32	1706	177517	8685084	464	mefenamic acid	pain	1.11	0.44	2.36	0.68	7	140	8462	188344	464	mefenamic acid	pain	23	79	1.03	0.03	6.2	0.63	1	32	1087	35985	464	mefenamic acid	pain	0	0	10.94	1	0	16	364	15301	464	mefenamic acid	pain	1.41	0.03	8.75	0.52	1	22	856	26568	464	mefenamic acid	pain	-0.21	0.810584245970187	1.02	0.83	-0.02	0	0	-0.28	0.06	0
465	aminocaproic acid	15.63	13.53	18	5.1e-192	259	812	177290	8685978	465	aminocaproic acid	coronary artery bypass	3.01	2.09	4.43	7.6e-11	156	38	2696	1976	465	aminocaproic acid	coronary artery bypass	69.7	83	0	0	4225.38	1	0	1	1	115	465	aminocaproic acid	coronary artery bypass	0	0	Inf	1	0	0	1	192	465	aminocaproic acid	coronary artery bypass	0	0	451.8	1	0	1	3	34	465	aminocaproic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
466	iodohippurate sodium i-131	0	0	260.7	1	0	2	177549	8686788	466	iodohippurate sodium i-131	hyperthyroidism	0	0	1655.83	1	0	1	89	3878	466	iodohippurate sodium i-131	hyperthyroidism	30.1	74.3	0	0	Inf	1	0	0	16	629	466	iodohippurate sodium i-131	hyperthyroidism	0	0	Inf	1	0	0	2	248	466	iodohippurate sodium i-131	hyperthyroidism	0	0	Inf	1	0	0	16	672	466	iodohippurate sodium i-131	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
467	tolazamide	3.91	1.64	8.02	0.0015	8	100	177541	8686690	467	tolazamide	diabetes mellitus	13.06	1.46	55.53	0.012	2	16	2325	242882	467	tolazamide	diabetes mellitus	39.3	82	0	0	728.77	1	0	2	377	52482	467	tolazamide	diabetes mellitus	0	0	1126.08	1	0	2	140	29742	467	tolazamide	diabetes mellitus	0	0	Inf	1	0	0	281	28202	467	tolazamide	diabetes mellitus	-7.08	0.000841773148378549	229.63	0.98	-0.01	0	0	-0.75	0.1	0
468	oxazepam	1.65	1.46	1.87	8.9e-14	265	7847	177284	8678943	468	oxazepam	depression	0.72	0.51	0.99	0.041	40	747	14331	192038	468	oxazepam	depression	21	73.3	0.16	0	0.92	0.03	1	85	2061	28257	468	oxazepam	depression	0	0	1.5	0.17	0	42	637	10405	468	oxazepam	depression	0.77	0.2	2.05	0.82	4	76	1667	24308	468	oxazepam	depression	-0.65	0.522045776761016	0.51	0.2	-0.01	0	0	-0.14	0.05	0
469	levomepromazine	1.39	1.07	1.79	0.011	64	2248	177485	8684542	469	levomepromazine	schizophrenia	1.07	0.55	1.9	0.76	12	440	1503	59084	469	levomepromazine	schizophrenia	20.1	64.1	1.33	0.26	4.13	0.5	3	54	291	6960	469	levomepromazine	schizophrenia	2.24	0.44	7.16	0.16	3	39	179	5223	469	levomepromazine	schizophrenia	0	0	4.3	1	0	21	148	3274	469	levomepromazine	schizophrenia	0.3	1.349858807576	0.6	0.61	-0.02	0	0	-0.31	0.11	0.01
470	metaproterenol	2.62	1.53	4.21	0.00036	18	336	177531	8686454	470	metaproterenol	asthma	0.57	0.01	3.3	1	1	58	3043	100316	470	metaproterenol	asthma	9	76	32.46	0.41	2490.04	0.059	1	1	539	17515	470	metaproterenol	asthma	0	0	1618.33	1	0	1	147	6257	470	metaproterenol	asthma	Inf	0.82	Inf	0.03	1	0	457	14562	470	metaproterenol	asthma	3.67	39.2519058603045	1.45	0.01	-0.02	0	0	-0.41	0.1	0
471	haloperidol	1.78	1.67	1.9	1.6e-55	914	25168	176635	8661622	471	haloperidol	schizophrenia	1.08	0.88	1.31	0.44	112	4110	1403	55414	471	haloperidol	schizophrenia	20.1	64.1	0.75	0.4	1.3	0.39	14	438	280	6576	471	haloperidol	schizophrenia	0.83	0.37	1.62	0.75	9	312	173	4950	471	haloperidol	schizophrenia	0.5	0.16	1.22	0.17	5	215	143	3080	471	haloperidol	schizophrenia	-0.4	0.670320046035639	0.28	0.15	-0.02	0	0	-0.31	0.11	0.01
472	haloperidol lactate	1.78	1.67	1.9	1.6e-55	914	25168	176635	8661622	472	haloperidol lactate	schizophrenia	1.08	0.88	1.31	0.44	112	4110	1403	55414	472	haloperidol lactate	schizophrenia	20.1	64.1	0.75	0.4	1.3	0.39	14	438	280	6576	472	haloperidol lactate	schizophrenia	0.83	0.37	1.62	0.75	9	312	173	4950	472	haloperidol lactate	schizophrenia	0.5	0.16	1.22	0.17	5	215	143	3080	472	haloperidol lactate	schizophrenia	-0.4	0.670320046035639	0.28	0.15	-0.02	0	0	-0.31	0.11	0.01
473	sulfameter	0	0	118.34	1	0	3	177549	8686787	473	sulfameter	diabetes mellitus non-insulin-dependent	0	0	4280.45	1	0	1	208	24464	473	sulfameter	diabetes mellitus non-insulin-dependent	NA	NA	0	0	Inf	1	0	0	0	0	473	sulfameter	diabetes mellitus non-insulin-dependent	0	0	Inf	1	0	0	0	0	473	sulfameter	diabetes mellitus non-insulin-dependent	0	0	Inf	1	0	0	0	0	473	sulfameter	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
474	protriptyline	2.42	1.46	3.78	0.00065	20	405	177529	8686385	474	protriptyline	narcolepsy	0.49	0.19	1.03	0.069	7	237	1847	30639	474	protriptyline	narcolepsy	18.4	61.1	0.31	0.01	1.8	0.37	1	45	639	8793	474	protriptyline	narcolepsy	0	0	3.67	0.62	0	20	162	2900	474	protriptyline	narcolepsy	0.29	0.01	1.73	0.38	1	47	550	7621	474	protriptyline	narcolepsy	-1.46	0.232236274729759	1.01	0.15	-0.01	0	0	-0.25	0.09	0.01
475	amantadine	1.8	1.6	2.01	1.1e-21	328	8935	177221	8677855	475	amantadine	parkinson s disease	1.39	1.1	1.74	0.0055	90	2135	782	25789	475	amantadine	parkinson s disease	50.1	85.7	0.81	0.32	1.73	0.72	7	340	156	6158	475	amantadine	parkinson s disease	0.91	0.24	2.46	1	4	184	94	3948	475	amantadine	parkinson s disease	1.12	0.39	2.58	0.82	6	191	79	2806	475	amantadine	parkinson s disease	-0.07	0.932393819905948	0.33	0.83	-0.03	0.01	0	-0.2	0.15	0.18
476	ethynodiol diacetate	4.23	2.64	6.49	3.2e-08	23	266	177526	8686524	476	ethynodiol diacetate	hormone replacement therapy	0	0	19.03	1	0	10	936	39859	476	ethynodiol diacetate	hormone replacement therapy	34.3	74	0	0	Inf	1	0	0	91	3006	476	ethynodiol diacetate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	476	ethynodiol diacetate	hormone replacement therapy	0	0	Inf	1	0	0	56	2204	476	ethynodiol diacetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
477	diphenidol	0	0	2.57	0.41	0	72	177549	8686718	477	diphenidol	hypertension	0	0	11.94	1	0	16	6895	317597	477	diphenidol	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	477	diphenidol	hypertension	0	0	Inf	1	0	0	341	31639	477	diphenidol	hypertension	0	0	279.37	1	0	2	762	39928	477	diphenidol	hypertension	-7.08	0.000841773148378549	139.27	0.96	-0.02	0	0	-0.59	0.07	0
478	droperidol	6.8	5.62	8.17	6.7e-60	131	943	177418	8685847	478	droperidol	anaesthesia	0	0	4.38	1	0	96	60	6508	478	droperidol	anaesthesia	23	71.2	0	0	32.79	1	0	10	9	559	478	droperidol	anaesthesia	0	0	12213.02	1	0	1	1	386	478	droperidol	anaesthesia	0	0	18.2	1	0	13	10	472	478	droperidol	anaesthesia	-14.63	4.42865378096327e-07	1731.47	0.99	0	0.01	0.91	-2.11	1.05	0.05
479	fentanyl citrate	2.29	2.21	2.37	0	3239	69918	174310	8616872	479	fentanyl citrate	pain	0.77	0.71	0.84	2e-09	570	16084	7899	172400	479	fentanyl citrate	pain	23	79	1.02	0.8	1.29	0.81	81	2621	1007	33396	479	fentanyl citrate	pain	1.25	0.85	1.78	0.24	35	1204	329	14113	479	fentanyl citrate	pain	1.02	0.76	1.34	0.89	57	1734	800	24856	479	fentanyl citrate	pain	0.07	1.07250818125422	0.11	0.51	-0.02	0	0	-0.28	0.06	0
480	meprednisone	1.7	0.9	2.94	0.067	13	374	177536	8686416	480	meprednisone	rheumatoid arthritis	0	0	4.78	1	0	106	3410	460271	480	meprednisone	rheumatoid arthritis	33	75	0	0	74.64	1	0	7	1060	113931	480	meprednisone	rheumatoid arthritis	0	0	214.88	1	0	4	180	25387	480	meprednisone	rheumatoid arthritis	0	0	162.57	1	0	4	1011	107960	480	meprednisone	rheumatoid arthritis	-7.76	0.000426456580685654	114.53	0.95	-0.01	0	0	-0.26	0.08	0
481	indomethacin	2.49	2.26	2.74	3.4e-62	454	8939	177095	8677851	481	indomethacin	rheumatoid arthritis	3.18	2.1	4.63	2.5e-07	28	1196	3382	459181	481	indomethacin	rheumatoid arthritis	33	75	3.82	1.02	10.07	0.023	4	113	1056	113825	481	indomethacin	rheumatoid arthritis	0	0	14.5	1	0	38	180	25353	481	indomethacin	rheumatoid arthritis	4.66	1.24	12.37	0.012	4	92	1007	107872	481	indomethacin	rheumatoid arthritis	1.25	3.49034295746184	0.51	0.01	-0.01	0	0	-0.26	0.08	0
482	allopurinol	1.01	0.96	1.06	0.78	1539	74757	176010	8612033	482	allopurinol	hypertension	0.68	0.58	0.8	4.8e-07	164	10929	6731	306684	482	allopurinol	hypertension	38	82.9	0.72	0.47	1.05	0.096	28	2449	953	59960	482	allopurinol	hypertension	0.49	0.23	0.92	0.025	10	1826	331	29813	482	allopurinol	hypertension	1.02	0.6	1.64	0.9	18	922	744	39008	482	allopurinol	hypertension	-0.16	0.852143788966211	0.19	0.41	-0.02	0	0	-0.59	0.07	0
485	intrinsic factor	5.44	0.12	39.23	0.18	1	9	177548	8686781	485	intrinsic factor	colorectal cancer metastatic	0	0	8828.62	1	0	1	47	12341	485	intrinsic factor	colorectal cancer metastatic	38.8	74.6	0	0	Inf	1	0	0	21	1814	485	intrinsic factor	colorectal cancer metastatic	0	0	Inf	1	0	0	14	1343	485	intrinsic factor	colorectal cancer metastatic	0	0	Inf	1	0	0	11	941	485	intrinsic factor	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
488	ethacrynic acid	2.26	1.19	3.92	0.0098	13	282	177536	8686508	488	ethacrynic acid	hypertension	9.97	4.01	21.76	4.4e-06	8	37	6887	317576	488	ethacrynic acid	hypertension	38	82.9	0	0	153.8	1	0	3	981	62406	488	ethacrynic acid	hypertension	0	0	3424.95	1	0	1	341	31638	488	ethacrynic acid	hypertension	0	0	126.83	1	0	3	762	39927	488	ethacrynic acid	hypertension	-8.42	0.000220414652830147	160	0.96	-0.02	0	0	-0.59	0.07	0
489	ethacrynate sodium	3.31	1.73	5.8	0.00029	13	192	177536	8686598	489	ethacrynate sodium	hypertension	11.9	4.72	26.48	1.4e-06	8	31	6887	317582	489	ethacrynate sodium	hypertension	38	82.9	0	0	339.78	1	0	2	981	62407	489	ethacrynate sodium	hypertension	0	0	Inf	1	0	0	341	31639	489	ethacrynate sodium	hypertension	0	0	126.83	1	0	3	762	39927	489	ethacrynate sodium	hypertension	-7.57	0.000515692448612414	112.43	0.95	-0.02	0	0	-0.59	0.07	0
490	thiabendazole	0	0	4.49	1	0	42	177549	8686748	490	thiabendazole	adult t-cell lymphoma/leukaemia	0	0	1228.32	1	0	9	1	288	490	thiabendazole	adult t-cell lymphoma/leukaemia	NA	NA	0	0	Inf	1	0	0	0	0	490	thiabendazole	adult t-cell lymphoma/leukaemia	0	0	Inf	1	0	0	0	33	490	thiabendazole	adult t-cell lymphoma/leukaemia	0	0	Inf	1	0	0	0	34	490	thiabendazole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
491	clofibrate	0	0	2.9	0.64	0	64	177549	8686726	491	clofibrate	blood cholesterol increased	0	0	21.18	1	0	9	2256	94219	491	clofibrate	blood cholesterol increased	39.3	79.8	0	0	40.32	1	0	7	293	16971	491	clofibrate	blood cholesterol increased	0	0	Inf	1	0	0	93	6689	491	clofibrate	blood cholesterol increased	0	0	37.23	1	0	7	234	12487	491	clofibrate	blood cholesterol increased	-9.41	8.1900947351399e-05	202.37	0.96	-0.03	0	0	-0.27	0.12	0.03
492	fluphenazine enanthate	0	0	41.55	1	0	6	177549	8686784	492	fluphenazine enanthate	drug exposure during pregnancy	0	0	1026.79	1	0	2	33	6449	492	fluphenazine enanthate	drug exposure during pregnancy	NA	NA	0	0	Inf	1	0	0	0	0	492	fluphenazine enanthate	drug exposure during pregnancy	0	0	Inf	1	0	0	0	0	492	fluphenazine enanthate	drug exposure during pregnancy	0	0	Inf	1	0	0	0	0	492	fluphenazine enanthate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
493	testolactone	0	0	33.97	1	0	7	177549	8686783	493	testolactone	precocious puberty	0	0	4209.92	1	0	1	11	1270	493	testolactone	precocious puberty	10	10.5	0	0	Inf	1	0	0	0	22	493	testolactone	precocious puberty	0	0	Inf	1	0	0	1	55	493	testolactone	precocious puberty	0	0	Inf	1	0	0	1	256	493	testolactone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
494	clomiphene citrate	1.14	0.75	1.65	0.48	28	1205	177521	8685585	494	clomiphene citrate	ovulation induction	0	0	2.74	0.34	0	207	6	661	494	clomiphene citrate	ovulation induction	34	34.9	0	0	Inf	1	0	0	0	9	494	clomiphene citrate	ovulation induction	0	0	Inf	1	0	0	0	4	494	clomiphene citrate	ovulation induction	0	0	8.62	1	0	36	3	124	494	clomiphene citrate	ovulation induction	-16.77	5.21052565397043e-08	2940.58	1	0.05	0.11	0.63	-15.07	8865.19	1
495	methenamine hippurate	0.59	0.24	1.23	0.18	7	578	177542	8686212	495	methenamine hippurate	multiple sclerosis	1.02	0.12	3.79	0.72	2	101	8343	430256	495	methenamine hippurate	multiple sclerosis	26.5	67	1.31	0.03	7.82	0.54	1	34	1303	58008	495	methenamine hippurate	multiple sclerosis	0	0	23.95	1	0	11	235	14038	495	methenamine hippurate	multiple sclerosis	1.42	0.03	8.55	0.51	1	30	1217	51819	495	methenamine hippurate	multiple sclerosis	0.22	1.24607673058738	1.01	0.83	-0.01	0	0	-0.34	0.07	0
496	pentazocine lactate	3.41	2.72	4.22	8.3e-22	91	1307	177458	8685483	496	pentazocine lactate	pain	5.52	3.86	7.76	5.3e-17	43	174	8426	188310	496	pentazocine lactate	pain	23	79	3.68	0.41	15.41	0.12	2	18	1086	35999	496	pentazocine lactate	pain	0	0	29.29	1	0	7	364	15310	496	pentazocine lactate	pain	4.78	0.52	21.17	0.078	2	13	855	26577	496	pentazocine lactate	pain	1.2	3.32011692273655	0.75	0.11	-0.02	0	0	-0.28	0.06	0
497	acetylcholine chloride	0	0	1.58	0.18	0	116	177549	8686674	497	acetylcholine chloride	adverse event	0	0	361.39	1	0	2	16	1049	497	acetylcholine chloride	adverse event	48.2	73.4	0	0	3986.29	1	0	2	1	217	497	acetylcholine chloride	adverse event	0	0	3934.8	1	0	2	1	214	497	acetylcholine chloride	adverse event	0	0	Inf	1	0	0	2	159	497	acetylcholine chloride	adverse event	-12.2	5.03045560711145e-06	2797.44	1	0	0.03	0.92	-0.98	1.24	0.43
499	pipobroman	0	0	1.05	0.054	0	174	177549	8686616	499	pipobroman	essential thrombocythaemia	0	0	21.05	1	0	45	7	1325	499	pipobroman	essential thrombocythaemia	48	82.1	0	0	4580.48	1	0	1	2	252	499	pipobroman	essential thrombocythaemia	0	0	2743.66	1	0	1	2	146	499	pipobroman	essential thrombocythaemia	0	0	Inf	1	0	0	2	203	499	pipobroman	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
500	deferoxamine mesylate	0.32	0.15	0.59	2.4e-05	10	1532	177539	8685258	500	deferoxamine mesylate	iron overload	1.59	0.41	4.44	0.33	4	471	40	7513	500	deferoxamine mesylate	iron overload	41.1	70.1	8.24	0.14	163.24	0.17	1	26	2	433	500	deferoxamine mesylate	iron overload	0	0	119.01	1	0	26	2	570	500	deferoxamine mesylate	iron overload	16.64	0.21	1309.17	0.11	1	35	1	590	500	deferoxamine mesylate	iron overload	1.85	6.35981952260183	1.16	0.11	0.01	0.02	0.78	0.07	1.01	0.94
501	furosemide	1.71	1.67	1.75	0	7638	222660	169911	8464130	501	furosemide	hypertension	1.19	1.1	1.29	2.1e-05	724	28530	6171	289083	501	furosemide	hypertension	38	82.9	0.77	0.59	0.98	0.032	69	5605	912	56804	501	furosemide	hypertension	0.32	0.16	0.57	7.6e-06	12	3227	329	28412	501	furosemide	hypertension	0.94	0.72	1.21	0.71	67	3716	695	36214	501	furosemide	hypertension	-0.21	0.810584245970187	0.12	0.08	-0.02	0	0	-0.59	0.07	0
502	hydroxyurea	0.55	0.44	0.68	1.3e-09	89	7874	177460	8678916	502	hydroxyurea	chronic myeloid leukaemia	0.47	0.13	1.21	0.16	4	1103	319	40930	502	hydroxyurea	chronic myeloid leukaemia	25.8	72.1	0.43	0.01	2.5	0.73	1	170	105	7735	502	hydroxyurea	chronic myeloid leukaemia	0.99	0.02	5.9	1	1	136	42	5633	502	hydroxyurea	chronic myeloid leukaemia	0	0	2.38	0.41	0	100	75	4644	502	hydroxyurea	chronic myeloid leukaemia	-1.03	0.357006960569147	1.01	0.31	-0.02	0.01	0	-0.74	0.19	0
503	ethambutol	0.34	0.25	0.46	6.5e-17	43	6117	177506	8680673	503	ethambutol	tuberculosis	0.5	0.19	1.17	0.094	8	1771	21	2317	503	ethambutol	tuberculosis	23.8	59	0.86	0.12	5.11	1	3	313	4	358	503	ethambutol	tuberculosis	0.21	0	2.09	0.18	1	343	4	281	503	ethambutol	tuberculosis	1.1	0.08	15.32	1	2	242	2	267	503	ethambutol	tuberculosis	-0.73	0.481908990090202	0.71	0.3	-0.01	0.02	0.6	0.11	0.68	0.88
504	betamethasone valerate	2.14	1.67	2.72	1.6e-08	71	1621	177478	8685169	504	betamethasone valerate	psoriasis	10.13	5.28	17.85	2e-09	13	176	1177	161515	504	betamethasone valerate	psoriasis	25	74.8	0	0	8.65	1	0	51	379	43474	504	betamethasone valerate	psoriasis	0	0	18.29	1	0	31	149	21313	504	betamethasone valerate	psoriasis	4.35	0.11	26.99	0.21	1	23	273	27320	504	betamethasone valerate	psoriasis	0.81	2.24790798667647	1.01	0.42	0	0	0.7	-0.36	0.1	0
505	azathioprine	0.62	0.57	0.68	1.4e-28	479	37536	177070	8649254	505	azathioprine	crohn s disease	0.89	0.74	1.07	0.24	131	14463	1346	132849	505	azathioprine	crohn s disease	15.6	67	1.03	0.7	1.47	0.86	34	2669	372	30025	505	azathioprine	crohn s disease	0.97	0.49	1.76	1	12	1168	136	12830	505	azathioprine	crohn s disease	1.2	0.78	1.78	0.39	28	1860	277	22037	505	azathioprine	crohn s disease	0.09	1.09417428370521	0.17	0.58	-0.01	0	0	-0.21	0.1	0.03
506	flumethasone pivalate	1.32	0.03	7.84	0.54	1	37	177548	8686753	506	flumethasone pivalate	insomnia	0	0	15.94	1	0	7	2943	67581	506	flumethasone pivalate	insomnia	26.9	78.5	0	0	Inf	1	0	0	531	11897	506	flumethasone pivalate	insomnia	0	0	984.83	1	0	1	212	5436	506	flumethasone pivalate	insomnia	0	0	Inf	1	0	0	379	8790	506	flumethasone pivalate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
507	acetaminophen	2.7	2.66	2.74	0	17231	332659	160318	8354131	507	acetaminophen	pain	2.04	1.96	2.14	3e-212	3705	51945	4764	136539	507	acetaminophen	pain	23	79	1.43	1.25	1.62	7.2e-08	380	9843	708	26174	507	acetaminophen	pain	1.07	0.83	1.35	0.59	98	3935	266	11382	507	acetaminophen	pain	1.58	1.37	1.82	2.9e-10	332	7590	525	19000	507	acetaminophen	pain	0.36	1.43332941456034	0.06	0	-0.02	0	0	-0.27	0.06	0
508	propranolol	2.61	2.48	2.75	1.4e-228	1569	29534	175980	8657256	508	propranolol	hypertension	2	1.68	2.37	1.4e-13	147	3420	6748	314193	508	propranolol	hypertension	38	82.9	1.15	0.55	2.14	0.61	10	553	971	61856	508	propranolol	hypertension	1.32	0.27	3.93	0.5	3	212	338	31427	508	propranolol	hypertension	1.24	0.59	2.33	0.47	10	422	752	39508	508	propranolol	hypertension	0.11	1.11627807045887	0.28	0.7	-0.02	0	0	-0.59	0.07	0
509	triamcinolone hexacetonide	4.01	1.26	9.88	0.01	5	61	177544	8686729	509	triamcinolone hexacetonide	juvenile idiopathic arthritis	12.05	0.26	100.67	0.092	1	6	106	7670	509	triamcinolone hexacetonide	juvenile idiopathic arthritis	5.9	32.9	0	0	2324.75	1	0	1	62	3834	509	triamcinolone hexacetonide	juvenile idiopathic arthritis	0	0	3289.98	1	0	1	14	1244	509	triamcinolone hexacetonide	juvenile idiopathic arthritis	0	0	146.01	1	0	3	57	3399	509	triamcinolone hexacetonide	juvenile idiopathic arthritis	-10.41	3.01296747430444e-05	440.53	0.98	0	0.01	0.86	-0.4	0.3	0.18
510	thiothixene	3.24	2.52	4.11	9.2e-17	73	1102	177476	8685688	510	thiothixene	schizophrenia	1.33	0.63	2.49	0.35	10	296	1505	59228	510	thiothixene	schizophrenia	20.1	64.1	0	0	26.12	1	0	5	294	7009	510	thiothixene	schizophrenia	0	0	Inf	1	0	0	182	5262	510	thiothixene	schizophrenia	0	0	19.03	1	0	6	148	3289	510	thiothixene	schizophrenia	-10.55	2.6193480867753e-05	217.91	0.96	-0.02	0	0	-0.31	0.11	0.01
511	carbamazepine	1.25	1.18	1.33	7.1e-13	1112	43436	176437	8643354	511	carbamazepine	epilepsy	1.4	1.16	1.69	0.00032	159	8653	481	36773	511	carbamazepine	epilepsy	13.6	68.1	1.05	0.58	1.81	0.89	17	998	70	4316	511	carbamazepine	epilepsy	0.97	0.36	2.24	1	7	622	34	2930	511	carbamazepine	epilepsy	1.45	0.69	2.81	0.27	12	662	44	3522	511	carbamazepine	epilepsy	0.2	1.22140275816017	0.26	0.44	0	0	0.59	-0.15	0.21	0.46
512	nitrofurantoin, macrocrystalline	3.26	3.03	3.51	1.5e-159	766	11524	176783	8675266	512	nitrofurantoin, macrocrystalline	urinary tract infection	0.86	0.66	1.09	0.22	75	2235	674	17199	512	nitrofurantoin, macrocrystalline	urinary tract infection	22.2	73.2	0.45	0.24	0.77	0.0018	15	513	168	2585	512	nitrofurantoin, macrocrystalline	urinary tract infection	0.46	0.01	2.87	0.72	1	83	30	1157	512	nitrofurantoin, macrocrystalline	urinary tract infection	0.46	0.24	0.8	0.0037	14	580	160	3056	512	nitrofurantoin, macrocrystalline	urinary tract infection	-0.78	0.458406011305224	0.27	0	-0.03	0	0	-0.44	0.2	0.03
513	medrysone	98.05	14.03	1072.69	2.3e-06	4	2	177545	8686788	513	medrysone	carcinoid tumour	116.09	11.36	5522.85	6.4e-06	4	1	101	2955	513	medrysone	carcinoid tumour	46	82.5	Inf	4.69	Inf	0.0015	2	0	19	510	513	medrysone	carcinoid tumour	Inf	6.27	Inf	0.00086	2	0	7	281	513	medrysone	carcinoid tumour	0	0	Inf	1	0	0	18	307	513	medrysone	carcinoid tumour	19.42	271643200.424326	1029.12	0.98	-0.03	0.02	0.04	-0.89	0.46	0.05
514	naloxone	3.15	2.97	3.35	8e-227	1149	17908	176400	8668882	514	naloxone	drug dependence	1.35	1.12	1.62	0.00099	370	6182	195	4391	514	naloxone	drug dependence	21.2	63.9	1.59	0.94	2.82	0.077	72	1244	19	522	514	naloxone	drug dependence	1.45	0.79	2.79	0.26	43	679	16	366	514	naloxone	drug dependence	1.47	0.66	3.71	0.37	36	689	8	225	514	naloxone	drug dependence	0.37	1.44773461466332	0.24	0.12	0.01	0.01	0.33	0.19	0.21	0.36
515	cholestyramine	2.43	2.13	2.76	2.6e-33	248	4999	177301	8681791	515	cholestyramine	crohn s disease	1.63	0.93	2.68	0.074	16	981	1461	146331	515	cholestyramine	crohn s disease	15.6	67	1.42	0.29	4.26	0.47	3	170	403	32524	515	cholestyramine	crohn s disease	0	0	3.94	1	0	91	148	13907	515	cholestyramine	crohn s disease	2.49	0.66	6.59	0.084	4	127	301	23770	515	cholestyramine	crohn s disease	0.53	1.69893230861855	0.51	0.29	-0.01	0	0	-0.21	0.1	0.03
516	norgestrel	3.46	2.85	4.16	1e-28	120	1699	177429	8685091	516	norgestrel	contraception	0.92	0.62	1.31	0.73	32	649	7969	147985	516	norgestrel	contraception	19	43	1.65	0.43	4.64	0.32	4	34	1711	24047	516	norgestrel	contraception	0	0	Inf	1	0	0	0	22	516	norgestrel	contraception	1.42	0.37	3.92	0.53	4	42	1935	28863	516	norgestrel	contraception	0.35	1.41906754859326	0.52	0.5	0	0	0.95	-10.86	114.15	0.92
517	dexamethasone acetate	2.75	1.87	3.9	6.8e-07	33	588	177516	8686202	517	dexamethasone acetate	prophylaxis	1.47	0.3	4.39	0.46	3	165	1276	103386	517	dexamethasone acetate	prophylaxis	23.9	79.7	0	0	45.87	1	0	11	207	23649	517	dexamethasone acetate	prophylaxis	0	0	86.22	1	0	9	82	13719	517	dexamethasone acetate	prophylaxis	0	0	147.81	1	0	4	148	14408	517	dexamethasone acetate	prophylaxis	-9.66	6.37845219315595e-05	243.17	0.97	-0.01	0	0.03	-0.52	0.14	0
518	calcium chloride	4.42	4	4.87	8.9e-135	445	4938	177104	8681852	518	calcium chloride	prophylaxis	1.44	0.46	3.41	0.41	5	281	1274	103270	518	calcium chloride	prophylaxis	23.9	79.7	0	0	7.42	1	0	59	207	23601	518	calcium chloride	prophylaxis	0	0	16.92	1	0	39	82	13689	518	calcium chloride	prophylaxis	0	0	14.99	1	0	26	148	14386	518	calcium chloride	prophylaxis	-11.7	8.29381916075737e-06	295.87	0.97	-0.01	0	0.03	-0.52	0.14	0
519	sodium lactate	0.55	0.33	0.87	0.0096	18	1596	177531	8685194	519	sodium lactate	prophylaxis	0	0	3.01	0.64	0	101	1279	103450	519	sodium lactate	prophylaxis	23.9	79.7	0	0	8.81	1	0	50	207	23610	519	sodium lactate	prophylaxis	0	0	17.88	1	0	37	82	13691	519	sodium lactate	prophylaxis	0	0	15.63	1	0	25	148	14387	519	sodium lactate	prophylaxis	-11.73	8.04869976061602e-06	303.27	0.97	-0.01	0	0.02	-0.52	0.14	0
520	liotrix\>	1.48	1.11	1.93	0.0054	56	1852	177493	8684938	520	liotrix\>	hypertension	2.21	1.37	3.39	0.0012	22	459	6873	317154	520	liotrix\>	hypertension	38	82.9	0	0	17.76	1	0	15	981	62394	520	liotrix\>	hypertension	0	0	223.89	1	0	3	341	31636	520	liotrix\>	hypertension	0	0	17.22	1	0	13	762	39917	520	liotrix\>	hypertension	-9.38	8.43952025333374e-05	132.98	0.94	-0.02	0	0	-0.59	0.07	0
522	invert sugar	0	0	12.68	1	0	16	177549	8686774	522	invert sugar	pneumonia	0	0	1697.89	1	0	1	395	17664	522	invert sugar	pneumonia	28	83	0	0	2004.6	1	0	1	49	2599	522	invert sugar	pneumonia	0	0	Inf	1	0	0	15	1629	522	invert sugar	pneumonia	0	0	1428.23	1	0	1	46	1722	522	invert sugar	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
523	flurazepam	4.83	4.19	5.54	1.2e-75	225	2282	177324	8684508	523	flurazepam	pain	9.82	7.25	13.17	9.4e-38	67	153	8402	188331	523	flurazepam	pain	23	79	3.68	0.41	15.41	0.12	2	18	1086	35999	523	flurazepam	pain	14.05	0.27	175.97	0.09	1	3	363	15314	523	flurazepam	pain	4.14	0.46	17.86	0.097	2	15	855	26575	523	flurazepam	pain	1.69	5.41948070513121	0.63	0.01	-0.02	0	0	-0.28	0.06	0
524	fluphenazine decanoate	1.9	1.4	2.54	5.6e-05	48	1234	177501	8685556	524	fluphenazine decanoate	schizophrenia	0.73	0.27	1.61	0.59	6	322	1509	59202	524	fluphenazine decanoate	schizophrenia	20.1	64.1	0.54	0.01	3.2	1	1	44	293	6970	524	fluphenazine decanoate	schizophrenia	0.9	0.02	5.47	1	1	32	181	5230	524	fluphenazine decanoate	schizophrenia	0	0	4.8	1	0	19	148	3276	524	fluphenazine decanoate	schizophrenia	-0.69	0.501576069066056	1.01	0.5	-0.02	0	0	-0.31	0.11	0.01
526	pentazocine	2.42	1.88	3.07	9.7e-11	72	1457	177477	8685333	526	pentazocine	pain	2.98	1.88	4.54	5.7e-06	25	187	8444	188297	526	pentazocine	pain	23	79	1.84	0.04	11.67	0.43	1	18	1087	35999	526	pentazocine	pain	0	0	46.05	1	0	5	364	15312	526	pentazocine	pain	2.07	0.05	13.48	0.4	1	15	856	26575	526	pentazocine	pain	0.31	1.36342511413218	1.03	0.77	-0.02	0	0	-0.28	0.06	0
527	sterile water for irrigation	0.2	0.06	0.52	4.7e-05	4	964	177545	8685826	527	sterile water for irrigation	parenteral nutrition	0	0	9.47	1	0	103	4	636	527	sterile water for irrigation	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	527	sterile water for irrigation	parenteral nutrition	0	0	Inf	1	0	6	0	58	527	sterile water for irrigation	parenteral nutrition	0	0	Inf	1	0	19	0	59	527	sterile water for irrigation	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
528	sorbitol	2.37	1.66	3.28	4.1e-06	38	786	177511	8686004	528	sorbitol	constipation	0.87	0.1	3.23	1	2	133	726	42156	528	sorbitol	constipation	2.6	80.7	1.63	0.04	9.75	0.47	1	38	168	10386	528	sorbitol	constipation	3.77	0.09	24.04	0.24	1	22	68	5648	528	sorbitol	constipation	0	0	12.22	1	0	21	120	7531	528	sorbitol	constipation	0.6	1.82211880039051	1.02	0.56	-0.03	0	0	-0.22	0.15	0.15
529	cosyntropin	2.13	0.77	4.75	0.071	6	138	177543	8686652	529	cosyntropin	maternal exposure during pregnancy	0	0	2203.08	1	0	2	3	1020	529	cosyntropin	maternal exposure during pregnancy	NA	NA	0	0	Inf	1	0	0	0	0	529	cosyntropin	maternal exposure during pregnancy	0	0	Inf	1	0	0	0	6	529	cosyntropin	maternal exposure during pregnancy	0	0	Inf	1	0	0	0	9	529	cosyntropin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
530	lypressin	48.93	6.55	363.03	0.00015	3	3	177546	8686787	530	lypressin	antibiotic therapy	0	0	722.63	1	0	1	154	2885	530	lypressin	antibiotic therapy	13.6	70.4	0	0	1577.51	1	0	1	17	704	530	lypressin	antibiotic therapy	0	0	Inf	1	0	0	4	534	530	lypressin	antibiotic therapy	0	0	1296.61	1	0	1	15	508	530	lypressin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
531	mafenide acetate	3.06	0.07	19.68	0.29	1	16	177548	8686774	531	mafenide acetate	immunodeficiency common variable	0	0	252.51	1	0	4	39	6350	531	mafenide acetate	immunodeficiency common variable	23.1	62.5	0	0	Inf	1	0	0	4	1084	531	mafenide acetate	immunodeficiency common variable	0	0	Inf	1	0	0	3	431	531	mafenide acetate	immunodeficiency common variable	0	0	Inf	1	0	0	3	1489	531	mafenide acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
532	ferrous fumarate	1.51	1.26	1.8	1.2e-05	129	4170	177420	8682620	532	ferrous fumarate	rheumatoid arthritis	2.65	0.85	6.27	0.044	5	255	3405	460122	532	ferrous fumarate	rheumatoid arthritis	33	75	0	0	8.07	1	0	51	1060	113887	532	ferrous fumarate	rheumatoid arthritis	0	0	83.09	1	0	8	180	25383	532	ferrous fumarate	rheumatoid arthritis	0	0	5.96	1	0	68	1011	107896	532	ferrous fumarate	rheumatoid arthritis	-9.81	5.48998467989523e-05	101.04	0.92	-0.01	0	0	-0.26	0.08	0
533	quinestrol	0	0	14.75	1	0	14	177549	8686776	533	quinestrol	hormone replacement therapy	0	0	36.2	1	0	6	936	39863	533	quinestrol	hormone replacement therapy	34.3	74	0	0	Inf	1	0	0	91	3006	533	quinestrol	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	533	quinestrol	hormone replacement therapy	0	0	Inf	1	0	0	56	2204	533	quinestrol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
534	flavoxate	2.05	1.2	3.28	0.0059	18	430	177531	8686360	534	flavoxate	multiple sclerosis	0	0	3.72	0.63	0	53	8345	430304	534	flavoxate	multiple sclerosis	26.5	67	0	0	17.75	1	0	11	1304	58031	534	flavoxate	multiple sclerosis	0	0	Inf	1	0	0	235	14049	534	flavoxate	multiple sclerosis	0	0	15.33	1	0	12	1218	51837	534	flavoxate	multiple sclerosis	-9.82	5.43535841961575e-05	154.4	0.95	-0.01	0	0	-0.34	0.07	0
535	mesoridazine besylate	3.19	0.63	9.93	0.075	3	46	177546	8686744	535	mesoridazine besylate	schizophrenia	0	0	14.15	1	0	12	1515	59512	535	mesoridazine besylate	schizophrenia	20.1	64.1	0	0	Inf	1	0	0	294	7014	535	mesoridazine besylate	schizophrenia	0	0	Inf	1	0	0	182	5262	535	mesoridazine besylate	schizophrenia	0	0	Inf	1	0	0	148	3295	535	mesoridazine besylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
536	lithium carbonate	2.61	2.42	2.82	7.3e-109	738	13847	176811	8672943	536	lithium carbonate	bipolar disorder	1.02	0.87	1.18	0.82	205	4070	2372	47879	536	lithium carbonate	bipolar disorder	19.9	69	0.82	0.43	1.44	0.59	13	254	352	5631	536	lithium carbonate	bipolar disorder	1.33	0.55	2.79	0.4	8	138	115	2639	536	lithium carbonate	bipolar disorder	0.44	0.16	0.99	0.039	6	210	279	4293	536	lithium carbonate	bipolar disorder	-0.35	0.704688089718713	0.28	0.21	0	0	0.42	-0.34	0.11	0
537	glycine	0.18	0.02	0.64	0.0021	2	556	177547	8686234	537	glycine	prophylaxis	0	0	4.66	1	0	66	1279	103485	537	glycine	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	537	glycine	prophylaxis	0	0	Inf	1	0	0	82	13728	537	glycine	prophylaxis	0	0	106.9	1	0	5	148	14407	537	glycine	prophylaxis	-9.07	0.000115066538646224	238.37	0.97	-0.01	0	0.03	-0.52	0.14	0
538	procarbazine	0.27	0.15	0.46	1.6e-09	14	2519	177535	8684271	538	procarbazine	hodgkin s disease	0.16	0	0.99	0.04	1	1089	21	3646	538	procarbazine	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	19	0	106	538	procarbazine	hodgkin s disease	0	0	Inf	1	0	66	0	452	538	procarbazine	hodgkin s disease	6.03	0.08	475.74	0.27	1	58	1	352	538	procarbazine	hodgkin s disease	1.84	6.29653826102666	1.43	0.2	-0.02	0.04	0.65	-18.07	3365.71	1
539	trimipramine maleate	2.2	1.55	3.05	1.7e-05	38	844	177511	8685946	539	trimipramine maleate	depression	0.96	0.52	1.66	1	14	195	14357	192590	539	trimipramine maleate	depression	21	73.3	0.81	0.02	5.16	1	1	17	2061	28325	539	trimipramine maleate	depression	0	0	13.95	1	0	6	637	10441	539	trimipramine maleate	depression	1.12	0.03	7.48	0.6	1	13	1670	24371	539	trimipramine maleate	depression	-0.09	0.913931185271228	1.03	0.93	-0.01	0	0	-0.14	0.05	0
540	cytarabine	0.22	0.17	0.26	5.7e-89	97	21964	177452	8664826	540	cytarabine	acute lymphocytic leukaemia	1.43	0.82	2.42	0.16	22	2929	48	9154	540	cytarabine	acute lymphocytic leukaemia	6.4	64.6	0.31	0.01	2.16	0.31	1	482	10	1472	540	cytarabine	acute lymphocytic leukaemia	0.74	0.08	3.6	1	2	347	9	1155	540	cytarabine	acute lymphocytic leukaemia	0	0	16.11	1	0	309	2	932	540	cytarabine	acute lymphocytic leukaemia	-0.55	0.576949810380487	0.77	0.48	0	0.01	0.71	1.5	0.77	0.05
541	doxepin	3.01	2.74	3.29	1e-93	502	8187	177047	8678603	541	doxepin	depression	0.76	0.58	0.97	0.031	65	1149	14306	191636	541	doxepin	depression	21	73.3	0.74	0.33	1.43	0.45	9	168	2053	28174	541	doxepin	depression	0.69	0.14	2.11	0.8	3	71	634	10376	541	doxepin	depression	0.8	0.32	1.71	0.72	7	127	1664	24257	541	doxepin	depression	-0.23	0.794533602503334	0.33	0.48	-0.01	0	0	-0.14	0.05	0
542	triclofos sodium	0	0	4.09	1	0	46	177549	8686744	542	triclofos sodium	infection	0	0	9.3	1	0	17	375	14326	542	triclofos sodium	infection	23	72	0	0	Inf	1	0	0	53	2147	542	triclofos sodium	infection	0	0	Inf	1	0	0	24	1576	542	triclofos sodium	infection	0	0	Inf	1	0	0	37	1648	542	triclofos sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
543	ketamine	1.37	1.1	1.68	0.0037	95	3403	177454	8683387	543	ketamine	pain	0.81	0.47	1.32	0.5	17	465	8452	188019	543	ketamine	pain	23	79	0.44	0.01	2.5	0.73	1	76	1087	35941	543	ketamine	pain	1.17	0.03	6.99	0.58	1	36	363	15281	543	ketamine	pain	0	0	2.11	0.42	0	56	857	26534	543	ketamine	pain	-1.23	0.292292577680859	1	0.22	-0.02	0	0	-0.28	0.06	0
544	benzquinamide	0	0	260.7	1	0	2	177549	8686788	544	benzquinamide	pain	0	0	856.37	1	0	1	8469	188483	544	benzquinamide	pain	23	79	0	0	Inf	1	0	0	1088	36017	544	benzquinamide	pain	0	0	Inf	1	0	0	364	15317	544	benzquinamide	pain	0	0	Inf	1	0	0	857	26590	544	benzquinamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
545	amino acids	0.78	0.51	1.15	0.25	26	1627	177523	8685163	545	amino acids	prophylaxis	0.6	0.02	3.4	1	1	135	1278	103416	545	amino acids	prophylaxis	23.9	79.7	0	0	34.72	1	0	14	207	23646	545	amino acids	prophylaxis	0	0	75.89	1	0	10	82	13718	545	amino acids	prophylaxis	0	0	83.35	1	0	6	148	14406	545	amino acids	prophylaxis	-9.67	6.31498553341106e-05	219.65	0.96	-0.01	0	0.03	-0.52	0.14	0
546	magnesium acetate	0	0	3.53	0.63	0	53	177549	8686737	546	magnesium acetate	pain	0	0	11.27	1	0	9	8469	188475	546	magnesium acetate	pain	23	79	0	0	1265.54	1	0	1	1088	36016	546	magnesium acetate	pain	0	0	Inf	1	0	0	364	15317	546	magnesium acetate	pain	0	0	1187.61	1	0	1	857	26589	546	magnesium acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
547	phosphoric acid	8.61	4.99	14.11	1.3e-11	19	108	177530	8686682	547	phosphoric acid	constipation	0	0	13.23	1	0	18	728	42271	547	phosphoric acid	constipation	2.6	80.7	0	0	20.4	1	0	13	169	10411	547	phosphoric acid	constipation	0	0	125.88	1	0	4	69	5666	547	phosphoric acid	constipation	0	0	28.38	1	0	10	120	7542	547	phosphoric acid	constipation	-11.23	1.32700624968067e-05	378.28	0.98	-0.03	0	0	-0.22	0.15	0.15
548	sodium acetate	0.19	0.1	0.35	3.6e-13	11	2790	177538	8684000	548	sodium acetate	peritoneal dialysis	0	0	7.24	1	0	475	128	117117	548	sodium acetate	peritoneal dialysis	29.7	77.4	0	0	Inf	1	0	0	14	15745	548	sodium acetate	peritoneal dialysis	0	0	Inf	1	0	0	9	10126	548	sodium acetate	peritoneal dialysis	0	0	Inf	1	0	0	7	8940	548	sodium acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
549	potassium acetate	1.85	1.4	2.39	2.6e-05	59	1564	177490	8685226	549	potassium acetate	hypertension	3.05	1.29	6.2	0.0065	8	121	6887	317492	549	potassium acetate	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	549	potassium acetate	hypertension	0	0	3424.95	1	0	1	341	31638	549	potassium acetate	hypertension	0	0	1980.45	1	0	1	762	39929	549	potassium acetate	hypertension	-7.02	0.000893825492848894	139.12	0.96	-0.02	0	0	-0.59	0.07	0
550	propoxyphene napsylate	7.1	6.71	7.52	0	1391	9643	176158	8677147	550	propoxyphene napsylate	pain	1.12	0.96	1.29	0.14	204	4078	8265	184406	550	propoxyphene napsylate	pain	23	79	1.95	0.05	12.45	0.41	1	17	1087	36000	550	propoxyphene napsylate	pain	0	0	1600.1	1	0	1	364	15316	550	propoxyphene napsylate	pain	3.66	0.41	15.44	0.12	2	17	855	26573	550	propoxyphene napsylate	pain	1.14	3.12676836518616	0.75	0.13	-0.02	0	0	-0.28	0.06	0
551	pemoline	0.84	0.17	2.51	1	3	174	177546	8686616	551	pemoline	bipolar disorder	0	0	7.26	1	0	12	2577	51937	551	pemoline	bipolar disorder	19.9	69	0	0	Inf	1	0	0	365	5885	551	pemoline	bipolar disorder	0	0	Inf	1	0	0	123	2777	551	pemoline	bipolar disorder	0	0	Inf	1	0	0	285	4503	551	pemoline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
556	oxymetholone	0	0	2.57	0.41	0	72	177549	8686718	556	oxymetholone	aplastic anaemia	0	0	156.05	1	0	8	13	3115	556	oxymetholone	aplastic anaemia	28.8	54.7	0	0	4597.29	1	0	1	1	126	556	oxymetholone	aplastic anaemia	0	0	3339.24	1	0	3	1	270	556	oxymetholone	aplastic anaemia	0	0	Inf	1	0	0	2	296	556	oxymetholone	aplastic anaemia	-12.01	6.08307641893218e-06	2275.77	1	-0.01	0.02	0.54	-0.64	1.23	0.6
557	mitotane	0.29	0.06	0.85	0.017	3	506	177546	8686284	557	mitotane	adrenocortical carcinoma	0	0	Inf	1	0	222	0	66	557	mitotane	adrenocortical carcinoma	NA	NA	0	0	Inf	1	0	0	0	0	557	mitotane	adrenocortical carcinoma	0	0	Inf	1	0	10	0	1	557	mitotane	adrenocortical carcinoma	0	0	Inf	1	0	39	0	14	557	mitotane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
558	fluocinonide	2.64	2.18	3.17	1.3e-19	120	2226	177429	8684564	558	fluocinonide	psoriasis	1.75	0.56	4.13	0.22	5	389	1185	161302	558	fluocinonide	psoriasis	25	74.8	1.74	0.21	6.47	0.32	2	132	377	43393	558	fluocinonide	psoriasis	2.05	0.05	12	0.39	1	70	148	21274	558	fluocinonide	psoriasis	1.25	0.03	7.22	0.55	1	80	273	27263	558	fluocinonide	psoriasis	0.44	1.55270721851134	0.71	0.54	0	0	0.71	-0.36	0.1	0
559	levodopa	1.86	1.73	1.99	1.7e-58	845	22280	176704	8664510	559	levodopa	parkinson s disease	1.67	1.46	1.92	8.1e-14	483	11888	389	16036	559	levodopa	parkinson s disease	50.1	85.7	1.76	1.27	2.43	0.00045	78	2231	85	4267	559	levodopa	parkinson s disease	1.84	1.21	2.81	0.0037	49	1454	49	2678	559	levodopa	parkinson s disease	1.9	1.2	2.99	0.0051	42	1019	43	1978	559	levodopa	parkinson s disease	0.6	1.82211880039051	0.15	0	-0.03	0.01	0	-0.21	0.15	0.16
560	tretinoin	4	3.56	4.48	2.5e-89	327	4008	177222	8682782	560	tretinoin	acute promyelocytic leukaemia	0.24	0.02	1.15	0.066	2	760	9	807	560	tretinoin	acute promyelocytic leukaemia	46	46	0	0	Inf	1	0	0	0	0	560	tretinoin	acute promyelocytic leukaemia	0	0	Inf	1	0	48	0	37	560	tretinoin	acute promyelocytic leukaemia	0	0	40.7	1	0	46	1	47	560	tretinoin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
561	technetium tc-99m sulfur colloid kit	4.89	0.55	20.14	0.071	2	20	177547	8686770	561	technetium tc-99m sulfur colloid kit	nuclear magnetic resonance imaging	0	0	13.78	1	0	3	1146	6520	561	technetium tc-99m sulfur colloid kit	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	561	technetium tc-99m sulfur colloid kit	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	561	technetium tc-99m sulfur colloid kit	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	561	technetium tc-99m sulfur colloid kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
562	floxuridine	0	0	2	0.27	0	92	177549	8686698	562	floxuridine	metastases to liver	0	0	47.64	1	0	9	31	2786	562	floxuridine	metastases to liver	46.4	70.7	0	0	Inf	1	0	0	5	485	562	floxuridine	metastases to liver	0	0	Inf	1	0	0	1	398	562	floxuridine	metastases to liver	0	0	Inf	1	0	0	6	378	562	floxuridine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
563	arginine	0.79	0.5	1.18	0.3	23	1431	177526	8685359	563	arginine	hypertension	0.77	0.21	1.99	0.82	4	240	6891	317373	563	arginine	hypertension	38	82.9	0.91	0.02	5.24	1	1	70	980	62339	563	arginine	hypertension	2.32	0.06	13.8	0.36	1	40	340	31599	563	arginine	hypertension	0	0	5.5	1	0	37	762	39893	563	arginine	hypertension	-0.17	0.843664816596384	1.01	0.86	-0.02	0	0	-0.59	0.07	0
564	haloprogin	0	0	1852.91	1	0	1	177549	8686789	564	haloprogin	bipolar i disorder	0	0	714.45	1	0	1	407	7539	564	haloprogin	bipolar i disorder	21.1	66.1	0	0	Inf	1	0	0	41	862	564	haloprogin	bipolar i disorder	0	0	Inf	1	0	0	20	433	564	haloprogin	bipolar i disorder	0	0	Inf	1	0	0	27	656	564	haloprogin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
565	bupivacaine	1.24	1.08	1.43	0.0022	211	8297	177338	8678493	565	bupivacaine	pain	1.32	0.97	1.75	0.06	51	864	8418	187620	565	bupivacaine	pain	23	79	1.73	0.95	2.91	0.057	15	289	1073	35728	565	bupivacaine	pain	2.46	0.96	5.28	0.03	7	121	357	15196	565	bupivacaine	pain	1.36	0.58	2.75	0.4	8	183	849	26407	565	bupivacaine	pain	0.48	1.61607440219289	0.27	0.07	-0.02	0	0	-0.28	0.06	0
566	carbachol	0.7	0.08	2.57	1	2	140	177547	8686650	566	carbachol	intraocular lens implant	0	0	Inf	1	0	16	0	271	566	carbachol	intraocular lens implant	NA	NA	0	0	Inf	1	0	0	0	0	566	carbachol	intraocular lens implant	0	0	Inf	1	0	2	0	39	566	carbachol	intraocular lens implant	0	0	Inf	1	0	3	0	56	566	carbachol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
567	megestrol acetate	4.05	3.74	4.38	3.1e-190	695	8418	176854	8678372	567	megestrol acetate	non-small cell lung cancer	0	0	1.05	0.054	0	682	173	33245	567	megestrol acetate	non-small cell lung cancer	43.2	79.8	0	0	15.16	1	0	55	26	5303	567	megestrol acetate	non-small cell lung cancer	0	0	27.01	1	0	36	15	3337	567	megestrol acetate	non-small cell lung cancer	0	0	29.63	1	0	28	15	2812	567	megestrol acetate	non-small cell lung cancer	-13.2	1.85060119758191e-06	814.27	0.99	-0.01	0.01	0.35	-0.15	0.37	0.67
568	cromolyn sodium	1.6	1.21	2.08	0.00098	57	1745	177492	8685045	568	cromolyn sodium	asthma	0.99	0.52	1.71	1	13	435	3031	99939	568	cromolyn sodium	asthma	9	76	0	0	2.84	0.64	0	44	540	17472	568	cromolyn sodium	asthma	0	0	8.69	1	0	20	147	6238	568	cromolyn sodium	asthma	0	0	3.77	0.63	0	33	458	14529	568	cromolyn sodium	asthma	-12.07	5.728825626433e-06	197.27	0.95	-0.02	0	0	-0.4	0.1	0
569	diazoxide	0.53	0.17	1.25	0.18	5	459	177544	8686331	569	diazoxide	hypoglycaemia	0.53	0.1	1.84	0.43	3	206	17	613	569	diazoxide	hypoglycaemia	36.9	70.7	14.5	1.51	189.42	0.0092	3	12	2	121	569	diazoxide	hypoglycaemia	0	0	77.91	1	0	45	1	89	569	diazoxide	hypoglycaemia	1.71	0.22	13.23	0.67	3	57	3	98	569	diazoxide	hypoglycaemia	0.44	1.55270721851134	0.78	0.58	0.02	0.01	0.23	-1.62	1.09	0.14
570	betamethasone benzoate	0	0	8.93	1	0	22	177549	8686768	570	betamethasone benzoate	eczema	0	0	60.63	1	0	3	145	3620	570	betamethasone benzoate	eczema	17.2	67.9	0	0	Inf	1	0	0	13	396	570	betamethasone benzoate	eczema	0	0	Inf	1	0	0	7	292	570	betamethasone benzoate	eczema	0	0	Inf	1	0	0	8	378	570	betamethasone benzoate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
571	flucytosine	0.26	0.03	0.94	0.041	2	378	177547	8686412	571	flucytosine	meningitis cryptococcal	0	0	Inf	1	0	75	0	344	571	flucytosine	meningitis cryptococcal	NA	NA	0	0	Inf	1	0	0	0	0	571	flucytosine	meningitis cryptococcal	0	0	Inf	1	0	5	0	49	571	flucytosine	meningitis cryptococcal	0	0	Inf	1	0	7	0	22	571	flucytosine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
572	desonide	3.22	2.63	3.92	1.3e-23	107	1624	177442	8685166	572	desonide	psoriasis	1.59	0.33	4.72	0.44	3	256	1187	161435	572	desonide	psoriasis	25	74.8	1.2	0.03	6.87	0.57	1	96	378	43429	572	desonide	psoriasis	3.43	0.08	20.46	0.26	1	42	148	21302	572	desonide	psoriasis	0	0	5.95	1	0	64	274	27279	572	desonide	psoriasis	0.07	1.07250818125422	1.01	0.95	0	0	0.71	-0.36	0.1	0
573	pancuronium bromide	49.29	42.62	57.05	0	376	374	177173	8686416	573	pancuronium bromide	coronary artery bypass	2.98	2.25	3.98	3.1e-17	265	67	2587	1947	573	pancuronium bromide	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	573	pancuronium bromide	coronary artery bypass	0	0	Inf	1	0	0	1	192	573	pancuronium bromide	coronary artery bypass	0	0	Inf	1	0	0	3	35	573	pancuronium bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
574	gonadotropin, chorionic	0.18	0.05	0.46	6.5e-06	4	1082	177545	8685708	574	gonadotropin, chorionic	in vitro fertilisation	0	0	1.94	0.22	0	211	10	907	574	gonadotropin, chorionic	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	3	0	64	574	gonadotropin, chorionic	in vitro fertilisation	0	0	Inf	1	0	0	0	1	574	gonadotropin, chorionic	in vitro fertilisation	0	0	37.36	1	0	24	2	164	574	gonadotropin, chorionic	in vitro fertilisation	-16.49	6.89420183071731e-08	3413.97	1	-0.08	0.15	0.59	-18.96	17730.37	1
575	sodium fluoride f-18	0	0	12.68	1	0	16	177549	8686774	575	sodium fluoride f-18	lymphoma	0	0	7183.81	1	0	1	39	8091	575	sodium fluoride f-18	lymphoma	54.3	80.9	0	0	Inf	1	0	0	6	1268	575	sodium fluoride f-18	lymphoma	0	0	Inf	1	0	0	3	1095	575	sodium fluoride f-18	lymphoma	0	0	Inf	1	0	0	5	754	575	sodium fluoride f-18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
578	pentagastrin	0	0	1852.91	1	0	1	177549	8686789	578	pentagastrin	chronic myeloid leukaemia	0	0	4702.37	1	0	1	323	42032	578	pentagastrin	chronic myeloid leukaemia	25.8	72.1	0	0	Inf	1	0	0	106	7905	578	pentagastrin	chronic myeloid leukaemia	0	0	Inf	1	0	0	43	5769	578	pentagastrin	chronic myeloid leukaemia	0	0	Inf	1	0	0	75	4744	578	pentagastrin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
579	isosorbide	1.39	1.29	1.5	3.1e-17	741	26070	176808	8660720	579	isosorbide	hypertension	0.99	0.78	1.24	0.95	78	3642	6817	313971	579	isosorbide	hypertension	38	82.9	0.34	0.09	0.87	0.017	4	752	977	61657	579	isosorbide	hypertension	0.39	0.05	1.43	0.25	2	471	339	31168	579	isosorbide	hypertension	0.42	0.09	1.25	0.17	3	369	759	39561	579	isosorbide	hypertension	-0.79	0.453844795282356	0.45	0.08	-0.02	0	0	-0.59	0.07	0
580	chromic phosphate p-32	0	0	4.49	1	0	42	177549	8686748	580	chromic phosphate p-32	adenocarcinoma pancreas	0	0	162.69	1	0	7	8	1584	580	chromic phosphate p-32	adenocarcinoma pancreas	NA	NA	0	0	Inf	1	0	0	0	0	580	chromic phosphate p-32	adenocarcinoma pancreas	0	0	Inf	1	0	0	0	244	580	chromic phosphate p-32	adenocarcinoma pancreas	0	0	Inf	1	0	0	0	186	580	chromic phosphate p-32	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
581	enflurane	0	0	2.69	0.65	0	69	177549	8686721	581	enflurane	anaesthesia	0	0	21.67	1	0	21	60	6583	581	enflurane	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	581	enflurane	anaesthesia	0	0	12213.02	1	0	1	1	386	581	enflurane	anaesthesia	0	0	Inf	1	0	0	10	485	581	enflurane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
582	imipramine pamoate	2.49	1.06	5.03	0.019	8	157	177541	8686633	582	imipramine pamoate	depression	0.34	0.01	1.98	0.37	1	40	14370	192745	582	imipramine pamoate	depression	21	73.3	0	0	73.11	1	0	2	2062	28340	582	imipramine pamoate	depression	0	0	633.29	1	0	1	637	10446	582	imipramine pamoate	depression	0	0	564.1	1	0	1	1671	24383	582	imipramine pamoate	depression	-8.59	0.000185956087655102	139.28	0.95	-0.01	0	0	-0.14	0.05	0
583	clorazepate dipotassium	2.97	2.59	3.38	5.6e-45	240	3963	177309	8682827	583	clorazepate dipotassium	depression	1.18	0.82	1.65	0.31	37	421	14334	192364	583	clorazepate dipotassium	depression	21	73.3	1.21	0.24	3.86	0.74	3	34	2059	28308	583	clorazepate dipotassium	depression	0	0	3.98	0.62	0	17	637	10430	583	clorazepate dipotassium	depression	1.62	0.31	5.28	0.44	3	27	1668	24357	583	clorazepate dipotassium	depression	0.14	1.15027379885723	0.6	0.81	-0.01	0	0	-0.14	0.05	0
584	molindone	1.86	0.38	5.63	0.23	3	79	177546	8686711	584	molindone	depression	1.68	0.19	7.13	0.36	2	16	14369	192769	584	molindone	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	584	molindone	depression	0	0	633.29	1	0	1	637	10446	584	molindone	depression	0	0	Inf	1	0	0	1671	24384	584	molindone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
585	iocetamic acid	0	0	2.43	0.41	0	76	177549	8686714	585	iocetamic acid	hypertension	0	0	9.33	1	0	20	6895	317593	585	iocetamic acid	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	585	iocetamic acid	hypertension	0	0	Inf	1	0	0	341	31639	585	iocetamic acid	hypertension	0	0	Inf	1	0	0	762	39930	585	iocetamic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
586	technetium tc-99m sodium pertechnetate generator	1.85	0.49	4.87	0.29	4	106	177545	8686684	586	technetium tc-99m sodium pertechnetate generator	cardiac stress test	2.86	0.07	20.23	0.32	1	19	17	925	586	technetium tc-99m sodium pertechnetate generator	cardiac stress test	61.9	61.9	0	0	Inf	1	0	0	0	0	586	technetium tc-99m sodium pertechnetate generator	cardiac stress test	0	0	Inf	1	0	0	0	69	586	technetium tc-99m sodium pertechnetate generator	cardiac stress test	0	0	Inf	1	0	0	1	88	586	technetium tc-99m sodium pertechnetate generator	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
587	mazindol	0	0	2.65	0.41	0	70	177549	8686720	587	mazindol	cataplexy	0	0	3.28	0.63	0	21	840	14296	587	mazindol	cataplexy	18	61.5	0	0	Inf	1	0	0	270	4001	587	mazindol	cataplexy	0	0	Inf	1	0	0	56	1292	587	mazindol	cataplexy	0	0	Inf	1	0	0	244	3586	587	mazindol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
588	technetium tc-99m pentetate kit	0.69	0.02	3.97	1	1	71	177548	8686719	588	technetium tc-99m pentetate kit	clear cell renal cell carcinoma	0	0	Inf	1	0	7	0	332	588	technetium tc-99m pentetate kit	clear cell renal cell carcinoma	NA	NA	0	0	Inf	1	0	0	0	0	588	technetium tc-99m pentetate kit	clear cell renal cell carcinoma	0	0	Inf	1	0	0	0	145	588	technetium tc-99m pentetate kit	clear cell renal cell carcinoma	0	0	Inf	1	0	0	0	69	588	technetium tc-99m pentetate kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
589	xenon xe-133	0	0	260.7	1	0	2	177549	8686788	589	xenon xe-133		0	0	Inf	1	0	0	0	0	589	xenon xe-133		NA	NA	0	0	Inf	1	0	0	0	0	589	xenon xe-133		0	0	Inf	1	0	0	0	0	589	xenon xe-133		0	0	Inf	1	0	0	0	0	589	xenon xe-133	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
592	technetium tc-99m sodium pertechnetate	0	0	260.7	1	0	2	177549	8686788	592	technetium tc-99m sodium pertechnetate	multiple gated acquisition scan	0	0	694.39	1	0	1	2	35	592	technetium tc-99m sodium pertechnetate	multiple gated acquisition scan	NA	NA	0	0	Inf	1	0	0	0	0	592	technetium tc-99m sodium pertechnetate	multiple gated acquisition scan	0	0	Inf	1	0	1	0	3	592	technetium tc-99m sodium pertechnetate	multiple gated acquisition scan	0	0	Inf	1	0	0	0	5	592	technetium tc-99m sodium pertechnetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
593	mebutamate	0	0	118.34	1	0	3	177549	8686787	593	mebutamate	myelodysplastic syndrome	0	0	1677.28	1	0	2	79	24432	593	mebutamate	myelodysplastic syndrome	54.7	84.3	0	0	Inf	1	0	0	13	4046	593	mebutamate	myelodysplastic syndrome	0	0	Inf	1	0	0	6	2741	593	mebutamate	myelodysplastic syndrome	0	0	Inf	1	0	0	8	2242	593	mebutamate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
594	trimethoprim	1.54	1.48	1.62	9.5e-71	1985	63120	175564	8623670	594	trimethoprim	hiv infection	0.54	0.35	0.8	0.00096	27	5586	473	52805	594	trimethoprim	hiv infection	25	64	0.34	0.04	1.26	0.13	2	363	118	7278	594	trimethoprim	hiv infection	0.39	0.05	1.45	0.24	2	299	94	5429	594	trimethoprim	hiv infection	0	0	2.4	0.4	0	135	40	3304	594	trimethoprim	hiv infection	-1.23	0.292292577680859	0.71	0.08	0	0.01	0.77	0.39	0.2	0.05
595	magnesium chloride	0.36	0.23	0.53	2.9e-09	24	3301	177525	8683489	595	magnesium chloride	peritoneal dialysis	0	0	7.04	1	0	488	128	117104	595	magnesium chloride	peritoneal dialysis	29.7	77.4	0	0	Inf	1	0	0	14	15745	595	magnesium chloride	peritoneal dialysis	0	0	Inf	1	0	0	9	10126	595	magnesium chloride	peritoneal dialysis	0	0	Inf	1	0	0	7	8940	595	magnesium chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
596	sodium gluconate	0.31	0.1	0.74	0.0031	5	779	177544	8686011	596	sodium gluconate	peritoneal dialysis	0	0	7.2	1	0	477	128	117115	596	sodium gluconate	peritoneal dialysis	29.7	77.4	0	0	Inf	1	0	0	14	15745	596	sodium gluconate	peritoneal dialysis	0	0	Inf	1	0	0	9	10126	596	sodium gluconate	peritoneal dialysis	0	0	Inf	1	0	0	7	8940	596	sodium gluconate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
597	silver sulfadiazine	6.87	5.66	8.28	1.4e-58	127	905	177422	8685885	597	silver sulfadiazine	pain	1.97	0.99	3.55	0.038	12	136	8457	188348	597	silver sulfadiazine	pain	23	79	2.31	0.46	7.24	0.15	3	43	1085	35974	597	silver sulfadiazine	pain	0	0	5.52	1	0	30	364	15287	597	silver sulfadiazine	pain	7.8	2.6	19.65	0.00028	6	24	851	26566	597	silver sulfadiazine	pain	1.34	3.81904350536634	0.44	0	-0.02	0	0	-0.29	0.06	0
598	magnesium acetate tetrahydrate	2.91	1.04	6.55	0.021	6	101	177543	8686689	598	magnesium acetate tetrahydrate	off label use	0	0	17.71	1	0	20	157	13581	598	magnesium acetate tetrahydrate	off label use	24.5	74.9	0	0	Inf	1	0	0	26	2287	598	magnesium acetate tetrahydrate	off label use	0	0	Inf	1	0	0	14	1199	598	magnesium acetate tetrahydrate	off label use	0	0	Inf	1	0	0	16	2074	598	magnesium acetate tetrahydrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
599	metolazone	3.43	3.14	3.74	1.1e-120	538	7690	177011	8679100	599	metolazone	pulmonary arterial hypertension	1.21	0.48	2.51	0.53	7	1049	475	85854	599	metolazone	pulmonary arterial hypertension	28	80	0.71	0.14	2.11	0.8	3	453	267	28591	599	metolazone	pulmonary arterial hypertension	0	0	4.06	1	0	149	55	8609	599	metolazone	pulmonary arterial hypertension	0.89	0.18	2.64	1	3	357	246	25929	599	metolazone	pulmonary arterial hypertension	-0.36	0.697676326071031	0.58	0.54	0	0	0.14	-0.41	0.15	0.01
600	dydrogesterone	1.55	0.42	4.08	0.34	4	126	177545	8686664	600	dydrogesterone	drug exposure during pregnancy	0	0	220.12	1	0	5	33	6446	600	dydrogesterone	drug exposure during pregnancy	NA	NA	0	0	Inf	1	0	0	0	0	600	dydrogesterone	drug exposure during pregnancy	0	0	Inf	1	0	0	0	0	600	dydrogesterone	drug exposure during pregnancy	0	0	Inf	1	0	0	0	0	600	dydrogesterone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
601	azathioprine sodium	0.62	0.57	0.68	3.1e-28	478	37376	177071	8649414	601	azathioprine sodium	crohn s disease	0.9	0.75	1.08	0.27	131	14362	1346	132950	601	azathioprine sodium	crohn s disease	15.6	67	1.04	0.71	1.48	0.78	34	2648	372	30046	601	azathioprine sodium	crohn s disease	0.98	0.49	1.78	1	12	1156	136	12842	601	azathioprine sodium	crohn s disease	1.21	0.78	1.79	0.33	28	1849	277	22048	601	azathioprine sodium	crohn s disease	0.1	1.10517091807565	0.17	0.55	-0.01	0	0	-0.21	0.1	0.03
602	dopamine	9.37	8.67	10.11	0	801	4201	176748	8682589	602	dopamine	prophylaxis	0.71	0.15	2.11	0.8	3	340	1276	103211	602	dopamine	prophylaxis	23.9	79.7	2.39	0.06	14.1	0.35	1	48	206	23612	602	dopamine	prophylaxis	0	0	18.96	1	0	35	82	13693	602	dopamine	prophylaxis	3.76	0.09	23.24	0.24	1	26	147	14386	602	dopamine	prophylaxis	0.67	1.95423732063594	1.01	0.51	-0.01	0	0.03	-0.52	0.14	0
604	clonidine	2.62	2.5	2.75	1.2e-276	1891	35489	175658	8651301	604	clonidine	hypertension	2.09	1.87	2.34	9.5e-32	336	7583	6559	310030	604	clonidine	hypertension	38	82.9	2.1	1.49	2.89	3.4e-05	41	1270	940	61139	604	clonidine	hypertension	2.6	1.39	4.46	0.0017	14	513	327	31126	604	clonidine	hypertension	1.77	1.2	2.54	0.0041	32	963	730	38967	604	clonidine	hypertension	0.6	1.82211880039051	0.15	0	-0.02	0	0	-0.59	0.07	0
605	copper	0.52	0.41	0.64	2.8e-11	85	8008	177464	8678782	605	copper	contraception	0.14	0.1	0.18	1.1e-91	53	6754	7948	141880	605	copper	contraception	19	43	0.07	0.05	0.11	3.9e-81	21	3477	1694	20604	605	copper	contraception	0	0	Inf	1	0	0	0	22	605	copper	contraception	0.09	0.06	0.13	3.7e-81	26	3896	1913	25009	605	copper	contraception	-2.44	0.0871608514619813	0.2	0	0	0	0.37	-10.98	114.13	0.92
606	prazepam	1.8	1.3	2.44	0.00043	43	1168	177506	8685622	606	prazepam	depression	0.89	0.42	1.68	0.88	10	151	14361	192634	606	prazepam	depression	21	73.3	4.58	0.09	57.12	0.24	1	3	2061	28339	606	prazepam	depression	Inf	3.08	Inf	0.0033	2	0	635	10447	606	prazepam	depression	0	0	15.93	1	0	5	1671	24379	606	prazepam	depression	1.97	7.17067648834661	0.84	0.02	-0.01	0	0	-0.14	0.05	0
607	carmustine	0.32	0.18	0.52	8.2e-08	15	2323	177534	8684467	607	carmustine	non-hodgkin s lymphoma	0	0	6.3	1	0	227	32	11609	607	carmustine	non-hodgkin s lymphoma	50.2	86.8	0	0	91.64	1	0	25	4	1459	607	carmustine	non-hodgkin s lymphoma	0	0	70.68	1	0	36	3	1029	607	carmustine	non-hodgkin s lymphoma	0	0	148.64	1	0	14	3	815	607	carmustine	non-hodgkin s lymphoma	-13.51	1.35731781555147e-06	1515.19	0.99	0.02	0.03	0.48	-0.22	0.82	0.79
608	pilocarpine	2.77	2.34	3.26	1.2e-26	154	2723	177395	8684067	608	pilocarpine	rheumatoid arthritis	3.91	2.06	6.77	5.2e-05	13	450	3397	459927	608	pilocarpine	rheumatoid arthritis	33	75	0.88	0.02	5.01	1	1	122	1059	113816	608	pilocarpine	rheumatoid arthritis	0	0	71.97	1	0	9	180	25382	608	pilocarpine	rheumatoid arthritis	0.87	0.02	4.94	1	1	123	1010	107841	608	pilocarpine	rheumatoid arthritis	-0.19	0.826959133943362	1	0.85	-0.01	0	0	-0.26	0.08	0
609	dinoprost tromethamine	0	0	1852.91	1	0	1	177549	8686789	609	dinoprost tromethamine		0	0	Inf	1	0	0	0	0	609	dinoprost tromethamine		NA	NA	0	0	Inf	1	0	0	0	0	609	dinoprost tromethamine		0	0	Inf	1	0	0	0	0	609	dinoprost tromethamine		0	0	Inf	1	0	0	0	0	609	dinoprost tromethamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
610	prazosin	1.2	0.96	1.48	0.099	88	3584	177461	8683206	610	prazosin	hypertension	0.64	0.31	1.18	0.2	10	719	6885	316894	610	prazosin	hypertension	38	82.9	1.77	0.36	5.33	0.25	3	108	978	62301	610	prazosin	hypertension	2.45	0.29	9.23	0.2	2	76	339	31563	610	prazosin	hypertension	0.86	0.02	4.98	1	1	61	761	39869	610	prazosin	hypertension	0.24	1.2712491503214	0.59	0.68	-0.02	0	0	-0.59	0.07	0
611	dantrolene sodium	0.91	0.56	1.39	0.75	21	1133	177528	8685657	611	dantrolene sodium	multiple sclerosis	0.3	0.01	1.71	0.39	1	170	8344	430187	611	dantrolene sodium	multiple sclerosis	26.5	67	0	0	10.79	1	0	17	1304	58025	611	dantrolene sodium	multiple sclerosis	0	0	51.08	1	0	6	235	14043	611	dantrolene sodium	multiple sclerosis	0	0	13.98	1	0	13	1218	51836	611	dantrolene sodium	multiple sclerosis	-9.66	6.37845219315595e-05	122.68	0.94	-0.01	0	0	-0.34	0.07	0
612	disopyramide phosphate	1.19	0.72	1.85	0.46	20	823	177529	8685967	612	disopyramide phosphate	atrial fibrillation	4.03	1.29	9.62	0.0095	5	172	803	111237	612	disopyramide phosphate	atrial fibrillation	49	86.6	0	0	32.43	1	0	32	132	34594	612	disopyramide phosphate	atrial fibrillation	0	0	180.15	1	0	10	56	22063	612	disopyramide phosphate	atrial fibrillation	0	0	28.4	1	0	27	94	17906	612	disopyramide phosphate	atrial fibrillation	-11.24	1.31380231688045e-05	391.97	0.98	-0.01	0	0	-0.76	0.17	0
613	miconazole nitrate	0.51	0.29	0.81	0.0028	17	1643	177532	8685147	613	miconazole nitrate	vulvovaginal mycotic infection	0.36	0.07	1.19	0.12	3	588	23	1611	613	miconazole nitrate	vulvovaginal mycotic infection	52.3	55.1	0	0	Inf	1	0	5	0	23	613	miconazole nitrate	vulvovaginal mycotic infection	0	0	Inf	1	0	0	0	5	613	miconazole nitrate	vulvovaginal mycotic infection	2.13	0.03	167.32	0.54	1	171	1	364	613	miconazole nitrate	vulvovaginal mycotic infection	0.76	2.13827622049682	1.42	0.59	0.03	0.04	0.46	-11.31	2916.66	1
614	technetium tc-99m etidronate kit	0	0	260.7	1	0	2	177549	8686788	614	technetium tc-99m etidronate kit	rheumatoid arthritis	0	0	4865.13	1	0	1	3410	460376	614	technetium tc-99m etidronate kit	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	614	technetium tc-99m etidronate kit	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	614	technetium tc-99m etidronate kit	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	614	technetium tc-99m etidronate kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
615	technetium tc-99m sulfur colloid	0	0	7.16	1	0	27	177549	8686763	615	technetium tc-99m sulfur colloid	lymphatic mapping	0	0	Inf	1	0	7	0	132	615	technetium tc-99m sulfur colloid	lymphatic mapping	NA	NA	0	0	Inf	1	0	0	0	0	615	technetium tc-99m sulfur colloid	lymphatic mapping	0	0	Inf	1	0	0	0	10	615	technetium tc-99m sulfur colloid	lymphatic mapping	0	0	Inf	1	0	7	0	40	615	technetium tc-99m sulfur colloid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
616	ibuprofen	2.65	2.59	2.71	0	7460	141384	170089	8545406	616	ibuprofen	pain	1.94	1.83	2.06	2.3e-90	1353	16826	7116	171658	616	ibuprofen	pain	23	79	1.59	1.33	1.89	3.3e-07	161	3540	927	32477	616	ibuprofen	pain	0.74	0.47	1.12	0.16	25	1387	339	13930	616	ibuprofen	pain	1.96	1.63	2.35	2.4e-12	158	2745	699	23845	616	ibuprofen	pain	0.34	1.40494759056359	0.08	0	-0.02	0	0	-0.28	0.06	0
617	terbutaline	1.23	1.02	1.47	0.026	123	4884	177426	8681906	617	terbutaline	asthma	1.19	0.83	1.65	0.32	37	1031	3007	99343	617	terbutaline	asthma	9	76	1.76	0.86	3.25	0.07	11	204	529	17312	617	terbutaline	asthma	0	0	2.15	0.42	0	75	147	6183	617	terbutaline	asthma	2.32	1.12	4.3	0.018	11	153	447	14409	617	terbutaline	asthma	0.48	1.61607440219289	0.31	0.12	-0.02	0	0	-0.41	0.1	0
618	pimozide	3.24	2.26	4.53	2.7e-09	37	558	177512	8686232	618	pimozide	psychotic disorder	0	0	3.16	0.63	0	33	542	14422	618	pimozide	psychotic disorder	18.9	65.5	0	0	46.74	1	0	3	99	1895	618	pimozide	psychotic disorder	0	0	903.57	1	0	1	60	1409	618	pimozide	psychotic disorder	0	0	114.35	1	0	2	51	1084	618	pimozide	psychotic disorder	-11.39	1.13080013358472e-05	509.64	0.98	-0.01	0.01	0.13	-0.14	0.2	0.48
619	gallium citrate ga-67	0	0	33.97	1	0	7	177549	8686783	619	gallium citrate ga-67	scan gallium	0	0	Inf	1	0	3	0	0	619	gallium citrate ga-67	scan gallium	NA	NA	0	0	Inf	1	0	0	0	0	619	gallium citrate ga-67	scan gallium	0	0	Inf	1	0	0	0	0	619	gallium citrate ga-67	scan gallium	0	0	Inf	1	0	0	0	0	619	gallium citrate ga-67	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
620	mebendazole	1.92	1.16	2.99	0.0076	20	511	177529	8686279	620	mebendazole	intentional self-injury	0	0	25.33	1	0	11	14	798	620	mebendazole	intentional self-injury	11.1	29.5	0	0	9.18	1	0	8	6	72	620	mebendazole	intentional self-injury	0	0	Inf	1	0	0	0	118	620	mebendazole	intentional self-injury	0	0	22.61	1	0	8	8	257	620	mebendazole	intentional self-injury	-19.84	2.4187861827158e-09	10319.39	1	-0.1	0.03	0	-17.64	2388.23	0.99
621	potassium phosphate, monobasic	0	0	9.91	1	0	20	177549	8686770	621	potassium phosphate, monobasic	induction of anaesthesia	0	0	159.46	1	0	9	13	3665	621	potassium phosphate, monobasic	induction of anaesthesia	38.2	60.8	0	0	Inf	1	0	0	0	223	621	potassium phosphate, monobasic	induction of anaesthesia	0	0	Inf	1	0	0	1	301	621	potassium phosphate, monobasic	induction of anaesthesia	0	0	Inf	1	0	0	1	354	621	potassium phosphate, monobasic	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
622	potassium phosphate, dibasic	0	0	33.97	1	0	7	177549	8686783	622	potassium phosphate, dibasic	prophylaxis of nausea and vomiting	0	0	253.33	1	0	3	80	8346	622	potassium phosphate, dibasic	prophylaxis of nausea and vomiting	14	75	0	0	Inf	1	0	0	9	1950	622	potassium phosphate, dibasic	prophylaxis of nausea and vomiting	0	0	Inf	1	0	0	5	1022	622	potassium phosphate, dibasic	prophylaxis of nausea and vomiting	0	0	Inf	1	0	0	8	1317	622	potassium phosphate, dibasic	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
623	calcitonin salmon	5.25	4.73	5.83	6.7e-144	400	3732	177149	8683058	623	calcitonin salmon	osteoporosis	2.63	2.23	3.09	1e-26	179	1234	8623	156452	623	calcitonin salmon	osteoporosis	53.1	85	0	0	3.28	0.63	0	36	808	24532	623	calcitonin salmon	osteoporosis	0	0	57.79	1	0	8	31	2927	623	calcitonin salmon	osteoporosis	0.91	0.02	5.44	1	1	34	867	26853	623	calcitonin salmon	osteoporosis	-0.19	0.826959133943362	1.01	0.85	-0.01	0	0	-1.15	0.18	0
624	glyburide	1.72	1.62	1.83	1.3e-61	1133	32251	176416	8654539	624	glyburide	diabetes mellitus	3.32	2.85	3.84	1.1e-43	203	6800	2124	236098	624	glyburide	diabetes mellitus	39.3	82	4.32	2.69	6.63	2.4e-08	23	778	354	51706	624	glyburide	diabetes mellitus	6.81	3.4	12.44	6.6e-07	12	404	128	29340	624	glyburide	diabetes mellitus	2.78	1.41	4.98	0.0021	12	446	269	27756	624	glyburide	diabetes mellitus	1.4	4.05519996684467	0.21	0	-0.01	0	0	-0.75	0.1	0
625	calcium	1.18	1.15	1.21	1.1e-41	7295	303770	170254	8383020	625	calcium	peritoneal dialysis	0.8	0.55	1.15	0.23	75	75245	53	42347	625	calcium	peritoneal dialysis	29.7	77.4	0.56	0.16	2.46	0.31	10	12854	4	2891	625	calcium	peritoneal dialysis	0.32	0.07	1.63	0.093	5	8046	4	2080	625	calcium	peritoneal dialysis	1.24	0.15	57.07	1	6	7409	1	1531	625	calcium	peritoneal dialysis	-0.61	0.5433508690745	0.54	0.26	-0.01	0.01	0.34	0.14	0.51	0.79
626	meglumine	3.8	2.4	5.76	1.1e-07	24	309	177525	8686481	626	meglumine	nuclear magnetic resonance imaging	1.77	0.87	3.38	0.085	13	42	1133	6481	626	meglumine	nuclear magnetic resonance imaging	26.3	65.4	0	0	2017	1	0	1	10	533	626	meglumine	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	626	meglumine	nuclear magnetic resonance imaging	0	0	2305.85	1	0	1	9	551	626	meglumine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
629	loxapine succinate	0.63	0.13	1.86	0.64	3	233	177546	8686557	629	loxapine succinate	bipolar disorder	0	0	2.95	0.64	0	27	2577	51922	629	loxapine succinate	bipolar disorder	19.9	69	0	0	Inf	1	0	0	365	5885	629	loxapine succinate	bipolar disorder	0	0	Inf	1	0	0	123	2777	629	loxapine succinate	bipolar disorder	0	0	Inf	1	0	0	285	4503	629	loxapine succinate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
630	trimethobenzamide	5.26	4.2	6.52	5.9e-35	93	866	177456	8685924	630	trimethobenzamide	nausea	2.59	1.38	4.52	0.002	14	135	1210	30273	630	trimethobenzamide	nausea	17.2	77	9	2.61	25.02	0.00051	5	20	213	7672	630	trimethobenzamide	nausea	27.67	2.57	174.25	0.0043	2	5	48	3336	630	trimethobenzamide	nausea	5.12	0.95	17.93	0.028	3	17	192	5577	630	trimethobenzamide	nausea	2.29	9.87493768117318	0.51	0	-0.03	0	0	-0.76	0.16	0
631	clonazepam	3.88	3.78	3.98	0	6492	84167	171057	8602623	631	clonazepam	depression	1.78	1.68	1.89	4.3e-74	1401	11028	12970	181757	631	clonazepam	depression	21	73.3	1.57	1.34	1.83	2.4e-08	206	1870	1856	26472	631	clonazepam	depression	2.24	1.67	2.95	1.1e-07	64	497	573	9950	631	clonazepam	depression	1.53	1.28	1.82	3.8e-06	157	1546	1514	22838	631	clonazepam	depression	0.55	1.7332530178674	0.07	0	-0.01	0	0	-0.13	0.05	0.01
632	butalbital	3.23	2.91	3.59	2.5e-79	380	5758	177169	8681032	632	butalbital	migraine	1.55	1.17	2.01	0.0017	62	913	1725	39332	632	butalbital	migraine	20.7	70.1	2.49	1.31	4.38	0.005	14	161	253	7239	632	butalbital	migraine	0	0	6.18	1	0	22	32	1027	632	butalbital	migraine	2.45	1.29	4.32	0.0052	14	160	251	7041	632	butalbital	migraine	0.91	2.48432253338482	0.29	0	-0.02	0	0	-0.2	0.19	0.29
633	probucol	0.15	0	0.85	0.026	1	323	177548	8686467	633	probucol	cerebral infarction	0	0	8.12	1	0	106	21	4411	633	probucol	cerebral infarction	49.8	69.9	0	0	6.06	1	0	34	5	181	633	probucol	cerebral infarction	0	0	37.78	1	0	57	2	400	633	probucol	cerebral infarction	0	0	10.52	1	0	30	5	277	633	probucol	cerebral infarction	-15.63	1.62921067808256e-07	1841.46	0.99	-0.04	0.02	0.01	-1.33	0.85	0.12
634	betamethasone dipropionate	2.29	1.96	2.65	5.9e-23	188	4025	177361	8682765	634	betamethasone dipropionate	psoriasis	1.93	1.11	3.11	0.016	17	1207	1173	160484	634	betamethasone dipropionate	psoriasis	25	74.8	0.35	0.01	2	0.54	1	322	378	43203	634	betamethasone dipropionate	psoriasis	0	0	3.51	0.63	0	153	149	21191	634	betamethasone dipropionate	psoriasis	0.49	0.01	2.8	0.73	1	202	273	27141	634	betamethasone dipropionate	psoriasis	-1.13	0.323033256422253	1	0.26	0	0	0.71	-0.36	0.1	0
635	technetium tc-99m pyrophosphate kit	0	0	19.5	1	0	11	177549	8686779	635	technetium tc-99m pyrophosphate kit	multiple gated acquisition scan	0	0	37.87	1	0	5	2	31	635	technetium tc-99m pyrophosphate kit	multiple gated acquisition scan	NA	NA	0	0	Inf	1	0	0	0	0	635	technetium tc-99m pyrophosphate kit	multiple gated acquisition scan	0	0	Inf	1	0	1	0	3	635	technetium tc-99m pyrophosphate kit	multiple gated acquisition scan	0	0	Inf	1	0	2	0	3	635	technetium tc-99m pyrophosphate kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
636	maprotiline	1.99	1.41	2.73	0.00012	40	983	177509	8685807	636	maprotiline	depression	0.94	0.6	1.43	0.92	24	341	14347	192444	636	maprotiline	depression	21	73.3	0	0	2.19	0.41	0	25	2062	28317	636	maprotiline	depression	0	0	17.92	1	0	5	637	10442	636	maprotiline	depression	1.27	0.14	5.14	0.67	2	23	1669	24361	636	maprotiline	depression	0.1	1.10517091807565	0.73	0.9	-0.01	0	0	-0.14	0.05	0
637	sodium nitroprusside	47.23	39.8	55.92	2e-294	267	277	177282	8686513	637	sodium nitroprusside	coronary artery bypass	4.23	2.78	6.65	5.9e-15	155	27	2697	1987	637	sodium nitroprusside	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	637	sodium nitroprusside	coronary artery bypass	0	0	Inf	1	0	0	1	192	637	sodium nitroprusside	coronary artery bypass	0	0	Inf	1	0	0	3	35	637	sodium nitroprusside	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
638	potassium perchlorate	0	0	6.89	1	0	28	177549	8686762	638	potassium perchlorate	neuroblastoma	0	0	Inf	1	0	11	0	1116	638	potassium perchlorate	neuroblastoma	NA	NA	0	0	Inf	1	0	0	0	0	638	potassium perchlorate	neuroblastoma	0	0	Inf	1	0	0	0	135	638	potassium perchlorate	neuroblastoma	0	0	Inf	1	0	0	0	103	638	potassium perchlorate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
639	carbidopa	2.01	1.88	2.16	2.4e-71	834	20307	176715	8666483	639	carbidopa	parkinson s disease	1.64	1.43	1.88	1e-12	440	10709	432	17215	639	carbidopa	parkinson s disease	50.1	85.7	1.65	1.18	2.28	0.0026	69	2002	94	4496	639	carbidopa	parkinson s disease	1.78	1.16	2.71	0.0059	44	1298	54	2834	639	carbidopa	parkinson s disease	1.75	1.1	2.76	0.017	37	918	48	2079	639	carbidopa	parkinson s disease	0.55	1.7332530178674	0.15	0	-0.03	0.01	0	-0.21	0.15	0.17
640	halcinonide	3.67	1.31	8.34	0.0078	6	80	177543	8686710	640	halcinonide	psoriasis	0	0	15.12	1	0	35	1190	161656	640	halcinonide	psoriasis	25	74.8	0	0	51.42	1	0	10	379	43515	640	halcinonide	psoriasis	0	0	157.47	1	0	5	149	21339	640	halcinonide	psoriasis	0	0	69.53	1	0	7	274	27336	640	halcinonide	psoriasis	-9.82	5.43535841961575e-05	254.37	0.97	0	0	0.71	-0.36	0.1	0
641	danazol	0.47	0.26	0.77	0.0012	15	1573	177534	8685217	641	danazol	idiopathic thrombocytopenic purpura	0.57	0.01	3.35	1	1	480	46	12584	641	danazol	idiopathic thrombocytopenic purpura	NA	NA	0	0	Inf	1	0	0	0	0	641	danazol	idiopathic thrombocytopenic purpura	0	0	Inf	1	0	0	0	0	641	danazol	idiopathic thrombocytopenic purpura	0	0	Inf	1	0	0	0	0	641	danazol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
642	albuterol	2.1	2.05	2.15	0	6983	166374	170566	8520416	642	albuterol	asthma	1.49	1.38	1.6	1.9e-26	1411	36897	1633	63477	642	albuterol	asthma	9	76	1.29	1.08	1.53	0.0044	251	7055	289	10461	642	albuterol	asthma	1.01	0.7	1.43	1	53	2249	94	4009	642	albuterol	asthma	1.4	1.16	1.7	0.00039	218	5721	240	8841	642	albuterol	asthma	0.23	1.25860000992948	0.08	0.01	-0.02	0	0	-0.4	0.1	0
643	colestipol	2.53	2.04	3.11	7.9e-15	95	1838	177454	8684952	643	colestipol	crohn s disease	1.43	0.52	3.15	0.32	6	419	1471	146893	643	colestipol	crohn s disease	15.6	67	0.79	0.02	4.52	1	1	102	405	32592	643	colestipol	crohn s disease	0	0	9.47	1	0	39	148	13959	643	colestipol	crohn s disease	0.98	0.02	5.66	1	1	80	304	23817	643	colestipol	crohn s disease	-0.26	0.771051585803566	1.01	0.79	-0.01	0	0	-0.21	0.1	0.04
644	sulfacytine	0	0	1852.91	1	0	1	177549	8686789	644	sulfacytine	elevated mood	0	0	541.39	1	0	1	4	55	644	sulfacytine	elevated mood	16	16	0	0	Inf	1	0	0	0	0	644	sulfacytine	elevated mood	0	0	155.62	1	0	1	1	3	644	sulfacytine	elevated mood	0	0	Inf	1	0	0	0	1	644	sulfacytine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
645	beclomethasone dipropionate	2.18	1.95	2.42	4e-37	352	7924	177197	8678866	645	beclomethasone dipropionate	asthma	1.07	0.81	1.39	0.58	60	1851	2984	98523	645	beclomethasone dipropionate	asthma	9	76	0.51	0.01	2.93	1	1	64	539	17452	645	beclomethasone dipropionate	asthma	0	0	8.24	1	0	21	147	6237	645	beclomethasone dipropionate	asthma	0.56	0.01	3.25	1	1	57	457	14505	645	beclomethasone dipropionate	asthma	-0.76	0.467666427009909	1.01	0.45	-0.02	0	0	-0.41	0.1	0
646	dacarbazine	0.49	0.33	0.71	3.6e-05	29	2868	177520	8683922	646	dacarbazine	hodgkin s disease	1.38	0.47	3.6	0.47	7	1198	15	3537	646	dacarbazine	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	21	0	104	646	dacarbazine	hodgkin s disease	0	0	Inf	1	0	123	0	395	646	dacarbazine	hodgkin s disease	0	0	17.81	1	0	95	2	315	646	dacarbazine	hodgkin s disease	-17.38	2.83114364241981e-08	4834.65	1	-0.01	0.04	0.8	-18.12	3355.1	1
647	oxybutynin chloride	2.33	2.11	2.55	6.3e-55	457	9630	177092	8677160	647	oxybutynin chloride	multiple sclerosis	0.76	0.51	1.1	0.16	29	1963	8316	428394	647	oxybutynin chloride	multiple sclerosis	26.5	67	0.49	0.16	1.17	0.14	5	448	1299	57594	647	oxybutynin chloride	multiple sclerosis	0.81	0.02	4.68	1	1	74	234	13975	647	oxybutynin chloride	multiple sclerosis	0.36	0.1	0.93	0.03	4	472	1214	51377	647	oxybutynin chloride	multiple sclerosis	-0.83	0.436049286321536	0.45	0.06	-0.01	0	0	-0.35	0.07	0
648	naproxen	2.67	2.56	2.78	0	2564	47476	174985	8639314	648	naproxen	rheumatoid arthritis	1.75	1.4	2.15	1.2e-06	93	7269	3317	453108	648	naproxen	rheumatoid arthritis	33	75	1.57	1.02	2.3	0.028	27	1870	1033	112068	648	naproxen	rheumatoid arthritis	2.8	1.25	5.49	0.0069	9	468	171	24923	648	naproxen	rheumatoid arthritis	1.13	0.67	1.8	0.61	18	1704	993	106260	648	naproxen	rheumatoid arthritis	0.33	1.39096812846378	0.2	0.1	-0.01	0	0	-0.26	0.08	0
649	lomustine	0.17	0.02	0.62	0.0015	2	569	177547	8686221	649	lomustine	brain neoplasm malignant	1.42	0.03	9.17	0.52	1	88	18	2243	649	lomustine	brain neoplasm malignant	29.4	56	1.17	0.03	9.1	0.6	1	24	9	253	649	lomustine	brain neoplasm malignant	3.24	0.07	27.88	0.3	1	16	7	365	649	lomustine	brain neoplasm malignant	0	0	22.44	1	0	19	4	266	649	lomustine	brain neoplasm malignant	0.56	1.7506725002961	1.06	0.6	-0.01	0.01	0.41	0.44	0.62	0.47
650	beta carotene	1.58	0.78	2.86	0.13	11	341	177538	8686449	650	beta carotene	supplementation therapy	4.35	0.1	29.55	0.22	1	12	318	16590	650	beta carotene	supplementation therapy	20	78.6	0	0	131.14	1	0	3	99	5329	650	beta carotene	supplementation therapy	0	0	203.56	1	0	3	24	1964	650	beta carotene	supplementation therapy	0	0	1847.17	1	0	1	87	4242	650	beta carotene	supplementation therapy	-10.32	3.29671152802416e-05	433.33	0.98	-0.02	0	0	-0.43	0.23	0.06
651	chloroxine	3.37	0.39	13.34	0.13	2	29	177547	8686761	651	chloroxine	atrial fibrillation	0	0	331.8	1	0	3	808	111406	651	chloroxine	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	651	chloroxine	atrial fibrillation	0	0	Inf	1	0	0	56	22073	651	chloroxine	atrial fibrillation	0	0	Inf	1	0	0	94	17933	651	chloroxine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
652	azatadine maleate	9.47	3.23	23.03	8.8e-05	6	31	177543	8686759	652	azatadine maleate	malignant melanoma of sites other than skin	0	0	168.56	1	0	3	1	12	652	azatadine maleate	malignant melanoma of sites other than skin	NA	NA	0	0	Inf	1	0	0	0	0	652	azatadine maleate	malignant melanoma of sites other than skin	0	0	Inf	1	0	0	0	1	652	azatadine maleate	malignant melanoma of sites other than skin	0	0	Inf	1	0	0	0	5	652	azatadine maleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
653	fenoprofen calcium	1.5	0.3	4.51	0.46	3	98	177546	8686692	653	fenoprofen calcium	rheumatoid arthritis	0	0	23.51	1	0	23	3410	460354	653	fenoprofen calcium	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	653	fenoprofen calcium	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	653	fenoprofen calcium	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	653	fenoprofen calcium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
655	clotrimazole	3.26	2.97	3.57	1.5e-103	494	7434	177055	8679356	655	clotrimazole	pain	3.02	2.31	3.89	5.3e-14	69	512	8400	187972	655	clotrimazole	pain	23	79	3.36	1.74	5.98	0.00029	13	129	1075	35888	655	clotrimazole	pain	4.09	1.27	10.25	0.01	5	52	359	15265	655	clotrimazole	pain	2.96	1.31	5.89	0.0053	9	95	848	26495	655	clotrimazole	pain	1.27	3.56085256235552	0.28	0	-0.02	0	0	-0.28	0.06	0
656	isoflurane	6.08	5.24	7.03	5e-86	208	1675	177341	8685115	656	isoflurane	anaesthesia	0.4	0.05	1.5	0.23	2	530	58	6074	656	isoflurane	anaesthesia	23	71.2	0	0	17.93	1	0	17	9	552	656	isoflurane	anaesthesia	0	0	612.99	1	0	23	1	364	656	isoflurane	anaesthesia	0	0	13.43	1	0	17	10	468	656	isoflurane	anaesthesia	-14.94	3.24818263581871e-07	1620.36	0.99	0	0.01	0.88	-2.06	1.05	0.05
657	tolmetin sodium	1.88	0.68	4.19	0.15	6	156	177543	8686634	657	tolmetin sodium	rheumatoid arthritis	0	0	21.49	1	0	25	3410	460352	657	tolmetin sodium	rheumatoid arthritis	33	75	0	0	3934.41	1	0	1	1060	113937	657	tolmetin sodium	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	657	tolmetin sodium	rheumatoid arthritis	0	0	3910.38	1	0	1	1011	107963	657	tolmetin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
658	sodium iodide i-123	0	0	8.13	1	0	24	177549	8686766	658	sodium iodide i-123	scan thyroid gland	0	0	Inf	1	0	10	0	22	658	sodium iodide i-123	scan thyroid gland	NA	NA	0	0	Inf	1	0	0	0	0	658	sodium iodide i-123	scan thyroid gland	0	0	Inf	1	0	0	0	0	658	sodium iodide i-123	scan thyroid gland	0	0	Inf	1	0	1	0	5	658	sodium iodide i-123	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
659	protirelin	0	0	8.13	1	0	24	177549	8686766	659	protirelin	diagnostic procedure	0	0	89.05	1	0	11	21	4373	659	protirelin	diagnostic procedure	43.1	71	0	0	Inf	1	0	0	6	1089	659	protirelin	diagnostic procedure	0	0	Inf	1	0	0	4	836	659	protirelin	diagnostic procedure	0	0	Inf	1	0	0	4	1172	659	protirelin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
660	soybean oil	0	0	0.6	0.0035	0	303	177549	8686487	660	soybean oil	prophylaxis	0	0	8.04	1	0	39	1279	103512	660	soybean oil	prophylaxis	23.9	79.7	0	0	275.81	1	0	3	207	23657	660	soybean oil	prophylaxis	0	0	256.29	1	0	4	82	13724	660	soybean oil	prophylaxis	0	0	3585.07	1	0	1	148	14411	660	soybean oil	prophylaxis	-8.67	0.00017165910422453	239.09	0.97	-0.01	0	0.03	-0.52	0.14	0
661	menotropins\>	0.86	0.47	1.45	0.71	14	798	177535	8685992	661	menotropins\>	in vitro fertilisation	2.02	0.42	8.6	0.28	4	277	6	841	661	menotropins\>	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	16	0	51	661	menotropins\>	in vitro fertilisation	0	0	Inf	1	0	0	0	1	661	menotropins\>	in vitro fertilisation	3.67	0.05	291.63	0.39	1	40	1	148	661	menotropins\>	in vitro fertilisation	1.47	4.34923514106274	1.47	0.32	-0.07	0.1	0.51	-14.8	3956.18	1
663	lactulose	1.43	1.31	1.55	1.5e-16	620	21284	176929	8665506	663	lactulose	constipation	1.08	0.81	1.42	0.57	58	3138	670	39151	663	lactulose	constipation	2.6	80.7	0.68	0.3	1.32	0.31	9	800	160	9624	663	lactulose	constipation	0.16	0	0.95	0.042	1	468	68	5202	663	lactulose	constipation	1.46	0.68	2.81	0.24	10	443	110	7109	663	lactulose	constipation	-0.16	0.852143788966211	0.31	0.62	-0.03	0	0	-0.22	0.15	0.15
664	loxapine	2.07	1.5	2.8	1.7e-05	44	1039	177505	8685751	664	loxapine	psychotic disorder	1.01	0.32	2.43	0.82	5	132	537	14323	664	loxapine	psychotic disorder	18.9	65.5	1.94	0.22	8.16	0.3	2	20	97	1878	664	loxapine	psychotic disorder	0	0	4.83	1	0	20	60	1390	664	loxapine	psychotic disorder	21.91	1.56	306.91	0.011	2	2	49	1084	664	loxapine	psychotic disorder	0.68	1.97387773223045	0.75	0.36	-0.01	0.01	0.14	-0.15	0.2	0.45
665	clemastine fumarate	0.96	0.58	1.49	1	20	1021	177529	8685769	665	clemastine fumarate	premedication	0.32	0.01	1.79	0.38	1	180	496	28182	665	clemastine fumarate	premedication	13.8	73.2	0	0	17.62	1	0	10	143	5591	665	clemastine fumarate	premedication	0	0	361.32	1	0	2	42	2805	665	clemastine fumarate	premedication	0	0	15.37	1	0	10	117	3981	665	clemastine fumarate	premedication	-11.91	6.7228391506356e-06	418.56	0.98	0	0	0.34	-0.68	0.18	0
667	lithium citrate	1.56	0.67	3.12	0.18	8	251	177541	8686539	667	lithium citrate	schizoaffective disorder	0	0	2.37	0.41	0	49	298	8972	667	lithium citrate	schizoaffective disorder	22.3	64.6	0	0	Inf	1	0	0	67	1303	667	lithium citrate	schizoaffective disorder	0	0	Inf	1	0	0	31	839	667	lithium citrate	schizoaffective disorder	0	0	Inf	1	0	0	44	684	667	lithium citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
668	bethanidine	0	0	53.4	1	0	5	177549	8686785	668	bethanidine	NA	0	0	Inf	1	0	0	0	0	668	bethanidine	NA	NA	NA	0	0	Inf	1	0	0	0	0	668	bethanidine	NA	0	0	Inf	1	0	0	0	0	668	bethanidine	NA	0	0	Inf	1	0	0	0	0	668	bethanidine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
670	loperamide	1.22	1.13	1.3	1.1e-07	801	32246	176748	8654544	670	loperamide	diarrhoea	0.44	0.34	0.57	2.3e-11	97	9237	191	8040	670	loperamide	diarrhoea	16	75.5	0.41	0.21	0.79	0.0047	16	2624	27	1820	670	loperamide	diarrhoea	0.4	0.13	1.14	0.086	7	1440	11	913	670	loperamide	diarrhoea	0.23	0.09	0.51	6.3e-05	9	2498	23	1436	670	loperamide	diarrhoea	-1.08	0.339595525644939	0.31	0	-0.02	0.01	0	-0.15	0.3	0.61
671	sincalide	1.28	0.26	3.82	0.51	3	115	177546	8686675	671	sincalide	hepatobiliary scan	0	0	0.78	0.015	0	68	3	20	671	sincalide	hepatobiliary scan	52	52	0	0	Inf	1	0	0	0	0	671	sincalide	hepatobiliary scan	0	0	Inf	1	0	14	0	1	671	sincalide	hepatobiliary scan	0	0	3.9	0.091	0	40	1	3	671	sincalide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
673	somatropin	0.48	0.33	0.66	8e-07	36	3696	177513	8683094	673	somatropin	growth hormone deficiency	1.23	0.68	2.11	0.47	18	1445	63	6223	673	somatropin	growth hormone deficiency	10.1	55.9	0.82	0.15	2.96	1	3	169	15	695	673	somatropin	growth hormone deficiency	0.45	0.01	3.2	0.7	1	155	10	696	673	somatropin	growth hormone deficiency	1.24	0.12	6.62	0.68	2	101	7	437	673	somatropin	growth hormone deficiency	-0.24	0.786627861066553	0.63	0.7	0	0.01	0.77	-0.23	0.46	0.61
674	halazepam	1.4	0.03	8.32	0.52	1	35	177548	8686755	674	halazepam	anxiety	0	0	3.24	0.62	0	10	11351	82467	674	halazepam	anxiety	20	75	0	0	Inf	1	0	0	1918	17297	674	halazepam	anxiety	0	0	Inf	1	0	0	654	6191	674	halazepam	anxiety	0	0	Inf	1	0	0	1484	14290	674	halazepam	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
675	diflorasone diacetate	3.66	1.79	6.75	0.00038	11	147	177538	8686643	675	diflorasone diacetate	psoriasis	0	0	24.84	1	0	22	1190	161669	675	diflorasone diacetate	psoriasis	25	74.8	0	0	174.92	1	0	4	379	43521	675	diflorasone diacetate	psoriasis	0	0	772.81	1	0	2	149	21342	675	diflorasone diacetate	psoriasis	0	0	527.64	1	0	2	274	27341	675	diflorasone diacetate	psoriasis	-7.79	0.000413852883978762	162.07	0.96	0	0	0.71	-0.36	0.1	0
676	difenoxin	0	0	5.98	1	0	32	177549	8686758	676	difenoxin	hypertension	0	0	50.28	1	0	5	6895	317608	676	difenoxin	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	676	difenoxin	hypertension	0	0	3424.95	1	0	1	341	31638	676	difenoxin	hypertension	0	0	1980.45	1	0	1	762	39929	676	difenoxin	hypertension	-7.73	0.000439444117101845	135.22	0.95	-0.02	0	0	-0.59	0.07	0
677	etidocaine	0	0	1852.91	1	0	1	177549	8686789	677	etidocaine	arthritis	0	0	769.1	1	0	1	2724	54370	677	etidocaine	arthritis	31.8	81	0	0	Inf	1	0	0	141	8212	677	etidocaine	arthritis	0	0	Inf	1	0	0	41	2514	677	etidocaine	arthritis	0	0	Inf	1	0	0	118	7209	677	etidocaine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
678	clocortolone pivalate	5.54	2.77	10.08	5e-06	12	106	177537	8686684	678	clocortolone pivalate	psoriasis	0	0	68.91	1	0	9	1190	161682	678	clocortolone pivalate	psoriasis	25	74.8	0	0	276.67	1	0	3	379	43522	678	clocortolone pivalate	psoriasis	0	0	772.81	1	0	2	149	21342	678	clocortolone pivalate	psoriasis	0	0	3668.84	1	0	1	274	27342	678	clocortolone pivalate	psoriasis	-7.74	0.000435071575078732	187.18	0.97	0	0	0.71	-0.36	0.1	0
679	chlorhexidine gluconate	24.92	23.5	26.37	0	1752	3475	175797	8683315	679	chlorhexidine gluconate	multiple myeloma	138.13	112.21	170.81	0	379	142	1104	57155	679	chlorhexidine gluconate	multiple myeloma	NA	NA	0	0	Inf	1	0	0	0	0	679	chlorhexidine gluconate	multiple myeloma	0	0	Inf	1	0	0	0	0	679	chlorhexidine gluconate	multiple myeloma	0	0	Inf	1	0	0	0	0	679	chlorhexidine gluconate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
680	technetium tc-99m albumin aggregated kit	3.06	0.07	19.68	0.29	1	16	177548	8686774	680	technetium tc-99m albumin aggregated kit	ventilation/perfusion scan	0	0	52.89	1	0	14	1	18	680	technetium tc-99m albumin aggregated kit	ventilation/perfusion scan	NA	NA	0	0	Inf	1	0	0	0	0	680	technetium tc-99m albumin aggregated kit	ventilation/perfusion scan	0	0	Inf	1	0	0	0	2	680	technetium tc-99m albumin aggregated kit	ventilation/perfusion scan	0	0	Inf	1	0	0	0	2	680	technetium tc-99m albumin aggregated kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
682	glipizide	1.66	1.57	1.75	2.1e-67	1418	41923	176131	8644867	682	glipizide	diabetes mellitus	2.64	2.27	3.05	1.5e-31	209	8763	2118	234135	682	glipizide	diabetes mellitus	39.3	82	2.07	1.33	3.09	0.001	26	1815	351	50669	682	glipizide	diabetes mellitus	2.58	1.25	4.79	0.0058	11	953	129	28791	682	glipizide	diabetes mellitus	1.84	1.08	2.94	0.017	19	1071	262	27131	682	glipizide	diabetes mellitus	0.77	2.15976625378492	0.19	0	-0.01	0	0	-0.75	0.1	0
684	dimethyl sulfoxide	0.47	0.01	2.71	0.73	1	103	177548	8686687	684	dimethyl sulfoxide	stem cell transplant	0	0	816.33	1	0	12	4	6067	684	dimethyl sulfoxide	stem cell transplant	NA	NA	0	0	Inf	1	0	0	0	0	684	dimethyl sulfoxide	stem cell transplant	0	0	Inf	1	0	0	0	411	684	dimethyl sulfoxide	stem cell transplant	0	0	Inf	1	0	1	0	248	684	dimethyl sulfoxide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
685	lorazepam	4.04	3.95	4.14	0	7325	91483	170224	8595307	685	lorazepam	anxiety	1.09	1.03	1.16	0.002	1632	10979	9719	71498	685	lorazepam	anxiety	20	75	0.82	0.71	0.95	0.0073	243	2588	1675	14709	685	lorazepam	anxiety	0.92	0.72	1.16	0.5	96	976	558	5215	685	lorazepam	anxiety	0.81	0.69	0.95	0.011	185	2133	1299	12157	685	lorazepam	anxiety	-0.09	0.913931185271228	0.07	0.2	-0.01	0	0	0	0.05	0.93
686	thallous chloride tl-201	0	0	4.09	1	0	46	177549	8686744	686	thallous chloride tl-201	cardiac stress test	0	0	22.47	1	0	11	18	933	686	thallous chloride tl-201	cardiac stress test	61.9	61.9	0	0	Inf	1	0	0	0	0	686	thallous chloride tl-201	cardiac stress test	0	0	Inf	1	0	0	0	69	686	thallous chloride tl-201	cardiac stress test	0	0	Inf	1	0	0	1	88	686	thallous chloride tl-201	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
687	dinoprostone	0.2	0.04	0.59	5e-04	3	727	177546	8686063	687	dinoprostone	labour induction	0.98	0.08	8.61	1	2	381	3	561	687	dinoprostone	labour induction	37.1	39.9	0	0	Inf	1	0	1	0	11	687	dinoprostone	labour induction	0	0	Inf	1	0	2	0	35	687	dinoprostone	labour induction	4.77	0.06	383.6	0.32	1	21	1	102	687	dinoprostone	labour induction	1.86	6.42373677142913	1.55	0.23	0.32	0.2	0.1	-4.82	2866.73	1
688	dobutamine	8.22	7.51	9	3.4e-286	560	3341	176989	8683449	688	dobutamine	cardiac failure	0	0	2.68	0.65	0	263	77	14241	688	dobutamine	cardiac failure	49.9	87.2	0	0	74.52	1	0	18	11	3101	688	dobutamine	cardiac failure	0	0	90.31	1	0	16	8	2264	688	dobutamine	cardiac failure	0	0	161.76	1	0	11	5	1467	688	dobutamine	cardiac failure	-13.12	2.00473234476427e-06	1246.08	0.99	-0.01	0.01	0.37	0.03	0.57	0.96
689	cyclobenzaprine	3.97	3.83	4.12	0	3011	37553	174538	8649237	689	cyclobenzaprine	pain	2.84	2.61	3.09	3.9e-109	692	5721	7777	182763	689	cyclobenzaprine	pain	23	79	1.52	1.17	1.95	0.0015	70	1557	1018	34460	689	cyclobenzaprine	pain	1.25	0.63	2.23	0.41	12	408	352	14909	689	cyclobenzaprine	pain	1.56	1.17	2.04	0.0021	59	1206	798	25384	689	cyclobenzaprine	pain	0.35	1.41906754859326	0.13	0	-0.02	0	0	-0.27	0.06	0
690	etidronate disodium	1.43	0.98	2.02	0.046	33	1128	177516	8685662	690	etidronate disodium	rheumatoid arthritis	4.77	2.7	7.84	6.7e-07	16	455	3394	459922	690	etidronate disodium	rheumatoid arthritis	33	75	0	0	568.66	1	0	2	1060	113936	690	etidronate disodium	rheumatoid arthritis	0	0	5065.99	1	0	1	180	25390	690	etidronate disodium	rheumatoid arthritis	0	0	564.88	1	0	2	1011	107962	690	etidronate disodium	rheumatoid arthritis	-6.94	0.000968269597161402	112.76	0.95	-0.01	0	0	-0.26	0.08	0
695	technetium tc-99m albumin aggregated	0	0	1852.91	1	0	1	177549	8686789	695	technetium tc-99m albumin aggregated	pulmonary embolism	0	0	3457.28	1	0	1	158	14805	695	technetium tc-99m albumin aggregated	pulmonary embolism	28.6	79	0	0	Inf	1	0	0	33	4818	695	technetium tc-99m albumin aggregated	pulmonary embolism	0	0	Inf	1	0	0	14	2663	695	technetium tc-99m albumin aggregated	pulmonary embolism	0	0	Inf	1	0	0	23	3512	695	technetium tc-99m albumin aggregated	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
696	baclofen	1.25	1.18	1.31	1.8e-15	1437	56484	176112	8630306	696	baclofen	multiple sclerosis	1.03	0.92	1.16	0.55	307	15323	8038	415034	696	baclofen	multiple sclerosis	26.5	67	0.99	0.78	1.24	1	82	3682	1222	54360	696	baclofen	multiple sclerosis	0.91	0.48	1.56	0.89	14	919	221	13130	696	baclofen	multiple sclerosis	0.94	0.73	1.19	0.68	73	3296	1145	48553	696	baclofen	multiple sclerosis	-0.02	0.980198673306755	0.11	0.86	-0.01	0	0	-0.34	0.07	0
697	metoclopramide	4.72	4.58	4.86	0	4932	52304	172617	8634486	697	metoclopramide	nausea	1.53	1.32	1.77	2.1e-08	245	4265	979	26143	697	metoclopramide	nausea	17.2	77	0.72	0.42	1.18	0.23	18	852	200	6840	697	metoclopramide	nausea	0.29	0.03	1.11	0.082	2	422	48	2919	697	metoclopramide	nausea	1.02	0.6	1.64	0.9	20	564	175	5030	697	metoclopramide	nausea	-0.11	0.895834135296528	0.23	0.62	-0.03	0	0	-0.77	0.16	0
698	desoximetasone	4.57	3.48	5.93	2.3e-21	63	674	177486	8686116	698	desoximetasone	psoriasis	0	0	3.53	0.63	0	144	1190	161547	698	desoximetasone	psoriasis	25	74.8	0	0	7.43	1	0	59	379	43466	698	desoximetasone	psoriasis	0	0	16.08	1	0	35	149	21309	698	desoximetasone	psoriasis	0	0	10.82	1	0	36	274	27307	698	desoximetasone	psoriasis	-10.8	2.03995034111719e-05	172.39	0.95	0	0	0.71	-0.36	0.1	0
699	butorphanol tartrate	2.03	1.59	2.54	2.8e-08	78	1884	177471	8684906	699	butorphanol tartrate	migraine	0.97	0.6	1.49	1	22	512	1765	39733	699	butorphanol tartrate	migraine	20.7	70.1	1.63	0.04	10.49	0.47	1	17	266	7383	699	butorphanol tartrate	migraine	0	0	Inf	1	0	0	32	1049	699	butorphanol tartrate	migraine	1.51	0.04	9.64	0.5	1	18	264	7183	699	butorphanol tartrate	migraine	0.51	1.66529119494589	1.03	0.62	-0.02	0	0	-0.21	0.19	0.28
700	fluorescein sodium	0.12	0	0.66	0.0043	1	417	177548	8686373	700	fluorescein sodium	angiogram retina	0	0	Inf	1	0	100	0	85	700	fluorescein sodium	angiogram retina	NA	NA	0	0	Inf	1	0	0	0	0	700	fluorescein sodium	angiogram retina	0	0	Inf	1	0	10	0	11	700	fluorescein sodium	angiogram retina	0	0	Inf	1	0	3	0	1	700	fluorescein sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
701	metyrosine	4.45	0.1	30.62	0.22	1	11	177548	8686779	701	metyrosine	phaeochromocytoma	0	0	Inf	1	0	5	0	116	701	metyrosine	phaeochromocytoma	NA	NA	0	0	Inf	1	0	0	0	0	701	metyrosine	phaeochromocytoma	0	0	Inf	1	0	0	0	15	701	metyrosine	phaeochromocytoma	0	0	Inf	1	0	0	0	11	701	metyrosine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
702	scopolamine	3.3	2.85	3.8	5.8e-45	205	3040	177344	8683750	702	scopolamine	nausea	1.55	0.94	2.42	0.072	21	339	1203	30069	702	scopolamine	nausea	17.2	77	1.88	0.59	4.61	0.2	5	95	213	7597	702	scopolamine	nausea	3.62	0.41	14.72	0.12	2	38	48	3303	702	scopolamine	nausea	1.84	0.57	4.55	0.21	5	79	190	5515	702	scopolamine	nausea	0.56	1.7506725002961	0.4	0.16	-0.03	0	0	-0.77	0.16	0
703	triazolam	1.68	1.48	1.9	3e-14	259	7555	177290	8679235	703	triazolam	insomnia	0.59	0.42	0.79	0.00026	44	1703	2899	65885	703	triazolam	insomnia	26.9	78.5	0.46	0.12	1.2	0.15	4	194	527	11703	703	triazolam	insomnia	0.57	0.11	1.72	0.49	3	134	209	5303	703	triazolam	insomnia	0.16	0	0.91	0.032	1	143	378	8647	703	triazolam	insomnia	-0.94	0.390627835358521	0.51	0.06	-0.02	0	0	-0.07	0.09	0.41
704	iodamide meglumine	0	0	260.7	1	0	2	177549	8686788	704	iodamide meglumine	endoscopic retrograde cholangiopancreatography	0	0	Inf	1	0	1	0	61	704	iodamide meglumine	endoscopic retrograde cholangiopancreatography	NA	NA	0	0	Inf	1	0	0	0	0	704	iodamide meglumine	endoscopic retrograde cholangiopancreatography	0	0	Inf	1	0	0	0	4	704	iodamide meglumine	endoscopic retrograde cholangiopancreatography	0	0	Inf	1	0	0	0	3	704	iodamide meglumine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
705	technetium tc-99m gluceptate kit	0	0	28.67	1	0	8	177549	8686782	705	technetium tc-99m gluceptate kit	hypoglycaemia	0	0	222.77	1	0	2	20	817	705	technetium tc-99m gluceptate kit	hypoglycaemia	36.9	70.7	0	0	Inf	1	0	0	5	133	705	technetium tc-99m gluceptate kit	hypoglycaemia	0	0	Inf	1	0	0	1	134	705	technetium tc-99m gluceptate kit	hypoglycaemia	0	0	147.9	1	0	2	6	153	705	technetium tc-99m gluceptate kit	hypoglycaemia	-13.98	8.48326713500191e-07	1696.73	0.99	0.02	0.02	0.25	-1.66	1.09	0.13
706	sulindac	1.99	1.61	2.42	6e-10	103	2539	177446	8684251	706	sulindac	rheumatoid arthritis	1.45	0.66	2.78	0.23	9	836	3401	459541	706	sulindac	rheumatoid arthritis	33	75	0	0	3.12	0.64	0	129	1060	113809	706	sulindac	rheumatoid arthritis	0	0	25.97	1	0	22	180	25369	706	sulindac	rheumatoid arthritis	0	0	3.2	0.63	0	125	1011	107839	706	sulindac	rheumatoid arthritis	-10.86	1.92115288153726e-05	119.86	0.93	-0.01	0	0	-0.26	0.08	0
707	cimetidine	3.53	3.22	3.86	1.8e-120	518	7203	177031	8679587	707	cimetidine	premedication	0.33	0.07	0.98	0.039	3	509	494	27853	707	cimetidine	premedication	13.8	73.2	1.35	0.03	8.28	0.53	1	29	142	5572	707	cimetidine	premedication	0	0	40.27	1	0	8	42	2799	707	cimetidine	premedication	1.42	0.03	8.89	0.52	1	24	116	3967	707	cimetidine	premedication	0.17	1.18530485132037	1.02	0.86	0	0	0.34	-0.68	0.18	0
708	desmopressin acetate	1.19	0.95	1.49	0.11	82	3361	177467	8683429	708	desmopressin acetate	hypopituitarism	0.75	0.08	3.13	1	2	455	19	3242	708	desmopressin acetate	hypopituitarism	32.5	56	0	0	39.8	1	0	16	2	115	708	desmopressin acetate	hypopituitarism	0	0	426.15	1	0	27	1	296	708	desmopressin acetate	hypopituitarism	0	0	25.01	1	0	27	3	270	708	desmopressin acetate	hypopituitarism	-15.55	1.76490285808479e-07	2362.72	0.99	0.01	0.02	0.53	-1.09	1.17	0.35
709	insulin pork	1.79	1.73	1.86	1.7e-169	2819	77488	174730	8609302	709	insulin pork	diabetes mellitus	2.08	1.84	2.34	6.4e-29	325	17580	2002	225318	709	insulin pork	diabetes mellitus	39.3	82	2.54	1.86	3.41	1.2e-08	54	3240	323	49244	709	insulin pork	diabetes mellitus	1.99	1.1	3.37	0.019	16	1809	124	27935	709	insulin pork	diabetes mellitus	2.33	1.62	3.28	6.5e-06	40	1875	241	26327	709	insulin pork	diabetes mellitus	0.79	2.20339642625594	0.14	0	-0.01	0	0	-0.74	0.1	0
710	insulin susp protamine zinc purified beef	0	0	74.11	1	0	4	177549	8686786	710	insulin susp protamine zinc purified beef	diabetes mellitus	0	0	158.86	1	0	4	2327	242894	710	insulin susp protamine zinc purified beef	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	710	insulin susp protamine zinc purified beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	710	insulin susp protamine zinc purified beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	710	insulin susp protamine zinc purified beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
711	insulin susp isophane beef	2.57	2.16	3.05	5.3e-22	143	2720	177406	8684070	711	insulin susp isophane beef	diabetes mellitus	2.21	1.13	3.9	0.015	12	568	2315	242330	711	insulin susp isophane beef	diabetes mellitus	39.3	82	3.47	0.7	10.47	0.059	3	121	374	52363	711	insulin susp isophane beef	diabetes mellitus	3.05	0.08	17.83	0.28	1	70	139	29674	711	insulin susp isophane beef	diabetes mellitus	3.25	0.38	12.37	0.13	2	62	279	28140	711	insulin susp isophane beef	diabetes mellitus	1.14	3.12676836518616	0.59	0.05	-0.01	0	0	-0.75	0.1	0
715	hydrocortisone valerate	11.43	8.23	15.62	4.8e-33	50	214	177499	8686576	715	hydrocortisone valerate	hiv infection	0	0	46.67	1	0	11	500	58380	715	hydrocortisone valerate	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	715	hydrocortisone valerate	hiv infection	0	0	Inf	1	0	0	96	5728	715	hydrocortisone valerate	hiv infection	0	0	Inf	1	0	0	40	3439	715	hydrocortisone valerate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
716	bretylium tosylate	0	0	1852.91	1	0	1	177549	8686789	716	bretylium tosylate	chest pain	0	0	672.97	1	0	1	367	6399	716	bretylium tosylate	chest pain	35.5	80.5	0	0	1185.1	1	0	1	50	1547	716	bretylium tosylate	chest pain	0	0	Inf	1	0	0	24	950	716	bretylium tosylate	chest pain	0	0	1083.12	1	0	1	32	903	716	bretylium tosylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
717	bromocriptine mesylate	1.27	0.93	1.71	0.11	45	1728	177504	8685062	717	bromocriptine mesylate	parkinson s disease	0.3	0.06	0.88	0.021	3	319	869	27605	717	bromocriptine mesylate	parkinson s disease	50.1	85.7	0	0	16	1	0	11	163	6487	717	bromocriptine mesylate	parkinson s disease	0	0	15.37	1	0	12	98	4120	717	bromocriptine mesylate	parkinson s disease	0	0	188.74	1	0	2	85	2995	717	bromocriptine mesylate	parkinson s disease	-11.68	8.46136542174425e-06	388.22	0.98	-0.03	0.01	0	-0.2	0.15	0.19
718	metoprolol tartrate	2.46	2.36	2.55	0	2840	57117	174709	8629673	718	metoprolol tartrate	hypertension	1.86	1.67	2.07	8.1e-26	372	9448	6523	308165	718	metoprolol tartrate	hypertension	38	82.9	1.57	1.06	2.24	0.018	32	1311	949	61098	718	metoprolol tartrate	hypertension	1.48	0.73	2.7	0.19	11	698	330	30941	718	metoprolol tartrate	hypertension	1.6	1.01	2.42	0.035	24	794	738	39136	718	metoprolol tartrate	hypertension	0.46	1.58407398499448	0.17	0.01	-0.02	0	0	-0.59	0.07	0
719	estradiol cypionate	2.34	1.37	3.75	0.0016	18	376	177531	8686414	719	estradiol cypionate	hormone replacement therapy	3.46	1.45	7.12	0.0033	8	99	928	39770	719	estradiol cypionate	hormone replacement therapy	34.3	74	0	0	10.98	1	0	13	91	2993	719	estradiol cypionate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	719	estradiol cypionate	hormone replacement therapy	0	0	10.43	1	0	16	56	2188	719	estradiol cypionate	hormone replacement therapy	-12.89	2.52315614902625e-06	593.96	0.98	-0.03	0.01	0	0.42	0.2	0.04
720	testosterone cypionate	3.24	2.86	3.65	3e-59	281	4254	177268	8682536	720	testosterone cypionate	androgen replacement therapy	12.75	9.53	17.17	1.3e-69	146	548	83	3978	720	testosterone cypionate	androgen replacement therapy	43	73.3	0.76	0.31	1.65	0.59	8	173	54	890	720	testosterone cypionate	androgen replacement therapy	0.98	0.46	1.94	1	11	191	59	1009	720	testosterone cypionate	androgen replacement therapy	0	0	Inf	1	0	0	0	2	720	testosterone cypionate	androgen replacement therapy	-0.01	0.990049833749168	0.34	0.99	0.01	0.01	0.51	11.26	624.19	0.99
721	tamoxifen citrate	7.86	7.38	8.35	0	1177	7374	176372	8679416	721	tamoxifen citrate	breast cancer	5.83	5.14	6.6	4.7e-130	367	3682	1079	63100	721	tamoxifen citrate	breast cancer	40	78	3.57	1.12	8.81	0.016	5	115	122	10032	721	tamoxifen citrate	breast cancer	0	0	Inf	1	0	0	0	116	721	tamoxifen citrate	breast cancer	3.01	0.95	7.37	0.03	5	139	139	11637	721	tamoxifen citrate	breast cancer	1.1	3.00416602394643	0.46	0.02	0	0.01	0.86	-13.14	367.32	0.97
722	technetium tc-99m medronate kit	1.81	0.04	10.99	0.43	1	27	177548	8686763	722	technetium tc-99m medronate kit	bone scan	0	0	27.48	1	0	11	3	115	722	technetium tc-99m medronate kit	bone scan	NA	NA	0	0	Inf	1	0	0	0	0	722	technetium tc-99m medronate kit	bone scan	0	0	Inf	1	0	0	0	3	722	technetium tc-99m medronate kit	bone scan	0	0	Inf	1	0	0	0	11	722	technetium tc-99m medronate kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
724	carboprost tromethamine	0.82	0.02	4.72	1	1	60	177548	8686730	724	carboprost tromethamine	postpartum haemorrhage	0	0	Inf	1	0	22	0	232	724	carboprost tromethamine	postpartum haemorrhage	NA	NA	0	0	Inf	1	0	0	0	0	724	carboprost tromethamine	postpartum haemorrhage	0	0	Inf	1	0	0	0	0	724	carboprost tromethamine	postpartum haemorrhage	0	0	Inf	1	0	1	0	30	724	carboprost tromethamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
725	insulin zinc susp prompt beef	13.35	2.39	50.57	0.0025	3	11	177546	8686779	725	insulin zinc susp prompt beef	diabetes mellitus	34.84	6.06	139.59	0.00018	3	9	2324	242889	725	insulin zinc susp prompt beef	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	725	insulin zinc susp prompt beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	725	insulin zinc susp prompt beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	725	insulin zinc susp prompt beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
726	insulin zinc susp extended beef	0	0	6.89	1	0	28	177549	8686762	726	insulin zinc susp extended beef	diabetes mellitus	0	0	88.74	1	0	6	2327	242892	726	insulin zinc susp extended beef	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	726	insulin zinc susp extended beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	726	insulin zinc susp extended beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	726	insulin zinc susp extended beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
727	insulin zinc susp beef	2.88	0.91	6.98	0.035	5	85	177544	8686705	727	insulin zinc susp beef	diabetes mellitus	9.5	1.86	30.32	0.0048	3	33	2324	242865	727	insulin zinc susp beef	diabetes mellitus	39.3	82	0	0	5004.87	1	0	1	377	52483	727	insulin zinc susp beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	727	insulin zinc susp beef	diabetes mellitus	0	0	530.71	1	0	2	281	28200	727	insulin zinc susp beef	diabetes mellitus	-7.7	0.000452827182886797	229.6	0.97	-0.01	0	0	-0.75	0.1	0
728	meclofenamate sodium	2.22	0.45	6.79	0.16	3	66	177546	8686724	728	meclofenamate sodium	renal cell carcinoma	0	0	237.04	1	0	8	48	18927	728	meclofenamate sodium	renal cell carcinoma	55.8	77	0	0	Inf	1	0	0	11	2413	728	meclofenamate sodium	renal cell carcinoma	0	0	Inf	1	0	0	10	2665	728	meclofenamate sodium	renal cell carcinoma	0	0	Inf	1	0	0	3	1160	728	meclofenamate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
730	timolol maleate	0.96	0.85	1.09	0.54	262	13339	177287	8673451	730	timolol maleate	glaucoma	0.97	0.69	1.33	0.87	51	4473	168	14262	730	timolol maleate	glaucoma	54.3	87	0.78	0.29	1.79	0.7	7	691	36	2771	730	timolol maleate	glaucoma	1.49	0.34	5.22	0.51	4	305	10	1139	730	timolol maleate	glaucoma	0.82	0.28	2.02	0.83	6	561	29	2217	730	timolol maleate	glaucoma	-0.01	0.990049833749168	0.36	0.97	-0.01	0.01	0.28	-0.27	0.32	0.4
731	amoxapine	2.32	1.49	3.47	0.00019	25	527	177524	8686263	731	amoxapine	depression	0.61	0.26	1.22	0.19	8	177	14363	192608	731	amoxapine	depression	21	73.3	0	0	11.68	1	0	6	2062	28336	731	amoxapine	depression	0	0	24.89	1	0	4	637	10443	731	amoxapine	depression	0	0	35.33	1	0	3	1671	24381	731	amoxapine	depression	-9.79	5.60088972715548e-05	122.22	0.94	-0.01	0	0	-0.14	0.05	0
732	nalbuphine	3.79	2.93	4.82	1.2e-19	71	918	177478	8685872	732	nalbuphine	pain	2.64	1.57	4.21	0.00021	20	169	8449	188315	732	nalbuphine	pain	23	79	3.68	0.08	26.61	0.26	1	9	1087	36008	732	nalbuphine	pain	1.92	0.05	11.91	0.42	1	22	363	15295	732	nalbuphine	pain	6.21	0.13	55.59	0.17	1	5	856	26585	732	nalbuphine	pain	0.38	1.46228458943422	0.74	0.61	-0.02	0	0	-0.28	0.06	0
733	technetium tc-99m medronate	0	0	13.64	1	0	15	177549	8686775	733	technetium tc-99m medronate	bone scan	0	0	24.82	1	0	12	3	114	733	technetium tc-99m medronate	bone scan	NA	NA	0	0	Inf	1	0	0	0	0	733	technetium tc-99m medronate	bone scan	0	0	Inf	1	0	0	0	3	733	technetium tc-99m medronate	bone scan	0	0	Inf	1	0	1	0	10	733	technetium tc-99m medronate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
734	miconazole	0.52	0.38	0.68	4.9e-07	49	4635	177500	8682155	734	miconazole	vulvovaginal mycotic infection	0.1	0.02	0.32	2e-06	3	1269	23	930	734	miconazole	vulvovaginal mycotic infection	52.3	55.1	0	0	Inf	1	0	13	0	15	734	miconazole	vulvovaginal mycotic infection	0	0	Inf	1	0	0	0	5	734	miconazole	vulvovaginal mycotic infection	0.77	0.01	60.33	1	1	303	1	232	734	miconazole	vulvovaginal mycotic infection	-0.22	0.802518797962478	1.42	0.87	0.03	0.04	0.46	-11.71	2916.64	1
735	calcitriol	1.47	1.32	1.64	2.2e-11	345	11467	177204	8675323	735	calcitriol	hypertension	1.22	0.83	1.73	0.28	32	1212	6863	316401	735	calcitriol	hypertension	38	82.9	0.23	0.01	1.27	0.14	1	280	980	62129	735	calcitriol	hypertension	0	0	2.24	0.42	0	155	341	31484	735	calcitriol	hypertension	0.29	0.01	1.62	0.27	1	182	761	39748	735	calcitriol	hypertension	-1.74	0.175520400616997	1	0.08	-0.02	0	0	-0.59	0.07	0
736	estramustine phosphate sodium	5.92	4.45	7.75	1.5e-25	60	496	177489	8686294	736	estramustine phosphate sodium	prostate cancer stage iv	0	0	170.63	1	0	181	1	793	736	estramustine phosphate sodium	prostate cancer stage iv	67	67	0	0	Inf	1	0	0	0	0	736	estramustine phosphate sodium	prostate cancer stage iv	0	0	Inf	1	0	0	1	207	736	estramustine phosphate sodium	prostate cancer stage iv	0	0	Inf	1	0	0	0	0	736	estramustine phosphate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
737	chlorpheniramine polistirex	2.98	1.91	4.47	3.7e-06	25	410	177524	8686380	737	chlorpheniramine polistirex	cough	1.62	0.32	4.96	0.44	3	70	375	14143	737	chlorpheniramine polistirex	cough	13.7	78	1.02	0.02	6.18	1	1	37	82	3081	737	chlorpheniramine polistirex	cough	0	0	22.06	1	0	13	25	1579	737	chlorpheniramine polistirex	cough	1.25	0.03	7.82	0.56	1	28	68	2386	737	chlorpheniramine polistirex	cough	0.09	1.09417428370521	1.02	0.93	-0.01	0	0	-0.63	0.24	0.01
739	cisplatin	0.3	0.27	0.34	6.9e-126	263	42325	177286	8644465	739	cisplatin	non-small cell lung cancer	1.99	1.38	2.81	0.00017	45	5104	128	28823	739	cisplatin	non-small cell lung cancer	43.2	79.8	0.86	0.02	5.33	1	1	237	25	5121	739	cisplatin	non-small cell lung cancer	1.58	0.04	10.51	0.49	1	146	14	3227	739	cisplatin	non-small cell lung cancer	0	0	7.02	1	0	110	15	2730	739	cisplatin	non-small cell lung cancer	-0.25	0.778800783071405	1.02	0.81	-0.01	0.01	0.34	-0.15	0.37	0.68
740	nadolol	1.86	1.62	2.14	7.1e-16	209	5489	177340	8681301	740	nadolol	hypertension	1.11	0.66	1.78	0.61	18	744	6877	316869	740	nadolol	hypertension	38	82.9	0	0	1.67	0.29	0	142	981	62267	740	nadolol	hypertension	0	0	5.71	1	0	62	341	31577	740	nadolol	hypertension	0	0	1.95	0.27	0	101	762	39829	740	nadolol	hypertension	-11.46	1.05435105610322e-05	112.71	0.92	-0.02	0	0	-0.59	0.07	0
741	cinoxacin	4.45	0.1	30.62	0.22	1	11	177548	8686779	741	cinoxacin	hepatitis c	Inf	0.94	Inf	0.027	1	0	2530	92766	741	cinoxacin	hepatitis c	32.8	65	0	0	Inf	1	0	0	557	17169	741	cinoxacin	hepatitis c	0	0	Inf	1	0	0	321	12291	741	cinoxacin	hepatitis c	0	0	Inf	1	0	0	306	9747	741	cinoxacin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
742	oxamniquine	0	0	118.34	1	0	3	177549	8686787	742	oxamniquine	schistosomiasis	0	0	Inf	1	0	2	0	48	742	oxamniquine	schistosomiasis	NA	NA	0	0	Inf	1	0	0	0	0	742	oxamniquine	schistosomiasis	0	0	Inf	1	0	0	0	6	742	oxamniquine	schistosomiasis	0	0	Inf	1	0	0	0	3	742	oxamniquine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
744	valproic acid	0.82	0.74	0.91	0.00013	385	22823	177164	8663967	744	valproic acid	epilepsy	0.59	0.43	0.81	4e-04	45	5125	595	40301	744	valproic acid	epilepsy	13.6	68.1	1.21	0.53	2.44	0.56	9	462	78	4852	744	valproic acid	epilepsy	1.87	0.69	4.32	0.18	7	353	34	3199	744	valproic acid	epilepsy	0.65	0.13	2.04	0.62	3	333	53	3851	744	valproic acid	epilepsy	0.19	1.20924959765725	0.34	0.58	0	0	0.55	-0.15	0.21	0.46
746	guanadrel	0	0	260.7	1	0	2	177549	8686788	746	guanadrel	epilepsy	0	0	380.75	1	0	2	640	45424	746	guanadrel	epilepsy	13.6	68.1	0	0	Inf	1	0	0	87	5314	746	guanadrel	epilepsy	0	0	Inf	1	0	0	41	3552	746	guanadrel	epilepsy	0	0	Inf	1	0	0	56	4184	746	guanadrel	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
747	phenylpropanolamine	3.46	2.42	4.81	3.3e-10	38	538	177511	8686252	747	phenylpropanolamine	nasopharyngitis	1.31	0.16	4.93	0.67	2	90	204	12031	747	phenylpropanolamine	nasopharyngitis	19.3	78	0	0	107.55	1	0	3	38	1652	747	phenylpropanolamine	nasopharyngitis	0	0	Inf	1	0	0	15	843	747	phenylpropanolamine	nasopharyngitis	0	0	117.13	1	0	3	29	1368	747	phenylpropanolamine	nasopharyngitis	-11.69	8.37717342908886e-06	840.27	0.99	0	0.01	0.79	-0.18	0.32	0.58
748	amcinonide	9.79	5.45	16.6	2.6e-11	17	85	177532	8686705	748	amcinonide	eczema	411.69	62.89	15436.19	4.5e-21	15	1	130	3622	748	amcinonide	eczema	17.2	67.9	0	0	1166.37	1	0	1	13	395	748	amcinonide	eczema	0	0	Inf	1	0	0	7	292	748	amcinonide	eczema	0	0	1791.2	1	0	1	8	377	748	amcinonide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
749	gonadorelin	0.32	0.01	1.8	0.38	1	154	177548	8686636	749	gonadorelin	in vitro fertilisation	0	0	31.51	1	0	17	10	1101	749	gonadorelin	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	0	0	67	749	gonadorelin	in vitro fertilisation	0	0	Inf	1	0	0	0	1	749	gonadorelin	in vitro fertilisation	0	0	Inf	1	0	0	2	188	749	gonadorelin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
750	piroxicam	3.29	2.93	3.69	1.9e-69	323	4805	177226	8681985	750	piroxicam	rheumatoid arthritis	6.07	4.06	8.77	3.7e-14	30	672	3380	459705	750	piroxicam	rheumatoid arthritis	33	75	2.87	0.34	10.76	0.16	2	75	1058	113863	750	piroxicam	rheumatoid arthritis	0	0	24.75	1	0	23	180	25368	750	piroxicam	rheumatoid arthritis	3.75	0.44	14.23	0.1	2	57	1009	107907	750	piroxicam	rheumatoid arthritis	1.05	2.85765111806316	0.72	0.14	-0.01	0	0	-0.26	0.08	0
751	flunisolide	4.48	3.86	5.18	2.4e-62	199	2174	177350	8684616	751	flunisolide	asthma	1.55	0.7	3	0.2	9	192	3035	100182	751	flunisolide	asthma	9	76	0	0	5.93	1	0	22	540	17494	751	flunisolide	asthma	0	0	15.45	1	0	12	147	6246	751	flunisolide	asthma	0	0	12.7	1	0	11	458	14551	751	flunisolide	asthma	-10.69	2.27715183061422e-05	183.2	0.95	-0.02	0	0	-0.41	0.1	0
752	minoxidil	0.65	0.56	0.75	3.6e-10	184	13912	177365	8672878	752	minoxidil	alopecia	0.02	0.01	0.02	0	39	7962	1132	3565	752	minoxidil	alopecia	19.9	60.6	0.04	0.02	0.08	1.6e-24	8	2021	42	406	752	minoxidil	alopecia	0.03	0.01	0.08	1.5e-21	5	1082	40	284	752	minoxidil	alopecia	0.07	0.02	0.29	8.9e-05	5	3548	6	308	752	minoxidil	alopecia	-2.99	0.0502874367235919	0.36	0	-0.03	0.01	0.01	1.32	0.38	0
753	temazepam	4.25	4.06	4.44	0	2138	24851	175411	8661939	753	temazepam	pain	3.06	2.72	3.45	1.3e-60	329	2455	8140	186029	753	temazepam	pain	23	79	1.79	1.16	2.66	0.006	27	504	1061	35513	753	temazepam	pain	3.12	1.66	5.43	0.00037	14	194	350	15123	753	temazepam	pain	1.36	0.77	2.26	0.23	16	366	841	26224	753	temazepam	pain	0.68	1.97387773223045	0.19	0	-0.02	0	0	-0.28	0.06	0
754	naproxen sodium	1.18	1.12	1.24	5.3e-10	1595	66448	175954	8620342	754	naproxen sodium	pain	0.94	0.82	1.07	0.36	242	5725	8227	182759	754	naproxen sodium	pain	23	79	0.74	0.47	1.11	0.17	24	1070	1064	34947	754	naproxen sodium	pain	1	0.49	1.83	1	11	462	353	14855	754	naproxen sodium	pain	0.59	0.34	0.96	0.031	17	880	840	25710	754	naproxen sodium	pain	-0.29	0.748263567578565	0.19	0.13	-0.02	0	0	-0.28	0.06	0
755	oxprenolol	0	0	2.09	0.43	0	88	177549	8686702	755	oxprenolol	hypertension	0	0	12.84	1	0	15	6895	317598	755	oxprenolol	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	755	oxprenolol	hypertension	0	0	Inf	1	0	0	341	31639	755	oxprenolol	hypertension	0	0	Inf	1	0	0	762	39930	755	oxprenolol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
756	insulin purified pork	2.68	1.51	4.43	0.00058	16	292	177533	8686498	756	insulin purified pork	diabetes mellitus	8.44	4.26	15.22	5.9e-08	12	149	2315	242749	756	insulin purified pork	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	756	insulin purified pork	diabetes mellitus	0	0	Inf	1	0	0	140	29744	756	insulin purified pork	diabetes mellitus	0	0	Inf	1	0	0	281	28202	756	insulin purified pork	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
757	insulin susp isophane purified pork	0.31	0.01	1.77	0.38	1	156	177548	8686634	757	insulin susp isophane purified pork	diabetes mellitus	0	0	20.06	1	0	21	2327	242877	757	insulin susp isophane purified pork	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	757	insulin susp isophane purified pork	diabetes mellitus	0	0	Inf	1	0	0	140	29744	757	insulin susp isophane purified pork	diabetes mellitus	0	0	Inf	1	0	0	281	28202	757	insulin susp isophane purified pork	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
758	amiloride	1.01	0.82	1.23	0.88	101	4884	177448	8681906	758	amiloride	hypertension	0.61	0.35	1	0.046	16	1206	6879	316407	758	amiloride	hypertension	38	82.9	1.98	0.72	4.41	0.13	6	193	975	62216	758	amiloride	hypertension	0	0	5.27	1	0	67	341	31572	758	amiloride	hypertension	2	0.72	4.47	0.13	6	158	756	39772	758	amiloride	hypertension	0.59	1.80398841539786	0.42	0.15	-0.02	0	0	-0.59	0.07	0
759	aminoglutethimide	8.15	2.47	21.23	0.00063	5	30	177544	8686760	759	aminoglutethimide	prostate cancer	51.95	11.4	194.82	3.9e-06	4	8	440	45743	759	aminoglutethimide	prostate cancer	56.9	87.4	0	0	Inf	1	0	0	102	12804	759	aminoglutethimide	prostate cancer	0	0	Inf	1	0	0	114	14676	759	aminoglutethimide	prostate cancer	0	0	Inf	1	0	0	0	51	759	aminoglutethimide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
760	safflower oil	0	0	11.12	1	0	18	177549	8686772	760	safflower oil	hypertension	0	0	50.28	1	0	5	6895	317608	760	safflower oil	hypertension	38	82.9	0	0	69.49	1	0	5	981	62404	760	safflower oil	hypertension	0	0	Inf	1	0	0	341	31639	760	safflower oil	hypertension	0	0	57.3	1	0	5	762	39925	760	safflower oil	hypertension	-8.59	0.000185956087655102	145.12	0.95	-0.02	0	0	-0.59	0.07	0
761	trazodone	3.42	3.31	3.54	0	3581	51918	173968	8634872	761	trazodone	depression	1.34	1.25	1.44	1.1e-14	860	8722	13511	184063	761	trazodone	depression	21	73.3	1.18	0.98	1.42	0.079	131	1536	1931	26806	761	trazodone	depression	1.58	1.12	2.18	0.0083	44	469	593	9978	761	trazodone	depression	1.15	0.93	1.43	0.19	99	1261	1572	23123	761	trazodone	depression	0.29	1.33642748802547	0.09	0	-0.01	0	0	-0.14	0.05	0
762	bumetanide	2.03	1.84	2.23	4.7e-40	449	10835	177100	8675955	762	bumetanide	hypertension	2.18	1.6	2.92	1.9e-06	48	1018	6847	316595	762	bumetanide	hypertension	38	82.9	2.76	1.3	5.19	0.0048	10	232	971	62177	762	bumetanide	hypertension	0.76	0.02	4.34	1	1	122	340	31517	762	bumetanide	hypertension	3.3	1.47	6.48	0.0025	9	144	753	39786	762	bumetanide	hypertension	1.01	2.74560101501692	0.32	0	-0.02	0	0	-0.59	0.07	0
763	etomidate	14.24	12.44	16.23	6.1e-206	291	1002	177258	8685788	763	etomidate	anaesthesia	0.58	0.01	3.43	1	1	186	59	6418	763	etomidate	anaesthesia	23	71.2	0	0	42.8	1	0	8	9	561	763	etomidate	anaesthesia	0	0	2854.22	1	0	5	1	382	763	etomidate	anaesthesia	0	0	46.2	1	0	6	10	479	763	etomidate	anaesthesia	-13.13	1.98478492464544e-06	1145.04	0.99	0	0.01	0.89	-2.08	1.05	0.05
764	sterile water for	0	0	0.48	0.0012	0	374	177549	8686416	764	sterile water for	parenteral nutrition	0	0	15.19	1	0	68	4	671	764	sterile water for	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	764	sterile water for	parenteral nutrition	0	0	Inf	1	0	0	0	64	764	sterile water for	parenteral nutrition	0	0	Inf	1	0	2	0	76	764	sterile water for	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
765	heparin calcium	0.09	0.03	0.24	1.2e-13	4	2095	177545	8684695	765	heparin calcium	hypertension	0	0	0.77	0.017	0	222	6895	317391	765	heparin calcium	hypertension	38	82.9	0	0	3.9	1	0	62	981	62347	765	heparin calcium	hypertension	0	0	10.05	1	0	36	341	31603	765	heparin calcium	hypertension	0	0	5.07	1	0	40	762	39890	765	heparin calcium	hypertension	-11.15	1.43752870900291e-05	164.96	0.95	-0.02	0	0	-0.59	0.07	0
766	dipivefrin	0.94	0.02	5.48	1	1	52	177548	8686738	766	dipivefrin	juvenile idiopathic arthritis	0	0	2680.65	1	0	1	107	7675	766	dipivefrin	juvenile idiopathic arthritis	5.9	32.9	0	0	Inf	1	0	0	62	3835	766	dipivefrin	juvenile idiopathic arthritis	0	0	Inf	1	0	0	14	1245	766	dipivefrin	juvenile idiopathic arthritis	0	0	Inf	1	0	0	57	3402	766	dipivefrin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
767	atenolol	1.84	1.78	1.9	2.4e-252	3906	104872	173643	8581918	767	atenolol	hypertension	1.43	1.32	1.54	4.3e-17	702	23385	6193	294228	767	atenolol	hypertension	38	82.9	1.27	1	1.6	0.045	81	4124	900	58285	767	atenolol	hypertension	1.21	0.76	1.85	0.35	24	1856	317	29783	767	atenolol	hypertension	1.15	0.87	1.5	0.28	61	2808	701	37122	767	atenolol	hypertension	0.15	1.16183424272828	0.11	0.18	-0.02	0	0	-0.59	0.07	0
768	tocainide	4.08	0.1	27.56	0.23	1	12	177548	8686778	768	tocainide	pain	0	0	118.53	1	0	2	8469	188482	768	tocainide	pain	23	79	0	0	Inf	1	0	0	1088	36017	768	tocainide	pain	0	0	Inf	1	0	0	364	15317	768	tocainide	pain	0	0	Inf	1	0	0	857	26590	768	tocainide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
769	technetium tc-99m albumin colloid kit	2.33	0.06	14.48	0.36	1	21	177548	8686769	769	technetium tc-99m albumin colloid kit	crohn s disease	0	0	108.79	1	0	5	1477	147307	769	technetium tc-99m albumin colloid kit	crohn s disease	15.6	67	0	0	Inf	1	0	0	406	32694	769	technetium tc-99m albumin colloid kit	crohn s disease	0	0	Inf	1	0	0	148	13998	769	technetium tc-99m albumin colloid kit	crohn s disease	0	0	Inf	1	0	0	305	23897	769	technetium tc-99m albumin colloid kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
770	sodium citrate	0.62	0.42	0.88	0.0051	31	2454	177518	8684336	770	sodium citrate	cataract operation	0	0	2.51	0.35	0	451	6	1327	770	sodium citrate	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	770	sodium citrate	cataract operation	0	0	Inf	1	0	41	0	60	770	sodium citrate	cataract operation	0	0	Inf	1	0	61	0	179	770	sodium citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
771	alprazolam	4.28	4.19	4.37	0	9623	114834	167926	8571956	771	alprazolam	anxiety	1.17	1.12	1.22	2.8e-11	2835	18279	8516	64198	771	alprazolam	anxiety	20	75	0.92	0.82	1.03	0.15	424	4080	1494	13217	771	alprazolam	anxiety	0.89	0.72	1.09	0.27	127	1323	527	4868	771	alprazolam	anxiety	0.93	0.82	1.06	0.3	334	3391	1150	10899	771	alprazolam	anxiety	0	1	0.06	0.98	-0.01	0	0	0	0.05	0.94
772	pindolol	2.58	1.84	3.51	1.6e-07	42	798	177507	8685992	772	pindolol	hypertension	2.05	0.81	4.34	0.092	7	157	6888	317456	772	pindolol	hypertension	38	82.9	0	0	9.71	1	0	26	981	62383	772	pindolol	hypertension	0	0	25.98	1	0	15	341	31624	772	pindolol	hypertension	0	0	12.72	1	0	17	762	39913	772	pindolol	hypertension	-10.45	2.89482732982116e-05	153.23	0.95	-0.02	0	0	-0.59	0.07	0
774	secretin	0	0	21.83	1	0	10	177549	8686780	774	secretin	exocrine pancreatic function test	0	0	Inf	1	0	3	0	1	774	secretin	exocrine pancreatic function test	NA	NA	0	0	Inf	1	0	0	0	0	774	secretin	exocrine pancreatic function test	0	0	Inf	1	0	0	0	0	774	secretin	exocrine pancreatic function test	0	0	Inf	1	0	0	0	0	774	secretin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
776	trifluridine	0.4	0.21	0.7	0.00038	12	1467	177537	8685323	776	trifluridine	colon cancer	0	0	1.08	0.081	0	676	74	14295	776	trifluridine	colon cancer	44.6	81.9	0	0	1.2	0.1	0	407	23	2798	776	trifluridine	colon cancer	0	0	2.44	0.38	0	264	12	1776	776	trifluridine	colon cancer	0	0	2.07	0.24	0	202	15	1484	776	trifluridine	colon cancer	-15.78	1.40227462590254e-07	818.56	0.98	0.01	0.01	0.47	-0.41	0.39	0.3
777	potassium iodide	0.84	0.36	1.67	0.74	8	465	177541	8686325	777	potassium iodide	nutritional supplementation	0	0	16.42	1	0	20	53	4165	777	potassium iodide	nutritional supplementation	13	80.3	0	0	Inf	1	0	0	28	2237	777	potassium iodide	nutritional supplementation	0	0	Inf	1	0	0	13	907	777	potassium iodide	nutritional supplementation	0	0	Inf	1	0	0	19	1770	777	potassium iodide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
778	isosulfan blue	0.6	0.01	3.42	1	1	82	177548	8686708	778	isosulfan blue	hormone replacement therapy	0	0	227.06	1	0	2	936	39867	778	isosulfan blue	hormone replacement therapy	34.3	74	0	0	Inf	1	0	0	91	3006	778	isosulfan blue	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	778	isosulfan blue	hormone replacement therapy	0	0	Inf	1	0	0	56	2204	778	isosulfan blue	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
779	calcifediol	0.26	0.01	1.47	0.19	1	188	177548	8686602	779	calcifediol	hypertension	0	0	4.23	1	0	42	6895	317571	779	calcifediol	hypertension	38	82.9	0	0	69.49	1	0	5	981	62404	779	calcifediol	hypertension	0	0	223.89	1	0	3	341	31636	779	calcifediol	hypertension	0	0	126.83	1	0	3	762	39927	779	calcifediol	hypertension	-8.19	0.000277413884240626	131.09	0.95	-0.02	0	0	-0.59	0.07	0
780	technetium tc-99m oxidronate kit	0.31	0.01	1.74	0.39	1	159	177548	8686631	780	technetium tc-99m oxidronate kit	bone scan	0	0	2.22	0.11	0	67	3	59	780	technetium tc-99m oxidronate kit	bone scan	NA	NA	0	0	Inf	1	0	0	0	0	780	technetium tc-99m oxidronate kit	bone scan	0	0	Inf	1	0	1	0	2	780	technetium tc-99m oxidronate kit	bone scan	0	0	Inf	1	0	4	0	7	780	technetium tc-99m oxidronate kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
781	sucralfate	2.8	2.58	3.03	2.7e-105	633	11087	176916	8675703	781	sucralfate	gastrooesophageal reflux disease	1.65	1.27	2.11	0.00017	69	1098	2899	75930	781	sucralfate	gastrooesophageal reflux disease	22.4	77.2	1.73	0.93	2.98	0.051	14	320	464	18377	781	sucralfate	gastrooesophageal reflux disease	1.43	0.29	4.38	0.47	3	112	149	7971	781	sucralfate	gastrooesophageal reflux disease	1.63	0.8	3.01	0.12	11	258	369	14131	781	sucralfate	gastrooesophageal reflux disease	0.45	1.56831218549017	0.28	0.1	-0.02	0	0	-0.34	0.1	0
782	magnesium	1.89	1.81	1.96	3e-195	2797	73111	174752	8613679	782	magnesium	prophylaxis	1.09	0.83	1.41	0.5	62	4627	1217	98924	782	magnesium	prophylaxis	23.9	79.7	0.95	0.45	1.78	1	10	1206	197	22454	782	magnesium	prophylaxis	1.24	0.39	3.03	0.61	5	684	77	13044	782	magnesium	prophylaxis	1.09	0.46	2.22	0.71	8	718	140	13694	782	magnesium	prophylaxis	0.15	1.16183424272828	0.29	0.61	-0.01	0	0.02	-0.52	0.14	0
783	sodium phosphate	0.84	0.69	1	0.054	122	7131	177427	8679659	783	sodium phosphate	prophylaxis	0	0	0.44	0.00057	0	678	1279	102873	783	sodium phosphate	prophylaxis	23.9	79.7	0	0	2.62	0.41	0	163	207	23497	783	sodium phosphate	prophylaxis	0	0	5.79	1	0	110	82	13618	783	sodium phosphate	prophylaxis	0	0	5.08	1	0	73	148	14339	783	sodium phosphate	prophylaxis	-12.73	2.96095117009214e-06	290.89	0.97	-0.01	0	0.02	-0.52	0.14	0
784	captopril	1.9	1.71	2.1	4.5e-29	384	9920	177165	8676870	784	captopril	hypertension	1.57	1.25	1.94	1e-04	89	2631	6806	314982	784	captopril	hypertension	38	82.9	2.43	1.24	4.33	0.0056	12	316	969	62093	784	captopril	hypertension	1.88	0.38	5.64	0.22	3	149	338	31490	784	captopril	hypertension	2.14	0.96	4.15	0.043	9	222	753	39708	784	captopril	hypertension	0.59	1.80398841539786	0.3	0.05	-0.02	0	0	-0.59	0.07	0
786	insulin zinc susp purified pork	2.45	1.41	3.98	0.001	17	340	177532	8686450	786	insulin zinc susp purified pork	diabetes mellitus	8.44	4.26	15.22	5.9e-08	12	149	2315	242749	786	insulin zinc susp purified pork	diabetes mellitus	39.3	82	0	0	335.36	1	0	3	377	52481	786	insulin zinc susp purified pork	diabetes mellitus	0	0	7336.16	1	0	1	140	29743	786	insulin zinc susp purified pork	diabetes mellitus	0	0	242.13	1	0	3	281	28199	786	insulin zinc susp purified pork	diabetes mellitus	-7.66	0.000471307410795765	161.26	0.96	-0.01	0	0	-0.75	0.1	0
787	bentiromide	0	0	1852.91	1	0	1	177549	8686789	787	bentiromide	rheumatoid arthritis	0	0	4865.13	1	0	1	3410	460376	787	bentiromide	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	787	bentiromide	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	787	bentiromide	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	787	bentiromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
788	insulin zinc susp prompt purified pork	4.08	0.8	12.91	0.043	3	36	177546	8686754	788	insulin zinc susp prompt purified pork	diabetes mellitus	20.89	3.88	73.85	0.00063	3	15	2324	242883	788	insulin zinc susp prompt purified pork	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	788	insulin zinc susp prompt purified pork	diabetes mellitus	0	0	Inf	1	0	0	140	29744	788	insulin zinc susp prompt purified pork	diabetes mellitus	0	0	Inf	1	0	0	281	28202	788	insulin zinc susp prompt purified pork	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
790	insulin zinc susp extended purified beef	2.61	0.69	6.97	0.074	4	75	177545	8686715	790	insulin zinc susp extended purified beef	diabetes mellitus	0	0	22.38	1	0	19	2327	242879	790	insulin zinc susp extended purified beef	diabetes mellitus	39.3	82	0	0	5004.87	1	0	1	377	52483	790	insulin zinc susp extended purified beef	diabetes mellitus	0	0	7336.16	1	0	1	140	29743	790	insulin zinc susp extended purified beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	790	insulin zinc susp extended purified beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
791	buprenorphine	1.33	1.26	1.41	7.2e-23	1338	49281	176211	8637509	791	buprenorphine	drug dependence	0.9	0.74	1.09	0.27	396	7643	169	2930	791	buprenorphine	drug dependence	21.2	63.9	1.49	0.83	2.89	0.19	77	1389	14	377	791	buprenorphine	drug dependence	1.45	0.74	3.04	0.29	47	763	12	282	791	buprenorphine	drug dependence	1.03	0.44	2.79	1	37	765	7	149	791	buprenorphine	drug dependence	0.25	1.28402541668774	0.26	0.34	0.01	0.01	0.31	0.18	0.21	0.39
792	gemfibrozil	2.3	2.11	2.5	2.6e-67	576	12264	176973	8674526	792	gemfibrozil	hypertension	3.14	2.52	3.88	4.5e-20	94	1392	6801	316221	792	gemfibrozil	hypertension	38	82.9	0.88	0.24	2.28	1	4	290	977	62119	792	gemfibrozil	hypertension	1.13	0.14	4.19	0.7	2	164	339	31475	792	gemfibrozil	hypertension	0.75	0.09	2.78	1	2	139	760	39791	792	gemfibrozil	hypertension	-0.13	0.878095430920561	0.5	0.8	-0.02	0	0	-0.59	0.07	0
793	diflunisal	5.31	3.98	6.98	1.1e-22	58	534	177491	8686256	793	diflunisal	rheumatoid arthritis	0	0	4.4	1	0	115	3410	460262	793	diflunisal	rheumatoid arthritis	33	75	0	0	18.73	1	0	23	1060	113915	793	diflunisal	rheumatoid arthritis	0	0	737.25	1	0	2	180	25389	793	diflunisal	rheumatoid arthritis	0	0	20.54	1	0	21	1011	107943	793	diflunisal	rheumatoid arthritis	-8.85	0.000143381736276293	111.57	0.94	-0.01	0	0	-0.26	0.08	0
795	glutathione disulfide	0	0	0.46	0.00084	0	396	177549	8686394	795	glutathione disulfide	eye irrigation	0	0	Inf	1	0	202	0	228	795	glutathione disulfide	eye irrigation	NA	NA	0	0	Inf	1	0	0	0	0	795	glutathione disulfide	eye irrigation	0	0	Inf	1	0	0	0	13	795	glutathione disulfide	eye irrigation	0	0	Inf	1	0	1	0	23	795	glutathione disulfide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
796	sodium bicarbonate	2.37	2.19	2.56	1.9e-87	711	14712	176838	8672078	796	sodium bicarbonate	prophylaxis	1.61	0.97	2.51	0.045	20	1014	1259	102537	796	sodium bicarbonate	prophylaxis	23.9	79.7	1.39	0.28	4.18	0.48	3	247	204	23413	796	sodium bicarbonate	prophylaxis	0.92	0.02	5.33	1	1	182	81	13546	796	sodium bicarbonate	prophylaxis	1.73	0.21	6.52	0.33	2	113	146	14299	796	sodium bicarbonate	prophylaxis	0.28	1.32312981233744	0.58	0.63	-0.01	0	0.03	-0.52	0.14	0
797	calcitonin human	0	0	118.34	1	0	3	177549	8686787	797	calcitonin human	osteoporosis	0	0	95.6	1	0	2	8802	157684	797	calcitonin human	osteoporosis	53.1	85	0	0	Inf	1	0	0	808	24568	797	calcitonin human	osteoporosis	0	0	Inf	1	0	0	31	2935	797	calcitonin human	osteoporosis	0	0	Inf	1	0	0	868	26887	797	calcitonin human	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
798	oxymetazoline	2.68	1.86	3.74	3.9e-07	36	658	177513	8686132	798	oxymetazoline	nasal congestion	1.26	0.33	3.39	0.56	4	113	154	5486	798	oxymetazoline	nasal congestion	18.8	78.9	0	0	9.43	1	0	28	22	1362	798	oxymetazoline	nasal congestion	0	0	47.35	1	0	15	5	603	798	oxymetazoline	nasal congestion	0	0	17.02	1	0	14	21	1099	798	oxymetazoline	nasal congestion	-13.24	1.77803808671934e-06	725.19	0.99	-0.01	0.01	0.41	-0.83	0.5	0.1
799	insulin zinc susp purified beef	3.26	0.86	8.8	0.04	4	60	177545	8686730	799	insulin zinc susp purified beef	diabetes mellitus	9.09	2.37	24.93	0.0013	4	46	2323	242852	799	insulin zinc susp purified beef	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	799	insulin zinc susp purified beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	799	insulin zinc susp purified beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	799	insulin zinc susp purified beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
800	insulin purified beef	2.2	0.59	5.83	0.12	4	89	177545	8686701	800	insulin purified beef	diabetes mellitus	7.34	1.93	19.85	0.0027	4	57	2323	242841	800	insulin purified beef	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	800	insulin purified beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	800	insulin purified beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	800	insulin purified beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
801	insulin susp isophane purified beef	3.11	1.31	6.31	0.0058	8	126	177541	8686664	801	insulin susp isophane purified beef	diabetes mellitus	9.95	2.59	27.47	0.00096	4	42	2323	242856	801	insulin susp isophane purified beef	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	801	insulin susp isophane purified beef	diabetes mellitus	0	0	Inf	1	0	0	140	29744	801	insulin susp isophane purified beef	diabetes mellitus	0	0	Inf	1	0	0	281	28202	801	insulin susp isophane purified beef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
802	nifedipine	1.33	1.25	1.41	2.3e-17	1005	37079	176544	8649711	802	nifedipine	hypertension	1.2	1.05	1.36	0.0054	266	10296	6629	307317	802	nifedipine	hypertension	38	82.9	0.79	0.49	1.22	0.37	21	1673	960	60736	802	nifedipine	hypertension	0.19	0.02	0.68	0.0037	2	975	339	30664	802	nifedipine	hypertension	1.09	0.67	1.67	0.65	22	1064	740	38866	802	nifedipine	hypertension	-0.34	0.71177032276261	0.21	0.11	-0.02	0	0	-0.59	0.07	0
803	alprostadil	0.35	0.22	0.51	4.5e-10	25	3518	177524	8683272	803	alprostadil	erectile dysfunction	0.56	0.26	1.04	0.081	10	1386	316	24411	803	alprostadil	erectile dysfunction	39	73	0.52	0.06	1.99	0.58	2	339	54	4775	803	alprostadil	erectile dysfunction	0.37	0.04	1.4	0.24	2	481	64	5675	803	alprostadil	erectile dysfunction	0	0	Inf	1	0	0	0	4	803	alprostadil	erectile dysfunction	-0.47	0.625002268282701	0.73	0.52	-0.05	0.01	0	9.94	427.23	0.98
804	verapamil	1.68	1.58	1.78	7.4e-56	1128	33013	176421	8653777	804	verapamil	hypertension	1.76	1.53	2.02	2.8e-14	226	5989	6669	311624	804	verapamil	hypertension	38	82.9	0.77	0.38	1.39	0.5	11	903	970	61506	804	verapamil	hypertension	1.95	0.77	4.1	0.1	7	337	334	31302	804	verapamil	hypertension	0.7	0.32	1.33	0.39	9	675	753	39255	804	verapamil	hypertension	0.02	1.02020134002676	0.25	0.95	-0.02	0	0	-0.59	0.07	0
806	tartaric acid	0	0	5.28	1	0	36	177549	8686754	806	tartaric acid	prophylaxis	0	0	56.24	1	0	7	1279	103544	806	tartaric acid	prophylaxis	23.9	79.7	0	0	79.7	1	0	7	207	23653	806	tartaric acid	prophylaxis	0	0	5924.82	1	0	1	82	13727	806	tartaric acid	prophylaxis	0	0	83.35	1	0	6	148	14406	806	tartaric acid	prophylaxis	-9.87	5.1702728614462e-05	332.84	0.98	-0.01	0	0.03	-0.52	0.14	0
807	chenodiol	0	0	33.97	1	0	7	177549	8686783	807	chenodiol	xanthomatosis	0	0	Inf	1	0	4	0	14	807	chenodiol	xanthomatosis	NA	NA	0	0	Inf	1	0	0	0	0	807	chenodiol	xanthomatosis	0	0	Inf	1	0	1	0	1	807	chenodiol	xanthomatosis	0	0	Inf	1	0	0	0	1	807	chenodiol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
808	hydrocortisone butyrate	0.21	0.07	0.49	8.6e-06	5	1163	177544	8685627	808	hydrocortisone butyrate	prophylaxis	0	0	1.33	0.12	0	226	1279	103325	808	hydrocortisone butyrate	prophylaxis	23.9	79.7	0	0	6.41	1	0	68	207	23592	808	hydrocortisone butyrate	prophylaxis	0	0	26.01	1	0	26	82	13702	808	hydrocortisone butyrate	prophylaxis	0	0	7.85	1	0	48	148	14364	808	hydrocortisone butyrate	prophylaxis	-11.87	6.99720342114394e-06	277.63	0.97	-0.01	0	0.02	-0.52	0.14	0
809	citric acid	1.34	0.84	2.02	0.18	23	841	177526	8685949	809	citric acid	bowel preparation	0	0	3.92	0.6	0	251	6	1151	809	citric acid	bowel preparation	NA	NA	0	0	Inf	1	0	0	0	0	809	citric acid	bowel preparation	0	0	Inf	1	0	50	0	106	809	citric acid	bowel preparation	0	0	Inf	1	0	112	0	199	809	citric acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
810	magnesium oxide	1.07	0.97	1.17	0.16	478	21919	177071	8664871	810	magnesium oxide	constipation	0.55	0.38	0.78	0.00038	33	3350	695	38939	810	magnesium oxide	constipation	2.6	80.7	0.79	0.31	1.68	0.72	7	540	162	9884	810	magnesium oxide	constipation	1.06	0.28	2.87	0.79	4	312	65	5358	810	magnesium oxide	constipation	0.59	0.12	1.79	0.49	3	314	117	7238	810	magnesium oxide	constipation	-0.14	0.869358235398806	0.39	0.71	-0.03	0	0	-0.22	0.15	0.15
811	sodium carbonate	1.85	0.73	3.89	0.11	7	185	177542	8686605	811	sodium carbonate	hypertension	0	0	10.48	1	0	18	6895	317595	811	sodium carbonate	hypertension	38	82.9	0	0	153.8	1	0	3	981	62406	811	sodium carbonate	hypertension	0	0	223.89	1	0	3	341	31636	811	sodium carbonate	hypertension	0	0	279.37	1	0	2	762	39928	811	sodium carbonate	hypertension	-8.66	0.000173384306903506	138.53	0.95	-0.02	0	0	-0.59	0.07	0
812	nitroglycerin	4.56	4.38	4.73	0	2874	31259	174675	8655531	812	nitroglycerin	hypertension	3.35	2.93	3.82	1.5e-54	250	3523	6645	314090	812	nitroglycerin	hypertension	38	82.9	1.54	0.87	2.53	0.11	16	665	965	61744	812	nitroglycerin	hypertension	1.18	0.38	2.8	0.62	5	395	336	31244	812	nitroglycerin	hypertension	1.78	0.91	3.17	0.053	12	355	750	39575	812	nitroglycerin	hypertension	0.53	1.69893230861855	0.25	0.03	-0.02	0	0	-0.6	0.07	0
813	ketoconazole	3.21	2.9	3.55	4.1e-85	413	6308	177136	8680482	813	ketoconazole	hypertension	1.69	0.98	2.74	0.038	17	463	6878	317150	813	ketoconazole	hypertension	38	82.9	0.88	0.11	3.24	1	2	145	979	62264	813	ketoconazole	hypertension	0	0	3.94	1	0	89	341	31550	813	ketoconazole	hypertension	1.42	0.17	5.32	0.66	2	74	760	39856	813	ketoconazole	hypertension	-0.22	0.802518797962478	0.71	0.75	-0.02	0	0	-0.59	0.07	0
815	indapamide	1.05	0.91	1.21	0.48	194	9022	177355	8677768	815	indapamide	hypertension	0.64	0.45	0.88	0.0043	38	2731	6857	314882	815	indapamide	hypertension	38	82.9	0.33	0.07	0.97	0.041	3	576	978	61833	815	indapamide	hypertension	0.61	0.07	2.26	0.78	2	301	339	31338	815	indapamide	hypertension	0.15	0	0.82	0.017	1	358	761	39572	815	indapamide	hypertension	-1.12	0.326279794623039	0.58	0.05	-0.02	0	0	-0.59	0.07	0
816	carprofen	0	0	10.49	1	0	19	177549	8686771	816	carprofen	suicide attempt	0	0	550.32	1	0	2	54	5577	816	carprofen	suicide attempt	13	53.8	0	0	Inf	1	0	0	14	1047	816	carprofen	suicide attempt	0	0	Inf	1	0	0	5	513	816	carprofen	suicide attempt	0	0	Inf	1	0	0	12	865	816	carprofen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
817	flutamide	3.13	2.36	4.07	2.9e-13	59	923	177490	8685867	817	flutamide	prostate cancer stage iv	0	0	174.15	1	0	178	1	796	817	flutamide	prostate cancer stage iv	67	67	0	0	Inf	1	0	0	0	0	817	flutamide	prostate cancer stage iv	0	0	Inf	1	0	0	1	207	817	flutamide	prostate cancer stage iv	0	0	Inf	1	0	0	0	0	817	flutamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
818	ritodrine	0.14	0	0.78	0.012	1	350	177548	8686440	818	ritodrine	threatened labour	0	0	16.83	1	0	42	2	130	818	ritodrine	threatened labour	35	35	0	0	Inf	1	0	0	0	0	818	ritodrine	threatened labour	0	0	Inf	1	0	1	0	1	818	ritodrine	threatened labour	0	0	46.77	1	0	15	1	17	818	ritodrine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
819	sulfadoxine	0	0	0.56	0.0024	0	325	177549	8686465	819	sulfadoxine	hiv infection	0	0	8.78	1	0	51	500	58340	819	sulfadoxine	hiv infection	25	64	0	0	341.22	1	0	2	120	7639	819	sulfadoxine	hiv infection	0	0	91.02	1	0	4	96	5724	819	sulfadoxine	hiv infection	0	0	3186.15	1	0	1	40	3438	819	sulfadoxine	hiv infection	-10.42	2.98298794702676e-05	394.26	0.98	0	0.01	0.8	0.38	0.2	0.05
820	morphine	2.29	2.21	2.37	0	3694	79931	173855	8606859	820	morphine	pain	1.27	1.18	1.37	3.1e-10	846	15117	7623	173367	820	morphine	pain	23	79	1.1	0.88	1.36	0.37	96	2913	992	33104	820	morphine	pain	1.12	0.78	1.58	0.52	38	1443	326	13874	820	morphine	pain	1.12	0.85	1.45	0.41	65	1821	792	24769	820	morphine	pain	0.07	1.07250818125422	0.1	0.49	-0.02	0	0	-0.28	0.06	0
821	calcium acetate	3.38	3.04	3.74	1.5e-87	396	5748	177153	8681042	821	calcium acetate	nuclear magnetic resonance imaging	2.91	2.38	3.55	4.2e-24	168	363	978	6160	821	calcium acetate	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	821	calcium acetate	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	821	calcium acetate	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	821	calcium acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
822	glycerin	0.96	0.62	1.44	1	24	1217	177525	8685573	822	glycerin	constipation	1.65	0.65	3.46	0.21	7	248	721	42041	822	glycerin	constipation	2.6	80.7	1.05	0.03	6.14	0.62	1	59	168	10365	822	glycerin	constipation	0	0	8.78	1	0	37	69	5633	822	glycerin	constipation	1.58	0.04	9.48	0.48	1	40	119	7512	822	glycerin	constipation	-0.43	0.650509094723317	1.02	0.67	-0.03	0	0	-0.22	0.15	0.15
823	guanabenz acetate	0.61	0.02	3.51	1	1	80	177548	8686710	823	guanabenz acetate	hypertension	0	0	6.74	1	0	27	6895	317586	823	guanabenz acetate	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	823	guanabenz acetate	hypertension	0	0	3424.95	1	0	1	341	31638	823	guanabenz acetate	hypertension	0	0	Inf	1	0	0	762	39930	823	guanabenz acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
824	diltiazem	1.96	1.88	2.05	3.6e-168	2160	54271	175389	8632519	824	diltiazem	hypertension	1.61	1.43	1.81	9.7e-14	300	8713	6595	308900	824	diltiazem	hypertension	38	82.9	1.49	1.04	2.08	0.025	37	1600	944	60809	824	diltiazem	hypertension	1.05	0.45	2.09	0.85	8	711	333	30928	824	diltiazem	hypertension	1.37	0.92	1.99	0.1	30	1156	732	38774	824	diltiazem	hypertension	0.34	1.40494759056359	0.17	0.04	-0.02	0	0	-0.59	0.07	0
825	acyclovir sodium	1.59	1.5	1.67	6.8e-54	1340	41458	176209	8645332	825	acyclovir sodium	plasma cell myeloma	1.95	1.54	2.46	7e-08	90	9870	444	95045	825	acyclovir sodium	plasma cell myeloma	47.4	82.5	1.81	1.18	2.71	0.0055	30	4376	134	35452	825	acyclovir sodium	plasma cell myeloma	1.9	1.05	3.26	0.026	17	2583	76	21979	825	acyclovir sodium	plasma cell myeloma	1.8	0.98	3.12	0.04	16	2225	75	18733	825	acyclovir sodium	plasma cell myeloma	0.56	1.7506725002961	0.19	0	-0.03	0.01	0	-0.15	0.15	0.31
826	acyclovir	1.59	1.5	1.67	9.3e-54	1340	41477	176209	8645313	826	acyclovir	plasma cell myeloma	1.95	1.54	2.46	7.1e-08	90	9871	444	95044	826	acyclovir	plasma cell myeloma	47.4	82.5	1.81	1.18	2.71	0.0055	30	4377	134	35451	826	acyclovir	plasma cell myeloma	1.9	1.05	3.26	0.026	17	2584	76	21978	826	acyclovir	plasma cell myeloma	1.8	0.98	3.12	0.04	16	2225	75	18733	826	acyclovir	plasma cell myeloma	0.56	1.7506725002961	0.19	0	-0.03	0.01	0	-0.15	0.15	0.31
827	nicotine polacrilex	0.76	0.68	0.85	6.6e-07	314	20179	177235	8666611	827	nicotine polacrilex	smoking cessation therapy	0.33	0.27	0.39	5.4e-50	134	3673	6298	56514	827	nicotine polacrilex	smoking cessation therapy	26.1	70	0.3	0.15	0.54	2.4e-06	12	809	239	4832	827	nicotine polacrilex	smoking cessation therapy	0.41	0.16	0.88	0.016	7	366	99	2113	827	nicotine polacrilex	smoking cessation therapy	0.21	0.07	0.46	3.8e-06	6	611	171	3619	827	nicotine polacrilex	smoking cessation therapy	-1.24	0.289384217939051	0.29	0	-0.02	0	0	-0.02	0.13	0.87
828	malathion	0	0	1.7	0.28	0	108	177549	8686682	828	malathion	lice infestation	0	0	9.54	1	0	61	6	670	828	malathion	lice infestation	36.2	68.2	0	0	Inf	1	0	1	0	52	828	malathion	lice infestation	0	0	Inf	1	0	0	0	24	828	malathion	lice infestation	0	0	93.55	1	0	6	2	96	828	malathion	lice infestation	-16.21	9.12192397449338e-08	6982.53	1	0.04	0.04	0.29	-17.04	3403.35	1
829	chymopapain	0	0	53.4	1	0	5	177549	8686785	829	chymopapain	intervertebral disc protrusion	0	0	99.98	1	0	2	162	3027	829	chymopapain	intervertebral disc protrusion	27.6	64	0	0	Inf	1	0	0	33	470	829	chymopapain	intervertebral disc protrusion	0	0	Inf	1	0	0	6	210	829	chymopapain	intervertebral disc protrusion	0	0	Inf	1	0	0	31	426	829	chymopapain	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
830	pentoxifylline	2.78	2.41	3.2	1.5e-35	208	3664	177341	8683126	830	pentoxifylline	hypertension	1.78	1.01	2.92	0.029	16	415	6879	317198	830	pentoxifylline	hypertension	38	82.9	0	0	3.9	1	0	62	981	62347	830	pentoxifylline	hypertension	0	0	9.24	1	0	39	341	31600	830	pentoxifylline	hypertension	0	0	6.41	1	0	32	762	39898	830	pentoxifylline	hypertension	-11.24	1.31380231688045e-05	171.06	0.95	-0.02	0	0	-0.59	0.07	0
831	povidone-iodine	0.36	0.22	0.56	1.4e-07	20	2683	177529	8684107	831	povidone-iodine	cataract operation	0	0	7.07	1	0	192	6	1586	831	povidone-iodine	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	831	povidone-iodine	cataract operation	0	0	Inf	1	0	16	0	85	831	povidone-iodine	cataract operation	0	0	Inf	1	0	34	0	206	831	povidone-iodine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
832	bupropion	3.62	3.52	3.72	0	5666	78381	171883	8608409	832	bupropion	depression	1.29	1.22	1.35	6.8e-22	1949	20977	12422	171808	832	bupropion	depression	21	73.3	1.26	1.1	1.45	0.00095	264	2953	1798	25389	832	bupropion	depression	1.12	0.84	1.48	0.42	61	901	576	9546	832	bupropion	depression	1.4	1.2	1.62	2.1e-05	217	2352	1454	22032	832	bupropion	depression	0.27	1.30996445073325	0.07	0	-0.01	0	0	-0.14	0.05	0
833	dronabinol	2.9	2.5	3.35	2.3e-36	199	3361	177350	8683429	833	dronabinol	nausea	1.9	1.29	2.71	0.0012	34	451	1190	29957	833	dronabinol	nausea	17.2	77	1.1	0.29	2.94	0.79	4	128	214	7564	833	dronabinol	nausea	2.82	0.55	9.07	0.1	3	74	47	3267	833	dronabinol	nausea	0.81	0.1	3.06	1	2	71	193	5523	833	dronabinol	nausea	0.25	1.28402541668774	0.46	0.58	-0.03	0	0	-0.77	0.16	0
834	midazolam	6.85	6.53	7.19	0	1932	13928	175617	8672862	834	midazolam	anaesthesia	1.11	0.54	2.14	0.74	12	1210	48	5394	834	midazolam	anaesthesia	23	71.2	1.1	0.11	5.9	1	2	117	7	452	834	midazolam	anaesthesia	0	0	149.8	1	0	80	1	307	834	midazolam	anaesthesia	1.08	0.11	5.55	1	2	91	8	394	834	midazolam	anaesthesia	-0.05	0.951229424500714	0.79	0.95	0	0.01	0.9	-2.08	1.05	0.05
835	dextromethorphan polistirex	1.04	0.76	1.38	0.77	48	2265	177501	8684525	835	dextromethorphan polistirex	cough	0.85	0.51	1.36	0.58	19	830	359	13383	835	dextromethorphan polistirex	cough	13.7	78	0.83	0.32	1.83	0.85	7	310	76	2808	835	dextromethorphan polistirex	cough	0.8	0.09	3.29	1	2	156	23	1436	835	dextromethorphan polistirex	cough	0.58	0.18	1.43	0.34	5	288	64	2126	835	dextromethorphan polistirex	cough	-0.61	0.5433508690745	0.4	0.13	-0.02	0	0	-0.65	0.24	0.01
836	isotretinoin	6.41	6.21	6.61	0	4551	35514	172998	8651276	836	isotretinoin	acne	1.74	1.63	1.86	3.1e-62	2852	15766	1524	14638	836	isotretinoin	acne	14.8	44.4	0.76	0.54	1.05	0.095	60	1164	113	1660	836	isotretinoin	acne	3.5	1.29	11.87	0.0066	23	642	5	489	836	isotretinoin	acne	0.91	0.62	1.31	0.65	43	673	121	1721	836	isotretinoin	acne	0.1	1.10517091807565	0.16	0.55	0	0.01	0.73	-1.06	0.21	0
837	levonorgestrel	1.5	1.45	1.54	9.4e-120	3951	130151	173598	8556639	837	levonorgestrel	contraception	0.75	0.71	0.79	1.6e-33	2658	59345	5343	89289	837	levonorgestrel	contraception	19	43	4.75	4.22	5.35	1.6e-183	1330	10142	385	13939	837	levonorgestrel	contraception	0	0	Inf	1	0	4	0	18	837	levonorgestrel	contraception	4.32	3.88	4.81	5.1e-189	1463	12021	476	16884	837	levonorgestrel	contraception	1.48	4.39294568091876	0.05	0	-0.01	0	0	-10.48	110.09	0.92
838	niclosamide	0	0	1852.91	1	0	1	177549	8686789	838	niclosamide	rheumatoid arthritis	0	0	4865.13	1	0	1	3410	460376	838	niclosamide	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	838	niclosamide	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	838	niclosamide	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	838	niclosamide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
839	nabilone	2.32	1.38	3.67	0.0012	19	401	177530	8686389	839	nabilone	pain	1.59	0.42	4.3	0.33	4	56	8465	188428	839	nabilone	pain	23	79	0	0	8.59	1	0	16	1088	36001	839	nabilone	pain	0	0	46.05	1	0	5	364	15312	839	nabilone	pain	2.59	0.06	17.52	0.34	1	12	856	26578	839	nabilone	pain	0.4	1.49182469764127	1.03	0.7	-0.02	0	0	-0.28	0.06	0
840	tioconazole	0.75	0.44	1.19	0.26	18	1174	177531	8685616	840	tioconazole	vulvovaginal mycotic infection	0	0	0.45	9e-04	0	562	26	1637	840	tioconazole	vulvovaginal mycotic infection	52.3	55.1	0	0	Inf	1	0	10	0	18	840	tioconazole	vulvovaginal mycotic infection	0	0	Inf	1	0	0	0	5	840	tioconazole	vulvovaginal mycotic infection	0	0	15.73	1	0	136	2	399	840	tioconazole	vulvovaginal mycotic infection	-16.24	8.85233037841618e-08	2474.26	0.99	0.03	0.04	0.46	-14.92	13071.57	1
841	aluminum hydroxide	1.24	1.06	1.44	0.0082	168	6643	177381	8680147	841	aluminum hydroxide	gastrooesophageal reflux disease	1.54	1.06	2.19	0.018	34	574	2934	76454	841	aluminum hydroxide	gastrooesophageal reflux disease	22.4	77.2	0.57	0.07	2.09	0.59	2	138	476	18559	841	aluminum hydroxide	gastrooesophageal reflux disease	0.61	0.02	3.53	1	1	87	151	7996	841	aluminum hydroxide	gastrooesophageal reflux disease	0.39	0.01	2.25	0.52	1	96	379	14293	841	aluminum hydroxide	gastrooesophageal reflux disease	-0.86	0.423162082317749	0.71	0.23	-0.02	0	0	-0.34	0.1	0
842	magnesium trisilicate	1.21	1.02	1.42	0.026	149	6026	177400	8680764	842	magnesium trisilicate	gastrooesophageal reflux disease	1.4	0.93	2.02	0.079	30	559	2938	76469	842	magnesium trisilicate	gastrooesophageal reflux disease	22.4	77.2	0.57	0.07	2.12	0.59	2	136	476	18561	842	magnesium trisilicate	gastrooesophageal reflux disease	0.62	0.02	3.58	1	1	86	151	7997	842	magnesium trisilicate	gastrooesophageal reflux disease	0.4	0.01	2.28	0.52	1	95	379	14294	842	magnesium trisilicate	gastrooesophageal reflux disease	-0.85	0.427414931948727	0.71	0.24	-0.02	0	0	-0.34	0.1	0
843	labetalol	2.95	2.69	3.23	2.8e-89	492	8179	177057	8678611	843	labetalol	hypertension	1.93	1.52	2.41	1.6e-07	81	1944	6814	315669	843	labetalol	hypertension	38	82.9	1.36	0.54	2.85	0.37	7	327	974	62082	843	labetalol	hypertension	0.59	0.01	3.38	1	1	156	340	31483	843	labetalol	hypertension	1.79	0.88	3.27	0.065	11	324	751	39606	843	labetalol	hypertension	0.14	1.15027379885723	0.3	0.65	-0.02	0	0	-0.59	0.07	0
844	auranofin	0.36	0.04	1.32	0.19	2	271	177547	8686519	844	auranofin	rheumatoid arthritis	0	0	2.51	0.41	0	200	3410	460177	844	auranofin	rheumatoid arthritis	33	75	0	0	74.64	1	0	7	1060	113931	844	auranofin	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	844	auranofin	rheumatoid arthritis	0	0	62.53	1	0	8	1011	107956	844	auranofin	rheumatoid arthritis	-7.83	0.000397625480289526	114.69	0.95	-0.01	0	0	-0.26	0.08	0
845	inamrinone lactate	98.06	43.72	234.58	2.7e-27	20	10	177529	8686780	845	inamrinone lactate	coronary artery bypass	2.55	0.91	8.81	0.059	18	5	2834	2009	845	inamrinone lactate	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	845	inamrinone lactate	coronary artery bypass	0	0	Inf	1	0	0	1	192	845	inamrinone lactate	coronary artery bypass	0	0	Inf	1	0	0	3	35	845	inamrinone lactate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
846	haloperidol decanoate	1.96	1.8	2.14	2.5e-43	532	13276	177017	8673514	846	haloperidol decanoate	schizophrenia	1	0.75	1.31	1	56	2204	1459	57320	846	haloperidol decanoate	schizophrenia	20.1	64.1	1.05	0.49	2	0.87	10	227	284	6787	846	haloperidol decanoate	schizophrenia	1.42	0.59	2.93	0.38	8	165	174	5097	846	haloperidol decanoate	schizophrenia	0.46	0.05	1.74	0.44	2	95	146	3200	846	haloperidol decanoate	schizophrenia	-0.01	0.990049833749168	0.33	0.98	-0.02	0	0	-0.31	0.11	0.01
847	alclometasone dipropionate	7.81	5.12	11.52	1.9e-16	30	188	177519	8686602	847	alclometasone dipropionate	adverse event	0	0	361.39	1	0	2	16	1049	847	alclometasone dipropionate	adverse event	48.2	73.4	0	0	3986.29	1	0	2	1	217	847	alclometasone dipropionate	adverse event	0	0	3934.8	1	0	2	1	214	847	alclometasone dipropionate	adverse event	0	0	Inf	1	0	0	2	159	847	alclometasone dipropionate	adverse event	-12.19	5.08101252647241e-06	2797.44	1	0	0.03	0.92	-0.98	1.23	0.43
848	ranitidine	1.97	1.9	2.05	5.2e-242	3068	76698	174481	8610092	848	ranitidine	gastrooesophageal reflux disease	1.48	1.33	1.65	4.4e-12	412	7557	2556	69471	848	ranitidine	gastrooesophageal reflux disease	22.4	77.2	1.16	0.85	1.55	0.31	53	1814	425	16883	848	ranitidine	gastrooesophageal reflux disease	1.29	0.74	2.14	0.33	18	761	134	7322	848	ranitidine	gastrooesophageal reflux disease	1.15	0.81	1.59	0.39	43	1440	337	12949	848	ranitidine	gastrooesophageal reflux disease	0.09	1.09417428370521	0.14	0.53	-0.02	0	0	-0.35	0.1	0
849	quazepam	0.79	0.45	1.29	0.43	16	991	177533	8685799	849	quazepam	schizophrenia	0.54	0.11	1.61	0.39	3	217	1512	59307	849	quazepam	schizophrenia	20.1	64.1	0	0	2.58	0.4	0	36	294	6978	849	quazepam	schizophrenia	0	0	5.58	1	0	21	182	5241	849	quazepam	schizophrenia	0	0	4.8	1	0	19	148	3276	849	quazepam	schizophrenia	-12.3	4.55174446308323e-06	228.48	0.96	-0.02	0	0	-0.31	0.11	0.01
850	praziquantel	0.39	0.01	2.24	0.53	1	124	177548	8686666	850	praziquantel	hiv infection	0	0	20.38	1	0	23	500	58368	850	praziquantel	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	850	praziquantel	hiv infection	0	0	Inf	1	0	0	96	5728	850	praziquantel	hiv infection	0	0	Inf	1	0	0	40	3439	850	praziquantel	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
851	trilostane	0	0	41.55	1	0	6	177549	8686784	851	trilostane	prostate cancer	0	0	3781.29	1	0	1	444	45750	851	trilostane	prostate cancer	56.9	87.4	0	0	Inf	1	0	0	102	12804	851	trilostane	prostate cancer	0	0	Inf	1	0	0	114	14676	851	trilostane	prostate cancer	0	0	Inf	1	0	0	0	51	851	trilostane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
852	divalproex sodium	2.42	2.3	2.55	8.5e-195	1537	31185	176012	8655605	852	divalproex sodium	bipolar disorder	1.1	0.97	1.25	0.13	299	5537	2278	46412	852	divalproex sodium	bipolar disorder	19.9	69	0.81	0.51	1.24	0.38	25	488	340	5397	852	divalproex sodium	bipolar disorder	0.57	0.22	1.23	0.2	7	265	116	2512	852	divalproex sodium	bipolar disorder	0.91	0.53	1.47	0.81	19	329	266	4174	852	divalproex sodium	bipolar disorder	-0.25	0.778800783071405	0.21	0.23	0	0	0.44	-0.34	0.11	0
853	buspirone	5.26	4.99	5.55	0	1505	14086	176044	8672704	853	buspirone	anxiety	1.06	0.95	1.18	0.27	393	2695	10958	79782	853	buspirone	anxiety	20	75	1.19	0.95	1.49	0.11	98	746	1820	16551	853	buspirone	anxiety	1.08	0.69	1.61	0.68	28	247	626	5944	853	buspirone	anxiety	1.29	0.99	1.65	0.053	75	567	1409	13723	853	buspirone	anxiety	0.19	1.20924959765725	0.11	0.08	-0.01	0	0	0	0.05	0.94
854	iopamidol	3.61	3.01	4.31	7.6e-34	135	1829	177414	8684961	854	iopamidol	computerised tomogram	0.96	0.37	2.11	1	7	552	58	4372	854	iopamidol	computerised tomogram	27.5	85	0	0	1529.66	1	0	11	1	441	854	iopamidol	computerised tomogram	0	0	202.53	1	0	6	2	210	854	iopamidol	computerised tomogram	0	0	1406.54	1	0	8	1	294	854	iopamidol	computerised tomogram	-14.5	5.04347662567888e-07	2814.96	1	0.01	0.03	0.66	1.02	1.23	0.41
855	sulconazole nitrate	0	0	8.51	1	0	23	177549	8686767	855	sulconazole nitrate	osteoporosis	0	0	43.32	1	0	3	8802	157683	855	sulconazole nitrate	osteoporosis	53.1	85	0	0	Inf	1	0	0	808	24568	855	sulconazole nitrate	osteoporosis	0	0	Inf	1	0	0	31	2935	855	sulconazole nitrate	osteoporosis	0	0	Inf	1	0	0	868	26887	855	sulconazole nitrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
856	antazoline phosphate	0	0	260.7	1	0	2	177549	8686788	856	antazoline phosphate	atrial fibrillation	0	0	4960.68	1	0	1	808	111408	856	antazoline phosphate	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	856	antazoline phosphate	atrial fibrillation	0	0	Inf	1	0	0	56	22073	856	antazoline phosphate	atrial fibrillation	0	0	Inf	1	0	0	94	17933	856	antazoline phosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
857	naphazoline	0.55	0.31	0.9	0.014	16	1425	177533	8685365	857	naphazoline	eye pruritus	0.28	0.01	1.78	0.35	1	321	20	1816	857	naphazoline	eye pruritus	43.6	81	0	0	85.92	1	0	19	2	299	857	naphazoline	eye pruritus	0	0	Inf	1	0	10	0	177	857	naphazoline	eye pruritus	0	0	31.28	1	0	21	4	413	857	naphazoline	eye pruritus	-16.39	7.61927136665264e-08	4909.58	1	0.02	0.03	0.37	-16.7	2085.49	0.99
858	ciclopirox	5.03	4.06	6.16	5.3e-37	103	1003	177446	8685787	858	ciclopirox	psoriasis	0	0	7.47	1	0	69	1190	161622	858	ciclopirox	psoriasis	25	74.8	0	0	34.77	1	0	14	379	43511	858	ciclopirox	psoriasis	0	0	122.15	1	0	6	149	21338	858	ciclopirox	psoriasis	0	0	39.91	1	0	11	274	27332	858	ciclopirox	psoriasis	-9.84	5.32773111185406e-05	213.73	0.96	0	0	0.71	-0.36	0.1	0
859	acetohydroxamic acid	0	0	41.55	1	0	6	177549	8686784	859	acetohydroxamic acid	diabetes mellitus	0	0	551.72	1	0	2	2327	242896	859	acetohydroxamic acid	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	859	acetohydroxamic acid	diabetes mellitus	0	0	Inf	1	0	0	140	29744	859	acetohydroxamic acid	diabetes mellitus	0	0	Inf	1	0	0	281	28202	859	acetohydroxamic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
860	econazole nitrate	5.18	3.92	6.74	1.4e-23	62	586	177487	8686204	860	econazole nitrate	hiv infection	0	0	18.62	1	0	25	500	58366	860	econazole nitrate	hiv infection	25	64	0	0	2390.6	1	0	1	120	7640	860	econazole nitrate	hiv infection	0	0	Inf	1	0	0	96	5728	860	econazole nitrate	hiv infection	0	0	3186.15	1	0	1	40	3438	860	econazole nitrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
861	ketoprofen	0.97	0.82	1.16	0.83	136	6827	177413	8679963	861	ketoprofen	rheumatoid arthritis	0.89	0.44	1.6	0.89	11	1663	3399	458714	861	ketoprofen	rheumatoid arthritis	33	75	6.2	1.96	15.07	0.0017	5	87	1055	113851	861	ketoprofen	rheumatoid arthritis	0	0	25.97	1	0	22	180	25369	861	ketoprofen	rheumatoid arthritis	5.96	1.88	14.46	0.002	5	90	1006	107874	861	ketoprofen	rheumatoid arthritis	1.59	4.90374892832662	0.46	0	-0.01	0	0	-0.26	0.08	0
863	flurbiprofen	1.6	1.19	2.11	0.0019	52	1592	177497	8685198	863	flurbiprofen	rheumatoid arthritis	5.83	2.76	10.93	1.5e-05	10	232	3400	460145	863	flurbiprofen	rheumatoid arthritis	33	75	8.61	0.99	34.61	0.026	2	25	1058	113913	863	flurbiprofen	rheumatoid arthritis	0	0	98.65	1	0	7	180	25384	863	flurbiprofen	rheumatoid arthritis	10.19	1.16	41.79	0.019	2	21	1009	107943	863	flurbiprofen	rheumatoid arthritis	2.11	8.24824128462666	0.73	0	-0.01	0	0	-0.26	0.08	0
864	etoposide	0.2	0.17	0.25	4.5e-109	108	25923	177441	8660867	864	etoposide	hodgkin s disease	0.34	0.04	1.39	0.2	2	1085	20	3650	864	etoposide	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	21	0	104	864	etoposide	hodgkin s disease	0	0	Inf	1	0	69	0	449	864	etoposide	hodgkin s disease	0	0	30.82	1	0	61	2	349	864	etoposide	hodgkin s disease	-17.64	2.18295779512548e-08	6287.77	1	-0.02	0.04	0.61	-18.16	3395.18	1
865	bitolterol mesylate	0	0	118.34	1	0	3	177549	8686787	865	bitolterol mesylate	diabetic foot infection	0	0	7168.83	1	0	1	1	206	865	bitolterol mesylate	diabetic foot infection	NA	NA	0	0	Inf	1	0	0	0	0	865	bitolterol mesylate	diabetic foot infection	0	0	Inf	1	0	0	0	29	865	bitolterol mesylate	diabetic foot infection	0	0	Inf	1	0	0	0	15	865	bitolterol mesylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
866	hydroxypropyl cellulose	0	0	2.12	0.43	0	87	177549	8686703	866	hydroxypropyl cellulose	dry eye	0	0	11.5	1	0	39	107	12196	866	hydroxypropyl cellulose	dry eye	42.4	82.3	0	0	25.81	1	0	16	34	3229	866	hydroxypropyl cellulose	dry eye	0	0	8175.76	1	0	3	1	720	866	hydroxypropyl cellulose	dry eye	0	0	19.82	1	0	19	37	3274	866	hydroxypropyl cellulose	dry eye	-12.94	2.40010037156368e-06	828.82	0.99	-0.02	0.01	0.01	-2.15	1.02	0.03
867	vecuronium bromide	5.16	4.46	5.94	2.8e-76	213	2023	177336	8684767	867	vecuronium bromide	anaesthesia	0.24	0.01	1.37	0.19	1	444	59	6160	867	vecuronium bromide	anaesthesia	23	71.2	0	0	61.08	1	0	6	9	563	867	vecuronium bromide	anaesthesia	0	0	2390.3	1	0	6	1	381	867	vecuronium bromide	anaesthesia	0	0	269.73	1	0	2	10	483	867	vecuronium bromide	anaesthesia	-12.53	3.61651392592813e-06	1326.2	0.99	0	0.01	0.9	-2.07	1.05	0.05
868	insulin zinc susp semisynthetic purified human	0	0	14.75	1	0	14	177549	8686776	868	insulin zinc susp semisynthetic purified human	diabetes mellitus	0	0	88.74	1	0	6	2327	242892	868	insulin zinc susp semisynthetic purified human	diabetes mellitus	39.3	82	0	0	Inf	1	0	0	377	52484	868	insulin zinc susp semisynthetic purified human	diabetes mellitus	0	0	Inf	1	0	0	140	29744	868	insulin zinc susp semisynthetic purified human	diabetes mellitus	0	0	Inf	1	0	0	281	28202	868	insulin zinc susp semisynthetic purified human	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
869	insulin recombinant purified human	1.4	1.19	1.63	6.2e-05	164	5745	177385	8681045	869	insulin recombinant purified human	diabetes mellitus	1.29	0.72	2.15	0.3	15	1211	2312	241687	869	insulin recombinant purified human	diabetes mellitus	39.3	82	0.89	0.02	5.07	1	1	156	376	52328	869	insulin recombinant purified human	diabetes mellitus	0	0	8.32	1	0	97	140	29647	869	insulin recombinant purified human	diabetes mellitus	1.2	0.03	6.9	0.57	1	84	280	28118	869	insulin recombinant purified human	diabetes mellitus	-0.25	0.778800783071405	1	0.8	-0.01	0	0	-0.75	0.1	0
870	insulin recombinant human	1.47	1.35	1.59	4.9e-19	623	20783	176926	8666007	870	insulin recombinant human	diabetes mellitus	1.94	1.6	2.33	7.1e-11	124	6854	2203	236044	870	insulin recombinant human	diabetes mellitus	39.3	82	2.26	1.15	4.01	0.014	12	754	365	51730	870	insulin recombinant human	diabetes mellitus	0.52	0.01	2.95	1	1	408	139	29336	870	insulin recombinant human	diabetes mellitus	2.94	1.57	5.07	0.00058	14	494	267	27708	870	insulin recombinant human	diabetes mellitus	0.82	2.27049983753241	0.27	0	-0.01	0	0	-0.75	0.1	0
871	insulin human	1.8	1.65	1.97	1.7e-34	533	14482	177016	8672308	871	insulin human	diabetes mellitus	2.18	1.73	2.7	1.7e-10	88	4310	2239	238588	871	insulin human	diabetes mellitus	39.3	82	3.42	1.68	6.25	0.00061	11	457	366	52027	871	insulin human	diabetes mellitus	1.74	0.21	6.49	0.32	2	245	138	29499	871	insulin human	diabetes mellitus	3.25	1.46	6.35	0.0027	9	284	272	27918	871	insulin human	diabetes mellitus	1.01	2.74560101501692	0.31	0	-0.01	0	0	-0.75	0.1	0
872	insulin susp isophane recombinant human	1.16	1.06	1.27	0.001	501	21078	177048	8665712	872	insulin susp isophane recombinant human	diabetes mellitus	1.93	1.61	2.31	1.9e-11	133	7382	2194	235516	872	insulin susp isophane recombinant human	diabetes mellitus	39.3	82	2.62	1.48	4.34	0.00075	16	872	361	51612	872	insulin susp isophane recombinant human	diabetes mellitus	2	0.53	5.28	0.15	4	431	136	29313	872	insulin susp isophane recombinant human	diabetes mellitus	3.22	1.9	5.17	2.3e-05	19	621	262	27581	872	insulin susp isophane recombinant human	diabetes mellitus	1.09	2.97427407256307	0.22	0	-0.01	0	0	-0.74	0.1	0
873	flecainide acetate	0.88	0.69	1.09	0.27	80	4465	177469	8682325	873	flecainide acetate	atrial fibrillation	1.47	0.75	2.59	0.21	12	1132	796	110277	873	flecainide acetate	atrial fibrillation	49	86.6	1.51	0.04	8.68	0.49	1	174	131	34452	873	flecainide acetate	atrial fibrillation	0	0	17.57	1	0	87	56	21986	873	flecainide acetate	atrial fibrillation	1.9	0.05	11.08	0.41	1	101	93	17832	873	flecainide acetate	atrial fibrillation	0.24	1.2712491503214	1.01	0.81	-0.01	0	0	-0.76	0.17	0
874	atracurium besylate	0.69	0.38	1.17	0.21	14	990	177535	8685800	874	atracurium besylate	anaesthesia	0	0	1.65	0.17	0	246	60	6358	874	atracurium besylate	anaesthesia	23	71.2	0	0	165.81	1	0	3	9	566	874	atracurium besylate	anaesthesia	0	0	3537.13	1	0	4	1	383	874	atracurium besylate	anaesthesia	0	0	58.9	1	0	5	10	480	874	atracurium besylate	anaesthesia	-13.12	2.00473234476427e-06	1264.75	0.99	0	0.01	0.9	-2.08	1.05	0.05
875	oxaprozin	3.61	2.98	4.33	3.6e-31	124	1683	177425	8685107	875	oxaprozin	rheumatoid arthritis	4.15	1.77	8.3	0.00096	8	261	3402	460116	875	oxaprozin	rheumatoid arthritis	33	75	0	0	8.6	1	0	48	1060	113890	875	oxaprozin	rheumatoid arthritis	0	0	71.97	1	0	9	180	25382	875	oxaprozin	rheumatoid arthritis	0	0	9.35	1	0	44	1011	107920	875	oxaprozin	rheumatoid arthritis	-9.86	5.22223496757448e-05	121.07	0.94	-0.01	0	0	-0.26	0.08	0
876	ribavirin	1.24	1.2	1.29	8e-27	2679	105668	174870	8581122	876	ribavirin	hepatitis c	1.48	1.33	1.64	1.5e-14	2078	70192	453	22574	876	ribavirin	hepatitis c	32.8	65	1.18	0.99	1.41	0.062	333	9574	224	7595	876	ribavirin	hepatitis c	1.23	0.97	1.55	0.079	189	6617	132	5674	876	ribavirin	hepatitis c	1.22	0.96	1.55	0.091	180	5252	126	4495	876	ribavirin	hepatitis c	0.14	1.15027379885723	0.08	0.09	-0.02	0	0	-0.17	0.08	0.03
877	nimodipine	0.3	0.1	0.71	0.0024	5	812	177544	8685978	877	nimodipine	hypertension	0.29	0.01	1.65	0.27	1	158	6894	317455	877	nimodipine	hypertension	38	82.9	0	0	11.09	1	0	23	981	62386	877	nimodipine	hypertension	0	0	33.52	1	0	12	341	31627	877	nimodipine	hypertension	0	0	11.24	1	0	19	762	39911	877	nimodipine	hypertension	-10.28	3.4312528777718e-05	156.26	0.95	-0.02	0	0	-0.59	0.07	0
878	mexiletine	1.69	1.31	2.14	7.7e-05	69	2002	177480	8684788	878	mexiletine	hypertension	0	0	0.6	0.0056	0	283	6895	317330	878	mexiletine	hypertension	38	82.9	0	0	6.15	1	0	40	981	62369	878	mexiletine	hypertension	0	0	10.68	1	0	34	341	31605	878	mexiletine	hypertension	0	0	17.22	1	0	13	762	39917	878	mexiletine	hypertension	-10.08	4.19094172885549e-05	127.01	0.94	-0.02	0	0	-0.59	0.07	0
879	indomethacin sodium	3.22	2.77	3.73	2e-40	190	2889	177359	8683901	879	indomethacin sodium	patent ductus arteriosus	0	0	Inf	1	0	591	0	654	879	indomethacin sodium	patent ductus arteriosus	NA	NA	0	0	Inf	1	0	0	0	0	879	indomethacin sodium	patent ductus arteriosus	0	0	Inf	1	0	2	0	17	879	indomethacin sodium	patent ductus arteriosus	0	0	Inf	1	0	1	0	38	879	indomethacin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
880	sodium phosphate, dibasic, heptahydrate	2.55	1.41	4.27	0.0014	15	288	177534	8686502	880	sodium phosphate, dibasic, heptahydrate	constipation	0	0	4.19	1	0	53	728	42236	880	sodium phosphate, dibasic, heptahydrate	constipation	2.6	80.7	0	0	149.65	1	0	3	169	10421	880	sodium phosphate, dibasic, heptahydrate	constipation	0	0	200.12	1	0	3	69	5667	880	sodium phosphate, dibasic, heptahydrate	constipation	0	0	Inf	1	0	0	120	7552	880	sodium phosphate, dibasic, heptahydrate	constipation	-9.35	8.69654190944029e-05	308.6	0.98	-0.03	0	0	-0.22	0.15	0.15
881	sodium phosphate, monobasic, anhydrous	2.71	1.49	4.55	0.00077	15	271	177534	8686519	881	sodium phosphate, monobasic, anhydrous	constipation	0	0	4.19	1	0	53	728	42236	881	sodium phosphate, monobasic, anhydrous	constipation	2.6	80.7	0	0	149.65	1	0	3	169	10421	881	sodium phosphate, monobasic, anhydrous	constipation	0	0	200.12	1	0	3	69	5667	881	sodium phosphate, monobasic, anhydrous	constipation	0	0	Inf	1	0	0	120	7552	881	sodium phosphate, monobasic, anhydrous	constipation	-9.35	8.69654190944029e-05	308.6	0.98	-0.03	0	0	-0.22	0.15	0.15
882	sodium acetate anhydrous	0	0	1.02	0.055	0	178	177549	8686612	882	sodium acetate anhydrous	parenteral nutrition	0	0	72.79	1	0	16	4	723	882	sodium acetate anhydrous	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	882	sodium acetate anhydrous	parenteral nutrition	0	0	Inf	1	0	1	0	63	882	sodium acetate anhydrous	parenteral nutrition	0	0	Inf	1	0	5	0	73	882	sodium acetate anhydrous	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
883	ioxaglate meglumine	0.61	0.17	1.59	0.43	4	319	177545	8686471	883	ioxaglate meglumine	arteriogram coronary	0.33	0.01	1.98	0.36	1	65	44	929	883	ioxaglate meglumine	arteriogram coronary	49.7	79.4	0	0	Inf	1	0	8	0	29	883	ioxaglate meglumine	arteriogram coronary	0	0	142.68	1	0	9	1	32	883	ioxaglate meglumine	arteriogram coronary	Inf	0.09	Inf	0.21	1	2	0	11	883	ioxaglate meglumine	arteriogram coronary	1.72	5.58452846427605	1.62	0.29	0.04	0.06	0.54	-1.38	1.52	0.36
884	ioxaglate sodium	0.61	0.17	1.58	0.43	4	320	177545	8686470	884	ioxaglate sodium	arteriogram coronary	0.33	0.01	1.98	0.36	1	65	44	929	884	ioxaglate sodium	arteriogram coronary	49.7	79.4	0	0	Inf	1	0	8	0	29	884	ioxaglate sodium	arteriogram coronary	0	0	142.68	1	0	9	1	32	884	ioxaglate sodium	arteriogram coronary	Inf	0.09	Inf	0.21	1	2	0	11	884	ioxaglate sodium	arteriogram coronary	1.72	5.58452846427605	1.62	0.29	0.04	0.06	0.54	-1.38	1.52	0.36
885	acebutolol	0.44	0.3	0.61	3e-08	35	3926	177514	8682864	885	acebutolol	hypertension	0.77	0.4	1.36	0.44	12	713	6883	316900	885	acebutolol	hypertension	38	82.9	1	0.12	3.7	1	2	127	979	62282	885	acebutolol	hypertension	4.24	0.5	16.35	0.086	2	44	339	31595	885	acebutolol	hypertension	2.08	0.55	5.52	0.13	4	101	758	39829	885	acebutolol	hypertension	1.03	2.80106583469908	0.42	0.01	-0.02	0	0	-0.59	0.07	0
886	etodolac	2.61	2.33	2.91	8.8e-51	337	6325	177212	8680465	886	etodolac	rheumatoid arthritis	0.89	0.44	1.61	0.89	11	1661	3399	458716	886	etodolac	rheumatoid arthritis	33	75	1.47	0.3	4.36	0.46	3	220	1057	113718	886	etodolac	rheumatoid arthritis	0	0	14.91	1	0	37	180	25354	886	etodolac	rheumatoid arthritis	1.62	0.33	4.82	0.44	3	198	1008	107766	886	etodolac	rheumatoid arthritis	0.35	1.41906754859326	0.58	0.55	-0.01	0	0	-0.26	0.08	0
887	codeine polistirex	6.12	0.14	45.61	0.17	1	8	177548	8686782	887	codeine polistirex	cough	37.64	0.48	2876.74	0.051	1	1	377	14212	887	codeine polistirex	cough	13.7	78	37.78	0.48	2900.19	0.051	1	1	82	3117	887	codeine polistirex	cough	0	0	Inf	1	0	0	25	1592	887	codeine polistirex	cough	35.23	0.45	2713.01	0.055	1	1	68	2413	887	codeine polistirex	cough	3.56	35.1631971451066	1.42	0.01	-0.01	0	0	-0.62	0.24	0.01
888	naltrexone	2.22	2	2.46	6.2e-42	381	8408	177168	8678382	888	naltrexone	drug dependence	1.33	1.06	1.66	0.011	107	1577	458	8996	888	naltrexone	drug dependence	21.2	63.9	0.65	0.23	1.52	0.46	6	172	85	1594	888	naltrexone	drug dependence	0.68	0.21	1.74	0.54	5	125	54	920	888	naltrexone	drug dependence	0.53	0.06	2.12	0.57	2	75	42	839	888	naltrexone	drug dependence	-0.42	0.657046819815057	0.4	0.3	0.01	0.01	0.4	0.17	0.2	0.42
889	fluoxetine	3.37	3.27	3.47	0	4975	73747	172574	8613043	889	fluoxetine	depression	1.15	1.09	1.22	8.1e-07	1484	17497	12887	175288	889	fluoxetine	depression	21	73.3	1.36	1.19	1.56	1e-05	271	2833	1791	25509	889	fluoxetine	depression	1.51	1.18	1.92	0.00091	87	990	550	9457	889	fluoxetine	depression	1.41	1.22	1.64	6.6e-06	228	2450	1443	21934	889	fluoxetine	depression	0.31	1.36342511413218	0.06	0	-0.01	0	0	-0.14	0.05	0
890	levocarnitine	1.02	0.65	1.52	0.92	24	1153	177525	8685637	890	levocarnitine	prophylaxis	1.65	0.04	9.67	0.46	1	49	1278	103502	890	levocarnitine	prophylaxis	23.9	79.7	0	0	16.21	1	0	28	207	23632	890	levocarnitine	prophylaxis	0	0	28.35	1	0	24	82	13704	890	levocarnitine	prophylaxis	0	0	57.55	1	0	8	148	14404	890	levocarnitine	prophylaxis	-10.7	2.25449379132122e-05	255.19	0.97	-0.01	0	0.02	-0.52	0.14	0
891	iohexol	4.43	3.73	5.21	6.1e-49	157	1737	177392	8685053	891	iohexol	prophylaxis	2.61	0.31	9.87	0.18	2	62	1277	103489	891	iohexol	prophylaxis	23.9	79.7	0	0	41.41	1	0	12	207	23648	891	iohexol	prophylaxis	0	0	99.75	1	0	8	82	13720	891	iohexol	prophylaxis	0	0	106.9	1	0	5	148	14407	891	iohexol	prophylaxis	-9.62	6.63876176530778e-05	243.71	0.97	-0.01	0	0.03	-0.52	0.14	0
892	zinc chloride	7.73	2.67	18.42	0.00024	6	38	177543	8686752	892	zinc chloride	parenteral nutrition	0	0	6476.24	1	0	1	4	738	892	zinc chloride	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	892	zinc chloride	parenteral nutrition	0	0	Inf	1	0	0	0	64	892	zinc chloride	parenteral nutrition	0	0	Inf	1	0	0	0	78	892	zinc chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
893	cupric chloride	0	0	260.7	1	0	2	177549	8686788	893	cupric chloride	prophylaxis	0	0	436.76	1	0	2	1279	103549	893	cupric chloride	prophylaxis	23.9	79.7	0	0	Inf	1	0	0	207	23660	893	cupric chloride	prophylaxis	0	0	Inf	1	0	0	82	13728	893	cupric chloride	prophylaxis	0	0	Inf	1	0	0	148	14412	893	cupric chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
894	chromic chloride	0	0	13.64	1	0	15	177549	8686775	894	chromic chloride	prophylaxis	0	0	195.31	1	0	3	1279	103548	894	chromic chloride	prophylaxis	23.9	79.7	0	0	4167.48	1	0	1	207	23659	894	chromic chloride	prophylaxis	0	0	Inf	1	0	0	82	13728	894	chromic chloride	prophylaxis	0	0	3585.07	1	0	1	148	14411	894	chromic chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
895	manganese chloride	0	0	1.78	0.28	0	103	177549	8686687	895	manganese chloride	prophylaxis	0	0	11.42	1	0	28	1279	103523	895	manganese chloride	prophylaxis	23.9	79.7	0	0	4167.48	1	0	1	207	23659	895	manganese chloride	prophylaxis	0	0	Inf	1	0	0	82	13728	895	manganese chloride	prophylaxis	0	0	3585.07	1	0	1	148	14411	895	manganese chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
896	technetium tc-99m mebrofenin kit	1.77	0.36	5.35	0.25	3	83	177546	8686707	896	technetium tc-99m mebrofenin kit	hepatobiliary scan	0	0	2.04	0.094	0	49	3	39	896	technetium tc-99m mebrofenin kit	hepatobiliary scan	52	52	0	0	Inf	1	0	0	0	0	896	technetium tc-99m mebrofenin kit	hepatobiliary scan	0	0	Inf	1	0	9	0	6	896	technetium tc-99m mebrofenin kit	hepatobiliary scan	0	0	39	1	0	22	1	21	896	technetium tc-99m mebrofenin kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
897	amiodarone	1.79	1.7	1.89	3.4e-90	1481	40600	176068	8646190	897	amiodarone	atrial fibrillation	2.04	1.7	2.45	3.6e-13	149	11096	659	100313	897	amiodarone	atrial fibrillation	49	86.6	1.01	0.51	1.83	0.88	12	3118	120	31508	897	amiodarone	atrial fibrillation	1.37	0.52	3.05	0.37	7	2079	49	19994	897	amiodarone	atrial fibrillation	1.09	0.46	2.26	0.7	8	1407	86	16526	897	amiodarone	atrial fibrillation	0.21	1.23367805995674	0.27	0.45	-0.01	0	0	-0.76	0.17	0
898	penbutolol	0.73	0.02	4.21	1	1	67	177548	8686723	898	penbutolol	nuclear magnetic resonance imaging	0	0	13.78	1	0	3	1146	6520	898	penbutolol	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	898	penbutolol	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	898	penbutolol	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	898	penbutolol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
899	polyethylene glycol 3350	1.61	1.52	1.7	2.5e-54	1272	38750	176277	8648040	899	polyethylene glycol 3350	constipation	1.23	1.04	1.45	0.012	209	10400	519	31889	899	polyethylene glycol 3350	constipation	2.6	80.7	1.01	0.71	1.42	0.93	51	3120	118	7304	899	polyethylene glycol 3350	constipation	1.84	1.1	3.05	0.013	31	1740	38	3930	899	polyethylene glycol 3350	constipation	0.57	0.36	0.86	0.0058	31	2877	89	4675	899	polyethylene glycol 3350	constipation	-0.21	0.810584245970187	0.16	0.18	-0.03	0	0	-0.23	0.15	0.14
900	sodium anhydrous	4.47	3.1	6.27	6e-13	37	405	177512	8686385	900	sodium anhydrous	colonoscopy	0.69	0.02	4.05	1	1	103	69	4886	900	sodium anhydrous	colonoscopy	31	72.5	2.66	0.06	18.76	0.34	1	32	13	1108	900	sodium anhydrous	colonoscopy	3.2	0.07	26.09	0.3	1	19	8	489	900	sodium anhydrous	colonoscopy	0	0	29.26	1	0	25	7	1001	900	sodium anhydrous	colonoscopy	0.77	2.15976625378492	1.05	0.46	-0.03	0.02	0.08	0.91	0.51	0.07
901	enalapril maleate	1.93	1.82	2.05	4.3e-87	1139	28894	176410	8657896	901	enalapril maleate	hypertension	1.37	1.18	1.58	3.5e-05	202	6864	6693	310749	901	enalapril maleate	hypertension	38	82.9	1.35	0.58	2.69	0.4	8	379	973	62030	901	enalapril maleate	hypertension	3.81	1.61	7.75	0.0017	8	198	333	31441	901	enalapril maleate	hypertension	0	0	0.82	0.026	0	237	762	39693	901	enalapril maleate	hypertension	0.21	1.23367805995674	0.36	0.55	-0.02	0	0	-0.59	0.07	0
902	bepridil	0.5	0.06	1.82	0.45	2	197	177547	8686593	902	bepridil	atrial fibrillation	0	0	12.38	1	0	43	808	111366	902	bepridil	atrial fibrillation	49	86.6	0	0	118	1	0	10	132	34616	902	bepridil	atrial fibrillation	0	0	341.01	1	0	6	56	22067	902	bepridil	atrial fibrillation	0	0	291.6	1	0	4	94	17929	902	bepridil	atrial fibrillation	-8.89	0.000137759657981586	277.11	0.97	-0.01	0	0	-0.76	0.17	0
903	pirbuterol acetate	3.91	3.17	4.79	9.1e-29	103	1288	177446	8685502	903	pirbuterol acetate	asthma	0.76	0.39	1.35	0.44	12	517	3032	99857	903	pirbuterol acetate	asthma	9	76	0	0	6.96	1	0	19	540	17497	903	pirbuterol acetate	asthma	0	0	46.78	1	0	5	147	6253	903	pirbuterol acetate	asthma	0	0	8.26	1	0	16	458	14546	903	pirbuterol acetate	asthma	-10.9	1.84582339957806e-05	191.93	0.95	-0.02	0	0	-0.41	0.1	0
904	leuprolide acetate	1.95	1.83	2.06	2.7e-88	1139	28741	176410	8658049	904	leuprolide acetate	prostate cancer	2.69	2.22	3.27	5.2e-23	192	10086	252	35665	904	leuprolide acetate	prostate cancer	56.9	87.4	1.51	0.89	2.45	0.098	22	1977	80	10827	904	leuprolide acetate	prostate cancer	1.63	1.01	2.55	0.036	26	2255	88	12421	904	leuprolide acetate	prostate cancer	0	0	Inf	1	0	8	0	43	904	leuprolide acetate	prostate cancer	0.5	1.64872127070013	0.22	0.03	-0.01	0.01	0.04	11.8	334.11	0.97
905	guanfacine	1.7	1.4	2.04	1.3e-07	118	3394	177431	8683396	905	guanfacine	attention deficit/hyperactivity disorder	0.53	0.37	0.75	9.2e-05	34	1388	2028	44037	905	guanfacine	attention deficit/hyperactivity disorder	7	57	0.42	0.19	0.82	0.0066	9	388	412	7543	905	guanfacine	attention deficit/hyperactivity disorder	0.45	0.18	0.95	0.038	7	391	226	5667	905	guanfacine	attention deficit/hyperactivity disorder	0.52	0.14	1.4	0.24	4	104	253	3438	905	guanfacine	attention deficit/hyperactivity disorder	-0.62	0.537944437594674	0.31	0.05	0.01	0	0	-0.48	0.1	0
906	hydromorphone	3.37	3.22	3.53	0	1988	29048	175561	8657742	906	hydromorphone	pain	1.39	1.25	1.53	8.3e-10	429	6987	8040	181497	906	hydromorphone	pain	23	79	1.15	0.86	1.51	0.3	57	1648	1031	34369	906	hydromorphone	pain	1.31	0.81	2.01	0.22	23	751	341	14566	906	hydromorphone	pain	1.35	0.97	1.84	0.062	45	1049	812	25541	906	hydromorphone	pain	0.2	1.22140275816017	0.13	0.11	-0.02	0	0	-0.29	0.06	0
907	indium in-111 oxyquinoline	0	0	53.4	1	0	5	177549	8686785	907	indium in-111 oxyquinoline	abscess	0	0	203.22	1	0	2	25	936	907	indium in-111 oxyquinoline	abscess	39	60.6	0	0	Inf	1	0	0	0	79	907	indium in-111 oxyquinoline	abscess	0	0	Inf	1	0	0	0	77	907	indium in-111 oxyquinoline	abscess	0	0	Inf	1	0	0	3	106	907	indium in-111 oxyquinoline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
908	sufentanil citrate	4.36	3.71	5.1	1.1e-52	172	1930	177377	8684860	908	sufentanil citrate	anaesthesia	0.58	0.07	2.22	0.77	2	369	58	6235	908	sufentanil citrate	anaesthesia	23	71.2	0	0	12.82	1	0	23	9	546	908	sufentanil citrate	anaesthesia	0	0	1025.18	1	0	14	1	373	908	sufentanil citrate	anaesthesia	0	0	16.73	1	0	14	10	471	908	sufentanil citrate	anaesthesia	-14.04	7.98924011666567e-07	1180.1	0.99	0	0.01	0.92	-2.07	1.05	0.05
909	terazosin	2.37	2.17	2.59	1.6e-67	544	11238	177005	8675552	909	terazosin	hypertension	1.52	1.15	1.97	0.0032	58	1765	6837	315848	909	terazosin	hypertension	38	82.9	0.39	0.05	1.42	0.26	2	326	979	62083	909	terazosin	hypertension	0.58	0.07	2.11	0.78	2	321	339	31318	909	terazosin	hypertension	0	0	4.59	1	0	44	762	39886	909	terazosin	hypertension	-0.66	0.516851334491699	0.71	0.35	-0.02	0	0	-0.59	0.07	0
910	insulin susp isophane semisynthetic purified human	1.04	0.87	1.25	0.61	123	5760	177426	8681030	910	insulin susp isophane semisynthetic purified human	diabetes mellitus	1.63	0.98	2.57	0.039	19	1217	2308	241681	910	insulin susp isophane semisynthetic purified human	diabetes mellitus	39.3	82	4.72	1.5	11.36	0.0051	5	149	372	52335	910	insulin susp isophane semisynthetic purified human	diabetes mellitus	8.02	1.6	24.77	0.0073	3	81	137	29663	910	insulin susp isophane semisynthetic purified human	diabetes mellitus	2.32	0.27	8.7	0.22	2	87	279	28115	910	insulin susp isophane semisynthetic purified human	diabetes mellitus	1.42	4.13712044025139	0.46	0	-0.01	0	0	-0.75	0.1	0
911	potassium citrate	1.96	1.55	2.45	6.4e-08	82	2046	177467	8684744	911	potassium citrate	hypertension	1.2	0.43	2.65	0.65	6	231	6889	317382	911	potassium citrate	hypertension	38	82.9	1.4	0.17	5.21	0.66	2	91	979	62318	911	potassium citrate	hypertension	3.45	0.41	13.18	0.12	2	54	339	31585	911	potassium citrate	hypertension	0	0	4.59	1	0	44	762	39886	911	potassium citrate	hypertension	0.38	1.46228458943422	0.72	0.6	-0.02	0	0	-0.59	0.07	0
912	fluorometholone acetate	0	0	2.4	0.41	0	77	177549	8686713	912	fluorometholone acetate	postoperative care	0	0	137.34	1	0	6	18	2714	912	fluorometholone acetate	postoperative care	19.8	69.3	0	0	Inf	1	0	0	2	372	912	fluorometholone acetate	postoperative care	0	0	Inf	1	0	0	2	254	912	fluorometholone acetate	postoperative care	0	0	6983.71	1	0	1	2	401	912	fluorometholone acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
913	estazolam	1.52	1.08	2.07	0.012	41	1324	177508	8685466	913	estazolam	insomnia	0.22	0.04	0.64	0.0011	3	317	2940	67271	913	estazolam	insomnia	26.9	78.5	0	0	2.16	0.42	0	40	531	11857	913	estazolam	insomnia	0	0	5.22	1	0	20	212	5417	913	estazolam	insomnia	0	0	3.04	0.63	0	30	379	8760	913	estazolam	insomnia	-12.36	4.28667150127027e-06	203.88	0.95	-0.02	0	0	-0.08	0.09	0.38
914	estradiol	3.82	3.7	3.94	0	4298	56031	173251	8630759	914	estradiol	hormone replacement therapy	1.65	1.44	1.89	2.2e-12	330	9888	606	29981	914	estradiol	hormone replacement therapy	34.3	74	0.63	0.36	1.05	0.083	20	930	71	2076	914	estradiol	hormone replacement therapy	0	0	133.37	1	0	2	48	1190	914	estradiol	hormone replacement therapy	0.83	0.46	1.48	0.59	23	1003	33	1201	914	estradiol	hormone replacement therapy	-0.2	0.818730753077982	0.27	0.47	-0.03	0.01	0	0.34	0.23	0.14
915	dezocine	0	0	9.91	1	0	20	177549	8686770	915	dezocine	anaesthesia	0	0	65.84	1	0	8	60	6596	915	dezocine	anaesthesia	23	71.2	0	0	2374.23	1	0	1	9	568	915	dezocine	anaesthesia	0	0	12213.02	1	0	1	1	386	915	dezocine	anaesthesia	0	0	Inf	1	0	0	10	485	915	dezocine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
916	ipratropium bromide	2.08	1.99	2.18	1.9e-180	1992	47146	175557	8639644	916	ipratropium bromide	chronic obstructive pulmonary disease	1.33	1.14	1.54	2e-04	219	11202	1039	70795	916	ipratropium bromide	chronic obstructive pulmonary disease	48.4	82.8	1.19	0.82	1.69	0.34	37	2195	254	17949	916	ipratropium bromide	chronic obstructive pulmonary disease	1.18	0.62	2.09	0.54	14	1091	94	8658	916	ipratropium bromide	chronic obstructive pulmonary disease	1.11	0.7	1.7	0.58	25	1417	192	12088	916	ipratropium bromide	chronic obstructive pulmonary disease	0.1	1.10517091807565	0.17	0.54	-0.03	0	0	-0.37	0.12	0
917	isosorbide mononitrate	1.83	1.7	1.96	2.6e-53	811	21773	176738	8665017	917	isosorbide mononitrate	hypertension	1.25	0.97	1.58	0.074	73	2703	6822	314910	917	isosorbide mononitrate	hypertension	38	82.9	0.59	0.19	1.4	0.29	5	533	976	61876	917	isosorbide mononitrate	hypertension	1.07	0.29	2.79	0.79	4	347	337	31292	917	isosorbide mononitrate	hypertension	0.39	0.05	1.43	0.25	2	267	760	39663	917	isosorbide mononitrate	hypertension	-0.26	0.771051585803566	0.41	0.52	-0.02	0	0	-0.59	0.07	0
918	somatrem	0	0	0.85	0.025	0	214	177549	8686576	918	somatrem	growth hormone deficiency	0	0	4.25	1	0	85	81	7583	918	somatrem	growth hormone deficiency	10.1	55.9	0	0	14.39	1	0	15	18	849	918	somatrem	growth hormone deficiency	0	0	31.64	1	0	12	11	839	918	somatrem	growth hormone deficiency	0	0	47.63	1	0	7	9	531	918	somatrem	growth hormone deficiency	-13.31	1.65783172361451e-06	906.87	0.99	0	0.01	0.77	-0.23	0.46	0.62
919	hydrocodone polistirex	2.99	1.93	4.45	2.3e-06	26	425	177523	8686365	919	hydrocodone polistirex	cough	1.07	0.13	4.06	0.71	2	70	376	14143	919	hydrocodone polistirex	cough	13.7	78	0	0	4.09	1	0	36	83	3082	919	hydrocodone polistirex	cough	0	0	22.06	1	0	13	25	1579	919	hydrocodone polistirex	cough	0	0	5.41	1	0	26	69	2388	919	hydrocodone polistirex	cough	-12.76	2.87344183807115e-06	381.71	0.97	-0.01	0	0	-0.64	0.24	0.01
920	propafenone	1.44	1.22	1.69	2.4e-05	155	5276	177394	8681514	920	propafenone	atrial fibrillation	3.8	2.73	5.18	8.1e-13	44	1662	764	109747	920	propafenone	atrial fibrillation	49	86.6	7.38	3.27	14.64	8e-06	9	340	123	34286	920	propafenone	atrial fibrillation	6.25	0.73	24.15	0.044	2	130	54	21943	920	propafenone	atrial fibrillation	7.97	3.48	16.11	5.1e-06	9	235	85	17698	920	propafenone	atrial fibrillation	2	7.38905609893065	0.32	0	-0.01	0	0	-0.71	0.17	0
921	ammonium lactate	3.88	2.94	5.02	8.3e-18	62	783	177487	8686007	921	ammonium lactate	pain	2.97	1.57	5.21	0.00062	14	105	8455	188379	921	ammonium lactate	pain	23	79	3.55	0.69	11.53	0.062	3	28	1085	35989	921	ammonium lactate	pain	3.83	0.09	26.51	0.25	1	11	363	15306	921	ammonium lactate	pain	3.11	0.35	12.83	0.15	2	20	855	26570	921	ammonium lactate	pain	1.23	3.42122953628967	0.61	0.04	-0.02	0	0	-0.28	0.06	0
922	methacholine chloride	31.39	18.19	53.15	6.5e-26	25	39	177524	8686751	922	methacholine chloride	breast cancer	Inf	280.72	Inf	5.6e-41	24	0	1422	66782	922	methacholine chloride	breast cancer	40	78	0	0	Inf	1	0	0	127	10147	922	methacholine chloride	breast cancer	0	0	Inf	1	0	0	0	116	922	methacholine chloride	breast cancer	0	0	Inf	1	0	0	144	11776	922	methacholine chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
923	trientine	0	0	2	0.27	0	92	177549	8686698	923	trientine	hepato-lenticular degeneration	0	0	8.27	1	0	53	3	177	923	trientine	hepato-lenticular degeneration	12	12	0	0	Inf	1	0	0	0	0	923	trientine	hepato-lenticular degeneration	0	0	77.91	1	0	11	1	21	923	trientine	hepato-lenticular degeneration	0	0	Inf	1	0	21	0	31	923	trientine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
924	diclofenac sodium	0.99	0.93	1.06	0.85	912	44942	176637	8641848	924	diclofenac sodium	rheumatoid arthritis	1.24	0.97	1.56	0.077	74	8098	3336	452279	924	diclofenac sodium	rheumatoid arthritis	33	75	3.04	2.04	4.36	1.9e-07	31	1119	1029	112819	924	diclofenac sodium	rheumatoid arthritis	5.52	2.32	11.33	0.00017	8	212	172	25179	924	diclofenac sodium	rheumatoid arthritis	2.33	1.46	3.54	0.00033	23	1068	988	106896	924	diclofenac sodium	rheumatoid arthritis	1.02	2.7731947639643	0.18	0	-0.01	0	0	-0.26	0.08	0
925	carteolol	0.25	0.05	0.75	0.0068	3	578	177546	8686212	925	carteolol	glaucoma	0	0	2.03	0.27	0	157	219	18578	925	carteolol	glaucoma	54.3	87	0	0	33.09	1	0	11	43	3451	925	carteolol	glaucoma	0	0	66.29	1	0	8	14	1436	925	carteolol	glaucoma	0	0	69.6	1	0	6	35	2772	925	carteolol	glaucoma	-12.03	5.96262343546093e-06	639.99	0.99	-0.01	0.01	0.28	-0.26	0.32	0.41
926	butoconazole nitrate	5.56	1.72	13.99	0.003	5	44	177544	8686746	926	butoconazole nitrate	anxiety	0	0	4.26	0.61	0	8	11351	82469	926	butoconazole nitrate	anxiety	20	75	0	0	Inf	1	0	0	1918	17297	926	butoconazole nitrate	anxiety	0	0	Inf	1	0	0	654	6191	926	butoconazole nitrate	anxiety	0	0	Inf	1	0	0	1484	14290	926	butoconazole nitrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
927	levobunolol	3.31	2.29	4.64	2.7e-09	36	532	177513	8686258	927	levobunolol	glaucoma	5.38	2.25	11.12	0.00022	8	131	211	18604	927	levobunolol	glaucoma	54.3	87	0	0	17.83	1	0	19	43	3443	927	levobunolol	glaucoma	0	0	37.51	1	0	13	14	1431	927	levobunolol	glaucoma	0	0	41.71	1	0	9	35	2769	927	levobunolol	glaucoma	-12.04	5.90329434098699e-06	511.07	0.98	-0.01	0.01	0.28	-0.26	0.32	0.41
928	manganese	1.48	0.8	2.51	0.14	14	463	177535	8686327	928	manganese	prophylaxis	5.29	1.05	16.49	0.022	3	46	1276	103505	928	manganese	prophylaxis	23.9	79.7	0	0	174.45	1	0	4	207	23656	928	manganese	prophylaxis	0	0	Inf	1	0	0	82	13728	928	manganese	prophylaxis	0	0	147.81	1	0	4	148	14408	928	manganese	prophylaxis	-8.91	0.000135031833988743	267.67	0.97	-0.01	0	0.03	-0.52	0.14	0
929	zinc	2.25	2.05	2.46	3.3e-54	485	10569	177064	8676221	929	zinc	hypertension	1.74	1.16	2.51	0.0051	30	796	6865	316817	929	zinc	hypertension	38	82.9	2.44	1.03	4.91	0.021	8	210	973	62199	929	zinc	hypertension	1.86	0.22	6.95	0.3	2	100	339	31539	929	zinc	hypertension	2.18	0.78	4.88	0.065	6	145	756	39785	929	zinc	hypertension	0.78	2.1814722654982	0.36	0.03	-0.02	0	0	-0.59	0.07	0
930	pentamidine isethionate	0.72	0.45	1.09	0.14	22	1504	177527	8685286	930	pentamidine isethionate	hiv infection	1.59	0.51	3.77	0.25	5	369	495	58022	930	pentamidine isethionate	hiv infection	25	64	0	0	14.64	1	0	18	120	7623	930	pentamidine isethionate	hiv infection	0	0	21.77	1	0	12	96	5716	930	pentamidine isethionate	hiv infection	0	0	51.93	1	0	8	40	3431	930	pentamidine isethionate	hiv infection	-11.35	1.17694896249317e-05	324.78	0.97	0	0.01	0.8	0.38	0.2	0.05
931	misoprostol	1.14	1.02	1.28	0.02	319	13655	177230	8673135	931	misoprostol	rheumatoid arthritis	2.21	1.58	3.02	6.6e-06	41	2517	3369	457860	931	misoprostol	rheumatoid arthritis	33	75	5.23	3.1	8.32	1.8e-08	19	396	1041	113542	931	misoprostol	rheumatoid arthritis	14.63	5.59	32.4	1.2e-06	7	70	173	25321	931	misoprostol	rheumatoid arthritis	3.48	1.78	6.19	0.00029	12	371	999	107593	931	misoprostol	rheumatoid arthritis	1.58	4.85495581123743	0.24	0	-0.01	0	0	-0.26	0.08	0
932	betaxolol	1.74	1.32	2.24	8.6e-05	61	1717	177488	8685073	932	betaxolol	hypertension	0.54	0.14	1.38	0.26	4	344	6891	317269	932	betaxolol	hypertension	38	82.9	0	0	3.97	1	0	61	981	62348	932	betaxolol	hypertension	0	0	13.64	1	0	27	341	31612	932	betaxolol	hypertension	1.19	0.03	7.01	0.57	1	44	761	39886	932	betaxolol	hypertension	-0.03	0.970445533548508	1.01	0.98	-0.02	0	0	-0.59	0.07	0
933	tranexamic acid	0.5	0.35	0.71	1.8e-05	33	3199	177516	8683591	933	tranexamic acid	prophylaxis	0	0	1.19	0.082	0	253	1279	103298	933	tranexamic acid	prophylaxis	23.9	79.7	0	0	6.71	1	0	65	207	23595	933	tranexamic acid	prophylaxis	0	0	16.92	1	0	39	82	13689	933	tranexamic acid	prophylaxis	0	0	8.2	1	0	46	148	14366	933	tranexamic acid	prophylaxis	-11.82	7.35595771211205e-06	258.75	0.96	-0.01	0	0.02	-0.52	0.14	0
934	sodium	1.4	1.37	1.43	4e-198	9351	330940	168198	8355850	934	sodium	rheumatoid arthritis	1.26	1.1	1.43	0.00076	253	27633	3157	432744	934	sodium	rheumatoid arthritis	33	75	1.44	1.09	1.87	0.0092	60	4553	1000	109385	934	sodium	rheumatoid arthritis	1.34	0.63	2.54	0.35	10	1067	170	24324	934	sodium	rheumatoid arthritis	1.36	1.02	1.79	0.03	55	4368	956	103596	934	sodium	rheumatoid arthritis	0.33	1.39096812846378	0.13	0.01	-0.01	0	0	-0.26	0.08	0
935	mitoxantrone	0.89	0.72	1.08	0.26	102	5618	177447	8681172	935	mitoxantrone	acute myeloid leukaemia	1	0.12	3.95	1	2	906	29	13103	935	mitoxantrone	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	35	0	785	935	mitoxantrone	acute myeloid leukaemia	0	0	790.24	1	0	64	1	1312	935	mitoxantrone	acute myeloid leukaemia	0	0	87.37	1	0	65	2	1061	935	mitoxantrone	acute myeloid leukaemia	-15.03	2.96861540633121e-07	2542.69	1	-0.01	0.03	0.83	-0.89	1.23	0.47
936	fenofibrate	1.58	1.48	1.68	2.1e-41	1043	32453	176506	8654337	936	fenofibrate	hypertension	1.29	1.06	1.55	0.0089	116	4162	6779	313451	936	fenofibrate	hypertension	38	82.9	1.42	0.86	2.23	0.14	20	899	961	61510	936	fenofibrate	hypertension	2.2	1.08	4.03	0.021	11	472	330	31167	936	fenofibrate	hypertension	1.02	0.49	1.91	0.87	10	512	752	39418	936	fenofibrate	hypertension	0.36	1.43332941456034	0.22	0.1	-0.02	0	0	-0.59	0.07	0
937	enalaprilat	4.2	3.85	4.58	3.8e-164	574	6698	176975	8680092	937	enalaprilat	hypertension	3.61	2.89	4.45	2.4e-24	96	1239	6799	316374	937	enalaprilat	hypertension	38	82.9	1.03	0.12	3.8	0.72	2	124	979	62285	937	enalaprilat	hypertension	3.39	0.4	12.93	0.12	2	55	339	31584	937	enalaprilat	hypertension	0	0	2.19	0.42	0	90	762	39840	937	enalaprilat	hypertension	-0.17	0.843664816596384	0.71	0.82	-0.02	0	0	-0.59	0.07	0
938	clobetasol propionate	1.88	1.62	2.18	1.3e-14	185	4812	177364	8681978	938	clobetasol propionate	psoriasis	2	1.26	3.03	0.0026	23	1574	1167	160117	938	clobetasol propionate	psoriasis	25	74.8	2.7	1.15	5.43	0.012	8	345	371	43180	938	clobetasol propionate	psoriasis	3.21	0.85	8.53	0.041	4	182	145	21162	938	clobetasol propionate	psoriasis	2.35	0.75	5.63	0.069	5	215	269	27128	938	clobetasol propionate	psoriasis	0.98	2.66445624192942	0.34	0	0	0	0.69	-0.36	0.1	0
939	selegiline	2.89	2.46	3.37	1e-31	173	2930	177376	8683860	939	selegiline	parkinson s disease	2.33	1.81	2.96	3.6e-10	79	1146	793	26778	939	selegiline	parkinson s disease	50.1	85.7	1.85	0.49	5.01	0.29	4	87	159	6411	939	selegiline	parkinson s disease	1	0.02	6.04	1	1	42	97	4090	939	selegiline	parkinson s disease	3.4	1.03	8.77	0.022	5	54	80	2943	939	selegiline	parkinson s disease	0.83	2.29331874026418	0.43	0.05	-0.03	0.01	0	-0.19	0.15	0.21
940	cupric	0.55	0.01	3.14	1	1	89	177548	8686701	940	cupric	prophylaxis	0	0	122.54	1	0	4	1279	103547	940	cupric	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	940	cupric	prophylaxis	0	0	Inf	1	0	0	82	13728	940	cupric	prophylaxis	0	0	515.28	1	0	2	148	14410	940	cupric	prophylaxis	-7.89	0.000374469574986078	229.59	0.97	-0.01	0	0.03	-0.52	0.14	0
941	alfentanil	0.23	0.05	0.67	0.0018	3	642	177546	8686148	941	alfentanil	anaesthesia	0	0	3.2	0.63	0	130	60	6474	941	alfentanil	anaesthesia	23	71.2	0	0	165.81	1	0	3	9	566	941	alfentanil	anaesthesia	0	0	Inf	1	0	0	1	387	941	alfentanil	anaesthesia	0	0	126.14	1	0	3	10	482	941	alfentanil	anaesthesia	-12.7	3.05112555803642e-06	1385.36	0.99	0	0.01	0.9	-2.09	1.05	0.05
942	naftifine	1.01	0.27	2.64	0.8	4	193	177545	8686597	942	naftifine	gastrooesophageal reflux disease	2.16	0.05	14.63	0.39	1	12	2967	77016	942	naftifine	gastrooesophageal reflux disease	22.4	77.2	0	0	33.26	1	0	6	478	18691	942	naftifine	gastrooesophageal reflux disease	0	0	37.18	1	0	7	152	8076	942	naftifine	gastrooesophageal reflux disease	0	0	Inf	1	0	0	380	14389	942	naftifine	gastrooesophageal reflux disease	-9.53	7.26396239924518e-05	201.9	0.96	-0.02	0	0	-0.35	0.1	0
943	ethanolamine oleate	0	0	17.61	1	0	12	177549	8686778	943	ethanolamine oleate	balloon-occluded retrograde transvenous obliteration	0	0	Inf	1	0	6	0	8	943	ethanolamine oleate	balloon-occluded retrograde transvenous obliteration	NA	NA	0	0	Inf	1	0	0	0	0	943	ethanolamine oleate	balloon-occluded retrograde transvenous obliteration	0	0	Inf	1	0	0	0	2	943	ethanolamine oleate	balloon-occluded retrograde transvenous obliteration	0	0	Inf	1	0	0	0	0	943	ethanolamine oleate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
945	etretinate	0	0	1.21	0.08	0	151	177549	8686639	945	etretinate	psoriasis	0	0	9.81	1	0	53	1190	161638	945	etretinate	psoriasis	25	74.8	0	0	97.94	1	0	6	379	43519	945	etretinate	psoriasis	0	0	157.47	1	0	5	149	21339	945	etretinate	psoriasis	0	0	3668.84	1	0	1	274	27342	945	etretinate	psoriasis	-8.66	0.000173384306903506	218.31	0.97	0	0	0.71	-0.36	0.1	0
946	insulin zinc susp recombinant human	2.31	1.48	3.45	0.00021	25	530	177524	8686260	946	insulin zinc susp recombinant human	diabetes mellitus	6.18	3.67	9.84	1.3e-09	19	323	2308	242575	946	insulin zinc susp recombinant human	diabetes mellitus	39.3	82	0	0	335.36	1	0	3	377	52481	946	insulin zinc susp recombinant human	diabetes mellitus	0	0	515.16	1	0	3	140	29741	946	insulin zinc susp recombinant human	diabetes mellitus	0	0	242.13	1	0	3	281	28199	946	insulin zinc susp recombinant human	diabetes mellitus	-8.86	0.000141955064163011	216.36	0.97	-0.01	0	0	-0.75	0.1	0
947	norfloxacin	0.7	0.46	1.02	0.072	27	1886	177522	8684904	947	norfloxacin	urinary tract infection	0.3	0.1	0.71	0.0026	5	424	744	19010	947	norfloxacin	urinary tract infection	22.2	73.2	0	0	5.58	1	0	13	183	3085	947	norfloxacin	urinary tract infection	0	0	62.24	1	0	4	31	1236	947	norfloxacin	urinary tract infection	0	0	4.03	0.62	0	21	174	3615	947	norfloxacin	urinary tract infection	-12.26	4.73750467854758e-06	280.62	0.97	-0.03	0	0	-0.39	0.2	0.05
948	pergolide mesylate	1.7	1.16	2.4	0.0058	33	950	177516	8685840	948	pergolide mesylate	parkinson s disease	1.22	0.79	1.8	0.33	27	713	845	27211	948	pergolide mesylate	parkinson s disease	50.1	85.7	0	0	11.19	1	0	15	163	6483	948	pergolide mesylate	parkinson s disease	0	0	17.01	1	0	11	98	4121	948	pergolide mesylate	parkinson s disease	0	0	24.78	1	0	7	85	2990	948	pergolide mesylate	parkinson s disease	-12.01	6.08307641893218e-06	339.1	0.97	-0.03	0.01	0	-0.2	0.15	0.18
949	esmolol	15.46	12.75	18.62	5.4e-110	148	469	177401	8686321	949	esmolol	prophylaxis	0	0	11.42	1	0	28	1279	103523	949	esmolol	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	949	esmolol	prophylaxis	0	0	256.29	1	0	4	82	13724	949	esmolol	prophylaxis	0	0	Inf	1	0	0	148	14412	949	esmolol	prophylaxis	-8.42	0.000220414652830147	267.38	0.97	-0.01	0	0.03	-0.52	0.14	0
950	suprofen	0	0	2.95	0.64	0	63	177549	8686727	950	suprofen	prophylaxis	0	0	56.24	1	0	7	1279	103544	950	suprofen	prophylaxis	23.9	79.7	0	0	Inf	1	0	0	207	23660	950	suprofen	prophylaxis	0	0	Inf	1	0	0	82	13728	950	suprofen	prophylaxis	0	0	Inf	1	0	0	148	14412	950	suprofen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
951	beclomethasone dipropionate monohydrate	2.71	1.83	3.9	1.8e-06	31	559	177518	8686231	951	beclomethasone dipropionate monohydrate	asthma	1.18	0.14	4.46	0.69	2	56	3042	100318	951	beclomethasone dipropionate monohydrate	asthma	9	76	0	0	5.4	1	0	24	540	17492	951	beclomethasone dipropionate monohydrate	asthma	0	0	29.74	1	0	7	147	6251	951	beclomethasone dipropionate monohydrate	asthma	0	0	7.25	1	0	18	458	14544	951	beclomethasone dipropionate monohydrate	asthma	-10.92	1.80927364742498e-05	175.17	0.95	-0.02	0	0	-0.41	0.1	0
953	flurbiprofen sodium	0	0	1.05	0.054	0	173	177549	8686617	953	flurbiprofen sodium	cataract operation	0	0	26.2	1	0	57	6	1721	953	flurbiprofen sodium	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	953	flurbiprofen sodium	cataract operation	0	0	Inf	1	0	2	0	99	953	flurbiprofen sodium	cataract operation	0	0	Inf	1	0	9	0	231	953	flurbiprofen sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
954	pyrithione zinc	0	0	8.13	1	0	24	177549	8686766	954	pyrithione zinc	medical diet	0	0	30.22	1	0	5	144	3957	954	pyrithione zinc	medical diet	49.4	56.6	0	0	Inf	1	0	0	0	16	954	pyrithione zinc	medical diet	0	0	Inf	1	0	0	0	30	954	pyrithione zinc	medical diet	0	0	Inf	1	0	0	2	85	954	pyrithione zinc	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
955	rubidium chloride rb-82	0	0	3.99	1	0	47	177549	8686743	955	rubidium chloride rb-82	scan myocardial perfusion	0	0	31.85	1	0	8	28	1450	955	rubidium chloride rb-82	scan myocardial perfusion	68.7	87.9	0	0	Inf	1	0	0	0	81	955	rubidium chloride rb-82	scan myocardial perfusion	0	0	Inf	1	0	0	2	97	955	rubidium chloride rb-82	scan myocardial perfusion	0	0	Inf	1	0	0	0	112	955	rubidium chloride rb-82	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
956	urofollitropin	1.53	0.55	3.39	0.3	6	192	177543	8686598	956	urofollitropin	in vitro fertilisation	0	0	7.28	1	0	66	10	1052	956	urofollitropin	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	4	0	63	956	urofollitropin	in vitro fertilisation	0	0	Inf	1	0	0	0	1	956	urofollitropin	in vitro fertilisation	0	0	74.63	1	0	13	2	175	956	urofollitropin	in vitro fertilisation	-14.99	3.08976689934304e-07	2974.19	1	-0.05	0.1	0.66	-16.62	10754.01	1
958	permethrin	1.55	0.94	2.41	0.067	20	632	177529	8686158	958	permethrin	lice infestation	1.02	0.09	7.15	1	2	241	4	490	958	permethrin	lice infestation	36.2	68.2	0	0	Inf	1	0	39	0	14	958	permethrin	lice infestation	0	0	Inf	1	0	17	0	7	958	permethrin	lice infestation	Inf	0.08	Inf	1	2	71	0	31	958	permethrin	lice infestation	17.75	51136035.3805973	4346.99	1	0.04	0.04	0.27	-18.04	5215.08	1
959	milrinone lactate	25.18	21.13	29.88	4.7e-184	203	395	177346	8686395	959	milrinone lactate	coronary artery bypass	3.91	2.57	6.17	3.2e-13	144	27	2708	1987	959	milrinone lactate	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	959	milrinone lactate	coronary artery bypass	0	0	Inf	1	0	0	1	192	959	milrinone lactate	coronary artery bypass	0	0	Inf	1	0	0	3	35	959	milrinone lactate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
961	famotidine	2.25	2.15	2.36	4.8e-213	1957	42734	175592	8644056	961	famotidine	prophylaxis	1.28	0.93	1.72	0.11	47	2994	1232	100557	961	famotidine	prophylaxis	23.9	79.7	1.46	0.62	2.96	0.28	8	632	199	23028	961	famotidine	prophylaxis	0.44	0.01	2.51	0.73	1	378	81	13350	961	famotidine	prophylaxis	2.84	1.37	5.3	0.003	11	396	137	14016	961	famotidine	prophylaxis	0.65	1.9155408290139	0.3	0.03	-0.01	0	0.03	-0.52	0.14	0
962	gluconolactone	0	0	17.61	1	0	12	177549	8686778	962	gluconolactone	multiple sclerosis	0	0	124.73	1	0	3	8345	430354	962	gluconolactone	multiple sclerosis	26.5	67	0	0	Inf	1	0	0	1304	58042	962	gluconolactone	multiple sclerosis	0	0	Inf	1	0	0	235	14049	962	gluconolactone	multiple sclerosis	0	0	Inf	1	0	0	1218	51849	962	gluconolactone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
963	magnesium carbonate	1.36	0.8	2.16	0.21	18	649	177531	8686141	963	magnesium carbonate	prophylaxis	0	0	8.04	1	0	39	1279	103512	963	magnesium carbonate	prophylaxis	23.9	79.7	0	0	45.87	1	0	11	207	23649	963	magnesium carbonate	prophylaxis	0	0	185.18	1	0	5	82	13723	963	magnesium carbonate	prophylaxis	0	0	57.55	1	0	8	148	14404	963	magnesium carbonate	prophylaxis	-9.76	5.77146221352103e-05	243.84	0.97	-0.01	0	0.03	-0.52	0.14	0
964	nicardipine	1.37	1.1	1.7	0.0046	88	3139	177461	8683651	964	nicardipine	hypertension	0.74	0.39	1.27	0.33	13	810	6882	316803	964	nicardipine	hypertension	38	82.9	0.96	0.02	5.57	1	1	66	980	62343	964	nicardipine	hypertension	1.72	0.04	10.06	0.45	1	54	340	31585	964	nicardipine	hypertension	0	0	3.57	0.63	0	56	762	39874	964	nicardipine	hypertension	-0.92	0.398519041084514	1.01	0.36	-0.02	0	0	-0.59	0.07	0
965	teriparatide acetate	0	0	11.12	1	0	18	177549	8686772	965	teriparatide acetate	rheumatoid arthritis	0	0	93.78	1	0	7	3410	460370	965	teriparatide acetate	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	965	teriparatide acetate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	965	teriparatide acetate	rheumatoid arthritis	0	0	564.88	1	0	2	1011	107962	965	teriparatide acetate	rheumatoid arthritis	-7.08	0.000841773148378549	138.26	0.96	-0.01	0	0	-0.26	0.08	0
966	clofazimine	0.59	0.22	1.3	0.26	6	496	177543	8686294	966	clofazimine	tuberculosis	0	0	2.99	0.64	0	179	29	3909	966	clofazimine	tuberculosis	23.8	59	0	0	5.01	1	0	83	7	588	966	clofazimine	tuberculosis	0	0	7.66	1	0	79	5	545	966	clofazimine	tuberculosis	0	0	29.27	1	0	26	4	483	966	clofazimine	tuberculosis	-15.96	1.17127822323428e-07	1727.76	0.99	-0.01	0.02	0.45	0.18	0.68	0.79
967	nizatidine	4.44	3.77	5.19	2.8e-53	171	1887	177378	8684903	967	nizatidine	rheumatoid arthritis	1.68	0.2	6.16	0.34	2	161	3408	460216	967	nizatidine	rheumatoid arthritis	33	75	0	0	42.88	1	0	11	1060	113927	967	nizatidine	rheumatoid arthritis	0	0	5065.99	1	0	1	180	25390	967	nizatidine	rheumatoid arthritis	0	0	38.5	1	0	12	1011	107952	967	nizatidine	rheumatoid arthritis	-8.86	0.000141955064163011	148.23	0.95	-0.01	0	0	-0.26	0.08	0
968	sodium phosphate, monobasic anhydrous	0	0	1852.91	1	0	1	177549	8686789	968	sodium phosphate, monobasic anhydrous	fluid replacement	0	0	4513.17	1	0	1	12	1493	968	sodium phosphate, monobasic anhydrous	fluid replacement	51.1	51.1	0	0	Inf	1	0	0	0	0	968	sodium phosphate, monobasic anhydrous	fluid replacement	0	0	Inf	1	0	0	1	198	968	sodium phosphate, monobasic anhydrous	fluid replacement	0	0	Inf	1	0	0	0	191	968	sodium phosphate, monobasic anhydrous	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
969	potassium lactate	0	0	53.4	1	0	5	177549	8686785	969	potassium lactate	gastrooesophageal reflux disease	0	0	996.42	1	0	1	2968	77027	969	potassium lactate	gastrooesophageal reflux disease	22.4	77.2	0	0	1490	1	0	1	478	18696	969	potassium lactate	gastrooesophageal reflux disease	0	0	Inf	1	0	0	152	8083	969	potassium lactate	gastrooesophageal reflux disease	0	0	1443.48	1	0	1	380	14388	969	potassium lactate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
970	sodium monofluorophosphate	0.49	0.01	2.79	0.73	1	100	177548	8686690	970	sodium monofluorophosphate	prophylaxis	0	0	15.56	1	0	21	1279	103530	970	sodium monofluorophosphate	prophylaxis	23.9	79.7	0	0	27.9	1	0	17	207	23643	970	sodium monofluorophosphate	prophylaxis	0	0	61.36	1	0	12	82	13716	970	sodium monofluorophosphate	prophylaxis	0	0	57.55	1	0	8	148	14404	970	sodium monofluorophosphate	prophylaxis	-10.62	2.44226396829177e-05	323.74	0.97	-0.01	0	0.03	-0.52	0.14	0
971	cysteine	0.62	0.28	1.19	0.18	9	709	177540	8686081	971	cysteine	prophylaxis	0	0	5.32	1	0	58	1279	103493	971	cysteine	prophylaxis	23.9	79.7	0	0	67.36	1	0	8	207	23652	971	cysteine	prophylaxis	0	0	75.89	1	0	10	82	13718	971	cysteine	prophylaxis	0	0	515.28	1	0	2	148	14410	971	cysteine	prophylaxis	-9.64	6.50730547475429e-05	252.98	0.97	-0.01	0	0.03	-0.52	0.14	0
972	sodium benzoate	1.24	0.45	2.75	0.49	6	236	177543	8686554	972	sodium benzoate	hyperammonaemia	0	0	Inf	1	0	45	0	143	972	sodium benzoate	hyperammonaemia	NA	NA	0	0	Inf	1	0	0	0	0	972	sodium benzoate	hyperammonaemia	0	0	Inf	1	0	3	0	20	972	sodium benzoate	hyperammonaemia	0	0	Inf	1	0	8	0	14	972	sodium benzoate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
973	sodium phenylacetate	0	0	2.73	0.65	0	68	177549	8686722	973	sodium phenylacetate	hyperammonaemia	0	0	Inf	1	0	29	0	159	973	sodium phenylacetate	hyperammonaemia	NA	NA	0	0	Inf	1	0	0	0	0	973	sodium phenylacetate	hyperammonaemia	0	0	Inf	1	0	3	0	20	973	sodium phenylacetate	hyperammonaemia	0	0	Inf	1	0	3	0	19	973	sodium phenylacetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
974	ciprofloxacin	3.44	3.32	3.56	0	3644	52641	173905	8634149	974	ciprofloxacin	urinary tract infection	2.58	2.22	2.99	2.7e-35	367	5279	382	14155	974	ciprofloxacin	urinary tract infection	22.2	73.2	2.7	1.97	3.69	1.6e-10	103	1001	80	2097	974	ciprofloxacin	urinary tract infection	3.52	1.61	7.9	0.00088	18	350	13	890	974	ciprofloxacin	urinary tract infection	3	2.18	4.14	4.1e-12	96	1057	78	2579	974	ciprofloxacin	urinary tract infection	1.08	2.94467955106552	0.15	0	-0.03	0	0	-0.4	0.2	0.05
975	mometasone furoate	2.29	2.16	2.41	2.3e-154	1368	29410	176181	8657380	975	mometasone furoate	asthma	1.17	1	1.35	0.043	199	5684	2845	94690	975	mometasone furoate	asthma	9	76	1.3	0.92	1.79	0.11	43	1092	497	16424	975	mometasone furoate	asthma	1.05	0.47	2.07	0.86	9	366	138	5892	975	mometasone furoate	asthma	1.46	1.01	2.06	0.034	38	848	420	13714	975	mometasone furoate	asthma	0.25	1.28402541668774	0.16	0.11	-0.02	0	0	-0.41	0.1	0
976	isradipine	2.81	2.13	3.64	1.2e-11	60	1046	177489	8685744	976	isradipine	hypertension	2.6	1.46	4.3	0.00081	16	284	6879	317329	976	isradipine	hypertension	38	82.9	0	0	69.49	1	0	5	981	62404	976	isradipine	hypertension	0	0	489.56	1	0	2	341	31637	976	isradipine	hypertension	0	0	30.73	1	0	8	762	39922	976	isradipine	hypertension	-9.74	5.88805348414794e-05	162.93	0.95	-0.02	0	0	-0.59	0.07	0
977	lisinopril	1.77	1.73	1.81	0	6690	188107	170859	8498683	977	lisinopril	hypertension	1.53	1.44	1.63	1.9e-41	1398	45196	5497	272417	977	lisinopril	hypertension	38	82.9	1.06	0.9	1.24	0.48	190	11547	791	50862	977	lisinopril	hypertension	1.35	1.04	1.73	0.023	84	6181	257	25458	977	lisinopril	hypertension	1.07	0.87	1.29	0.52	131	6514	631	33416	977	lisinopril	hypertension	0.09	1.09417428370521	0.08	0.22	-0.02	0	0	-0.6	0.07	0
978	prednicarbate	6.47	4.08	9.85	2.4e-12	25	189	177524	8686601	978	prednicarbate	eczema	51.84	20.23	144.24	1.1e-16	15	8	130	3615	978	prednicarbate	eczema	17.2	67.9	0	0	Inf	1	0	0	13	396	978	prednicarbate	eczema	0	0	Inf	1	0	0	7	292	978	prednicarbate	eczema	0	0	Inf	1	0	0	8	378	978	prednicarbate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
979	tiopronin	0.56	0.24	1.1	0.11	8	705	177541	8686085	979	tiopronin	rheumatoid arthritis	0	0	7.1	1	0	72	3410	460305	979	tiopronin	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	979	tiopronin	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	979	tiopronin	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	979	tiopronin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
980	insulin zinc susp extended recombinant human	2.92	1.68	4.76	0.00016	17	285	177532	8686505	980	insulin zinc susp extended recombinant human	diabetes mellitus	7.67	3.88	13.8	1.6e-07	12	164	2315	242734	980	insulin zinc susp extended recombinant human	diabetes mellitus	39.3	82	0	0	97.01	1	0	7	377	52477	980	insulin zinc susp extended recombinant human	diabetes mellitus	0	0	7336.16	1	0	1	140	29743	980	insulin zinc susp extended recombinant human	diabetes mellitus	0	0	85.61	1	0	6	281	28196	980	insulin zinc susp extended recombinant human	diabetes mellitus	-8.87	0.000140542587674442	201.7	0.96	-0.01	0	0	-0.75	0.1	0
981	mefloquine	18.62	16.62	20.82	0	432	1138	177117	8685652	981	mefloquine	malaria prophylaxis	10.68	8.08	14.26	2e-81	284	584	73	1605	981	mefloquine	malaria prophylaxis	16	61	7.29	2.51	22.29	6.1e-05	13	20	9	103	981	mefloquine	malaria prophylaxis	6.68	1.63	30.64	0.0031	8	13	5	56	981	mefloquine	malaria prophylaxis	4.81	1.07	19.69	0.02	5	10	10	98	981	mefloquine	malaria prophylaxis	1.65	5.20697982717985	0.45	0	-0.02	0.01	0.11	0.08	0.45	0.86
982	terconazole	7.13	5.48	9.17	1.8e-34	71	487	177478	8686303	982	terconazole	depression	0.71	0.14	2.17	0.8	3	57	14368	192728	982	terconazole	depression	21	73.3	0	0	33.28	1	0	3	2062	28339	982	terconazole	depression	0	0	Inf	1	0	0	637	10447	982	terconazole	depression	0	0	22.12	1	0	4	1671	24380	982	terconazole	depression	-9.1	0.000111665808490115	97.83	0.93	-0.01	0	0	-0.14	0.05	0
983	iotrolan	0	0	21.83	1	0	10	177549	8686780	983	iotrolan	cervicobrachial syndrome	0	0	103.45	1	0	2	17	320	983	iotrolan	cervicobrachial syndrome	NA	NA	0	0	Inf	1	0	0	0	0	983	iotrolan	cervicobrachial syndrome	0	0	Inf	1	0	0	0	20	983	iotrolan	cervicobrachial syndrome	0	0	Inf	1	0	0	0	35	983	iotrolan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
984	nabumetone	4.62	4.25	5.02	8.8e-197	623	6613	176926	8680177	984	nabumetone	rheumatoid arthritis	3.03	2.12	4.2	1.1e-08	37	1660	3373	458717	984	nabumetone	rheumatoid arthritis	33	75	1.08	0.22	3.2	0.76	3	298	1057	113640	984	nabumetone	rheumatoid arthritis	0	0	13.38	1	0	41	180	25350	984	nabumetone	rheumatoid arthritis	1.11	0.23	3.28	0.75	3	289	1008	107675	984	nabumetone	rheumatoid arthritis	-0.02	0.980198673306755	0.58	0.97	-0.01	0	0	-0.26	0.08	0
985	ursodiol	0.6	0.5	0.72	8e-10	130	10513	177419	8676277	985	ursodiol	prophylaxis	0.39	0.14	0.84	0.013	6	1251	1273	102300	985	ursodiol	prophylaxis	23.9	79.7	4.82	0.96	14.85	0.028	3	72	204	23588	985	ursodiol	prophylaxis	0	0	13.32	1	0	49	82	13679	985	ursodiol	prophylaxis	11.89	4.1	28.33	2.4e-05	6	51	142	14361	985	ursodiol	prophylaxis	1.91	6.75308879853129	0.43	0	-0.01	0	0.05	-0.52	0.14	0
986	gadopentetate dimeglumine	8.15	7.69	8.63	0	1373	8303	176176	8678487	986	gadopentetate dimeglumine	nuclear magnetic resonance imaging	24.17	17.69	33.85	3.9e-220	1104	3398	42	3125	986	gadopentetate dimeglumine	nuclear magnetic resonance imaging	26.3	65.4	0	0	5.73	1	0	40	10	494	986	gadopentetate dimeglumine	nuclear magnetic resonance imaging	0	0	64.02	1	0	10	3	244	986	gadopentetate dimeglumine	nuclear magnetic resonance imaging	0	0	5.91	1	0	45	9	507	986	gadopentetate dimeglumine	nuclear magnetic resonance imaging	-15.48	1.89287275441489e-07	1448.34	0.99	0	0.02	0.9	-0.36	0.67	0.59
987	enoxacin	1.81	0.04	10.99	0.43	1	27	177548	8686763	987	enoxacin	cough	0	0	200.54	1	0	2	378	14211	987	enoxacin	cough	13.7	78	0	0	Inf	1	0	0	83	3118	987	enoxacin	cough	0	0	Inf	1	0	0	25	1592	987	enoxacin	cough	0	0	Inf	1	0	0	69	2414	987	enoxacin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
988	mesalamine	1	0.93	1.08	0.95	667	32571	176882	8654219	988	mesalamine	crohn s disease	1.27	1.09	1.48	0.0025	198	15993	1279	131319	988	mesalamine	crohn s disease	15.6	67	1.7	1.22	2.32	0.0016	46	2284	360	30410	988	mesalamine	crohn s disease	0.99	0.48	1.83	1	11	1055	137	12943	988	mesalamine	crohn s disease	2.22	1.57	3.08	8.9e-06	44	1688	261	22209	988	mesalamine	crohn s disease	0.6	1.82211880039051	0.15	0	-0.01	0	0	-0.22	0.1	0.03
989	propofol	2.07	1.92	2.23	1.3e-67	738	17495	176811	8669295	989	propofol	anaesthesia	0.77	0.44	1.34	0.36	23	2942	37	3662	989	propofol	anaesthesia	23	71.2	0.28	0.03	1.46	0.1	2	290	7	279	989	propofol	anaesthesia	Inf	0.02	Inf	1	1	214	0	173	989	propofol	anaesthesia	0.44	0.07	1.96	0.34	3	239	7	246	989	propofol	anaesthesia	-0.58	0.559898366565402	0.64	0.37	0	0.01	0.79	-2.06	1.05	0.05
990	pipecuronium bromide	0	0	16.05	1	0	13	177549	8686777	990	pipecuronium bromide	prophylaxis	0	0	195.31	1	0	3	1279	103548	990	pipecuronium bromide	prophylaxis	23.9	79.7	0	0	Inf	1	0	0	207	23660	990	pipecuronium bromide	prophylaxis	0	0	Inf	1	0	0	82	13728	990	pipecuronium bromide	prophylaxis	0	0	Inf	1	0	0	148	14412	990	pipecuronium bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
991	somatropin recombinant	0.46	0.39	0.53	8e-35	192	20520	177357	8666270	991	somatropin recombinant	growth hormone deficiency	1.46	0.78	2.96	0.27	69	6118	12	1550	991	somatropin recombinant	growth hormone deficiency	10.1	55.9	1.38	0.38	7.52	0.78	15	677	3	187	991	somatropin recombinant	growth hormone deficiency	2.72	0.38	118.65	0.47	10	669	1	182	991	somatropin recombinant	growth hormone deficiency	0.89	0.17	8.89	1	7	429	2	109	991	somatropin recombinant	growth hormone deficiency	0.39	1.47698079388264	0.63	0.53	0	0.01	0.78	-0.23	0.46	0.62
992	lovastatin	2.25	2.1	2.41	5.2e-95	865	18892	176684	8667898	992	lovastatin	hypertension	1.86	1.52	2.27	1e-08	105	2612	6790	315001	992	lovastatin	hypertension	38	82.9	1.62	0.88	2.75	0.084	14	553	967	61856	992	lovastatin	hypertension	4.06	1.81	7.94	0.00061	9	210	332	31429	992	lovastatin	hypertension	0.64	0.2	1.5	0.46	5	411	757	39519	992	lovastatin	hypertension	0.43	1.53725752354828	0.27	0.11	-0.02	0	0	-0.59	0.07	0
993	ketorolac tromethamine	7.23	6.73	7.75	0	899	6112	176650	8680678	993	ketorolac tromethamine	pain	3.93	3.32	4.64	1.2e-44	171	983	8298	187501	993	ketorolac tromethamine	pain	23	79	2.35	1.23	4.15	0.0084	13	184	1075	35833	993	ketorolac tromethamine	pain	0.6	0.01	3.48	1	1	70	363	15247	993	ketorolac tromethamine	pain	4.09	2.3	6.84	4e-06	17	131	840	26459	993	ketorolac tromethamine	pain	0.89	2.43512965128987	0.25	0	-0.02	0	0	-0.28	0.06	0
994	rimantadine	9.6	6.26	14.27	1.3e-18	30	153	177519	8686637	994	rimantadine	osteoporosis	0	0	4.08	0.62	0	18	8802	157668	994	rimantadine	osteoporosis	53.1	85	0	0	Inf	1	0	0	808	24568	994	rimantadine	osteoporosis	0	0	Inf	1	0	0	31	2935	994	rimantadine	osteoporosis	0	0	Inf	1	0	0	868	26887	994	rimantadine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
995	norgestimate	5.65	5.22	6.1	2.4e-276	725	6302	176824	8680488	995	norgestimate	contraception	2.09	1.83	2.38	2.3e-24	262	2369	7739	146265	995	norgestimate	contraception	19	43	0.89	0.46	1.56	0.79	13	205	1702	23876	995	norgestimate	contraception	0	0	Inf	1	0	0	0	22	995	norgestimate	contraception	1.02	0.57	1.7	0.9	16	234	1923	28671	995	norgestimate	contraception	0.02	1.02020134002676	0.26	0.94	0	0	0.94	-10.86	114.15	0.92
996	zidovudine	0.32	0.27	0.38	5.6e-64	147	22494	177402	8664296	996	zidovudine	hiv infection	0.78	0.61	0.98	0.032	93	13243	407	45148	996	zidovudine	hiv infection	25	64	2.13	1.3	3.36	0.0018	25	841	95	6800	996	zidovudine	hiv infection	2.82	1.62	4.72	0.00018	20	488	76	5240	996	zidovudine	hiv infection	1.71	0.77	3.55	0.15	11	624	29	2815	996	zidovudine	hiv infection	0.88	2.41089970641721	0.21	0	0	0.01	0.65	0.45	0.2	0.02
997	loratadine	1.97	1.89	2.05	7.1e-184	2341	58625	175208	8628165	997	loratadine	hypersensitivity	0.92	0.8	1.05	0.2	277	7496	1084	26857	997	loratadine	hypersensitivity	15.2	73.8	1.17	0.83	1.62	0.35	50	1662	159	6170	997	loratadine	hypersensitivity	1.3	0.65	2.46	0.4	14	619	40	2297	997	loratadine	hypersensitivity	1.15	0.79	1.64	0.46	42	1483	137	5555	997	loratadine	hypersensitivity	0.08	1.08328706767496	0.16	0.62	-0.01	0	0	-0.38	0.16	0.02
998	nedocromil sodium	1.03	0.33	2.43	0.82	5	238	177544	8686552	998	nedocromil sodium	asthma	0.34	0.01	1.94	0.38	1	97	3043	100277	998	nedocromil sodium	asthma	9	76	0	0	49.22	1	0	4	540	17512	998	nedocromil sodium	asthma	0	0	227.46	1	0	2	147	6256	998	nedocromil sodium	asthma	0	0	48.26	1	0	4	458	14558	998	nedocromil sodium	asthma	-10.01	4.4948192913572e-05	216.92	0.96	-0.02	0	0	-0.41	0.1	0
999	ganciclovir sodium	0.3	0.19	0.44	9.3e-14	25	4124	177524	8682666	999	ganciclovir sodium	prophylaxis	0.7	0.22	1.64	0.57	5	580	1274	102971	999	ganciclovir sodium	prophylaxis	23.9	79.7	0	0	4.55	1	0	95	207	23565	999	ganciclovir sodium	prophylaxis	0	0	8.95	1	0	72	82	13656	999	ganciclovir sodium	prophylaxis	0	0	7.85	1	0	48	148	14364	999	ganciclovir sodium	prophylaxis	-12.81	2.73330242596469e-06	358.88	0.97	-0.01	0	0.02	-0.52	0.14	0
1000	octreotide acetate	1.87	1.74	2.01	4.9e-55	779	20416	176770	8666374	1000	octreotide acetate	acromegaly	9.55	4.71	22.56	7e-18	156	3349	8	1640	1000	octreotide acetate	acromegaly	33.7	68.4	7.7	2.77	29.79	1.1e-06	44	509	4	357	1000	octreotide acetate	acromegaly	11.17	1.67	475.48	0.0028	14	241	1	193	1000	octreotide acetate	acromegaly	9.19	2.88	46.81	2.3e-06	39	462	3	327	1000	octreotide acetate	acromegaly	2.42	11.2458593148818	0.53	0	-0.03	0.01	0	-0.38	0.31	0.22
1001	doxazosin mesylate	1.69	1.53	1.85	3.8e-24	453	13143	177096	8673647	1001	doxazosin mesylate	hypertension	0.7	0.52	0.93	0.012	51	3332	6844	314281	1001	doxazosin mesylate	hypertension	38	82.9	0.84	0.23	2.18	1	4	303	977	62106	1001	doxazosin mesylate	hypertension	0.89	0.11	3.29	1	2	208	339	31431	1001	doxazosin mesylate	hypertension	1.05	0.21	3.13	0.76	3	150	759	39780	1001	doxazosin mesylate	hypertension	0.05	1.05127109637602	0.45	0.9	-0.02	0	0	-0.59	0.07	0
1002	somatropin [rdna origin]	0.6	0.44	0.81	0.00036	44	3578	177505	8683212	1002	somatropin [rdna origin]	growth hormone deficiency	2.04	1.16	3.45	0.0089	20	1060	61	6608	1002	somatropin [rdna origin]	growth hormone deficiency	10.1	55.9	5.74	1.71	17.14	0.0025	6	69	12	795	1002	somatropin [rdna origin]	growth hormone deficiency	3.61	0.6	15.41	0.081	3	80	8	771	1002	somatropin [rdna origin]	growth hormone deficiency	9.36	1.79	45.34	0.0041	4	42	5	496	1002	somatropin [rdna origin]	growth hormone deficiency	1.73	5.64065390842832	0.48	0	0	0.01	0.76	-0.27	0.47	0.57
1003	gonadorelin acetate	0	0	9.4	1	0	21	177549	8686769	1003	gonadorelin acetate	prostate cancer	0	0	248.32	1	0	3	444	45748	1003	gonadorelin acetate	prostate cancer	56.9	87.4	0	0	4547.83	1	0	1	102	12803	1003	gonadorelin acetate	prostate cancer	0	0	4655.58	1	0	1	114	14675	1003	gonadorelin acetate	prostate cancer	0	0	Inf	1	0	0	0	51	1003	gonadorelin acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1005	ioversol	2.26	1.87	2.71	4.7e-15	122	2639	177427	8684151	1005	ioversol	computerised tomogram	0.21	0.06	0.57	0.00032	4	1167	61	3757	1005	ioversol	computerised tomogram	27.5	85	0	0	878.63	1	0	19	1	433	1005	ioversol	computerised tomogram	0	0	147.43	1	0	8	2	208	1005	ioversol	computerised tomogram	0	0	931.99	1	0	12	1	290	1005	ioversol	computerised tomogram	-14.4	5.5739036926946e-07	2353.48	1	0.01	0.03	0.67	1.02	1.23	0.41
1006	olsalazine sodium	1.94	0.83	3.89	0.077	8	202	177541	8686588	1006	olsalazine sodium	crohn s disease	0	0	10.18	1	0	38	1477	147274	1006	olsalazine sodium	crohn s disease	15.6	67	0	0	122.07	1	0	4	406	32690	1006	olsalazine sodium	crohn s disease	0	0	3487.7	1	0	1	148	13997	1006	olsalazine sodium	crohn s disease	0	0	189.39	1	0	3	305	23894	1006	olsalazine sodium	crohn s disease	-8.06	0.000315926805301555	162.26	0.96	-0.01	0	0	-0.21	0.1	0.04
1007	goserelin acetate	2.26	2	2.53	8.4e-35	302	6552	177247	8680238	1007	goserelin acetate	prostate cancer	1.39	0.98	1.93	0.047	41	3110	403	42641	1007	goserelin acetate	prostate cancer	56.9	87.4	1.24	0.44	2.82	0.64	6	614	96	12190	1007	goserelin acetate	prostate cancer	1.1	0.4	2.49	0.82	6	703	108	13973	1007	goserelin acetate	prostate cancer	0	0	Inf	1	0	1	0	50	1007	goserelin acetate	prostate cancer	0.12	1.12749685157938	0.42	0.78	-0.01	0.01	0.05	11.79	335.43	0.97
1008	ofloxacin	2.47	2.11	2.88	2.5e-24	172	3407	177377	8683383	1008	ofloxacin	hypertension	3.43	1.93	5.71	4.3e-05	16	215	6879	317398	1008	ofloxacin	hypertension	38	82.9	0	0	19.21	1	0	14	981	62395	1008	ofloxacin	hypertension	0	0	37.12	1	0	11	341	31628	1008	ofloxacin	hypertension	0	0	30.73	1	0	8	762	39922	1008	ofloxacin	hypertension	-9.27	9.42085138398996e-05	121.32	0.94	-0.02	0	0	-0.59	0.07	0
1009	moricizine	3.26	0.08	21.2	0.28	1	15	177548	8686775	1009	moricizine	premedication	0	0	304.32	1	0	2	497	28360	1009	moricizine	premedication	13.8	73.2	0	0	Inf	1	0	0	143	5601	1009	moricizine	premedication	0	0	Inf	1	0	0	42	2807	1009	moricizine	premedication	0	0	Inf	1	0	0	117	3991	1009	moricizine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1010	clozapine	0.69	0.64	0.74	3.2e-27	748	53188	176801	8633602	1010	clozapine	schizophrenia	0.43	0.38	0.48	3.1e-51	380	26164	1135	33360	1010	clozapine	schizophrenia	20.1	64.1	0.36	0.26	0.51	1.4e-11	45	2323	249	4691	1010	clozapine	schizophrenia	0.36	0.23	0.54	4.2e-08	29	1819	153	3443	1010	clozapine	schizophrenia	0.41	0.24	0.67	0.00011	19	871	129	2424	1010	clozapine	schizophrenia	-0.9	0.406569659740599	0.16	0	-0.01	0	0	-0.25	0.11	0.03
1011	testosterone	2.27	2.16	2.39	7.1e-185	1661	35913	175888	8650877	1011	testosterone	blood testosterone decreased	4.23	1.62	15.7	0.00056	754	11139	4	250	1011	testosterone	blood testosterone decreased	41.1	71	Inf	2.13	Inf	0.00097	286	2610	0	74	1011	testosterone	blood testosterone decreased	9.85	1.72	393.74	0.0019	321	3257	1	100	1011	testosterone	blood testosterone decreased	0	0	Inf	1	0	18	0	2	1011	testosterone	blood testosterone decreased	2.31	10.0744246550136	1.01	0.02	-0.01	0.01	0.13	13.2	320.63	0.97
1012	ifosfamide	0.29	0.21	0.39	6.3e-24	43	7275	177506	8679515	1012	ifosfamide	diffuse large b-cell lymphoma	2.98	0.33	13.02	0.17	2	433	14	9021	1012	ifosfamide	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	60	0	1154	1012	ifosfamide	diffuse large b-cell lymphoma	0	0	135.61	1	0	48	2	1210	1012	ifosfamide	diffuse large b-cell lymphoma	0	0	Inf	1	0	34	0	1003	1012	ifosfamide	diffuse large b-cell lymphoma	-16.6	6.17606133558036e-08	8111.2	1	-0.02	0.04	0.71	17.13	2445.27	0.99
1013	mesna	0.9	0.71	1.13	0.38	76	4144	177473	8682646	1013	mesna	prophylaxis	0.62	0.23	1.37	0.32	6	777	1273	102774	1013	mesna	prophylaxis	23.9	79.7	1.29	0.03	7.43	0.54	1	89	206	23571	1013	mesna	prophylaxis	0	0	6.66	1	0	96	82	13632	1013	mesna	prophylaxis	10.23	2.62	28.91	0.00093	4	39	144	14373	1013	mesna	prophylaxis	1.27	3.56085256235552	0.52	0.01	-0.01	0	0.04	-0.54	0.14	0
1014	simvastatin	1.58	1.54	1.62	8.7e-233	6219	195415	171330	8491375	1014	simvastatin	hypertension	1.48	1.38	1.59	3.7e-24	861	27912	6034	289701	1014	simvastatin	hypertension	38	82.9	1.03	0.82	1.29	0.78	89	5496	892	56913	1014	simvastatin	hypertension	1.07	0.73	1.53	0.71	34	2964	307	28675	1014	simvastatin	hypertension	1.11	0.85	1.43	0.42	67	3193	695	36737	1014	simvastatin	hypertension	0.18	1.19721736312181	0.11	0.09	-0.02	0	0	-0.6	0.07	0
1015	apraclonidine	0.24	0.01	1.33	0.14	1	208	177548	8686582	1015	apraclonidine	glaucoma	0	0	8.77	1	0	38	219	18697	1015	apraclonidine	glaucoma	54.3	87	0	0	70.17	1	0	6	43	3456	1015	apraclonidine	glaucoma	0	0	261.65	1	0	3	14	1441	1015	apraclonidine	glaucoma	0	0	69.6	1	0	6	35	2772	1015	apraclonidine	glaucoma	-12.22	4.93084591221916e-06	795.53	0.99	-0.01	0.01	0.28	-0.27	0.32	0.4
1016	technetium tc-99m sestamibi kit	2.66	1.78	3.85	3.7e-06	30	551	177519	8686239	1016	technetium tc-99m sestamibi kit	cardiac stress test	0.26	0.01	1.67	0.22	1	175	17	769	1016	technetium tc-99m sestamibi kit	cardiac stress test	61.9	61.9	0	0	Inf	1	0	0	0	0	1016	technetium tc-99m sestamibi kit	cardiac stress test	0	0	Inf	1	0	6	0	63	1016	technetium tc-99m sestamibi kit	cardiac stress test	0	0	535	1	0	6	1	82	1016	technetium tc-99m sestamibi kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1017	metoprolol fumarate	4.07	3.86	4.29	0	1481	17914	176068	8668876	1017	metoprolol fumarate	hypertension	3.24	2.77	3.77	5.3e-39	184	2665	6711	314948	1017	metoprolol fumarate	hypertension	38	82.9	1.73	0.89	3.07	0.081	12	443	969	61966	1017	metoprolol fumarate	hypertension	2.01	0.64	4.79	0.11	5	233	336	31406	1017	metoprolol fumarate	hypertension	1.92	0.91	3.61	0.047	10	274	752	39656	1017	metoprolol fumarate	hypertension	0.7	2.01375270747048	0.26	0.01	-0.02	0	0	-0.59	0.07	0
1018	amlodipine besylate	1.62	1.57	1.68	1.1e-166	3913	118870	173636	8567920	1018	amlodipine besylate	hypertension	1.1	1.02	1.19	0.01	818	34553	6077	283060	1018	amlodipine besylate	hypertension	38	82.9	1.58	1.28	1.93	2e-05	112	4712	869	57697	1018	amlodipine besylate	hypertension	1.19	0.79	1.74	0.35	30	2376	311	29263	1018	amlodipine besylate	hypertension	1.56	1.23	1.95	0.00027	87	3055	675	36875	1018	amlodipine besylate	hypertension	0.39	1.47698079388264	0.1	0	-0.02	0	0	-0.59	0.07	0
1019	podofilox	2.04	0.41	6.2	0.19	3	72	177546	8686718	1019	podofilox	anogenital warts	11.58	0.14	948.52	0.16	1	10	1	121	1019	podofilox	anogenital warts	NA	NA	0	0	Inf	1	0	0	0	0	1019	podofilox	anogenital warts	0	0	Inf	1	0	2	0	12	1019	podofilox	anogenital warts	0	0	Inf	1	0	0	0	12	1019	podofilox	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1020	acrivastine	7.15	4.5	10.92	3.3e-13	25	171	177524	8686619	1020	acrivastine	premedication	0	0	33.5	1	0	8	497	28354	1020	acrivastine	premedication	13.8	73.2	0	0	1491.96	1	0	1	143	5600	1020	acrivastine	premedication	0	0	2504.54	1	0	1	42	2806	1020	acrivastine	premedication	0	0	Inf	1	0	0	117	3991	1020	acrivastine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1021	omeprazole	1.78	1.74	1.82	0	7860	220329	169689	8466461	1021	omeprazole	hypertension	1.53	1.42	1.66	1.2e-24	741	23149	6154	294464	1021	omeprazole	hypertension	38	82.9	1.33	1.08	1.61	0.0059	119	5887	862	56522	1021	omeprazole	hypertension	1.45	1.01	2.03	0.031	40	2653	301	28986	1021	omeprazole	hypertension	1.23	0.97	1.53	0.084	89	3890	673	36040	1021	omeprazole	hypertension	0.28	1.32312981233744	0.09	0	-0.02	0	0	-0.59	0.07	0
1022	fentanyl	2.41	2.34	2.49	0	4099	84208	173450	8602582	1022	fentanyl	pain	0.9	0.84	0.97	0.0057	869	21154	7600	167330	1022	fentanyl	pain	23	79	1.03	0.81	1.3	0.77	80	2570	1008	33447	1022	fentanyl	pain	1.29	0.88	1.85	0.16	35	1164	329	14153	1022	fentanyl	pain	1.01	0.75	1.33	0.89	56	1718	801	24872	1022	fentanyl	pain	0.08	1.08328706767496	0.11	0.46	-0.02	0	0	-0.28	0.06	0
1023	midodrine	2.5	2.14	2.91	3.5e-26	181	3541	177368	8683249	1023	midodrine	nuclear magnetic resonance imaging	3.02	2.11	4.28	1.9e-09	53	103	1093	6420	1023	midodrine	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	1023	midodrine	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	1023	midodrine	nuclear magnetic resonance imaging	0	0	2305.85	1	0	1	9	551	1023	midodrine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1024	pegademase bovine	0	0	1.48	0.19	0	124	177549	8686666	1024	pegademase bovine	combined immunodeficiency	0	0	Inf	1	0	82	0	253	1024	pegademase bovine	combined immunodeficiency	NA	NA	0	0	Inf	1	0	0	0	0	1024	pegademase bovine	combined immunodeficiency	0	0	Inf	1	0	4	0	24	1024	pegademase bovine	combined immunodeficiency	0	0	Inf	1	0	2	0	31	1024	pegademase bovine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1025	acitretin	0.41	0.26	0.61	5.7e-07	24	2887	177525	8683903	1025	acitretin	psoriasis	1.14	0.6	1.97	0.55	13	1549	1177	160142	1025	acitretin	psoriasis	25	74.8	1.43	0.29	4.27	0.47	3	241	376	43284	1025	acitretin	psoriasis	0.85	0.02	4.85	1	1	169	148	21175	1025	acitretin	psoriasis	2.64	0.53	8.01	0.11	3	114	271	27229	1025	acitretin	psoriasis	0.55	1.7332530178674	0.51	0.27	0	0	0.69	-0.36	0.1	0
1026	oxiconazole nitrate	1.04	0.12	3.87	0.72	2	94	177547	8686696	1026	oxiconazole nitrate	diffuse large b-cell lymphoma	0	0	950.38	1	0	4	16	9450	1026	oxiconazole nitrate	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	0	0	1214	1026	oxiconazole nitrate	diffuse large b-cell lymphoma	0	0	Inf	1	0	0	2	1258	1026	oxiconazole nitrate	diffuse large b-cell lymphoma	0	0	Inf	1	0	0	0	1037	1026	oxiconazole nitrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1027	technetium tc-99m exametazime kit	0	0	11.85	1	0	17	177549	8686773	1027	technetium tc-99m exametazime kit	diagnostic procedure	0	0	89.05	1	0	11	21	4373	1027	technetium tc-99m exametazime kit	diagnostic procedure	43.1	71	0	0	322.63	1	0	4	6	1085	1027	technetium tc-99m exametazime kit	diagnostic procedure	0	0	413.07	1	0	4	4	832	1027	technetium tc-99m exametazime kit	diagnostic procedure	0	0	9695.97	1	0	1	4	1171	1027	technetium tc-99m exametazime kit	diagnostic procedure	-12.19	5.08101252647241e-06	1767.06	0.99	0	0.02	0.9	0.35	0.71	0.62
1028	felodipine	1.96	1.77	2.17	1.2e-32	397	9930	177152	8676860	1028	felodipine	hypertension	1.6	1.28	1.98	5.6e-05	88	2544	6807	315069	1028	felodipine	hypertension	38	82.9	0.35	0.04	1.29	0.19	2	359	979	62050	1028	felodipine	hypertension	0	0	1.6	0.18	0	216	341	31423	1028	felodipine	hypertension	0.56	0.07	2.04	0.59	2	188	760	39742	1028	felodipine	hypertension	-0.97	0.379083038103399	0.71	0.17	-0.02	0	0	-0.59	0.07	0
1029	cetirizine	2.25	2.16	2.34	5.9e-280	2597	56968	174952	8629822	1029	cetirizine	hypersensitivity	1.23	1.07	1.4	0.0022	313	6726	1048	27627	1029	cetirizine	hypersensitivity	15.2	73.8	1.18	0.84	1.64	0.34	50	1650	159	6182	1029	cetirizine	hypersensitivity	1.6	0.82	3	0.12	15	564	39	2352	1029	cetirizine	hypersensitivity	1.07	0.74	1.54	0.71	41	1525	138	5513	1029	cetirizine	hypersensitivity	0.12	1.12749685157938	0.16	0.44	-0.01	0	0	-0.38	0.16	0.02
1030	histrelin acetate	0.4	0.15	0.87	0.017	6	740	177543	8686050	1030	histrelin acetate	precocious puberty	0.83	0.09	4.05	1	2	268	9	1003	1030	histrelin acetate	precocious puberty	10	10.5	0	0	Inf	1	0	11	0	11	1030	histrelin acetate	precocious puberty	Inf	0.08	Inf	0.25	1	13	0	42	1030	histrelin acetate	precocious puberty	0	0	106.09	1	0	69	1	187	1030	histrelin acetate	precocious puberty	1.07	2.915379499977	1.43	0.45	0.07	0.25	0.78	1.44	1.49	0.33
1031	sertraline	3.74	3.66	3.83	0	7633	102998	169916	8583792	1031	sertraline	depression	1.2	1.14	1.26	1.1e-13	2214	25409	12157	167376	1031	sertraline	depression	21	73.3	0.98	0.86	1.12	0.84	280	3903	1782	24439	1031	sertraline	depression	1.02	0.81	1.28	0.86	96	1546	541	8901	1031	sertraline	depression	0.85	0.73	0.98	0.029	212	3572	1459	20812	1031	sertraline	depression	-0.14	0.869358235398806	0.06	0.02	-0.01	0	0	-0.14	0.05	0
1032	indium in-111 chloride	12.23	0.25	123.27	0.096	1	4	177548	8686786	1032	indium in-111 chloride	stem cell transplant	0	0	5166.68	1	0	3	4	6076	1032	indium in-111 chloride	stem cell transplant	NA	NA	0	0	Inf	1	0	0	0	0	1032	indium in-111 chloride	stem cell transplant	0	0	Inf	1	0	0	0	411	1032	indium in-111 chloride	stem cell transplant	0	0	Inf	1	0	0	0	249	1032	indium in-111 chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1033	dapiprazole	24.45	0.41	468.52	0.059	1	2	177548	8686788	1033	dapiprazole	cystic fibrosis	0	0	6166.28	1	0	1	57	9972	1033	dapiprazole	cystic fibrosis	14.3	57.2	0	0	Inf	1	0	0	18	3379	1033	dapiprazole	cystic fibrosis	0	0	Inf	1	0	0	7	2062	1033	dapiprazole	cystic fibrosis	0	0	Inf	1	0	0	13	2425	1033	dapiprazole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1034	benazepril	2.39	2.25	2.53	3.6e-144	1169	24070	176380	8662720	1034	benazepril	hypertension	1.6	1.38	1.85	2e-09	196	5695	6699	311918	1034	benazepril	hypertension	38	82.9	1.19	0.71	1.88	0.44	19	1017	962	61392	1034	benazepril	hypertension	1.07	0.39	2.36	0.83	6	523	335	31116	1034	benazepril	hypertension	1.34	0.74	2.24	0.29	15	590	747	39340	1034	benazepril	hypertension	0.24	1.2712491503214	0.22	0.29	-0.02	0	0	-0.59	0.07	0
1035	penicillamine	0.51	0.19	1.12	0.1	6	572	177543	8686218	1035	penicillamine	rheumatoid arthritis	0	0	2.1	0.43	0	239	3410	460138	1035	penicillamine	rheumatoid arthritis	33	75	0	0	62.95	1	0	8	1060	113930	1035	penicillamine	rheumatoid arthritis	0	0	5065.99	1	0	1	180	25390	1035	penicillamine	rheumatoid arthritis	0	0	32.23	1	0	14	1011	107950	1035	penicillamine	rheumatoid arthritis	-8.76	0.000156884608586522	138.13	0.95	-0.01	0	0	-0.26	0.08	0
1036	sermorelin acetate	0	0	16.05	1	0	13	177549	8686777	1036	sermorelin acetate	sleep disorder	0	0	35.32	1	0	3	2199	32079	1036	sermorelin acetate	sleep disorder	22.7	75	0	0	Inf	1	0	0	396	6112	1036	sermorelin acetate	sleep disorder	0	0	Inf	1	0	0	153	2581	1036	sermorelin acetate	sleep disorder	0	0	Inf	1	0	0	303	5058	1036	sermorelin acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1037	sotalol	1	0.88	1.14	0.97	237	11586	177312	8675204	1037	sotalol	atrial fibrillation	1.2	0.76	1.8	0.36	24	2771	784	108638	1037	sotalol	atrial fibrillation	49	86.6	1.28	0.34	3.37	0.56	4	825	128	33801	1037	sotalol	atrial fibrillation	2.65	0.53	8.23	0.11	3	461	53	21612	1037	sotalol	atrial fibrillation	0.87	0.1	3.26	1	2	436	92	17497	1037	sotalol	atrial fibrillation	0.37	1.44773461466332	0.46	0.41	-0.01	0	0	-0.76	0.17	0
1038	eflornithine	2.75	1.66	4.31	9.5e-05	20	356	177529	8686434	1038	eflornithine	hair growth abnormal	0	0	4.68	1	0	141	9	1287	1038	eflornithine	hair growth abnormal	NA	NA	0	0	Inf	1	0	0	0	0	1038	eflornithine	hair growth abnormal	0	0	Inf	1	0	1	0	186	1038	eflornithine	hair growth abnormal	0	0	Inf	1	0	29	0	533	1038	eflornithine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1039	carboplatin	0.75	0.7	0.81	6.8e-14	657	42593	176892	8644197	1039	carboplatin	non-small cell lung cancer	1.45	1.02	2.02	0.029	52	7771	121	26156	1039	carboplatin	non-small cell lung cancer	43.2	79.8	0.65	0.07	2.63	0.76	2	609	24	4749	1039	carboplatin	non-small cell lung cancer	0.49	0.01	3.23	0.71	1	430	14	2943	1039	carboplatin	non-small cell lung cancer	0.8	0.02	5.27	1	1	234	14	2606	1039	carboplatin	non-small cell lung cancer	-0.48	0.618783391806141	0.73	0.51	-0.01	0.01	0.36	-0.14	0.37	0.71
1040	technetium tc-99m mertiatide kit	0	0	4.85	1	0	39	177549	8686751	1040	technetium tc-99m mertiatide kit	renal scan	0	0	1.26	0.056	0	21	5	21	1040	technetium tc-99m mertiatide kit	renal scan	NA	NA	0	0	Inf	1	0	0	0	0	1040	technetium tc-99m mertiatide kit	renal scan	0	0	Inf	1	0	0	0	2	1040	technetium tc-99m mertiatide kit	renal scan	0	0	Inf	1	0	0	0	2	1040	technetium tc-99m mertiatide kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1041	quinapril	2.54	2.35	2.74	3.7e-101	722	13955	176827	8672835	1041	quinapril	hypertension	1.66	1.36	2.01	1.1e-06	112	3128	6783	314485	1041	quinapril	hypertension	38	82.9	1.24	0.53	2.48	0.55	8	410	973	61999	1041	quinapril	hypertension	1.45	0.29	4.33	0.47	3	193	338	31446	1041	quinapril	hypertension	0.97	0.31	2.31	1	5	269	757	39661	1041	quinapril	hypertension	0.19	1.20924959765725	0.36	0.59	-0.02	0	0	-0.59	0.07	0
1042	nafarelin acetate	0.24	0.01	1.34	0.14	1	206	177548	8686584	1042	nafarelin acetate	in vitro fertilisation	0	0	9.62	1	0	51	10	1067	1042	nafarelin acetate	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	7	0	60	1042	nafarelin acetate	in vitro fertilisation	0	0	Inf	1	0	0	0	1	1042	nafarelin acetate	in vitro fertilisation	0	0	63.7	1	0	15	2	173	1042	nafarelin acetate	in vitro fertilisation	-15.1	2.76791865854081e-07	2769.35	1	-0.05	0.1	0.63	-16.72	10754.01	1
1043	pravastatin sodium	2.17	2.03	2.31	5.2e-96	948	21458	176601	8665332	1043	pravastatin sodium	hypertension	2.29	1.89	2.75	1.6e-15	123	2496	6772	315117	1043	pravastatin sodium	hypertension	38	82.9	0.9	0.33	1.98	1	6	424	975	61985	1043	pravastatin sodium	hypertension	0	0	1.82	0.28	0	190	341	31449	1043	pravastatin sodium	hypertension	1.06	0.38	2.34	0.83	6	297	756	39633	1043	pravastatin sodium	hypertension	-0.21	0.810584245970187	0.41	0.61	-0.02	0	0	-0.59	0.07	0
1044	ramipril	1.09	1.03	1.15	0.0011	1543	69342	176006	8617448	1044	ramipril	hypertension	0.89	0.79	0.99	0.039	309	15975	6586	301638	1044	ramipril	hypertension	38	82.9	1.39	1.06	1.78	0.013	68	3184	913	59225	1044	ramipril	hypertension	1.54	1.03	2.24	0.03	31	1927	310	29712	1044	ramipril	hypertension	1.19	0.84	1.64	0.29	40	1781	722	38149	1044	ramipril	hypertension	0.29	1.33642748802547	0.12	0.02	-0.02	0	0	-0.6	0.07	0
1045	clomipramine	2.17	1.89	2.48	1.1e-24	228	5136	177321	8681654	1045	clomipramine	depression	0.75	0.58	0.96	0.023	68	1209	14303	191576	1045	clomipramine	depression	21	73.3	1.12	0.57	2.03	0.64	12	147	2050	28195	1045	clomipramine	depression	1.58	0.49	3.95	0.38	5	52	632	10395	1045	clomipramine	depression	1.17	0.55	2.23	0.6	10	125	1661	24259	1045	clomipramine	depression	0.23	1.25860000992948	0.27	0.39	-0.01	0	0	-0.14	0.05	0
1046	metipranolol	1.88	0.22	7.15	0.29	2	52	177547	8686738	1046	metipranolol	glaucoma	0	0	25.96	1	0	14	219	18721	1046	metipranolol	glaucoma	54.3	87	0	0	2993.15	1	0	1	43	3461	1046	metipranolol	glaucoma	0	0	Inf	1	0	0	14	1444	1046	metipranolol	glaucoma	0	0	2952.72	1	0	1	35	2777	1046	metipranolol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1047	zolpidem tartrate	4.26	4.15	4.39	0	5460	64160	172089	8622630	1047	zolpidem tartrate	insomnia	1.6	1.47	1.75	2.9e-25	741	11734	2202	55854	1047	zolpidem tartrate	insomnia	26.9	78.5	1.14	0.9	1.44	0.27	92	1845	439	10052	1047	zolpidem tartrate	insomnia	0.98	0.64	1.47	1	29	754	183	4683	1047	zolpidem tartrate	insomnia	1.18	0.89	1.56	0.24	65	1308	314	7482	1047	zolpidem tartrate	insomnia	0.09	1.09417428370521	0.12	0.41	-0.02	0	0	-0.08	0.09	0.39
1048	fosinopril sodium	3.18	2.85	3.55	4.5e-70	342	5263	177207	8681527	1048	fosinopril sodium	hypertension	2.35	1.75	3.09	5.6e-08	54	1065	6841	316548	1048	fosinopril sodium	hypertension	38	82.9	1.87	0.22	7.05	0.3	2	68	979	62341	1048	fosinopril sodium	hypertension	0	0	8.77	1	0	41	341	31598	1048	fosinopril sodium	hypertension	2.92	0.34	11.36	0.16	2	36	760	39894	1048	fosinopril sodium	hypertension	0.6	1.82211880039051	0.72	0.41	-0.02	0	0	-0.59	0.07	0
1049	fenoldopam mesylate	82.93	39.9	179.33	5e-29	22	13	177527	8686777	1049	fenoldopam mesylate	coronary artery bypass	6.74	1.62	59.81	0.0029	19	2	2833	2012	1049	fenoldopam mesylate	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	1049	fenoldopam mesylate	coronary artery bypass	0	0	Inf	1	0	0	1	192	1049	fenoldopam mesylate	coronary artery bypass	0	0	Inf	1	0	0	3	35	1049	fenoldopam mesylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1050	altretamine	24.45	10.23	54.75	2.2e-10	10	20	177539	8686770	1050	altretamine	ovarian cancer	195.8	59.81	759.73	4.9e-17	10	5	105	10348	1050	altretamine	ovarian cancer	45.7	74.2	0	0	Inf	1	0	0	32	1732	1050	altretamine	ovarian cancer	0	0	Inf	1	0	0	0	3	1050	altretamine	ovarian cancer	0	0	Inf	1	0	0	36	2193	1050	altretamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1051	technetium tc-99m teboroxime kit	0	0	28.67	1	0	8	177549	8686782	1051	technetium tc-99m teboroxime kit	crohn s disease	0	0	526.65	1	0	2	1477	147310	1051	technetium tc-99m teboroxime kit	crohn s disease	15.6	67	0	0	Inf	1	0	0	406	32694	1051	technetium tc-99m teboroxime kit	crohn s disease	0	0	Inf	1	0	0	148	13998	1051	technetium tc-99m teboroxime kit	crohn s disease	0	0	Inf	1	0	0	305	23897	1051	technetium tc-99m teboroxime kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1052	adenosine	1.89	1.43	2.45	1.4e-05	59	1529	177490	8685261	1052	adenosine	supraventricular tachycardia	0.88	0.17	2.9	1	3	159	30	1407	1052	adenosine	supraventricular tachycardia	33.2	60.4	0	0	56.51	1	0	4	3	74	1052	adenosine	supraventricular tachycardia	0	0	48.19	1	0	6	3	103	1052	adenosine	supraventricular tachycardia	0	0	72.06	1	0	15	2	196	1052	adenosine	supraventricular tachycardia	-15.87	1.28158251092688e-07	2299.77	0.99	-0.03	0.02	0.12	1.1	0.93	0.24
1053	masoprocol	24.45	0.41	468.52	0.059	1	2	177548	8686788	1053	masoprocol	chronic obstructive pulmonary disease	0	0	348.38	1	0	2	1258	81995	1053	masoprocol	chronic obstructive pulmonary disease	48.4	82.8	0	0	Inf	1	0	0	291	20144	1053	masoprocol	chronic obstructive pulmonary disease	0	0	Inf	1	0	0	108	9749	1053	masoprocol	chronic obstructive pulmonary disease	0	0	Inf	1	0	0	217	13505	1053	masoprocol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1054	doxacurium chloride	0	0	33.97	1	0	7	177549	8686783	1054	doxacurium chloride	gastric disorder	0	0	152.33	1	0	2	375	10711	1054	doxacurium chloride	gastric disorder	29.2	80.2	0	0	Inf	1	0	0	61	2341	1054	doxacurium chloride	gastric disorder	0	0	Inf	1	0	0	11	871	1054	doxacurium chloride	gastric disorder	0	0	Inf	1	0	0	58	1833	1054	doxacurium chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1055	fluconazole	2.43	2.32	2.55	9.5e-224	1759	35609	175790	8651181	1055	fluconazole	prophylaxis	0.46	0.29	0.7	8.2e-05	22	3774	1257	99777	1055	fluconazole	prophylaxis	23.9	79.7	0.98	0.39	2.07	1	7	814	200	22846	1055	fluconazole	prophylaxis	1.25	0.33	3.36	0.57	4	540	78	13188	1055	fluconazole	prophylaxis	1.27	0.46	2.86	0.48	6	464	142	13948	1055	fluconazole	prophylaxis	0.2	1.22140275816017	0.33	0.54	-0.01	0	0.03	-0.52	0.14	0
1056	fluticasone propionate	1.97	1.91	2.03	0	4744	119414	172805	8567376	1056	fluticasone propionate	asthma	0.93	0.86	1.01	0.11	817	28293	2227	72081	1056	fluticasone propionate	asthma	9	76	1.26	1.04	1.53	0.016	162	4434	378	13082	1056	fluticasone propionate	asthma	1.04	0.69	1.53	0.84	36	1488	111	4770	1056	fluticasone propionate	asthma	1.29	1.04	1.58	0.016	139	3686	319	10876	1056	fluticasone propionate	asthma	0.22	1.24607673058738	0.09	0.01	-0.02	0	0	-0.4	0.1	0
1057	gallium nitrate	3.06	0.07	19.68	0.29	1	16	177548	8686774	1057	gallium nitrate	non-hodgkin s lymphoma refractory	0	0	Inf	1	0	4	0	64	1057	gallium nitrate	non-hodgkin s lymphoma refractory	NA	NA	0	0	Inf	1	0	0	0	0	1057	gallium nitrate	non-hodgkin s lymphoma refractory	0	0	Inf	1	0	0	0	9	1057	gallium nitrate	non-hodgkin s lymphoma refractory	0	0	Inf	1	0	0	0	2	1057	gallium nitrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1058	metoprolol succinate	2.7	2.6	2.8	0	2905	53262	174644	8633528	1058	metoprolol succinate	hypertension	2.44	2.2	2.69	9.3e-56	439	8625	6456	308988	1058	metoprolol succinate	hypertension	38	82.9	1.23	0.61	2.22	0.5	11	571	970	61838	1058	metoprolol succinate	hypertension	0.65	0.08	2.4	0.77	2	283	339	31356	1058	metoprolol succinate	hypertension	1.31	0.59	2.52	0.44	9	362	753	39568	1058	metoprolol succinate	hypertension	0.12	1.12749685157938	0.31	0.69	-0.02	0	0	-0.59	0.07	0
1059	halobetasol propionate	2.85	1.81	4.3	1.2e-05	24	412	177525	8686378	1059	halobetasol propionate	psoriasis	4.38	1.58	9.73	0.0031	6	187	1184	161504	1059	halobetasol propionate	psoriasis	25	74.8	7.88	1.56	24.77	0.0078	3	44	376	43481	1059	halobetasol propionate	psoriasis	4.97	0.12	30.34	0.19	1	29	148	21315	1059	halobetasol propionate	psoriasis	12.6	2.41	41.89	0.0024	3	24	271	27319	1059	halobetasol propionate	psoriasis	2.21	9.11571639304031	0.52	0	0	0	0.66	-0.37	0.1	0
1060	ticlopidine	1.04	0.83	1.3	0.69	82	3847	177467	8682943	1060	ticlopidine	hypertension	1.66	1.07	2.47	0.019	25	695	6870	316918	1060	ticlopidine	hypertension	38	82.9	1.45	0.04	8.51	0.5	1	44	980	62365	1060	ticlopidine	hypertension	3.87	0.09	23.9	0.24	1	24	340	31615	1060	ticlopidine	hypertension	0	0	5.83	1	0	35	762	39895	1060	ticlopidine	hypertension	0.38	1.46228458943422	1.01	0.71	-0.02	0	0	-0.59	0.07	0
1061	technetium tc-99m red blood cell kit	0	0	2.34	0.41	0	79	177549	8686711	1061	technetium tc-99m red blood cell kit	radioisotope scan	0	0	8.89	0.53	0	48	2	78	1061	technetium tc-99m red blood cell kit	radioisotope scan	NA	NA	0	0	Inf	1	0	0	0	0	1061	technetium tc-99m red blood cell kit	radioisotope scan	0	0	Inf	1	0	0	0	2	1061	technetium tc-99m red blood cell kit	radioisotope scan	0	0	Inf	1	0	0	0	9	1061	technetium tc-99m red blood cell kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1062	bisoprolol fumarate	0.98	0.89	1.08	0.72	397	19801	177152	8666989	1062	bisoprolol fumarate	hypertension	0.79	0.62	0.99	0.043	77	4461	6818	313152	1062	bisoprolol fumarate	hypertension	38	82.9	0.34	0.04	1.23	0.14	2	376	979	62033	1062	bisoprolol fumarate	hypertension	0	0	1.63	0.18	0	211	341	31428	1062	bisoprolol fumarate	hypertension	0.44	0.05	1.6	0.34	2	239	760	39691	1062	bisoprolol fumarate	hypertension	-1.13	0.323033256422253	0.71	0.11	-0.02	0	0	-0.59	0.07	0
1063	nicotine	1.7	1.59	1.81	2.7e-49	944	27246	176605	8659544	1063	nicotine	smoking cessation therapy	0.33	0.3	0.37	3.9e-120	363	9232	6069	50955	1063	nicotine	smoking cessation therapy	26.1	70	0.53	0.4	0.69	1.6e-06	83	2731	168	2910	1063	nicotine	smoking cessation therapy	0.6	0.39	0.92	0.013	38	1193	68	1286	1063	nicotine	smoking cessation therapy	0.49	0.35	0.67	5.1e-06	61	2197	116	2033	1063	nicotine	smoking cessation therapy	-0.61	0.5433508690745	0.13	0	-0.02	0	0	-0.05	0.13	0.71
1064	succimer	3.16	0.37	12.41	0.14	2	31	177547	8686759	1064	succimer	metal poisoning	0	0	56.68	1	0	11	1	15	1064	succimer	metal poisoning	NA	NA	0	0	Inf	1	0	0	0	0	1064	succimer	metal poisoning	0	0	Inf	1	0	2	0	0	1064	succimer	metal poisoning	0	0	Inf	1	0	1	0	0	1064	succimer	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1065	ondansetron	2.83	2.74	2.93	0	3904	68372	173645	8618418	1065	ondansetron	nausea	0.87	0.77	0.99	0.026	428	11589	796	18819	1065	ondansetron	nausea	17.2	77	0.97	0.73	1.28	0.84	105	3773	113	3919	1065	ondansetron	nausea	0.69	0.37	1.27	0.25	20	1638	30	1703	1065	ondansetron	nausea	0.98	0.73	1.32	0.88	95	2756	100	2838	1065	ondansetron	nausea	-0.14	0.869358235398806	0.13	0.27	-0.03	0	0	-0.77	0.16	0
1066	lomefloxacin	3.94	1.54	8.46	0.0029	7	87	177542	8686703	1066	lomefloxacin	sinusitis	0	0	26.47	1	0	4	816	14242	1066	lomefloxacin	sinusitis	22.9	65.1	0	0	28.47	1	0	3	144	1684	1066	lomefloxacin	sinusitis	0	0	Inf	1	0	0	36	718	1066	lomefloxacin	sinusitis	0	0	34.56	1	0	3	124	1760	1066	lomefloxacin	sinusitis	-11.92	6.65594578340917e-06	509.59	0.98	-0.02	0	0	-0.38	0.2	0.05
1067	paroxetine	4.83	4.71	4.95	0	7634	80059	169915	8606731	1067	paroxetine	depression	1.68	1.6	1.76	1.1e-94	2317	19814	12054	172971	1067	paroxetine	depression	21	73.3	2.38	2.03	2.78	2.1e-24	211	1295	1851	27047	1067	paroxetine	depression	3.37	2.62	4.31	1e-18	89	480	548	9967	1067	paroxetine	depression	1.99	1.66	2.38	1.3e-12	153	1176	1518	23208	1067	paroxetine	depression	0.86	2.36316069370579	0.07	0	-0.01	0	0	-0.14	0.05	0
1068	beractant	0.16	0	0.9	0.037	1	304	177548	8686486	1068	beractant	acute respiratory distress syndrome	0	0	17.7	1	0	92	2	303	1068	beractant	acute respiratory distress syndrome	NA	NA	0	0	Inf	1	0	0	0	0	1068	beractant	acute respiratory distress syndrome	0	0	Inf	1	0	1	0	35	1068	beractant	acute respiratory distress syndrome	0	0	Inf	1	0	0	0	26	1068	beractant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1069	levamisole	0	0	0.92	0.038	0	199	177549	8686591	1069	levamisole	drug abuse	0	0	29.04	1	0	12	60	4721	1069	levamisole	drug abuse	21	60.4	0	0	Inf	1	0	0	19	951	1069	levamisole	drug abuse	0	0	Inf	1	0	0	17	587	1069	levamisole	drug abuse	0	0	Inf	1	0	0	8	675	1069	levamisole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1070	pamidronate disodium	22.18	21.43	22.96	0	4902	11102	172647	8675688	1070	pamidronate disodium	multiple myeloma	27.57	24.68	30.89	0	913	3144	570	54153	1070	pamidronate disodium	multiple myeloma	NA	NA	0	0	Inf	1	0	0	0	0	1070	pamidronate disodium	multiple myeloma	0	0	Inf	1	0	0	0	0	1070	pamidronate disodium	multiple myeloma	0	0	Inf	1	0	0	0	0	1070	pamidronate disodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1071	fludarabine phosphate	0.12	0.08	0.17	4.8e-65	27	11411	177522	8675379	1071	fludarabine phosphate	chronic lymphocytic leukaemia	0.44	0.12	1.17	0.14	4	2593	68	19266	1071	fludarabine phosphate	chronic lymphocytic leukaemia	50.7	85	1.89	0.05	11.55	0.42	1	129	30	7313	1071	fludarabine phosphate	chronic lymphocytic leukaemia	2.25	0.05	14.07	0.37	1	98	24	5289	1071	fludarabine phosphate	chronic lymphocytic leukaemia	0	0	34.24	1	0	40	10	2959	1071	fludarabine phosphate	chronic lymphocytic leukaemia	0.47	1.59999419321736	1.02	0.64	-0.02	0.01	0.2	0.31	0.38	0.41
1072	cetyl alcohol	0	0	19.5	1	0	11	177549	8686779	1072	cetyl alcohol	acne	0	0	269.83	1	0	1	4376	30403	1072	cetyl alcohol	acne	14.8	44.4	0	0	Inf	1	0	0	173	2824	1072	cetyl alcohol	acne	0	0	Inf	1	0	0	28	1131	1072	cetyl alcohol	acne	0	0	Inf	1	0	0	164	2394	1072	cetyl alcohol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1074	tyloxapol	0	0	41.55	1	0	6	177549	8686784	1074	tyloxapol	periarthritis	0	0	1395.66	1	0	1	12	438	1074	tyloxapol	periarthritis	45	51.3	0	0	Inf	1	0	0	0	11	1074	tyloxapol	periarthritis	0	0	Inf	1	0	0	3	25	1074	tyloxapol	periarthritis	0	0	1671.22	1	0	1	1	43	1074	tyloxapol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1075	avobenzone	0	0	3.46	0.63	0	54	177549	8686736	1075	avobenzone	prophylaxis against solar radiation	0	0	2739.19	1	0	8	1	586	1075	avobenzone	prophylaxis against solar radiation	NA	NA	0	0	Inf	1	0	0	0	0	1075	avobenzone	prophylaxis against solar radiation	0	0	Inf	1	0	1	0	53	1075	avobenzone	prophylaxis against solar radiation	0	0	Inf	1	0	1	0	294	1075	avobenzone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1076	octinoxate	0.89	0.02	5.17	1	1	55	177548	8686735	1076	octinoxate	osteopenia	0	0	3.34	0.61	0	7	2789	13400	1076	octinoxate	osteopenia	55.3	78.8	0	0	Inf	1	0	0	71	983	1076	octinoxate	osteopenia	0	0	Inf	1	0	0	6	136	1076	octinoxate	osteopenia	0	0	Inf	1	0	0	73	1226	1076	octinoxate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1077	oxybenzone	1	0.02	5.83	1	1	49	177548	8686741	1077	oxybenzone	osteopenia	0	0	3.34	0.61	0	7	2789	13400	1077	oxybenzone	osteopenia	55.3	78.8	0	0	Inf	1	0	0	71	983	1077	oxybenzone	osteopenia	0	0	Inf	1	0	0	6	136	1077	oxybenzone	osteopenia	0	0	Inf	1	0	0	73	1226	1077	oxybenzone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1078	alglucerase	0	0	5.98	1	0	32	177549	8686758	1078	alglucerase	gaucher s disease	0	0	12.95	1	0	30	46	4388	1078	alglucerase	gaucher s disease	39.9	49.4	0	0	Inf	1	0	0	5	86	1078	alglucerase	gaucher s disease	0	0	Inf	1	0	0	1	345	1078	alglucerase	gaucher s disease	0	0	437.52	1	0	2	6	460	1078	alglucerase	gaucher s disease	-12.48	3.80193655996962e-06	1696.66	0.99	0.01	0.02	0.6	-1.52	1.08	0.16
1079	pheniramine maleate	0.66	0.39	1.04	0.08	18	1342	177531	8685448	1079	pheniramine maleate	eye pruritus	0.29	0.01	1.79	0.35	1	319	20	1818	1079	pheniramine maleate	eye pruritus	43.6	81	0	0	85.92	1	0	19	2	299	1079	pheniramine maleate	eye pruritus	0	0	Inf	1	0	10	0	177	1079	pheniramine maleate	eye pruritus	0	0	31.28	1	0	21	4	413	1079	pheniramine maleate	eye pruritus	-16.39	7.61927136665264e-08	4909.58	1	0.02	0.03	0.37	-16.7	2085.49	0.99
1080	foscarnet sodium	0.05	0	0.27	5.7e-08	1	1006	177548	8685784	1080	foscarnet sodium	hiv infection	0	0	2.61	0.41	0	167	500	58224	1080	foscarnet sodium	hiv infection	25	64	0	0	19.41	1	0	14	120	7627	1080	foscarnet sodium	hiv infection	0	0	16.87	1	0	15	96	5713	1080	foscarnet sodium	hiv infection	0	0	3186.15	1	0	1	40	3438	1080	foscarnet sodium	hiv infection	-11.45	1.06494746038243e-05	363.68	0.97	0	0.01	0.81	0.38	0.2	0.05
1081	tacrine	0	0	7.16	1	0	27	177549	8686763	1081	tacrine	hypertension	0	0	245.46	1	0	2	6895	317611	1081	tacrine	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	1081	tacrine	hypertension	0	0	Inf	1	0	0	341	31639	1081	tacrine	hypertension	0	0	1980.45	1	0	1	762	39929	1081	tacrine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1082	desogestrel	4.25	3.71	4.85	1.1e-70	240	2767	177309	8684023	1082	desogestrel	contraception	3.03	2.54	3.59	1.1e-29	159	989	7842	147645	1082	desogestrel	contraception	19	43	1.53	0.71	2.95	0.23	10	92	1705	23989	1082	desogestrel	contraception	0	0	Inf	1	0	0	0	22	1082	desogestrel	contraception	1.63	0.84	2.91	0.1	13	119	1926	28786	1082	desogestrel	contraception	0.49	1.63231621995538	0.29	0.09	0	0	0.98	-10.86	114.15	0.92
1083	flumazenil	3.59	2.41	5.17	5.9e-09	31	423	177518	8686367	1083	flumazenil	sedation	6.51	2.23	15.75	0.00062	6	46	108	5399	1083	flumazenil	sedation	9.5	66	0	0	1311.58	1	0	1	18	617	1083	flumazenil	sedation	0	0	206.36	1	0	3	7	534	1083	flumazenil	sedation	0	0	1181.24	1	0	1	14	431	1083	flumazenil	sedation	-12.27	4.69036571938194e-06	1186.81	0.99	-0.01	0.01	0.28	-0.93	0.47	0.05
1084	sumatriptan succinate	2.14	2	2.28	3.2e-98	1002	23000	176547	8663790	1084	sumatriptan succinate	migraine	0.79	0.7	0.88	2.8e-05	408	10976	1379	29269	1084	sumatriptan succinate	migraine	20.7	70.1	0.65	0.46	0.9	0.0062	48	1867	219	5533	1084	sumatriptan succinate	migraine	0.46	0.09	1.5	0.25	3	193	29	856	1084	sumatriptan succinate	migraine	0.67	0.48	0.93	0.013	48	1779	217	5422	1084	sumatriptan succinate	migraine	-0.41	0.663650250136319	0.16	0.01	-0.02	0	0	-0.23	0.19	0.23
1085	itraconazole	0.71	0.58	0.85	0.00017	109	7548	177440	8679242	1085	itraconazole	prophylaxis	0.57	0.23	1.17	0.15	7	997	1272	102554	1085	itraconazole	prophylaxis	23.9	79.7	2.05	0.24	7.68	0.26	2	112	205	23548	1085	itraconazole	prophylaxis	2.11	0.05	12.41	0.38	1	80	81	13648	1085	itraconazole	prophylaxis	1.78	0.04	10.47	0.44	1	55	147	14357	1085	itraconazole	prophylaxis	0.62	1.85892804184634	0.72	0.39	-0.01	0	0.03	-0.52	0.14	0
1086	iobenguane i-131	0	0	28.67	1	0	8	177549	8686782	1086	iobenguane i-131	neuroblastoma	0	0	Inf	1	0	7	0	1120	1086	iobenguane i-131	neuroblastoma	NA	NA	0	0	Inf	1	0	0	0	0	1086	iobenguane i-131	neuroblastoma	0	0	Inf	1	0	0	0	135	1086	iobenguane i-131	neuroblastoma	0	0	Inf	1	0	1	0	102	1086	iobenguane i-131	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1087	perflubron	0	0	74.11	1	0	4	177549	8686786	1087	perflubron	myelodysplastic syndrome	0	0	10149.58	1	0	1	79	24433	1087	perflubron	myelodysplastic syndrome	54.7	84.3	0	0	10203.08	1	0	1	13	4045	1087	perflubron	myelodysplastic syndrome	0	0	13936.92	1	0	1	6	2740	1087	perflubron	myelodysplastic syndrome	0	0	Inf	1	0	0	8	2242	1087	perflubron	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1088	mivacurium chloride	0.55	0.01	3.14	1	1	89	177548	8686701	1088	mivacurium chloride	general anaesthesia	0	0	30.65	1	0	19	21	2780	1088	mivacurium chloride	general anaesthesia	19.4	52.5	0	0	Inf	1	0	0	3	245	1088	mivacurium chloride	general anaesthesia	0	0	Inf	1	0	0	1	248	1088	mivacurium chloride	general anaesthesia	0	0	Inf	1	0	0	4	358	1088	mivacurium chloride	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1089	azelastine	2.39	2.17	2.64	1.7e-53	420	8594	177129	8678196	1089	azelastine	asthma	0.99	0.68	1.42	1	32	1061	3012	99313	1089	azelastine	asthma	9	76	0.72	0.23	1.7	0.69	5	226	535	17290	1089	azelastine	asthma	1.26	0.15	4.8	0.68	2	68	145	6190	1089	azelastine	asthma	0.71	0.19	1.86	0.67	4	179	454	14383	1089	azelastine	asthma	-0.21	0.810584245970187	0.42	0.62	-0.02	0	0	-0.41	0.1	0
1090	desflurane	0.74	0.44	1.18	0.26	18	1187	177531	8685603	1090	desflurane	anaesthesia	0	0	1.51	0.18	0	268	60	6336	1090	desflurane	anaesthesia	23	71.2	0	0	10.75	1	0	27	9	542	1090	desflurane	anaesthesia	0	0	894.1	1	0	16	1	371	1090	desflurane	anaesthesia	0	0	8.36	1	0	26	10	459	1090	desflurane	anaesthesia	-15.26	2.35866469323924e-07	1602.66	0.99	0	0.01	0.92	-2.09	1.05	0.05
1091	teniposide	0	0	0.79	0.017	0	231	177549	8686559	1091	teniposide	burkitt s lymphoma	0	0	223.61	1	0	24	2	988	1091	teniposide	burkitt s lymphoma	NA	NA	0	0	Inf	1	0	0	0	0	1091	teniposide	burkitt s lymphoma	0	0	Inf	1	0	2	0	73	1091	teniposide	burkitt s lymphoma	0	0	Inf	1	0	0	0	51	1091	teniposide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1092	pentostatin	0.13	0.02	0.49	9.5e-05	2	726	177547	8686064	1092	pentostatin	chronic lymphocytic leukaemia	0	0	4.98	1	0	230	72	21629	1092	pentostatin	chronic lymphocytic leukaemia	50.7	85	0	0	31.92	1	0	31	31	7411	1092	pentostatin	chronic lymphocytic leukaemia	0	0	44.05	1	0	21	25	5366	1092	pentostatin	chronic lymphocytic leukaemia	0	0	154.76	1	0	10	10	2989	1092	pentostatin	chronic lymphocytic leukaemia	-12.14	5.34152160940495e-06	709.87	0.99	-0.02	0.01	0.19	0.31	0.38	0.4
1093	gadodiamide	12.38	11.57	13.23	0	1094	4349	176455	8682441	1093	gadodiamide	nuclear magnetic resonance imaging	19.42	16.5	22.91	0	930	1183	216	5340	1093	gadodiamide	nuclear magnetic resonance imaging	26.3	65.4	0	0	27.21	1	0	10	10	524	1093	gadodiamide	nuclear magnetic resonance imaging	0	0	529.54	1	0	2	3	252	1093	gadodiamide	nuclear magnetic resonance imaging	0	0	28.48	1	0	11	9	541	1093	gadodiamide	nuclear magnetic resonance imaging	-13.42	1.48514224859136e-06	1096.25	0.99	0	0.02	0.95	-0.33	0.67	0.62
1094	gadoteridol	26.28	24.17	28.56	0	862	1612	176687	8685178	1094	gadoteridol	nuclear magnetic resonance imaging	11.33	9.83	13.06	9.8e-270	741	907	405	5616	1094	gadoteridol	nuclear magnetic resonance imaging	26.3	65.4	3.83	0.08	30.97	0.26	1	15	9	519	1094	gadoteridol	nuclear magnetic resonance imaging	5.77	0.09	115.46	0.23	1	20	2	234	1094	gadoteridol	nuclear magnetic resonance imaging	0	0	23.5	1	0	13	9	539	1094	gadoteridol	nuclear magnetic resonance imaging	0.89	2.43512965128987	1.08	0.41	0	0.02	0.89	-0.39	0.68	0.57
1095	strontium chloride sr-89	0.94	0.4	1.88	1	8	415	177541	8686375	1095	strontium chloride sr-89	metastatic pain	0	0	1.91	0.086	0	338	3	265	1095	strontium chloride sr-89	metastatic pain	NA	NA	0	0	Inf	1	0	0	0	0	1095	strontium chloride sr-89	metastatic pain	0	0	Inf	1	0	6	0	23	1095	strontium chloride sr-89	metastatic pain	0	0	Inf	1	0	2	0	14	1095	strontium chloride sr-89	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1096	torsemide	1.51	1.36	1.66	4.4e-14	397	12913	177152	8673877	1096	torsemide	hypertension	0.73	0.5	1.02	0.073	34	2147	6861	315466	1096	torsemide	hypertension	38	82.9	0.58	0.07	2.12	0.78	2	220	979	62189	1096	torsemide	hypertension	0.72	0.02	4.13	1	1	128	340	31511	1096	torsemide	hypertension	0.4	0.01	2.27	0.52	1	131	761	39799	1096	torsemide	hypertension	-0.52	0.594520547970194	0.71	0.47	-0.02	0	0	-0.59	0.07	0
1097	levoleucovorin calcium	0	0	0.25	8.2e-07	0	725	177549	8686065	1097	levoleucovorin calcium	colorectal cancer	0	0	3.56	0.63	0	244	54	12191	1097	levoleucovorin calcium	colorectal cancer	40.9	75	0	0	5690.36	1	0	1	7	1120	1097	levoleucovorin calcium	colorectal cancer	0	0	5769.79	1	0	1	5	812	1097	levoleucovorin calcium	colorectal cancer	0	0	Inf	1	0	0	4	582	1097	levoleucovorin calcium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1098	diclofenac potassium	1.34	1.06	1.69	0.013	76	2767	177473	8684023	1098	diclofenac potassium	rheumatoid arthritis	1.48	0.3	4.39	0.46	3	273	3407	460104	1098	diclofenac potassium	rheumatoid arthritis	33	75	2.05	0.24	7.61	0.26	2	105	1058	113833	1098	diclofenac potassium	rheumatoid arthritis	17.71	0.4	133.25	0.062	1	8	179	25383	1098	diclofenac potassium	rheumatoid arthritis	1	0.03	5.69	1	1	107	1010	107857	1098	diclofenac potassium	rheumatoid arthritis	0.62	1.85892804184634	0.71	0.39	-0.01	0	0	-0.26	0.08	0
1099	venlafaxine	3.89	3.79	3.99	0	6059	78229	171490	8608561	1099	venlafaxine	depression	1.3	1.23	1.36	3.2e-23	1942	20736	12429	172049	1099	venlafaxine	depression	21	73.3	1.22	1.06	1.39	0.0045	275	3183	1787	25159	1099	venlafaxine	depression	1.69	1.33	2.12	1.8e-05	95	983	542	9464	1099	venlafaxine	depression	1.13	0.97	1.32	0.11	208	2719	1463	21665	1099	venlafaxine	depression	0.24	1.2712491503214	0.06	0	-0.01	0	0	-0.14	0.05	0
1100	nefazodone	6.41	5.7	7.18	1.7e-144	338	2585	177211	8684205	1100	nefazodone	depression	1.92	1.56	2.34	1.9e-09	114	799	14257	191986	1100	nefazodone	depression	21	73.3	1.79	0.34	5.95	0.42	3	23	2059	28319	1100	nefazodone	depression	1.82	0.04	13.19	0.45	1	9	636	10438	1100	nefazodone	depression	2.09	0.23	9.09	0.27	2	14	1669	24370	1100	nefazodone	depression	0.78	2.1814722654982	0.62	0.2	-0.01	0	0	-0.14	0.05	0
1101	didanosine	0.47	0.37	0.6	2.3e-12	70	7242	177479	8679548	1101	didanosine	hiv infection	0.64	0.43	0.94	0.021	29	5103	471	53288	1101	didanosine	hiv infection	25	64	0.84	0.22	2.23	1	4	302	116	7339	1101	didanosine	hiv infection	0.35	0.01	2.04	0.53	1	166	95	5562	1101	didanosine	hiv infection	1.22	0.24	3.91	0.74	3	214	37	3225	1101	didanosine	hiv infection	-0.3	0.740818220681718	0.51	0.56	0	0.01	0.77	0.37	0.2	0.06
1102	corticorelin ovine triflutate	0	0	33.97	1	0	7	177549	8686783	1102	corticorelin ovine triflutate	alcoholism	0	0	1485.71	1	0	1	63	2456	1102	corticorelin ovine triflutate	alcoholism	23	63	0	0	1646.55	1	0	1	9	389	1102	corticorelin ovine triflutate	alcoholism	0	0	Inf	1	0	0	6	308	1102	corticorelin ovine triflutate	alcoholism	0	0	608.42	1	0	1	8	125	1102	corticorelin ovine triflutate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1103	enoxaparin sodium	2.15	2.04	2.26	5.6e-141	1434	32808	176115	8653982	1103	enoxaparin sodium	pain	1.5	1.26	1.78	6.5e-06	148	2208	8321	186276	1103	enoxaparin sodium	pain	23	79	0.43	0.16	0.95	0.036	6	456	1082	35561	1103	enoxaparin sodium	pain	0.5	0.1	1.49	0.29	3	250	361	15067	1103	enoxaparin sodium	pain	0.33	0.07	0.97	0.039	3	281	854	26309	1103	enoxaparin sodium	pain	-0.83	0.436049286321536	0.41	0.04	-0.02	0	0	-0.28	0.06	0
1104	sodium thiosulfate	4.64	2.25	8.61	5.5e-05	11	116	177538	8686674	1104	sodium thiosulfate	calciphylaxis	0	0	Inf	1	0	24	0	13	1104	sodium thiosulfate	calciphylaxis	NA	NA	0	0	Inf	1	0	0	0	0	1104	sodium thiosulfate	calciphylaxis	0	0	Inf	1	0	0	0	1	1104	sodium thiosulfate	calciphylaxis	0	0	Inf	1	0	11	0	2	1104	sodium thiosulfate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1105	nilutamide	13.17	8.8	19.26	2.3e-25	35	130	177514	8686660	1105	nilutamide	prostate cancer	37.11	19.86	66.33	6.1e-20	17	49	427	45702	1105	nilutamide	prostate cancer	56.9	87.4	0	0	33.01	1	0	16	102	12788	1105	nilutamide	prostate cancer	0	0	31.58	1	0	17	114	14659	1105	nilutamide	prostate cancer	0	0	Inf	1	0	0	0	51	1105	nilutamide	prostate cancer	-12.64	3.23979662562167e-06	959.13	0.99	-0.01	0.01	0.05	12.8	553.02	0.98
1106	pantothenic acid	1.9	0.81	3.82	0.081	8	206	177541	8686584	1106	pantothenic acid	prophylaxis	16.23	3.01	57.36	0.0013	3	15	1276	103536	1106	pantothenic acid	prophylaxis	23.9	79.7	0	0	124.98	1	0	5	207	23655	1106	pantothenic acid	prophylaxis	0	0	5924.82	1	0	1	82	13727	1106	pantothenic acid	prophylaxis	0	0	147.81	1	0	4	148	14408	1106	pantothenic acid	prophylaxis	-8.92	0.0001336882447914	238.94	0.97	-0.01	0	0.03	-0.52	0.14	0
1107	finasteride	5.96	5.73	6.21	0	2713	22548	174836	8664242	1107	finasteride	alopecia	69.59	54.89	89.16	0	1094	1954	77	9573	1107	finasteride	alopecia	19.9	60.6	20.63	10.8	41.32	5.5e-23	35	246	15	2181	1107	finasteride	alopecia	21.28	9.26	57.19	2.8e-19	38	277	7	1089	1107	finasteride	alopecia	0	0	49.86	1	0	32	11	3824	1107	finasteride	alopecia	2.71	15.0292755148754	0.37	0	-0.03	0.01	0	0.67	0.45	0.13
1108	perindopril erbumine	0.56	0.44	0.7	2.2e-08	78	6853	177471	8679937	1108	perindopril erbumine	hypertension	0.37	0.19	0.63	3.3e-05	13	1631	6882	315982	1108	perindopril erbumine	hypertension	38	82.9	0	0	1.48	0.19	0	160	981	62249	1108	perindopril erbumine	hypertension	0	0	3.85	1	0	91	341	31548	1108	perindopril erbumine	hypertension	0.49	0.01	2.82	0.73	1	106	761	39824	1108	perindopril erbumine	hypertension	-1.01	0.364218979571523	1	0.32	-0.02	0	0	-0.59	0.07	0
1109	felbamate	0.26	0.07	0.66	0.0016	4	757	177545	8686033	1109	felbamate	epilepsy	0.67	0.08	2.48	1	2	210	638	45216	1109	felbamate	epilepsy	13.6	68.1	1.75	0.04	10.69	0.44	1	35	86	5279	1109	felbamate	epilepsy	3.39	0.08	21.7	0.27	1	26	40	3526	1109	felbamate	epilepsy	0	0	10.78	1	0	28	56	4156	1109	felbamate	epilepsy	0.43	1.53725752354828	1.02	0.67	0	0	0.56	-0.15	0.21	0.47
1110	lodoxamide tromethamine	2.57	0.3	9.96	0.19	2	38	177547	8686752	1110	lodoxamide tromethamine	asthma	0	0	16.71	1	0	9	3044	100365	1110	lodoxamide tromethamine	asthma	9	76	0	0	Inf	1	0	0	540	17516	1110	lodoxamide tromethamine	asthma	0	0	Inf	1	0	0	147	6258	1110	lodoxamide tromethamine	asthma	0	0	Inf	1	0	0	458	14562	1110	lodoxamide tromethamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1111	terbinafine	1.61	1.43	1.8	5.3e-15	324	9872	177225	8676918	1111	terbinafine	onychomycosis	3.86	1.98	8.27	1e-05	49	2148	11	1864	1111	terbinafine	onychomycosis	33.9	68.2	7.28	1.6	67.69	0.0045	12	231	2	281	1111	terbinafine	onychomycosis	12.83	1.69	573.29	0.0031	8	142	1	229	1111	terbinafine	onychomycosis	3.94	0.64	41.88	0.12	5	182	2	288	1111	terbinafine	onychomycosis	1.79	5.98945246638311	0.65	0.01	-0.03	0.01	0.05	0.53	0.51	0.3
1112	pentosan polysulfate sodium	2.35	1.93	2.84	4.7e-15	112	2332	177437	8684458	1112	pentosan polysulfate sodium	cystitis interstitial	1.09	0.61	2.03	0.89	38	947	19	518	1112	pentosan polysulfate sodium	cystitis interstitial	31	74.9	0.19	0.03	0.8	0.012	3	155	9	89	1112	pentosan polysulfate sodium	cystitis interstitial	Inf	0.01	Inf	1	1	28	0	8	1112	pentosan polysulfate sodium	cystitis interstitial	0.16	0.03	0.62	0.0032	3	173	11	100	1112	pentosan polysulfate sodium	cystitis interstitial	-1.64	0.193980042290892	0.6	0.01	-0.02	0.02	0.32	-0.19	1.07	0.86
1113	zalcitabine	0.51	0.1	1.49	0.3	3	290	177546	8686500	1113	zalcitabine	hiv infection	1.68	0.34	5.01	0.27	3	209	497	58182	1113	zalcitabine	hiv infection	25	64	0	0	10.24	1	0	25	120	7616	1113	zalcitabine	hiv infection	0	0	10.52	1	0	23	96	5705	1113	zalcitabine	hiv infection	0	0	96.36	1	0	5	40	3434	1113	zalcitabine	hiv infection	-12.43	3.99686601575135e-06	452.98	0.98	0	0.01	0.8	0.38	0.2	0.05
1114	cisapride monohydrate	6.15	5.03	7.45	1.2e-49	117	932	177432	8685858	1114	cisapride monohydrate	gastrooesophageal reflux disease	3.71	2.54	5.29	3.2e-10	36	254	2932	76774	1114	cisapride monohydrate	gastrooesophageal reflux disease	22.4	77.2	0	0	10.16	1	0	16	478	18681	1114	cisapride monohydrate	gastrooesophageal reflux disease	0	0	80.99	1	0	4	152	8079	1114	cisapride monohydrate	gastrooesophageal reflux disease	0	0	9.85	1	0	16	380	14373	1114	cisapride monohydrate	gastrooesophageal reflux disease	-11.25	1.30072976540676e-05	194.51	0.95	-0.02	0	0	-0.35	0.1	0
1115	dexrazoxane	2.77	1.83	4.02	2.7e-06	29	513	177520	8686277	1115	dexrazoxane	burkitt s lymphoma	0	0	155.37	1	0	34	2	978	1115	dexrazoxane	burkitt s lymphoma	NA	NA	0	0	Inf	1	0	0	0	0	1115	dexrazoxane	burkitt s lymphoma	0	0	Inf	1	0	0	0	75	1115	dexrazoxane	burkitt s lymphoma	0	0	Inf	1	0	0	0	51	1115	dexrazoxane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1116	rocuronium bromide	2.42	2.03	2.86	1.7e-19	141	2854	177408	8683936	1116	rocuronium bromide	anaesthesia	0.49	0.06	1.86	0.43	2	435	58	6169	1116	rocuronium bromide	anaesthesia	23	71.2	0	0	5.82	1	0	47	9	522	1116	rocuronium bromide	anaesthesia	0	0	347.11	1	0	39	1	348	1116	rocuronium bromide	anaesthesia	1.57	0.03	11.98	0.5	1	32	9	453	1116	rocuronium bromide	anaesthesia	0.29	1.33642748802547	1.06	0.78	0	0.01	0.91	-2.09	1.05	0.05
1117	levocabastine	4.96	3.31	7.18	3.8e-12	31	306	177518	8686484	1117	levocabastine	prophylaxis	24.27	11.14	48.75	1.3e-11	11	37	1268	103514	1117	levocabastine	prophylaxis	23.9	79.7	5.74	0.14	36.17	0.17	1	20	206	23640	1117	levocabastine	prophylaxis	0	0	75.89	1	0	10	82	13718	1117	levocabastine	prophylaxis	9.79	0.22	69.49	0.11	1	10	147	14402	1117	levocabastine	prophylaxis	1.77	5.8708533613826	1.03	0.08	-0.01	0	0.03	-0.52	0.14	0
1118	iopromide	0.61	0.47	0.78	3.3e-05	63	5054	177486	8681736	1118	iopromide	computerised tomogram	0.47	0.21	0.93	0.025	10	1381	55	3543	1118	iopromide	computerised tomogram	27.5	85	0	0	2779.36	1	0	6	1	446	1118	iopromide	computerised tomogram	0	0	248.39	1	0	5	2	211	1118	iopromide	computerised tomogram	0	0	2788.29	1	0	4	1	298	1118	iopromide	computerised tomogram	-13.66	1.16825427038899e-06	2140.42	0.99	0.01	0.03	0.66	1.03	1.23	0.4
1119	amifostine	2.39	1.73	3.24	5.2e-07	44	900	177505	8685890	1119	amifostine	radiotherapy	0.32	0.1	0.87	0.017	7	316	13	185	1119	amifostine	radiotherapy	NA	NA	0	0	Inf	1	0	0	0	0	1119	amifostine	radiotherapy	0	0	Inf	1	0	5	0	15	1119	amifostine	radiotherapy	0	0	Inf	1	0	5	0	19	1119	amifostine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1121	cladribine	0.23	0.08	0.5	8e-06	6	1269	177543	8685521	1121	cladribine	chronic lymphocytic leukaemia	4.31	0.51	16.43	0.083	2	144	70	21715	1121	cladribine	chronic lymphocytic leukaemia	50.7	85	0	0	374.29	1	0	4	31	7438	1121	cladribine	chronic lymphocytic leukaemia	0	0	1132.01	1	0	2	25	5385	1121	cladribine	chronic lymphocytic leukaemia	0	0	507.86	1	0	4	10	2995	1121	cladribine	chronic lymphocytic leukaemia	-10.31	3.3298440297091e-05	591.05	0.99	-0.02	0.01	0.19	0.31	0.38	0.41
1122	sodium fluoride	1.23	0.82	1.78	0.25	29	1153	177520	8685637	1122	sodium fluoride	pain	9.28	3.96	20.15	1.1e-06	10	24	8459	188460	1122	sodium fluoride	pain	23	79	3.01	0.07	20.75	0.3	1	11	1087	36006	1122	sodium fluoride	pain	0	0	63.84	1	0	4	364	15313	1122	sodium fluoride	pain	3.45	0.08	24.95	0.27	1	9	856	26581	1122	sodium fluoride	pain	0.91	2.48432253338482	1.05	0.38	-0.02	0	0	-0.28	0.06	0
1123	triclosan	0.07	0	0.41	4.1e-05	1	668	177548	8686122	1123	triclosan	prostate cancer	0	0	71.67	1	0	7	444	45744	1123	triclosan	prostate cancer	56.9	87.4	0	0	Inf	1	0	0	102	12804	1123	triclosan	prostate cancer	0	0	Inf	1	0	0	114	14676	1123	triclosan	prostate cancer	0	0	Inf	1	0	0	0	51	1123	triclosan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1124	budesonide	1.25	1.2	1.31	3.8e-21	1926	75287	175623	8611503	1124	budesonide	asthma	0.79	0.71	0.87	2.5e-06	436	17618	2608	82756	1124	budesonide	asthma	9	76	1.41	1.16	1.71	0.00055	156	3918	384	13598	1124	budesonide	asthma	0.97	0.63	1.45	0.92	32	1397	115	4861	1124	budesonide	asthma	1.53	1.24	1.88	8.2e-05	134	3099	324	11463	1124	budesonide	asthma	0.35	1.41906754859326	0.09	0	-0.02	0	0	-0.41	0.1	0
1125	gabapentin	2.3	2.24	2.36	0	6910	150310	170639	8536480	1125	gabapentin	pain	1.72	1.62	1.83	1.6e-60	1289	17814	7180	170670	1125	gabapentin	pain	23	79	1.36	1.15	1.6	0.00028	186	4741	902	31276	1125	gabapentin	pain	1.81	1.37	2.36	2.8e-05	71	1810	293	13507	1125	gabapentin	pain	1.11	0.9	1.35	0.3	121	3433	736	23157	1125	gabapentin	pain	0.29	1.33642748802547	0.08	0	-0.02	0	0	-0.28	0.06	0
1126	salmeterol xinafoate	1.74	1.67	1.81	4.5e-142	2615	74175	174934	8612615	1126	salmeterol xinafoate	asthma	0.86	0.79	0.94	0.0012	607	22495	2437	77879	1126	salmeterol xinafoate	asthma	9	76	1.08	0.87	1.34	0.44	114	3467	426	14049	1126	salmeterol xinafoate	asthma	0.91	0.56	1.41	0.75	25	1155	122	5103	1126	salmeterol xinafoate	asthma	1.09	0.86	1.37	0.47	95	2820	363	11742	1126	salmeterol xinafoate	asthma	0.11	1.11627807045887	0.1	0.29	-0.02	0	0	-0.4	0.1	0
1127	granisetron	1.61	1.46	1.76	5.7e-21	466	14194	177083	8672596	1127	granisetron	prophylaxis	0.46	0.24	0.79	0.0026	13	2260	1266	101291	1127	granisetron	prophylaxis	23.9	79.7	0.55	0.07	2.04	0.59	2	409	205	23251	1127	granisetron	prophylaxis	0.6	0.01	3.46	1	1	277	81	13451	1127	granisetron	prophylaxis	1.65	0.44	4.38	0.31	4	238	144	14174	1127	granisetron	prophylaxis	0.16	1.17351087099181	0.46	0.73	-0.01	0	0.03	-0.52	0.14	0
1128	spirapril	0	0	8.51	1	0	23	177549	8686767	1128	spirapril	rheumatoid arthritis	0	0	79.05	1	0	8	3410	460369	1128	spirapril	rheumatoid arthritis	33	75	0	0	Inf	1	0	0	1060	113938	1128	spirapril	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	1128	spirapril	rheumatoid arthritis	0	0	Inf	1	0	0	1011	107964	1128	spirapril	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1129	lamotrigine	1.65	1.58	1.72	1e-107	2371	70833	175178	8615957	1129	lamotrigine	epilepsy	1.11	0.93	1.32	0.24	183	12057	457	33369	1129	lamotrigine	epilepsy	13.6	68.1	1	0.59	1.64	1	23	1406	64	3908	1129	lamotrigine	epilepsy	1.58	0.71	3.27	0.23	11	668	30	2884	1129	lamotrigine	epilepsy	1.07	0.56	1.96	0.88	16	1140	40	3044	1129	lamotrigine	epilepsy	0.23	1.25860000992948	0.23	0.32	0	0	0.54	-0.13	0.21	0.54
1130	fluvoxamine maleate	3.17	2.79	3.59	7.2e-55	267	4123	177282	8682667	1130	fluvoxamine maleate	depression	1.18	0.95	1.46	0.13	94	1068	14277	191717	1130	fluvoxamine maleate	depression	21	73.3	0.86	0.23	2.31	1	4	64	2058	28278	1130	fluvoxamine maleate	depression	2.47	0.47	8.35	0.14	3	20	634	10427	1130	fluvoxamine maleate	depression	0.56	0.07	2.13	0.58	2	52	1669	24332	1130	fluvoxamine maleate	depression	0.03	1.03045453395352	0.46	0.96	-0.01	0	0	-0.14	0.05	0
1131	halofantrine	0	0	9.4	1	0	21	177549	8686769	1131	halofantrine	malaria	0	0	9.42	1	0	13	25	673	1131	halofantrine	malaria	25	45.3	0	0	Inf	1	0	0	1	51	1131	halofantrine	malaria	0	0	Inf	1	0	0	1	45	1131	halofantrine	malaria	0	0	Inf	1	0	0	3	45	1131	halofantrine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1132	technetium tc-99m bicisate kit	0	0	21.83	1	0	10	177549	8686780	1132	technetium tc-99m bicisate kit	cerebral infarction	0	0	7416.7	1	0	1	21	4516	1132	technetium tc-99m bicisate kit	cerebral infarction	49.8	69.9	0	0	Inf	1	0	0	5	215	1132	technetium tc-99m bicisate kit	cerebral infarction	0	0	Inf	1	0	0	2	457	1132	technetium tc-99m bicisate kit	cerebral infarction	0	0	Inf	1	0	0	5	307	1132	technetium tc-99m bicisate kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1133	atovaquone	1.41	1.16	1.7	0.00048	117	4060	177432	8682730	1133	atovaquone	hiv infection	0.28	0.01	1.56	0.28	1	419	499	57972	1133	atovaquone	hiv infection	25	64	0	0	7.15	1	0	35	120	7606	1133	atovaquone	hiv infection	0	0	5.99	1	0	39	96	5689	1133	atovaquone	hiv infection	0	0	75.08	1	0	6	40	3433	1133	atovaquone	hiv infection	-12.45	3.91772276602433e-06	357.35	0.97	0	0.01	0.78	0.38	0.2	0.05
1134	fluvastatin sodium	2.19	1.9	2.5	1.7e-24	223	4989	177326	8681801	1134	fluvastatin sodium	hypertension	1.59	1.02	2.36	0.03	25	727	6870	316886	1134	fluvastatin sodium	hypertension	38	82.9	0.91	0.02	5.24	1	1	70	980	62339	1134	fluvastatin sodium	hypertension	0	0	7.13	1	0	50	341	31589	1134	fluvastatin sodium	hypertension	1.75	0.04	10.54	0.44	1	30	761	39900	1134	fluvastatin sodium	hypertension	-0.17	0.843664816596384	1.01	0.87	-0.02	0	0	-0.59	0.07	0
1135	paclitaxel	1.2	1.13	1.27	1e-09	1207	49216	176342	8637574	1135	paclitaxel	breast cancer	1.7	1.49	1.93	9.4e-15	310	9243	1136	57539	1135	paclitaxel	breast cancer	40	78	1.46	0.89	2.33	0.11	23	1332	104	8815	1135	paclitaxel	breast cancer	0	0	Inf	1	0	9	0	107	1135	paclitaxel	breast cancer	1.47	0.92	2.27	0.082	26	1537	118	10239	1135	paclitaxel	breast cancer	0.38	1.46228458943422	0.22	0.08	0	0.01	0.97	-13.14	367.05	0.97
1136	risperidone	1.3	1.25	1.36	8.4e-32	2234	84237	175315	8602553	1136	risperidone	schizophrenia	1.46	1.29	1.64	9.6e-10	393	11549	1122	47975	1136	risperidone	schizophrenia	20.1	64.1	1.63	1.25	2.12	0.00028	90	1491	204	5523	1136	risperidone	schizophrenia	1.74	1.26	2.4	0.00075	64	1248	118	4014	1136	risperidone	schizophrenia	1.31	0.86	1.94	0.17	36	650	112	2645	1136	risperidone	schizophrenia	0.4	1.49182469764127	0.12	0	-0.01	0	0	-0.33	0.11	0
1137	calcipotriene	0.79	0.53	1.12	0.2	31	1930	177518	8684860	1137	calcipotriene	psoriasis	1.59	0.86	2.69	0.089	14	1201	1176	160490	1137	calcipotriene	psoriasis	25	74.8	0.86	0.1	3.15	1	2	268	377	43257	1137	calcipotriene	psoriasis	1.02	0.03	5.84	0.63	1	141	148	21203	1137	calcipotriene	psoriasis	1.23	0.15	4.57	0.68	2	162	272	27181	1137	calcipotriene	psoriasis	0.15	1.16183424272828	0.58	0.8	0	0	0.7	-0.36	0.1	0
1138	tramadol	2	1.94	2.07	9.79999999999998e-310	3813	94295	173736	8592495	1138	tramadol	pain	1.26	1.17	1.35	3e-10	934	16891	7535	171593	1138	tramadol	pain	23	79	1.58	1.34	1.86	1.1e-07	184	4108	904	31909	1138	tramadol	pain	2.04	1.54	2.68	9.2e-07	69	1573	295	13744	1138	tramadol	pain	1.37	1.13	1.66	0.0015	133	3140	724	23450	1138	tramadol	pain	0.47	1.59999419321736	0.08	0	-0.02	0	0	-0.28	0.06	0
1139	dalteparin sodium	0.71	0.58	0.87	0.00039	103	7075	177446	8679715	1139	dalteparin sodium	prophylaxis	0.34	0.07	1.01	0.056	3	704	1276	102847	1139	dalteparin sodium	prophylaxis	23.9	79.7	0	0	3.58	0.63	0	120	207	23540	1139	dalteparin sodium	prophylaxis	0	0	7.37	1	0	87	82	13641	1139	dalteparin sodium	prophylaxis	0	0	4.35	1	0	85	148	14327	1139	dalteparin sodium	prophylaxis	-12.83	2.67917941167673e-06	299.99	0.97	-0.01	0	0.02	-0.52	0.14	0
1140	ferric ammonium citrate	1.69	0.04	10.18	0.46	1	29	177548	8686761	1140	ferric ammonium citrate	hiv infection	0	0	127.28	1	0	5	500	58386	1140	ferric ammonium citrate	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	1140	ferric ammonium citrate	hiv infection	0	0	Inf	1	0	0	96	5728	1140	ferric ammonium citrate	hiv infection	0	0	Inf	1	0	0	40	3439	1140	ferric ammonium citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1141	carvedilol	1.58	1.52	1.65	1.1e-87	2247	69846	175302	8616944	1141	carvedilol	hypertension	1.26	1.12	1.41	1e-04	321	11840	6574	305773	1141	carvedilol	hypertension	38	82.9	1.11	0.81	1.48	0.48	48	2775	933	59634	1141	carvedilol	hypertension	1.78	1.19	2.59	0.0049	31	1681	310	29958	1141	carvedilol	hypertension	0.8	0.5	1.21	0.33	23	1503	739	38427	1141	carvedilol	hypertension	0.19	1.20924959765725	0.14	0.17	-0.02	0	0	-0.6	0.07	0
1142	allopurinol sodium	0.34	0.09	0.89	0.023	4	568	177545	8686222	1142	allopurinol sodium	hypertension	0.84	0.02	4.87	1	1	55	6894	317558	1142	allopurinol sodium	hypertension	38	82.9	15.92	0.32	161.23	0.075	1	4	980	62405	1142	allopurinol sodium	hypertension	0	0	489.56	1	0	2	341	31637	1142	allopurinol sodium	hypertension	26.22	0.44	502.82	0.055	1	2	761	39928	1142	allopurinol sodium	hypertension	2.99	19.8856824915647	1.12	0.01	-0.02	0	0	-0.59	0.07	0
1143	aprotinin	174.41	165.21	182.35	0	8051	2372	169498	8684418	1143	aprotinin	coronary artery bypass	243.05	165.18	374.99	0	2824	590	28	1424	1143	aprotinin	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	1143	aprotinin	coronary artery bypass	0	0	Inf	1	0	0	1	192	1143	aprotinin	coronary artery bypass	0	0	Inf	1	0	0	3	35	1143	aprotinin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1144	fludeoxyglucose f-18	0	0	1852.91	1	0	1	177549	8686789	1144	fludeoxyglucose f-18	positron emission tomogram	0	0	3432.53	1	0	1	1	92	1144	fludeoxyglucose f-18	positron emission tomogram	NA	NA	0	0	Inf	1	0	0	0	0	1144	fludeoxyglucose f-18	positron emission tomogram	0	0	Inf	1	0	0	0	6	1144	fludeoxyglucose f-18	positron emission tomogram	0	0	Inf	1	0	0	0	13	1144	fludeoxyglucose f-18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1145	moexipril	4.5	3.57	5.6	1.1e-28	88	958	177461	8685832	1145	moexipril	hypertension	3.28	1.76	5.64	2e-04	14	197	6881	317416	1145	moexipril	hypertension	38	82.9	0	0	13.65	1	0	19	981	62390	1145	moexipril	hypertension	0	0	79.01	1	0	6	341	31633	1145	moexipril	hypertension	0	0	14.63	1	0	15	762	39915	1145	moexipril	hypertension	-9.3	9.14242314781733e-05	116.18	0.94	-0.02	0	0	-0.59	0.07	0
1146	indium in-111 pentetreotide kit	0	0	1.92	0.27	0	96	177549	8686694	1146	indium in-111 pentetreotide kit	somatostatin receptor scan	0	0	Inf	1	0	35	0	0	1146	indium in-111 pentetreotide kit	somatostatin receptor scan	NA	NA	0	0	Inf	1	0	0	0	0	1146	indium in-111 pentetreotide kit	somatostatin receptor scan	0	0	Inf	1	0	1	0	0	1146	indium in-111 pentetreotide kit	somatostatin receptor scan	0	0	Inf	1	0	0	0	0	1146	indium in-111 pentetreotide kit	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1147	levomethadyl acetate	0	0	19.5	1	0	11	177549	8686779	1147	levomethadyl acetate	drug dependence	0	0	45.28	1	0	3	565	10570	1147	levomethadyl acetate	drug dependence	21.2	63.9	0	0	748.02	1	0	1	91	1765	1147	levomethadyl acetate	drug dependence	0	0	Inf	1	0	0	59	1045	1147	levomethadyl acetate	drug dependence	0	0	800.02	1	0	1	44	913	1147	levomethadyl acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1148	ioxilan	7.93	2.74	18.97	0.00021	6	37	177543	8686753	1148	ioxilan	hypertension	Inf	8.65	Inf	0.00045	2	0	6893	317613	1148	ioxilan	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	1148	ioxilan	hypertension	0	0	Inf	1	0	0	341	31639	1148	ioxilan	hypertension	0	0	Inf	1	0	0	762	39930	1148	ioxilan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1149	trimetrexate glucuronate	0	0	1852.91	1	0	1	177549	8686789	1149	trimetrexate glucuronate	neuropathy peripheral	0	0	1389.36	1	0	1	586	21338	1149	trimetrexate glucuronate	neuropathy peripheral	40.9	83	0	0	Inf	1	0	0	178	6818	1149	trimetrexate glucuronate	neuropathy peripheral	0	0	Inf	1	0	0	62	2926	1149	trimetrexate glucuronate	neuropathy peripheral	0	0	Inf	1	0	0	137	4736	1149	trimetrexate glucuronate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1150	anagrelide	0.99	0.67	1.41	1	31	1538	177518	8685252	1150	anagrelide	essential thrombocythaemia	0.5	0.05	3.06	0.47	2	610	5	760	1150	anagrelide	essential thrombocythaemia	48	82.1	1.75	0.02	138.06	1	1	92	1	161	1150	anagrelide	essential thrombocythaemia	1.77	0.02	140.52	1	1	53	1	94	1150	anagrelide	essential thrombocythaemia	1.41	0.02	112.03	1	1	84	1	119	1150	anagrelide	essential thrombocythaemia	0.49	1.63231621995538	1.01	0.63	-0.02	0.03	0.58	0.37	1.01	0.71
1151	adapalene	4.01	3.34	4.78	1.1e-38	137	1672	177412	8685118	1151	adapalene	acne	0.55	0.43	0.7	1.8e-07	74	919	4302	29485	1151	adapalene	acne	14.8	44.4	0.5	0.2	1.07	0.075	7	220	166	2604	1151	adapalene	acne	0	0	2.16	0.41	0	71	28	1060	1151	adapalene	acne	0.7	0.34	1.32	0.33	11	222	153	2172	1151	adapalene	acne	-0.49	0.612626394184416	0.32	0.13	0	0.01	0.56	-1.05	0.21	0
1152	iodixanol	5.15	3.36	7.62	1.8e-11	28	266	177521	8686524	1152	iodixanol	computerised tomogram	0	0	6.16	1	0	48	65	4876	1152	iodixanol	computerised tomogram	27.5	85	0	0	2779.36	1	0	6	1	446	1152	iodixanol	computerised tomogram	0	0	446.97	1	0	3	2	213	1152	iodixanol	computerised tomogram	0	0	3676.05	1	0	3	1	299	1152	iodixanol	computerised tomogram	-13.67	1.15662994617537e-06	2592.3	1	0.01	0.03	0.66	1.03	1.23	0.4
1153	nisoldipine	3.33	2.65	4.15	2.3e-20	87	1277	177462	8685513	1153	nisoldipine	hypertension	1.28	0.58	2.47	0.44	9	323	6886	317290	1153	nisoldipine	hypertension	38	82.9	2.65	0.06	16.29	0.32	1	24	980	62385	1153	nisoldipine	hypertension	7.75	0.18	52.66	0.13	1	12	340	31627	1153	nisoldipine	hypertension	0	0	17.22	1	0	13	762	39917	1153	nisoldipine	hypertension	1	2.71828182845905	1.02	0.33	-0.02	0	0	-0.59	0.07	0
1154	metformin	0.96	0.93	0.99	0.006	4967	252601	172582	8434189	1154	metformin	diabetes mellitus	2.51	2.31	2.73	2.2e-101	1064	60995	1263	181903	1154	metformin	diabetes mellitus	39.3	82	2.27	1.84	2.8	6.6e-15	185	15636	192	36848	1154	metformin	diabetes mellitus	2.2	1.55	3.12	6.5e-06	64	8226	76	21518	1154	metformin	diabetes mellitus	2.36	1.85	3.01	1.5e-12	146	8853	135	19349	1154	metformin	diabetes mellitus	0.84	2.31636697678109	0.1	0	-0.01	0	0	-0.72	0.1	0
1155	famciclovir	7.68	6.91	8.5	4.7e-208	426	2721	177123	8684069	1155	famciclovir	herpes zoster	0.7	0.22	1.69	0.56	5	507	123	8730	1155	famciclovir	herpes zoster	45.7	81.5	3.88	0.94	12	0.03	4	55	22	1177	1155	famciclovir	herpes zoster	0	0	18.67	1	0	28	6	588	1155	famciclovir	herpes zoster	3.11	0.75	9.68	0.058	4	64	20	997	1155	famciclovir	herpes zoster	0.97	2.63794445935415	0.55	0.08	-0.02	0.01	0.13	-0.81	0.46	0.08
1156	imiglucerase	0.49	0.35	0.68	1.1e-06	39	3868	177510	8682922	1156	imiglucerase	gaucher s disease	1.08	0.5	2.7	1	38	3598	8	820	1156	imiglucerase	gaucher s disease	39.9	49.4	Inf	0.89	Inf	0.056	5	42	0	44	1156	imiglucerase	gaucher s disease	Inf	0.02	Inf	1	1	203	0	142	1156	imiglucerase	gaucher s disease	2.77	0.31	132.09	0.43	5	297	1	165	1156	imiglucerase	gaucher s disease	1.26	3.52542148736538	1.08	0.25	0.01	0.02	0.57	-1.46	1.08	0.18
1157	technetium tc-99m tetrofosmin kit	2.1	0.9	4.23	0.063	8	186	177541	8686604	1157	technetium tc-99m tetrofosmin kit	diagnostic procedure	6.58	0.73	28.15	0.044	2	69	19	4315	1157	technetium tc-99m tetrofosmin kit	diagnostic procedure	43.1	71	30.98	2.64	233.12	0.0041	2	17	4	1072	1157	technetium tc-99m tetrofosmin kit	diagnostic procedure	72.07	4.83	1051	0.0013	2	11	2	825	1157	technetium tc-99m tetrofosmin kit	diagnostic procedure	0	0	145.14	1	0	13	4	1159	1157	technetium tc-99m tetrofosmin kit	diagnostic procedure	3.35	28.5027336437673	0.86	0	-0.01	0.02	0.71	0.29	0.72	0.69
1158	follitropin alfa/beta	0.6	0.36	0.94	0.024	19	1546	177530	8685244	1158	follitropin alfa/beta	in vitro fertilisation	1.17	0.24	4.96	1	4	406	6	712	1158	follitropin alfa/beta	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	21	0	46	1158	follitropin alfa/beta	in vitro fertilisation	0	0	Inf	1	0	0	0	1	1158	follitropin alfa/beta	in vitro fertilisation	1.54	0.02	121.86	1	1	74	1	114	1158	follitropin alfa/beta	in vitro fertilisation	0.53	1.69893230861855	1.45	0.71	-0.06	0.1	0.59	-13.65	2399.55	1
1159	losartan potassium	1.74	1.66	1.82	2e-104	1891	53415	175658	8633375	1159	losartan potassium	hypertension	1.36	1.22	1.5	1.3e-08	414	14282	6481	303331	1159	losartan potassium	hypertension	38	82.9	1.24	0.87	1.71	0.2	39	2018	942	60391	1159	losartan potassium	hypertension	1.51	0.79	2.63	0.16	13	811	328	30828	1159	losartan potassium	hypertension	1.14	0.76	1.64	0.49	31	1435	731	38495	1159	losartan potassium	hypertension	0.22	1.24607673058738	0.16	0.16	-0.02	0	0	-0.59	0.07	0
1160	vinorelbine tartrate	4.87	4.43	5.35	2.5e-163	489	4921	177060	8681869	1160	vinorelbine tartrate	breast cancer	9.11	7.61	10.86	4.5e-89	166	937	1280	65845	1160	vinorelbine tartrate	breast cancer	40	78	3.3	0.87	8.93	0.039	4	99	123	10048	1160	vinorelbine tartrate	breast cancer	0	0	Inf	1	0	2	0	114	1160	vinorelbine tartrate	breast cancer	5.27	2.03	11.51	0.00062	7	113	137	11663	1160	vinorelbine tartrate	breast cancer	1.66	5.2593108444469	0.4	0	0	0.01	0.92	-13.18	365.13	0.97
1161	cysteamine bitartrate	0.35	0.07	1.02	0.055	3	424	177546	8686366	1161	cysteamine bitartrate	cystinosis	0.44	0.01	34.37	0.52	1	306	1	133	1161	cysteamine bitartrate	cystinosis	16.7	65.3	0	0	Inf	1	0	60	0	5	1161	cysteamine bitartrate	cystinosis	Inf	0	Inf	1	1	51	0	5	1161	cysteamine bitartrate	cystinosis	0	0	4.22	0.098	0	74	1	7	1161	cysteamine bitartrate	cystinosis	-0.8	0.449328964117222	2.56	0.75	0.05	0.06	0.44	1.05	1.71	0.54
1162	tizanidine	2.57	2.41	2.74	1.9e-143	1007	19235	176542	8667555	1162	tizanidine	multiple sclerosis	1.48	1.23	1.77	5.2e-05	123	4306	8222	426051	1162	tizanidine	multiple sclerosis	26.5	67	1.71	1.21	2.36	0.0023	40	1054	1264	56988	1162	tizanidine	multiple sclerosis	1.58	0.57	3.55	0.29	6	229	229	13820	1162	tizanidine	multiple sclerosis	1.69	1.18	2.37	0.0034	37	941	1181	50908	1162	tizanidine	multiple sclerosis	0.56	1.7506725002961	0.16	0	-0.01	0	0	-0.34	0.07	0
1163	lansoprazole	2.05	1.98	2.12	1.1e-299	3477	83989	174072	8602801	1163	lansoprazole	hypertension	1.51	1.32	1.72	3.6e-09	248	7665	6647	309948	1163	lansoprazole	hypertension	38	82.9	0.79	0.47	1.26	0.39	18	1440	963	60969	1163	lansoprazole	hypertension	0.49	0.13	1.27	0.2	4	751	337	30888	1163	lansoprazole	hypertension	0.93	0.53	1.53	0.9	16	899	746	39031	1163	lansoprazole	hypertension	-0.18	0.835270211411272	0.23	0.44	-0.02	0	0	-0.59	0.07	0
1164	dorzolamide	0.91	0.77	1.06	0.25	155	8369	177394	8678421	1164	dorzolamide	glaucoma	0.69	0.43	1.08	0.1	23	2707	196	16028	1164	dorzolamide	glaucoma	54.3	87	0.83	0.25	2.14	1	5	472	38	2990	1164	dorzolamide	glaucoma	2.93	0.76	9.84	0.06	5	230	9	1214	1164	dorzolamide	glaucoma	0	0	0.69	0.011	0	385	35	2393	1164	dorzolamide	glaucoma	-0.41	0.663650250136319	0.47	0.38	-0.01	0.01	0.27	-0.26	0.32	0.42
1165	ferumoxsil	36.7	10.5	120.59	1.7e-07	6	8	177543	8686782	1165	ferumoxsil	nuclear magnetic resonance imaging	8.57	2.03	41.35	0.0013	6	4	1140	6519	1165	ferumoxsil	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	1165	ferumoxsil	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	1165	ferumoxsil	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	1165	ferumoxsil	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1166	stavudine	0.29	0.21	0.39	4.4e-25	45	7629	177504	8679161	1166	stavudine	hiv infection	0.54	0.35	0.81	0.0013	26	5365	474	53026	1166	stavudine	hiv infection	25	64	0	0	0.69	0.01	0	333	120	7308	1166	stavudine	hiv infection	0	0	1.2	0.076	0	183	96	5545	1166	stavudine	hiv infection	0	0	1.36	0.11	0	230	40	3209	1166	stavudine	hiv infection	-14.36	5.80137901766728e-07	320.4	0.96	0	0.01	0.62	0.35	0.2	0.07
1167	mirtazapine	3.27	3.14	3.41	0	2505	37827	175044	8648963	1167	mirtazapine	depression	1.05	0.98	1.13	0.16	808	10312	13563	182473	1167	mirtazapine	depression	21	73.3	1.45	1.2	1.74	0.00013	135	1306	1927	27036	1167	mirtazapine	depression	1.92	1.48	2.46	1.3e-06	80	727	557	9720	1167	mirtazapine	depression	1.05	0.8	1.34	0.7	70	978	1601	23406	1167	mirtazapine	depression	0.36	1.43332941456034	0.09	0	-0.01	0	0	-0.15	0.05	0
1168	ferumoxides	16.31	0.31	203.27	0.078	1	3	177548	8686787	1168	ferumoxides	thrombosis prophylaxis	0	0	776.32	1	0	2	297	42803	1168	ferumoxides	thrombosis prophylaxis	39.1	80.2	0	0	Inf	1	0	0	51	14983	1168	ferumoxides	thrombosis prophylaxis	0	0	2364.53	1	0	2	25	10719	1168	ferumoxides	thrombosis prophylaxis	0	0	Inf	1	0	0	32	9154	1168	ferumoxides	thrombosis prophylaxis	-7.99	0.000338834083363426	624.19	0.99	-0.03	0.01	0	-0.39	0.27	0.14
1169	arbutamine	0	0	74.11	1	0	4	177549	8686786	1169	arbutamine	non-hodgkin s lymphoma	0	0	585.01	1	0	4	32	11832	1169	arbutamine	non-hodgkin s lymphoma	50.2	86.8	0	0	Inf	1	0	0	4	1484	1169	arbutamine	non-hodgkin s lymphoma	0	0	Inf	1	0	0	3	1065	1169	arbutamine	non-hodgkin s lymphoma	0	0	Inf	1	0	0	3	829	1169	arbutamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1170	vigabatrin	0.13	0.08	0.2	1.8e-45	22	8293	177527	8678497	1170	vigabatrin	infantile spasms	Inf	0	Inf	1	1	3730	0	304	1170	vigabatrin	infantile spasms	NA	NA	0	0	Inf	1	0	0	0	0	1170	vigabatrin	infantile spasms	0	0	Inf	1	0	533	0	43	1170	vigabatrin	infantile spasms	0	0	Inf	1	0	480	0	30	1170	vigabatrin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1171	azelaic acid	1.77	1.29	2.38	0.00036	46	1269	177503	8685521	1171	azelaic acid	rosacea	0.46	0.14	1.13	0.087	5	515	67	3154	1171	azelaic acid	rosacea	34.4	68	2.1	0.21	11.23	0.3	2	101	7	743	1171	azelaic acid	rosacea	0	0	11.57	1	0	39	4	289	1171	azelaic acid	rosacea	1.52	0.16	7.49	0.64	2	118	9	810	1171	azelaic acid	rosacea	0.08	1.08328706767496	0.76	0.92	0	0.02	0.8	0.02	0.59	0.97
1172	danaparoid sodium	0.05	0	0.26	4.2e-08	1	1034	177548	8685756	1172	danaparoid sodium	prophylaxis	0	0	2.37	0.41	0	128	1279	103423	1172	danaparoid sodium	prophylaxis	23.9	79.7	0	0	79.7	1	0	7	207	23653	1172	danaparoid sodium	prophylaxis	0	0	67.83	1	0	11	82	13717	1172	danaparoid sodium	prophylaxis	0	0	32.24	1	0	13	148	14399	1172	danaparoid sodium	prophylaxis	-11.04	1.60468177351501e-05	295.52	0.97	-0.01	0	0.02	-0.52	0.14	0
1173	timolol	1.08	0.93	1.25	0.32	185	8401	177364	8678389	1173	timolol	glaucoma	1.2	0.79	1.75	0.35	32	2343	187	16392	1173	timolol	glaucoma	54.3	87	1.75	0.76	3.65	0.13	10	512	33	2950	1173	timolol	glaucoma	0.8	0.09	3.61	1	2	250	12	1194	1173	timolol	glaucoma	1.86	0.73	4.26	0.14	8	381	27	2397	1173	timolol	glaucoma	0.39	1.47698079388264	0.36	0.27	-0.01	0.01	0.28	-0.28	0.32	0.38
1174	epoprostenol sodium	0.66	0.56	0.76	1.1e-08	164	12244	177385	8674546	1174	epoprostenol sodium	pulmonary arterial hypertension	3.43	2.75	4.26	6.7e-24	111	6972	371	79931	1174	epoprostenol sodium	pulmonary arterial hypertension	28	80	2.28	1.67	3.09	5.4e-07	56	2986	214	26058	1174	epoprostenol sodium	pulmonary arterial hypertension	2.52	1.13	5.1	0.013	10	710	45	8048	1174	epoprostenol sodium	pulmonary arterial hypertension	2.27	1.63	3.12	2e-06	50	2615	199	23671	1174	epoprostenol sodium	pulmonary arterial hypertension	0.82	2.27049983753241	0.15	0	0	0	0.6	-0.39	0.15	0.01
1175	docetaxel	1.82	1.72	1.92	1.5e-87	1371	37028	176178	8649762	1175	docetaxel	breast cancer	2.16	1.91	2.43	4.4e-32	374	9305	1072	57477	1175	docetaxel	breast cancer	40	78	0.77	0.4	1.37	0.43	13	1313	114	8834	1175	docetaxel	breast cancer	0	0	Inf	1	0	8	0	108	1175	docetaxel	breast cancer	0.8	0.43	1.37	0.45	15	1502	129	10274	1175	docetaxel	breast cancer	-0.24	0.786627861066553	0.28	0.38	0	0.01	0.69	-13.17	367.22	0.97
1176	fosphenytoin sodium	1.78	1.16	2.63	0.0079	26	714	177523	8686076	1176	fosphenytoin sodium	convulsion	3.77	2.09	6.36	1.8e-05	16	153	678	24414	1176	fosphenytoin sodium	convulsion	25	66	0	0	109.58	1	0	3	8	327	1176	fosphenytoin sodium	convulsion	0	0	50.3	1	0	4	8	233	1176	fosphenytoin sodium	convulsion	0	0	77.61	1	0	6	5	349	1176	fosphenytoin sodium	convulsion	-13.54	1.31720301170775e-06	1226.34	0.99	0.01	0.01	0.38	0.9	0.58	0.12
1177	porfimer sodium	0	0	0.58	0.0037	0	315	177549	8686475	1177	porfimer sodium	prophylaxis	0	0	26.6	1	0	13	1279	103538	1177	porfimer sodium	prophylaxis	23.9	79.7	0	0	37.76	1	0	13	207	23647	1177	porfimer sodium	prophylaxis	0	0	75.89	1	0	10	82	13718	1177	porfimer sodium	prophylaxis	0	0	235.52	1	0	3	148	14409	1177	porfimer sodium	prophylaxis	-9.59	6.84094216089865e-05	243.89	0.97	-0.01	0	0.03	-0.52	0.14	0
1178	hydrocortisone probutate	0.75	0.02	4.34	1	1	65	177548	8686725	1178	hydrocortisone probutate	rash	0	0	10.23	1	0	19	135	6365	1178	hydrocortisone probutate	rash	24.3	72	0	0	Inf	1	0	0	27	1218	1178	hydrocortisone probutate	rash	0	0	Inf	1	0	0	4	834	1178	hydrocortisone probutate	rash	0	0	Inf	1	0	0	27	1117	1178	hydrocortisone probutate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1179	etoposide phosphate	0.23	0.05	0.68	0.0026	3	634	177546	8686156	1179	etoposide phosphate	hodgkin s disease	6.39	0.15	42.07	0.15	1	35	21	4700	1179	etoposide phosphate	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	1	0	124	1179	etoposide phosphate	hodgkin s disease	0	0	Inf	1	0	1	0	517	1179	etoposide phosphate	hodgkin s disease	0	0	1454.19	1	0	2	2	408	1179	etoposide phosphate	hodgkin s disease	-17.93	1.63342778765403e-08	43318.47	1	-0.01	0.04	0.69	-18.2	3473.8	1
1180	nalmefene	1.06	0.03	6.23	0.61	1	46	177548	8686744	1180	nalmefene	anaesthesia	0	0	65.84	1	0	8	60	6596	1180	nalmefene	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	1180	nalmefene	anaesthesia	0	0	Inf	1	0	0	1	387	1180	nalmefene	anaesthesia	0	0	Inf	1	0	0	10	485	1180	nalmefene	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1181	ganciclovir	0.31	0.21	0.46	2.8e-13	27	4226	177522	8682564	1181	ganciclovir	prophylaxis	0.7	0.22	1.64	0.57	5	580	1274	102971	1181	ganciclovir	prophylaxis	23.9	79.7	0	0	4.55	1	0	95	207	23565	1181	ganciclovir	prophylaxis	0	0	8.95	1	0	72	82	13656	1181	ganciclovir	prophylaxis	0	0	7.85	1	0	48	148	14364	1181	ganciclovir	prophylaxis	-12.81	2.73330242596469e-06	358.88	0.97	-0.01	0	0.02	-0.52	0.14	0
1182	zileuton	0.9	0.43	1.68	0.88	10	541	177539	8686249	1182	zileuton	asthma	0.58	0.19	1.38	0.29	5	283	3039	100091	1182	zileuton	asthma	9	76	0	0	3.14	0.63	0	40	540	17476	1182	zileuton	asthma	0	0	46.78	1	0	5	147	6253	1182	zileuton	asthma	0	0	3.54	0.63	0	35	458	14527	1182	zileuton	asthma	-12.11	5.50419516062203e-06	228.38	0.96	-0.02	0	0	-0.41	0.1	0
1183	rimexolone	0.3	0.01	1.71	0.39	1	162	177548	8686628	1183	rimexolone	attention deficit/hyperactivity disorder	0	0	3.83	0.62	0	23	2062	45402	1183	rimexolone	attention deficit/hyperactivity disorder	7	57	0	0	Inf	1	0	0	421	7931	1183	rimexolone	attention deficit/hyperactivity disorder	0	0	Inf	1	0	0	233	6058	1183	rimexolone	attention deficit/hyperactivity disorder	0	0	Inf	1	0	0	257	3542	1183	rimexolone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1184	sevoflurane	0.59	0.46	0.75	5.8e-06	66	5452	177483	8681338	1184	sevoflurane	anaesthesia	0.33	0.1	0.82	0.011	5	1421	55	5183	1184	sevoflurane	anaesthesia	23	71.2	0.71	0.02	5.43	1	1	85	8	484	1184	sevoflurane	anaesthesia	0	0	179.8	1	0	69	1	318	1184	sevoflurane	anaesthesia	1.23	0.12	6.31	0.68	2	82	8	403	1184	sevoflurane	anaesthesia	0.08	1.08328706767496	0.79	0.92	0	0.01	0.9	-2.08	1.05	0.05
1185	acarbose	0.92	0.68	1.23	0.67	48	2544	177501	8684246	1185	acarbose	diabetes mellitus	1.13	0.45	2.34	0.68	7	649	2320	242249	1185	acarbose	diabetes mellitus	39.3	82	0	0	3.99	1	0	131	377	52353	1185	acarbose	diabetes mellitus	0	0	8.59	1	0	94	140	29650	1185	acarbose	diabetes mellitus	0	0	6.62	1	0	58	281	28144	1185	acarbose	diabetes mellitus	-11.49	1.02319027318752e-05	192.54	0.95	-0.01	0	0	-0.75	0.1	0
1186	tinzaparin sodium	0.28	0.17	0.42	6.5e-14	22	3905	177527	8682885	1186	tinzaparin sodium	prophylaxis	0	0	0.79	0.017	0	380	1279	103171	1186	tinzaparin sodium	prophylaxis	23.9	79.7	0	0	3.91	1	0	110	207	23550	1186	tinzaparin sodium	prophylaxis	0	0	12.28	1	0	53	82	13675	1186	tinzaparin sodium	prophylaxis	0	0	6.02	1	0	62	148	14350	1186	tinzaparin sodium	prophylaxis	-11.74	7.96861385989486e-06	222.58	0.96	-0.01	0	0.03	-0.52	0.14	0
1187	valacyclovir	1.99	1.88	2.12	5.2e-91	1098	27015	176451	8659775	1187	valacyclovir	herpes zoster	0.82	0.56	1.18	0.28	52	4210	76	5027	1187	valacyclovir	herpes zoster	45.7	81.5	0.11	0	0.7	0.006	1	321	25	911	1187	valacyclovir	herpes zoster	0.51	0.01	4.59	1	1	174	5	442	1187	valacyclovir	herpes zoster	0.25	0.03	1.01	0.058	2	287	22	774	1187	valacyclovir	herpes zoster	-1.22	0.295230166924014	0.61	0.05	-0.02	0.01	0.15	-0.82	0.46	0.08
1188	brimonidine tartrate	0.98	0.86	1.13	0.86	217	10783	177332	8676007	1188	brimonidine tartrate	glaucoma	0.58	0.36	0.88	0.008	25	3414	194	15321	1188	brimonidine tartrate	glaucoma	54.3	87	0.93	0.39	1.99	1	9	766	34	2696	1188	brimonidine tartrate	glaucoma	1.37	0.31	4.78	0.53	4	327	10	1117	1188	brimonidine tartrate	glaucoma	1.08	0.42	2.45	0.84	8	599	27	2179	1188	brimonidine tartrate	glaucoma	0.15	1.16183424272828	0.33	0.65	-0.01	0.01	0.28	-0.27	0.32	0.4
1189	ibutilide fumarate	0	0	7.46	1	0	26	177549	8686764	1189	ibutilide fumarate	atrial fibrillation	0	0	41.64	1	0	14	808	111395	1189	ibutilide fumarate	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	1189	ibutilide fumarate	atrial fibrillation	0	0	Inf	1	0	0	56	22073	1189	ibutilide fumarate	atrial fibrillation	0	0	Inf	1	0	0	94	17933	1189	ibutilide fumarate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1190	glimepiride	0.78	0.72	0.84	8.9e-12	717	44916	176832	8641874	1190	glimepiride	diabetes mellitus	1.32	1.11	1.56	0.0015	153	12308	2174	230590	1190	glimepiride	diabetes mellitus	39.3	82	0.77	0.43	1.29	0.41	15	2682	362	49802	1190	glimepiride	diabetes mellitus	0.81	0.29	1.81	0.85	6	1559	134	28185	1190	glimepiride	diabetes mellitus	0.76	0.37	1.39	0.49	11	1432	270	26770	1190	glimepiride	diabetes mellitus	-0.21	0.810584245970187	0.25	0.4	-0.01	0	0	-0.75	0.1	0
1191	toremifene citrate	1.83	1.06	2.97	0.02	17	454	177532	8686336	1191	toremifene citrate	breast cancer	3.26	1.86	5.34	4.8e-05	17	243	1429	66539	1191	toremifene citrate	breast cancer	40	78	0	0	9.25	1	0	34	127	10113	1191	toremifene citrate	breast cancer	0	0	Inf	1	0	0	0	116	1191	toremifene citrate	breast cancer	0	0	7.76	1	0	41	144	11735	1191	toremifene citrate	breast cancer	-13.16	1.92612566517659e-06	617.84	0.98	0	0.01	0.8	-13.16	367.31	0.97
1192	bicalutamide	2.68	2.45	2.93	3e-80	516	9437	177033	8677353	1192	bicalutamide	prostate cancer	3.96	3.22	4.85	3.1e-34	145	4993	299	40758	1192	bicalutamide	prostate cancer	56.9	87.4	1.69	0.84	3.12	0.087	12	936	90	11868	1192	bicalutamide	prostate cancer	1.67	0.86	3	0.097	13	1049	101	13627	1192	bicalutamide	prostate cancer	0	0	Inf	1	0	0	0	51	1192	bicalutamide	prostate cancer	0.51	1.66529119494589	0.3	0.08	-0.01	0.01	0.05	11.75	335.42	0.97
1193	topiramate	2.04	1.94	2.13	7e-171	1986	48008	175563	8638782	1193	topiramate	epilepsy	1.42	1.12	1.79	0.0031	89	4634	551	40792	1193	topiramate	epilepsy	13.6	68.1	0.97	0.38	2.11	1	7	440	80	4874	1193	topiramate	epilepsy	1.53	0.47	3.96	0.39	5	295	36	3257	1193	topiramate	epilepsy	0.4	0.05	1.53	0.33	2	355	54	3829	1193	topiramate	epilepsy	-0.14	0.869358235398806	0.4	0.73	0	0	0.61	-0.15	0.21	0.47
1194	diltiazem malate	1.6	0.58	3.56	0.29	6	183	177543	8686607	1194	diltiazem malate	hypertension	6.01	1.16	19.9	0.017	3	23	6892	317590	1194	diltiazem malate	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	1194	diltiazem malate	hypertension	0	0	Inf	1	0	0	341	31639	1194	diltiazem malate	hypertension	0	0	Inf	1	0	0	762	39930	1194	diltiazem malate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1195	gemcitabine	0.91	0.84	0.99	0.024	621	33276	176928	8653514	1195	gemcitabine	non-small cell lung cancer	1.38	0.89	2.07	0.11	29	4315	144	29612	1195	gemcitabine	non-small cell lung cancer	43.2	79.8	1.76	0.04	10.94	0.44	1	119	25	5239	1195	gemcitabine	non-small cell lung cancer	7.04	0.76	31.96	0.041	2	72	13	3301	1195	gemcitabine	non-small cell lung cancer	0	0	14	1	0	57	15	2783	1195	gemcitabine	non-small cell lung cancer	1.23	3.42122953628967	0.74	0.1	-0.01	0.01	0.34	-0.16	0.37	0.66
1196	amlexanox	0	0	9.4	1	0	21	177549	8686769	1196	amlexanox	stomatitis	0	0	177.16	1	0	4	16	1754	1196	amlexanox	stomatitis	19.2	70.8	0	0	Inf	1	0	0	3	308	1196	amlexanox	stomatitis	0	0	Inf	1	0	0	2	183	1196	amlexanox	stomatitis	0	0	Inf	1	0	0	3	249	1196	amlexanox	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1197	calfactant	0	0	1.98	0.27	0	93	177549	8686697	1197	calfactant	neonatal respiratory distress syndrome	0	0	Inf	1	0	24	0	230	1197	calfactant	neonatal respiratory distress syndrome	NA	NA	0	0	Inf	1	0	0	0	0	1197	calfactant	neonatal respiratory distress syndrome	0	0	Inf	1	0	0	0	19	1197	calfactant	neonatal respiratory distress syndrome	0	0	Inf	1	0	2	0	10	1197	calfactant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1198	butenafine	1.04	0.55	1.78	0.89	13	614	177536	8686176	1198	butenafine	hypertension	0	0	3.46	0.63	0	51	6895	317562	1198	butenafine	hypertension	38	82.9	0	0	153.8	1	0	3	981	62406	1198	butenafine	hypertension	0	0	Inf	1	0	0	341	31639	1198	butenafine	hypertension	0	0	126.83	1	0	3	762	39927	1198	butenafine	hypertension	-7.38	0.000623600885999444	113.64	0.95	-0.02	0	0	-0.59	0.07	0
1199	trandolapril	1.58	1.33	1.86	3.8e-07	146	4536	177403	8682254	1199	trandolapril	hypertension	0.93	0.6	1.36	0.77	26	1294	6869	316319	1199	trandolapril	hypertension	38	82.9	2.26	0.72	5.42	0.077	5	141	976	62268	1199	trandolapril	hypertension	2.78	0.33	10.52	0.17	2	67	339	31572	1199	trandolapril	hypertension	2.99	0.94	7.28	0.031	5	88	757	39842	1199	trandolapril	hypertension	1.06	2.88637098926796	0.39	0.01	-0.02	0	0	-0.59	0.07	0
1201	ropivacaine	0.45	0.27	0.69	6.9e-05	20	2185	177529	8684605	1201	ropivacaine	anaesthesia	1.25	0.25	3.89	0.73	3	266	57	6338	1201	ropivacaine	anaesthesia	23	71.2	0	0	9.93	1	0	29	9	540	1201	ropivacaine	anaesthesia	0	0	1105.58	1	0	13	1	374	1201	ropivacaine	anaesthesia	0	0	8.73	1	0	25	10	460	1201	ropivacaine	anaesthesia	-15.32	2.22130675471008e-07	1690.15	0.99	0	0.01	0.89	-2.1	1.05	0.05
1202	anastrozole	3.05	2.87	3.24	2.4e-217	1155	18599	176394	8668191	1202	anastrozole	breast cancer	2.86	2.54	3.23	2.3e-57	390	7632	1056	59150	1202	anastrozole	breast cancer	40	78	2.55	1.51	4.13	4e-04	21	731	106	9416	1202	anastrozole	breast cancer	0	0	Inf	1	0	5	0	111	1202	anastrozole	breast cancer	2.31	1.39	3.68	0.00098	22	852	122	10924	1202	anastrozole	breast cancer	0.86	2.36316069370579	0.24	0	0	0.01	0.55	-13.12	366.25	0.97
1203	zafirlukast	2.28	1.85	2.78	6.4e-13	101	2170	177448	8684620	1203	zafirlukast	asthma	0.97	0.6	1.48	1	22	749	3022	99625	1203	zafirlukast	asthma	9	76	0.7	0.08	2.6	1	2	93	538	17423	1203	zafirlukast	asthma	0	0	10.4	1	0	17	147	6241	1203	zafirlukast	asthma	0.75	0.09	2.8	1	2	85	456	14477	1203	zafirlukast	asthma	-0.29	0.748263567578565	0.72	0.68	-0.02	0	0	-0.41	0.1	0
1204	cisatracurium besylate	3.6	2.76	4.63	2.3e-17	66	897	177483	8685893	1204	cisatracurium besylate	anaesthesia	0	0	2.55	0.41	0	162	60	6442	1204	cisatracurium besylate	anaesthesia	23	71.2	0	0	50.37	1	0	7	9	562	1204	cisatracurium besylate	anaesthesia	0	0	2854.22	1	0	5	1	382	1204	cisatracurium besylate	anaesthesia	0	0	126.14	1	0	3	10	482	1204	cisatracurium besylate	anaesthesia	-12.81	2.73330242596469e-06	1329.63	0.99	0	0.01	0.89	-2.08	1.05	0.05
1205	ranitidine bismuth citrate	0	0	7.78	1	0	25	177549	8686765	1205	ranitidine bismuth citrate	rash	0	0	114.97	1	0	3	135	6381	1205	ranitidine bismuth citrate	rash	24.3	72	0	0	Inf	1	0	0	27	1218	1205	ranitidine bismuth citrate	rash	0	0	614.26	1	0	3	4	831	1205	ranitidine bismuth citrate	rash	0	0	Inf	1	0	0	27	1117	1205	ranitidine bismuth citrate	rash	-10.05	4.31857490603413e-05	840.27	0.99	-0.01	0.01	0.21	-1.61	0.54	0
1206	alendronate sodium	6.08	5.95	6.22	0	9115	76592	168434	8610198	1206	alendronate sodium	osteoporosis	10.36	9.87	10.87	0	6280	30565	2522	127121	1206	alendronate sodium	osteoporosis	53.1	85	3.49	2.82	4.29	8.2e-26	116	1126	692	23442	1206	alendronate sodium	osteoporosis	1.27	0.15	5.11	0.67	2	151	29	2784	1206	alendronate sodium	osteoporosis	3.34	2.71	4.09	4.3e-25	119	1221	749	25666	1206	alendronate sodium	osteoporosis	1.16	3.18993327611618	0.1	0	-0.01	0	0	-1.16	0.18	0
1207	insulin lispro recombinant	0.81	0.76	0.85	9.2e-14	1140	69135	176409	8617655	1207	insulin lispro recombinant	diabetes mellitus	2	1.78	2.25	1.3e-27	344	19374	1983	223524	1207	insulin lispro recombinant	diabetes mellitus	39.3	82	2.12	1.53	2.88	7.9e-06	48	3378	329	49106	1207	insulin lispro recombinant	diabetes mellitus	2.42	1.4	3.95	0.0011	19	1815	121	27929	1207	insulin lispro recombinant	diabetes mellitus	1.92	1.34	2.71	0.00036	40	2240	241	25962	1207	insulin lispro recombinant	diabetes mellitus	0.71	2.03399125864675	0.14	0	-0.01	0	0	-0.74	0.1	0
1208	lamivudine	0.38	0.34	0.43	1.2e-86	300	38495	177249	8648295	1208	lamivudine	hiv infection	1.03	0.86	1.24	0.75	202	23141	298	35250	1208	lamivudine	hiv infection	25	64	2.47	1.69	3.61	1.8e-06	59	2149	61	5492	1208	lamivudine	hiv infection	2.8	1.83	4.29	1e-06	48	1506	48	4222	1208	lamivudine	hiv infection	2.24	1.14	4.45	0.012	22	1213	18	2226	1208	lamivudine	hiv infection	0.97	2.63794445935415	0.17	0	0	0.01	0.81	0.45	0.2	0.02
1209	samarium sm-153 lexidronam pentasodium	12.67	8.85	17.82	3.3e-30	43	166	177506	8686624	1209	samarium sm-153 lexidronam pentasodium	metastases to bone	0	0	1.08	0.078	0	53	1193	17819	1209	samarium sm-153 lexidronam pentasodium	metastases to bone	43.9	84.9	0	0	4075.76	1	0	1	31	3459	1209	samarium sm-153 lexidronam pentasodium	metastases to bone	0	0	6834.75	1	0	1	10	1961	1209	samarium sm-153 lexidronam pentasodium	metastases to bone	0	0	Inf	1	0	0	25	1834	1209	samarium sm-153 lexidronam pentasodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1210	irinotecan	0.2	0.16	0.24	4.2e-100	94	23270	177455	8663520	1210	irinotecan	colorectal cancer metastatic	0.43	0.18	0.9	0.021	9	4406	38	7936	1210	irinotecan	colorectal cancer metastatic	38.8	74.6	0.21	0.02	0.86	0.019	2	612	19	1202	1210	irinotecan	colorectal cancer metastatic	0.73	0.17	2.55	0.78	4	475	10	868	1210	irinotecan	colorectal cancer metastatic	0	0	0.89	0.022	0	293	11	648	1210	irinotecan	colorectal cancer metastatic	-0.96	0.382892885975112	0.55	0.08	-0.02	0.01	0.09	0	0.41	0.99
1211	sodium phenylbutyrate	0.47	0.06	1.73	0.45	2	207	177547	8686583	1211	sodium phenylbutyrate	ornithine transcarbamoylase deficiency	1.09	0.02	11.44	1	1	38	4	166	1211	sodium phenylbutyrate	ornithine transcarbamoylase deficiency	13	28.3	0	0	Inf	1	0	14	0	33	1211	sodium phenylbutyrate	ornithine transcarbamoylase deficiency	0	0	Inf	1	0	12	0	48	1211	sodium phenylbutyrate	ornithine transcarbamoylase deficiency	0	0	12.51	1	0	20	3	98	1211	sodium phenylbutyrate	ornithine transcarbamoylase deficiency	-17.61	2.24943875741622e-08	4773.51	1	-0.03	0.04	0.46	-18.04	3613.99	1
1212	betaine	2.16	1.22	3.56	0.0051	16	362	177533	8686428	1212	betaine	homocystinuria	0	0	Inf	1	0	114	0	6	1212	betaine	homocystinuria	NA	NA	0	0	Inf	1	0	0	0	0	1212	betaine	homocystinuria	0	0	Inf	1	0	21	0	1	1212	betaine	homocystinuria	0	0	Inf	1	0	24	0	1	1212	betaine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1213	tamsulosin	1.22	1.15	1.29	7.6e-12	1316	52914	176233	8633876	1213	tamsulosin	hypertension	0.92	0.75	1.11	0.4	111	5570	6784	312043	1213	tamsulosin	hypertension	38	82.9	0.93	0.57	1.46	0.91	20	1360	961	61049	1213	tamsulosin	hypertension	1.23	0.74	1.94	0.37	20	1525	321	30114	1213	tamsulosin	hypertension	1.81	0.04	10.93	0.43	1	29	761	39901	1213	tamsulosin	hypertension	0.41	1.50681778511285	0.23	0.07	-0.02	0	0	-0.61	0.07	0
1214	pancrelipase\>	0.77	0.65	0.9	0.00082	156	9922	177393	8676868	1214	pancrelipase\>	cystic fibrosis	1.16	0.57	2.19	0.62	13	2029	44	7944	1214	pancrelipase\>	cystic fibrosis	14.3	57.2	0.64	0.12	2.28	0.59	3	803	15	2576	1214	pancrelipase\>	cystic fibrosis	1.05	0.1	6.45	1	2	568	5	1494	1214	pancrelipase\>	cystic fibrosis	0.65	0.07	2.97	0.75	2	533	11	1892	1214	pancrelipase\>	cystic fibrosis	-0.1	0.90483741803596	0.57	0.85	0.02	0.01	0.07	-0.44	0.47	0.35
1215	lipase	0.84	0.71	0.98	0.031	156	9087	177393	8677703	1215	lipase	cystic fibrosis	1.21	0.6	2.29	0.51	13	1956	44	8017	1215	lipase	cystic fibrosis	14.3	57.2	0.66	0.12	2.34	0.78	3	787	15	2592	1215	lipase	cystic fibrosis	1.07	0.1	6.56	1	2	561	5	1501	1215	lipase	cystic fibrosis	0.66	0.07	3.04	0.75	2	524	11	1901	1215	lipase	cystic fibrosis	-0.08	0.923116346386636	0.57	0.89	0.02	0.01	0.07	-0.44	0.47	0.35
1217	loteprednol etabonate	1.81	1.43	2.27	2e-06	79	2131	177470	8684659	1217	loteprednol etabonate	dry eye	0.87	0.18	2.64	1	3	391	104	11844	1217	loteprednol etabonate	dry eye	42.4	82.3	0.87	0.02	5.31	1	1	109	33	3136	1217	loteprednol etabonate	dry eye	0	0	1343.99	1	0	20	1	703	1217	loteprednol etabonate	dry eye	0.73	0.02	4.44	1	1	120	36	3173	1217	loteprednol etabonate	dry eye	-0.34	0.71177032276261	1.02	0.74	-0.02	0.01	0.01	-2.15	1.02	0.03
1218	urea c-13	0	0	118.34	1	0	3	177549	8686787	1218	urea c-13	helicobacter test	0	0	Inf	1	0	2	0	4	1218	urea c-13	helicobacter test	NA	NA	0	0	Inf	1	0	0	0	0	1218	urea c-13	helicobacter test	0	0	Inf	1	0	0	0	0	1218	urea c-13	helicobacter test	0	0	Inf	1	0	1	0	1	1218	urea c-13	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1219	talc	0	0	4.09	1	0	46	177549	8686744	1219	talc	constipation	0	0	309.69	1	0	2	728	42287	1219	talc	constipation	2.6	80.7	0	0	329.83	1	0	2	169	10422	1219	talc	constipation	0	0	3052	1	0	1	69	5669	1219	talc	constipation	0	0	2363.79	1	0	1	120	7551	1219	talc	constipation	-9.42	8.1086019309152e-05	377.92	0.98	-0.03	0	0	-0.22	0.15	0.15
1220	olanzapine	2.11	2.03	2.2	3.2e-234	2507	58575	175042	8628215	1220	olanzapine	schizophrenia	1.54	1.36	1.75	5.9e-11	329	9083	1186	50441	1220	olanzapine	schizophrenia	20.1	64.1	1.62	1.2	2.16	0.0012	66	1063	228	5951	1220	olanzapine	schizophrenia	1.81	1.25	2.58	0.0012	45	807	137	4455	1220	olanzapine	schizophrenia	1.46	0.93	2.22	0.078	30	489	118	2806	1220	olanzapine	schizophrenia	0.51	1.66529119494589	0.14	0	-0.02	0	0	-0.32	0.11	0.01
1221	valproate sodium	0.97	0.85	1.1	0.67	234	11798	177315	8674992	1221	valproate sodium	epilepsy	0.75	0.48	1.13	0.2	24	2237	616	43189	1221	valproate sodium	epilepsy	13.6	68.1	1.41	0.17	5.42	0.65	2	87	85	5227	1221	valproate sodium	epilepsy	2.75	0.32	11.03	0.18	2	65	39	3487	1221	valproate sodium	epilepsy	0	0	3.82	0.63	0	75	56	4109	1221	valproate sodium	epilepsy	0.15	1.16183424272828	0.72	0.84	0	0	0.57	-0.15	0.21	0.47
1222	latanoprost	0.79	0.71	0.88	3.3e-06	385	23751	177164	8663039	1222	latanoprost	glaucoma	0.69	0.52	0.92	0.0094	81	8596	138	10139	1222	latanoprost	glaucoma	54.3	87	0.82	0.41	1.6	0.64	15	1364	28	2098	1222	latanoprost	glaucoma	1.78	0.53	5.97	0.28	7	520	7	924	1222	latanoprost	glaucoma	0.43	0.17	0.97	0.037	8	1138	27	1640	1222	latanoprost	glaucoma	-0.38	0.683861409212356	0.31	0.23	-0.01	0.01	0.31	-0.28	0.32	0.38
1223	riluzole	1.13	0.67	1.77	0.62	19	826	177530	8685964	1223	riluzole	amyotrophic lateral sclerosis	0.5	0.06	6.11	0.6	3	331	2	111	1223	riluzole	amyotrophic lateral sclerosis	57	57	0	0	Inf	1	0	0	0	0	1223	riluzole	amyotrophic lateral sclerosis	0	0	Inf	1	0	19	0	11	1223	riluzole	amyotrophic lateral sclerosis	Inf	0.01	Inf	1	1	20	0	5	1223	riluzole	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1224	tazarotene	2.04	1.37	2.94	0.00055	30	719	177519	8686071	1224	tazarotene	acne	0.25	0.11	0.48	6.6e-07	9	250	4367	30154	1224	tazarotene	acne	14.8	44.4	0.54	0.01	3.3	1	1	30	172	2794	1224	tazarotene	acne	0	0	12.73	1	0	14	28	1117	1224	tazarotene	acne	0.69	0.02	4.37	1	1	21	163	2373	1224	tazarotene	acne	-0.59	0.554327284734507	1.02	0.56	0	0.01	0.66	-1.03	0.21	0
1225	simethicone	1.17	0.98	1.38	0.066	141	5892	177408	8680898	1225	simethicone	diarrhoea	0.3	0.15	0.54	2.1e-06	12	2167	276	15110	1225	simethicone	diarrhoea	16	75.5	0	0	0.37	0.00014	0	875	43	3569	1225	simethicone	diarrhoea	0.27	0.01	1.72	0.23	1	423	17	1930	1225	simethicone	diarrhoea	0	0	0.33	6.6e-05	0	1067	32	2867	1225	simethicone	diarrhoea	-2.51	0.0812682392408917	1.01	0.01	-0.02	0.01	0	-0.22	0.3	0.47
1226	balsalazide disodium	2.57	1.96	3.32	1.7e-10	62	1179	177487	8685611	1226	balsalazide disodium	colitis ulcerative	2.25	1.14	4	0.014	12	469	427	37475	1226	balsalazide disodium	colitis ulcerative	16.4	70.9	0	0	3.94	1	0	72	169	12542	1226	balsalazide disodium	colitis ulcerative	0	0	11.7	1	0	36	59	6212	1226	balsalazide disodium	colitis ulcerative	0	0	5.27	1	0	46	130	8096	1226	balsalazide disodium	colitis ulcerative	-12.21	4.98040173750325e-06	263.77	0.96	-0.01	0	0.21	-0.52	0.16	0
1228	glatiramer acetate	0.84	0.77	0.92	8.9e-05	515	29876	177034	8656914	1228	glatiramer acetate	multiple sclerosis	0.84	0.75	0.93	0.00096	352	21529	7993	408828	1228	glatiramer acetate	multiple sclerosis	26.5	67	0.97	0.79	1.19	0.84	104	4741	1200	53301	1228	glatiramer acetate	multiple sclerosis	1.23	0.75	1.91	0.39	22	1092	213	12957	1228	glatiramer acetate	multiple sclerosis	0.88	0.7	1.1	0.29	90	4293	1128	47556	1228	glatiramer acetate	multiple sclerosis	-0.07	0.932393819905948	0.1	0.46	-0.01	0	0	-0.34	0.07	0
1229	dolasetron mesylate	8.13	7.1	9.27	1.6e-133	261	1573	177288	8685217	1229	dolasetron mesylate	premedication	0.47	0.06	1.72	0.45	2	242	495	28120	1229	dolasetron mesylate	premedication	13.8	73.2	0	0	Inf	1	0	0	143	5601	1229	dolasetron mesylate	premedication	0	0	Inf	1	0	0	42	2807	1229	dolasetron mesylate	premedication	0	0	Inf	1	0	0	117	3991	1229	dolasetron mesylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1230	fexofenadine	2.33	2.23	2.43	1.5e-253	2177	46033	175372	8640757	1230	fexofenadine	hypersensitivity	1.25	1.09	1.43	0.0016	270	5680	1091	28673	1230	fexofenadine	hypersensitivity	15.2	73.8	0.88	0.56	1.33	0.62	27	1133	182	6699	1230	fexofenadine	hypersensitivity	1.09	0.44	2.35	0.84	8	402	46	2514	1230	fexofenadine	hypersensitivity	0.71	0.42	1.12	0.15	21	1116	158	5922	1230	fexofenadine	hypersensitivity	-0.2	0.818730753077982	0.2	0.32	-0.01	0	0	-0.38	0.16	0.02
1231	sumatriptan	2.23	2.1	2.37	1.2e-115	1075	23652	176474	8663138	1231	sumatriptan	migraine	0.77	0.69	0.86	4.2e-06	427	11621	1360	28624	1231	sumatriptan	migraine	20.7	70.1	0.68	0.49	0.92	0.012	51	1917	216	5483	1231	sumatriptan	migraine	0.67	0.22	1.69	0.54	6	269	26	780	1231	sumatriptan	migraine	0.85	0.62	1.15	0.31	59	1815	206	5386	1231	sumatriptan	migraine	-0.14	0.869358235398806	0.14	0.31	-0.02	0	0	-0.21	0.19	0.27
1232	saquinavir mesylate	0.35	0.15	0.69	0.00062	8	1123	177541	8685667	1232	saquinavir mesylate	hiv infection	0.71	0.19	1.83	0.67	4	660	496	57731	1232	saquinavir mesylate	hiv infection	25	64	1.52	0.04	9.11	0.49	1	42	119	7599	1232	saquinavir mesylate	hiv infection	2.07	0.05	12.74	0.39	1	29	95	5699	1232	saquinavir mesylate	hiv infection	0	0	16.26	1	0	22	40	3417	1232	saquinavir mesylate	hiv infection	0.29	1.33642748802547	1.01	0.77	0	0.01	0.81	0.38	0.2	0.05
1233	penciclovir	4.67	2.97	7.05	1.3e-09	25	262	177524	8686528	1233	penciclovir	oral herpes	0	0	11.16	1	0	40	48	5343	1233	penciclovir	oral herpes	24.6	54.1	0	0	1682.6	1	0	3	2	790	1233	penciclovir	oral herpes	0	0	Inf	1	0	2	0	435	1233	penciclovir	oral herpes	0	0	224.69	1	0	10	4	1338	1233	penciclovir	oral herpes	-16.08	1.03883059326824e-07	13358.75	1	-0.04	0.03	0.18	-16.75	2230.16	0.99
1234	remifentanil	0.29	0.17	0.45	2.8e-11	19	3224	177530	8683566	1234	remifentanil	induction of anaesthesia	0.63	0.07	2.89	0.75	2	824	11	2850	1234	remifentanil	induction of anaesthesia	38.2	60.8	0	0	Inf	1	0	56	0	167	1234	remifentanil	induction of anaesthesia	0	0	93.2	1	0	89	1	212	1234	remifentanil	induction of anaesthesia	0	0	119.91	1	0	87	1	267	1234	remifentanil	induction of anaesthesia	-17.19	3.42355931050604e-08	3624.09	1	0.01	0.03	0.78	0.21	1.42	0.88
1235	sibutramine	2.33	1.86	2.9	1.3e-11	85	1782	177464	8685008	1235	sibutramine	obesity	1.3	0.6	2.52	0.45	10	345	97	4335	1235	sibutramine	obesity	26	65.1	0	0	114.89	1	0	2	33	701	1235	sibutramine	obesity	0	0	Inf	1	0	0	8	163	1235	sibutramine	obesity	0	0	58.49	1	0	3	29	681	1235	sibutramine	obesity	-12.5	3.72665317207867e-06	838.54	0.99	-0.01	0.01	0.41	0.13	0.41	0.74
1236	levofloxacin	3.68	3.56	3.81	0	3753	50644	173796	8636146	1236	levofloxacin	prophylaxis	1.63	1.17	2.2	0.0034	44	2220	1235	101331	1236	levofloxacin	prophylaxis	23.9	79.7	0.82	0.22	2.14	1	4	556	203	23104	1236	levofloxacin	prophylaxis	0.9	0.11	3.37	1	2	372	80	13356	1236	levofloxacin	prophylaxis	1.82	0.58	4.39	0.21	5	272	143	14140	1236	levofloxacin	prophylaxis	0.34	1.40494759056359	0.39	0.37	-0.01	0	0.03	-0.53	0.14	0
1237	nevirapine	0.41	0.33	0.5	1.5e-24	96	11560	177453	8675230	1237	nevirapine	hiv infection	0.82	0.6	1.1	0.21	49	6848	451	51543	1237	nevirapine	hiv infection	25	64	0.39	0.08	1.17	0.12	3	472	117	7169	1237	nevirapine	hiv infection	0.53	0.11	1.63	0.37	3	326	93	5402	1237	nevirapine	hiv infection	0.93	0.18	2.96	1	3	276	37	3163	1237	nevirapine	hiv infection	-0.39	0.677056874498165	0.42	0.35	0	0.01	0.77	0.37	0.2	0.06
1238	cidofovir	0.08	0	0.45	0.00012	1	605	177548	8686185	1238	cidofovir	hiv infection	0	0	5.13	1	0	86	500	58305	1238	cidofovir	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	1238	cidofovir	hiv infection	0	0	Inf	1	0	0	96	5728	1238	cidofovir	hiv infection	0	0	Inf	1	0	0	40	3439	1238	cidofovir	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1239	quetiapine fumarate	2.49	2.42	2.57	0	4364	86861	173185	8599929	1239	quetiapine fumarate	depression	1.01	0.94	1.07	0.85	1113	14846	13258	177939	1239	quetiapine fumarate	depression	21	73.3	1.6	1.31	1.93	5.2e-06	124	1093	1938	27249	1239	quetiapine fumarate	depression	1.83	1.29	2.55	0.00073	43	397	594	10050	1239	quetiapine fumarate	depression	1.8	1.45	2.22	3.1e-07	104	867	1567	23517	1239	quetiapine fumarate	depression	0.57	1.76826705143374	0.09	0	-0.01	0	0	-0.14	0.05	0
1240	tiagabine	3.77	3.1	4.55	2.5e-31	118	1532	177431	8685258	1240	tiagabine	epilepsy	2.4	0.48	7.27	0.14	3	89	637	45337	1240	tiagabine	epilepsy	13.6	68.1	0	0	67.43	1	0	5	87	5309	1240	tiagabine	epilepsy	0	0	97.05	1	0	5	41	3547	1240	tiagabine	epilepsy	0	0	2787.01	1	0	1	56	4183	1240	tiagabine	epilepsy	-10.16	3.86872681666037e-05	360.26	0.98	0	0	0.57	-0.15	0.21	0.48
1242	ropinirole	1.83	1.7	1.97	1.2e-49	745	19928	176804	8666862	1242	ropinirole	parkinson s disease	1.1	0.91	1.32	0.31	141	4167	731	23757	1242	ropinirole	parkinson s disease	50.1	85.7	1.02	0.52	1.81	0.88	13	511	150	5987	1242	ropinirole	parkinson s disease	0.25	0.03	0.92	0.032	2	322	96	3810	1242	ropinirole	parkinson s disease	1.87	0.91	3.53	0.067	12	242	73	2755	1242	ropinirole	parkinson s disease	-0.15	0.860707976425058	0.28	0.6	-0.03	0.01	0	-0.2	0.15	0.18
1243	ritonavir	0.29	0.25	0.33	1.5e-135	256	43290	177293	8643500	1243	ritonavir	hiv infection	0.41	0.34	0.5	1.5e-20	139	28192	361	30199	1243	ritonavir	hiv infection	25	64	0.21	0.11	0.37	1.7e-10	13	2830	107	4811	1243	ritonavir	hiv infection	0.27	0.13	0.5	2.5e-06	11	1870	85	3858	1243	ritonavir	hiv infection	0.14	0.04	0.4	6.9e-06	4	1495	36	1944	1243	ritonavir	hiv infection	-1.52	0.218711886952215	0.28	0	0	0.01	0.66	0.27	0.2	0.17
1244	cabergoline	1.35	1.11	1.63	0.0024	113	4086	177436	8682704	1244	cabergoline	parkinson s disease	0.13	0.04	0.33	7.9e-09	4	959	868	26965	1244	cabergoline	parkinson s disease	50.1	85.7	0	0	10.41	1	0	16	163	6482	1244	cabergoline	parkinson s disease	0	0	15.37	1	0	12	98	4120	1244	cabergoline	parkinson s disease	0	0	20.95	1	0	8	85	2989	1244	cabergoline	parkinson s disease	-12.15	5.28837258135896e-06	323.4	0.97	-0.03	0.01	0	-0.2	0.15	0.18
1245	valsartan	1.14	1.1	1.19	2.1e-10	2538	109124	175011	8577666	1245	valsartan	hypertension	0.87	0.81	0.94	0.00043	736	38281	6159	279332	1245	valsartan	hypertension	38	82.9	1.35	1.09	1.67	0.0051	102	4925	879	57484	1245	valsartan	hypertension	1.1	0.71	1.63	0.6	27	2301	314	29338	1245	valsartan	hypertension	1.3	1.02	1.65	0.029	81	3336	681	36594	1245	valsartan	hypertension	0.27	1.30996445073325	0.1	0.01	-0.02	0	0	-0.59	0.07	0
1246	albendazole	0.49	0.22	0.94	0.031	9	895	177540	8685895	1246	albendazole	hiv infection	0	0	7.18	1	0	62	500	58329	1246	albendazole	hiv infection	25	64	0	0	9.81	1	0	26	120	7615	1246	albendazole	hiv infection	0	0	12.96	1	0	19	96	5709	1246	albendazole	hiv infection	0	0	61.57	1	0	7	40	3432	1246	albendazole	hiv infection	-12.4	4.11858870753571e-06	469.83	0.98	0	0.01	0.79	0.38	0.2	0.05
1247	pramipexole	2.9	2.72	3.09	1.1e-178	1022	17279	176527	8669511	1247	pramipexole	parkinson s disease	3.73	3.23	4.3	3.8e-66	337	4037	535	23887	1247	pramipexole	parkinson s disease	50.1	85.7	1.1	0.58	1.92	0.77	14	513	149	5985	1247	pramipexole	parkinson s disease	1.22	0.53	2.45	0.56	9	317	89	3815	1247	pramipexole	parkinson s disease	1.18	0.49	2.48	0.69	8	243	77	2754	1247	pramipexole	parkinson s disease	0.09	1.09417428370521	0.26	0.72	-0.03	0.01	0	-0.2	0.15	0.18
1248	topotecan	0.32	0.21	0.46	1.1e-13	29	4458	177520	8682332	1248	topotecan	ovarian cancer	2.8	1.56	4.76	0.00041	17	603	98	9750	1248	topotecan	ovarian cancer	45.7	74.2	2.15	0.24	8.88	0.26	2	52	30	1680	1248	topotecan	ovarian cancer	0	0	Inf	1	0	0	0	3	1248	topotecan	ovarian cancer	2.09	0.24	8.49	0.26	2	60	34	2133	1248	topotecan	ovarian cancer	0.72	2.05443321064389	0.74	0.33	0.01	0.01	0.62	-11.42	840.27	0.99
1249	sparfloxacin	0	0	2.95	0.64	0	63	177549	8686727	1249	sparfloxacin	hiv infection	0	0	17.86	1	0	26	500	58365	1249	sparfloxacin	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	1249	sparfloxacin	hiv infection	0	0	Inf	1	0	0	96	5728	1249	sparfloxacin	hiv infection	0	0	Inf	1	0	0	40	3439	1249	sparfloxacin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1250	miglitol	0.29	0.13	0.56	8.8e-06	9	1505	177540	8685285	1250	miglitol	diabetes mellitus	0	0	0.69	0.0079	0	559	2327	242339	1250	miglitol	diabetes mellitus	39.3	82	0	0	26.85	1	0	21	377	52463	1250	miglitol	diabetes mellitus	0	0	55.68	1	0	16	140	29728	1250	miglitol	diabetes mellitus	0	0	45	1	0	10	281	28192	1250	miglitol	diabetes mellitus	-9.41	8.1900947351399e-05	171.52	0.96	-0.01	0	0	-0.75	0.1	0
1251	indinavir	0.44	0.25	0.72	0.00035	16	1762	177533	8685028	1251	indinavir	hiv infection	1.05	0.52	1.91	0.75	11	1220	489	57171	1251	indinavir	hiv infection	25	64	2.28	0.45	7.05	0.15	3	85	117	7556	1251	indinavir	hiv infection	0.89	0.02	5.25	1	1	67	95	5661	1251	indinavir	hiv infection	4.83	0.55	19.96	0.073	2	37	38	3402	1251	indinavir	hiv infection	0.67	1.95423732063594	0.59	0.26	0	0.01	0.82	0.38	0.2	0.05
1252	manganese chloride tetrahydrate	0	0	1852.91	1	0	1	177549	8686789	1252	manganese chloride tetrahydrate	nuclear magnetic resonance imaging	0	0	221.22	1	0	1	1146	6522	1252	manganese chloride tetrahydrate	nuclear magnetic resonance imaging	26.3	65.4	0	0	2017	1	0	1	10	533	1252	manganese chloride tetrahydrate	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	1252	manganese chloride tetrahydrate	nuclear magnetic resonance imaging	0	0	2305.85	1	0	1	9	551	1252	manganese chloride tetrahydrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1253	mifepristone	0.25	0.16	0.37	2.8e-18	25	4829	177524	8681961	1253	mifepristone	abortion induced	0.19	0.05	0.89	0.018	7	3934	4	428	1253	mifepristone	abortion induced	23	32.5	Inf	0	Inf	1	1	432	0	15	1253	mifepristone	abortion induced	0	0	Inf	1	0	0	0	0	1253	mifepristone	abortion induced	Inf	0.03	Inf	1	4	919	0	46	1253	mifepristone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1254	olopatadine	1.59	1.35	1.85	5.2e-08	165	5091	177384	8681699	1254	olopatadine	asthma	1.42	0.85	2.25	0.13	19	441	3025	99933	1254	olopatadine	asthma	9	76	2.73	1.14	5.63	0.013	8	96	532	17420	1254	olopatadine	asthma	0	0	6.28	1	0	27	147	6231	1254	olopatadine	asthma	3.26	1.35	6.79	0.005	8	79	450	14483	1254	olopatadine	asthma	0.85	2.33964685192599	0.37	0.02	-0.02	0	0	-0.4	0.1	0
1255	donepezil	1.1	1.01	1.21	0.037	477	21163	177072	8665627	1255	donepezil	dementia alzheimer s type	1.23	0.91	1.64	0.18	75	5092	133	11065	1255	donepezil	dementia alzheimer s type	63	90	0.91	0.33	2.34	1	8	726	14	1159	1255	donepezil	dementia alzheimer s type	1.35	0.38	4.48	0.58	6	306	8	551	1255	donepezil	dementia alzheimer s type	0.78	0.17	2.8	0.78	4	508	9	889	1255	donepezil	dementia alzheimer s type	0.04	1.04081077419239	0.4	0.92	0	0.02	0.85	0.56	0.39	0.15
1256	grepafloxacin	13.98	1.42	73.45	0.013	2	7	177547	8686783	1256	grepafloxacin	hypertension	0	0	69.79	1	0	4	6895	317609	1256	grepafloxacin	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	1256	grepafloxacin	hypertension	0	0	Inf	1	0	0	341	31639	1256	grepafloxacin	hypertension	0	0	Inf	1	0	0	762	39930	1256	grepafloxacin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1257	fomepizole	0	0	6.4	1	0	30	177549	8686760	1257	fomepizole	prophylaxis	0	0	195.31	1	0	3	1279	103548	1257	fomepizole	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	1257	fomepizole	prophylaxis	0	0	Inf	1	0	0	82	13728	1257	fomepizole	prophylaxis	0	0	515.28	1	0	2	148	14410	1257	fomepizole	prophylaxis	-7.96	0.000349153117459826	229.63	0.97	-0.01	0	0.03	-0.52	0.14	0
1258	tolcapone	0.66	0.18	1.7	0.54	4	297	177545	8686493	1258	tolcapone	parkinson s disease	0.58	0.16	1.51	0.43	4	220	868	27704	1258	tolcapone	parkinson s disease	50.1	85.7	1.14	0.03	6.87	0.59	1	35	162	6463	1258	tolcapone	parkinson s disease	0	0	6.78	1	0	25	98	4107	1258	tolcapone	parkinson s disease	2.96	0.07	20.43	0.31	1	12	84	2985	1258	tolcapone	parkinson s disease	-0.02	0.980198673306755	1.02	0.99	-0.03	0.01	0	-0.2	0.15	0.18
1259	atorvastatin calcium	1.53	1.48	1.57	6.7e-181	5535	179424	172014	8507366	1259	atorvastatin calcium	hypertension	1.47	1.35	1.6	1.3e-18	648	20903	6247	296710	1259	atorvastatin calcium	hypertension	38	82.9	1.09	0.81	1.42	0.52	57	3354	924	59055	1259	atorvastatin calcium	hypertension	0.96	0.55	1.57	1	17	1640	324	29999	1259	atorvastatin calcium	hypertension	1.11	0.8	1.52	0.46	44	2084	718	37846	1259	atorvastatin calcium	hypertension	0.09	1.09417428370521	0.13	0.48	-0.02	0	0	-0.59	0.07	0
1260	delavirdine mesylate	1.13	0.3	2.95	0.78	4	173	177545	8686617	1260	delavirdine mesylate	hiv infection	1.13	0.03	6.49	0.59	1	103	499	58288	1260	delavirdine mesylate	hiv infection	25	64	2.78	0.07	17.42	0.31	1	23	119	7618	1260	delavirdine mesylate	hiv infection	2.73	0.07	17.24	0.32	1	22	95	5706	1260	delavirdine mesylate	hiv infection	0	0	457.3	1	0	2	40	3437	1260	delavirdine mesylate	hiv infection	0.95	2.58570965931585	1.03	0.35	0	0.01	0.79	0.37	0.2	0.06
1261	emedastine difumarate	0	0	5.61	1	0	34	177549	8686756	1261	emedastine difumarate	depression	0	0	14.65	1	0	5	14371	192780	1261	emedastine difumarate	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	1261	emedastine difumarate	depression	0	0	Inf	1	0	0	637	10447	1261	emedastine difumarate	depression	0	0	Inf	1	0	0	1671	24384	1261	emedastine difumarate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1262	tiludronate disodium	0	0	10.49	1	0	19	177549	8686771	1262	tiludronate disodium	hypertension	0	0	23.34	1	0	9	6895	317604	1262	tiludronate disodium	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	1262	tiludronate disodium	hypertension	0	0	Inf	1	0	0	341	31639	1262	tiludronate disodium	hypertension	0	0	Inf	1	0	0	762	39930	1262	tiludronate disodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1263	triptorelin pamoate	2.75	1.99	3.72	7e-09	45	800	177504	8685990	1263	triptorelin pamoate	prostate cancer	4.9	2.62	8.44	2.9e-06	14	302	430	45449	1263	triptorelin pamoate	prostate cancer	56.9	87.4	2.07	0.05	12.23	0.39	1	61	101	12743	1263	triptorelin pamoate	prostate cancer	1.82	0.05	10.68	0.43	1	71	113	14605	1263	triptorelin pamoate	prostate cancer	0	0	Inf	1	0	0	0	51	1263	triptorelin pamoate	prostate cancer	0.6	1.82211880039051	1.01	0.55	-0.01	0.01	0.05	11.79	335.42	0.97
1264	modafinil	2.73	2.57	2.91	3.5e-170	1075	19312	176474	8667478	1264	modafinil	narcolepsy	0.96	0.85	1.08	0.49	358	6177	1496	24699	1264	modafinil	narcolepsy	18.4	61.1	0.95	0.76	1.19	0.7	105	1507	535	7331	1264	modafinil	narcolepsy	0.89	0.57	1.35	0.68	29	575	133	2345	1264	modafinil	narcolepsy	1.04	0.82	1.31	0.72	95	1278	456	6390	1264	modafinil	narcolepsy	0.01	1.01005016708417	0.1	0.94	-0.01	0	0	-0.25	0.09	0.01
1265	eptifibatide	2.71	2.25	3.23	1e-21	129	2333	177420	8684457	1265	eptifibatide	anticoagulant therapy	0.78	0.21	2.03	0.82	4	262	423	21574	1265	eptifibatide	anticoagulant therapy	46.5	82.9	0	0	11.96	1	0	22	86	5529	1265	eptifibatide	anticoagulant therapy	0	0	21.29	1	0	17	43	3637	1265	eptifibatide	anticoagulant therapy	0	0	31.14	1	0	9	55	3297	1265	eptifibatide	anticoagulant therapy	-12.37	4.24401840716993e-06	468.65	0.98	-0.02	0.01	0.01	-0.33	0.21	0.1
1266	troglitazone	6.5	4.28	9.53	1.5e-14	30	226	177519	8686564	1266	troglitazone	diabetes mellitus	5.81	1.54	15.54	0.006	4	72	2323	242826	1266	troglitazone	diabetes mellitus	39.3	82	0	0	728.77	1	0	2	377	52482	1266	troglitazone	diabetes mellitus	0	0	Inf	1	0	0	140	29744	1266	troglitazone	diabetes mellitus	0	0	530.71	1	0	2	281	28200	1266	troglitazone	diabetes mellitus	-8	0.000335462627902512	229.53	0.97	-0.01	0	0	-0.75	0.1	0
1267	imiquimod	1.68	1.27	2.19	0.00037	57	1661	177492	8685129	1267	imiquimod	actinic keratosis	3.68	0.84	12.85	0.042	4	351	10	3232	1267	imiquimod	actinic keratosis	27.4	78.9	0	0	30.02	1	0	69	3	846	1267	imiquimod	actinic keratosis	0	0	Inf	1	0	49	0	407	1267	imiquimod	actinic keratosis	0	0	15.6	1	0	40	5	555	1267	imiquimod	actinic keratosis	-16.74	5.36920978441495e-08	4543.23	1	-0.03	0.04	0.37	-17.45	2198.76	0.99
1268	letrozole	4.44	4.2	4.69	0	1423	15789	176126	8671001	1268	letrozole	breast cancer	4.32	3.84	4.85	9.9e-111	439	6126	1007	60656	1268	letrozole	breast cancer	40	78	1.16	0.67	1.9	0.51	19	1340	108	8807	1268	letrozole	breast cancer	0	0	Inf	1	0	10	0	106	1268	letrozole	breast cancer	1.07	0.63	1.72	0.8	20	1548	124	10228	1268	letrozole	breast cancer	0.07	1.07250818125422	0.24	0.77	0	0.01	0.77	-13.16	367.3	0.97
1269	eprosartan mesylate	2.13	1.5	2.95	4e-05	38	871	177511	8685919	1269	eprosartan mesylate	hypertension	2.43	1.51	3.74	0.00031	22	417	6873	317196	1269	eprosartan mesylate	hypertension	38	82.9	0	0	22.93	1	0	12	981	62397	1269	eprosartan mesylate	hypertension	0	0	47.19	1	0	9	341	31630	1269	eprosartan mesylate	hypertension	0	0	79.45	1	0	4	762	39926	1269	eprosartan mesylate	hypertension	-9.2	0.000101039401837093	148.12	0.95	-0.02	0	0	-0.59	0.07	0
1270	cerivastatin sodium	6.38	4.51	8.82	1.8e-19	42	322	177507	8686468	1270	cerivastatin sodium	blood cholesterol increased	6.09	2.5	12.88	0.00011	8	55	2248	94173	1270	cerivastatin sodium	blood cholesterol increased	39.3	79.8	0	0	2182.83	1	0	1	293	16977	1270	cerivastatin sodium	blood cholesterol increased	0	0	Inf	1	0	0	93	6689	1270	cerivastatin sodium	blood cholesterol increased	0	0	2016.75	1	0	1	234	12493	1270	cerivastatin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1271	repaglinide	1.2	1.01	1.41	0.036	147	6011	177402	8680779	1271	repaglinide	type 2 diabetes mellitus	1.34	0.75	2.23	0.29	15	1297	1207	139801	1271	repaglinide	type 2 diabetes mellitus	43	80.7	1.62	0.19	6.01	0.35	2	196	212	33698	1271	repaglinide	type 2 diabetes mellitus	0	0	4.92	1	0	162	85	17774	1271	repaglinide	type 2 diabetes mellitus	4.29	0.86	13.15	0.036	3	99	151	21375	1271	repaglinide	type 2 diabetes mellitus	0.73	2.07508060767412	0.59	0.21	0	0	0.67	-0.42	0.14	0
1272	poractant alfa	0	0	0.8	0.017	0	227	177549	8686563	1272	poractant alfa	neonatal respiratory distress syndrome	0	0	Inf	1	0	102	0	152	1272	poractant alfa	neonatal respiratory distress syndrome	NA	NA	0	0	Inf	1	0	0	0	0	1272	poractant alfa	neonatal respiratory distress syndrome	0	0	Inf	1	0	8	0	11	1272	poractant alfa	neonatal respiratory distress syndrome	0	0	Inf	1	0	5	0	7	1272	poractant alfa	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1273	exemestane	3.73	3.47	4	9.9e-209	844	11123	176705	8675667	1273	exemestane	breast cancer	2.91	2.53	3.33	2.2e-44	273	4946	1173	61836	1273	exemestane	breast cancer	40	78	2.33	1.48	3.58	0.00021	29	1143	98	9004	1273	exemestane	breast cancer	0	0	Inf	1	0	7	0	109	1273	exemestane	breast cancer	2.4	1.57	3.57	3.7e-05	34	1345	110	10431	1273	exemestane	breast cancer	0.9	2.45960311115695	0.2	0	-0.01	0.01	0.39	-13.08	365.74	0.97
1274	irbesartan	1.38	1.29	1.48	6e-18	820	29124	176729	8657666	1274	irbesartan	hypertension	1.04	0.89	1.21	0.58	174	7702	6721	309911	1274	irbesartan	hypertension	38	82.9	1.21	0.76	1.84	0.35	23	1210	958	61199	1274	irbesartan	hypertension	0.77	0.25	1.82	0.69	5	603	336	31036	1274	irbesartan	hypertension	1.43	0.87	2.21	0.11	21	777	741	39153	1274	irbesartan	hypertension	0.26	1.29693008666577	0.2	0.19	-0.02	0	0	-0.59	0.07	0
1275	trovafloxacin mesylate	1.32	0.03	7.84	0.54	1	37	177548	8686753	1275	trovafloxacin mesylate	ill-defined disorder	0	0	58.34	1	0	5	568	30275	1275	trovafloxacin mesylate	ill-defined disorder	33.1	82	0	0	Inf	1	0	0	21	637	1275	trovafloxacin mesylate	ill-defined disorder	0	0	Inf	1	0	0	11	272	1275	trovafloxacin mesylate	ill-defined disorder	0	0	Inf	1	0	0	14	470	1275	trovafloxacin mesylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1276	alatrofloxacin mesylate	1.32	0.03	7.84	0.54	1	37	177548	8686753	1276	alatrofloxacin mesylate	ill-defined disorder	0	0	58.34	1	0	5	568	30275	1276	alatrofloxacin mesylate	ill-defined disorder	33.1	82	0	0	Inf	1	0	0	21	637	1276	alatrofloxacin mesylate	ill-defined disorder	0	0	Inf	1	0	0	11	272	1276	alatrofloxacin mesylate	ill-defined disorder	0	0	Inf	1	0	0	14	470	1276	alatrofloxacin mesylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1277	naratriptan	3.55	2.76	4.49	6.2e-19	74	1021	177475	8685769	1277	naratriptan	migraine	0.9	0.54	1.41	0.74	20	501	1767	39744	1277	naratriptan	migraine	20.7	70.1	0.65	0.08	2.44	0.77	2	85	265	7315	1277	naratriptan	migraine	0	0	13.55	1	0	11	32	1038	1277	naratriptan	migraine	0.64	0.08	2.42	0.77	2	84	263	7117	1277	naratriptan	migraine	-0.54	0.58274825237399	0.72	0.45	-0.02	0	0	-0.21	0.19	0.28
1278	orlistat	0.65	0.58	0.72	2.7e-16	311	23537	177238	8663253	1278	orlistat	weight loss diet	0.36	0.18	0.78	0.0053	60	2105	11	140	1278	orlistat	weight loss diet	40.8	55.3	Inf	0.01	Inf	1	2	174	0	10	1278	orlistat	weight loss diet	0	0	Inf	1	0	69	0	3	1278	orlistat	weight loss diet	0.06	0	0.81	0.017	2	465	2	26	1278	orlistat	weight loss diet	-2.88	0.0561347628341337	1.02	0	0	0.04	0.97	-15.54	1985.96	0.99
1279	zolmitriptan	2.44	2.11	2.8	2.7e-28	207	4156	177342	8682634	1279	zolmitriptan	migraine	1.18	0.93	1.48	0.14	85	1634	1702	38611	1279	zolmitriptan	migraine	20.7	70.1	1.57	0.79	2.84	0.14	12	216	255	7184	1279	zolmitriptan	migraine	0	0	5.37	1	0	25	32	1024	1279	zolmitriptan	migraine	1.83	0.97	3.2	0.042	14	213	251	6988	1279	zolmitriptan	migraine	0.54	1.71600686218486	0.28	0.05	-0.02	0	0	-0.21	0.19	0.28
1280	tolterodine tartrate	1.78	1.64	1.93	1.8e-38	618	16968	176931	8669822	1280	tolterodine tartrate	multiple sclerosis	1.09	0.77	1.49	0.61	39	1853	8306	428504	1280	tolterodine tartrate	multiple sclerosis	26.5	67	1.57	0.74	2.94	0.16	10	284	1294	57758	1280	tolterodine tartrate	multiple sclerosis	0	0	5.38	1	0	43	235	14006	1280	tolterodine tartrate	multiple sclerosis	1.41	0.67	2.63	0.26	10	303	1208	51546	1280	tolterodine tartrate	multiple sclerosis	0.32	1.37712776433596	0.32	0.33	-0.01	0	0	-0.34	0.07	0
1281	sacrosidase	0	0	4.38	1	0	43	177549	8686747	1281	sacrosidase	sucrase-isomaltase deficiency	0	0	Inf	1	0	30	0	0	1281	sacrosidase	sucrase-isomaltase deficiency	NA	NA	0	0	Inf	1	0	0	0	0	1281	sacrosidase	sucrase-isomaltase deficiency	0	0	Inf	1	0	13	0	0	1281	sacrosidase	sucrase-isomaltase deficiency	0	0	Inf	1	0	11	0	0	1281	sacrosidase	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1283	oxaprozin potassium	0	0	260.7	1	0	2	177549	8686788	1283	oxaprozin potassium	juvenile arthritis	0	0	4375.85	1	0	1	53	6382	1283	oxaprozin potassium	juvenile arthritis	NA	NA	0	0	Inf	1	0	0	0	0	1283	oxaprozin potassium	juvenile arthritis	0	0	Inf	1	0	0	0	0	1283	oxaprozin potassium	juvenile arthritis	0	0	Inf	1	0	0	0	0	1283	oxaprozin potassium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1284	nelfinavir mesylate	0.53	0.35	0.77	0.00036	27	2502	177522	8684288	1284	nelfinavir mesylate	hiv infection	0.67	0.31	1.29	0.32	9	1545	491	56846	1284	nelfinavir mesylate	hiv infection	25	64	0.9	0.02	5.25	1	1	71	119	7570	1284	nelfinavir mesylate	hiv infection	1.58	0.04	9.54	0.48	1	38	95	5690	1284	nelfinavir mesylate	hiv infection	0	0	6.02	1	0	56	40	3383	1284	nelfinavir mesylate	hiv infection	-0.27	0.763379494336853	1.01	0.79	0	0.01	0.79	0.38	0.2	0.05
1285	thalidomide	2.11	1.99	2.23	4.8e-121	1286	30004	176263	8656786	1285	thalidomide	multiple myeloma	2.32	2.08	2.59	1.4e-49	558	11806	925	45491	1285	thalidomide	multiple myeloma	NA	NA	0	0	Inf	1	0	0	0	0	1285	thalidomide	multiple myeloma	0	0	Inf	1	0	0	0	0	1285	thalidomide	multiple myeloma	0	0	Inf	1	0	0	0	0	1285	thalidomide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1286	zonisamide	1.45	1.26	1.66	4.8e-07	213	7196	177336	8679594	1286	zonisamide	epilepsy	1.33	0.91	1.88	0.13	34	1842	606	43584	1286	zonisamide	epilepsy	13.6	68.1	1.6	0.56	3.69	0.28	6	235	81	5079	1286	zonisamide	epilepsy	1.55	0.18	6.1	0.38	2	114	39	3438	1286	zonisamide	epilepsy	1.64	0.43	4.54	0.32	4	187	52	3997	1286	zonisamide	epilepsy	0.48	1.61607440219289	0.43	0.26	0	0	0.55	-0.14	0.21	0.5
1287	caffeine citrate	0.83	0.38	1.6	0.76	9	528	177540	8686262	1287	caffeine citrate	headache	0	0	1.68	0.28	0	53	1294	30102	1287	caffeine citrate	headache	18	65	0	0	60.44	1	0	3	184	4568	1287	caffeine citrate	headache	0	0	1427.42	1	0	1	46	1721	1287	caffeine citrate	headache	0	0	152.48	1	0	2	162	4624	1287	caffeine citrate	headache	-10.13	3.98654708885523e-05	308.47	0.97	-0.02	0	0	-0.3	0.17	0.08
1288	entacapone	1.78	1.56	2.03	3.2e-16	244	6694	177305	8680096	1288	entacapone	parkinson s disease	1.5	1.27	1.76	2.1e-06	201	4655	671	23269	1288	entacapone	parkinson s disease	50.1	85.7	1.52	0.82	2.61	0.14	15	407	148	6091	1288	entacapone	parkinson s disease	1.5	0.66	3.02	0.29	9	261	89	3871	1288	entacapone	parkinson s disease	1.43	0.55	3.15	0.35	7	177	78	2820	1288	entacapone	parkinson s disease	0.35	1.41906754859326	0.27	0.19	-0.03	0.01	0	-0.2	0.15	0.18
1289	lepirudin recombinant	1.33	0.53	2.77	0.38	7	258	177542	8686532	1289	lepirudin recombinant	heparin-induced thrombocytopenia	0	0	289.53	1	0	94	1	700	1289	lepirudin recombinant	heparin-induced thrombocytopenia	NA	NA	0	0	Inf	1	0	0	0	0	1289	lepirudin recombinant	heparin-induced thrombocytopenia	0	0	Inf	1	0	0	0	31	1289	lepirudin recombinant	heparin-induced thrombocytopenia	0	0	Inf	1	0	0	0	31	1289	lepirudin recombinant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1290	raloxifene	1.74	1.6	1.88	2.7e-35	617	17415	176932	8669375	1290	raloxifene	osteoporosis	0.87	0.77	0.98	0.027	292	5961	8510	151725	1290	raloxifene	osteoporosis	53.1	85	0.49	0.25	0.86	0.011	12	736	796	23832	1290	raloxifene	osteoporosis	0	0	Inf	1	0	0	31	2935	1290	raloxifene	osteoporosis	0.44	0.23	0.78	0.0024	12	829	856	26058	1290	raloxifene	osteoporosis	-0.84	0.43171052342908	0.29	0	-0.01	0	0	-1.17	0.18	0
1291	brinzolamide	0.76	0.58	0.98	0.033	62	3971	177487	8682819	1291	brinzolamide	glaucoma	0.6	0.28	1.13	0.12	10	1387	209	17348	1291	brinzolamide	glaucoma	54.3	87	0.42	0.05	1.64	0.31	2	359	41	3103	1291	brinzolamide	glaucoma	0.7	0.02	4.73	1	1	143	13	1301	1291	brinzolamide	glaucoma	0.26	0.01	1.55	0.25	1	284	34	2494	1291	brinzolamide	glaucoma	-0.94	0.390627835358521	0.72	0.19	-0.01	0.01	0.33	-0.27	0.32	0.4
1292	paricalcitol	0.68	0.58	0.79	7e-08	179	12850	177370	8673940	1292	paricalcitol	hyperparathyroidism secondary	1.47	0.75	2.74	0.24	15	2562	39	9806	1292	paricalcitol	hyperparathyroidism secondary	45	69.5	0	0	4.87	1	0	410	9	3927	1292	paricalcitol	hyperparathyroidism secondary	0	0	35.1	1	0	449	2	2956	1292	paricalcitol	hyperparathyroidism secondary	0	0	4.83	1	0	382	9	3626	1292	paricalcitol	hyperparathyroidism secondary	-15.03	2.96861540633121e-07	992.08	0.99	0	0.02	0.92	-1.3	0.78	0.1
1293	citalopram	2.94	2.85	3.03	0	4892	82935	172657	8603855	1293	citalopram	depression	1.02	0.96	1.08	0.47	1419	18675	12952	174110	1293	citalopram	depression	21	73.3	0.9	0.76	1.05	0.17	187	2838	1875	25504	1293	citalopram	depression	0.95	0.72	1.23	0.74	65	1120	572	9327	1293	citalopram	depression	0.87	0.73	1.04	0.12	152	2509	1519	21875	1293	citalopram	depression	-0.1	0.90483741803596	0.07	0.16	-0.01	0	0	-0.14	0.05	0
1294	rivastigmine tartrate	0.85	0.76	0.96	0.0083	284	16253	177265	8670537	1294	rivastigmine tartrate	dementia alzheimer s type	0.92	0.68	1.23	0.61	73	5988	135	10169	1294	rivastigmine tartrate	dementia alzheimer s type	63	90	1.55	0.59	3.93	0.37	10	660	12	1225	1294	rivastigmine tartrate	dementia alzheimer s type	1.01	0.26	3.38	1	5	305	9	552	1294	rivastigmine tartrate	dementia alzheimer s type	2.05	0.59	7.42	0.25	7	507	6	890	1294	rivastigmine tartrate	dementia alzheimer s type	0.38	1.46228458943422	0.4	0.34	-0.01	0.02	0.71	0.55	0.39	0.16
1295	ziprasidone	2.92	2.74	3.11	3.1e-183	1040	17495	176509	8669295	1295	ziprasidone	bipolar disorder	1.56	1.36	1.79	5.7e-10	251	3352	2326	48597	1295	ziprasidone	bipolar disorder	19.9	69	2.23	1.39	3.45	0.00083	25	188	340	5697	1295	ziprasidone	bipolar disorder	2.22	0.68	5.67	0.092	5	52	118	2725	1295	ziprasidone	bipolar disorder	1.97	1.15	3.21	0.01	20	166	265	4337	1295	ziprasidone	bipolar disorder	0.71	2.03399125864675	0.22	0	0	0	0.44	-0.33	0.11	0
1296	saquinavir	0.29	0.14	0.51	5.9e-07	11	1874	177538	8684916	1296	saquinavir	hiv infection	0.8	0.34	1.59	0.63	8	1163	492	57228	1296	saquinavir	hiv infection	25	64	0	0	3.32	0.63	0	73	120	7568	1296	saquinavir	hiv infection	0	0	3.88	1	0	59	96	5669	1296	saquinavir	hiv infection	0	0	14.79	1	0	24	40	3415	1296	saquinavir	hiv infection	-13.39	1.53037156362688e-06	433.59	0.98	0	0.01	0.81	0.38	0.2	0.05
1297	montelukast sodium	2.45	2.36	2.55	0	3042	61278	174507	8625512	1297	montelukast sodium	asthma	1.89	1.75	2.05	1.6e-55	1022	21149	2022	79225	1297	montelukast sodium	asthma	9	76	1.77	1.46	2.15	1.2e-08	158	3311	382	14205	1297	montelukast sodium	asthma	2.21	1.52	3.19	3.5e-05	46	1068	101	5190	1297	montelukast sodium	asthma	1.78	1.43	2.19	1.9e-07	131	2679	327	11883	1297	montelukast sodium	asthma	0.55	1.7332530178674	0.09	0	-0.02	0	0	-0.4	0.1	0
1298	formoterol fumarate	1.05	0.94	1.17	0.35	341	15857	177208	8670933	1298	formoterol fumarate	asthma	1.03	0.86	1.23	0.71	133	4247	2911	96127	1298	formoterol fumarate	asthma	9	76	1.54	1.05	2.2	0.022	34	733	506	16783	1298	formoterol fumarate	asthma	1.51	0.63	3.11	0.26	8	230	139	6028	1298	formoterol fumarate	asthma	1.68	1.11	2.46	0.011	30	584	428	13978	1298	formoterol fumarate	asthma	0.48	1.61607440219289	0.17	0.01	-0.02	0	0	-0.4	0.1	0
1299	isopropyl alcohol	1.18	0.62	2.03	0.54	13	541	177536	8686249	1299	isopropyl alcohol	preoperative care	0.16	0	1	0.048	1	332	30	1640	1299	isopropyl alcohol	preoperative care	NA	NA	0	0	Inf	1	0	0	0	0	1299	isopropyl alcohol	preoperative care	0	0	Inf	1	0	8	0	150	1299	isopropyl alcohol	preoperative care	0	0	Inf	1	0	17	0	186	1299	isopropyl alcohol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1300	risedronate sodium	2.54	2.4	2.69	4.5e-175	1264	24476	176285	8662314	1300	risedronate sodium	osteoporosis	1.5	1.37	1.64	6.5e-18	580	7090	8222	150596	1300	risedronate sodium	osteoporosis	53.1	85	2.28	1.58	3.2	1.3e-05	38	521	770	24047	1300	risedronate sodium	osteoporosis	0	0	4.87	1	0	76	31	2859	1300	risedronate sodium	osteoporosis	2.25	1.57	3.15	1.2e-05	39	550	829	26337	1300	risedronate sodium	osteoporosis	0.76	2.13827622049682	0.17	0	-0.01	0	0	-1.15	0.18	0
1301	levalbuterol	2.6	2.38	2.84	3.2e-80	543	10221	177006	8676569	1301	levalbuterol	asthma	1.38	1.13	1.69	0.002	106	2549	2938	97825	1301	levalbuterol	asthma	9	76	1.17	0.61	2.04	0.54	13	363	527	17153	1301	levalbuterol	asthma	0.51	0.01	2.96	1	1	83	146	6175	1301	levalbuterol	asthma	1.39	0.74	2.38	0.26	14	324	444	14238	1301	levalbuterol	asthma	0.14	1.15027379885723	0.27	0.6	-0.02	0	0	-0.4	0.1	0
1302	candesartan cilexetil	0.9	0.82	0.99	0.024	451	24569	177098	8662221	1302	candesartan cilexetil	hypertension	0.69	0.57	0.84	6.1e-05	115	7570	6780	310043	1302	candesartan cilexetil	hypertension	38	82.9	1.8	1.12	2.77	0.013	22	784	959	61625	1302	candesartan cilexetil	hypertension	0.72	0.15	2.15	0.8	3	384	338	31255	1302	candesartan cilexetil	hypertension	1.92	1.14	3.04	0.0099	19	526	743	39404	1302	candesartan cilexetil	hypertension	0.49	1.63231621995538	0.22	0.02	-0.02	0	0	-0.59	0.07	0
1303	clopidogrel bisulfate	1.46	1.41	1.52	6.1e-84	3035	101941	174514	8584849	1303	clopidogrel bisulfate	hypertension	1.23	1.09	1.39	0.00095	289	10911	6606	306702	1303	clopidogrel bisulfate	hypertension	38	82.9	0.57	0.33	0.93	0.022	17	1859	964	60550	1303	clopidogrel bisulfate	hypertension	0.68	0.31	1.3	0.32	9	1221	332	30418	1303	clopidogrel bisulfate	hypertension	0.5	0.23	0.96	0.037	9	930	753	39000	1303	clopidogrel bisulfate	hypertension	-0.42	0.657046819815057	0.24	0.08	-0.02	0	0	-0.59	0.07	0
1304	nitric oxide	0.46	0.2	0.92	0.026	8	842	177541	8685948	1304	nitric oxide	pulmonary hypertension	0	0	3.21	0.63	0	181	273	42328	1304	nitric oxide	pulmonary hypertension	23.5	83	0	0	55.27	1	0	10	140	17178	1304	nitric oxide	pulmonary hypertension	0	0	74.35	1	0	14	21	4811	1304	nitric oxide	pulmonary hypertension	0	0	35.35	1	0	13	135	14382	1304	nitric oxide	pulmonary hypertension	-10.7	2.25449379132122e-05	277.83	0.97	0	0	0.41	-0.78	0.24	0
1305	telmisartan	0.78	0.71	0.86	4.4e-07	399	24970	177150	8661820	1305	telmisartan	hypertension	0.59	0.49	0.7	6.2e-11	137	10539	6758	307074	1305	telmisartan	hypertension	38	82.9	0.48	0.24	0.86	0.0097	11	1453	970	60956	1305	telmisartan	hypertension	0.69	0.25	1.54	0.49	6	795	335	30844	1305	telmisartan	hypertension	0.7	0.36	1.23	0.26	12	897	750	39033	1305	telmisartan	hypertension	-0.35	0.704688089718713	0.24	0.14	-0.02	0	0	-0.59	0.07	0
1306	zaleplon	5.34	4.68	6.08	2.5e-94	256	2346	177293	8684444	1306	zaleplon	insomnia	1.24	0.78	1.87	0.3	24	446	2919	67142	1306	zaleplon	insomnia	26.9	78.5	1.46	0.29	4.58	0.47	3	46	528	11851	1306	zaleplon	insomnia	1.43	0.03	9.12	0.52	1	18	211	5419	1306	zaleplon	insomnia	1.79	0.35	5.67	0.25	3	39	376	8751	1306	zaleplon	insomnia	0.39	1.47698079388264	0.52	0.46	-0.02	0	0	-0.08	0.09	0.39
1307	doxercalciferol	2.48	1.89	3.2	7.5e-10	62	1224	177487	8685566	1307	doxercalciferol	nuclear magnetic resonance imaging	3.31	1.99	5.4	2.7e-06	28	49	1118	6474	1307	doxercalciferol	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	1307	doxercalciferol	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	1307	doxercalciferol	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	1307	doxercalciferol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1308	cilostazol	1.03	0.88	1.2	0.69	170	8073	177379	8678717	1308	cilostazol	hypertension	1.44	1.01	1.99	0.031	38	1219	6857	316394	1308	cilostazol	hypertension	38	82.9	0.58	0.07	2.13	0.78	2	219	979	62190	1308	cilostazol	hypertension	0.57	0.01	3.23	1	1	163	340	31476	1308	cilostazol	hypertension	1.05	0.12	3.9	0.72	2	100	760	39830	1308	cilostazol	hypertension	-0.07	0.932393819905948	0.58	0.9	-0.02	0	0	-0.59	0.07	0
1309	rizatriptan benzoate	3.08	2.75	3.44	2.8e-67	344	5470	177205	8681320	1309	rizatriptan benzoate	migraine	1.19	0.98	1.45	0.075	118	2252	1669	37993	1309	rizatriptan benzoate	migraine	20.7	70.1	1.49	0.87	2.4	0.11	19	363	248	7037	1309	rizatriptan benzoate	migraine	3.79	0.92	11.65	0.032	4	38	28	1011	1309	rizatriptan benzoate	migraine	1.25	0.69	2.09	0.39	16	353	249	6848	1309	rizatriptan benzoate	migraine	0.38	1.46228458943422	0.24	0.11	-0.02	0	0	-0.2	0.19	0.29
1310	bivalirudin	0.42	0.26	0.64	5.7e-06	21	2474	177528	8684316	1310	bivalirudin	percutaneous coronary intervention	0	0	2.04	0.17	0	1017	5	1893	1310	bivalirudin	percutaneous coronary intervention	40.1	60.4	0	0	Inf	1	0	25	0	121	1310	bivalirudin	percutaneous coronary intervention	0	0	190.75	1	0	53	1	259	1310	bivalirudin	percutaneous coronary intervention	0	0	214.5	1	0	27	1	148	1310	bivalirudin	percutaneous coronary intervention	-16.33	8.0904207951584e-08	3065.69	1	-0.06	0.04	0.11	-0.55	1.45	0.71
1311	argatroban	0.71	0.41	1.16	0.2	16	1097	177533	8685693	1311	argatroban	heparin-induced thrombocytopenia	0	0	44.77	1	0	370	1	424	1311	argatroban	heparin-induced thrombocytopenia	NA	NA	0	0	Inf	1	0	0	0	0	1311	argatroban	heparin-induced thrombocytopenia	0	0	Inf	1	0	3	0	28	1311	argatroban	heparin-induced thrombocytopenia	0	0	Inf	1	0	5	0	26	1311	argatroban	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1312	alitretinoin	0	0	8.13	1	0	24	177549	8686766	1312	alitretinoin	eczema	0	0	27.44	1	0	5	145	3618	1312	alitretinoin	eczema	17.2	67.9	0	0	Inf	1	0	0	13	396	1312	alitretinoin	eczema	0	0	Inf	1	0	0	7	292	1312	alitretinoin	eczema	0	0	Inf	1	0	0	8	378	1312	alitretinoin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1314	valrubicin	0.33	0.01	1.88	0.38	1	147	177548	8686643	1314	valrubicin	bladder cancer	0	0	35.3	1	0	46	14	5209	1314	valrubicin	bladder cancer	77.6	77.6	0	0	Inf	1	0	0	0	0	1314	valrubicin	bladder cancer	0	0	Inf	1	0	12	0	532	1314	valrubicin	bladder cancer	0	0	3951.97	1	0	1	1	107	1314	valrubicin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1315	sildenafil citrate	0.69	0.65	0.74	6.4e-32	933	65708	176616	8621082	1315	sildenafil citrate	pulmonary arterial hypertension	1.32	1.05	1.64	0.015	104	14995	378	71908	1315	sildenafil citrate	pulmonary arterial hypertension	28	80	1.31	0.95	1.78	0.078	53	4553	217	24491	1315	sildenafil citrate	pulmonary arterial hypertension	1.01	0.41	2.16	1	8	1264	47	7494	1315	sildenafil citrate	pulmonary arterial hypertension	1.49	1.07	2.03	0.013	53	4047	196	22239	1315	sildenafil citrate	pulmonary arterial hypertension	0.32	1.37712776433596	0.14	0.03	0	0	0.18	-0.41	0.15	0.01
1316	capecitabine	1.11	1.05	1.18	0.00055	1075	47218	176474	8639572	1316	capecitabine	breast cancer	1.74	1.52	1.99	2.6e-14	268	7721	1178	59061	1316	capecitabine	breast cancer	40	78	0.41	0.11	1.09	0.083	4	741	123	9406	1316	capecitabine	breast cancer	0	0	Inf	1	0	8	0	108	1316	capecitabine	breast cancer	0.47	0.15	1.13	0.1	5	835	139	10941	1316	capecitabine	breast cancer	-0.76	0.467666427009909	0.46	0.1	0	0.01	0.75	-13.16	366.72	0.97
1317	thyrotropin alfa	1.34	0.73	2.27	0.27	14	512	177535	8686278	1317	thyrotropin alfa	diagnostic procedure	0.96	0.02	6.09	1	1	216	20	4168	1317	thyrotropin alfa	diagnostic procedure	43.1	71	7.83	0.16	73.46	0.14	1	27	5	1062	1317	thyrotropin alfa	diagnostic procedure	0	0	103.38	1	0	13	4	823	1317	thyrotropin alfa	diagnostic procedure	10.76	0.2	137.58	0.12	1	35	3	1137	1317	thyrotropin alfa	diagnostic procedure	1.83	6.23388665852472	1.09	0.09	0	0.02	0.95	0.41	0.72	0.56
1318	albumin human	0.51	0.16	1.19	0.14	5	484	177544	8686306	1318	albumin human	prophylaxis	0	0	5.05	1	0	61	1279	103490	1318	albumin human	prophylaxis	23.9	79.7	0	0	17.55	1	0	26	207	23634	1318	albumin human	prophylaxis	0	0	36.57	1	0	19	82	13709	1318	albumin human	prophylaxis	0	0	25.5	1	0	16	148	14396	1318	albumin human	prophylaxis	-10.79	2.06045218288883e-05	244.11	0.96	-0.01	0	0.02	-0.52	0.14	0
1319	leflunomide	0.5	0.45	0.55	6.7e-47	340	33373	177209	8653417	1319	leflunomide	rheumatoid arthritis	1.26	1.1	1.44	0.00093	234	25415	3176	434962	1319	leflunomide	rheumatoid arthritis	33	75	1.39	1.07	1.77	0.01	71	5614	989	108324	1319	leflunomide	rheumatoid arthritis	2.29	1.29	3.79	0.0029	17	1108	163	24283	1319	leflunomide	rheumatoid arthritis	1.18	0.89	1.54	0.24	58	5301	953	102663	1319	leflunomide	rheumatoid arthritis	0.29	1.33642748802547	0.12	0.02	-0.01	0	0	-0.26	0.08	0
1320	tirofiban	0.54	0.26	1	0.057	10	905	177539	8685885	1320	tirofiban	acute coronary syndrome	0	0	2.04	0.27	0	147	104	8211	1320	tirofiban	acute coronary syndrome	51.9	87.2	0	0	99.65	1	0	4	26	1649	1320	tirofiban	acute coronary syndrome	0	0	370.52	1	0	3	9	1270	1320	tirofiban	acute coronary syndrome	0	0	1177.66	1	0	1	21	645	1320	tirofiban	acute coronary syndrome	-11.25	1.30072976540676e-05	707.63	0.99	0.01	0.02	0.34	-1.49	0.4	0
1321	glucagon recombinant	1.72	1.27	2.3	0.00056	48	1362	177501	8685428	1321	glucagon recombinant	diabetes mellitus	3.84	1.23	9.21	0.011	5	136	2322	242762	1321	glucagon recombinant	diabetes mellitus	39.3	82	0	0	20.46	1	0	27	377	52457	1321	glucagon recombinant	diabetes mellitus	0	0	55.68	1	0	16	140	29728	1321	glucagon recombinant	diabetes mellitus	0	0	14.2	1	0	28	281	28174	1321	glucagon recombinant	diabetes mellitus	-10.88	1.88311150570227e-05	215.94	0.96	-0.01	0	0	-0.75	0.1	0
1322	ziprasidone mesylate	3.04	2.83	3.25	5.1e-166	886	14330	176663	8672460	1322	ziprasidone mesylate	bipolar disorder	1.54	1.33	1.77	1.1e-08	229	3102	2348	48847	1322	ziprasidone mesylate	bipolar disorder	19.9	69	1.88	1.05	3.16	0.027	17	149	348	5736	1322	ziprasidone mesylate	bipolar disorder	1.33	0.15	5.31	0.66	2	34	121	2743	1322	ziprasidone mesylate	bipolar disorder	1.85	0.99	3.23	0.032	15	131	270	4372	1322	ziprasidone mesylate	bipolar disorder	0.57	1.76826705143374	0.26	0.03	0	0	0.45	-0.33	0.11	0
1323	nesiritide recombinant	8.76	6.41	11.77	5.9e-30	53	296	177496	8686494	1323	nesiritide recombinant	cardiac failure congestive	0.4	0.01	2.3	0.52	1	109	206	8994	1323	nesiritide recombinant	cardiac failure congestive	43.4	87.2	0	0	Inf	1	0	0	22	2045	1323	nesiritide recombinant	cardiac failure congestive	0	0	Inf	1	0	0	10	1284	1323	nesiritide recombinant	cardiac failure congestive	0	0	Inf	1	0	0	15	1054	1323	nesiritide recombinant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1324	mequinol	0	0	11.12	1	0	18	177549	8686772	1324	mequinol	lentigo	0	0	Inf	1	0	4	0	21	1324	mequinol	lentigo	NA	NA	0	0	Inf	1	0	0	0	0	1324	mequinol	lentigo	0	0	Inf	1	0	0	0	1	1324	mequinol	lentigo	0	0	Inf	1	0	0	0	8	1324	mequinol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1325	sevelamer	3.22	2.96	3.51	1.1e-118	577	8784	176972	8678006	1325	sevelamer	hyperphosphataemia	1.44	0.4	5.02	0.57	6	1832	7	3083	1325	sevelamer	hyperphosphataemia	45.1	65.8	0	0	Inf	1	0	51	0	267	1325	sevelamer	hyperphosphataemia	0	0	196	1	0	73	1	367	1325	sevelamer	hyperphosphataemia	0	0	235.52	1	0	49	1	296	1325	sevelamer	hyperphosphataemia	-15.79	1.38832176024549e-07	2621.47	1	-0.02	0.04	0.55	-0.18	1.42	0.9
1326	dofetilide	0.82	0.67	0.99	0.041	106	6330	177443	8680460	1326	dofetilide	atrial fibrillation	2.72	2.03	3.57	2.8e-10	56	2974	752	108435	1326	dofetilide	atrial fibrillation	49	86.6	3.61	1.75	6.72	0.00047	11	851	121	33775	1326	dofetilide	atrial fibrillation	3.63	0.95	9.93	0.029	4	458	52	21615	1326	dofetilide	atrial fibrillation	3.52	1.46	7.3	0.0032	8	462	86	17471	1326	dofetilide	atrial fibrillation	1.25	3.49034295746184	0.3	0	-0.01	0	0	-0.75	0.17	0
1327	gadoversetamide	26.14	24.16	28.27	0	982	1848	176567	8684942	1327	gadoversetamide	nuclear magnetic resonance imaging	13.46	11.6	15.65	1.19999999999999e-310	848	1138	298	5385	1327	gadoversetamide	nuclear magnetic resonance imaging	26.3	65.4	0	0	30.81	1	0	9	10	525	1327	gadoversetamide	nuclear magnetic resonance imaging	0	0	3140.04	1	0	1	3	253	1327	gadoversetamide	nuclear magnetic resonance imaging	0	0	28.48	1	0	11	9	541	1327	gadoversetamide	nuclear magnetic resonance imaging	-13.45	1.44124966182967e-06	1141.65	0.99	0	0.02	0.93	-0.34	0.67	0.62
1328	meloxicam	1.82	1.72	1.92	3.1e-85	1327	35768	176222	8651022	1328	meloxicam	rheumatoid arthritis	1.01	0.77	1.31	0.89	59	7874	3351	452503	1328	meloxicam	rheumatoid arthritis	33	75	1.15	0.68	1.83	0.52	18	1687	1042	112251	1328	meloxicam	rheumatoid arthritis	0.37	0.01	2.13	0.53	1	373	179	25018	1328	meloxicam	rheumatoid arthritis	1.2	0.7	1.94	0.42	17	1512	994	106452	1328	meloxicam	rheumatoid arthritis	0.07	1.07250818125422	0.24	0.78	-0.01	0	0	-0.26	0.08	0
1329	docosanol	0.07	0.04	0.12	7.6e-60	13	8981	177536	8677809	1329	docosanol	oral herpes	0.01	0	0.04	4.5e-28	1	4095	47	1288	1329	docosanol	oral herpes	24.6	54.1	0.23	0	18.13	0.34	1	645	1	148	1329	docosanol	oral herpes	0	0	Inf	1	0	336	0	101	1329	docosanol	oral herpes	0.09	0	1.15	0.034	1	1057	3	291	1329	docosanol	oral herpes	-2.56	0.0773047404432997	1.16	0.03	-0.05	0.03	0.11	-16.75	2037.39	0.99
1330	sodium ferric gluconate complex	2.81	2.22	3.51	2.7e-15	82	1430	177467	8685360	1330	sodium ferric gluconate complex	nuclear magnetic resonance imaging	3.34	2.13	5.17	1.4e-07	35	61	1111	6462	1330	sodium ferric gluconate complex	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	1330	sodium ferric gluconate complex	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	1330	sodium ferric gluconate complex	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	1330	sodium ferric gluconate complex	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1331	calcium carbonate	1.63	1.53	1.73	3.4e-49	1104	33299	176445	8653491	1331	calcium carbonate	osteoporosis	0.56	0.47	0.66	1.4e-13	146	4603	8656	153083	1331	calcium carbonate	osteoporosis	53.1	85	0.3	0.04	1.09	0.071	2	204	806	24364	1331	calcium carbonate	osteoporosis	0	0	6.34	1	0	59	31	2876	1331	calcium carbonate	osteoporosis	0.46	0.09	1.38	0.22	3	200	865	26687	1331	calcium carbonate	osteoporosis	-0.91	0.402524224033636	0.58	0.12	-0.01	0	0	-1.14	0.18	0
1332	magnesium hydroxide	2.69	2.39	3.01	1.3e-48	306	5579	177243	8681211	1332	magnesium hydroxide	gastrooesophageal reflux disease	0.94	0.6	1.4	0.84	25	689	2943	76339	1332	magnesium hydroxide	gastrooesophageal reflux disease	22.4	77.2	1.24	0.4	2.98	0.61	5	158	473	18539	1332	magnesium hydroxide	gastrooesophageal reflux disease	0.95	0.02	5.59	1	1	56	151	8027	1332	magnesium hydroxide	gastrooesophageal reflux disease	1.62	0.58	3.65	0.28	6	141	374	14248	1332	magnesium hydroxide	gastrooesophageal reflux disease	0.37	1.44773461466332	0.39	0.34	-0.02	0	0	-0.35	0.1	0
1334	aminolevulinic acid	0.65	0.13	1.92	0.64	3	226	177546	8686564	1334	aminolevulinic acid	actinic keratosis	10.22	1.8	39.56	0.0054	3	93	11	3490	1334	aminolevulinic acid	actinic keratosis	27.4	78.9	9.39	0.16	183.24	0.15	1	46	2	869	1334	aminolevulinic acid	actinic keratosis	0	0	Inf	1	0	32	0	424	1334	aminolevulinic acid	actinic keratosis	6.46	0.13	68.94	0.18	1	22	4	573	1334	aminolevulinic acid	actinic keratosis	2	7.38905609893065	1.15	0.08	-0.04	0.04	0.31	-17.61	2169.83	0.99
1335	articaine	4.26	3.16	5.63	2.6e-17	54	621	177495	8686169	1335	articaine	local anaesthesia	1.82	0.83	3.65	0.093	11	377	40	2493	1335	articaine	local anaesthesia	9	63.2	3.18	0.62	15.15	0.092	4	76	5	303	1335	articaine	local anaesthesia	0	0	Inf	1	0	33	0	190	1335	articaine	local anaesthesia	3.01	0.71	12.21	0.073	5	76	6	276	1335	articaine	local anaesthesia	1.1	3.00416602394643	0.62	0.08	-0.01	0.02	0.41	-16.97	1164.22	0.99
1336	efavirenz	0.54	0.46	0.62	2.4e-20	184	16710	177365	8670080	1336	efavirenz	hiv infection	1.3	1.05	1.6	0.014	118	11207	382	47184	1336	efavirenz	hiv infection	25	64	1.1	0.68	1.72	0.65	26	1535	94	6106	1336	efavirenz	hiv infection	1	0.56	1.69	1	18	1075	78	4653	1336	efavirenz	hiv infection	1.02	0.42	2.2	1	9	763	31	2676	1336	efavirenz	hiv infection	0	1	0.22	0.99	0	0.01	0.81	0.38	0.2	0.05
1337	rabeprazole sodium	2.72	2.56	2.89	2.3e-175	1117	20166	176432	8666624	1337	rabeprazole sodium	rheumatoid arthritis	1.19	0.68	1.94	0.49	16	1815	3394	458562	1337	rabeprazole sodium	rheumatoid arthritis	33	75	1.31	0.03	7.53	0.54	1	82	1059	113856	1337	rabeprazole sodium	rheumatoid arthritis	7.46	0.18	47.44	0.13	1	19	179	25372	1337	rabeprazole sodium	rheumatoid arthritis	0	0	5.05	1	0	80	1011	107884	1337	rabeprazole sodium	rheumatoid arthritis	0.18	1.19721736312181	1.01	0.86	-0.01	0	0	-0.26	0.08	0
1338	abacavir	0.5	0.42	0.59	4.1e-20	142	13872	177407	8672918	1338	abacavir	hiv infection	1.5	1.21	1.86	0.00027	114	9604	386	48787	1338	abacavir	hiv infection	25	64	3.14	2.11	4.62	2.6e-08	45	1227	75	6414	1338	abacavir	hiv infection	2.34	1.48	3.64	0.00018	33	1047	63	4681	1338	abacavir	hiv infection	4.38	2.2	8.62	1.4e-05	18	541	22	2898	1338	abacavir	hiv infection	1.04	2.82921701435156	0.18	0	0	0.01	0.75	0.35	0.2	0.08
1339	rapacuronium bromide	0	0	260.7	1	0	2	177549	8686788	1339	rapacuronium bromide	anaesthesia	0	0	4022.84	1	0	1	60	6603	1339	rapacuronium bromide	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	1339	rapacuronium bromide	anaesthesia	0	0	Inf	1	0	0	1	387	1339	rapacuronium bromide	anaesthesia	0	0	Inf	1	0	0	10	485	1339	rapacuronium bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1340	insulin aspart recombinant	1.27	1.18	1.37	2e-09	691	26624	176858	8660166	1340	insulin aspart recombinant	type 2 diabetes mellitus	1.38	1.05	1.78	0.019	62	5271	1160	135827	1340	insulin aspart recombinant	type 2 diabetes mellitus	43	80.7	1.15	0.6	2.01	0.65	13	1807	201	32087	1340	insulin aspart recombinant	type 2 diabetes mellitus	0.99	0.26	2.63	1	4	855	81	17081	1340	insulin aspart recombinant	type 2 diabetes mellitus	1.36	0.66	2.51	0.37	11	1153	143	20321	1340	insulin aspart recombinant	type 2 diabetes mellitus	0.21	1.23367805995674	0.27	0.43	0	0	0.7	-0.41	0.14	0
1341	pantoprazole sodium	2.98	2.89	3.08	0	3817	63517	173732	8623273	1341	pantoprazole sodium	hypertension	2.31	2.03	2.61	1e-31	268	5476	6627	312137	1341	pantoprazole sodium	hypertension	38	82.9	1.28	0.78	2	0.25	20	998	961	61411	1341	pantoprazole sodium	hypertension	1.48	0.59	3.1	0.35	7	443	334	31196	1341	pantoprazole sodium	hypertension	1.05	0.57	1.78	0.78	14	702	748	39228	1341	pantoprazole sodium	hypertension	0.15	1.16183424272828	0.22	0.51	-0.02	0	0	-0.59	0.07	0
1342	cevimeline	2.93	2.33	3.65	7.9e-17	85	1418	177464	8685372	1342	cevimeline	rheumatoid arthritis	1.5	0.41	3.87	0.35	4	361	3406	460016	1342	cevimeline	rheumatoid arthritis	33	75	0	0	4.83	1	0	84	1060	113854	1342	cevimeline	rheumatoid arthritis	0	0	71.97	1	0	9	180	25382	1342	cevimeline	rheumatoid arthritis	0	0	4.8	1	0	84	1011	107880	1342	cevimeline	rheumatoid arthritis	-10.86	1.92115288153726e-05	150.75	0.94	-0.01	0	0	-0.26	0.08	0
1343	estrogens synthetic a	2.92	2.2	3.81	6.2e-12	58	972	177491	8685818	1343	estrogens synthetic a	hormone replacement therapy	1.63	0.77	3.05	0.15	10	263	926	39606	1343	estrogens synthetic a	hormone replacement therapy	34.3	74	0	0	80.56	1	0	3	91	3003	1343	estrogens synthetic a	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	1343	estrogens synthetic a	hormone replacement therapy	0	0	96.53	1	0	3	56	2201	1343	estrogens synthetic a	hormone replacement therapy	-10.94	1.77344762885484e-05	509.34	0.98	-0.03	0.01	0	0.43	0.2	0.03
1344	levobupivacaine	0.31	0.04	1.12	0.1	2	318	177547	8686472	1344	levobupivacaine	anaesthesia	0	0	8.44	1	0	51	60	6553	1344	levobupivacaine	anaesthesia	23	71.2	0	0	355.67	1	0	2	9	567	1344	levobupivacaine	anaesthesia	0	0	6735.01	1	0	2	1	385	1344	levobupivacaine	anaesthesia	0	0	38	1	0	7	10	478	1344	levobupivacaine	anaesthesia	-13.43	1.47036483631174e-06	1292.08	0.99	0	0.01	0.91	-2.09	1.05	0.05
1345	celecoxib	2.15	2.08	2.23	0	3670	84271	173879	8602519	1345	celecoxib	rheumatoid arthritis	1.88	1.61	2.18	1.6e-14	189	13932	3221	446445	1345	celecoxib	rheumatoid arthritis	33	75	1.48	1.04	2.06	0.021	38	2785	1022	111153	1345	celecoxib	rheumatoid arthritis	3.4	1.76	6.02	0.00026	13	568	167	24823	1345	celecoxib	rheumatoid arthritis	1.18	0.78	1.71	0.36	29	2638	982	105326	1345	celecoxib	rheumatoid arthritis	0.42	1.52196155561863	0.16	0.01	-0.01	0	0	-0.26	0.08	0
1346	almotriptan malate	2.86	1.97	4.02	1.3e-07	35	599	177514	8686191	1346	almotriptan malate	migraine	1.49	0.87	2.41	0.11	18	273	1769	39972	1346	almotriptan malate	migraine	20.7	70.1	1.68	0.19	6.65	0.35	2	33	265	7367	1346	almotriptan malate	migraine	0	0	81.07	1	0	3	32	1046	1346	almotriptan malate	migraine	1.56	0.18	6.12	0.38	2	35	263	7166	1346	almotriptan malate	migraine	0.47	1.59999419321736	0.73	0.52	-0.02	0	0	-0.21	0.19	0.28
1347	frovatriptan succinate	2.6	1.83	3.6	3.7e-07	38	715	177511	8686075	1347	frovatriptan succinate	migraine	1.31	0.76	2.11	0.27	18	310	1769	39935	1347	frovatriptan succinate	migraine	20.7	70.1	4.39	1.33	11.48	0.0086	5	32	262	7368	1347	frovatriptan succinate	migraine	0	0	51.02	1	0	4	32	1045	1347	frovatriptan succinate	migraine	4.31	1.3	11.26	0.0093	5	32	260	7169	1347	frovatriptan succinate	migraine	1.37	3.93535069547047	0.48	0	-0.02	0	0	-0.2	0.19	0.29
1348	amprenavir	1.1	0.54	1.98	0.75	11	490	177538	8686300	1348	amprenavir	hiv infection	0	0	1.2	0.081	0	361	500	58030	1348	amprenavir	hiv infection	25	64	0	0	15.6	1	0	17	120	7624	1348	amprenavir	hiv infection	0	0	26.98	1	0	10	96	5718	1348	amprenavir	hiv infection	0	0	35.43	1	0	11	40	3428	1348	amprenavir	hiv infection	-11.3	1.23729242617882e-05	317.01	0.97	0	0.01	0.8	0.38	0.2	0.05
1350	oxcarbazepine	1.49	1.37	1.62	8.2e-18	542	17817	177007	8668973	1350	oxcarbazepine	epilepsy	1.15	0.85	1.55	0.34	50	3106	590	42320	1350	oxcarbazepine	epilepsy	13.6	68.1	1.43	0.55	3.13	0.35	7	306	80	5008	1350	oxcarbazepine	epilepsy	2.29	0.69	5.95	0.085	5	203	36	3349	1350	oxcarbazepine	epilepsy	0.67	0.08	2.59	1	2	218	54	3966	1350	oxcarbazepine	epilepsy	0.33	1.39096812846378	0.4	0.41	0	0	0.53	-0.15	0.21	0.47
1351	eletriptan	2	1.73	2.3	1.9e-18	204	5003	177345	8681787	1351	eletriptan	migraine	0.9	0.73	1.11	0.36	100	2477	1687	37768	1351	eletriptan	migraine	20.7	70.1	0.47	0.21	0.92	0.025	9	510	258	6890	1351	eletriptan	migraine	0	0	2.2	0.41	0	57	32	992	1351	eletriptan	migraine	0.55	0.26	1.03	0.059	10	482	255	6719	1351	eletriptan	migraine	-0.65	0.522045776761016	0.33	0.05	-0.02	0	0	-0.22	0.19	0.26
1352	insulin lispro protamine recombinant	0.81	0.6	1.08	0.15	49	2955	177500	8683835	1352	insulin lispro protamine recombinant	diabetes mellitus	1.64	0.99	2.54	0.042	20	1280	2307	241618	1352	insulin lispro protamine recombinant	diabetes mellitus	39.3	82	0	0	335.36	1	0	3	377	52481	1352	insulin lispro protamine recombinant	diabetes mellitus	0	0	515.16	1	0	3	140	29741	1352	insulin lispro protamine recombinant	diabetes mellitus	0	0	Inf	1	0	0	281	28202	1352	insulin lispro protamine recombinant	diabetes mellitus	-7.36	0.000636198459538505	187.46	0.97	-0.01	0	0	-0.75	0.1	0
1353	cyclosporine	0.51	0.47	0.55	1.9e-71	557	53629	176992	8633161	1353	cyclosporine	renal transplant	0.96	0.57	1.57	1	24	6359	60	15280	1353	cyclosporine	renal transplant	34	58.8	0.95	0.02	7.14	1	1	195	8	1480	1353	cyclosporine	renal transplant	0	0	9.6	1	0	312	4	1969	1353	cyclosporine	renal transplant	6.91	1.28	37.43	0.012	4	190	4	1316	1353	cyclosporine	renal transplant	1.31	3.7061737122102	0.62	0.04	-0.02	0.02	0.32	-1.1	0.61	0.07
1354	rifapentine	0	0	2.22	0.42	0	83	177549	8686707	1354	rifapentine	latent tuberculosis	0	0	10.39	1	0	39	6	461	1354	rifapentine	latent tuberculosis	31	31	0	0	Inf	1	0	0	0	0	1354	rifapentine	latent tuberculosis	0	0	Inf	1	0	11	0	85	1354	rifapentine	latent tuberculosis	0	0	751.58	1	0	4	1	77	1354	rifapentine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1355	petrolatum, white	1.14	0.03	6.69	0.59	1	43	177548	8686747	1355	petrolatum, white	dermatitis diaper	0	0	941.46	1	0	8	1	195	1355	petrolatum, white	dermatitis diaper	NA	NA	0	0	Inf	1	0	0	0	0	1355	petrolatum, white	dermatitis diaper	0	0	Inf	1	0	0	0	15	1355	petrolatum, white	dermatitis diaper	0	0	Inf	1	0	0	0	3	1355	petrolatum, white	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1356	zinc oxide	2.39	1.7	3.27	1.4e-06	41	840	177508	8685950	1356	zinc oxide	hypertension	0	0	1.79	0.28	0	97	6895	317516	1356	zinc oxide	hypertension	38	82.9	0	0	8.64	1	0	29	981	62380	1356	zinc oxide	hypertension	0	0	18.87	1	0	20	341	31619	1356	zinc oxide	hypertension	0	0	10.63	1	0	20	762	39910	1356	zinc oxide	hypertension	-10.19	3.7543886597474e-05	136.78	0.94	-0.02	0	0	-0.59	0.07	0
1357	temozolomide	0.34	0.26	0.43	2.7e-25	64	9237	177485	8677553	1357	temozolomide	glioblastoma multiforme	3	1.33	7.38	0.004	23	2063	9	2420	1357	temozolomide	glioblastoma multiforme	NA	NA	0	0	Inf	1	0	0	0	0	1357	temozolomide	glioblastoma multiforme	0	0	Inf	1	0	93	0	121	1357	temozolomide	glioblastoma multiforme	0	0	Inf	1	0	72	0	57	1357	temozolomide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1358	levetiracetam	1.06	1	1.12	0.065	1087	50239	176462	8636551	1358	levetiracetam	epilepsy	1.47	1.24	1.73	7.9e-06	222	12068	418	33358	1358	levetiracetam	epilepsy	13.6	68.1	2.13	1.36	3.34	0.00054	45	1776	42	3538	1358	levetiracetam	epilepsy	1.12	0.55	2.2	0.74	15	1209	26	2343	1358	levetiracetam	epilepsy	2.6	1.48	4.63	0.00053	32	1418	24	2766	1358	levetiracetam	epilepsy	0.6	1.82211880039051	0.21	0	0	0	0.72	-0.15	0.21	0.47
1359	zanamivir	0.26	0.16	0.41	1.8e-13	19	3563	177530	8683227	1359	zanamivir	influenza	0.36	0.2	0.62	3.9e-05	15	2181	139	7319	1359	zanamivir	influenza	5.9	81.3	0	0	1.55	0.16	0	102	31	1230	1359	zanamivir	influenza	0	0	2.89	0.63	0	54	17	624	1359	zanamivir	influenza	0	0	3.64	0.62	0	55	18	852	1359	zanamivir	influenza	-14.8	3.73629937988526e-07	623.31	0.98	0.01	0.01	0.35	0.28	0.34	0.41
1360	dexmedetomidine	1.81	1.34	2.41	0.00015	49	1321	177500	8685469	1360	dexmedetomidine	sedation	0.57	0.18	1.38	0.28	5	406	109	5039	1360	dexmedetomidine	sedation	9.5	66	1.93	0.35	7.11	0.4	3	58	15	560	1360	dexmedetomidine	sedation	0	0	6	1	0	57	7	480	1360	dexmedetomidine	sedation	1.83	0.32	7.21	0.41	3	56	11	376	1360	dexmedetomidine	sedation	0.16	1.17351087099181	0.63	0.8	-0.01	0.01	0.27	-0.93	0.47	0.05
1361	rofecoxib	4.75	4.63	4.87	0	6717	71305	170832	8615485	1361	rofecoxib	arthritis	4.54	4.19	4.92	3.10000000000167e-312	1662	13933	1062	40438	1361	rofecoxib	arthritis	31.8	81	14.64	0.3	149.24	0.082	1	4	140	8208	1361	rofecoxib	arthritis	0	0	Inf	1	0	0	41	2514	1361	rofecoxib	arthritis	12.3	0.26	111.4	0.093	1	5	117	7204	1361	rofecoxib	arthritis	2.41	11.1339611450653	1.11	0.03	-0.02	0	0	0	0.18	1
1362	piperonyl butoxide	0	0	1.03	0.055	0	177	177549	8686613	1362	piperonyl butoxide	lice infestation	0	0	3.8	0.6	0	135	6	596	1362	piperonyl butoxide	lice infestation	36.2	68.2	0	0	Inf	1	0	0	0	53	1362	piperonyl butoxide	lice infestation	0	0	Inf	1	0	0	0	24	1362	piperonyl butoxide	lice infestation	0	0	1929.08	1	0	1	2	101	1362	piperonyl butoxide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1363	pyrethrins	0	0	1.05	0.054	0	173	177549	8686617	1363	pyrethrins	lice infestation	0	0	3.9	0.6	0	132	6	599	1363	pyrethrins	lice infestation	36.2	68.2	0	0	Inf	1	0	0	0	53	1363	pyrethrins	lice infestation	0	0	Inf	1	0	0	0	24	1363	pyrethrins	lice infestation	0	0	Inf	1	0	0	2	102	1363	pyrethrins	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1364	bexarotene	0.94	0.48	1.65	1	12	625	177537	8686165	1364	bexarotene	mycosis fungoides	5.68	0.41	78.51	0.11	2	298	2	1695	1364	bexarotene	mycosis fungoides	39.4	63.3	Inf	1.38	Inf	0.014	2	42	0	319	1364	bexarotene	mycosis fungoides	17.18	0.88	1018.95	0.031	2	57	1	495	1364	bexarotene	mycosis fungoides	0	0	Inf	1	0	51	0	427	1364	bexarotene	mycosis fungoides	2.79	16.2810198017884	1.26	0.03	-0.06	0.03	0.05	18.51	3147.51	1
1365	ganirelix acetate	0.55	0.15	1.42	0.34	4	356	177545	8686434	1365	ganirelix acetate	in vitro fertilisation	0	0	3.63	0.61	0	124	10	994	1365	ganirelix acetate	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	6	0	61	1365	ganirelix acetate	in vitro fertilisation	0	0	Inf	1	0	0	0	1	1365	ganirelix acetate	in vitro fertilisation	0	0	74.63	1	0	13	2	175	1365	ganirelix acetate	in vitro fertilisation	-15.04	2.93907718950344e-07	2977.28	1	-0.05	0.1	0.65	-16.65	10754.01	1
1366	ziconotide acetate	2.39	1.86	3.03	1.9e-10	71	1454	177478	8685336	1366	ziconotide acetate	pain	1.24	0.87	1.73	0.2	38	681	8431	187803	1366	ziconotide acetate	pain	23	79	1.49	0.67	2.9	0.22	9	200	1079	35817	1366	ziconotide acetate	pain	2.14	0.68	5.21	0.095	5	99	359	15218	1366	ziconotide acetate	pain	1.11	0.3	2.93	0.79	4	112	853	26478	1366	ziconotide acetate	pain	0.42	1.52196155561863	0.34	0.22	-0.02	0	0	-0.28	0.06	0
1367	perflutren	0.51	0.32	0.77	0.00051	22	2130	177527	8684660	1367	perflutren	echocardiogram	0.11	0.05	0.25	4e-08	12	802	17	126	1367	perflutren	echocardiogram	26.6	85.1	Inf	0.03	Inf	1	2	159	0	24	1367	perflutren	echocardiogram	0	0	Inf	1	0	105	0	16	1367	perflutren	echocardiogram	Inf	0.07	Inf	1	4	65	0	8	1367	perflutren	echocardiogram	17.39	35676401.2941734	5187	1	0	0.03	0.87	-18.57	2601.11	0.99
1368	ketotifen fumarate	0.95	0.63	1.37	0.86	29	1497	177520	8685293	1368	ketotifen fumarate	eye pruritus	0.82	0.15	2.82	1	3	362	18	1775	1368	ketotifen fumarate	eye pruritus	43.6	81	0	0	61.06	1	0	26	2	292	1368	ketotifen fumarate	eye pruritus	0	0	Inf	1	0	8	0	179	1368	ketotifen fumarate	eye pruritus	0	0	17.81	1	0	35	4	399	1368	ketotifen fumarate	eye pruritus	-16.8	5.05653134833552e-08	4282.91	1	0.02	0.03	0.35	-16.74	2087.41	0.99
1369	rosiglitazone maleate	0.49	0.46	0.51	3.4e-212	1481	147867	176068	8538923	1369	rosiglitazone maleate	diabetes mellitus	0.19	0.17	0.22	4.6e-220	290	103707	2037	139191	1369	rosiglitazone maleate	diabetes mellitus	39.3	82	0.02	0.01	0.05	5e-80	6	22521	371	29963	1369	rosiglitazone maleate	diabetes mellitus	0.02	0	0.06	9.4e-34	2	13583	138	16161	1369	rosiglitazone maleate	diabetes mellitus	0.03	0.01	0.07	2.6e-47	4	10145	277	18057	1369	rosiglitazone maleate	diabetes mellitus	-3.85	0.0212797364383772	0.41	0	-0.02	0	0	-0.58	0.1	0
1370	pioglitazone	1.09	1.02	1.16	0.0077	994	44627	176555	8642163	1370	pioglitazone	type 2 diabetes mellitus	0.81	0.66	0.99	0.036	113	15729	1109	125369	1370	pioglitazone	type 2 diabetes mellitus	43	80.7	1.65	0.83	2.95	0.093	12	1181	202	32713	1370	pioglitazone	type 2 diabetes mellitus	0.72	0.14	2.18	0.8	3	870	82	17066	1370	pioglitazone	type 2 diabetes mellitus	2.86	1.33	5.46	0.0041	10	509	144	20965	1370	pioglitazone	type 2 diabetes mellitus	0.54	1.71600686218486	0.29	0.06	0	0	0.69	-0.43	0.14	0
1371	proguanil	1.76	1.38	2.21	8.1e-06	76	2114	177473	8684676	1371	proguanil	malaria prophylaxis	0.15	0.11	0.21	2.9e-45	54	1177	303	1012	1371	proguanil	malaria prophylaxis	16	61	0.42	0.13	1.18	0.1	7	65	15	58	1371	proguanil	malaria prophylaxis	0.81	0.19	3.17	1	5	30	8	39	1371	proguanil	malaria prophylaxis	0.25	0.06	0.92	0.025	4	64	11	44	1371	proguanil	malaria prophylaxis	-0.79	0.453844795282356	0.44	0.07	-0.02	0.01	0.06	0.3	0.42	0.48
1372	pemirolast potassium	1.22	0.03	7.22	0.56	1	40	177548	8686750	1372	pemirolast potassium	asthma	0	0	22.89	1	0	7	3044	100367	1372	pemirolast potassium	asthma	9	76	0	0	Inf	1	0	0	540	17516	1372	pemirolast potassium	asthma	0	0	Inf	1	0	0	147	6258	1372	pemirolast potassium	asthma	0	0	Inf	1	0	0	458	14562	1372	pemirolast potassium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1373	insulin glargine recombinant	0.8	0.76	0.84	2.8e-19	1605	97576	175944	8589214	1373	insulin glargine recombinant	type 2 diabetes mellitus	0.92	0.79	1.07	0.31	200	24729	1022	116369	1373	insulin glargine recombinant	type 2 diabetes mellitus	43	80.7	0.98	0.69	1.35	0.94	48	7750	166	26144	1373	insulin glargine recombinant	type 2 diabetes mellitus	0.79	0.41	1.41	0.5	14	3595	71	14341	1373	insulin glargine recombinant	type 2 diabetes mellitus	0.99	0.66	1.44	1	37	5205	117	16269	1373	insulin glargine recombinant	type 2 diabetes mellitus	-0.08	0.923116346386636	0.16	0.63	0	0	0.76	-0.42	0.14	0
1374	sirolimus	0.31	0.24	0.4	2.3e-32	70	10909	177479	8675881	1374	sirolimus	prophylaxis against transplant rejection	0.15	0.05	0.34	1.7e-08	6	3850	64	5998	1374	sirolimus	prophylaxis against transplant rejection	14.5	68.6	0	0	7.06	1	0	159	5	1020	1374	sirolimus	prophylaxis against transplant rejection	0	0	7.34	1	0	113	5	751	1374	sirolimus	prophylaxis against transplant rejection	0	0	23.85	1	0	105	2	467	1374	sirolimus	prophylaxis against transplant rejection	-16.27	8.59070447722975e-08	1970.91	0.99	-0.01	0.02	0.62	0.46	0.84	0.58
1377	moxifloxacin	2.9	2.75	3.05	2.1e-254	1469	24947	176080	8661843	1377	moxifloxacin	pneumonia	1.37	1.02	1.82	0.032	60	2039	335	15626	1377	moxifloxacin	pneumonia	28	83	2.76	1.03	6.34	0.022	7	148	42	2452	1377	moxifloxacin	pneumonia	3.28	0.35	14.88	0.15	2	73	13	1556	1377	moxifloxacin	pneumonia	1.86	0.56	4.84	0.21	5	106	41	1617	1377	moxifloxacin	pneumonia	0.73	2.07508060767412	0.41	0.07	-0.01	0.01	0.03	-1.04	0.3	0
1378	oseltamivir phosphate	1.12	0.99	1.26	0.07	281	12312	177268	8674478	1378	oseltamivir phosphate	influenza	1.13	0.81	1.58	0.46	78	4519	76	4981	1378	oseltamivir phosphate	influenza	5.9	81.3	1.21	0.56	2.68	0.72	17	667	14	665	1378	oseltamivir phosphate	influenza	2.31	0.75	8.48	0.14	12	345	5	333	1378	oseltamivir phosphate	influenza	0.71	0.24	2.01	0.48	8	482	10	425	1378	oseltamivir phosphate	influenza	0.29	1.33642748802547	0.35	0.41	0.01	0.01	0.23	0.27	0.34	0.43
1379	sodium phosphate, dibasic anhydrous	3.6	2.27	5.46	2.6e-07	24	326	177525	8686464	1379	sodium phosphate, dibasic anhydrous	colonoscopy	0.84	0.1	3.2	1	2	169	68	4820	1379	sodium phosphate, dibasic anhydrous	colonoscopy	31	72.5	0	0	Inf	1	0	0	14	1140	1379	sodium phosphate, dibasic anhydrous	colonoscopy	0	0	Inf	1	0	0	9	508	1379	sodium phosphate, dibasic anhydrous	colonoscopy	0	0	Inf	1	0	0	7	1026	1379	sodium phosphate, dibasic anhydrous	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1380	sodium phosphate, monobasic, monohydrate	3.07	2.2	4.18	7.5e-10	43	686	177506	8686104	1380	sodium phosphate, monobasic, monohydrate	colonoscopy	0.54	0.11	1.66	0.37	3	383	67	4606	1380	sodium phosphate, monobasic, monohydrate	colonoscopy	31	72.5	0	0	39.97	1	0	10	14	1130	1380	sodium phosphate, monobasic, monohydrate	colonoscopy	0	0	95.13	1	0	4	9	504	1380	sodium phosphate, monobasic, monohydrate	colonoscopy	0	0	147.93	1	0	6	7	1020	1380	sodium phosphate, monobasic, monohydrate	colonoscopy	-13.11	2.02488023978819e-06	1229.72	0.99	-0.03	0.02	0.09	0.92	0.51	0.07
1381	drospirenone	10.78	10.57	10.99	0	13451	65588	164098	8621202	1381	drospirenone	contraception	6.52	6.21	6.83	0	3429	15339	4572	133295	1381	drospirenone	contraception	19	43	3.67	3.03	4.43	1.5e-34	152	621	1563	23460	1381	drospirenone	contraception	0	0	Inf	1	0	0	0	22	1381	drospirenone	contraception	3.86	3.25	4.58	2.7e-44	185	768	1754	28137	1381	drospirenone	contraception	1.35	3.85742553069697	0.09	0	0	0	0.55	-10.8	114.14	0.92
1382	pegvisomant	0.57	0.33	0.91	0.016	17	1472	177532	8685318	1382	pegvisomant	acromegaly	0.31	0.15	0.55	6.5e-06	12	1025	152	3964	1382	pegvisomant	acromegaly	33.7	68.4	0.18	0.04	0.57	0.00059	3	234	45	632	1382	pegvisomant	acromegaly	0	0	0.72	0.015	0	123	15	311	1382	pegvisomant	acromegaly	0.19	0.04	0.62	0.0012	3	225	39	564	1382	pegvisomant	acromegaly	-1.99	0.136695425445524	0.6	0	-0.02	0.01	0.04	-0.43	0.31	0.16
1383	alosetron	1.42	0.9	2.13	0.11	24	828	177525	8685962	1383	alosetron	irritable bowel syndrome	0.47	0.21	0.92	0.02	9	463	377	9179	1383	alosetron	irritable bowel syndrome	21	70.7	4.75	0.5	22.45	0.084	2	11	62	1622	1383	alosetron	irritable bowel syndrome	0	0	359.06	1	0	2	8	505	1383	alosetron	irritable bowel syndrome	6.34	0.65	31.58	0.053	2	9	63	1803	1383	alosetron	irritable bowel syndrome	1.75	5.75460267600573	0.79	0.03	-0.03	0.01	0	-0.88	0.38	0.02
1384	hydroquinone	1.71	1.02	2.69	0.033	19	544	177530	8686246	1384	hydroquinone	therapeutic skin care topical	0	0	16.78	1	0	112	4	1229	1384	hydroquinone	therapeutic skin care topical	14.1	34.4	0	0	Inf	1	0	6	0	149	1384	hydroquinone	therapeutic skin care topical	0	0	528.61	1	0	9	1	122	1384	hydroquinone	therapeutic skin care topical	0	0	252.78	1	0	71	1	461	1384	hydroquinone	therapeutic skin care topical	-14.91	3.34710452418847e-07	3137.26	1	-0.06	0.05	0.21	1.13	1.43	0.43
1386	levothyroxine sodium	2.04	1.99	2.08	0	7833	192455	169716	8494335	1386	levothyroxine sodium	hypothyroidism	2.16	1.95	2.4	6.9e-54	1602	33495	483	21796	1386	levothyroxine sodium	hypothyroidism	28	82.3	1.7	1.36	2.13	1.5e-06	186	5261	154	7415	1386	levothyroxine sodium	hypothyroidism	2.04	1.16	3.58	0.01	29	893	28	1760	1386	levothyroxine sodium	hypothyroidism	1.63	1.3	2.05	1.8e-05	176	4986	147	6788	1386	levothyroxine sodium	hypothyroidism	0.53	1.69893230861855	0.1	0	-0.02	0	0	-0.19	0.15	0.18
1387	verteporfin	0.25	0.12	0.48	3.3e-07	9	1740	177540	8685050	1387	verteporfin	macular degeneration	0.5	0.06	1.93	0.43	2	804	36	7171	1387	verteporfin	macular degeneration	55.9	75.8	0	0	277.63	1	0	4	2	183	1387	verteporfin	macular degeneration	0	0	Inf	1	0	3	0	180	1387	verteporfin	macular degeneration	0	0	110.67	1	0	9	3	376	1387	verteporfin	macular degeneration	-15.89	1.25620547694366e-07	7917.51	1	-0.06	0.03	0.04	-16.54	2098.13	0.99
1388	linezolid	1.2	1.05	1.36	0.0056	254	10386	177295	8676404	1388	linezolid	tuberculosis	0	0	1.92	0.26	0	272	29	3816	1388	linezolid	tuberculosis	23.8	59	0	0	4.68	0.6	0	88	7	583	1388	linezolid	tuberculosis	0	0	6.84	1	0	87	5	537	1388	linezolid	tuberculosis	0	0	25.03	1	0	30	4	479	1388	linezolid	tuberculosis	-16	1.12535174719259e-07	1635.65	0.99	-0.01	0.02	0.43	0.2	0.68	0.77
1389	iron sucrose	1.14	0.92	1.41	0.21	90	3851	177459	8682939	1389	iron sucrose	anaemia	1.33	0.77	2.14	0.27	18	568	450	18842	1389	iron sucrose	anaemia	22.2	83.9	0.78	0.02	4.62	1	1	91	56	3959	1389	iron sucrose	anaemia	0	0	37.98	1	0	42	6	1824	1389	iron sucrose	anaemia	0.81	0.02	4.87	1	1	57	58	2674	1389	iron sucrose	anaemia	-0.35	0.704688089718713	1.02	0.73	-0.01	0.01	0.15	-1.85	0.43	0
1391	colesevelam	1	0.83	1.18	1	135	6628	177414	8680162	1391	colesevelam	blood cholesterol increased	0.76	0.44	1.23	0.33	17	928	2239	93300	1391	colesevelam	blood cholesterol increased	39.3	79.8	0	0	1.23	0.13	0	175	293	16803	1391	colesevelam	blood cholesterol increased	0	0	5.05	1	0	55	93	6634	1391	colesevelam	blood cholesterol increased	0	0	1.39	0.12	0	143	234	12351	1391	colesevelam	blood cholesterol increased	-13.43	1.47036483631174e-06	279.57	0.96	-0.03	0	0	-0.27	0.12	0.03
1392	telithromycin	0.99	0.8	1.22	1	94	4631	177455	8682159	1392	telithromycin	sinusitis	0.17	0.08	0.31	9.8e-15	11	1055	805	13191	1392	telithromycin	sinusitis	22.9	65.1	0	0	453.66	1	0	1	144	1686	1392	telithromycin	sinusitis	0	0	768.51	1	0	1	36	717	1392	telithromycin	sinusitis	0	0	Inf	1	0	0	124	1763	1392	telithromycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1393	choriogonadotropin alfa	0.18	0	0.99	0.05	1	278	177548	8686512	1393	choriogonadotropin alfa	in vitro fertilisation	0	0	8.37	1	0	58	10	1060	1393	choriogonadotropin alfa	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	0	0	67	1393	choriogonadotropin alfa	in vitro fertilisation	0	0	Inf	1	0	1	0	0	1393	choriogonadotropin alfa	in vitro fertilisation	0	0	664.69	1	0	2	2	186	1393	choriogonadotropin alfa	in vitro fertilisation	-13.87	9.46968506864711e-07	4610.98	1	-0.05	0.1	0.64	-1.78	7987.86	1
1394	esomeprazole magnesium	1.84	1.79	1.9	0	5164	138933	172385	8547857	1394	esomeprazole magnesium	gastrooesophageal reflux disease	1.35	1.25	1.46	3.5e-14	1065	22569	1903	54459	1394	esomeprazole magnesium	gastrooesophageal reflux disease	22.4	77.2	1.78	1.46	2.16	7.2e-09	170	4421	308	14276	1394	esomeprazole magnesium	gastrooesophageal reflux disease	2.09	1.45	2.97	6.4e-05	50	1537	102	6546	1394	esomeprazole magnesium	gastrooesophageal reflux disease	1.59	1.27	1.98	3.7e-05	133	3643	247	10746	1394	esomeprazole magnesium	gastrooesophageal reflux disease	0.58	1.78603843075007	0.09	0	-0.02	0	0	-0.31	0.1	0
1395	gemifloxacin mesylate	0.73	0.44	1.13	0.18	20	1344	177529	8685446	1395	gemifloxacin mesylate	respiratory tract infection bacterial	Inf	0.05	Inf	1	5	1067	0	55	1395	gemifloxacin mesylate	respiratory tract infection bacterial	NA	NA	0	0	Inf	1	0	0	0	0	1395	gemifloxacin mesylate	respiratory tract infection bacterial	0	0	Inf	1	0	0	0	4	1395	gemifloxacin mesylate	respiratory tract infection bacterial	0	0	Inf	1	0	0	0	16	1395	gemifloxacin mesylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1396	alpha-tocopherol acetate	1.96	0.05	11.95	0.41	1	25	177548	8686765	1396	alpha-tocopherol acetate	parenteral nutrition	0	0	218.5	1	0	6	4	733	1396	alpha-tocopherol acetate	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	1396	alpha-tocopherol acetate	parenteral nutrition	0	0	Inf	1	0	0	0	64	1396	alpha-tocopherol acetate	parenteral nutrition	0	0	Inf	1	0	0	0	78	1396	alpha-tocopherol acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1397	cholecalciferol	6.07	5.74	6.42	0	1407	11420	176142	8675370	1397	cholecalciferol	osteoporosis	5.56	5.17	5.97	0	1060	3791	7742	153895	1397	cholecalciferol	osteoporosis	53.1	85	1.56	0.56	3.52	0.29	6	117	802	24451	1397	cholecalciferol	osteoporosis	0	0	12.96	1	0	30	31	2905	1397	cholecalciferol	osteoporosis	1.83	0.72	3.9	0.12	7	119	861	26768	1397	cholecalciferol	osteoporosis	0.49	1.63231621995538	0.39	0.21	-0.01	0	0	-1.15	0.18	0
1398	vitamin k	1.79	1.48	2.15	1.2e-08	119	3259	177430	8683531	1398	vitamin k	prophylaxis	1.29	0.35	3.36	0.56	4	251	1275	103300	1398	vitamin k	prophylaxis	23.9	79.7	1.94	0.05	11.36	0.41	1	59	206	23601	1398	vitamin k	prophylaxis	3.93	0.1	23.7	0.23	1	43	81	13685	1398	vitamin k	prophylaxis	0	0	10.02	1	0	38	148	14374	1398	vitamin k	prophylaxis	0.39	1.47698079388264	1.01	0.7	-0.01	0	0.03	-0.52	0.14	0
1399	desloratadine	2.9	2.62	3.19	1.1e-76	433	7327	177116	8679463	1399	desloratadine	asthma	0.99	0.61	1.51	1	22	734	3022	99640	1399	desloratadine	asthma	9	76	0.91	0.11	3.44	1	2	71	538	17445	1399	desloratadine	asthma	0	0	8.24	1	0	21	147	6237	1399	desloratadine	asthma	1.08	0.13	4.09	0.71	2	59	456	14503	1399	desloratadine	asthma	-0.17	0.843664816596384	0.72	0.82	-0.02	0	0	-0.41	0.1	0
1400	galantamine	0.93	0.69	1.23	0.68	52	2727	177497	8684063	1400	galantamine	dementia alzheimer s type	1.47	0.82	2.46	0.16	16	867	192	15290	1400	galantamine	dementia alzheimer s type	63	90	5.27	0.58	23.14	0.066	2	35	20	1850	1400	galantamine	dementia alzheimer s type	3.38	0.08	24.86	0.28	1	19	13	838	1400	galantamine	dementia alzheimer s type	9.18	0.95	45.23	0.028	2	27	11	1370	1400	galantamine	dementia alzheimer s type	1.78	5.92985641859115	0.63	0	0	0.02	0.92	0.55	0.39	0.16
1401	insulin aspart protamine recombinant	0.6	0.4	0.87	0.0043	29	2356	177520	8684434	1401	insulin aspart protamine recombinant	type 2 diabetes mellitus	0.19	0	1.06	0.072	1	608	1221	140490	1401	insulin aspart protamine recombinant	type 2 diabetes mellitus	43	80.7	1.11	0.03	6.34	0.6	1	143	213	33751	1401	insulin aspart protamine recombinant	type 2 diabetes mellitus	0	0	11.79	1	0	69	85	17867	1401	insulin aspart protamine recombinant	type 2 diabetes mellitus	1.49	0.04	8.61	0.49	1	94	153	21380	1401	insulin aspart protamine recombinant	type 2 diabetes mellitus	0	1	1.01	1	0	0	0.71	-0.41	0.14	0
1402	gemtuzumab ozogamicin	0.06	0.02	0.14	2.7e-25	4	3520	177545	8683270	1402	gemtuzumab ozogamicin	acute myeloid leukaemia	0.72	0.18	2.08	0.81	4	2383	27	11626	1402	gemtuzumab ozogamicin	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	69	0	751	1402	gemtuzumab ozogamicin	acute myeloid leukaemia	0	0	594.75	1	0	84	1	1292	1402	gemtuzumab ozogamicin	acute myeloid leukaemia	0	0	87.37	1	0	65	2	1061	1402	gemtuzumab ozogamicin	acute myeloid leukaemia	-14.9	3.38074348390474e-07	2367.07	0.99	0	0.03	0.87	-0.88	1.23	0.47
1403	norelgestromin	0.27	0.22	0.33	1.8e-64	108	19292	177441	8667498	1403	norelgestromin	contraception	0.09	0.07	0.12	9.5e-243	84	15096	7917	133538	1403	norelgestromin	contraception	19	43	0.22	0.11	0.39	2.7e-11	12	751	1703	23330	1403	norelgestromin	contraception	0	0	Inf	1	0	3	0	19	1403	norelgestromin	contraception	0.22	0.12	0.38	1.6e-12	14	911	1925	27994	1403	norelgestromin	contraception	-1.5	0.22313016014843	0.27	0	0	0	0.86	-10.76	112.99	0.92
1404	etonogestrel	1.86	1.77	1.95	4.8e-119	1752	46272	175797	8640518	1404	etonogestrel	contraception	0.89	0.84	0.95	0.00018	1330	27155	6671	121479	1404	etonogestrel	contraception	19	43	0.28	0.23	0.34	4.1e-56	124	5206	1591	18875	1404	etonogestrel	contraception	0	0	Inf	1	0	2	0	20	1404	etonogestrel	contraception	0.29	0.24	0.34	3.4e-64	152	6537	1787	22368	1404	etonogestrel	contraception	-1.28	0.278037300453194	0.09	0	-0.01	0	0	-11.02	113.31	0.92
1405	dimyristoyl lecithin	0	0	118.34	1	0	3	177549	8686787	1405	dimyristoyl lecithin	scan with contrast	0	0	2038.94	1	0	1	13	701	1405	dimyristoyl lecithin	scan with contrast	18.7	31.3	0	0	Inf	1	0	0	0	16	1405	dimyristoyl lecithin	scan with contrast	0	0	Inf	1	0	0	1	75	1405	dimyristoyl lecithin	scan with contrast	0	0	Inf	1	0	0	1	106	1405	dimyristoyl lecithin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1406	perflexane	0	0	118.34	1	0	3	177549	8686787	1406	perflexane	scan with contrast	0	0	2038.94	1	0	1	13	701	1406	perflexane	scan with contrast	18.7	31.3	0	0	Inf	1	0	0	0	16	1406	perflexane	scan with contrast	0	0	Inf	1	0	0	1	75	1406	perflexane	scan with contrast	0	0	Inf	1	0	0	1	106	1406	perflexane	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1407	sodium oxybate	2.86	2.74	2.99	0	2187	37730	175362	8649060	1407	sodium oxybate	narcolepsy	1.43	1.16	1.79	0.00061	1760	28680	94	2196	1407	sodium oxybate	narcolepsy	18.4	61.1	1.35	0.77	2.58	0.37	627	8598	13	240	1407	sodium oxybate	narcolepsy	0.86	0.39	2.22	0.67	155	2811	7	109	1407	sodium oxybate	narcolepsy	1.78	0.91	3.96	0.11	542	7448	9	220	1407	sodium oxybate	narcolepsy	0.27	1.30996445073325	0.26	0.29	-0.01	0	0	-0.25	0.09	0.01
1408	cetrorelix	0.36	0.04	1.3	0.19	2	275	177547	8686515	1408	cetrorelix	ovulation induction	0	0	10.19	1	0	68	6	800	1408	cetrorelix	ovulation induction	34	34.9	0	0	Inf	1	0	3	0	6	1408	cetrorelix	ovulation induction	0	0	Inf	1	0	0	0	4	1408	cetrorelix	ovulation induction	0	0	14.31	1	0	24	3	136	1408	cetrorelix	ovulation induction	-16.92	4.48474099173973e-08	3590.37	1	0.08	0.11	0.5	-14.23	8865.19	1
1409	tegaserod maleate	3	2.69	3.34	1.2e-66	354	5775	177195	8681015	1409	tegaserod maleate	irritable bowel syndrome	0.8	0.61	1.05	0.11	70	2082	316	7560	1409	tegaserod maleate	irritable bowel syndrome	21	70.7	0	0	136.75	1	0	2	64	1631	1409	tegaserod maleate	irritable bowel syndrome	0	0	2379.76	1	0	1	8	506	1409	tegaserod maleate	irritable bowel syndrome	0	0	1069.06	1	0	1	65	1811	1409	tegaserod maleate	irritable bowel syndrome	-11.31	1.22498116083745e-05	603.93	0.99	-0.03	0.01	0	-0.89	0.38	0.02
1410	polidocanol	0	0	0.94	0.037	0	194	177549	8686596	1410	polidocanol	varicose vein	0	0	4.92	0.6	0	64	7	443	1410	polidocanol	varicose vein	91	91.5	0	0	Inf	1	0	0	0	0	1410	polidocanol	varicose vein	0	0	Inf	1	0	4	0	33	1410	polidocanol	varicose vein	0	0	23.46	1	0	18	2	76	1410	polidocanol	varicose vein	100.66	5.20094843996054e+43	92852.37	1	19.76	2654.74	0.99	117.02	87507.76	1
1411	nateglinide	1.33	1.08	1.61	0.0055	105	3872	177444	8682918	1411	nateglinide	diabetes mellitus	1.42	0.7	2.56	0.27	11	810	2316	242088	1411	nateglinide	diabetes mellitus	39.3	82	1.74	0.04	10.05	0.44	1	80	376	52404	1411	nateglinide	diabetes mellitus	3.96	0.1	23.36	0.23	1	54	139	29690	1411	nateglinide	diabetes mellitus	0	0	8.82	1	0	44	281	28158	1411	nateglinide	diabetes mellitus	0.47	1.59999419321736	1.01	0.64	-0.01	0	0	-0.75	0.1	0
1413	unoprostone isopropyl	0.56	0.01	3.18	1	1	88	177548	8686702	1413	unoprostone isopropyl	glaucoma	0	0	10.88	1	0	31	219	18704	1413	unoprostone isopropyl	glaucoma	54.3	87	0	0	427.27	1	0	2	43	3460	1413	unoprostone isopropyl	glaucoma	0	0	Inf	1	0	0	14	1444	1413	unoprostone isopropyl	glaucoma	0	0	433.27	1	0	2	35	2776	1413	unoprostone isopropyl	glaucoma	-10.1	4.10795552253007e-05	624.12	0.99	-0.01	0.01	0.28	-0.27	0.32	0.4
1414	cefditoren pivoxil	0.61	0.32	1.05	0.078	13	1044	177536	8685746	1414	cefditoren pivoxil	adverse event	0	0	105.28	1	0	4	16	1047	1414	cefditoren pivoxil	adverse event	48.2	73.4	0	0	2038.94	1	0	4	1	215	1414	cefditoren pivoxil	adverse event	0	0	2011.51	1	0	4	1	212	1414	cefditoren pivoxil	adverse event	0	0	Inf	1	0	0	2	159	1414	cefditoren pivoxil	adverse event	-12.21	4.98040173750325e-06	1978.09	1	0	0.03	0.92	-0.97	1.23	0.43
1415	zoledronic acid	6.76	6.6	6.92	0	8283	62455	169266	8624335	1415	zoledronic acid	metastases to bone	13.13	9.99	17.57	2.6e-162	1138	10934	55	6938	1415	zoledronic acid	metastases to bone	43.9	84.9	1.3	0.58	2.82	0.46	13	1235	18	2225	1415	zoledronic acid	metastases to bone	1.7	0.35	7.19	0.48	4	553	6	1409	1415	zoledronic acid	metastases to bone	1.13	0.46	2.7	0.84	11	751	14	1083	1415	zoledronic acid	metastases to bone	0.25	1.28402541668774	0.35	0.48	0.02	0.01	0.28	-1.06	0.39	0.01
1416	lopinavir	0.29	0.23	0.35	2.6e-58	106	18157	177443	8668633	1416	lopinavir	hiv infection	0.44	0.32	0.59	1.9e-09	48	11418	452	46973	1416	lopinavir	hiv infection	25	64	0.14	0.02	0.53	4e-04	2	809	118	6832	1416	lopinavir	hiv infection	0.11	0	0.64	0.0045	1	493	95	5235	1416	lopinavir	hiv infection	0.31	0.04	1.22	0.11	2	496	38	2943	1416	lopinavir	hiv infection	-1.64	0.193980042290892	0.59	0	0	0.01	0.65	0.34	0.2	0.09
1417	caspofungin acetate	0.17	0.09	0.3	7.5e-17	12	3396	177537	8683394	1417	caspofungin acetate	prophylaxis	0.3	0.01	1.67	0.27	1	273	1278	103278	1417	caspofungin acetate	prophylaxis	23.9	79.7	1.43	0.04	8.29	0.51	1	80	206	23580	1417	caspofungin acetate	prophylaxis	2.68	0.07	15.9	0.32	1	63	81	13665	1417	caspofungin acetate	prophylaxis	0	0	12.01	1	0	32	148	14380	1417	caspofungin acetate	prophylaxis	0.31	1.36342511413218	1.01	0.76	-0.01	0	0.03	-0.52	0.14	0
1418	omeprazole magnesium	3.41	3.3	3.51	0	4373	63909	173176	8622881	1418	omeprazole magnesium	gastrooesophageal reflux disease	1.92	1.76	2.1	1.6e-41	648	9770	2320	67258	1418	omeprazole magnesium	gastrooesophageal reflux disease	22.4	77.2	1.49	1.15	1.92	0.0023	78	2159	400	16538	1418	omeprazole magnesium	gastrooesophageal reflux disease	1.76	1.09	2.73	0.014	25	814	127	7269	1418	omeprazole magnesium	gastrooesophageal reflux disease	1.48	1.11	1.96	0.0075	62	1671	318	12718	1418	omeprazole magnesium	gastrooesophageal reflux disease	0.42	1.52196155561863	0.12	0	-0.02	0	0	-0.34	0.1	0
1419	nitisinone	0.24	0.03	0.87	0.021	2	409	177547	8686381	1419	nitisinone	tyrosinaemia	0	0	Inf	1	2	331	0	0	1419	nitisinone	tyrosinaemia	0	0	0	0	Inf	1	0	0	0	0	1419	nitisinone	tyrosinaemia	0	0	Inf	1	1	36	0	0	1419	nitisinone	tyrosinaemia	0	0	Inf	1	0	25	0	0	1419	nitisinone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1420	diclofenac epolamine	0.94	0.72	1.2	0.67	63	3288	177486	8683502	1420	diclofenac epolamine	back pain	0.12	0.02	0.35	1.4e-07	3	542	2398	51543	1420	diclofenac epolamine	back pain	26	81	0	0	2.95	0.64	0	49	235	8801	1420	diclofenac epolamine	back pain	0	0	10.92	1	0	18	87	4099	1420	diclofenac epolamine	back pain	0	0	3.61	0.63	0	37	177	6031	1420	diclofenac epolamine	back pain	-12.82	2.70610561241254e-06	320.27	0.97	-0.03	0	0	-0.34	0.13	0.01
1421	arsenic trioxide	0.51	0.28	0.84	0.0049	15	1446	177534	8685344	1421	arsenic trioxide	acute promyelocytic leukaemia	3.6	0.86	21.12	0.064	8	667	3	900	1421	arsenic trioxide	acute promyelocytic leukaemia	46	46	0	0	Inf	1	0	0	0	0	1421	arsenic trioxide	acute promyelocytic leukaemia	0	0	Inf	1	0	31	0	54	1421	arsenic trioxide	acute promyelocytic leukaemia	0	0	54.95	1	0	39	1	54	1421	arsenic trioxide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1422	secretin synthetic human	0	0	1852.91	1	0	1	177549	8686789	1422	secretin synthetic human	nuclear magnetic resonance imaging	0	0	221.22	1	0	1	1146	6522	1422	secretin synthetic human	nuclear magnetic resonance imaging	26.3	65.4	0	0	Inf	1	0	0	10	534	1422	secretin synthetic human	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	3	254	1422	secretin synthetic human	nuclear magnetic resonance imaging	0	0	Inf	1	0	0	9	552	1422	secretin synthetic human	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1423	travoprost	1.35	1.14	1.58	0.00048	154	5597	177395	8681193	1423	travoprost	glaucoma	2.49	1.73	3.5	1.2e-06	43	1675	176	17060	1423	travoprost	glaucoma	54.3	87	2.17	0.91	4.65	0.047	9	377	34	3085	1423	travoprost	glaucoma	4.08	1.06	13.73	0.02	5	173	9	1271	1423	travoprost	glaucoma	1.39	0.42	3.65	0.42	5	298	30	2480	1423	travoprost	glaucoma	0.72	2.05443321064389	0.36	0.04	-0.01	0.01	0.28	-0.28	0.32	0.38
1424	apomorphine	0.76	0.48	1.13	0.21	24	1548	177525	8685242	1424	apomorphine	parkinson s disease	0.62	0.38	0.95	0.03	21	1075	851	26849	1424	apomorphine	parkinson s disease	50.1	85.7	0.69	0.22	1.66	0.56	5	285	158	6213	1424	apomorphine	parkinson s disease	0.78	0.21	2.1	0.82	4	213	94	3919	1424	apomorphine	parkinson s disease	0.68	0.08	2.61	1	2	102	83	2895	1424	apomorphine	parkinson s disease	-0.41	0.663650250136319	0.42	0.33	-0.03	0.01	0	-0.2	0.15	0.19
1425	tocopherol acetate	0.43	0.01	2.42	0.73	1	115	177548	8686675	1425	tocopherol acetate	behcet s syndrome	0	0	545.02	1	0	2	17	1707	1425	tocopherol acetate	behcet s syndrome	NA	NA	0	0	Inf	1	0	0	0	0	1425	tocopherol acetate	behcet s syndrome	0	0	Inf	1	0	0	0	169	1425	tocopherol acetate	behcet s syndrome	0	0	Inf	1	0	2	0	296	1425	tocopherol acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1426	voriconazole	0.37	0.31	0.45	5.4e-34	109	14284	177440	8672506	1426	voriconazole	prophylaxis	0.38	0.14	0.83	0.0097	6	1271	1273	102280	1426	voriconazole	prophylaxis	23.9	79.7	0.94	0.11	3.49	1	2	242	205	23418	1426	voriconazole	prophylaxis	0.93	0.02	5.39	1	1	180	81	13548	1426	voriconazole	prophylaxis	0.69	0.02	3.96	1	1	141	147	14271	1426	voriconazole	prophylaxis	-0.31	0.733446956224289	0.71	0.66	-0.01	0	0.02	-0.52	0.14	0
1427	desirudin recombinant	0	0	1852.91	1	0	1	177549	8686789	1427	desirudin recombinant	pain	0	0	856.37	1	0	1	8469	188483	1427	desirudin recombinant	pain	23	79	0	0	Inf	1	0	0	1088	36017	1427	desirudin recombinant	pain	0	0	Inf	1	0	0	364	15317	1427	desirudin recombinant	pain	0	0	Inf	1	0	0	857	26590	1427	desirudin recombinant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1428	treprostinil	0.36	0.32	0.41	9.7e-97	299	40246	177250	8646544	1428	treprostinil	pulmonary arterial hypertension	2.19	1.81	2.64	2e-15	181	18730	301	68173	1428	treprostinil	pulmonary arterial hypertension	28	80	1.99	1.55	2.55	5e-08	120	8340	150	20704	1428	treprostinil	pulmonary arterial hypertension	2.64	1.5	4.67	0.00044	28	2470	27	6288	1428	treprostinil	pulmonary arterial hypertension	1.79	1.38	2.33	1e-05	103	7416	146	18870	1428	treprostinil	pulmonary arterial hypertension	0.64	1.89648087930495	0.12	0	0	0	0.54	-0.41	0.15	0.01
1429	bimatoprost	0.51	0.43	0.59	1.1e-21	160	15447	177389	8671343	1429	bimatoprost	growth of eyelashes	Inf	0	Inf	1	4	5353	0	2	1429	bimatoprost	growth of eyelashes	31.8	39	0	0	Inf	1	0	79	0	0	1429	bimatoprost	growth of eyelashes	0	0	Inf	1	0	3	0	0	1429	bimatoprost	growth of eyelashes	Inf	0	Inf	1	3	704	0	1	1429	bimatoprost	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1430	dexmethylphenidate	2.02	1.61	2.49	3.3e-09	90	2184	177459	8684606	1430	dexmethylphenidate	attention deficit/hyperactivity disorder	0.98	0.69	1.36	1	39	872	2023	44553	1430	dexmethylphenidate	attention deficit/hyperactivity disorder	7	57	0.87	0.37	1.77	0.86	8	173	413	7758	1430	dexmethylphenidate	attention deficit/hyperactivity disorder	1.26	0.53	2.59	0.54	8	166	225	5892	1430	dexmethylphenidate	attention deficit/hyperactivity disorder	0.98	0.19	3.11	1	3	42	254	3500	1430	dexmethylphenidate	attention deficit/hyperactivity disorder	0.25	1.28402541668774	0.32	0.42	0.01	0	0	-0.49	0.1	0
1431	guaifenesin	2.52	2.36	2.69	4.1e-138	1004	19539	176545	8667251	1431	guaifenesin	chronic obstructive pulmonary disease	1.65	1.09	2.39	0.012	29	1158	1229	80839	1431	guaifenesin	chronic obstructive pulmonary disease	48.4	82.8	2.34	1.1	4.42	0.014	10	302	281	19842	1431	guaifenesin	chronic obstructive pulmonary disease	1.23	0.15	4.64	0.68	2	147	106	9602	1431	guaifenesin	chronic obstructive pulmonary disease	2.47	1.04	5.05	0.021	8	206	209	13299	1431	guaifenesin	chronic obstructive pulmonary disease	0.77	2.15976625378492	0.33	0.02	-0.03	0	0	-0.37	0.12	0
1432	olmesartan medoxomil	1.78	1.67	1.89	3.6e-67	1121	30953	176428	8655837	1432	olmesartan medoxomil	hypertension	1.75	1.59	1.94	2.4e-25	439	11849	6456	305764	1432	olmesartan medoxomil	hypertension	38	82.9	2.56	1.94	3.33	4.6e-10	62	1604	919	60805	1432	olmesartan medoxomil	hypertension	4.78	3.2	6.92	3.5e-12	33	694	308	30945	1432	olmesartan medoxomil	hypertension	1.6	1.09	2.28	0.014	33	1099	729	38831	1432	olmesartan medoxomil	hypertension	0.86	2.36316069370579	0.13	0	-0.02	0	0	-0.59	0.07	0
1433	alfuzosin	1.48	1.26	1.72	1.4e-06	175	5794	177374	8680996	1433	alfuzosin	benign prostatic hyperplasia	0.84	0.4	1.59	0.76	10	968	224	18290	1433	alfuzosin	benign prostatic hyperplasia	51.5	84.6	2.02	0.23	8.38	0.28	2	154	21	3266	1433	alfuzosin	benign prostatic hyperplasia	1.95	0.22	7.98	0.29	2	164	24	3843	1433	alfuzosin	benign prostatic hyperplasia	0	0	175.02	1	0	2	1	8	1433	alfuzosin	benign prostatic hyperplasia	0.5	1.64872127070013	0.75	0.51	-0.03	0.01	0.02	-2.42	1.09	0.03
1434	bosentan	0.25	0.22	0.29	3.8e-156	226	43858	177323	8642932	1434	bosentan	pulmonary arterial hypertension	0.71	0.58	0.86	0.00047	144	32655	338	54248	1434	bosentan	pulmonary arterial hypertension	28	80	1.28	0.95	1.7	0.09	64	5680	206	23364	1434	bosentan	pulmonary arterial hypertension	1.28	0.64	2.39	0.41	14	1850	41	6908	1434	bosentan	pulmonary arterial hypertension	1.21	0.89	1.63	0.19	62	5646	187	20640	1434	bosentan	pulmonary arterial hypertension	0.19	1.20924959765725	0.13	0.15	0	0	0.16	-0.41	0.15	0.01
1435	paroxetine mesylate	1.57	1	2.36	0.038	24	746	177525	8686044	1435	paroxetine mesylate	hot flush	0.35	0.12	0.77	0.0052	6	402	224	5188	1435	paroxetine mesylate	hot flush	38	72	0.49	0.06	2.01	0.57	2	186	23	1047	1435	paroxetine mesylate	hot flush	0	0	Inf	1	0	0	0	42	1435	paroxetine mesylate	hot flush	0.65	0.12	2.13	0.61	3	205	27	1195	1435	paroxetine mesylate	hot flush	-0.44	0.644036421083141	0.61	0.47	-0.03	0.02	0.06	-14.38	993.62	0.99
1436	pimecrolimus	1.91	1.56	2.31	1.1e-09	111	2849	177438	8683941	1436	pimecrolimus	eczema	1.55	1.07	2.23	0.018	48	876	97	2747	1436	pimecrolimus	eczema	17.2	67.9	2.27	0.05	17.52	0.39	1	14	12	382	1436	pimecrolimus	eczema	9.36	0.17	106.59	0.13	1	5	6	287	1436	pimecrolimus	eczema	0	0	13.54	1	0	17	8	361	1436	pimecrolimus	eczema	0.73	2.07508060767412	1.07	0.49	-0.01	0.01	0.19	0.17	0.53	0.75
1437	valganciclovir	0.72	0.58	0.88	0.00071	98	6683	177451	8680107	1437	valganciclovir	renal transplant	1.39	0.5	3.18	0.45	6	1131	78	20508	1437	valganciclovir	renal transplant	34	58.8	0	0	7.17	1	0	112	9	1563	1437	valganciclovir	renal transplant	0	0	21.07	1	0	154	4	2127	1437	valganciclovir	renal transplant	0	0	9.37	1	0	90	8	1416	1437	valganciclovir	renal transplant	-14.82	3.66231569524039e-07	1112.44	0.99	-0.01	0.02	0.46	-1.08	0.61	0.08
1438	teriparatide recombinant human	1.07	1.02	1.11	0.0025	2214	101489	175335	8585301	1438	teriparatide recombinant human	osteoporosis	0.31	0.29	0.33	0	1685	68168	7117	89518	1438	teriparatide recombinant human	osteoporosis	53.1	85	1.67	1.44	1.94	4.8e-12	526	12978	282	11590	1438	teriparatide recombinant human	osteoporosis	5.17	2.22	13.43	1.7e-05	23	1048	8	1887	1438	teriparatide recombinant human	osteoporosis	1.71	1.48	1.98	6.3e-14	570	14205	298	12682	1438	teriparatide recombinant human	osteoporosis	0.57	1.76826705143374	0.07	0	-0.01	0	0	-1.05	0.18	0
1439	dutasteride	0.96	0.84	1.08	0.47	272	13928	177277	8672862	1439	dutasteride	benign prostatic hyperplasia	0.62	0.42	0.9	0.0095	33	4023	201	15235	1439	dutasteride	benign prostatic hyperplasia	51.5	84.6	0.91	0.1	3.74	1	2	325	21	3095	1439	dutasteride	benign prostatic hyperplasia	0.81	0.09	3.27	1	2	375	24	3632	1439	dutasteride	benign prostatic hyperplasia	0	0	Inf	1	0	0	1	10	1439	dutasteride	benign prostatic hyperplasia	-0.13	0.878095430920561	0.74	0.86	-0.03	0.01	0.02	-2.5	1.07	0.02
1440	abarelix	0.64	0.02	3.65	1	1	77	177548	8686713	1440	abarelix	prostate cancer	0	0	7.04	1	0	56	444	45695	1440	abarelix	prostate cancer	56.9	87.4	0	0	4547.83	1	0	1	102	12803	1440	abarelix	prostate cancer	0	0	4655.58	1	0	1	114	14675	1440	abarelix	prostate cancer	0	0	Inf	1	0	0	0	51	1440	abarelix	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1441	icodextrin	0.06	0.04	0.08	2.8e-168	28	24274	177521	8662516	1441	icodextrin	peritoneal dialysis	1.09	0.67	1.71	0.73	24	20588	104	97004	1441	icodextrin	peritoneal dialysis	29.7	77.4	1.76	0.4	6.11	0.31	4	2914	10	12831	1441	icodextrin	peritoneal dialysis	1.99	0.32	9.34	0.4	3	2032	6	8094	1441	icodextrin	peritoneal dialysis	0.92	0.02	7.6	1	1	1370	6	7570	1441	icodextrin	peritoneal dialysis	0.46	1.58407398499448	0.58	0.43	-0.02	0.01	0.27	0.15	0.51	0.77
1442	lutropin alfa	0	0	2.69	0.65	0	69	177549	8686721	1442	lutropin alfa	in vitro fertilisation	0	0	20.68	1	0	25	10	1093	1442	lutropin alfa	in vitro fertilisation	30.9	35.7	0	0	Inf	1	0	2	0	65	1442	lutropin alfa	in vitro fertilisation	0	0	Inf	1	0	0	0	1	1442	lutropin alfa	in vitro fertilisation	0	0	215.6	1	0	5	2	183	1442	lutropin alfa	in vitro fertilisation	-14.12	7.37499814690196e-07	2912.81	1	-0.05	0.1	0.62	-15.71	6522.64	1
1443	escitalopram oxalate	3.79	3.68	3.9	0	4990	65801	172559	8620989	1443	escitalopram oxalate	depression	1.24	1.17	1.31	3.2e-13	1459	16104	12912	176681	1443	escitalopram oxalate	depression	21	73.3	0.96	0.81	1.14	0.71	162	2302	1900	26040	1443	escitalopram oxalate	depression	1.11	0.81	1.47	0.5	55	823	582	9624	1443	escitalopram oxalate	depression	0.98	0.81	1.17	0.86	138	2056	1533	22328	1443	escitalopram oxalate	depression	0.03	1.03045453395352	0.08	0.73	-0.01	0	0	-0.14	0.05	0
1444	pramlintide acetate	0.61	0.43	0.83	0.0012	39	3139	177510	8683651	1444	pramlintide acetate	type 2 diabetes mellitus	0.53	0.14	1.37	0.27	4	864	1218	140234	1444	pramlintide acetate	type 2 diabetes mellitus	43	80.7	0	0	8.75	1	0	69	214	33825	1444	pramlintide acetate	type 2 diabetes mellitus	0	0	30.27	1	0	28	85	17908	1444	pramlintide acetate	type 2 diabetes mellitus	0	0	11.24	1	0	48	154	21426	1444	pramlintide acetate	type 2 diabetes mellitus	-11.49	1.02319027318752e-05	274.6	0.97	0	0	0.71	-0.41	0.14	0
1445	imatinib mesylate	0.44	0.38	0.5	2.3e-45	221	24740	177328	8662050	1445	imatinib mesylate	chronic myeloid leukaemia	1.24	0.97	1.57	0.088	100	11184	223	30849	1445	imatinib mesylate	chronic myeloid leukaemia	25.8	72.1	1.79	0.64	4.1	0.16	6	256	100	7649	1445	imatinib mesylate	chronic myeloid leukaemia	0.84	0.02	5.01	1	1	159	42	5610	1445	imatinib mesylate	chronic myeloid leukaemia	1.71	0.53	4.26	0.23	5	190	70	4554	1445	imatinib mesylate	chronic myeloid leukaemia	0.47	1.59999419321736	0.42	0.27	-0.02	0.01	0	-0.74	0.19	0
1446	ertapenem sodium	1.56	1.22	1.97	0.00043	74	2322	177475	8684468	1446	ertapenem sodium	infection	0	0	0.65	0.0074	0	217	375	14126	1446	ertapenem sodium	infection	23	72	0	0	12.5	1	0	14	53	2133	1446	ertapenem sodium	infection	0	0	16.85	1	0	17	24	1559	1446	ertapenem sodium	infection	0	0	23.32	1	0	9	37	1639	1446	ertapenem sodium	infection	-13.17	1.90696039458808e-06	764.57	0.99	-0.03	0.01	0	-0.33	0.27	0.21
1447	valdecoxib	3.04	2.85	3.23	2.9e-201	1076	17403	176473	8669387	1447	valdecoxib	arthritis	1.35	1.16	1.57	0.00012	203	3061	2521	51310	1447	valdecoxib	arthritis	31.8	81	0	0	141.46	1	0	3	141	8209	1447	valdecoxib	arthritis	0	0	2305.27	1	0	1	41	2513	1447	valdecoxib	arthritis	0	0	326.97	1	0	2	118	7207	1447	valdecoxib	arthritis	-9.5	7.48518298877006e-05	308.52	0.98	-0.02	0	0	-0.01	0.18	0.96
1448	fulvestrant	7.75	7.21	8.33	0	863	5471	176686	8681319	1448	fulvestrant	breast cancer	5.99	5.09	7.03	7e-77	198	1722	1248	65060	1448	fulvestrant	breast cancer	40	78	0.7	0.19	1.85	0.66	4	450	123	9697	1448	fulvestrant	breast cancer	0	0	Inf	1	0	1	0	115	1448	fulvestrant	breast cancer	0.76	0.24	1.84	0.69	5	530	139	11246	1448	fulvestrant	breast cancer	-0.27	0.763379494336853	0.46	0.56	0	0.01	0.81	-13.17	367.3	0.97
1449	fondaparinux sodium	0.72	0.6	0.86	0.00019	123	8336	177426	8678454	1449	fondaparinux sodium	thrombosis prophylaxis	0.5	0.18	1.09	0.099	6	1711	291	41094	1449	fondaparinux sodium	thrombosis prophylaxis	39.1	80.2	6.35	0.15	38.76	0.15	1	47	50	14936	1449	fondaparinux sodium	thrombosis prophylaxis	13.48	0.32	87.9	0.076	1	33	24	10688	1449	fondaparinux sodium	thrombosis prophylaxis	0	0	33.43	1	0	35	32	9119	1449	fondaparinux sodium	thrombosis prophylaxis	1.65	5.20697982717985	1.02	0.11	-0.03	0.01	0	-0.39	0.27	0.14
1450	miglustat	0.67	0.33	1.21	0.21	11	800	177538	8685990	1450	miglustat	niemann-pick disease	Inf	0.13	Inf	1	9	433	0	29	1450	miglustat	niemann-pick disease	4.9	20.1	0	0	Inf	1	0	69	0	7	1450	miglustat	niemann-pick disease	Inf	0	Inf	1	1	89	0	12	1450	miglustat	niemann-pick disease	Inf	0	Inf	1	1	56	0	5	1450	miglustat	niemann-pick disease	15.11	3649132.40483969	2571.52	1	-0.04	0.07	0.54	-0.5	1.43	0.73
1451	oxybutynin	1.06	0.96	1.16	0.27	422	19553	177127	8667237	1451	oxybutynin	multiple sclerosis	0.69	0.48	0.96	0.028	36	2679	8309	427678	1451	oxybutynin	multiple sclerosis	26.5	67	0.56	0.27	1.04	0.068	10	788	1294	57254	1451	oxybutynin	multiple sclerosis	0.46	0.01	2.62	0.73	1	130	234	13919	1451	oxybutynin	multiple sclerosis	0.46	0.21	0.87	0.014	9	831	1209	51018	1451	oxybutynin	multiple sclerosis	-0.71	0.491644197460965	0.32	0.03	-0.01	0	0	-0.35	0.07	0
1452	tenofovir disoproxil fumarate	0.52	0.47	0.57	1.9e-49	411	38723	177138	8648067	1452	tenofovir disoproxil fumarate	hiv infection	1.3	1.09	1.56	0.0034	235	23651	265	34740	1452	tenofovir disoproxil fumarate	hiv infection	25	64	0.94	0.64	1.37	0.78	58	3817	62	3824	1452	tenofovir disoproxil fumarate	hiv infection	0.86	0.56	1.32	0.54	45	2897	51	2831	1452	tenofovir disoproxil fumarate	hiv infection	1.11	0.56	2.17	0.75	19	1548	21	1891	1452	tenofovir disoproxil fumarate	hiv infection	-0.08	0.923116346386636	0.17	0.66	0	0.01	0.8	0.38	0.2	0.05
1453	gadobenate dimeglumine	12.48	11.58	13.43	0	897	3533	176652	8683257	1453	gadobenate dimeglumine	nuclear magnetic resonance imaging	5.23	4.56	6	3.3e-138	766	1815	380	4708	1453	gadobenate dimeglumine	nuclear magnetic resonance imaging	26.3	65.4	2.65	0.54	11.42	0.13	4	107	6	427	1453	gadobenate dimeglumine	nuclear magnetic resonance imaging	1.69	0.03	32.94	0.54	1	58	2	196	1453	gadobenate dimeglumine	nuclear magnetic resonance imaging	2.46	0.39	11.78	0.19	3	93	6	459	1453	gadobenate dimeglumine	nuclear magnetic resonance imaging	0.81	2.24790798667647	0.62	0.19	0	0.02	0.87	-0.37	0.67	0.58
1454	rifaximin	0.67	0.51	0.87	0.0022	56	4076	177493	8682714	1454	rifaximin	crohn s disease	0	0	1.03	0.056	0	358	1477	146954	1454	rifaximin	crohn s disease	15.6	67	0	0	5.21	1	0	59	406	32635	1454	rifaximin	crohn s disease	0	0	13.98	1	0	27	148	13971	1454	rifaximin	crohn s disease	0	0	7.22	1	0	42	305	23855	1454	rifaximin	crohn s disease	-11.08	1.54176130119344e-05	174.85	0.95	-0.01	0	0	-0.21	0.1	0.04
1455	rosuvastatin calcium	0.91	0.87	0.95	5.3e-05	1749	94186	175800	8592604	1455	rosuvastatin calcium	hypertension	0.78	0.67	0.9	0.00054	197	11509	6698	306104	1455	rosuvastatin calcium	hypertension	38	82.9	1.36	1.02	1.78	0.029	58	2763	923	59646	1455	rosuvastatin calcium	hypertension	1.16	0.68	1.87	0.51	18	1451	323	30188	1455	rosuvastatin calcium	hypertension	1.48	1.05	2.02	0.018	43	1555	719	38375	1455	rosuvastatin calcium	hypertension	0.38	1.46228458943422	0.13	0	-0.02	0	0	-0.6	0.07	0
1456	estradiol acetate	0.7	0.19	1.82	0.67	4	278	177545	8686512	1456	estradiol acetate	menopausal symptoms	0	0	1.82	0.27	0	41	290	5556	1456	estradiol acetate	menopausal symptoms	43	61	0	0	35.07	1	0	4	18	394	1456	estradiol acetate	menopausal symptoms	0	0	Inf	1	0	0	0	4	1456	estradiol acetate	menopausal symptoms	0	0	26.53	1	0	6	22	649	1456	estradiol acetate	menopausal symptoms	-14.27	6.34771973115853e-07	1602.13	0.99	-0.04	0.02	0.01	-13.48	1955.11	0.99
1457	tadalafil	0.57	0.53	0.63	8.8e-44	528	44908	177021	8641882	1457	tadalafil	pulmonary arterial hypertension	1.79	1.43	2.22	5e-07	109	12217	373	74686	1457	tadalafil	pulmonary arterial hypertension	28	80	1.27	0.94	1.69	0.11	64	5716	206	23328	1457	tadalafil	pulmonary arterial hypertension	1.17	0.58	2.23	0.62	13	1830	42	6928	1457	tadalafil	pulmonary arterial hypertension	1.36	1	1.83	0.044	61	5068	188	21218	1457	tadalafil	pulmonary arterial hypertension	0.27	1.30996445073325	0.13	0.05	0	0	0.18	-0.42	0.15	0.01
1458	estradiol hemihydrate	0.53	0.06	1.96	0.59	2	183	177547	8686607	1458	estradiol hemihydrate	hormone replacement therapy	1.22	0.03	7.26	0.57	1	35	935	39834	1458	estradiol hemihydrate	hormone replacement therapy	34.3	74	0	0	28.38	1	0	6	91	3000	1458	estradiol hemihydrate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	1458	estradiol hemihydrate	hormone replacement therapy	0	0	27.86	1	0	7	56	2197	1458	estradiol hemihydrate	hormone replacement therapy	-11.91	6.7228391506356e-06	546.7	0.98	-0.03	0.01	0	0.42	0.2	0.03
1459	palonosetron	2.51	2.23	2.8	1.6e-45	324	6332	177225	8680458	1459	palonosetron	premedication	0.41	0.15	0.9	0.02	6	821	491	27541	1459	palonosetron	premedication	13.8	73.2	0.17	0	0.99	0.045	1	219	142	5382	1459	palonosetron	premedication	0	0	2.03	0.26	0	123	42	2684	1459	palonosetron	premedication	0.46	0.06	1.75	0.44	2	144	115	3847	1459	palonosetron	premedication	-1.11	0.329558961075189	0.72	0.12	0	0	0.42	-0.67	0.18	0
1460	sertaconazole nitrate	0	0	3.91	1	0	48	177549	8686742	1460	sertaconazole nitrate	pruritus	0	0	30.58	1	0	8	151	7817	1460	sertaconazole nitrate	pruritus	30.5	76	0	0	2104.67	1	0	1	30	1673	1460	sertaconazole nitrate	pruritus	0	0	Inf	1	0	0	6	895	1460	sertaconazole nitrate	pruritus	0	0	1869.57	1	0	1	29	1431	1460	sertaconazole nitrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1461	diphenhydramine citrate	0.98	0.75	1.25	0.9	62	3111	177487	8683679	1461	diphenhydramine citrate	insomnia	0.51	0.31	0.79	0.0015	20	896	2923	66692	1461	diphenhydramine citrate	insomnia	26.9	78.5	0.63	0.13	1.89	0.63	3	107	528	11790	1461	diphenhydramine citrate	insomnia	1.33	0.26	4.14	0.5	3	58	209	5379	1461	diphenhydramine citrate	insomnia	0.24	0.01	1.39	0.19	1	95	378	8695	1461	diphenhydramine citrate	insomnia	-0.33	0.718923733431926	0.51	0.52	-0.02	0	0	-0.08	0.09	0.38
1462	tiotropium bromide	0.74	0.7	0.77	1.2e-35	1528	101337	176021	8585453	1462	tiotropium bromide	chronic obstructive pulmonary disease	0.55	0.49	0.61	4.6e-26	490	44218	768	37779	1462	tiotropium bromide	chronic obstructive pulmonary disease	48.4	82.8	0.72	0.57	0.92	0.0066	126	10340	165	9804	1462	tiotropium bromide	chronic obstructive pulmonary disease	0.53	0.34	0.81	0.0018	35	4629	73	5120	1462	tiotropium bromide	chronic obstructive pulmonary disease	0.73	0.55	0.97	0.024	99	7215	118	6290	1462	tiotropium bromide	chronic obstructive pulmonary disease	-0.39	0.677056874498165	0.11	0	-0.02	0	0	-0.39	0.12	0
1463	conjugated estrogens/medroxyprogesterone acetate	0	0	1.48	0.19	0	124	177549	8686666	1463	conjugated estrogens/medroxyprogesterone acetate	hormone replacement therapy	0	0	3.41	0.63	0	48	936	39821	1463	conjugated estrogens/medroxyprogesterone acetate	hormone replacement therapy	34.3	74	0	0	Inf	1	0	0	91	3006	1463	conjugated estrogens/medroxyprogesterone acetate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	1463	conjugated estrogens/medroxyprogesterone acetate	hormone replacement therapy	0	0	Inf	1	0	0	56	2204	1463	conjugated estrogens/medroxyprogesterone acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1464	gefitinib	0.31	0.22	0.41	6.1e-22	45	7130	177504	8679660	1464	gefitinib	non-small cell lung cancer	1.78	1.07	2.83	0.018	21	2444	152	31483	1464	gefitinib	non-small cell lung cancer	43.2	79.8	0	0	7.99	1	0	102	26	5256	1464	gefitinib	non-small cell lung cancer	0	0	21.37	1	0	45	15	3328	1464	gefitinib	non-small cell lung cancer	0	0	8.99	1	0	87	15	2753	1464	gefitinib	non-small cell lung cancer	-14.24	6.5410365772385e-07	934.51	0.99	-0.01	0.01	0.37	-0.17	0.37	0.64
1465	vardenafil	0.84	0.71	0.98	0.027	158	9220	177391	8677570	1465	vardenafil	erectile dysfunction	0.98	0.72	1.32	1	54	4338	272	21459	1465	vardenafil	erectile dysfunction	39	73	1.03	0.12	3.95	0.72	2	178	54	4936	1465	vardenafil	erectile dysfunction	1.27	0.25	3.94	0.52	3	222	63	5934	1465	vardenafil	erectile dysfunction	0	0	Inf	1	0	0	0	4	1465	vardenafil	erectile dysfunction	0.38	1.46228458943422	0.6	0.53	-0.06	0.01	0	9.9	426.72	0.98
1466	calcitonin salmon recombinant	7.45	5.58	9.8	2.7e-30	60	394	177489	8686396	1466	calcitonin salmon recombinant	osteoporosis	0.26	0.03	0.96	0.036	2	138	8800	157548	1466	calcitonin salmon recombinant	osteoporosis	53.1	85	0	0	21.13	1	0	7	808	24561	1466	calcitonin salmon recombinant	osteoporosis	0	0	3491.06	1	0	1	31	2934	1466	calcitonin salmon recombinant	osteoporosis	0	0	12.36	1	0	11	868	26876	1466	calcitonin salmon recombinant	osteoporosis	-9.94	4.82073046323988e-05	154.01	0.95	-0.01	0	0	-1.15	0.18	0
1467	atomoxetine	1.97	1.84	2.11	8.5e-69	849	21119	176700	8665671	1467	atomoxetine	attention deficit/hyperactivity disorder	0.95	0.86	1.05	0.28	560	12843	1502	32582	1467	atomoxetine	attention deficit/hyperactivity disorder	7	57	0.94	0.74	1.2	0.68	93	1831	328	6100	1467	atomoxetine	attention deficit/hyperactivity disorder	1.23	0.9	1.66	0.18	62	1383	171	4675	1467	atomoxetine	attention deficit/hyperactivity disorder	0.85	0.61	1.16	0.32	53	832	204	2710	1467	atomoxetine	attention deficit/hyperactivity disorder	0.02	1.02020134002676	0.11	0.88	0.01	0	0	-0.48	0.1	0
1468	methyl aminolevulinate	1.16	0.14	4.34	0.69	2	84	177547	8686706	1468	methyl aminolevulinate	actinic keratosis	14.01	1.48	65.99	0.012	2	42	12	3541	1468	methyl aminolevulinate	actinic keratosis	27.4	78.9	0	0	Inf	1	0	0	3	915	1468	methyl aminolevulinate	actinic keratosis	0	0	Inf	1	0	1	0	455	1468	methyl aminolevulinate	actinic keratosis	0	0	Inf	1	0	0	5	595	1468	methyl aminolevulinate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1469	duloxetine	3.03	2.95	3.12	0	5861	96691	171688	8590099	1469	duloxetine	depression	1.05	1	1.1	0.056	1956	25159	12415	167626	1469	duloxetine	depression	21	73.3	1.28	1.15	1.43	1.3e-05	436	4898	1626	23444	1469	duloxetine	depression	1.07	0.84	1.35	0.55	93	1438	544	9009	1469	duloxetine	depression	1.39	1.23	1.56	2.3e-07	372	4177	1299	20207	1469	duloxetine	depression	0.29	1.33642748802547	0.05	0	-0.01	0	0	-0.13	0.05	0.01
1470	acamprosate calcium	2.08	1.4	2.98	0.00024	31	729	177518	8686061	1470	acamprosate calcium	alcoholism	0.5	0.13	1.38	0.23	4	291	59	2166	1470	acamprosate calcium	alcoholism	23	63	0	0	29.16	1	0	8	9	382	1470	acamprosate calcium	alcoholism	0	0	67.44	1	0	5	6	303	1470	acamprosate calcium	alcoholism	0	0	41.49	1	0	3	8	123	1470	acamprosate calcium	alcoholism	-14.07	7.75312238766476e-07	1365.86	0.99	-0.03	0.02	0.16	-1.23	0.55	0.03
1471	amlodipine maleate	1.15	0.52	2.21	0.59	9	382	177540	8686408	1471	amlodipine maleate	hypertension	1.39	0.37	3.63	0.54	4	133	6891	317480	1471	amlodipine maleate	hypertension	38	82.9	4.55	0.11	29.96	0.21	1	14	980	62395	1471	amlodipine maleate	hypertension	11.63	0.26	87.13	0.092	1	8	340	31631	1471	amlodipine maleate	hypertension	0	0	23.42	1	0	10	762	39920	1471	amlodipine maleate	hypertension	1.45	4.26311451516882	1.03	0.16	-0.02	0	0	-0.59	0.07	0
1472	aripiprazole	1.81	1.73	1.89	2.6e-132	2126	57798	175423	8628992	1472	aripiprazole	depression	0.75	0.68	0.82	5.5e-10	451	8032	13920	184753	1472	aripiprazole	depression	21	73.3	0.96	0.77	1.18	0.75	100	1427	1962	26915	1472	aripiprazole	depression	0.86	0.56	1.26	0.46	29	551	608	9896	1472	aripiprazole	depression	1.08	0.85	1.35	0.52	88	1197	1583	23187	1472	aripiprazole	depression	-0.07	0.932393819905948	0.1	0.46	-0.01	0	0	-0.14	0.05	0
1473	eplerenone	0.85	0.66	1.08	0.2	71	4075	177478	8682715	1473	eplerenone	hypertension	0.6	0.29	1.11	0.13	10	766	6885	316847	1473	eplerenone	hypertension	38	82.9	0	0	1.41	0.12	0	168	981	62241	1473	eplerenone	hypertension	0	0	2.83	0.64	0	123	341	31516	1473	eplerenone	hypertension	0	0	3.27	0.63	0	61	762	39869	1473	eplerenone	hypertension	-12.16	5.2357523949781e-06	175.12	0.94	-0.02	0	0	-0.59	0.07	0
1474	estrogens synthetic b	1.59	0.72	3.06	0.2	9	277	177540	8686513	1474	estrogens synthetic b	hormone replacement therapy	0	0	4.23	1	0	39	936	39830	1474	estrogens synthetic b	hormone replacement therapy	34.3	74	0	0	80.56	1	0	3	91	3003	1474	estrogens synthetic b	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	1474	estrogens synthetic b	hormone replacement therapy	0	0	96.53	1	0	3	56	2201	1474	estrogens synthetic b	hormone replacement therapy	-10.98	1.70390975269345e-05	506.29	0.98	-0.03	0.01	0	0.43	0.2	0.03
1475	ezetimibe	1.57	1.49	1.65	2.4e-63	1664	52113	175885	8634677	1475	ezetimibe	blood cholesterol increased	1.11	0.95	1.28	0.17	211	8040	2045	86188	1475	ezetimibe	blood cholesterol increased	39.3	79.8	1.2	0.66	2.03	0.47	15	728	278	16250	1475	ezetimibe	blood cholesterol increased	0.94	0.25	2.51	1	4	306	89	6383	1475	ezetimibe	blood cholesterol increased	1.38	0.72	2.43	0.24	13	510	221	11984	1475	ezetimibe	blood cholesterol increased	0.28	1.32312981233744	0.25	0.27	-0.03	0	0	-0.27	0.12	0.03
1476	pregabalin	1.46	1.42	1.51	1.3e-114	4190	141009	173359	8545781	1476	pregabalin	pain	0.87	0.8	0.94	0.00045	712	17976	7757	170508	1476	pregabalin	pain	23	79	1.35	1.15	1.57	0.00026	204	5270	884	30747	1476	pregabalin	pain	1.9	1.45	2.48	5.2e-06	73	1783	291	13534	1476	pregabalin	pain	1.18	0.98	1.42	0.074	150	4047	707	22543	1476	pregabalin	pain	0.35	1.41906754859326	0.08	0	-0.02	0	0	-0.27	0.06	0
1477	adefovir dipivoxil	0.13	0.06	0.26	2.8e-18	9	3265	177540	8683525	1477	adefovir dipivoxil	hepatitis b	0.44	0.11	1.24	0.15	4	1818	31	6175	1477	adefovir dipivoxil	hepatitis b	36	46.4	0	0	21.52	1	0	51	2	203	1477	adefovir dipivoxil	hepatitis b	0	0	8.32	1	0	250	3	855	1477	adefovir dipivoxil	hepatitis b	0	0	203.98	1	0	81	1	424	1477	adefovir dipivoxil	hepatitis b	-15.71	1.50395100864567e-07	1576.85	0.99	-0.04	0.03	0.17	0.48	1.16	0.68
1478	ibandronate sodium	3.48	3.29	3.67	4.9e-309	1372	19417	176177	8667373	1478	ibandronate sodium	osteoporosis	3.02	2.81	3.23	4.3e-177	1069	6912	7733	150774	1478	ibandronate sodium	osteoporosis	53.1	85	15.08	11.79	19.2	3.1e-76	110	254	698	24314	1478	ibandronate sodium	osteoporosis	7.48	0.17	52.9	0.14	1	13	30	2922	1478	ibandronate sodium	osteoporosis	14.2	11.2	17.93	1.6e-77	115	286	753	26601	1478	ibandronate sodium	osteoporosis	2.61	13.5990508518309	0.12	0	-0.01	0	0	-1.06	0.18	0
1479	pemetrexed disodium	0.3	0.24	0.37	7.6e-48	95	15525	177454	8671265	1479	pemetrexed disodium	non-small cell lung cancer	0.64	0.38	1.04	0.077	19	5471	154	28456	1479	pemetrexed disodium	non-small cell lung cancer	43.2	79.8	0.84	0.1	3.41	1	2	482	24	4876	1479	pemetrexed disodium	non-small cell lung cancer	2.81	0.51	10.52	0.12	3	275	12	3098	1479	pemetrexed disodium	non-small cell lung cancer	0	0	2.86	0.39	0	254	15	2586	1479	pemetrexed disodium	non-small cell lung cancer	0.18	1.19721736312181	0.61	0.77	-0.01	0.01	0.35	-0.15	0.37	0.68
1480	lanthanum carbonate	1.16	0.93	1.42	0.16	95	4014	177454	8682776	1480	lanthanum carbonate	hyperphosphataemia	0	0	0.46	0.0011	0	2054	13	2861	1480	lanthanum carbonate	hyperphosphataemia	45.1	65.8	0	0	Inf	1	0	89	0	229	1480	lanthanum carbonate	hyperphosphataemia	0	0	71.88	1	0	155	1	285	1480	lanthanum carbonate	hyperphosphataemia	0	0	97.16	1	0	99	1	246	1480	lanthanum carbonate	hyperphosphataemia	-16.91	4.52981338803594e-08	3004.19	1	-0.02	0.04	0.63	-0.13	1.42	0.92
1481	ecamsule	0	0	11.85	1	0	17	177549	8686773	1481	ecamsule	prophylaxis	0	0	195.31	1	0	3	1279	103548	1481	ecamsule	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	1481	ecamsule	prophylaxis	0	0	Inf	1	0	0	82	13728	1481	ecamsule	prophylaxis	0	0	515.28	1	0	2	148	14410	1481	ecamsule	prophylaxis	-7.96	0.000349153117459826	229.61	0.97	-0.01	0	0.03	-0.52	0.14	0
1482	octocrylene	0	0	4.85	1	0	39	177549	8686751	1482	octocrylene	prophylaxis against solar radiation	0	0	3116.52	1	0	7	1	587	1482	octocrylene	prophylaxis against solar radiation	NA	NA	0	0	Inf	1	0	0	0	0	1482	octocrylene	prophylaxis against solar radiation	0	0	Inf	1	0	1	0	53	1482	octocrylene	prophylaxis against solar radiation	0	0	Inf	1	0	1	0	294	1482	octocrylene	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1483	titanium dioxide	3.06	0.61	9.49	0.082	3	48	177546	8686742	1483	titanium dioxide	non-small cell lung cancer	0	0	215.19	1	0	5	173	33922	1483	titanium dioxide	non-small cell lung cancer	43.2	79.8	0	0	Inf	1	0	0	26	5358	1483	titanium dioxide	non-small cell lung cancer	0	0	Inf	1	0	0	15	3373	1483	titanium dioxide	non-small cell lung cancer	0	0	Inf	1	0	0	15	2840	1483	titanium dioxide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1484	eszopiclone	2.38	2.22	2.54	2.3e-110	898	18553	176651	8668237	1484	eszopiclone	insomnia	0.6	0.52	0.7	7.8e-13	197	7167	2746	60421	1484	eszopiclone	insomnia	26.9	78.5	0.75	0.38	1.33	0.43	12	357	519	11540	1484	eszopiclone	insomnia	1.3	0.54	2.68	0.41	8	159	204	5278	1484	eszopiclone	insomnia	0.43	0.14	1.03	0.06	5	263	374	8527	1484	eszopiclone	insomnia	-0.31	0.733446956224289	0.29	0.28	-0.02	0	0	-0.08	0.09	0.38
1485	enfuvirtide	0.48	0.33	0.68	2.9e-06	33	3363	177516	8683427	1485	enfuvirtide	hiv infection	0.77	0.42	1.31	0.4	14	2103	486	56288	1485	enfuvirtide	hiv infection	25	64	3.35	0.66	10.54	0.068	3	58	117	7583	1485	enfuvirtide	hiv infection	3.98	0.78	12.75	0.046	3	46	93	5682	1485	enfuvirtide	hiv infection	0	0	18.04	1	0	20	40	3419	1485	enfuvirtide	hiv infection	1.11	3.03435839443568	0.6	0.06	0	0.01	0.81	0.37	0.2	0.06
1486	memantine	1.05	0.94	1.17	0.4	318	14841	177231	8671949	1486	memantine	dementia alzheimer s type	1.72	1.29	2.29	0.00016	92	5093	116	11064	1486	memantine	dementia alzheimer s type	63	90	2.07	0.71	5.46	0.16	7	346	15	1539	1486	memantine	dementia alzheimer s type	1.08	0.19	4.14	1	3	173	11	684	1486	memantine	dementia alzheimer s type	2.22	0.5	8.03	0.25	4	233	9	1164	1486	memantine	dementia alzheimer s type	0.44	1.55270721851134	0.44	0.32	0	0.02	0.84	0.54	0.39	0.17
1487	oxaliplatin	0.23	0.2	0.27	2.5e-124	154	32512	177395	8654278	1487	oxaliplatin	colon cancer	3.44	2.1	5.75	1.9e-07	47	5029	27	9942	1487	oxaliplatin	colon cancer	44.6	81.9	3.58	1.45	9.16	0.0032	13	853	10	2352	1487	oxaliplatin	colon cancer	6.6	1.76	30.09	0.0018	8	474	4	1566	1487	oxaliplatin	colon cancer	1.21	0.32	3.92	0.78	5	492	10	1194	1487	oxaliplatin	colon cancer	0.98	2.66445624192942	0.39	0.01	0.01	0.01	0.43	-0.35	0.39	0.37
1488	gatifloxacin	2.3	1.86	2.81	5.6e-13	99	2109	177450	8684681	1488	gatifloxacin	postoperative care	0	0	5.09	1	0	118	18	2602	1488	gatifloxacin	postoperative care	19.8	69.3	0	0	1315.16	1	0	2	2	370	1488	gatifloxacin	postoperative care	0	0	527.42	1	0	3	2	251	1488	gatifloxacin	postoperative care	0	0	597.18	1	0	4	2	398	1488	gatifloxacin	postoperative care	-14.03	8.0695333147137e-07	2338.66	1	-0.03	0.02	0.18	0.3	1.02	0.76
1489	nitazoxanide	0.68	0.14	2.01	0.81	3	216	177546	8686574	1489	nitazoxanide	hiv infection	0	0	15.32	1	0	30	500	58361	1489	nitazoxanide	hiv infection	25	64	0	0	2390.6	1	0	1	120	7640	1489	nitazoxanide	hiv infection	0	0	Inf	1	0	0	96	5728	1489	nitazoxanide	hiv infection	0	0	3186.15	1	0	1	40	3438	1489	nitazoxanide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1490	emtricitabine	0.59	0.54	0.66	3.6e-28	385	31615	177164	8655175	1490	emtricitabine	hiv infection	1.62	1.36	1.95	1.1e-07	232	20298	268	38093	1490	emtricitabine	hiv infection	25	64	1.01	0.69	1.47	1	63	3997	57	3644	1490	emtricitabine	hiv infection	0.94	0.62	1.44	0.84	50	3068	46	2660	1490	emtricitabine	hiv infection	1.29	0.66	2.54	0.43	21	1589	19	1850	1490	emtricitabine	hiv infection	0.03	1.03045453395352	0.17	0.85	0	0.01	0.8	0.38	0.2	0.06
1491	micafungin sodium	0.21	0.1	0.4	1.2e-09	9	2099	177540	8684691	1491	micafungin sodium	prophylaxis	0.77	0.21	1.98	0.82	4	422	1275	103129	1491	micafungin sodium	prophylaxis	23.9	79.7	0	0	8.63	1	0	51	207	23609	1491	micafungin sodium	prophylaxis	0	0	11.61	1	0	56	82	13672	1491	micafungin sodium	prophylaxis	9.29	1.8	30.23	0.0053	3	32	145	14380	1491	micafungin sodium	prophylaxis	1.38	3.97490162749475	0.6	0.02	-0.01	0	0.04	-0.53	0.14	0
1492	darifenacin	1.2	0.98	1.46	0.061	107	4349	177442	8682441	1492	darifenacin	hypertonic bladder	0.56	0.18	1.35	0.28	5	1158	92	11853	1492	darifenacin	hypertonic bladder	55.5	80	0	0	60.49	1	0	11	12	1604	1492	darifenacin	hypertonic bladder	0	0	399.91	1	0	5	3	703	1492	darifenacin	hypertonic bladder	0	0	44.85	1	0	20	11	2089	1492	darifenacin	hypertonic bladder	-13.34	1.60883539155672e-06	1303.2	0.99	-0.01	0.02	0.6	-0.18	0.66	0.78
1493	solifenacin succinate	0.84	0.74	0.94	0.0016	304	17796	177245	8668994	1493	solifenacin succinate	hypertonic bladder	0.94	0.56	1.53	0.91	23	3227	74	9784	1493	solifenacin succinate	hypertonic bladder	55.5	80	1.03	0.11	4.86	1	2	263	10	1352	1493	solifenacin succinate	hypertonic bladder	2.06	0.03	39.88	0.48	1	138	2	570	1493	solifenacin succinate	hypertonic bladder	0.52	0.01	3.68	1	1	340	10	1769	1493	solifenacin succinate	hypertonic bladder	-0.21	0.810584245970187	0.77	0.78	-0.01	0.02	0.6	-0.17	0.66	0.79
1494	ranolazine	0.5	0.4	0.6	2.8e-15	102	10059	177447	8676731	1494	ranolazine	angina pectoris	0.27	0.16	0.42	1.3e-11	22	4438	174	9353	1494	ranolazine	angina pectoris	42	83	0.76	0.3	1.94	0.53	11	2130	11	1620	1494	ranolazine	angina pectoris	0.12	0.01	0.56	0.0017	2	1462	12	1093	1494	ranolazine	angina pectoris	1.14	0.36	3.91	1	9	1104	6	839	1494	ranolazine	angina pectoris	-0.72	0.486752255959972	0.39	0.06	-0.03	0.01	0.01	-0.38	0.37	0.3
1495	insulin detemir recombinant	0.58	0.5	0.65	3.2e-20	236	20048	177313	8666742	1495	insulin detemir recombinant	type 2 diabetes mellitus	0.86	0.6	1.19	0.43	37	4946	1185	136152	1495	insulin detemir recombinant	type 2 diabetes mellitus	43	80.7	1.48	0.83	2.46	0.16	16	1760	198	32134	1495	insulin detemir recombinant	type 2 diabetes mellitus	2.08	0.87	4.33	0.065	8	852	77	17084	1495	insulin detemir recombinant	type 2 diabetes mellitus	1.22	0.57	2.32	0.48	10	1157	144	20317	1495	insulin detemir recombinant	type 2 diabetes mellitus	0.41	1.50681778511285	0.25	0.1	0	0	0.68	-0.41	0.14	0
1496	fosamprenavir calcium	0.86	0.52	1.33	0.6	20	1141	177529	8685649	1496	fosamprenavir calcium	hiv infection	1.06	0.42	2.21	0.84	7	772	493	57619	1496	fosamprenavir calcium	hiv infection	25	64	0	0	8.13	1	0	31	120	7610	1496	fosamprenavir calcium	hiv infection	0	0	7.38	1	0	32	96	5696	1496	fosamprenavir calcium	hiv infection	0	0	17.1	1	0	21	40	3418	1496	fosamprenavir calcium	hiv infection	-12.35	4.32975326609298e-06	328.97	0.97	0	0.01	0.8	0.38	0.2	0.05
1497	aprepitant	0.69	0.57	0.82	1.6e-05	122	8671	177427	8678119	1497	aprepitant	prophylaxis of nausea and vomiting	0.99	0.56	1.69	1	19	1995	61	6354	1497	aprepitant	prophylaxis of nausea and vomiting	14	75	0.68	0.07	3.59	1	2	577	7	1373	1497	aprepitant	prophylaxis of nausea and vomiting	0.68	0.01	6.87	1	1	276	4	746	1497	aprepitant	prophylaxis of nausea and vomiting	0.39	0.01	3.02	0.69	1	356	7	961	1497	aprepitant	prophylaxis of nausea and vomiting	-0.75	0.472366552741015	0.77	0.33	-0.04	0.01	0	-0.17	0.57	0.77
1498	bisacodyl	2.22	1.95	2.52	4.6e-28	251	5543	177298	8681247	1498	bisacodyl	constipation	0.65	0.32	1.18	0.21	11	974	717	41315	1498	bisacodyl	constipation	2.6	80.7	0.93	0.3	2.24	1	5	331	164	10093	1498	bisacodyl	constipation	1.5	0.3	4.65	0.46	3	167	66	5503	1498	bisacodyl	constipation	0.62	0.07	2.31	0.77	2	202	118	7350	1498	bisacodyl	constipation	-0.01	0.990049833749168	0.46	0.98	-0.03	0	0	-0.22	0.15	0.15
1499	everolimus	0.31	0.26	0.36	1.5e-70	154	24174	177395	8662616	1499	everolimus	breast cancer	0.2	0.11	0.34	1.3e-14	14	3049	1432	63733	1499	everolimus	breast cancer	40	78	0.6	0.27	1.18	0.16	9	1143	118	9004	1499	everolimus	breast cancer	0	0	Inf	1	0	14	0	102	1499	everolimus	breast cancer	0.73	0.37	1.33	0.35	12	1299	132	10477	1499	everolimus	breast cancer	-0.31	0.733446956224289	0.3	0.31	0	0.01	0.84	-13.16	367.12	0.97
1500	epinastine	0.2	0.07	0.48	6.5e-06	5	1194	177544	8685596	1500	epinastine	prophylaxis	0	0	3.07	0.64	0	99	1279	103452	1500	epinastine	prophylaxis	23.9	79.7	0	0	16.85	1	0	27	207	23633	1500	epinastine	prophylaxis	0	0	38.8	1	0	18	82	13710	1500	epinastine	prophylaxis	0	0	19.92	1	0	20	148	14392	1500	epinastine	prophylaxis	-10.78	2.0811600715958e-05	234.77	0.96	-0.01	0	0.03	-0.52	0.14	0
1501	atazanavir	0.32	0.25	0.39	7.2e-42	93	14377	177456	8672413	1501	atazanavir	hiv infection	0.73	0.54	0.96	0.021	58	8926	442	49465	1501	atazanavir	hiv infection	25	64	0.44	0.2	0.88	0.015	9	1182	111	6459	1501	atazanavir	hiv infection	0.61	0.24	1.32	0.26	7	654	89	5074	1501	atazanavir	hiv infection	0.31	0.06	0.98	0.047	3	717	37	2722	1501	atazanavir	hiv infection	-0.74	0.477113915521034	0.33	0.02	0	0.01	0.78	0.32	0.2	0.1
1502	daptomycin	0.48	0.37	0.62	5.3e-11	66	6664	177483	8680126	1502	daptomycin	staphylococcal infection	0.11	0	0.66	0.0045	1	808	47	4265	1502	daptomycin	staphylococcal infection	40.8	69.2	0	0	287.6	1	0	54	1	399	1502	daptomycin	staphylococcal infection	0	0	195.42	1	0	77	1	386	1502	daptomycin	staphylococcal infection	0	0	33.5	1	0	55	2	342	1502	daptomycin	staphylococcal infection	-16.04	1.08122607403426e-07	2520.13	0.99	0	0.03	0.89	-0.82	1.23	0.5
1503	iodine povacrylex	0	0	1.4	0.12	0	131	177549	8686659	1503	iodine povacrylex	preoperative care	0	0	2.05	0.26	0	116	31	1856	1503	iodine povacrylex	preoperative care	NA	NA	0	0	Inf	1	0	0	0	0	1503	iodine povacrylex	preoperative care	0	0	Inf	1	0	1	0	157	1503	iodine povacrylex	preoperative care	0	0	Inf	1	0	2	0	201	1503	iodine povacrylex	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1504	trospium chloride	1.5	1.15	1.91	0.0023	66	2155	177483	8684635	1504	trospium chloride	hypertonic bladder	2.19	0.78	5	0.066	6	380	91	12631	1504	trospium chloride	hypertonic bladder	55.5	80	12.07	0.26	96.54	0.092	1	12	11	1603	1504	trospium chloride	hypertonic bladder	37.55	0.59	776.35	0.042	1	9	2	699	1504	trospium chloride	hypertonic bladder	0	0	50.29	1	0	18	11	2091	1504	trospium chloride	hypertonic bladder	2.11	8.24824128462666	1.06	0.05	-0.01	0.02	0.6	-0.21	0.66	0.75
1505	bortezomib	1.01	0.94	1.08	0.76	831	40249	176718	8646541	1505	bortezomib	plasma cell myeloma	1.44	1.16	1.78	0.0011	110	16024	424	88891	1505	bortezomib	plasma cell myeloma	47.4	82.5	1.34	0.89	1.96	0.14	35	6703	129	33125	1505	bortezomib	plasma cell myeloma	1.95	1.19	3.11	0.0073	26	4083	67	20479	1505	bortezomib	plasma cell myeloma	0.73	0.35	1.38	0.39	11	3316	80	17642	1505	bortezomib	plasma cell myeloma	0.16	1.17351087099181	0.19	0.4	-0.03	0.01	0	-0.15	0.15	0.3
1506	tinidazole	5.21	3.3	7.88	1.7e-10	25	235	177524	8686555	1506	tinidazole	crohn s disease	0	0	21.38	1	0	19	1477	147293	1506	tinidazole	crohn s disease	15.6	67	0	0	47.32	1	0	8	406	32686	1506	tinidazole	crohn s disease	0	0	Inf	1	0	0	148	13998	1506	tinidazole	crohn s disease	0	0	46.11	1	0	8	305	23889	1506	tinidazole	crohn s disease	-9.17	0.000104116509730984	189.01	0.96	-0.01	0	0	-0.21	0.1	0.03
1507	tetracaine	1.09	0.56	1.92	0.76	12	539	177537	8686251	1507	tetracaine	cataract operation	0	0	20.17	1	0	73	6	1705	1507	tetracaine	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	1507	tetracaine	cataract operation	0	0	Inf	1	0	2	0	99	1507	tetracaine	cataract operation	0	0	Inf	1	0	4	0	236	1507	tetracaine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1509	insulin glulisine recombinant	0.28	0.2	0.4	7.2e-20	34	5858	177515	8680932	1509	insulin glulisine recombinant	type 2 diabetes mellitus	0.35	0.09	0.89	0.023	4	1324	1218	139774	1509	insulin glulisine recombinant	type 2 diabetes mellitus	43	80.7	0.37	0.01	2.08	0.53	1	427	213	33467	1509	insulin glulisine recombinant	type 2 diabetes mellitus	1.11	0.03	6.41	0.6	1	191	84	17745	1509	insulin glulisine recombinant	type 2 diabetes mellitus	0	0	1.83	0.27	0	283	154	21191	1509	insulin glulisine recombinant	type 2 diabetes mellitus	-1.08	0.339595525644939	1	0.28	0	0	0.72	-0.42	0.14	0
1510	anidulafungin	0.1	0	0.54	0.00071	1	503	177548	8686287	1510	anidulafungin	aspergillosis	0	0	6.94	1	0	67	16	1750	1510	anidulafungin	aspergillosis	NA	NA	0	0	Inf	1	0	0	0	0	1510	anidulafungin	aspergillosis	0	0	Inf	1	0	0	0	0	1510	anidulafungin	aspergillosis	0	0	Inf	1	0	0	0	0	1510	anidulafungin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1511	rasagiline mesylate	1.78	1.47	2.13	1.1e-08	120	3308	177429	8683482	1511	rasagiline mesylate	parkinson s disease	1.46	1.17	1.81	0.00067	103	2343	769	25581	1511	rasagiline mesylate	parkinson s disease	50.1	85.7	1.73	1.06	2.7	0.019	24	591	139	5907	1511	rasagiline mesylate	parkinson s disease	2.08	1.14	3.58	0.012	17	379	81	3753	1511	rasagiline mesylate	parkinson s disease	1.26	0.55	2.56	0.55	9	257	76	2740	1511	rasagiline mesylate	parkinson s disease	0.49	1.63231621995538	0.22	0.02	-0.03	0.01	0	-0.2	0.15	0.18
1512	omega-3-acid ethyl esters	1.41	1.28	1.56	5.3e-11	408	14124	177141	8672666	1512	omega-3-acid ethyl esters	hypertension	0.69	0.42	1.05	0.097	21	1410	6874	316203	1512	omega-3-acid ethyl esters	hypertension	38	82.9	1.44	0.39	3.76	0.37	4	177	977	62232	1512	omega-3-acid ethyl esters	hypertension	1.96	0.23	7.33	0.28	2	95	339	31544	1512	omega-3-acid ethyl esters	hypertension	1.19	0.14	4.45	0.69	2	88	760	39842	1512	omega-3-acid ethyl esters	hypertension	0.36	1.43332941456034	0.51	0.47	-0.02	0	0	-0.59	0.07	0
1513	ciclesonide	1.32	1.06	1.61	0.0098	97	3609	177452	8683181	1513	ciclesonide	asthma	1.2	0.92	1.54	0.17	65	1796	2979	98578	1513	ciclesonide	asthma	9	76	1.61	1.08	2.33	0.016	32	658	508	16858	1513	ciclesonide	asthma	1.82	0.81	3.63	0.11	9	216	138	6042	1513	ciclesonide	asthma	1.75	1.12	2.64	0.012	26	483	432	14079	1513	ciclesonide	asthma	0.55	1.7332530178674	0.18	0	-0.02	0	0	-0.4	0.1	0
1514	bromfenac sodium	0.29	0.08	0.74	0.0038	4	676	177545	8686114	1514	bromfenac sodium	postoperative care	0	0	5.53	1	0	109	18	2611	1514	bromfenac sodium	postoperative care	19.8	69.3	0	0	122.25	1	0	16	2	356	1514	bromfenac sodium	postoperative care	0	0	123.19	1	0	11	2	243	1514	bromfenac sodium	postoperative care	0	0	69.7	1	0	29	2	373	1514	bromfenac sodium	postoperative care	-14.06	7.83104256308479e-07	1689.83	0.99	-0.02	0.02	0.22	0.28	1.02	0.78
1515	glutamine	2.63	1.98	3.42	3.8e-10	58	1080	177491	8685710	1515	glutamine	rheumatoid arthritis	0	0	4.65	1	0	109	3410	460268	1515	glutamine	rheumatoid arthritis	33	75	0	0	91.45	1	0	6	1060	113932	1515	glutamine	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	1515	glutamine	rheumatoid arthritis	0	0	54.17	1	0	9	1011	107955	1515	glutamine	rheumatoid arthritis	-7.86	0.000385873871372051	108.1	0.94	-0.01	0	0	-0.26	0.08	0
1516	trypan blue	0	0	5.28	1	0	36	177549	8686754	1516	trypan blue	postoperative care	0	0	72.79	1	0	10	18	2710	1516	trypan blue	postoperative care	19.8	69.3	0	0	257.32	1	0	8	2	364	1516	trypan blue	postoperative care	0	0	865.86	1	0	2	2	252	1516	trypan blue	postoperative care	0	0	278.46	1	0	8	2	394	1516	trypan blue	postoperative care	-13.4	1.51514411214325e-06	2037.03	0.99	-0.03	0.02	0.19	0.27	1.02	0.79
1517	clofarabine	0.35	0.22	0.52	1.3e-09	24	3362	177525	8683428	1517	clofarabine	acute myeloid leukaemia	1.04	0.2	3.36	0.76	3	1312	28	12697	1517	clofarabine	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	53	0	767	1517	clofarabine	acute myeloid leukaemia	0	0	699.16	1	0	72	1	1304	1517	clofarabine	acute myeloid leukaemia	0	0	118.25	1	0	49	2	1077	1517	clofarabine	acute myeloid leukaemia	-14.86	3.51871424282876e-07	2624.65	1	0	0.03	0.87	-0.87	1.23	0.48
1518	pemetrexed	0.3	0.24	0.37	7.6e-48	95	15525	177454	8671265	1518	pemetrexed	non-small cell lung cancer	0.64	0.38	1.04	0.077	19	5471	154	28456	1518	pemetrexed	non-small cell lung cancer	43.2	79.8	0.84	0.1	3.41	1	2	482	24	4876	1518	pemetrexed	non-small cell lung cancer	2.81	0.51	10.52	0.12	3	275	12	3098	1518	pemetrexed	non-small cell lung cancer	0	0	2.86	0.39	0	254	15	2586	1518	pemetrexed	non-small cell lung cancer	0.18	1.19721736312181	0.61	0.77	-0.01	0.01	0.35	-0.15	0.37	0.68
1519	cinacalcet	0.66	0.59	0.74	3.7e-14	300	22167	177249	8664623	1519	cinacalcet	hyperparathyroidism secondary	0.66	0.37	1.22	0.17	34	8894	20	3474	1519	cinacalcet	hyperparathyroidism secondary	45	69.5	Inf	0.34	Inf	0.37	9	3699	0	638	1519	cinacalcet	hyperparathyroidism secondary	Inf	0.05	Inf	1	2	2746	0	659	1519	cinacalcet	hyperparathyroidism secondary	Inf	0.33	Inf	0.62	9	3438	0	570	1519	cinacalcet	hyperparathyroidism secondary	16.1	9820670.92207137	1345.66	0.99	0	0.02	0.88	-1.29	0.78	0.1
1520	esomeprazole sodium	0.76	0.46	1.2	0.27	19	1220	177530	8685570	1520	esomeprazole sodium	hypertension	0	0	1.44	0.19	0	120	6895	317493	1520	esomeprazole sodium	hypertension	38	82.9	0	0	7.08	1	0	35	981	62374	1520	esomeprazole sodium	hypertension	0	0	21.18	1	0	18	341	31621	1520	esomeprazole sodium	hypertension	0	0	8	1	0	26	762	39904	1520	esomeprazole sodium	hypertension	-10.28	3.4312528777718e-05	131.91	0.94	-0.02	0	0	-0.59	0.07	0
1521	conivaptan	0	0	2.86	0.64	0	65	177549	8686725	1521	conivaptan	hyponatraemia	0	0	183.52	1	0	29	2	983	1521	conivaptan	hyponatraemia	78	78	0	0	Inf	1	0	0	0	0	1521	conivaptan	hyponatraemia	0	0	Inf	1	0	0	0	151	1521	conivaptan	hyponatraemia	0	0	Inf	1	0	0	1	118	1521	conivaptan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1522	lactic acid	0.31	0.06	0.91	0.031	3	476	177546	8686314	1522	lactic acid	prophylaxis	0	0	3.92	1	0	78	1279	103473	1522	lactic acid	prophylaxis	23.9	79.7	0	0	67.36	1	0	8	207	23652	1522	lactic acid	prophylaxis	0	0	61.36	1	0	12	82	13716	1522	lactic acid	prophylaxis	0	0	515.28	1	0	2	148	14410	1522	lactic acid	prophylaxis	-9.7	6.12834950532221e-05	234.96	0.97	-0.01	0	0.02	-0.52	0.14	0
1523	gadofosveset trisodium	0	0	4.49	1	0	42	177549	8686748	1523	gadofosveset trisodium	angiogram	0	0	1.59	0.15	0	16	357	2171	1523	gadofosveset trisodium	angiogram	84	84	0	0	Inf	1	0	0	0	0	1523	gadofosveset trisodium	angiogram	0	0	Inf	1	0	3	0	113	1523	gadofosveset trisodium	angiogram	0	0	694.39	1	0	4	1	71	1523	gadofosveset trisodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1524	levalbuterol tartrate	1.98	1.42	2.7	7.2e-05	42	1037	177507	8685753	1524	levalbuterol tartrate	asthma	0.78	0.28	1.71	0.71	6	255	3038	100119	1524	levalbuterol tartrate	asthma	9	76	1.12	0.13	4.25	0.7	2	58	538	17458	1524	levalbuterol tartrate	asthma	0	0	12.94	1	0	14	147	6244	1524	levalbuterol tartrate	asthma	1.35	0.16	5.2	0.66	2	47	456	14515	1524	levalbuterol tartrate	asthma	0	1	0.72	1	-0.02	0	0	-0.41	0.1	0
1525	nebivolol	0.85	0.75	0.96	0.0071	265	15300	177284	8671490	1525	nebivolol	hypertension	0.85	0.68	1.05	0.15	88	4750	6807	312863	1525	nebivolol	hypertension	38	82.9	1.42	0.9	2.14	0.11	24	1083	957	61326	1525	nebivolol	hypertension	2.49	1.34	4.28	0.0025	14	534	327	31105	1525	nebivolol	hypertension	0.73	0.35	1.36	0.41	10	713	752	39217	1525	nebivolol	hypertension	0.22	1.24607673058738	0.21	0.29	-0.02	0	0	-0.59	0.07	0
1526	erlotinib	0.36	0.32	0.41	1.2e-88	271	36624	177278	8650166	1526	erlotinib	non-small cell lung cancer	1.17	0.81	1.66	0.41	43	7496	130	26431	1526	erlotinib	non-small cell lung cancer	43.2	79.8	0.62	0.07	2.51	0.76	2	635	24	4723	1526	erlotinib	non-small cell lung cancer	1.97	0.36	7.36	0.23	3	379	12	2994	1526	erlotinib	non-small cell lung cancer	0	0	1.67	0.15	0	408	15	2432	1526	erlotinib	non-small cell lung cancer	-0.23	0.794533602503334	0.61	0.71	-0.01	0.01	0.37	-0.16	0.37	0.66
1527	lucinactant	0	0	24.79	1	0	9	177549	8686781	1527	lucinactant	neonatal respiratory distress syndrome	0	0	Inf	1	0	4	0	250	1527	lucinactant	neonatal respiratory distress syndrome	NA	NA	0	0	Inf	1	0	0	0	0	1527	lucinactant	neonatal respiratory distress syndrome	0	0	Inf	1	0	1	0	18	1527	lucinactant	neonatal respiratory distress syndrome	0	0	Inf	1	0	1	0	11	1527	lucinactant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1530	pegaptanib sodium	0.14	0.02	0.5	0.00013	2	707	177547	8686083	1530	pegaptanib sodium	macular degeneration	1.22	0.14	4.78	0.68	2	347	36	7628	1530	pegaptanib sodium	macular degeneration	55.9	75.8	0	0	3449.99	1	0	1	2	186	1530	pegaptanib sodium	macular degeneration	0	0	Inf	1	0	0	0	183	1530	pegaptanib sodium	macular degeneration	0	0	809.29	1	0	2	3	383	1530	pegaptanib sodium	macular degeneration	-16.9	4.57533876944581e-08	20158.38	1	-0.06	0.03	0.04	-16.54	2102.53	0.99
1531	exenatide synthetic	0.44	0.4	0.47	3e-119	599	66795	176950	8619995	1531	exenatide synthetic	type 2 diabetes mellitus	1.29	1.12	1.48	4e-04	259	24335	963	116763	1531	exenatide synthetic	type 2 diabetes mellitus	43	80.7	1.7	1.16	2.43	0.0047	38	3824	176	30070	1531	exenatide synthetic	type 2 diabetes mellitus	1.45	0.69	2.75	0.26	11	1668	74	16268	1531	exenatide synthetic	type 2 diabetes mellitus	1.8	1.16	2.72	0.0071	29	2449	125	19025	1531	exenatide synthetic	type 2 diabetes mellitus	0.52	1.68202764969889	0.17	0	0	0	0.79	-0.4	0.14	0
1532	alvimopan	0.36	0.04	1.3	0.19	2	274	177547	8686516	1532	alvimopan	postoperative ileus	Inf	0	Inf	1	1	177	0	15	1532	alvimopan	postoperative ileus	70.3	70.3	0	0	Inf	1	0	0	0	0	1532	alvimopan	postoperative ileus	0	0	Inf	1	0	1	0	0	1532	alvimopan	postoperative ileus	0	0	Inf	1	1	0	0	0	1532	alvimopan	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1533	iloprost	0.26	0.19	0.35	5.8e-33	50	9313	177499	8677477	1533	iloprost	pulmonary arterial hypertension	1.01	0.68	1.46	0.93	31	5536	451	81367	1533	iloprost	pulmonary arterial hypertension	28	80	1.14	0.61	1.96	0.56	14	1325	256	27719	1533	iloprost	pulmonary arterial hypertension	1.96	0.61	4.91	0.19	5	426	50	8332	1533	iloprost	pulmonary arterial hypertension	1.02	0.5	1.86	0.88	11	1140	238	25146	1533	iloprost	pulmonary arterial hypertension	0.19	1.20924959765725	0.26	0.46	0	0	0.14	-0.41	0.15	0.01
1534	ramelteon	1.77	1.52	2.05	1.7e-12	188	5204	177361	8681586	1534	ramelteon	insomnia	0.73	0.55	0.94	0.016	58	1823	2885	65765	1534	ramelteon	insomnia	26.9	78.5	0.59	0.16	1.55	0.42	4	151	527	11746	1534	ramelteon	insomnia	0	0	0.91	0.034	0	105	212	5332	1534	ramelteon	insomnia	0.76	0.2	2.02	0.82	4	121	375	8669	1534	ramelteon	insomnia	-0.78	0.458406011305224	0.51	0.12	-0.02	0	0	-0.07	0.09	0.4
1535	decitabine	0.16	0.07	0.32	6.3e-13	8	2439	177541	8684351	1535	decitabine	acute myeloid leukaemia	0.48	0.01	2.88	0.72	1	913	30	13096	1535	decitabine	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	46	0	774	1535	decitabine	acute myeloid leukaemia	0	0	459.58	1	0	107	1	1269	1535	decitabine	acute myeloid leukaemia	0	0	71.95	1	0	78	2	1048	1535	decitabine	acute myeloid leukaemia	-14.85	3.55407790889063e-07	2125.54	0.99	0	0.03	0.94	-0.88	1.23	0.47
1536	dapsone	1.27	1.04	1.54	0.015	110	4231	177439	8682559	1536	dapsone	hiv infection	0.17	0	0.93	0.035	1	696	499	57695	1536	dapsone	hiv infection	25	64	0	0	8.13	1	0	31	120	7610	1536	dapsone	hiv infection	0	0	8.2	1	0	29	96	5699	1536	dapsone	hiv infection	0	0	51.93	1	0	8	40	3431	1536	dapsone	hiv infection	-12.41	4.07760806517693e-06	393.96	0.97	0	0.01	0.8	0.38	0.2	0.05
1537	entecavir	0.12	0.07	0.2	6.6e-34	15	5996	177534	8680794	1537	entecavir	hepatitis b	0.12	0.01	0.48	2e-04	2	2640	33	5353	1537	entecavir	hepatitis b	36	46.4	1.85	0.02	146.23	1	1	89	1	165	1537	entecavir	hepatitis b	3.77	0.2	222.43	0.28	2	383	1	722	1537	entecavir	hepatitis b	0	0	70.56	1	0	180	1	325	1537	entecavir	hepatitis b	0.64	1.89648087930495	1	0.52	-0.04	0.03	0.15	0.4	1.16	0.73
1538	quinine	2.47	2.23	2.72	2e-57	426	8465	177123	8678325	1538	quinine	muscle spasms	0.93	0.71	1.2	0.62	69	1361	815	14928	1538	quinine	muscle spasms	24.9	74.1	0.45	0.05	1.71	0.44	2	116	141	3717	1538	quinine	muscle spasms	0.59	0.01	3.69	1	1	72	29	1239	1538	quinine	muscle spasms	0.6	0.12	1.83	0.49	3	125	126	3136	1538	quinine	muscle spasms	-0.21	0.810584245970187	0.52	0.69	-0.02	0	0	-0.51	0.21	0.01
1539	tipranavir	0.04	0	0.14	2.9e-19	2	2502	177547	8684288	1539	tipranavir	hiv infection	0.06	0	0.32	1.2e-06	1	1972	499	56419	1539	tipranavir	hiv infection	25	64	1.94	0.05	11.77	0.41	1	33	119	7608	1539	tipranavir	hiv infection	0	0	11.61	1	0	21	96	5707	1539	tipranavir	hiv infection	4.61	0.11	30.52	0.21	1	19	39	3420	1539	tipranavir	hiv infection	0.56	1.7506725002961	1.02	0.58	0	0.01	0.81	0.38	0.2	0.05
1540	tigecycline	0.58	0.39	0.84	0.0024	29	2434	177520	8684356	1540	tigecycline	infection	0	0	0.92	0.036	0	155	375	14188	1540	tigecycline	infection	23	72	0	0	6.87	1	0	24	53	2123	1540	tigecycline	infection	0	0	14.08	1	0	20	24	1556	1540	tigecycline	infection	0	0	9.87	1	0	19	37	1629	1540	tigecycline	infection	-13.59	1.25296226277737e-06	618.77	0.98	-0.03	0.01	0	-0.34	0.27	0.2
1541	deferiprone	0.15	0.02	0.54	0.00038	2	653	177547	8686137	1541	deferiprone	haemochromatosis	0.52	0.01	3.9	1	1	189	8	783	1541	deferiprone	haemochromatosis	NA	NA	0	0	Inf	1	0	0	0	0	1541	deferiprone	haemochromatosis	0	0	Inf	1	0	55	0	50	1541	deferiprone	haemochromatosis	0	0	Inf	1	0	63	0	50	1541	deferiprone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1542	rotigotine	1.02	0.81	1.27	0.82	83	3963	177466	8682827	1542	rotigotine	parkinson s disease	0.82	0.62	1.07	0.15	60	2314	812	25610	1542	rotigotine	parkinson s disease	50.1	85.7	0.64	0.27	1.31	0.29	8	484	155	6014	1542	rotigotine	parkinson s disease	0.49	0.13	1.3	0.19	4	333	94	3799	1542	rotigotine	parkinson s disease	0.8	0.25	1.97	0.83	5	218	80	2779	1542	rotigotine	parkinson s disease	-0.48	0.618783391806141	0.35	0.17	-0.03	0.01	0	-0.2	0.15	0.19
1543	mecasermin recombinant	0.28	0.06	0.81	0.012	3	531	177546	8686259	1543	mecasermin recombinant	insulin-like growth factor decreased	0	0	1.49	0.048	0	120	2	32	1543	mecasermin recombinant	insulin-like growth factor decreased	NA	NA	0	0	Inf	1	0	0	0	0	1543	mecasermin recombinant	insulin-like growth factor decreased	0	0	Inf	1	0	2	0	1	1543	mecasermin recombinant	insulin-like growth factor decreased	0	0	Inf	1	0	2	0	4	1543	mecasermin recombinant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1544	urokinase	0.23	0.01	1.31	0.14	1	211	177548	8686579	1544	urokinase	depression	0	0	2.13	0.41	0	25	14371	192760	1544	urokinase	depression	21	73.3	0	0	33.28	1	0	3	2062	28339	1544	urokinase	depression	0	0	Inf	1	0	0	637	10447	1544	urokinase	depression	0	0	35.33	1	0	3	1671	24381	1544	urokinase	depression	-8.76	0.000156884608586522	113.72	0.94	-0.01	0	0	-0.14	0.05	0
1545	calcipotriene hydrate	0.57	0.29	1	0.046	12	1035	177537	8685755	1545	calcipotriene hydrate	psoriasis	1.68	0.8	3.11	0.1	10	813	1180	160878	1545	calcipotriene hydrate	psoriasis	25	74.8	0	0	1.97	0.27	0	217	379	43308	1545	calcipotriene hydrate	psoriasis	0	0	5.42	1	0	100	149	21244	1545	calcipotriene hydrate	psoriasis	0	0	2.86	0.64	0	131	274	27212	1545	calcipotriene hydrate	psoriasis	-12.82	2.70610561241254e-06	259.8	0.96	0	0	0.7	-0.36	0.1	0
1546	omega-3acid ethyl esters	1.08	0.79	1.45	0.58	45	2033	177504	8684757	1546	omega-3acid ethyl esters	hypertension	0	0	0.61	0.0054	0	278	6895	317335	1546	omega-3acid ethyl esters	hypertension	38	82.9	0	0	8.05	1	0	31	981	62378	1546	omega-3acid ethyl esters	hypertension	0	0	14.2	1	0	26	341	31613	1546	omega-3acid ethyl esters	hypertension	0	0	26.59	1	0	9	762	39921	1546	omega-3acid ethyl esters	hypertension	-10.24	3.57128496416352e-05	147.8	0.94	-0.02	0	0	-0.59	0.07	0
1547	febuxostat	0.23	0.15	0.35	6.2e-21	25	5231	177524	8681559	1547	febuxostat	gout	0.37	0.2	0.63	3.8e-05	15	2183	234	12645	1547	febuxostat	gout	41	78.7	0.28	0.05	0.87	0.024	3	671	43	2655	1547	febuxostat	gout	0.45	0.11	1.28	0.15	4	705	30	2376	1547	febuxostat	gout	0.24	0.01	1.55	0.22	1	291	16	1115	1547	febuxostat	gout	-1.28	0.278037300453194	0.5	0.01	-0.02	0.01	0.01	-0.16	0.3	0.6
1548	hyaluronidase recombinant human	0	0	3.91	1	0	48	177549	8686742	1548	hyaluronidase recombinant human	adjuvant therapy	0	0	7.9	1	0	19	45	1599	1548	hyaluronidase recombinant human	adjuvant therapy	34	77	0	0	Inf	1	0	0	12	403	1548	hyaluronidase recombinant human	adjuvant therapy	0	0	Inf	1	0	0	2	209	1548	hyaluronidase recombinant human	adjuvant therapy	0	0	Inf	1	0	0	13	309	1548	hyaluronidase recombinant human	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1549	nepafenac	0.76	0.46	1.17	0.24	20	1294	177529	8685496	1549	nepafenac	cataract operation	2.83	0.25	19.84	0.23	2	267	4	1511	1549	nepafenac	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	1549	nepafenac	cataract operation	0	0	Inf	1	0	8	0	93	1549	nepafenac	cataract operation	0	0	Inf	1	0	16	0	224	1549	nepafenac	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1550	armodafinil	2.83	2.63	3.05	1.4e-123	731	12657	176818	8674133	1550	armodafinil	narcolepsy	1.02	0.9	1.14	0.79	377	6199	1477	24677	1550	armodafinil	narcolepsy	18.4	61.1	0.84	0.68	1.05	0.12	110	1744	530	7094	1550	armodafinil	narcolepsy	0.7	0.43	1.09	0.13	24	584	138	2336	1550	armodafinil	narcolepsy	0.92	0.73	1.16	0.5	96	1430	455	6238	1550	armodafinil	narcolepsy	-0.15	0.860707976425058	0.1	0.14	-0.01	0	0	-0.25	0.09	0.01
1551	nelarabine	0.1	0	0.55	0.0011	1	502	177548	8686288	1551	nelarabine	t-cell type acute leukaemia	0.82	0.02	10.24	1	1	155	3	379	1551	nelarabine	t-cell type acute leukaemia	8	8	0	0	Inf	1	0	0	0	0	1551	nelarabine	t-cell type acute leukaemia	Inf	0.08	Inf	0.25	1	30	0	92	1551	nelarabine	t-cell type acute leukaemia	0	0	Inf	1	0	10	0	27	1551	nelarabine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1552	insulin detemir	0.58	0.51	0.66	8e-21	258	21587	177291	8665203	1552	insulin detemir	type 2 diabetes mellitus	0.83	0.58	1.15	0.29	38	5242	1184	135856	1552	insulin detemir	type 2 diabetes mellitus	43	80.7	1.44	0.81	2.41	0.17	16	1796	198	32098	1552	insulin detemir	type 2 diabetes mellitus	2.02	0.84	4.2	0.071	8	877	77	17059	1552	insulin detemir	type 2 diabetes mellitus	1.19	0.56	2.26	0.59	10	1186	144	20288	1552	insulin detemir	type 2 diabetes mellitus	0.38	1.46228458943422	0.25	0.12	0	0	0.69	-0.41	0.14	0
1553	lenalidomide	0.41	0.39	0.44	1e-266	1166	136903	176383	8549887	1553	lenalidomide	plasma cell myeloma	0.78	0.65	0.94	0.0081	344	73250	190	31665	1553	lenalidomide	plasma cell myeloma	47.4	82.5	1.11	0.79	1.58	0.56	114	26768	50	13060	1553	lenalidomide	plasma cell myeloma	1.07	0.68	1.72	0.83	64	16540	29	8022	1553	lenalidomide	plasma cell myeloma	1.11	0.7	1.82	0.74	64	14266	27	6692	1553	lenalidomide	plasma cell myeloma	0.13	1.13882838332462	0.16	0.4	-0.03	0.01	0	-0.15	0.15	0.31
1554	sodium ascorbate	0.52	0.32	0.8	0.0013	21	1968	177528	8684822	1554	sodium ascorbate	constipation	0	0	0.74	0.018	0	290	728	41999	1554	sodium ascorbate	constipation	2.6	80.7	0	0	93.78	1	0	4	169	10420	1554	sodium ascorbate	constipation	0	0	434.58	1	0	2	69	5668	1554	sodium ascorbate	constipation	0	0	152.92	1	0	3	120	7549	1554	sodium ascorbate	constipation	-10.02	4.45009509214075e-05	393.05	0.98	-0.03	0	0	-0.22	0.15	0.15
1555	deferasirox	0.23	0.19	0.28	8.1e-101	124	26255	177425	8660535	1555	deferasirox	iron overload	0.94	0.37	3.06	0.81	39	7127	5	857	1555	deferasirox	iron overload	41.1	70.1	Inf	0.07	Inf	1	3	388	0	71	1555	deferasirox	iron overload	Inf	0.03	Inf	1	2	502	0	94	1555	deferasirox	iron overload	0.17	0	13.52	0.27	1	534	1	91	1555	deferasirox	iron overload	-0.62	0.537944437594674	1.16	0.59	0.01	0.02	0.78	0.01	1.01	0.99
1556	dalbavancin	0	0	2.09	0.43	0	88	177549	8686702	1556	dalbavancin	cellulitis	0	0	8.09	1	0	25	82	4088	1556	dalbavancin	cellulitis	19	83.5	0	0	27.9	1	0	18	9	915	1556	dalbavancin	cellulitis	0	0	Inf	1	0	16	0	514	1556	dalbavancin	cellulitis	0	0	37.66	1	0	7	11	528	1556	dalbavancin	cellulitis	-16.04	1.08122607403426e-07	5273.64	1	-0.01	0.02	0.41	-17.65	1259.96	0.99
1557	mecasermin rinfabate recombinant	0	0	7.78	1	0	25	177549	8686765	1557	mecasermin rinfabate recombinant	insulin-like growth factor decreased	0	0	50.58	1	0	15	2	137	1557	mecasermin rinfabate recombinant	insulin-like growth factor decreased	NA	NA	0	0	Inf	1	0	0	0	0	1557	mecasermin rinfabate recombinant	insulin-like growth factor decreased	0	0	Inf	1	0	0	0	3	1557	mecasermin rinfabate recombinant	insulin-like growth factor decreased	0	0	Inf	1	0	0	0	6	1557	mecasermin rinfabate recombinant	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1558	sodium phosphate, dibasic, anhydrous	2.58	1.54	4.09	3e-04	19	360	177530	8686430	1558	sodium phosphate, dibasic, anhydrous	colonoscopy	0.32	0.01	1.88	0.37	1	214	69	4775	1558	sodium phosphate, dibasic, anhydrous	colonoscopy	31	72.5	0	0	39.97	1	0	10	14	1130	1558	sodium phosphate, dibasic, anhydrous	colonoscopy	0	0	95.13	1	0	4	9	504	1558	sodium phosphate, dibasic, anhydrous	colonoscopy	0	0	147.93	1	0	6	7	1020	1558	sodium phosphate, dibasic, anhydrous	colonoscopy	-13.11	2.02488023978819e-06	1229.72	0.99	-0.03	0.02	0.09	0.92	0.51	0.07
1559	tetrabenazine	1.84	1.61	2.09	4.1e-17	237	6314	177312	8680476	1559	tetrabenazine	huntington s disease	1.25	0.46	4.75	0.82	99	2967	4	150	1559	tetrabenazine	huntington s disease	22.8	72.1	1.32	0.33	11.55	1	37	897	2	64	1559	tetrabenazine	huntington s disease	2.32	0.36	98.3	0.71	21	415	1	46	1559	tetrabenazine	huntington s disease	1.1	0.17	46.85	1	22	678	1	34	1559	tetrabenazine	huntington s disease	0.5	1.64872127070013	0.74	0.5	-0.03	0.01	0	0.35	0.31	0.25
1560	sinecatechins	0	0	9.91	1	0	20	177549	8686770	1560	sinecatechins	anogenital warts	0	0	87.36	1	0	8	2	123	1560	sinecatechins	anogenital warts	NA	NA	0	0	Inf	1	0	0	0	0	1560	sinecatechins	anogenital warts	0	0	Inf	1	0	1	0	13	1560	sinecatechins	anogenital warts	0	0	Inf	1	0	0	0	12	1560	sinecatechins	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1561	ibuprofen lysine	0	0	0.51	0.0018	0	359	177549	8686431	1561	ibuprofen lysine	patent ductus arteriosus	0	0	Inf	1	0	229	0	1016	1561	ibuprofen lysine	patent ductus arteriosus	NA	NA	0	0	Inf	1	0	0	0	0	1561	ibuprofen lysine	patent ductus arteriosus	0	0	Inf	1	0	1	0	18	1561	ibuprofen lysine	patent ductus arteriosus	0	0	Inf	1	0	5	0	34	1561	ibuprofen lysine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1562	lubiprostone	2.92	2.55	3.34	1.6e-43	237	3968	177312	8682822	1562	lubiprostone	constipation	3.21	2.42	4.2	8.1e-14	62	1192	666	41097	1562	lubiprostone	constipation	2.6	80.7	1.41	0.55	3	0.36	7	311	162	10113	1562	lubiprostone	constipation	0.59	0.01	3.43	1	1	139	68	5531	1562	lubiprostone	constipation	1.64	0.58	3.73	0.28	6	235	114	7317	1562	lubiprostone	constipation	0.18	1.19721736312181	0.39	0.65	-0.03	0	0	-0.22	0.15	0.15
1563	rufinamide	0.52	0.21	1.08	0.094	7	657	177542	8686133	1563	rufinamide	epilepsy	0.82	0.1	3.04	1	2	172	638	45254	1563	rufinamide	epilepsy	13.6	68.1	2.93	0.07	18.64	0.3	1	21	86	5293	1563	rufinamide	epilepsy	3.14	0.08	20.03	0.28	1	28	40	3524	1563	rufinamide	epilepsy	0	0	15.51	1	0	20	56	4164	1563	rufinamide	epilepsy	0.59	1.80398841539786	1.02	0.56	0	0	0.54	-0.15	0.21	0.47
1564	arformoterol tartrate	0.73	0.43	1.16	0.22	18	1206	177531	8685584	1564	arformoterol tartrate	chronic obstructive pulmonary disease	1.01	0.4	2.11	0.85	7	451	1251	81546	1564	arformoterol tartrate	chronic obstructive pulmonary disease	48.4	82.8	1.54	0.31	4.65	0.45	3	135	288	20009	1564	arformoterol tartrate	chronic obstructive pulmonary disease	2.11	0.05	12.65	0.38	1	43	107	9706	1564	arformoterol tartrate	chronic obstructive pulmonary disease	1.15	0.14	4.32	0.69	2	108	215	13397	1564	arformoterol tartrate	chronic obstructive pulmonary disease	0.37	1.44773461466332	0.59	0.53	-0.03	0	0	-0.36	0.12	0
1565	sorafenib tosylate	0.35	0.29	0.42	4e-43	118	16604	177431	8670186	1565	sorafenib tosylate	hepatic neoplasm malignant	0.44	0.11	1.54	0.17	5	5100	8	3621	1565	sorafenib tosylate	hepatic neoplasm malignant	NA	NA	0	0	Inf	1	0	0	0	0	1565	sorafenib tosylate	hepatic neoplasm malignant	0	0	Inf	1	0	0	0	0	1565	sorafenib tosylate	hepatic neoplasm malignant	0	0	Inf	1	0	0	0	0	1565	sorafenib tosylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1566	varenicline tartrate	6.1	5.96	6.25	0	8323	69437	169226	8617353	1566	varenicline tartrate	smoking cessation therapy	2.72	2.53	2.93	8.3e-198	5521	41524	911	18663	1566	varenicline tartrate	smoking cessation therapy	26.1	70	1.72	1.33	2.24	3.5e-05	120	1958	131	3683	1566	varenicline tartrate	smoking cessation therapy	1.6	1.05	2.42	0.025	45	782	61	1697	1566	varenicline tartrate	smoking cessation therapy	1.84	1.34	2.51	9e-05	84	1394	93	2836	1566	varenicline tartrate	smoking cessation therapy	0.57	1.76826705143374	0.12	0	-0.02	0	0	-0.02	0.13	0.85
1567	formoterol fumarate dihydrate	1.15	1.08	1.22	1.5e-05	1019	43352	176530	8643438	1567	formoterol fumarate dihydrate	asthma	0.88	0.78	0.99	0.036	298	11037	2746	89337	1567	formoterol fumarate dihydrate	asthma	9	76	1.52	1.23	1.86	7.7e-05	132	3081	408	14435	1567	formoterol fumarate dihydrate	asthma	1.2	0.77	1.83	0.37	29	1062	118	5196	1567	formoterol fumarate dihydrate	asthma	1.57	1.25	1.96	1e-04	109	2414	349	12148	1567	formoterol fumarate dihydrate	asthma	0.45	1.56831218549017	0.1	0	-0.02	0	0	-0.41	0.1	0
1568	sunitinib malate	0.36	0.32	0.4	7.9e-93	277	37842	177272	8648948	1568	sunitinib malate	metastatic renal cell carcinoma	2.43	1.5	4.06	0.00011	65	7820	24	7010	1568	sunitinib malate	metastatic renal cell carcinoma	54.5	76.5	3.44	1.17	13.74	0.015	23	1332	4	798	1568	sunitinib malate	metastatic renal cell carcinoma	2.95	0.97	12.03	0.048	18	1325	4	870	1568	sunitinib malate	metastatic renal cell carcinoma	4.67	0.62	207.81	0.17	8	512	1	299	1568	sunitinib malate	metastatic renal cell carcinoma	1.19	3.28708120738312	0.49	0.01	0.03	0.02	0.06	-0.06	0.4	0.89
1569	methylnaltrexone bromide	2.6	1.72	3.78	8.3e-06	29	546	177520	8686244	1569	methylnaltrexone bromide	constipation	3.04	1.63	5.22	0.00041	14	271	714	42018	1569	methylnaltrexone bromide	constipation	2.6	80.7	3.68	0.73	11.55	0.055	3	51	166	10373	1569	methylnaltrexone bromide	constipation	0	0	19.08	1	0	18	69	5652	1569	methylnaltrexone bromide	constipation	5.2	1.01	16.8	0.024	3	37	117	7515	1569	methylnaltrexone bromide	constipation	1.34	3.81904350536634	0.6	0.03	-0.03	0	0	-0.22	0.15	0.16
1570	darunavir ethanolate	0.44	0.34	0.56	1.8e-13	62	6904	177487	8679886	1570	darunavir ethanolate	hiv infection	0.84	0.57	1.18	0.37	35	4824	465	53567	1570	darunavir ethanolate	hiv infection	25	64	0.53	0.22	1.08	0.087	8	914	112	6727	1570	darunavir ethanolate	hiv infection	0.5	0.2	1.08	0.095	7	775	89	4953	1570	darunavir ethanolate	hiv infection	0.49	0.06	1.9	0.43	2	336	38	3103	1570	darunavir ethanolate	hiv infection	-0.7	0.49658530379141	0.35	0.04	0	0.01	0.81	0.4	0.2	0.04
1571	lisdexamfetamine dimesylate	2.58	2.37	2.81	2e-84	580	11001	176969	8675789	1571	lisdexamfetamine dimesylate	attention deficit/hyperactivity disorder	1.38	1.21	1.56	1.2e-06	303	5051	1759	40374	1571	lisdexamfetamine dimesylate	attention deficit/hyperactivity disorder	7	57	1.42	1.08	1.83	0.0091	77	1083	344	6848	1571	lisdexamfetamine dimesylate	attention deficit/hyperactivity disorder	1.65	1.13	2.36	0.0081	40	675	193	5383	1571	lisdexamfetamine dimesylate	attention deficit/hyperactivity disorder	1.07	0.75	1.49	0.67	47	614	210	2928	1571	lisdexamfetamine dimesylate	attention deficit/hyperactivity disorder	0.24	1.2712491503214	0.12	0.05	0.01	0	0	-0.47	0.1	0
1572	aliskiren hemifumarate	1.08	0.88	1.31	0.47	103	4686	177446	8682104	1572	aliskiren hemifumarate	hypertension	1.13	0.81	1.54	0.45	41	1672	6854	315941	1572	aliskiren hemifumarate	hypertension	38	82.9	4.62	1.64	10.52	0.0026	6	83	975	62326	1572	aliskiren hemifumarate	hypertension	3.58	0.42	13.71	0.11	2	52	339	31587	1572	aliskiren hemifumarate	hypertension	4.38	1.15	12.02	0.016	4	48	758	39882	1572	aliskiren hemifumarate	hypertension	1.48	4.39294568091876	0.42	0	-0.02	0	0	-0.6	0.07	0
1573	dasatinib	0.42	0.35	0.5	1.3e-29	130	15032	177419	8671758	1573	dasatinib	chronic myeloid leukaemia	0.9	0.66	1.21	0.51	53	7535	270	34498	1573	dasatinib	chronic myeloid leukaemia	25.8	72.1	0.48	0.26	0.83	0.0067	15	2027	91	5878	1573	dasatinib	chronic myeloid leukaemia	0.96	0.42	1.99	1	10	1388	33	4381	1573	dasatinib	chronic myeloid leukaemia	0.3	0.12	0.63	0.00039	8	1346	67	3398	1573	dasatinib	chronic myeloid leukaemia	-0.7	0.49658530379141	0.26	0.01	-0.02	0.01	0	-0.77	0.19	0
1574	vorinostat	0.68	0.48	0.94	0.017	38	2727	177511	8684063	1574	vorinostat	acute myeloid leukaemia	1.11	0.03	6.7	0.6	1	409	30	13600	1574	vorinostat	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	33	0	787	1574	vorinostat	acute myeloid leukaemia	0	0	742.06	1	0	68	1	1308	1574	vorinostat	acute myeloid leukaemia	0	0	111.13	1	0	52	2	1074	1574	vorinostat	acute myeloid leukaemia	-14.84	3.58979698570514e-07	2638.86	1	0	0.03	0.91	-0.88	1.23	0.47
1575	desvenlafaxine succinate	3.91	3.71	4.12	0	1521	19156	176028	8667634	1575	desvenlafaxine succinate	depression	1.34	1.24	1.44	4.3e-13	771	7838	13600	184947	1575	desvenlafaxine succinate	depression	21	73.3	1.23	0.97	1.54	0.074	88	993	1974	27349	1575	desvenlafaxine succinate	depression	1.5	0.9	2.37	0.099	21	232	616	10215	1575	desvenlafaxine succinate	depression	1.38	1.07	1.74	0.0098	80	859	1591	23525	1575	desvenlafaxine succinate	depression	0.34	1.40494759056359	0.11	0	-0.01	0	0	-0.13	0.05	0.01
1576	sitagliptin phosphate	0.63	0.58	0.68	3e-38	665	51865	176884	8634925	1576	sitagliptin phosphate	type 2 diabetes mellitus	2.32	2.01	2.67	3.2e-28	260	14723	962	126375	1576	sitagliptin phosphate	type 2 diabetes mellitus	43	80.7	0.99	0.56	1.66	1	16	2550	198	31344	1576	sitagliptin phosphate	type 2 diabetes mellitus	0.66	0.21	1.6	0.44	5	1561	80	16375	1576	sitagliptin phosphate	type 2 diabetes mellitus	1.11	0.54	2.06	0.74	11	1390	143	20084	1576	sitagliptin phosphate	type 2 diabetes mellitus	-0.09	0.913931185271228	0.26	0.74	0	0	0.72	-0.41	0.14	0
1577	paliperidone	0.75	0.68	0.82	4.7e-11	480	31360	177069	8655430	1577	paliperidone	schizophrenia	1.36	1.16	1.6	0.00017	186	5537	1329	53987	1577	paliperidone	schizophrenia	20.1	64.1	1.22	0.84	1.73	0.26	39	783	255	6231	1577	paliperidone	schizophrenia	1.32	0.83	2.01	0.2	27	615	155	4647	1577	paliperidone	schizophrenia	0.99	0.55	1.67	1	17	381	131	2914	1577	paliperidone	schizophrenia	0.04	1.04081077419239	0.17	0.79	-0.02	0	0	-0.31	0.11	0.01
1578	posaconazole	0.41	0.27	0.59	3.3e-08	29	3484	177520	8683306	1578	posaconazole	prophylaxis	0.14	0	0.8	0.019	1	568	1278	102983	1578	posaconazole	prophylaxis	23.9	79.7	0.72	0.02	4.13	1	1	158	206	23502	1578	posaconazole	prophylaxis	1.67	0.04	9.76	0.46	1	101	81	13627	1578	posaconazole	prophylaxis	0	0	4.57	1	0	81	148	14331	1578	posaconazole	prophylaxis	-0.44	0.644036421083141	1.01	0.66	-0.01	0	0.02	-0.52	0.14	0
1579	telbivudine	0	0	0.51	0.0018	0	357	177549	8686433	1579	telbivudine	chronic hepatitis b	0	0	29.25	1	0	81	4	1545	1579	telbivudine	chronic hepatitis b	22.7	36.2	0	0	Inf	1	0	8	0	109	1579	telbivudine	chronic hepatitis b	0	0	1151.52	1	0	15	1	450	1579	telbivudine	chronic hepatitis b	0	0	1516.71	1	0	6	1	238	1579	telbivudine	chronic hepatitis b	-15.5	1.85539136261598e-07	3694.81	1	-0.07	0.04	0.1	-0.68	1.43	0.63
1580	carvedilol phosphate	0.63	0.44	0.88	0.0042	35	2720	177514	8684070	1580	carvedilol phosphate	hypertension	0.59	0.28	1.09	0.11	10	779	6885	316834	1580	carvedilol phosphate	hypertension	38	82.9	1.04	0.03	6.05	0.62	1	61	980	62348	1580	carvedilol phosphate	hypertension	0	0	12.63	1	0	29	341	31610	1580	carvedilol phosphate	hypertension	1.38	0.03	8.19	0.52	1	38	761	39892	1580	carvedilol phosphate	hypertension	0.04	1.04081077419239	1.01	0.97	-0.02	0	0	-0.59	0.07	0
1581	fosaprepitant dimeglumine	0.65	0.53	0.8	1.3e-05	94	7047	177455	8679743	1581	fosaprepitant dimeglumine	prophylaxis of nausea and vomiting	0.99	0.55	1.7	1	18	1891	62	6458	1581	fosaprepitant dimeglumine	prophylaxis of nausea and vomiting	14	75	0.75	0.08	3.98	1	2	536	7	1414	1581	fosaprepitant dimeglumine	prophylaxis of nausea and vomiting	0.75	0.02	7.65	1	1	255	4	767	1581	fosaprepitant dimeglumine	prophylaxis of nausea and vomiting	0.42	0.01	3.29	0.69	1	334	7	983	1581	fosaprepitant dimeglumine	prophylaxis of nausea and vomiting	-0.7	0.49658530379141	0.77	0.37	-0.04	0.01	0	-0.19	0.58	0.75
1582	menthol	1.67	1.25	2.17	0.00049	56	1645	177493	8685145	1582	menthol	pain	2.09	1.02	3.89	0.026	11	117	8458	188367	1582	menthol	pain	23	79	0	0	4.49	1	0	29	1088	35988	1582	menthol	pain	0	0	8.55	1	0	20	364	15297	1582	menthol	pain	0	0	5.97	1	0	21	857	26569	1582	menthol	pain	-10.84	1.95996274414058e-05	136.4	0.94	-0.02	0	0	-0.28	0.06	0
1583	methyl salicylate	0.78	0.43	1.32	0.47	14	875	177535	8685915	1583	methyl salicylate	dental disorder prophylaxis	0	0	1.72	0.26	0	123	22	1144	1583	methyl salicylate	dental disorder prophylaxis	13.2	68.8	0	0	Inf	1	0	0	4	119	1583	methyl salicylate	dental disorder prophylaxis	0	0	Inf	1	0	0	4	68	1583	methyl salicylate	dental disorder prophylaxis	0	0	Inf	1	0	0	2	97	1583	methyl salicylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1584	fesoterodine fumarate	0.47	0.36	0.6	1.4e-11	65	6722	177484	8680068	1584	fesoterodine fumarate	hypertonic bladder	0.75	0.35	1.44	0.45	10	1735	87	11276	1584	fesoterodine fumarate	hypertonic bladder	55.5	80	3.23	0.56	13.12	0.097	3	151	9	1464	1584	fesoterodine fumarate	hypertonic bladder	0	0	24.69	1	0	64	3	644	1584	fesoterodine fumarate	hypertonic bladder	3.76	0.64	15.84	0.072	3	191	8	1918	1584	fesoterodine fumarate	hypertonic bladder	1.02	2.7731947639643	0.66	0.12	-0.01	0.02	0.58	-0.17	0.66	0.79
1585	hydroxocobalamin	0.4	0.21	0.7	0.00039	12	1474	177537	8685316	1585	hydroxocobalamin	prophylaxis	0	0	2.21	0.42	0	137	1279	103414	1585	hydroxocobalamin	prophylaxis	23.9	79.7	0	0	24.67	1	0	19	207	23641	1585	hydroxocobalamin	prophylaxis	0	0	117.57	1	0	7	82	13721	1585	hydroxocobalamin	prophylaxis	0	0	29.64	1	0	14	148	14398	1585	hydroxocobalamin	prophylaxis	-10.76	2.12320229385221e-05	316.37	0.97	-0.01	0	0.03	-0.52	0.14	0
1586	fluticasone furoate	0.94	0.78	1.12	0.54	127	6598	177422	8680192	1586	fluticasone furoate	chronic obstructive pulmonary disease	1.3	0.93	1.77	0.11	42	2129	1216	79868	1586	fluticasone furoate	chronic obstructive pulmonary disease	48.4	82.8	1.16	0.66	1.9	0.5	17	1024	274	19120	1586	fluticasone furoate	chronic obstructive pulmonary disease	1.03	0.37	2.33	0.83	6	527	102	9222	1586	fluticasone furoate	chronic obstructive pulmonary disease	1.49	0.82	2.54	0.15	15	640	202	12865	1586	fluticasone furoate	chronic obstructive pulmonary disease	0.33	1.39096812846378	0.23	0.15	-0.03	0	0	-0.37	0.12	0
1587	retapamulin	0.62	0.28	1.19	0.18	9	708	177540	8686082	1587	retapamulin	impetigo	0	0	Inf	1	0	98	0	152	1587	retapamulin	impetigo	NA	NA	0	0	Inf	1	0	0	0	0	1587	retapamulin	impetigo	0	0	Inf	1	0	0	0	21	1587	retapamulin	impetigo	0	0	Inf	1	0	1	0	18	1587	retapamulin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1588	lapatinib ditosylate	0.72	0.61	0.85	7.4e-05	141	9540	177408	8677250	1588	lapatinib ditosylate	breast cancer	0.47	0.35	0.62	6.3e-09	50	4744	1396	62038	1588	lapatinib ditosylate	breast cancer	40	78	0.94	0.25	2.49	1	4	340	123	9807	1588	lapatinib ditosylate	breast cancer	0	0	Inf	1	0	0	0	116	1588	lapatinib ditosylate	breast cancer	1.05	0.33	2.53	0.81	5	390	139	11386	1588	lapatinib ditosylate	breast cancer	0.04	1.04081077419239	0.46	0.92	0	0.01	0.79	-13.16	367.31	0.97
1590	levocetirizine	1.46	1.26	1.68	1.2e-06	191	6409	177358	8680381	1590	levocetirizine	asthma	0.84	0.48	1.38	0.56	16	627	3028	99747	1590	levocetirizine	asthma	9	76	0.91	0.24	2.4	1	4	142	536	17374	1590	levocetirizine	asthma	1.25	0.03	7.58	0.56	1	34	146	6224	1590	levocetirizine	asthma	0.77	0.16	2.31	1	3	124	455	14438	1590	levocetirizine	asthma	-0.26	0.771051585803566	0.51	0.62	-0.02	0	0	-0.41	0.1	0
1591	ixabepilone	0.69	0.46	1	0.055	28	1980	177521	8684810	1591	ixabepilone	breast cancer	0.55	0.24	1.09	0.11	8	668	1438	66114	1591	ixabepilone	breast cancer	40	78	0	0	14.05	1	0	23	127	10124	1591	ixabepilone	breast cancer	0	0	Inf	1	0	0	0	116	1591	ixabepilone	breast cancer	0	0	13.72	1	0	24	144	11752	1591	ixabepilone	breast cancer	-13.17	1.90696039458808e-06	807.54	0.99	0	0.01	0.79	-13.16	367.31	0.97
1592	nilotinib monohydrate	0.51	0.43	0.6	6.4e-21	156	15007	177393	8671783	1592	nilotinib monohydrate	chronic myeloid leukaemia	1.81	1.44	2.28	5.4e-07	125	10851	198	31182	1592	nilotinib monohydrate	chronic myeloid leukaemia	25.8	72.1	3.86	2.57	5.86	1.1e-11	64	2237	42	5668	1592	nilotinib monohydrate	chronic myeloid leukaemia	2.93	1.53	5.64	0.00054	23	1627	20	4142	1592	nilotinib monohydrate	chronic myeloid leukaemia	4.24	2.6	7.01	1e-09	45	1239	30	3505	1592	nilotinib monohydrate	chronic myeloid leukaemia	1.31	3.7061737122102	0.19	0	-0.02	0.01	0	-0.77	0.19	0
1593	lanreotide acetate	0.47	0.19	0.98	0.046	7	723	177542	8686067	1593	lanreotide acetate	acromegaly	0.21	0.04	0.63	0.0016	3	404	161	4585	1593	lanreotide acetate	acromegaly	33.7	68.4	0.57	0.01	3.6	1	1	31	47	835	1593	lanreotide acetate	acromegaly	0	0	6.65	1	0	19	15	415	1593	lanreotide acetate	acromegaly	0.66	0.02	4.23	1	1	28	41	761	1593	lanreotide acetate	acromegaly	-0.81	0.444858066222941	1.02	0.43	-0.02	0.01	0.05	-0.43	0.31	0.16
1594	ambrisentan	0.21	0.19	0.23	0	414	97316	177135	8589474	1594	ambrisentan	pulmonary arterial hypertension	0.72	0.59	0.88	0.0013	134	30230	348	56673	1594	ambrisentan	pulmonary arterial hypertension	28	80	0.55	0.41	0.72	6.6e-06	74	11842	196	17202	1594	ambrisentan	pulmonary arterial hypertension	0.42	0.2	0.83	0.0076	11	3256	44	5502	1594	ambrisentan	pulmonary arterial hypertension	0.61	0.46	0.8	0.00027	73	10665	176	15621	1594	ambrisentan	pulmonary arterial hypertension	-0.56	0.571209063848815	0.13	0	0	0	0.14	-0.43	0.15	0
1595	rivastigmine	0.85	0.76	0.96	0.0083	284	16253	177265	8670537	1595	rivastigmine	dementia alzheimer s type	0.92	0.68	1.23	0.61	73	5988	135	10169	1595	rivastigmine	dementia alzheimer s type	63	90	1.55	0.59	3.93	0.37	10	660	12	1225	1595	rivastigmine	dementia alzheimer s type	1.01	0.26	3.38	1	5	305	9	552	1595	rivastigmine	dementia alzheimer s type	2.05	0.59	7.42	0.25	7	507	6	890	1595	rivastigmine	dementia alzheimer s type	0.38	1.46228458943422	0.4	0.34	-0.01	0.02	0.71	0.55	0.39	0.16
1596	temsirolimus	0.45	0.34	0.59	9.1e-11	53	5707	177496	8681083	1596	temsirolimus	renal cell carcinoma	0	0	0.86	0.032	0	1618	48	17317	1596	temsirolimus	renal cell carcinoma	55.8	77	0	0	13.83	1	0	69	11	2344	1596	temsirolimus	renal cell carcinoma	0	0	12.97	1	0	90	10	2575	1596	temsirolimus	renal cell carcinoma	0	0	87.43	1	0	32	3	1128	1596	temsirolimus	renal cell carcinoma	-13.87	9.46968506864711e-07	966.44	0.99	0.02	0.02	0.47	0.37	0.66	0.57
1597	gadoxetate disodium	0.59	0.12	1.74	0.5	3	250	177546	8686540	1597	gadoxetate disodium	nuclear magnetic resonance imaging	0.17	0.03	0.52	0.00019	3	98	1143	6425	1597	gadoxetate disodium	nuclear magnetic resonance imaging	26.3	65.4	0	0	30.81	1	0	9	10	525	1597	gadoxetate disodium	nuclear magnetic resonance imaging	0	0	142.51	1	0	5	3	249	1597	gadoxetate disodium	nuclear magnetic resonance imaging	0	0	41.44	1	0	8	9	544	1597	gadoxetate disodium	nuclear magnetic resonance imaging	-13.34	1.60883539155672e-06	1095.65	0.99	0	0.02	0.95	-0.32	0.67	0.64
1598	doripenem	0.14	0.03	0.41	2.3e-06	3	1038	177546	8685752	1598	doripenem	prophylaxis	0	0	3.11	0.64	0	98	1279	103453	1598	doripenem	prophylaxis	23.9	79.7	0	0	97.72	1	0	6	207	23654	1598	doripenem	prophylaxis	0	0	99.75	1	0	8	82	13720	1598	doripenem	prophylaxis	0	0	106.9	1	0	5	148	14407	1598	doripenem	prophylaxis	-9.74	5.88805348414794e-05	241.94	0.97	-0.01	0	0.03	-0.52	0.14	0
1599	telavancin	0	0	1.33	0.12	0	138	177549	8686652	1599	telavancin	fungal infection	0	0	58.35	1	0	4	170	6503	1599	telavancin	fungal infection	17.1	59	0	0	41.19	1	0	4	23	599	1599	telavancin	fungal infection	0	0	186.7	1	0	4	6	625	1599	telavancin	fungal infection	0	0	Inf	1	0	0	22	890	1599	telavancin	fungal infection	-11.35	1.17694896249317e-05	727.7	0.99	-0.04	0.01	0	-0.88	0.47	0.06
1600	asenapine maleate	1.29	1.1	1.5	0.0015	170	6441	177379	8680349	1600	asenapine maleate	bipolar disorder	0.48	0.35	0.65	1.8e-07	44	1802	2533	50147	1600	asenapine maleate	bipolar disorder	19.9	69	1.02	0.32	2.51	0.82	5	79	360	5806	1600	asenapine maleate	bipolar disorder	3.13	0.59	10.63	0.087	3	22	120	2755	1600	asenapine maleate	bipolar disorder	0.51	0.06	1.93	0.59	2	62	283	4441	1600	asenapine maleate	bipolar disorder	0.03	1.03045453395352	0.46	0.95	0	0	0.48	-0.35	0.11	0
1601	ammonia n-13	0	0	260.7	1	0	2	177549	8686788	1601	ammonia n-13	coronary artery disease	0	0	629.73	1	0	2	112	13255	1601	ammonia n-13	coronary artery disease	55.9	83	0	0	Inf	1	0	0	10	2922	1601	ammonia n-13	coronary artery disease	0	0	Inf	1	0	0	8	2478	1601	ammonia n-13	coronary artery disease	0	0	Inf	1	0	0	6	1278	1601	ammonia n-13	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1602	sevelamer carbonate	0.42	0.32	0.53	1.7e-15	62	7303	177487	8679487	1602	sevelamer carbonate	hyperphosphataemia	1.95	0.34	7.6	0.4	3	655	10	4260	1602	sevelamer carbonate	hyperphosphataemia	45.1	65.8	0	0	Inf	1	0	116	0	202	1602	sevelamer carbonate	hyperphosphataemia	Inf	0.07	Inf	0.26	1	112	0	328	1602	sevelamer carbonate	hyperphosphataemia	0	0	70.63	1	0	123	1	222	1602	sevelamer carbonate	hyperphosphataemia	0.8	2.22554092849247	1.42	0.58	-0.02	0.04	0.6	-0.14	1.42	0.92
1603	maraviroc	0.2	0.09	0.37	1.3e-10	9	2236	177540	8684554	1603	maraviroc	hiv infection	0.4	0.15	0.89	0.022	6	1702	494	56689	1603	maraviroc	hiv infection	25	64	0.36	0.01	2.09	0.53	1	173	119	7468	1603	maraviroc	hiv infection	0.34	0.01	1.98	0.53	1	171	95	5557	1603	maraviroc	hiv infection	0	0	7.41	1	0	46	40	3393	1603	maraviroc	hiv infection	-1.24	0.289384217939051	1.01	0.22	0	0.01	0.85	0.39	0.2	0.05
1604	benzyl alcohol	0	0	1.23	0.13	0	148	177549	8686642	1604	benzyl alcohol	lice infestation	0	0	9.9	1	0	59	6	672	1604	benzyl alcohol	lice infestation	36.2	68.2	0	0	Inf	1	0	0	0	53	1604	benzyl alcohol	lice infestation	0	0	Inf	1	0	0	0	24	1604	benzyl alcohol	lice infestation	0	0	Inf	1	0	0	2	102	1604	benzyl alcohol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1605	alcaftadine	0.42	0.13	0.98	0.039	5	587	177544	8686203	1605	alcaftadine	hypersensitivity	0.32	0.01	1.83	0.38	1	79	1360	34274	1605	alcaftadine	hypersensitivity	15.2	73.8	1.5	0.04	9.26	0.5	1	25	208	7807	1605	alcaftadine	hypersensitivity	0	0	289.94	1	0	2	54	2914	1605	alcaftadine	hypersensitivity	1.27	0.03	7.71	0.55	1	31	178	7007	1605	alcaftadine	hypersensitivity	0.28	1.32312981233744	1.02	0.78	-0.01	0	0	-0.38	0.16	0.02
1606	raltegravir potassium	0.69	0.57	0.82	1.7e-05	123	8717	177426	8678073	1606	raltegravir potassium	hiv infection	1.67	1.29	2.13	9.1e-05	78	5824	422	52567	1606	raltegravir potassium	hiv infection	25	64	0.77	0.4	1.39	0.5	13	1036	107	6605	1606	raltegravir potassium	hiv infection	0.67	0.32	1.27	0.26	11	928	85	4800	1606	raltegravir potassium	hiv infection	0.49	0.06	1.91	0.43	2	333	38	3106	1606	raltegravir potassium	hiv infection	-0.46	0.631283645506926	0.29	0.12	0	0.01	0.89	0.4	0.2	0.04
1607	icatibant acetate	0.4	0.2	0.72	0.00064	11	1344	177538	8685446	1607	icatibant acetate	hereditary angioedema	0.69	0.32	1.39	0.34	11	1221	38	2929	1607	icatibant acetate	hereditary angioedema	19.7	61.8	0.92	0.15	4.31	1	3	466	6	854	1607	icatibant acetate	hereditary angioedema	0	0	Inf	1	0	109	0	220	1607	icatibant acetate	hereditary angioedema	1.14	0.24	4.52	1	4	440	7	879	1607	icatibant acetate	hereditary angioedema	0.12	1.12749685157938	0.63	0.85	0.01	0.02	0.75	-16.8	1610.3	0.99
1608	clevidipine	0	0	0.87	0.025	0	209	177549	8686581	1608	clevidipine	hypertension	0	0	4.03	1	0	44	6895	317569	1608	clevidipine	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	1608	clevidipine	hypertension	0	0	3424.95	1	0	1	341	31638	1608	clevidipine	hypertension	0	0	Inf	1	0	0	762	39930	1608	clevidipine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1609	regadenoson	0.46	0.3	0.69	2.2e-05	25	2634	177524	8684156	1609	regadenoson	scan myocardial perfusion	0.43	0.19	0.97	0.035	14	1023	14	435	1609	regadenoson	scan myocardial perfusion	68.7	87.9	0	0	Inf	1	0	71	0	10	1609	regadenoson	scan myocardial perfusion	Inf	0.05	Inf	1	2	76	0	21	1609	regadenoson	scan myocardial perfusion	0	0	Inf	1	0	100	0	12	1609	regadenoson	scan myocardial perfusion	17.91	60008693.4185527	7150.04	1	0.12	0.08	0.15	19.18	3970.78	1
1610	olanzapine pamoate	1.65	1.07	2.44	0.016	26	771	177523	8686019	1610	olanzapine pamoate	schizophrenia	1.78	0.88	3.26	0.066	11	243	1504	59281	1610	olanzapine pamoate	schizophrenia	20.1	64.1	0.47	0.01	2.74	0.72	1	51	293	6963	1610	olanzapine pamoate	schizophrenia	0.88	0.02	5.29	1	1	33	181	5229	1610	olanzapine pamoate	schizophrenia	0	0	4.3	1	0	21	148	3274	1610	olanzapine pamoate	schizophrenia	-0.68	0.50661699236559	1.01	0.5	-0.02	0	0	-0.31	0.11	0.01
1611	ferumoxytol	2.02	1.38	2.87	0.00027	33	798	177516	8685992	1611	ferumoxytol	iron deficiency anaemia	2.57	1.31	4.81	0.0037	15	433	40	2974	1611	ferumoxytol	iron deficiency anaemia	22.7	82.4	11.55	2.69	47.28	0.00055	5	48	6	671	1611	ferumoxytol	iron deficiency anaemia	8.56	0.68	79.11	0.049	2	21	3	274	1611	ferumoxytol	iron deficiency anaemia	6.98	1.09	34.23	0.02	3	38	6	534	1611	ferumoxytol	iron deficiency anaemia	2.03	7.61408635877997	0.57	0	0	0.01	0.74	-0.01	0.59	0.99
1612	sapropterin	0.95	0.67	1.32	0.87	37	1896	177512	8684894	1612	sapropterin	phenylketonuria	Inf	0.03	Inf	1	30	1508	0	8	1612	sapropterin	phenylketonuria	10.9	49.1	0	0	Inf	1	9	250	0	0	1612	sapropterin	phenylketonuria	0	0	Inf	1	3	152	0	0	1612	sapropterin	phenylketonuria	0	0	Inf	1	8	248	0	0	1612	sapropterin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1613	etravirine	0.46	0.32	0.65	7.1e-07	34	3580	177515	8683210	1613	etravirine	hiv infection	0.6	0.33	1.02	0.066	14	2665	486	55726	1613	etravirine	hiv infection	25	64	0.36	0.04	1.35	0.18	2	342	118	7299	1613	etravirine	hiv infection	0.4	0.05	1.51	0.24	2	287	94	5441	1613	etravirine	hiv infection	0	0	3.15	0.63	0	104	40	3335	1613	etravirine	hiv infection	-1.13	0.323033256422253	0.71	0.11	0	0.01	0.9	0.39	0.2	0.05
1614	iloperidone	2.01	1.45	2.73	4.7e-05	43	1045	177506	8685745	1614	iloperidone	schizophrenia	0.88	0.28	2.08	1	5	224	1510	59300	1614	iloperidone	schizophrenia	20.1	64.1	1.04	0.03	6.43	1	1	23	293	6991	1614	iloperidone	schizophrenia	2.07	0.05	13.75	0.4	1	14	181	5248	1614	iloperidone	schizophrenia	0	0	8.94	1	0	11	148	3284	1614	iloperidone	schizophrenia	-0.01	0.990049833749168	1.02	0.99	-0.02	0	0	-0.31	0.11	0.01
1615	oxiglutatione	0	0	53.4	1	0	5	177549	8686785	1615	oxiglutatione	adverse event	0	0	361.39	1	0	2	16	1049	1615	oxiglutatione	adverse event	48.2	73.4	0	0	3986.29	1	0	2	1	217	1615	oxiglutatione	adverse event	0	0	3934.8	1	0	2	1	214	1615	oxiglutatione	adverse event	0	0	Inf	1	0	0	2	159	1615	oxiglutatione	adverse event	-12.2	5.03045560711145e-06	2797.44	1	0	0.03	0.92	-0.98	1.24	0.43
1616	degarelix acetate	0.09	0.01	0.32	1.3e-07	2	1104	177547	8685686	1616	degarelix acetate	prostate cancer	0.28	0.03	1.01	0.054	2	739	442	45012	1616	degarelix acetate	prostate cancer	56.9	87.4	0	0	2.13	0.42	0	219	102	12585	1616	degarelix acetate	prostate cancer	0	0	1.89	0.27	0	253	114	14423	1616	degarelix acetate	prostate cancer	0	0	Inf	1	0	0	0	51	1616	degarelix acetate	prostate cancer	-13.75	1.06770401003478e-06	409.58	0.97	-0.01	0.01	0.05	13.81	911.73	0.99
1617	silodosin	0.74	0.53	1.02	0.076	38	2498	177511	8684292	1617	silodosin	benign prostatic hyperplasia	0.27	0.03	0.99	0.053	2	597	232	18661	1617	silodosin	benign prostatic hyperplasia	51.5	84.6	0	0	4.25	1	0	136	23	3284	1617	silodosin	benign prostatic hyperplasia	0	0	3.66	0.62	0	162	26	3845	1617	silodosin	benign prostatic hyperplasia	0	0	Inf	1	0	0	1	10	1617	silodosin	benign prostatic hyperplasia	-14.53	4.89441936494637e-07	839.39	0.99	-0.03	0.01	0.02	-2.48	1.07	0.02
1618	difluprednate	0.89	0.56	1.36	0.68	22	1203	177527	8685587	1618	difluprednate	prophylaxis	0	0	3.17	0.63	0	96	1279	103455	1618	difluprednate	prophylaxis	23.9	79.7	0	0	20.03	1	0	23	207	23637	1618	difluprednate	prophylaxis	0	0	38.8	1	0	18	82	13710	1618	difluprednate	prophylaxis	0	0	57.55	1	0	8	148	14404	1618	difluprednate	prophylaxis	-10.64	2.39390390158448e-05	284.2	0.97	-0.01	0	0.03	-0.52	0.14	0
1619	testosterone undecanoate	0.76	0.36	1.4	0.48	10	647	177539	8686143	1619	testosterone undecanoate	blood testosterone decreased	0.16	0	0.94	0.046	1	91	757	11298	1619	testosterone undecanoate	blood testosterone decreased	41.1	71	0	0	1.14	0.068	0	32	286	2652	1619	testosterone undecanoate	blood testosterone decreased	0.26	0.01	1.54	0.26	1	40	321	3317	1619	testosterone undecanoate	blood testosterone decreased	0	0	Inf	1	0	0	0	20	1619	testosterone undecanoate	blood testosterone decreased	-1.37	0.2541069595528	1.01	0.18	-0.01	0.01	0.15	13.29	325.15	0.97
1620	choline fenofibrate	0.76	0.6	0.95	0.014	78	5027	177471	8681763	1620	choline fenofibrate	blood cholesterol increased	0.57	0.3	0.97	0.041	13	956	2243	93272	1620	choline fenofibrate	blood cholesterol increased	39.3	79.8	0.97	0.02	5.63	1	1	60	292	16918	1620	choline fenofibrate	blood cholesterol increased	1.9	0.05	11.52	0.42	1	38	92	6651	1620	choline fenofibrate	blood cholesterol increased	0	0	7.56	1	0	28	234	12466	1620	choline fenofibrate	blood cholesterol increased	-0.16	0.852143788966211	1.01	0.87	-0.03	0	0	-0.27	0.12	0.03
1621	sugammadex sodium	0.09	0	0.51	0.00034	1	541	177548	8686249	1621	sugammadex sodium	neuromuscular blockade reversal	0.3	0.01	5.79	0.56	1	303	2	181	1621	sugammadex sodium	neuromuscular blockade reversal	61	61	0	0	Inf	1	0	0	0	0	1621	sugammadex sodium	neuromuscular blockade reversal	0	0	Inf	1	0	72	0	16	1621	sugammadex sodium	neuromuscular blockade reversal	Inf	0.01	Inf	1	1	65	0	29	1621	sugammadex sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1622	fospropofol disodium	16.31	0.31	203.27	0.078	1	3	177548	8686787	1622	fospropofol disodium	sedation	0	0	255.42	1	0	2	114	5443	1622	fospropofol disodium	sedation	9.5	66	0	0	Inf	1	0	0	18	618	1622	fospropofol disodium	sedation	0	0	Inf	1	0	0	7	537	1622	fospropofol disodium	sedation	0	0	Inf	1	0	0	14	432	1622	fospropofol disodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1623	bazedoxifene acetate	0.52	0.19	1.15	0.13	6	560	177543	8686230	1623	bazedoxifene acetate	hot flush	0	0	0.88	0.035	0	103	230	5487	1623	bazedoxifene acetate	hot flush	38	72	0	0	3.26	0.63	0	59	25	1174	1623	bazedoxifene acetate	hot flush	0	0	Inf	1	0	0	0	42	1623	bazedoxifene acetate	hot flush	0	0	2.91	0.64	0	62	30	1338	1623	bazedoxifene acetate	hot flush	-15.98	1.14808536048733e-07	1340.41	0.99	-0.03	0.02	0.04	-15.33	1632.18	0.99
1624	bendamustine	0.07	0.04	0.12	6.3e-70	15	10489	177534	8676301	1624	bendamustine	chronic lymphocytic leukaemia	0.3	0.06	0.91	0.031	3	2779	69	19080	1624	bendamustine	chronic lymphocytic leukaemia	50.7	85	0.23	0.01	1.4	0.17	1	937	30	6505	1624	bendamustine	chronic lymphocytic leukaemia	0.28	0.01	1.72	0.24	1	700	24	4687	1624	bendamustine	chronic lymphocytic leukaemia	0	0	4.18	0.61	0	291	10	2708	1624	bendamustine	chronic lymphocytic leukaemia	-1.55	0.212247973826743	1.02	0.13	-0.02	0.01	0.18	0.34	0.38	0.37
1625	dalfampridine	0.66	0.6	0.72	1.9e-21	454	33780	177095	8653010	1625	dalfampridine	multiple sclerosis	0.86	0.76	0.98	0.018	261	15544	8084	414813	1625	dalfampridine	multiple sclerosis	26.5	67	0.9	0.74	1.1	0.33	110	5367	1194	52675	1625	dalfampridine	multiple sclerosis	0.94	0.58	1.45	0.91	23	1456	212	12593	1625	dalfampridine	multiple sclerosis	0.87	0.7	1.07	0.21	100	4826	1118	47023	1625	dalfampridine	multiple sclerosis	-0.05	0.951229424500714	0.1	0.58	-0.01	0	0	-0.34	0.07	0
1626	dienogest	0.4	0.11	1.04	0.073	4	486	177545	8686304	1626	dienogest	contraception	0.12	0	0.65	0.0037	1	161	8000	148473	1626	dienogest	contraception	19	43	0	0	3.4	0.62	0	17	1715	24064	1626	dienogest	contraception	0	0	Inf	1	0	0	0	22	1626	dienogest	contraception	0	0	2.48	0.4	0	24	1939	28881	1626	dienogest	contraception	-11.87	6.99720342114394e-06	180.19	0.95	0	0	0.93	-11.86	188.2	0.95
1627	lacosamide	0.96	0.82	1.11	0.59	185	9454	177364	8677336	1627	lacosamide	epilepsy	1.23	0.89	1.67	0.18	46	2684	594	42742	1627	lacosamide	epilepsy	13.6	68.1	1.3	0.6	2.55	0.45	10	482	77	4832	1627	lacosamide	epilepsy	0.6	0.07	2.34	0.77	2	280	39	3272	1627	lacosamide	epilepsy	1.79	0.72	3.85	0.14	8	357	48	3827	1627	lacosamide	epilepsy	0.24	1.2712491503214	0.34	0.47	0	0	0.58	-0.15	0.21	0.48
1628	milnacipran	2.37	2.08	2.69	6e-32	250	5166	177299	8681624	1628	milnacipran	fibromyalgia	1.37	1.14	1.64	0.00076	143	2132	1505	30753	1628	milnacipran	fibromyalgia	28.6	70.9	1.67	0.99	2.68	0.038	20	237	367	7267	1628	milnacipran	fibromyalgia	2.78	0.29	13	0.19	2	13	38	689	1628	milnacipran	fibromyalgia	1.47	0.85	2.41	0.14	18	251	373	7656	1628	milnacipran	fibromyalgia	0.4	1.49182469764127	0.24	0.09	-0.02	0	0	0.1	0.17	0.55
1629	paliperidone palmitate	1.04	0.9	1.18	0.6	222	10489	177327	8676301	1629	paliperidone palmitate	schizophrenia	1.19	0.95	1.46	0.12	96	3213	1419	56311	1629	paliperidone palmitate	schizophrenia	20.1	64.1	1.44	0.95	2.12	0.072	31	530	263	6484	1629	paliperidone palmitate	schizophrenia	1.59	0.96	2.52	0.052	22	419	160	4843	1629	paliperidone palmitate	schizophrenia	1.17	0.6	2.11	0.53	13	250	135	3045	1629	paliperidone palmitate	schizophrenia	0.21	1.23367805995674	0.19	0.25	-0.01	0	0	-0.31	0.11	0.01
1630	artemether	0	0	0.93	0.037	0	196	177549	8686594	1630	artemether	malaria	0	0	0.85	0.022	0	110	25	576	1630	artemether	malaria	25	45.3	0	0	129.74	1	0	12	1	39	1630	artemether	malaria	0	0	110.31	1	0	12	1	33	1630	artemether	malaria	0	0	6.64	0.55	0	13	3	32	1630	artemether	malaria	-16.82	4.9564053191725e-08	2108.53	0.99	-0.01	0.03	0.87	-1.11	1.18	0.35
1631	lumefantrine	0	0	1.13	0.083	0	161	177549	8686629	1631	lumefantrine	malaria	0	0	1.2	0.1	0	82	25	604	1631	lumefantrine	malaria	25	45.3	0	0	145.04	1	0	11	1	40	1631	lumefantrine	malaria	0	0	140.09	1	0	10	1	35	1631	lumefantrine	malaria	0	0	6.64	0.55	0	13	3	32	1631	lumefantrine	malaria	-16.83	4.90708826224023e-08	2196.25	0.99	0	0.03	0.9	-1.18	1.18	0.32
1632	alogliptin benzoate	0.17	0.06	0.4	1.2e-07	5	1422	177544	8685368	1632	alogliptin benzoate	diabetes mellitus	0.2	0.01	1.13	0.1	1	517	2326	242381	1632	alogliptin benzoate	diabetes mellitus	39.3	82	0.63	0.02	3.56	1	1	221	376	52263	1632	alogliptin benzoate	diabetes mellitus	0	0	4.93	1	0	162	140	29582	1632	alogliptin benzoate	diabetes mellitus	1	0.03	5.77	1	1	100	280	28102	1632	alogliptin benzoate	diabetes mellitus	-0.56	0.571209063848815	1	0.58	-0.01	0	0	-0.75	0.1	0
1633	tolvaptan	0.12	0.06	0.24	2.4e-20	9	3537	177540	8683253	1633	tolvaptan	cardiac failure	0	0	1.08	0.082	0	635	77	13869	1633	tolvaptan	cardiac failure	49.9	87.2	0	0	12.08	1	0	101	11	3018	1633	tolvaptan	cardiac failure	0	0	16.83	1	0	78	8	2202	1633	tolvaptan	cardiac failure	0	0	25.39	1	0	62	5	1416	1633	tolvaptan	cardiac failure	-13.93	8.91821354186416e-07	904.64	0.99	-0.01	0.01	0.39	0.02	0.57	0.97
1634	dexlansoprazole	1.41	1.23	1.62	2.5e-06	211	7303	177338	8679487	1634	dexlansoprazole	gastrooesophageal reflux disease	0.75	0.56	0.98	0.039	55	1892	2913	75136	1634	dexlansoprazole	gastrooesophageal reflux disease	22.4	77.2	1.16	0.7	1.83	0.53	20	677	458	18020	1634	dexlansoprazole	gastrooesophageal reflux disease	1.86	0.66	4.22	0.15	6	175	146	7908	1634	dexlansoprazole	gastrooesophageal reflux disease	1.01	0.57	1.68	0.9	16	600	364	13789	1634	dexlansoprazole	gastrooesophageal reflux disease	0.09	1.09417428370521	0.22	0.68	-0.02	0	0	-0.34	0.1	0
1635	bepotastine besilate	1.13	0.49	2.26	0.7	8	345	177541	8686445	1635	bepotastine besilate	rheumatoid arthritis	0	0	27.37	1	0	20	3410	460357	1635	bepotastine besilate	rheumatoid arthritis	33	75	0	0	91.45	1	0	6	1060	113932	1635	bepotastine besilate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	1635	bepotastine besilate	rheumatoid arthritis	0	0	90.86	1	0	6	1011	107958	1635	bepotastine besilate	rheumatoid arthritis	-7.92	0.000363402326495048	132.49	0.95	-0.01	0	0	-0.26	0.08	0
1636	iobenguane i-123	0	0	8.13	1	0	24	177549	8686766	1636	iobenguane i-123	diagnostic procedure	0	0	39.16	1	0	23	21	4361	1636	iobenguane i-123	diagnostic procedure	43.1	71	0	0	499.44	1	0	3	6	1086	1636	iobenguane i-123	diagnostic procedure	0	0	615.81	1	0	3	4	833	1636	iobenguane i-123	diagnostic procedure	0	0	434.47	1	0	5	4	1167	1636	iobenguane i-123	diagnostic procedure	-12.09	5.61538727863537e-06	1395.98	0.99	0	0.02	0.89	0.35	0.71	0.63
1637	eltrombopag olamine	0.14	0.08	0.22	9.4e-31	16	5678	177533	8681112	1637	eltrombopag olamine	idiopathic thrombocytopenic purpura	0.72	0.22	1.82	0.67	5	1853	42	11211	1637	eltrombopag olamine	idiopathic thrombocytopenic purpura	NA	NA	0	0	Inf	1	0	0	0	0	1637	eltrombopag olamine	idiopathic thrombocytopenic purpura	0	0	Inf	1	0	0	0	0	1637	eltrombopag olamine	idiopathic thrombocytopenic purpura	0	0	Inf	1	0	0	0	0	1637	eltrombopag olamine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1638	tapentadol	1.43	1.2	1.69	7.5e-05	141	4831	177408	8681959	1638	tapentadol	pain	0.9	0.68	1.17	0.48	57	1408	8412	187076	1638	tapentadol	pain	23	79	1.21	0.64	2.11	0.44	13	355	1075	35662	1638	tapentadol	pain	1.05	0.21	3.18	0.76	3	120	361	15197	1638	tapentadol	pain	1.56	0.82	2.73	0.12	13	260	844	26330	1638	tapentadol	pain	0.29	1.33642748802547	0.26	0.27	-0.02	0	0	-0.28	0.06	0
1639	purified water	0	0	24.79	1	0	9	177549	8686781	1639	purified water	asthma	0	0	175.68	1	0	2	3044	100372	1639	purified water	asthma	9	76	0	0	Inf	1	0	0	540	17516	1639	purified water	asthma	0	0	Inf	1	0	0	147	6258	1639	purified water	asthma	0	0	Inf	1	0	0	458	14562	1639	purified water	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1640	prasugrel	0.45	0.35	0.56	8e-16	77	8438	177472	8678352	1640	prasugrel	stent placement	0.96	0.61	1.48	0.92	28	2037	96	6708	1640	prasugrel	stent placement	46.6	77.8	0.67	0.24	1.6	0.44	7	563	26	1404	1640	prasugrel	stent placement	0.44	0.08	1.5	0.23	3	395	19	1099	1640	prasugrel	stent placement	0.95	0.22	3.26	1	4	261	11	685	1640	prasugrel	stent placement	-0.55	0.576949810380487	0.42	0.2	-0.02	0.01	0.06	-0.11	0.34	0.75
1641	besifloxacin	0.38	0.1	0.98	0.041	4	513	177545	8686277	1641	besifloxacin	postoperative care	0	0	3.7	0.62	0	159	18	2561	1641	besifloxacin	postoperative care	19.8	69.3	0	0	75.39	1	0	25	2	347	1641	besifloxacin	postoperative care	0	0	81.71	1	0	16	2	238	1641	besifloxacin	postoperative care	0	0	104.48	1	0	20	2	382	1641	besifloxacin	postoperative care	-14.46	5.24930481139405e-07	1768.51	0.99	-0.03	0.02	0.19	0.29	1.02	0.78
1642	plerixafor	0.64	0.31	1.18	0.2	10	764	177539	8686026	1642	plerixafor	acute myeloid leukaemia	0	0	9.33	1	0	189	31	13820	1642	plerixafor	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	10	0	810	1642	plerixafor	acute myeloid leukaemia	0	0	4921.42	1	0	10	1	1366	1642	plerixafor	acute myeloid leukaemia	0	0	2400.84	1	0	3	2	1123	1642	plerixafor	acute myeloid leukaemia	-11.61	9.07488363940224e-06	1791.86	0.99	0	0.03	0.9	-0.88	1.23	0.47
1643	benzoyl peroxide	4.69	4.07	5.39	2.8e-72	221	2306	177328	8684484	1643	benzoyl peroxide	acne	0.72	0.6	0.87	0.00038	129	1226	4247	29178	1643	benzoyl peroxide	acne	14.8	44.4	0.44	0.18	0.9	0.017	8	281	165	2543	1643	benzoyl peroxide	acne	0.42	0.01	2.6	0.72	1	92	27	1039	1643	benzoyl peroxide	acne	0.59	0.29	1.08	0.099	12	283	152	2111	1643	benzoyl peroxide	acne	-0.57	0.565525438699537	0.29	0.05	0	0.01	0.58	-1.05	0.21	0
1644	liraglutide recombinant	0.27	0.22	0.31	5.8e-96	153	28135	177396	8658655	1644	liraglutide recombinant	type 2 diabetes mellitus	0.44	0.34	0.57	4.3e-12	61	14939	1161	126159	1644	liraglutide recombinant	type 2 diabetes mellitus	43	80.7	0.27	0.1	0.61	0.00024	6	3224	208	30670	1644	liraglutide recombinant	type 2 diabetes mellitus	0.42	0.08	1.27	0.16	3	1441	82	16495	1644	liraglutide recombinant	type 2 diabetes mellitus	0.25	0.07	0.65	0.0014	4	2076	150	19398	1644	liraglutide recombinant	type 2 diabetes mellitus	-1.2	0.301194211912202	0.38	0	0	0	0.6	-0.43	0.14	0
1645	ezogabine	1.06	0.45	2.11	0.85	8	370	177541	8686420	1645	ezogabine	epilepsy	2.64	0.7	6.99	0.071	4	108	636	45318	1645	ezogabine	epilepsy	13.6	68.1	4.4	0.1	29.55	0.22	1	14	86	5300	1645	ezogabine	epilepsy	0	0	61.77	1	0	7	41	3545	1645	ezogabine	epilepsy	9.47	0.21	72.72	0.11	1	8	55	4176	1645	ezogabine	epilepsy	1.68	5.36555597112197	1.04	0.11	0	0	0.57	-0.15	0.21	0.47
1646	saxagliptin	0.29	0.22	0.38	7.5e-28	52	8674	177497	8678116	1646	saxagliptin	type 2 diabetes mellitus	0.74	0.44	1.16	0.23	19	2968	1203	138130	1646	saxagliptin	type 2 diabetes mellitus	43	80.7	0.72	0.15	2.14	0.8	3	656	211	33238	1646	saxagliptin	type 2 diabetes mellitus	1.22	0.14	4.57	0.68	2	348	83	17588	1646	saxagliptin	type 2 diabetes mellitus	0.34	0.01	1.92	0.38	1	407	153	21067	1646	saxagliptin	type 2 diabetes mellitus	-0.42	0.657046819815057	0.58	0.47	0	0	0.72	-0.41	0.14	0
1647	pitavastatin calcium	0.27	0.18	0.4	1.5e-17	28	4980	177521	8681810	1647	pitavastatin calcium	hypertension	0.12	0.03	0.36	1.4e-07	3	1131	6892	316482	1647	pitavastatin calcium	hypertension	38	82.9	0	0	0.8	0.017	0	295	981	62114	1647	pitavastatin calcium	hypertension	0	0	1.94	0.27	0	178	341	31461	1647	pitavastatin calcium	hypertension	0	0	1.34	0.12	0	146	762	39784	1647	pitavastatin calcium	hypertension	-12.25	4.78511739212901e-06	131.75	0.93	-0.02	0	0	-0.59	0.07	0
1648	potassium	1.75	1.69	1.8	1.8e-226	4134	117013	173415	8569777	1648	potassium	hypertension	1.38	1.25	1.52	4.2e-10	450	15282	6445	302331	1648	potassium	hypertension	38	82.9	0.8	0.57	1.1	0.19	41	3229	940	59180	1648	potassium	hypertension	0.85	0.43	1.5	0.68	12	1309	329	30330	1648	potassium	hypertension	0.87	0.61	1.2	0.44	39	2333	723	37597	1648	potassium	hypertension	-0.11	0.895834135296528	0.14	0.44	-0.02	0	0	-0.6	0.07	0
1649	indacaterol maleate	0.46	0.01	2.6	0.73	1	107	177548	8686683	1649	indacaterol maleate	chronic obstructive pulmonary disease	2.1	0.05	12.65	0.39	1	31	1257	81966	1649	indacaterol maleate	chronic obstructive pulmonary disease	48.4	82.8	0	0	20.96	1	0	14	291	20130	1649	indacaterol maleate	chronic obstructive pulmonary disease	0	0	40.74	1	0	10	108	9739	1649	indacaterol maleate	chronic obstructive pulmonary disease	0	0	68.23	1	0	5	217	13500	1649	indacaterol maleate	chronic obstructive pulmonary disease	-10.1	4.10795552253007e-05	227.14	0.96	-0.03	0	0	-0.37	0.12	0
1650	romidepsin	0.07	0	0.41	4.1e-05	1	669	177548	8686121	1650	romidepsin	peripheral t-cell lymphoma unspecified	Inf	0.08	Inf	0.23	1	188	0	625	1650	romidepsin	peripheral t-cell lymphoma unspecified	60.1	60.1	0	0	Inf	1	0	0	0	0	1650	romidepsin	peripheral t-cell lymphoma unspecified	0	0	Inf	1	0	43	0	43	1650	romidepsin	peripheral t-cell lymphoma unspecified	Inf	0.03	Inf	0.45	1	28	0	36	1650	romidepsin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1651	capsaicin	2.23	1.6	3.04	4.6e-06	42	920	177507	8685870	1651	capsaicin	pain	3.38	1.82	5.85	0.00012	15	99	8454	188385	1651	capsaicin	pain	23	79	6.39	1.91	16.95	0.0019	5	26	1083	35991	1651	capsaicin	pain	2.48	0.06	15.9	0.34	1	17	363	15300	1651	capsaicin	pain	9.58	2.27	31.11	0.0016	4	13	853	26577	1651	capsaicin	pain	1.85	6.35981952260183	0.49	0	-0.02	0	0	-0.28	0.06	0
1652	gabapentin enacarbil	1.52	0.9	2.43	0.079	18	579	177531	8686211	1652	gabapentin enacarbil	restless legs syndrome	0.28	0.06	0.84	0.014	3	208	695	13633	1652	gabapentin enacarbil	restless legs syndrome	39	77.3	0	0	4.18	1	0	31	67	2156	1652	gabapentin enacarbil	restless legs syndrome	0	0	17.63	1	0	12	16	711	1652	gabapentin enacarbil	restless legs syndrome	1.05	0.03	6.56	0.62	1	31	58	1895	1652	gabapentin enacarbil	restless legs syndrome	-0.32	0.726149037073691	1.02	0.75	-0.02	0.01	0.01	-0.3	0.29	0.29
1653	codeine	2.04	1.94	2.14	7.3e-152	1753	42275	175796	8644515	1653	codeine	pain	1.57	1.41	1.76	3e-14	350	5022	8119	183462	1653	codeine	pain	23	79	2.34	1.75	3.07	2.7e-08	59	862	1029	35155	1653	codeine	pain	4.07	2.7	5.97	4.6e-10	32	354	332	14963	1653	codeine	pain	1.45	0.97	2.09	0.06	31	671	826	25919	1653	codeine	pain	0.81	2.24790798667647	0.13	0	-0.02	0	0	-0.28	0.06	0
1654	vandetanib	0.31	0.12	0.63	0.00025	7	1115	177542	8685675	1654	vandetanib	thyroid cancer	1.43	0.53	3.37	0.35	7	476	29	2828	1654	vandetanib	thyroid cancer	37.5	77.9	19.39	1.67	144.24	0.0098	2	21	4	826	1654	vandetanib	thyroid cancer	0	0	860.65	1	0	19	1	424	1654	vandetanib	thyroid cancer	13.41	1.2	89.63	0.018	2	17	5	578	1654	vandetanib	thyroid cancer	2.08	8.00446891429635	0.94	0.03	-0.02	0.02	0.46	-1.74	1.08	0.11
1655	rivaroxaban	0.18	0.16	0.2	0	332	89141	177217	8597649	1655	rivaroxaban	atrial fibrillation	0.29	0.23	0.36	3.2e-39	92	34505	716	76904	1655	rivaroxaban	atrial fibrillation	49	86.6	0.48	0.33	0.7	4.5e-05	51	19563	81	15063	1655	rivaroxaban	atrial fibrillation	0.53	0.3	0.94	0.022	23	12492	33	9581	1655	rivaroxaban	atrial fibrillation	0.4	0.25	0.63	2.3e-05	32	10083	62	7850	1655	rivaroxaban	atrial fibrillation	-0.85	0.427414931948727	0.17	0	-0.02	0	0	-0.76	0.17	0
1656	spinosad	0	0	13.64	1	0	15	177549	8686775	1656	spinosad	lice infestation	0	0	51.63	1	0	13	6	718	1656	spinosad	lice infestation	36.2	68.2	0	0	Inf	1	0	0	0	53	1656	spinosad	lice infestation	0	0	Inf	1	0	0	0	24	1656	spinosad	lice infestation	0	0	1929.08	1	0	1	2	101	1656	spinosad	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1657	eslicarbazepine acetate	1.11	0.51	2.14	0.72	9	395	177540	8686395	1657	eslicarbazepine acetate	partial seizures	0.43	0.01	2.49	0.73	1	97	82	3380	1657	eslicarbazepine acetate	partial seizures	14.5	84	0	0	5.34	1	0	31	15	562	1657	eslicarbazepine acetate	partial seizures	0	0	22.48	1	0	14	6	338	1657	eslicarbazepine acetate	partial seizures	0	0	5.84	1	0	21	15	406	1657	eslicarbazepine acetate	partial seizures	-15.1	2.76791865854081e-07	1083.7	0.99	0.01	0.01	0.1	-0.69	0.49	0.16
1658	fenofibric acid	2.18	1.26	3.54	0.0036	17	381	177532	8686409	1658	fenofibric acid	hypertension	1.97	0.4	6.02	0.2	3	70	6892	317543	1658	fenofibric acid	hypertension	38	82.9	3.18	0.08	19.94	0.28	1	20	980	62389	1658	fenofibric acid	hypertension	0	0	30.57	1	0	13	341	31626	1658	fenofibric acid	hypertension	7.49	0.17	58.46	0.14	1	7	761	39923	1658	fenofibric acid	hypertension	1.19	3.28708120738312	1.03	0.25	-0.02	0	0	-0.59	0.07	0
1659	dronedarone	0.51	0.41	0.63	1.1e-12	93	8873	177456	8677917	1659	dronedarone	atrial fibrillation	1.44	1.08	1.89	0.011	56	5480	752	105929	1659	dronedarone	atrial fibrillation	49	86.6	4.69	2.53	8.1	2.9e-06	15	921	117	33705	1659	dronedarone	atrial fibrillation	0.8	0.02	4.68	1	1	489	55	21584	1659	dronedarone	atrial fibrillation	6.62	3.51	11.69	6.6e-08	15	500	79	17433	1659	dronedarone	atrial fibrillation	1.51	4.52673079431425	0.27	0	-0.01	0	0	-0.74	0.17	0
1660	repository corticotropin	1.12	0.81	1.51	0.43	45	1965	177504	8684825	1660	repository corticotropin	sarcoidosis	0.74	0.23	1.89	0.67	5	347	41	2102	1660	repository corticotropin	sarcoidosis	39.7	66.5	1.06	0.17	4.7	1	3	172	7	425	1660	repository corticotropin	sarcoidosis	1.02	0.02	19.85	1	1	80	2	163	1660	repository corticotropin	sarcoidosis	1.36	0.22	6.46	0.71	3	159	6	433	1660	repository corticotropin	sarcoidosis	0.23	1.25860000992948	0.62	0.71	-0.01	0.02	0.7	-0.24	0.67	0.72
1661	ticagrelor	0.75	0.64	0.87	0.00016	164	10701	177385	8676089	1661	ticagrelor	acute coronary syndrome	3.8	2.39	6.24	4.6e-10	79	3793	25	4565	1661	ticagrelor	acute coronary syndrome	51.9	87.2	1.93	0.81	4.95	0.12	17	817	9	836	1661	ticagrelor	acute coronary syndrome	8.15	1.09	362.26	0.021	8	630	1	643	1661	ticagrelor	acute coronary syndrome	1.47	0.56	4.01	0.51	12	307	9	339	1661	ticagrelor	acute coronary syndrome	0.77	2.15976625378492	0.39	0.05	0.01	0.01	0.34	-1.51	0.4	0
1662	ioflupane i-123	0	0	3.16	0.63	0	59	177549	8686731	1662	ioflupane i-123	diagnostic procedure	0	0	16.19	1	0	53	21	4331	1662	ioflupane i-123	diagnostic procedure	43.1	71	0	0	77.27	1	0	13	6	1076	1662	ioflupane i-123	diagnostic procedure	0	0	103.38	1	0	13	4	823	1662	ioflupane i-123	diagnostic procedure	0	0	219.69	1	0	9	4	1163	1662	ioflupane i-123	diagnostic procedure	-13.1	2.04523062452349e-06	1388.35	0.99	0	0.02	0.91	0.35	0.71	0.62
1663	taliglucerase alfa	0.29	0.01	1.66	0.27	1	166	177548	8686624	1663	taliglucerase alfa	gaucher s disease	0	0	3.29	0.63	0	111	46	4307	1663	taliglucerase alfa	gaucher s disease	39.9	49.4	0	0	4.86	0.58	0	17	5	69	1663	taliglucerase alfa	gaucher s disease	0	0	423.5	1	0	29	1	316	1663	taliglucerase alfa	gaucher s disease	0	0	12.32	1	0	31	6	431	1663	taliglucerase alfa	gaucher s disease	-14.82	3.66231569524039e-07	1348.22	0.99	0.01	0.02	0.58	-1.5	1.08	0.17
1664	tenofovir	0.18	0.13	0.23	1.5e-69	55	15091	177494	8671699	1664	tenofovir	hiv infection	0.34	0.23	0.49	1.6e-11	32	9687	468	48704	1664	tenofovir	hiv infection	25	64	0.12	0.03	0.31	6.3e-09	4	1742	116	5899	1664	tenofovir	hiv infection	0.27	0.1	0.61	0.00026	6	1146	90	4582	1664	tenofovir	hiv infection	0.08	0	0.46	0.00029	1	860	39	2579	1664	tenofovir	hiv infection	-1.62	0.197898699083615	0.39	0	0	0.01	0.75	0.33	0.2	0.09
1665	pazopanib	0.21	0.16	0.26	2.2e-65	65	15482	177484	8671308	1665	pazopanib	renal cancer	1.1	0.64	1.84	0.7	22	3099	54	8376	1665	pazopanib	renal cancer	41.9	73	1.16	0.44	2.79	0.67	8	666	19	1836	1665	pazopanib	renal cancer	1.48	0.45	4.39	0.42	6	632	11	1716	1665	pazopanib	renal cancer	0.69	0.12	2.63	0.77	3	311	11	785	1665	pazopanib	renal cancer	0.11	1.11627807045887	0.4	0.78	-0.03	0.01	0.01	-0.59	0.36	0.11
1666	pralatrexate	0	0	0.61	0.0055	0	297	177549	8686493	1666	pralatrexate	peripheral t-cell lymphoma unspecified	0	0	324.25	1	0	87	1	726	1666	pralatrexate	peripheral t-cell lymphoma unspecified	60.1	60.1	0	0	Inf	1	0	0	0	0	1666	pralatrexate	peripheral t-cell lymphoma unspecified	0	0	Inf	1	0	13	0	73	1666	pralatrexate	peripheral t-cell lymphoma unspecified	0	0	276.68	1	0	8	1	56	1666	pralatrexate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1667	ulipristal acetate	0.48	0.06	1.77	0.45	2	202	177547	8686588	1667	ulipristal acetate	post coital contraception	6.51	0.16	38.99	0.15	1	47	95	29077	1667	ulipristal acetate	post coital contraception	16	39.8	0	0	61.21	1	0	11	30	4383	1667	ulipristal acetate	post coital contraception	0	0	Inf	1	0	0	0	1	1667	ulipristal acetate	post coital contraception	11.64	0.27	83.03	0.091	1	12	34	4757	1667	ulipristal acetate	post coital contraception	2.28	9.7766804095289	1.06	0.03	0.04	0.02	0.04	-9.64	882.74	0.99
1668	tesamorelin acetate	0.63	0.35	1.04	0.077	15	1171	177534	8685619	1668	tesamorelin acetate	lipodystrophy acquired	2.5	0.37	106.95	0.71	13	759	1	146	1668	tesamorelin acetate	lipodystrophy acquired	64.4	64.4	0	0	Inf	1	0	0	0	0	1668	tesamorelin acetate	lipodystrophy acquired	Inf	0.01	Inf	1	1	31	0	10	1668	tesamorelin acetate	lipodystrophy acquired	0	0	Inf	1	0	1	0	32	1668	tesamorelin acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1669	dabigatran etexilate mesylate	0.17	0.14	0.19	2.9e-258	187	54643	177362	8632147	1669	dabigatran etexilate mesylate	atrial fibrillation	0.38	0.31	0.47	2.9e-24	105	31199	703	80210	1669	dabigatran etexilate mesylate	atrial fibrillation	49	86.6	0.8	0.45	1.34	0.47	17	5401	115	29225	1669	dabigatran etexilate mesylate	atrial fibrillation	0.7	0.24	1.63	0.57	6	3232	50	18841	1669	dabigatran etexilate mesylate	atrial fibrillation	0.66	0.32	1.25	0.26	11	2985	83	14948	1669	dabigatran etexilate mesylate	atrial fibrillation	-0.36	0.697676326071031	0.26	0.16	-0.01	0	0	-0.76	0.17	0
1670	roflumilast	2.23	1.88	2.63	2e-17	148	3247	177401	8683543	1670	roflumilast	chronic obstructive pulmonary disease	3.79	3.05	4.65	2.1e-27	105	1926	1153	80071	1670	roflumilast	chronic obstructive pulmonary disease	48.4	82.8	3.1	1.76	5.12	9.5e-05	17	395	274	19749	1670	roflumilast	chronic obstructive pulmonary disease	2.57	0.91	5.88	0.036	6	218	102	9531	1670	roflumilast	chronic obstructive pulmonary disease	3.71	1.85	6.75	0.00022	12	210	205	13295	1670	roflumilast	chronic obstructive pulmonary disease	1.14	3.12676836518616	0.25	0	-0.03	0	0	-0.38	0.12	0
1671	flibanserin	0.8	0.02	4.64	1	1	61	177548	8686729	1671	flibanserin	libido decreased	0.61	0.01	4.01	1	1	32	22	427	1671	flibanserin	libido decreased	42.4	58.6	0	0	12.78	1	0	9	6	116	1671	flibanserin	libido decreased	0	0	Inf	1	0	0	8	211	1671	flibanserin	libido decreased	0	0	Inf	1	0	15	0	19	1671	flibanserin	libido decreased	0.35	1.41906754859326	3584.91	1	-0.06	0.04	0.13	17.02	2363.63	0.99
1672	fingolimod	0.93	0.87	1	0.057	829	43374	176720	8643416	1672	fingolimod	multiple sclerosis	1.12	1.03	1.22	0.0064	619	28634	7726	401723	1672	fingolimod	multiple sclerosis	26.5	67	1.4	1.21	1.62	1.1e-05	227	7592	1077	50450	1672	fingolimod	multiple sclerosis	1.56	1.09	2.18	0.011	44	1811	191	12238	1672	fingolimod	multiple sclerosis	1.39	1.18	1.62	5.4e-05	200	6437	1018	45412	1672	fingolimod	multiple sclerosis	0.3	1.349858807576	0.07	0	-0.01	0	0	-0.35	0.07	0
1673	lorcaserin	0.66	0.46	0.91	0.01	35	2612	177514	8684178	1673	lorcaserin	weight decreased	0.35	0.2	0.56	1.1e-06	18	1562	209	6269	1673	lorcaserin	weight decreased	27	73.2	0.22	0.08	0.5	2.2e-05	7	897	50	1429	1673	lorcaserin	weight decreased	0	0	0.96	0.042	0	114	12	298	1673	lorcaserin	weight decreased	0.23	0.09	0.51	3.3e-05	7	821	48	1293	1673	lorcaserin	weight decreased	-1.53	0.216535667316007	0.4	0	-0.02	0.01	0.04	0.07	0.33	0.83
1674	levomefolate calcium	5.29	4.53	6.13	2.9e-71	194	1797	177355	8684993	1674	levomefolate calcium	contraception	1.89	1.35	2.58	0.00023	44	434	7957	148200	1674	levomefolate calcium	contraception	19	43	1.88	0.86	3.66	0.075	10	75	1705	24006	1674	levomefolate calcium	contraception	0	0	Inf	1	0	0	0	22	1674	levomefolate calcium	contraception	2.19	1.12	3.94	0.013	13	89	1926	28816	1674	levomefolate calcium	contraception	0.78	2.1814722654982	0.3	0.01	0	0	0.95	-10.86	114.15	0.92
1675	pirfenidone	0.57	0.46	0.7	5.1e-09	94	8020	177455	8678770	1675	pirfenidone	idiopathic pulmonary fibrosis	1.25	0.81	1.98	0.35	84	6566	29	2830	1675	pirfenidone	idiopathic pulmonary fibrosis	55.7	80.4	1.72	0.91	3.48	0.093	46	2570	13	1247	1675	pirfenidone	idiopathic pulmonary fibrosis	2.24	1.02	5.6	0.036	36	2128	8	1060	1675	pirfenidone	idiopathic pulmonary fibrosis	0.93	0.37	2.55	0.83	15	1094	8	542	1675	pirfenidone	idiopathic pulmonary fibrosis	0.5	1.64872127070013	0.29	0.09	-0.02	0.01	0.01	0	0.26	1
1677	hexaminolevulinate	0	0	24.79	1	0	9	177549	8686781	1677	hexaminolevulinate	bladder cancer	0	0	346.69	1	0	6	14	5249	1677	hexaminolevulinate	bladder cancer	77.6	77.6	0	0	Inf	1	0	0	0	0	1677	hexaminolevulinate	bladder cancer	0	0	Inf	1	0	0	0	544	1677	hexaminolevulinate	bladder cancer	0	0	Inf	1	0	0	1	108	1677	hexaminolevulinate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1678	carglumic acid	1.72	0.2	6.49	0.33	2	57	177547	8686733	1678	carglumic acid	hyperammonaemia	0	0	Inf	1	0	31	0	157	1678	carglumic acid	hyperammonaemia	NA	NA	0	0	Inf	1	0	0	0	0	1678	carglumic acid	hyperammonaemia	0	0	Inf	1	0	2	0	21	1678	carglumic acid	hyperammonaemia	0	0	Inf	1	0	9	0	13	1678	carglumic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1679	vilazodone	3.7	3.31	4.11	3.2e-90	363	4812	177186	8681978	1679	vilazodone	depression	1.24	1.06	1.45	0.0068	180	1945	14191	190840	1679	vilazodone	depression	21	73.3	1.06	0.66	1.62	0.74	23	299	2039	28043	1679	vilazodone	depression	1.42	0.55	3.08	0.35	7	81	630	10366	1679	vilazodone	depression	1.25	0.76	1.97	0.31	21	245	1650	24139	1679	vilazodone	depression	0.24	1.2712491503214	0.2	0.22	-0.01	0	0	-0.14	0.05	0
1680	mitomycin	0.32	0.17	0.53	2.4e-07	14	2166	177535	8684624	1680	mitomycin	breast cancer	0.54	0.01	3.08	1	1	86	1445	66696	1680	mitomycin	breast cancer	40	78	0	0	193.72	1	0	3	127	10144	1680	mitomycin	breast cancer	0	0	Inf	1	0	0	0	116	1680	mitomycin	breast cancer	0	0	198.11	1	0	3	144	11773	1680	mitomycin	breast cancer	-13.17	1.90696039458808e-06	2284.08	1	0	0.01	0.79	-13.16	367.31	0.97
1681	velaglucerase alfa	0.55	0.2	1.21	0.17	6	532	177543	8686258	1681	velaglucerase alfa	gaucher s disease	1.11	0.34	2.82	0.8	5	438	41	3980	1681	velaglucerase alfa	gaucher s disease	39.9	49.4	0	0	8.45	1	0	11	5	75	1681	velaglucerase alfa	gaucher s disease	0	0	156.19	1	0	69	1	276	1681	velaglucerase alfa	gaucher s disease	0	0	4.78	0.6	0	71	6	391	1681	velaglucerase alfa	gaucher s disease	-15.89	1.25620547694366e-07	1458.7	0.99	0.01	0.02	0.57	-1.46	1.08	0.18
1682	aluminum acetate	1.02	0.12	3.78	0.72	2	96	177547	8686694	1682	aluminum acetate	pain	0	0	4.27	1	0	21	8469	188463	1682	aluminum acetate	pain	23	79	0	0	Inf	1	0	0	1088	36017	1682	aluminum acetate	pain	0	0	Inf	1	0	0	364	15317	1682	aluminum acetate	pain	0	0	Inf	1	0	0	857	26590	1682	aluminum acetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1683	cyclopentolate	1.66	1.11	2.4	0.011	29	854	177520	8685936	1683	cyclopentolate	cataract operation	0	0	13.84	1	0	104	6	1674	1683	cyclopentolate	cataract operation	NA	NA	0	0	Inf	1	0	0	0	0	1683	cyclopentolate	cataract operation	0	0	Inf	1	0	7	0	94	1683	cyclopentolate	cataract operation	0	0	Inf	1	0	24	0	216	1683	cyclopentolate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1684	estropipate	2.58	2.16	3.06	9.4e-22	141	2675	177408	8684115	1684	estropipate	hormone replacement therapy	0.67	0.4	1.07	0.11	18	1130	918	38739	1684	estropipate	hormone replacement therapy	34.3	74	0	0	8.67	1	0	16	91	2990	1684	estropipate	hormone replacement therapy	0	0	Inf	1	0	0	48	1192	1684	estropipate	hormone replacement therapy	0	0	9.14	1	0	18	56	2186	1684	estropipate	hormone replacement therapy	-12.86	2.5999976936368e-06	561.49	0.98	-0.03	0.01	0	0.42	0.2	0.04
1685	dimenhydrinate	0.88	0.54	1.35	0.68	21	1165	177528	8685625	1685	dimenhydrinate	prophylaxis	0.79	0.02	4.48	1	1	103	1278	103448	1685	dimenhydrinate	prophylaxis	23.9	79.7	4.59	0.11	28.31	0.2	1	25	206	23635	1685	dimenhydrinate	prophylaxis	15.38	0.35	108.15	0.069	1	11	81	13717	1685	dimenhydrinate	prophylaxis	0	0	22.37	1	0	18	148	14394	1685	dimenhydrinate	prophylaxis	1.42	4.13712044025139	1.02	0.16	-0.01	0	0.02	-0.52	0.14	0
1686	doxycycline	3.34	3.17	3.52	3.29999999999988e-311	1458	21476	176091	8665314	1686	doxycycline	acne	0.98	0.82	1.16	0.83	151	1072	4225	29332	1686	doxycycline	acne	14.8	44.4	1.4	0.76	2.4	0.22	16	192	157	2632	1686	doxycycline	acne	0.47	0.01	2.95	0.72	1	82	27	1049	1686	doxycycline	acne	1.58	0.88	2.7	0.11	17	163	147	2231	1686	doxycycline	acne	0.34	1.40494759056359	0.26	0.19	0	0.01	0.6	-1.04	0.21	0
1687	doxycycline hyclate	3.4	3.22	3.59	0	1486	21501	176063	8665289	1687	doxycycline hyclate	acne	0.94	0.79	1.12	0.52	154	1135	4222	29269	1687	doxycycline hyclate	acne	14.8	44.4	1.52	0.86	2.55	0.13	18	200	155	2624	1687	doxycycline hyclate	acne	0.46	0.01	2.84	0.72	1	85	27	1046	1687	doxycycline hyclate	acne	1.82	1.04	3.04	0.026	19	161	145	2233	1687	doxycycline hyclate	acne	0.46	1.58407398499448	0.25	0.06	0	0.01	0.63	-1.04	0.21	0
1688	erythromycin estolate	0	0	1.62	0.18	0	113	177549	8686677	1688	erythromycin estolate	rheumatoid arthritis	0	0	93.78	1	0	7	3410	460370	1688	erythromycin estolate	rheumatoid arthritis	33	75	0	0	163.61	1	0	4	1060	113934	1688	erythromycin estolate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	1688	erythromycin estolate	rheumatoid arthritis	0	0	162.57	1	0	4	1011	107960	1688	erythromycin estolate	rheumatoid arthritis	-6.86	0.00104891393262779	98.48	0.94	-0.01	0	0	-0.26	0.08	0
1689	dicloxacillin sodium	0.59	0.01	3.38	1	1	83	177548	8686707	1689	dicloxacillin sodium	plasma cell myeloma	0	0	78.4	1	0	11	534	104904	1689	dicloxacillin sodium	plasma cell myeloma	47.4	82.5	0	0	1278.28	1	0	2	164	39826	1689	dicloxacillin sodium	plasma cell myeloma	0	0	8872.4	1	0	1	93	24561	1689	dicloxacillin sodium	plasma cell myeloma	0	0	7876.68	1	0	1	91	20957	1689	dicloxacillin sodium	plasma cell myeloma	-7.99	0.000338834083363426	378.16	0.98	-0.03	0.01	0	-0.15	0.15	0.31
1690	ampicillin/ampicillin trihydrate	19.29	13.1	27.94	7e-35	41	104	177508	8686686	1690	ampicillin/ampicillin trihydrate	acne	20.89	6.33	89.05	1.7e-08	12	4	4364	30400	1690	ampicillin/ampicillin trihydrate	acne	14.8	44.4	0	0	Inf	1	0	0	173	2824	1690	ampicillin/ampicillin trihydrate	acne	0	0	Inf	1	0	0	28	1131	1690	ampicillin/ampicillin trihydrate	acne	0	0	Inf	1	0	0	164	2394	1690	ampicillin/ampicillin trihydrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1691	neomycin	2.42	2.08	2.8	2.7e-25	187	3787	177362	8683003	1691	neomycin	pain	1.94	1.13	3.14	0.012	18	207	8451	188277	1691	neomycin	pain	23	79	1.35	0.16	5.16	0.66	2	49	1086	35968	1691	neomycin	pain	0	0	9.05	1	0	19	364	15298	1691	neomycin	pain	1.94	0.23	7.63	0.29	2	32	855	26558	1691	neomycin	pain	0.29	1.33642748802547	0.72	0.68	-0.02	0	0	-0.28	0.06	0
1692	polymyxin b	2.29	1.95	2.68	1.4e-20	167	3568	177382	8683222	1692	polymyxin b	prophylaxis	0.66	0.08	2.4	0.77	2	247	1277	103304	1692	polymyxin b	prophylaxis	23.9	79.7	0	0	10.06	1	0	44	207	23616	1692	polymyxin b	prophylaxis	0	0	16.92	1	0	39	82	13689	1692	polymyxin b	prophylaxis	0	0	12.42	1	0	31	148	14381	1692	polymyxin b	prophylaxis	-11.84	7.21029999031283e-06	284.66	0.97	-0.01	0	0.02	-0.52	0.14	0
1693	gentamicin	1.85	1.65	2.07	1.7e-23	326	8610	177223	8678180	1693	gentamicin	prophylaxis	0.24	0.03	0.89	0.03	2	659	1277	102892	1693	gentamicin	prophylaxis	23.9	79.7	0	0	5.79	1	0	75	207	23585	1693	gentamicin	prophylaxis	0	0	13.05	1	0	50	82	13678	1693	gentamicin	prophylaxis	0	0	8.59	1	0	44	148	14368	1693	gentamicin	prophylaxis	-11.77	7.73310572890771e-06	246.27	0.96	-0.01	0	0.02	-0.52	0.14	0
1694	griseofulvin, microcrystalline	1.88	0.05	11.45	0.42	1	26	177548	8686764	1694	griseofulvin, microcrystalline	fungal infection	0	0	41.96	1	0	5	170	6502	1694	griseofulvin, microcrystalline	fungal infection	17.1	59	0	0	Inf	1	0	0	23	603	1694	griseofulvin, microcrystalline	fungal infection	0	0	Inf	1	0	0	6	629	1694	griseofulvin, microcrystalline	fungal infection	0	0	Inf	1	0	0	22	890	1694	griseofulvin, microcrystalline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1695	hetacillin	Inf	149.3	Inf	8.3e-23	13	0	177536	8686790	1695	hetacillin	breast cancer	Inf	142.27	Inf	1.7e-22	13	0	1433	66782	1695	hetacillin	breast cancer	40	78	0	0	Inf	1	0	0	127	10147	1695	hetacillin	breast cancer	0	0	Inf	1	0	0	0	116	1695	hetacillin	breast cancer	0	0	Inf	1	0	0	144	11776	1695	hetacillin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1696	ampicillin sodium	4.38	3.89	4.92	5.2e-94	311	3478	177238	8683312	1696	ampicillin sodium	pneumonia	0	0	0.32	3.1e-05	0	504	395	17161	1696	ampicillin sodium	pneumonia	28	83	0	0	7.66	1	0	28	49	2572	1696	ampicillin sodium	pneumonia	0	0	16.25	1	0	29	15	1600	1696	ampicillin sodium	pneumonia	0	0	13.84	1	0	12	46	1711	1696	ampicillin sodium	pneumonia	-13.33	1.62500445605279e-06	600.26	0.98	-0.01	0.01	0.03	-1.05	0.3	0
1697	chloramphenicol	0.55	0.3	0.92	0.02	14	1248	177535	8685542	1697	chloramphenicol	prophylaxis	0	0	3.47	0.63	0	88	1279	103463	1697	chloramphenicol	prophylaxis	23.9	79.7	0	0	58.29	1	0	9	207	23651	1697	chloramphenicol	prophylaxis	0	0	99.75	1	0	8	82	13720	1697	chloramphenicol	prophylaxis	0	0	68.1	1	0	7	148	14405	1697	chloramphenicol	prophylaxis	-9.75	5.82946637308688e-05	225.5	0.97	-0.01	0	0.03	-0.52	0.14	0
1698	capreomycin	0	0	0.91	0.038	0	200	177549	8686590	1698	capreomycin	tuberculosis	0	0	3.85	0.62	0	141	29	3947	1698	capreomycin	tuberculosis	23.8	59	0	0	9.72	1	0	46	7	625	1698	capreomycin	tuberculosis	0	0	24.22	1	0	28	5	596	1698	capreomycin	tuberculosis	0	0	23.34	1	0	32	4	477	1698	capreomycin	tuberculosis	-14.94	3.24818263581871e-07	1386.8	0.99	-0.01	0.02	0.47	0.07	0.68	0.92
1699	colistimethate sodium	0	0	0.83	0.026	0	219	177549	8686571	1699	colistimethate sodium	acinetobacter infection	0	0	Inf	1	0	11	0	204	1699	colistimethate sodium	acinetobacter infection	NA	NA	0	0	Inf	1	0	0	0	0	1699	colistimethate sodium	acinetobacter infection	0	0	Inf	1	0	0	0	15	1699	colistimethate sodium	acinetobacter infection	0	0	Inf	1	0	0	0	15	1699	colistimethate sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1701	nafcillin sodium	0.77	0.16	2.29	1	3	190	177546	8686600	1701	nafcillin sodium	staphylococcal bacteraemia	0	0	Inf	1	0	32	0	815	1701	nafcillin sodium	staphylococcal bacteraemia	NA	NA	0	0	Inf	1	0	0	0	0	1701	nafcillin sodium	staphylococcal bacteraemia	0	0	Inf	1	0	3	0	67	1701	nafcillin sodium	staphylococcal bacteraemia	0	0	Inf	1	0	1	0	36	1701	nafcillin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1702	benzylpenicilloyl polylysine	0	0	41.55	1	0	6	177549	8686784	1702	benzylpenicilloyl polylysine	allergy test	0	0	3315.87	1	0	3	1	268	1702	benzylpenicilloyl polylysine	allergy test	49	49	0	0	Inf	1	0	0	0	0	1702	benzylpenicilloyl polylysine	allergy test	0	0	Inf	1	0	0	1	24	1702	benzylpenicilloyl polylysine	allergy test	0	0	Inf	1	0	1	0	53	1702	benzylpenicilloyl polylysine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1703	methicillin sodium	0	0	260.7	1	0	2	177549	8686788	1703	methicillin sodium	acute lymphocytic leukaemia	0	0	6091.33	1	0	1	70	12082	1703	methicillin sodium	acute lymphocytic leukaemia	6.4	64.6	0	0	6251.24	1	0	1	11	1953	1703	methicillin sodium	acute lymphocytic leukaemia	0	0	4916.28	1	0	1	11	1501	1703	methicillin sodium	acute lymphocytic leukaemia	0	0	Inf	1	0	0	2	1241	1703	methicillin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1704	oxacillin sodium	0.82	0.02	4.72	1	1	60	177548	8686730	1704	oxacillin sodium	infection	0	0	32.58	1	0	6	375	14337	1704	oxacillin sodium	infection	23	72	0	0	Inf	1	0	0	53	2147	1704	oxacillin sodium	infection	0	0	Inf	1	0	0	24	1576	1704	oxacillin sodium	infection	0	0	Inf	1	0	0	37	1648	1704	oxacillin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1705	penicillin g benzathine	0.61	0.22	1.34	0.33	6	479	177543	8686311	1705	penicillin g benzathine	lyme disease	0	0	1.37	0.1	0	74	37	945	1705	penicillin g benzathine	lyme disease	38.7	54.5	0	0	808.66	1	0	1	4	83	1705	penicillin g benzathine	lyme disease	0	0	3917.62	1	0	1	1	106	1705	penicillin g benzathine	lyme disease	0	0	122.19	1	0	2	5	103	1705	penicillin g benzathine	lyme disease	-14.2	6.80798134397634e-07	2216.63	0.99	0.01	0.03	0.84	-1.64	1.1	0.14
1706	penicillin g procaine	0.91	0.33	2.01	1	6	321	177543	8686469	1706	penicillin g procaine	syphilis	0	0	39.21	1	0	18	2	128	1706	penicillin g procaine	syphilis	NA	NA	0	0	Inf	1	0	0	0	0	1706	penicillin g procaine	syphilis	0	0	Inf	1	0	0	0	33	1706	penicillin g procaine	syphilis	0	0	Inf	1	0	0	0	2	1706	penicillin g procaine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1707	chloramphenicol sodium succinate	0.55	0.3	0.93	0.02	14	1246	177535	8685544	1707	chloramphenicol sodium succinate	prophylaxis	0	0	3.47	0.63	0	88	1279	103463	1707	chloramphenicol sodium succinate	prophylaxis	23.9	79.7	0	0	58.29	1	0	9	207	23651	1707	chloramphenicol sodium succinate	prophylaxis	0	0	99.75	1	0	8	82	13720	1707	chloramphenicol sodium succinate	prophylaxis	0	0	68.1	1	0	7	148	14405	1707	chloramphenicol sodium succinate	prophylaxis	-9.75	5.82946637308688e-05	225.5	0.97	-0.01	0	0.03	-0.52	0.14	0
1708	clindamycin	5.29	5.03	5.55	0	1806	16848	175743	8669942	1708	clindamycin	pain	4.91	4.21	5.72	2.5e-68	210	970	8259	187514	1708	clindamycin	pain	23	79	1.17	0.53	2.26	0.58	9	256	1079	35761	1708	clindamycin	pain	1.8	0.48	4.8	0.29	4	94	360	15223	1708	clindamycin	pain	0.78	0.25	1.86	0.84	5	198	852	26392	1708	clindamycin	pain	-0.02	0.980198673306755	0.34	0.96	-0.02	0	0	-0.28	0.06	0
1709	bacitracin zinc	3.3	2.73	3.96	1.1e-27	123	1824	177426	8684966	1709	bacitracin zinc	pain	2.76	1.5	4.74	8e-04	15	121	8454	188363	1709	bacitracin zinc	pain	23	79	1.14	0.03	6.9	0.59	1	29	1087	35988	1709	bacitracin zinc	pain	0	0	18.84	1	0	10	364	15307	1709	bacitracin zinc	pain	1.35	0.03	8.33	0.53	1	23	856	26567	1709	bacitracin zinc	pain	-0.01	0.990049833749168	1.02	0.99	-0.02	0	0	-0.28	0.06	0
1710	erythromycin lactobionate	2.47	2.25	2.71	3e-65	483	9573	177066	8677217	1710	erythromycin lactobionate	acne	1.82	1.41	2.31	3.6e-06	86	332	4290	30072	1710	erythromycin lactobionate	acne	14.8	44.4	3.54	0.65	12.85	0.071	3	14	170	2810	1710	erythromycin lactobionate	acne	0	0	29.19	1	0	7	28	1124	1710	erythromycin lactobionate	acne	2.6	0.48	9.14	0.13	3	17	161	2377	1710	erythromycin lactobionate	acne	0.81	2.24790798667647	0.62	0.19	0	0.01	0.66	-1.03	0.21	0
1711	cloxacillin sodium	0.23	0.01	1.29	0.14	1	213	177548	8686577	1711	cloxacillin sodium	nephrotic syndrome	0	0	70.02	1	0	8	20	2234	1711	cloxacillin sodium	nephrotic syndrome	14.9	65.8	0	0	Inf	1	0	0	5	331	1711	cloxacillin sodium	nephrotic syndrome	0	0	Inf	1	0	0	2	393	1711	cloxacillin sodium	nephrotic syndrome	0	0	Inf	1	0	0	5	253	1711	cloxacillin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1712	erythromycin ethylsuccinate	0.98	0.39	2.05	1	7	348	177542	8686442	1712	erythromycin ethylsuccinate	unevaluable event	0	0	42.26	1	0	4	76	2095	1712	erythromycin ethylsuccinate	unevaluable event	35.7	67.4	0	0	Inf	1	0	0	6	216	1712	erythromycin ethylsuccinate	unevaluable event	0	0	Inf	1	0	0	3	159	1712	erythromycin ethylsuccinate	unevaluable event	0	0	Inf	1	0	0	5	251	1712	erythromycin ethylsuccinate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1713	tetracycline phosphate complex	5.15	0.58	21.35	0.066	2	19	177547	8686771	1713	tetracycline phosphate complex	depression	1.22	0.03	8.39	0.58	1	11	14370	192774	1713	tetracycline phosphate complex	depression	21	73.3	0	0	531.61	1	0	1	2062	28341	1713	tetracycline phosphate complex	depression	0	0	Inf	1	0	0	637	10447	1713	tetracycline phosphate complex	depression	0	0	564.1	1	0	1	1671	24383	1713	tetracycline phosphate complex	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1715	nystatin	3.54	3.32	3.78	1.4e-239	1034	14335	176515	8672455	1715	nystatin	pain	1.88	1.54	2.28	3e-09	114	1357	8355	187127	1715	nystatin	pain	23	79	1.18	0.65	1.99	0.47	15	420	1073	35597	1715	nystatin	pain	0.81	0.17	2.44	1	3	155	361	15162	1715	nystatin	pain	1.37	0.74	2.35	0.26	14	318	843	26272	1715	nystatin	pain	0.21	1.23367805995674	0.25	0.41	-0.02	0	0	-0.28	0.06	0
1716	clioquinol	0	0	2.31	0.41	0	80	177549	8686710	1716	clioquinol	psoriasis	0	0	115.13	1	0	6	1190	161685	1716	clioquinol	psoriasis	25	74.8	0	0	4185.95	1	0	1	379	43524	1716	clioquinol	psoriasis	0	0	Inf	1	0	0	149	21344	1716	clioquinol	psoriasis	0	0	3668.84	1	0	1	274	27342	1716	clioquinol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1717	demeclocycline	3.62	2.11	5.85	7.2e-06	18	243	177531	8686547	1717	demeclocycline	inappropriate antidiuretic hormone secretion	0	0	Inf	1	0	36	0	369	1717	demeclocycline	inappropriate antidiuretic hormone secretion	NA	NA	0	0	Inf	1	0	0	0	0	1717	demeclocycline	inappropriate antidiuretic hormone secretion	0	0	Inf	1	0	2	0	25	1717	demeclocycline	inappropriate antidiuretic hormone secretion	0	0	Inf	1	0	3	0	24	1717	demeclocycline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1718	tetracycline	3.97	3.49	4.49	1.6e-73	270	3332	177279	8683458	1718	tetracycline	acne	1.17	0.83	1.62	0.34	44	262	4332	30142	1718	tetracycline	acne	14.8	44.4	2.05	0.23	8.84	0.28	2	16	171	2808	1718	tetracycline	acne	0	0	18.83	1	0	10	28	1121	1718	tetracycline	acne	1.47	0.16	6.12	0.65	2	20	162	2374	1718	tetracycline	acne	0.2	1.22140275816017	0.74	0.79	0	0.01	0.66	-1.03	0.21	0
1719	oxytetracycline	0.83	0.4	1.55	0.77	10	586	177539	8686204	1719	oxytetracycline	prophylaxis	0	0	12.35	1	0	26	1279	103525	1719	oxytetracycline	prophylaxis	23.9	79.7	0	0	79.7	1	0	7	207	23653	1719	oxytetracycline	prophylaxis	0	0	406.52	1	0	3	82	13725	1719	oxytetracycline	prophylaxis	0	0	106.9	1	0	5	148	14407	1719	oxytetracycline	prophylaxis	-9.75	5.82946637308688e-05	311.38	0.98	-0.01	0	0.03	-0.52	0.14	0
1720	desoxyribonuclease	0	0	260.7	1	0	2	177549	8686788	1720	desoxyribonuclease	acute promyelocytic leukaemia	0	0	795.12	1	0	2	11	1565	1720	desoxyribonuclease	acute promyelocytic leukaemia	46	46	0	0	Inf	1	0	0	0	0	1720	desoxyribonuclease	acute promyelocytic leukaemia	0	0	Inf	1	0	0	0	85	1720	desoxyribonuclease	acute promyelocytic leukaemia	0	0	Inf	1	0	0	1	93	1720	desoxyribonuclease	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1721	fibrinolysin	0	0	11.12	1	0	18	177549	8686772	1721	fibrinolysin	hypertension	0	0	69.79	1	0	4	6895	317609	1721	fibrinolysin	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	1721	fibrinolysin	hypertension	0	0	Inf	1	0	0	341	31639	1721	fibrinolysin	hypertension	0	0	Inf	1	0	0	762	39930	1721	fibrinolysin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1722	carbenicillin disodium	0	0	118.34	1	0	3	177549	8686787	1722	carbenicillin disodium	heart transplant	0	0	1703.63	1	0	1	73	3275	1722	carbenicillin disodium	heart transplant	18.6	47	0	0	Inf	1	0	0	1	151	1722	carbenicillin disodium	heart transplant	0	0	Inf	1	0	0	1	394	1722	carbenicillin disodium	heart transplant	0	0	Inf	1	0	0	3	141	1722	carbenicillin disodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1723	amphotericin b	0.22	0.16	0.29	2.7e-44	50	10995	177499	8675795	1723	amphotericin b	prophylaxis	0.28	0.08	0.71	0.0028	4	1160	1275	102391	1723	amphotericin b	prophylaxis	23.9	79.7	0.58	0.01	3.28	1	1	198	206	23462	1723	amphotericin b	prophylaxis	0	0	3.95	1	0	160	82	13568	1723	amphotericin b	prophylaxis	3.75	0.99	10.09	0.026	4	106	144	14306	1723	amphotericin b	prophylaxis	0.56	1.7506725002961	0.51	0.28	-0.01	0	0.03	-0.53	0.14	0
1724	minocycline	3.09	2.84	3.35	2.6e-118	612	9724	176937	8677066	1724	minocycline	acne	0.87	0.76	1	0.043	267	2106	4109	28298	1724	minocycline	acne	14.8	44.4	0.78	0.44	1.31	0.4	17	346	156	2478	1724	minocycline	acne	0.54	0.06	2.18	0.57	2	142	26	989	1724	minocycline	acne	0.89	0.5	1.48	0.71	18	292	146	2102	1724	minocycline	acne	-0.19	0.826959133943362	0.24	0.44	0	0.01	0.64	-1.03	0.21	0
1725	lincomycin	4.78	3.03	7.22	8.7e-10	25	256	177524	8686534	1725	lincomycin	pharyngitis	0	0	8.25	1	0	15	81	2351	1725	lincomycin	pharyngitis	13.2	59	0	0	Inf	1	0	0	11	253	1725	lincomycin	pharyngitis	0	0	Inf	1	0	0	5	161	1725	lincomycin	pharyngitis	0	0	Inf	1	0	0	8	286	1725	lincomycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1726	troleandomycin	0	0	11.12	1	0	18	177549	8686772	1726	troleandomycin	asthma	0	0	49.97	1	0	4	3044	100370	1726	troleandomycin	asthma	9	76	0	0	Inf	1	0	0	540	17516	1726	troleandomycin	asthma	0	0	Inf	1	0	0	147	6258	1726	troleandomycin	asthma	0	0	Inf	1	0	0	458	14562	1726	troleandomycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1727	novobiocin sodium	0	0	118.34	1	0	3	177549	8686787	1727	novobiocin sodium	oesophagogastroduodenoscopy	0	0	2868.45	1	0	1	1	76	1727	novobiocin sodium	oesophagogastroduodenoscopy	NA	NA	0	0	Inf	1	0	0	0	0	1727	novobiocin sodium	oesophagogastroduodenoscopy	0	0	Inf	1	0	0	0	4	1727	novobiocin sodium	oesophagogastroduodenoscopy	0	0	Inf	1	0	0	0	4	1727	novobiocin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1728	spectinomycin	0	0	21.83	1	0	10	177549	8686780	1728	spectinomycin	gonorrhoea	0	0	Inf	1	0	4	0	47	1728	spectinomycin	gonorrhoea	NA	NA	0	0	Inf	1	0	0	0	0	1728	spectinomycin	gonorrhoea	0	0	Inf	1	0	1	0	2	1728	spectinomycin	gonorrhoea	0	0	Inf	1	0	0	0	4	1728	spectinomycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1729	colistin	0.14	0.03	0.4	1.2e-06	3	1087	177546	8685703	1729	colistin	cystic fibrosis	1.05	0.03	6.17	0.62	1	167	56	9806	1729	colistin	cystic fibrosis	14.3	57.2	0	0	12.49	1	0	62	18	3317	1729	colistin	cystic fibrosis	0	0	41.69	1	0	35	7	2027	1729	colistin	cystic fibrosis	5.37	0.12	38.09	0.19	1	37	12	2388	1729	colistin	cystic fibrosis	1.2	3.32011692273655	1.03	0.25	0.02	0.01	0.06	-0.45	0.47	0.33
1730	thonzonium bromide	0	0	33.97	1	0	7	177549	8686783	1730	thonzonium bromide	lung transplant	0	0	725.69	1	0	2	13	1749	1730	thonzonium bromide	lung transplant	54.4	62.8	0	0	Inf	1	0	0	5	78	1730	thonzonium bromide	lung transplant	0	0	Inf	1	0	0	2	172	1730	thonzonium bromide	lung transplant	0	0	Inf	1	0	0	5	143	1730	thonzonium bromide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1731	erythromycin	3	2.76	3.26	4.6e-109	587	9585	176962	8677205	1731	erythromycin	acne	2.25	1.84	2.74	2.2e-14	138	433	4238	29971	1731	erythromycin	acne	14.8	44.4	2.25	0.43	7.59	0.17	3	22	170	2802	1731	erythromycin	acne	0	0	18.83	1	0	10	28	1121	1731	erythromycin	acne	1.84	0.35	6.15	0.25	3	24	161	2370	1731	erythromycin	acne	0.46	1.58407398499448	0.61	0.45	0	0.01	0.65	-1.03	0.21	0
1733	chlortetracycline	1.63	0.04	9.81	0.47	1	30	177548	8686760	1733	chlortetracycline	head and neck cancer	0	0	296.06	1	0	5	15	3785	1733	chlortetracycline	head and neck cancer	NA	NA	0	0	Inf	1	0	0	0	0	1733	chlortetracycline	head and neck cancer	0	0	Inf	1	0	0	0	290	1733	chlortetracycline	head and neck cancer	0	0	Inf	1	0	0	0	62	1733	chlortetracycline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1734	cephalexin	8.05	7.7	8.41	0	2322	14278	175227	8672512	1734	cephalexin	pain	6.39	5.61	7.28	4.9e-124	308	1106	8161	187378	1734	cephalexin	pain	23	79	3.22	1.99	4.97	3.7e-06	23	240	1065	35777	1734	cephalexin	pain	2.93	1.04	6.71	0.021	6	87	358	15230	1734	cephalexin	pain	3.45	2.08	5.47	3.7e-06	21	192	836	26398	1734	cephalexin	pain	1.2	3.32011692273655	0.21	0	-0.02	0	0	-0.28	0.06	0
1735	rifampin	0.92	0.75	1.13	0.48	95	5034	177454	8681756	1735	rifampin	tuberculosis	1.02	0.37	2.48	1	7	971	22	3117	1735	rifampin	tuberculosis	23.8	59	1.89	0.18	11.73	0.36	2	117	5	554	1735	rifampin	tuberculosis	1.37	0.03	14.09	0.57	1	96	4	528	1735	rifampin	tuberculosis	4.83	0.35	67.54	0.14	2	87	2	422	1735	rifampin	tuberculosis	0.94	2.55998141832927	0.71	0.19	-0.01	0.02	0.56	0.1	0.68	0.88
1736	carbenicillin indanyl sodium	0	0	13.64	1	0	15	177549	8686775	1736	carbenicillin indanyl sodium	acute myeloid leukaemia	0	0	13818.99	1	0	1	31	14008	1736	carbenicillin indanyl sodium	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	0	0	820	1736	carbenicillin indanyl sodium	acute myeloid leukaemia	0	0	Inf	1	0	0	1	1376	1736	carbenicillin indanyl sodium	acute myeloid leukaemia	0	0	Inf	1	0	0	2	1126	1736	carbenicillin indanyl sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1737	clindamycin phosphate	4.75	4.29	5.25	5e-139	426	4397	177123	8682393	1737	clindamycin phosphate	acne	0.5	0.38	0.65	8.1e-09	64	876	4312	29528	1737	clindamycin phosphate	acne	14.8	44.4	0.83	0.32	1.79	0.85	7	137	166	2687	1737	clindamycin phosphate	acne	0.89	0.02	5.68	1	1	45	27	1086	1737	clindamycin phosphate	acne	0.74	0.29	1.61	0.6	7	136	157	2258	1737	clindamycin phosphate	acne	-0.27	0.763379494336853	0.37	0.46	0	0.01	0.68	-1.04	0.21	0
1738	bleomycin	0.22	0.14	0.33	1.5e-22	25	5466	177524	8681324	1738	bleomycin	hodgkin s disease	0.84	0.29	2.19	0.83	7	1695	15	3040	1738	bleomycin	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	21	0	104	1738	bleomycin	hodgkin s disease	0	0	Inf	1	0	125	0	393	1738	bleomycin	hodgkin s disease	0	0	23.63	1	0	76	2	334	1738	bleomycin	hodgkin s disease	-17.26	3.1921055431973e-08	4947.23	1	-0.02	0.04	0.68	-18.05	3342.43	1
1739	cephapirin sodium	0	0	1852.91	1	0	1	177549	8686789	1739	cephapirin sodium		0	0	Inf	1	0	0	0	0	1739	cephapirin sodium		NA	NA	0	0	Inf	1	0	0	0	0	1739	cephapirin sodium		0	0	Inf	1	0	0	0	0	1739	cephapirin sodium		0	0	Inf	1	0	0	0	0	1739	cephapirin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1740	amoxicillin	3.49	3.36	3.63	0	2855	40492	174694	8646298	1740	amoxicillin	hypertension	3.68	3.1	4.34	3.4e-39	156	1987	6739	315626	1740	amoxicillin	hypertension	38	82.9	0.8	0.29	1.77	0.85	6	474	975	61935	1740	amoxicillin	hypertension	0.66	0.08	2.43	0.77	2	280	339	31359	1740	amoxicillin	hypertension	1.14	0.42	2.53	0.66	6	275	756	39655	1740	amoxicillin	hypertension	-0.09	0.913931185271228	0.36	0.8	-0.02	0	0	-0.59	0.07	0
1741	cefazolin sodium	9.86	9.31	10.45	0	1423	7109	176126	8679681	1741	cefazolin sodium	prophylaxis	1.91	1.08	3.14	0.022	16	682	1263	102869	1741	cefazolin sodium	prophylaxis	23.9	79.7	0	0	3.41	0.63	0	126	207	23534	1741	cefazolin sodium	prophylaxis	0	0	8.14	1	0	79	82	13649	1741	cefazolin sodium	prophylaxis	0	0	4.94	1	0	75	148	14337	1741	cefazolin sodium	prophylaxis	-12.8	2.7607725720372e-06	316.84	0.97	-0.01	0	0.02	-0.52	0.14	0
1742	doxorubicin	0.86	0.8	0.93	2.6e-05	811	45907	176738	8640883	1742	doxorubicin	diffuse large b-cell lymphoma	0.36	0.11	1.09	0.066	6	5909	10	3545	1742	doxorubicin	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	634	0	580	1742	doxorubicin	diffuse large b-cell lymphoma	Inf	0.2	Inf	0.23	2	604	0	654	1742	doxorubicin	diffuse large b-cell lymphoma	0	0	Inf	1	0	538	0	499	1742	doxorubicin	diffuse large b-cell lymphoma	18.11	73294783.6550083	3574.56	1	0	0.05	0.92	18.03	3729.08	1
1743	griseofulvin	5.29	3.32	8.08	2.9e-10	24	222	177525	8686568	1743	griseofulvin	hiv infection	0	0	68.58	1	0	8	500	58383	1743	griseofulvin	hiv infection	25	64	0	0	97.14	1	0	4	120	7637	1743	griseofulvin	hiv infection	0	0	145.24	1	0	3	96	5725	1743	griseofulvin	hiv infection	0	0	3186.15	1	0	1	40	3438	1743	griseofulvin	hiv infection	-10.42	2.98298794702676e-05	440.69	0.98	0	0.01	0.8	0.38	0.2	0.05
1744	tobramycin	1.77	1.6	1.95	5.9e-25	402	11133	177147	8675657	1744	tobramycin	cystic fibrosis	2.16	1.24	3.78	0.0046	30	3390	27	6583	1744	tobramycin	cystic fibrosis	14.3	57.2	2.64	0.92	7.52	0.059	9	929	9	2450	1744	tobramycin	cystic fibrosis	0.91	0.09	5.58	1	2	629	5	1433	1744	tobramycin	cystic fibrosis	4.35	1.25	16.96	0.0093	8	652	5	1773	1744	tobramycin	cystic fibrosis	0.94	2.55998141832927	0.45	0.04	0.02	0.01	0.06	-0.49	0.47	0.3
1745	doxycycline calcium	2.64	1.93	3.54	1.1e-08	47	871	177502	8685919	1745	doxycycline calcium	pain	3.8	1.44	8.56	0.0042	7	41	8462	188443	1745	doxycycline calcium	pain	23	79	8.29	0.86	41.61	0.033	2	8	1086	36009	1745	doxycycline calcium	pain	0	0	63.84	1	0	4	364	15313	1745	doxycycline calcium	pain	15.54	1.4	108.81	0.013	2	4	855	26586	1745	doxycycline calcium	pain	2.01	7.46331734731919	0.8	0.01	-0.02	0	0	-0.28	0.06	0
1746	cephalothin sodium	0.72	0.09	2.65	1	2	136	177547	8686654	1746	cephalothin sodium	diffuse large b-cell lymphoma	0	0	534.4	1	0	6	16	9448	1746	cephalothin sodium	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	0	0	1214	1746	cephalothin sodium	diffuse large b-cell lymphoma	0	0	Inf	1	0	0	2	1258	1746	cephalothin sodium	diffuse large b-cell lymphoma	0	0	Inf	1	0	0	0	1037	1746	cephalothin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1747	daunorubicin	0.22	0.15	0.31	5.6e-28	30	6743	177519	8680047	1747	daunorubicin	acute lymphocytic leukaemia	0.75	0.29	1.64	0.59	7	1559	63	10524	1747	daunorubicin	acute lymphocytic leukaemia	6.4	64.6	0	0	3.34	0.62	0	210	11	1744	1747	daunorubicin	acute lymphocytic leukaemia	0	0	3.4	0.62	0	159	11	1343	1747	daunorubicin	acute lymphocytic leukaemia	0	0	44.92	1	0	132	2	1109	1747	daunorubicin	acute lymphocytic leukaemia	-15.39	2.07113269020702e-07	1012.82	0.99	-0.01	0.01	0.57	1.51	0.77	0.05
1748	vidarabine	0	0	0.88	0.025	0	207	177549	8686583	1748	vidarabine	herpes zoster	0	0	3.34	0.63	0	82	128	9155	1748	vidarabine	herpes zoster	45.7	81.5	0	0	42.03	1	0	6	26	1226	1748	vidarabine	herpes zoster	0	0	182.86	1	0	4	6	612	1748	vidarabine	herpes zoster	0	0	32.18	1	0	7	24	1054	1748	vidarabine	herpes zoster	-12.38	4.20178971844699e-06	717.12	0.99	-0.01	0.01	0.16	-0.82	0.46	0.07
1749	amikacin	0.36	0.25	0.5	1.7e-12	34	4647	177515	8682143	1749	amikacin	prophylaxis	0.62	0.13	1.84	0.64	3	389	1276	103162	1749	amikacin	prophylaxis	23.9	79.7	1.82	0.05	10.62	0.43	1	63	206	23597	1749	amikacin	prophylaxis	2.48	0.06	14.69	0.34	1	68	81	13660	1749	amikacin	prophylaxis	0	0	22.37	1	0	18	148	14394	1749	amikacin	prophylaxis	0.42	1.52196155561863	1.01	0.67	-0.01	0	0.03	-0.52	0.14	0
1750	ticarcillin disodium	4.19	2.86	5.95	2.5e-11	34	397	177515	8686393	1750	ticarcillin disodium	prophylaxis	0	0	10.61	1	0	30	1279	103521	1750	ticarcillin disodium	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	1750	ticarcillin disodium	prophylaxis	0	0	5924.82	1	0	1	82	13727	1750	ticarcillin disodium	prophylaxis	0	0	3585.07	1	0	1	148	14411	1750	ticarcillin disodium	prophylaxis	-7.71	0.000448321477134178	228.78	0.97	-0.01	0	0.03	-0.52	0.14	0
1751	cefamandole nafate	3.06	0.36	11.99	0.15	2	32	177547	8686758	1751	cefamandole nafate	joint prosthesis user	0	0	Inf	1	0	2	0	37	1751	cefamandole nafate	joint prosthesis user	NA	NA	0	0	Inf	1	0	0	0	0	1751	cefamandole nafate	joint prosthesis user	0	0	Inf	1	0	0	0	3	1751	cefamandole nafate	joint prosthesis user	0	0	Inf	1	0	0	0	1	1751	cefamandole nafate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1753	cefadroxil/cefadroxil hemihydrate	4.52	3.58	5.64	3.4e-28	86	932	177463	8685858	1753	cefadroxil/cefadroxil hemihydrate	pain	1.97	0.77	4.26	0.1	7	79	8462	188405	1753	cefadroxil/cefadroxil hemihydrate	pain	23	79	0	0	16.79	1	0	9	1088	36008	1753	cefadroxil/cefadroxil hemihydrate	pain	0	0	224.46	1	0	2	364	15315	1753	cefadroxil/cefadroxil hemihydrate	pain	0	0	21.56	1	0	7	857	26583	1753	cefadroxil/cefadroxil hemihydrate	pain	-9.02	0.00012096612623881	107.9	0.93	-0.02	0	0	-0.28	0.06	0
1754	natamycin	0	0	3.53	0.63	0	53	177549	8686737	1754	natamycin	endophthalmitis	0	0	Inf	1	0	3	0	157	1754	natamycin	endophthalmitis	NA	NA	0	0	Inf	1	0	0	0	0	1754	natamycin	endophthalmitis	0	0	Inf	1	0	3	0	16	1754	natamycin	endophthalmitis	0	0	Inf	1	0	0	0	25	1754	natamycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1755	cefoxitin sodium	3.42	2.34	4.84	3.5e-09	34	487	177515	8686303	1755	cefoxitin sodium	mycobacterium abscessus infection	0	0	154.28	1	0	29	1	114	1755	cefoxitin sodium	mycobacterium abscessus infection	52	52	0	0	Inf	1	0	0	0	0	1755	cefoxitin sodium	mycobacterium abscessus infection	0	0	Inf	1	0	6	0	16	1755	cefoxitin sodium	mycobacterium abscessus infection	0	0	58.45	1	0	10	1	14	1755	cefoxitin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1756	meclocycline sulfosalicylate	0	0	260.7	1	0	2	177549	8686788	1756	meclocycline sulfosalicylate	atrial fibrillation	0	0	4960.68	1	0	1	808	111408	1756	meclocycline sulfosalicylate	atrial fibrillation	49	86.6	0	0	Inf	1	0	0	132	34626	1756	meclocycline sulfosalicylate	atrial fibrillation	0	0	Inf	1	0	0	56	22073	1756	meclocycline sulfosalicylate	atrial fibrillation	0	0	Inf	1	0	0	94	17933	1756	meclocycline sulfosalicylate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1757	bacampicillin	0	0	8.13	1	0	24	177549	8686766	1757	bacampicillin	diabetes mellitus	0	0	251.21	1	0	3	2327	242895	1757	bacampicillin	diabetes mellitus	39.3	82	0	0	5004.87	1	0	1	377	52483	1757	bacampicillin	diabetes mellitus	0	0	Inf	1	0	0	140	29744	1757	bacampicillin	diabetes mellitus	0	0	3688.62	1	0	1	281	28201	1757	bacampicillin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1758	cefaclor	1.94	1.47	2.52	4.4e-06	59	1485	177490	8685305	1758	cefaclor	rheumatoid arthritis	0	0	10.34	1	0	50	3410	460327	1758	cefaclor	rheumatoid arthritis	33	75	0	0	16.41	1	0	26	1060	113912	1758	cefaclor	rheumatoid arthritis	0	0	5065.99	1	0	1	180	25390	1758	cefaclor	rheumatoid arthritis	0	0	16.3	1	0	26	1011	107938	1758	cefaclor	rheumatoid arthritis	-8.86	0.000141955064163011	103.01	0.93	-0.01	0	0	-0.26	0.08	0
1759	cephradine	8.04	4.93	12.55	3.3e-13	23	140	177526	8686650	1759	cephradine	prophylaxis	0	0	14.1	1	0	23	1279	103528	1759	cephradine	prophylaxis	23.9	79.7	0	0	174.45	1	0	4	207	23656	1759	cephradine	prophylaxis	0	0	406.52	1	0	3	82	13725	1759	cephradine	prophylaxis	0	0	3585.07	1	0	1	148	14411	1759	cephradine	prophylaxis	-8.66	0.000173384306903506	265.9	0.97	-0.01	0	0.03	-0.52	0.14	0
1760	netilmicin	0.57	0.07	2.09	0.59	2	172	177547	8686618	1760	netilmicin	bronchitis	0	0	22.98	1	0	6	543	14660	1760	netilmicin	bronchitis	28	73.7	0	0	Inf	1	0	0	78	1801	1760	netilmicin	bronchitis	0	0	Inf	1	0	0	16	879	1760	netilmicin	bronchitis	0	0	Inf	1	0	0	73	1793	1760	netilmicin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1761	piperacillin sodium	1.28	1.15	1.42	5.5e-06	374	14306	177175	8672484	1761	piperacillin sodium	prophylaxis	0.15	0.02	0.55	0.00037	2	1059	1277	102492	1761	piperacillin sodium	prophylaxis	23.9	79.7	0	0	1.62	0.18	0	262	207	23398	1761	piperacillin sodium	prophylaxis	0	0	3.36	0.63	0	187	82	13541	1761	piperacillin sodium	prophylaxis	0	0	2.63	0.41	0	139	148	14273	1761	piperacillin sodium	prophylaxis	-13.75	1.06770401003478e-06	359.19	0.97	-0.01	0	0.02	-0.52	0.14	0
1762	cefotaxime sodium	0.89	0.68	1.15	0.42	60	3297	177489	8683493	1762	cefotaxime sodium	prophylaxis	0	0	1.23	0.13	0	244	1279	103307	1762	cefotaxime sodium	prophylaxis	23.9	79.7	0	0	18.3	1	0	25	207	23635	1762	cefotaxime sodium	prophylaxis	0	0	34.51	1	0	20	82	13708	1762	cefotaxime sodium	prophylaxis	0	0	17.95	1	0	22	148	14390	1762	cefotaxime sodium	prophylaxis	-10.94	1.77344762885484e-05	223.09	0.96	-0.01	0	0.02	-0.52	0.14	0
1765	cefoperazone sodium	0.07	0	0.4	2.8e-05	1	684	177548	8686106	1765	cefoperazone sodium	prophylaxis	0	0	5.23	1	0	59	1279	103492	1765	cefoperazone sodium	prophylaxis	23.9	79.7	0	0	26.19	1	0	18	207	23642	1765	cefoperazone sodium	prophylaxis	0	0	51.38	1	0	14	82	13714	1765	cefoperazone sodium	prophylaxis	0	0	68.1	1	0	7	148	14405	1765	cefoperazone sodium	prophylaxis	-10.71	2.2320612032861e-05	315.47	0.97	-0.01	0	0.03	-0.52	0.14	0
1766	ceforanide	0	0	260.7	1	0	2	177549	8686788	1766	ceforanide	postoperative care	0	0	829.19	1	0	2	18	2718	1766	ceforanide	postoperative care	19.8	69.3	0	0	Inf	1	0	0	2	372	1766	ceforanide	postoperative care	0	0	Inf	1	0	0	2	254	1766	ceforanide	postoperative care	0	0	Inf	1	0	0	2	402	1766	ceforanide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1767	cefuroxime sodium	9.5	8.32	10.81	1.1e-156	277	1429	177272	8685361	1767	cefuroxime sodium	coronary artery bypass	5.67	3.61	9.32	7.5e-20	168	22	2684	1992	1767	cefuroxime sodium	coronary artery bypass	69.7	83	0	0	Inf	1	0	0	1	116	1767	cefuroxime sodium	coronary artery bypass	0	0	Inf	1	0	0	1	192	1767	cefuroxime sodium	coronary artery bypass	0	0	Inf	1	0	0	3	35	1767	cefuroxime sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1768	ceftizoxime sodium	9.01	3.4	20.43	3e-05	7	38	177542	8686752	1768	ceftizoxime sodium	pyrexia	0	0	141.43	1	0	4	182	16961	1768	ceftizoxime sodium	pyrexia	13.2	74.9	0	0	3947.29	1	0	1	22	2372	1768	ceftizoxime sodium	pyrexia	0	0	Inf	1	0	0	3	2080	1768	ceftizoxime sodium	pyrexia	0	0	3070.45	1	0	1	23	1901	1768	ceftizoxime sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1769	azlocillin sodium	0	0	1852.91	1	0	1	177549	8686789	1769	azlocillin sodium	epilepsy	0	0	2653.42	1	0	1	640	45425	1769	azlocillin sodium	epilepsy	13.6	68.1	0	0	Inf	1	0	0	87	5314	1769	azlocillin sodium	epilepsy	0	0	3209.35	1	0	1	41	3551	1769	azlocillin sodium	epilepsy	0	0	Inf	1	0	0	56	4184	1769	azlocillin sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1770	clavulanate potassium	2.22	1.96	2.49	6e-32	288	6366	177261	8680424	1770	clavulanate potassium	hypertension	0.98	0.39	2.05	1	7	328	6888	317285	1770	clavulanate potassium	hypertension	38	82.9	0	0	7.3	1	0	34	981	62375	1770	clavulanate potassium	hypertension	0	0	15.48	1	0	24	341	31615	1770	clavulanate potassium	hypertension	0	0	11.94	1	0	18	762	39912	1770	clavulanate potassium	hypertension	-10.39	3.07383345474242e-05	133.61	0.94	-0.02	0	0	-0.59	0.07	0
1771	amdinocillin	0	0	21.83	1	0	10	177549	8686780	1771	amdinocillin	spondylitis	0	0	54.89	1	0	3	99	2226	1771	amdinocillin	spondylitis	32	50.9	0	0	Inf	1	0	0	1	171	1771	amdinocillin	spondylitis	0	0	Inf	1	0	0	1	183	1771	amdinocillin	spondylitis	0	0	Inf	1	0	0	2	323	1771	amdinocillin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1772	cefmenoxime	0	0	5.44	1	0	35	177549	8686755	1772	cefmenoxime	age-related macular degeneration	0	0	103.94	1	0	7	46	6692	1772	cefmenoxime	age-related macular degeneration	50.4	78.8	0	0	Inf	1	0	0	4	516	1772	cefmenoxime	age-related macular degeneration	0	0	Inf	1	0	0	1	524	1772	cefmenoxime	age-related macular degeneration	0	0	Inf	1	0	0	5	584	1772	cefmenoxime	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1773	streptozocin	0	0	3.75	0.63	0	50	177549	8686740	1773	streptozocin	colon cancer	0	0	1108.37	1	0	2	74	14969	1773	streptozocin	colon cancer	44.6	81.9	0	0	763.62	1	0	2	23	3203	1773	streptozocin	colon cancer	0	0	Inf	1	0	0	12	2040	1773	streptozocin	colon cancer	0	0	613.05	1	0	2	15	1684	1773	streptozocin	colon cancer	-10.84	1.95996274414058e-05	1029.12	0.99	0.01	0.01	0.53	-0.42	0.39	0.28
1774	ceftazidime	1.13	0.9	1.39	0.26	91	3954	177458	8682836	1774	ceftazidime	prophylaxis	0	0	0.97	0.037	0	309	1279	103242	1774	ceftazidime	prophylaxis	23.9	79.7	0	0	12.07	1	0	37	207	23623	1774	ceftazidime	prophylaxis	0	0	27.13	1	0	25	82	13703	1774	ceftazidime	prophylaxis	0	0	12.42	1	0	31	148	14381	1774	ceftazidime	prophylaxis	-11.88	6.92758008381266e-06	319.26	0.97	-0.01	0	0.02	-0.52	0.14	0
1775	cefonicid sodium	0	0	41.55	1	0	6	177549	8686784	1775	cefonicid sodium	respiratory disorder	0	0	1324.51	1	0	1	81	2808	1775	cefonicid sodium	respiratory disorder	13.4	70.1	0	0	Inf	1	0	0	10	463	1775	cefonicid sodium	respiratory disorder	0	0	Inf	1	0	0	3	269	1775	cefonicid sodium	respiratory disorder	0	0	Inf	1	0	0	9	475	1775	cefonicid sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1776	aztreonam	0.71	0.55	0.91	0.0051	66	4519	177483	8682271	1776	aztreonam	cystic fibrosis	0.35	0.11	0.88	0.022	5	2137	52	7836	1776	aztreonam	cystic fibrosis	14.3	57.2	0.1	0	0.65	0.0053	1	1236	17	2143	1776	aztreonam	cystic fibrosis	0	0	1.44	0.1	0	672	7	1390	1776	aztreonam	cystic fibrosis	0.33	0.04	1.54	0.16	2	854	11	1571	1776	aztreonam	cystic fibrosis	-1.6	0.201896517994655	0.75	0.03	0.02	0.01	0.04	-0.47	0.47	0.31
1777	ceftriaxone sodium	1.72	1.59	1.86	1.4e-38	698	19864	176851	8666926	1777	ceftriaxone sodium	pneumonia	0.31	0.16	0.55	3e-06	12	1616	383	16049	1777	ceftriaxone sodium	pneumonia	28	83	0	0	0.87	0.03	0	216	49	2384	1777	ceftriaxone sodium	pneumonia	0	0	2.7	0.39	0	154	15	1475	1777	ceftriaxone sodium	pneumonia	0.5	0.06	1.95	0.58	2	144	44	1579	1777	ceftriaxone sodium	pneumonia	-1.1	0.33287108369808	0.72	0.13	-0.01	0.01	0.02	-1.06	0.3	0
1778	cilastatin sodium	1.06	0.82	1.36	0.61	67	3080	177482	8683710	1778	cilastatin sodium	pneumonia	0.39	0.08	1.15	0.095	3	343	392	17322	1778	cilastatin sodium	pneumonia	28	83	0	0	285.12	1	0	2	49	2598	1778	cilastatin sodium	pneumonia	0	0	591.91	1	0	2	15	1627	1778	cilastatin sodium	pneumonia	0	0	Inf	1	0	0	46	1723	1778	cilastatin sodium	pneumonia	-9.69	6.18994044180088e-05	623.81	0.99	-0.01	0.01	0.03	-1.06	0.3	0
1779	imipenem	1.05	0.87	1.26	0.57	118	5494	177431	8681296	1779	imipenem	pneumonia	0.45	0.15	1.07	0.083	5	487	390	17178	1779	imipenem	pneumonia	28	83	0	0	6.64	1	0	32	49	2568	1779	imipenem	pneumonia	0	0	17.55	1	0	27	15	1602	1779	imipenem	pneumonia	0	0	11.59	1	0	14	46	1709	1779	imipenem	pneumonia	-13.43	1.47036483631174e-06	601.41	0.98	-0.01	0.01	0.03	-1.06	0.3	0
1780	cefotetan disodium	5.92	3.22	10.15	1.6e-07	15	124	177534	8686666	1780	cefotetan disodium	prophylaxis	4.5	0.11	28.55	0.21	1	18	1278	103533	1780	cefotetan disodium	prophylaxis	23.9	79.7	0	0	4167.48	1	0	1	207	23659	1780	cefotetan disodium	prophylaxis	0	0	Inf	1	0	0	82	13728	1780	cefotetan disodium	prophylaxis	0	0	3585.07	1	0	1	148	14411	1780	cefotetan disodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1781	mupirocin	3.49	3.12	3.89	3.7e-79	342	4805	177207	8681985	1781	mupirocin	pain	1.7	1.17	2.41	0.005	35	458	8434	188026	1781	mupirocin	pain	23	79	1.48	0.58	3.13	0.34	7	157	1081	35860	1781	mupirocin	pain	1.33	0.27	4.04	0.5	3	95	361	15222	1781	mupirocin	pain	1.87	0.59	4.57	0.2	5	83	852	26507	1781	mupirocin	pain	0.5	1.64872127070013	0.36	0.17	-0.02	0	0	-0.29	0.06	0
1782	bacitracin	5.95	5.04	6.98	2.1e-69	170	1399	177379	8685391	1782	bacitracin	pain	0.55	0.11	1.64	0.38	3	122	8466	188362	1782	bacitracin	pain	23	79	0	0	3.57	0.63	0	36	1088	35981	1782	bacitracin	pain	0	0	9.61	1	0	18	364	15299	1782	bacitracin	pain	0.97	0.02	5.82	1	1	32	856	26558	1782	bacitracin	pain	-0.64	0.527292424043049	1.01	0.53	-0.02	0	0	-0.28	0.06	0
1783	cefotiam	0.15	0.02	0.54	0.00026	2	663	177547	8686127	1783	cefotiam	prophylaxis	1.47	0.04	8.57	0.5	1	55	1278	103496	1783	cefotiam	prophylaxis	23.9	79.7	0	0	51.32	1	0	10	207	23650	1783	cefotiam	prophylaxis	0	0	99.75	1	0	8	82	13720	1783	cefotiam	prophylaxis	0	0	83.35	1	0	6	148	14406	1783	cefotiam	prophylaxis	-9.75	5.82946637308688e-05	235.03	0.97	-0.01	0	0.03	-0.52	0.14	0
1784	cefuroxime axetil	4.98	4.38	5.63	2.2e-96	280	2756	177269	8684034	1784	cefuroxime axetil	hypertension	1.52	0.41	4	0.34	4	121	6891	317492	1784	cefuroxime axetil	hypertension	38	82.9	0	0	9.71	1	0	26	981	62383	1784	cefuroxime axetil	hypertension	0	0	33.52	1	0	12	341	31627	1784	cefuroxime axetil	hypertension	3.08	0.07	19.74	0.29	1	17	761	39913	1784	cefuroxime axetil	hypertension	0.76	2.13827622049682	1.02	0.46	-0.02	0	0	-0.59	0.07	0
1785	vancomycin	2.96	2.82	3.1	4.94065645841247e-324	1818	30305	175731	8656485	1785	vancomycin	prophylaxis	1.47	1	2.09	0.039	32	1780	1247	101771	1785	vancomycin	prophylaxis	23.9	79.7	0.93	0.19	2.78	1	3	368	204	23292	1785	vancomycin	prophylaxis	1.33	0.16	5.02	0.66	2	253	80	13475	1785	vancomycin	prophylaxis	2.28	0.72	5.52	0.077	5	218	143	14194	1785	vancomycin	prophylaxis	0.58	1.78603843075007	0.39	0.13	-0.01	0	0.03	-0.53	0.14	0
1786	sulbactam sodium	3.59	3.15	4.08	2.7e-61	253	3451	177296	8683339	1786	sulbactam sodium	pneumonia	0.08	0	0.48	0.00031	1	514	394	17151	1786	sulbactam sodium	pneumonia	28	83	0	0	7.37	1	0	29	49	2571	1786	sulbactam sodium	pneumonia	0	0	15.13	1	0	31	15	1598	1786	sulbactam sodium	pneumonia	0	0	15.32	1	0	11	46	1712	1786	sulbactam sodium	pneumonia	-13.28	1.70832021613054e-06	592.69	0.98	-0.01	0.01	0.03	-1.05	0.3	0
1787	cefixime	0.83	0.48	1.34	0.57	17	1001	177532	8685789	1787	cefixime	urinary tract infection	0.35	0.01	2.04	0.53	1	73	748	19361	1787	cefixime	urinary tract infection	22.2	73.2	0	0	653.5	1	0	1	183	3097	1787	cefixime	urinary tract infection	0	0	62.24	1	0	4	31	1236	1787	cefixime	urinary tract infection	0	0	10.65	1	0	9	174	3627	1787	cefixime	urinary tract infection	-13.29	1.69132214597039e-06	375.2	0.97	-0.03	0	0	-0.39	0.2	0.05
1788	cefpiramide sodium	0	0	8.51	1	0	23	177549	8686767	1788	cefpiramide sodium	infection prophylaxis	0	0	703.78	1	0	2	82	10895	1788	cefpiramide sodium	infection prophylaxis	19.4	77.2	0	0	Inf	1	0	0	17	2222	1788	cefpiramide sodium	infection prophylaxis	0	0	Inf	1	0	0	10	1531	1788	cefpiramide sodium	infection prophylaxis	0	0	Inf	1	0	0	9	1239	1788	cefpiramide sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1789	ceftazidime sodium	2.66	1.83	3.73	6.6e-07	35	645	177514	8686145	1789	ceftazidime sodium	pain	17.84	8.64	36.25	4.3e-13	16	20	8453	188464	1789	ceftazidime sodium	pain	23	79	16.56	0.28	317.51	0.085	1	2	1087	36015	1789	ceftazidime sodium	pain	0	0	224.46	1	0	2	364	15315	1789	ceftazidime sodium	pain	15.52	0.26	297.75	0.091	1	2	856	26588	1789	ceftazidime sodium	pain	1.67	5.31216779718117	1.15	0.15	-0.02	0	0	-0.28	0.06	0
1790	cefmetazole sodium	0.89	0.29	2.09	1	5	276	177544	8686514	1790	cefmetazole sodium	prophylaxis	0	0	9.59	1	0	33	1279	103518	1790	cefmetazole sodium	prophylaxis	23.9	79.7	0	0	606.56	1	0	2	207	23658	1790	cefmetazole sodium	prophylaxis	0	0	67.83	1	0	11	82	13717	1790	cefmetazole sodium	prophylaxis	0	0	Inf	1	0	0	148	14412	1790	cefmetazole sodium	prophylaxis	-9.34	8.78394360868463e-05	265.88	0.97	-0.01	0	0.03	-0.52	0.14	0
1791	penicillin g potassium	8.61	8.12	9.11	0	1391	7963	176158	8678827	1791	penicillin g potassium	pain	6.16	4.95	7.61	1.1e-45	113	413	8356	188071	1791	penicillin g potassium	pain	23	79	2.41	0.76	5.91	0.066	5	69	1083	35948	1791	penicillin g potassium	pain	0	0	5.16	1	0	32	364	15285	1791	penicillin g potassium	pain	2.88	0.9	7.18	0.037	5	54	852	26536	1791	penicillin g potassium	pain	0.49	1.63231621995538	0.46	0.29	-0.02	0	0	-0.28	0.06	0
1792	idarubicin	0.09	0.04	0.2	7.8e-23	7	3618	177542	8683172	1792	idarubicin	acute myeloid leukaemia	0.84	0.16	2.73	1	3	1582	28	12427	1792	idarubicin	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	156	0	664	1792	idarubicin	acute myeloid leukaemia	0	0	228.7	1	0	200	1	1176	1792	idarubicin	acute myeloid leukaemia	Inf	1.07	Inf	0.022	2	167	0	959	1792	idarubicin	acute myeloid leukaemia	2.59	13.3297716031958	1.29	0.04	0.01	0.03	0.71	-0.94	1.24	0.45
1793	clarithromycin	2.27	2.14	2.42	8.2e-117	1041	22466	176508	8664324	1793	clarithromycin	helicobacter infection	0.85	0.5	1.44	0.53	32	1419	32	1202	1793	clarithromycin	helicobacter infection	29	65	0.73	0.16	2.69	0.77	4	136	9	224	1793	clarithromycin	helicobacter infection	12.49	1.68	554.83	0.0057	9	95	1	133	1793	clarithromycin	helicobacter infection	0.35	0.04	1.73	0.22	2	159	9	251	1793	clarithromycin	helicobacter infection	0.51	1.66529119494589	0.45	0.26	0.01	0.01	0.43	0.46	0.45	0.3
1794	cefprozil	4.53	3.48	5.81	1e-22	68	735	177481	8686055	1794	cefprozil	pain	3.07	1.27	6.47	0.0073	8	58	8461	188426	1794	cefprozil	pain	23	79	0	0	80.19	1	0	3	1088	36014	1794	cefprozil	pain	0	0	224.46	1	0	2	364	15315	1794	cefprozil	pain	0	0	165.35	1	0	2	857	26588	1794	cefprozil	pain	-9.46	7.79065910151345e-05	160.95	0.95	-0.02	0	0	-0.28	0.06	0
1795	loracarbef	4.29	2	8.18	0.00021	10	114	177539	8686676	1795	loracarbef	depression	67.12	7.51	3108.95	9.1e-06	5	1	14366	192784	1795	loracarbef	depression	21	73.3	0	0	Inf	1	0	0	2062	28342	1795	loracarbef	depression	0	0	Inf	1	0	0	637	10447	1795	loracarbef	depression	0	0	Inf	1	0	0	1671	24384	1795	loracarbef	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1796	azithromycin	4.08	3.92	4.24	0	2727	33095	174822	8653695	1796	azithromycin	hiv infection	0.27	0.07	0.7	0.0027	4	1678	496	56713	1796	azithromycin	hiv infection	25	64	0	0	1.91	0.27	0	125	120	7516	1796	azithromycin	hiv infection	0	0	2.32	0.41	0	97	96	5631	1796	azithromycin	hiv infection	0	0	8.36	1	0	41	40	3398	1796	azithromycin	hiv infection	-13.4	1.51514411214325e-06	336.18	0.97	0	0.01	0.78	0.38	0.2	0.05
1797	cefpodoxime proxetil	1.64	1.17	2.25	0.0041	40	1190	177509	8685600	1797	cefpodoxime proxetil	prophylaxis	1.14	0.03	6.57	0.59	1	71	1278	103480	1797	cefpodoxime proxetil	prophylaxis	23.9	79.7	0	0	26.19	1	0	18	207	23642	1797	cefpodoxime proxetil	prophylaxis	0	0	44.21	1	0	16	82	13712	1797	cefpodoxime proxetil	prophylaxis	0	0	147.81	1	0	4	148	14408	1797	cefpodoxime proxetil	prophylaxis	-10.61	2.46680912923674e-05	324.3	0.97	-0.01	0	0.03	-0.52	0.14	0
1798	dirithromycin	4.89	0.96	15.73	0.028	3	30	177546	8686760	1798	dirithromycin	pain	0	0	53.9	1	0	3	8469	188481	1798	dirithromycin	pain	23	79	0	0	Inf	1	0	0	1088	36017	1798	dirithromycin	pain	0	0	Inf	1	0	0	364	15317	1798	dirithromycin	pain	0	0	Inf	1	0	0	857	26590	1798	dirithromycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1799	cefepime	1.33	1.16	1.53	7.9e-05	213	7831	177336	8678959	1799	cefepime	prophylaxis	0.36	0.1	0.94	0.031	4	884	1275	102667	1799	cefepime	prophylaxis	23.9	79.7	0.56	0.01	3.2	1	1	203	206	23457	1799	cefepime	prophylaxis	1.16	0.03	6.73	0.58	1	145	81	13583	1799	cefepime	prophylaxis	1.69	0.2	6.35	0.34	2	116	146	14296	1799	cefepime	prophylaxis	0.32	1.37712776433596	0.59	0.58	-0.01	0	0.03	-0.52	0.14	0
1800	dactinomycin	0	0	0.12	3.3e-13	0	1454	177549	8685336	1800	dactinomycin	rhabdomyosarcoma	0	0	5.04	0.24	0	302	2	284	1800	dactinomycin	rhabdomyosarcoma	5	5	0	0	Inf	1	0	0	0	0	1800	dactinomycin	rhabdomyosarcoma	0	0	Inf	1	0	1	0	41	1800	dactinomycin	rhabdomyosarcoma	0	0	97.35	1	0	8	1	19	1800	dactinomycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1801	tazobactam sodium	2.31	2.06	2.59	3.1e-37	308	6519	177241	8680271	1801	tazobactam sodium	prophylaxis	0	0	0.61	0.0057	0	491	1279	103060	1801	tazobactam sodium	prophylaxis	23.9	79.7	0	0	3.41	0.63	0	126	207	23534	1801	tazobactam sodium	prophylaxis	0	0	6.96	1	0	92	82	13636	1801	tazobactam sodium	prophylaxis	0	0	5.01	1	0	74	148	14338	1801	tazobactam sodium	prophylaxis	-12.74	2.93148921368913e-06	305.33	0.97	-0.01	0	0.02	-0.52	0.14	0
1802	ceftibuten dihydrate	0.84	0.23	2.18	1	4	233	177545	8686557	1802	ceftibuten dihydrate	urinary tract infection	0	0	3.4	0.63	0	30	749	19404	1802	ceftibuten dihydrate	urinary tract infection	22.2	73.2	0	0	25.75	1	0	4	183	3094	1802	ceftibuten dihydrate	urinary tract infection	0	0	99.11	1	0	3	31	1237	1802	ceftibuten dihydrate	urinary tract infection	0	0	31.78	1	0	4	174	3632	1802	ceftibuten dihydrate	urinary tract infection	-11.73	8.04869976061602e-06	311.28	0.97	-0.03	0	0	-0.39	0.2	0.05
1803	rifabutin	0.73	0.44	1.14	0.2	19	1276	177530	8685514	1803	rifabutin	hiv infection	2	0.79	4.19	0.096	7	412	493	57979	1803	rifabutin	hiv infection	25	64	1.45	0.04	8.67	0.51	1	44	119	7597	1803	rifabutin	hiv infection	1.36	0.03	8.16	0.53	1	44	95	5684	1803	rifabutin	hiv infection	0	0	45	1	0	9	40	3430	1803	rifabutin	hiv infection	0.17	1.18530485132037	1.01	0.86	0	0.01	0.8	0.38	0.2	0.05
1804	mupirocin calcium	3.49	3.12	3.9	2.9e-79	342	4800	177207	8681990	1804	mupirocin calcium	pain	1.7	1.17	2.41	0.005	35	458	8434	188026	1804	mupirocin calcium	pain	23	79	1.48	0.58	3.13	0.34	7	157	1081	35860	1804	mupirocin calcium	pain	1.33	0.27	4.04	0.5	3	95	361	15222	1804	mupirocin calcium	pain	1.87	0.59	4.57	0.2	5	83	852	26507	1804	mupirocin calcium	pain	0.5	1.64872127070013	0.36	0.17	-0.02	0	0	-0.29	0.06	0
1805	daunorubicin citrate	0	0	1.68	0.29	0	109	177549	8686681	1805	daunorubicin citrate	acute myeloid leukaemia	0	0	38.09	1	0	48	31	13961	1805	daunorubicin citrate	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	0	0	820	1805	daunorubicin citrate	acute myeloid leukaemia	0	0	9168.63	1	0	5	1	1371	1805	daunorubicin citrate	acute myeloid leukaemia	0	0	4160.19	1	0	2	2	1124	1805	daunorubicin citrate	acute myeloid leukaemia	-11.81	7.42988631618285e-06	2438.55	1	0	0.03	0.89	-0.88	1.23	0.47
1806	pyrazinamide	0.24	0.15	0.37	1.3e-16	21	4229	177528	8682561	1806	pyrazinamide	tuberculosis	0.81	0.34	1.82	0.71	11	1758	18	2330	1806	pyrazinamide	tuberculosis	23.8	59	0.98	0.14	5.84	1	3	291	4	380	1806	pyrazinamide	tuberculosis	0.26	0.01	2.63	0.37	1	307	4	317	1806	pyrazinamide	tuberculosis	1.28	0.09	17.81	1	2	223	2	286	1806	pyrazinamide	tuberculosis	-0.59	0.554327284734507	0.71	0.41	-0.01	0.02	0.51	0.1	0.68	0.88
1807	meropenem	0.31	0.24	0.39	3.3e-32	68	10717	177481	8676073	1807	meropenem	prophylaxis	0.45	0.17	0.99	0.049	6	1066	1273	102485	1807	meropenem	prophylaxis	23.9	79.7	1.13	0.14	4.2	0.7	2	202	205	23458	1807	meropenem	prophylaxis	0	0	4.05	1	0	156	82	13572	1807	meropenem	prophylaxis	4.59	1.44	11.28	0.0061	5	109	143	14303	1807	meropenem	prophylaxis	0.84	2.31636697678109	0.46	0.07	-0.01	0	0.03	-0.53	0.14	0
1808	tacrolimus	0.44	0.4	0.48	1.7e-100	501	55993	177048	8630797	1808	tacrolimus	renal transplant	1.51	0.96	2.39	0.063	48	10157	36	11482	1808	tacrolimus	renal transplant	34	58.8	6.1	0.81	270.96	0.087	8	950	1	725	1808	tacrolimus	renal transplant	Inf	0.54	Inf	0.13	4	1254	0	1027	1808	tacrolimus	renal transplant	0.87	0.16	4.71	1	4	804	4	702	1808	tacrolimus	renal transplant	0.49	1.63231621995538	0.62	0.43	-0.01	0.02	0.55	-1.1	0.61	0.07
1809	fosfomycin tromethamine	0	0	0.92	0.037	0	197	177549	8686593	1809	fosfomycin tromethamine	urinary tract infection	0	0	1.11	0.081	0	88	749	19346	1809	fosfomycin tromethamine	urinary tract infection	22.2	73.2	0	0	2.58	0.4	0	26	183	3072	1809	fosfomycin tromethamine	urinary tract infection	0	0	1522.9	1	0	1	31	1239	1809	fosfomycin tromethamine	urinary tract infection	0	0	2.32	0.41	0	35	174	3601	1809	fosfomycin tromethamine	urinary tract infection	-13.52	1.34381227763152e-06	389.3	0.97	-0.03	0	0	-0.4	0.2	0.05
1810	bismuth subsalicylate	3.72	2.65	5.09	4.8e-12	42	553	177507	8686237	1810	bismuth subsalicylate	gastrooesophageal reflux disease	3.25	1.25	7.15	0.0087	7	56	2961	76972	1810	bismuth subsalicylate	gastrooesophageal reflux disease	22.4	77.2	0	0	1490	1	0	1	478	18696	1810	bismuth subsalicylate	gastrooesophageal reflux disease	0	0	2008.86	1	0	1	152	8082	1810	bismuth subsalicylate	gastrooesophageal reflux disease	0	0	1443.48	1	0	1	380	14388	1810	bismuth subsalicylate	gastrooesophageal reflux disease	-9.18	0.000103080533149705	228.64	0.97	-0.02	0	0	-0.35	0.1	0
1811	mycophenolate mofetil	0.49	0.44	0.54	1.3e-62	431	43096	177118	8643694	1811	mycophenolate mofetil	renal transplant	0.92	0.57	1.47	0.82	31	8391	53	13248	1811	mycophenolate mofetil	renal transplant	34	58.8	0.23	0.01	1.73	0.17	1	589	8	1086	1811	mycophenolate mofetil	renal transplant	0	0	2.59	0.3	0	843	4	1438	1811	mycophenolate mofetil	renal transplant	1.14	0.18	5.87	1	3	520	5	986	1811	mycophenolate mofetil	renal transplant	-0.53	0.588604969678355	0.67	0.43	-0.01	0.02	0.43	-1.08	0.61	0.08
1812	cefdinir	3.18	2.78	3.61	8.7e-52	251	3871	177298	8682919	1812	cefdinir	pain	5.29	3.65	7.51	2.2e-15	40	169	8429	188315	1812	cefdinir	pain	23	79	2.29	0.26	9.05	0.23	2	29	1086	35988	1812	cefdinir	pain	0	0	12.73	1	0	14	364	15303	1812	cefdinir	pain	4.91	0.93	16.73	0.03	3	19	854	26571	1812	cefdinir	pain	1.12	3.064854203293	0.61	0.06	-0.02	0	0	-0.28	0.06	0
1813	ivermectin	0.08	0.02	0.21	4e-16	4	2397	177545	8684393	1813	ivermectin	acarodermatitis	0.12	0	1.47	0.057	1	480	3	168	1813	ivermectin	acarodermatitis	46.8	46.8	0	0	Inf	1	0	0	0	0	1813	ivermectin	acarodermatitis	0	0	Inf	1	0	26	0	28	1813	ivermectin	acarodermatitis	Inf	0.03	Inf	0.48	1	28	0	31	1813	ivermectin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1814	quinupristin	0	0	1.04	0.055	0	175	177549	8686615	1814	quinupristin	enterococcal infection	0	0	29.81	1	0	38	4	728	1814	quinupristin	enterococcal infection	72	72	0	0	Inf	1	0	0	0	0	1814	quinupristin	enterococcal infection	0	0	349.09	1	0	8	1	71	1814	quinupristin	enterococcal infection	0	0	Inf	1	0	0	0	55	1814	quinupristin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1815	dalfopristin	0	0	1.04	0.055	0	176	177549	8686614	1815	dalfopristin	enterococcal infection	0	0	29.81	1	0	38	4	728	1815	dalfopristin	enterococcal infection	72	72	0	0	Inf	1	0	0	0	0	1815	dalfopristin	enterococcal infection	0	0	349.09	1	0	8	1	71	1815	dalfopristin	enterococcal infection	0	0	Inf	1	0	0	0	55	1815	dalfopristin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1816	azithromycin dihydrate	0.98	0.02	5.71	1	1	50	177548	8686740	1816	azithromycin dihydrate	hiv infection	0	0	38.44	1	0	13	500	58378	1816	azithromycin dihydrate	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	1816	azithromycin dihydrate	hiv infection	0	0	Inf	1	0	0	96	5728	1816	azithromycin dihydrate	hiv infection	0	0	Inf	1	0	0	40	3439	1816	azithromycin dihydrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1817	epirubicin	0.29	0.22	0.36	1.5e-39	71	12164	177478	8674626	1817	epirubicin	breast cancer	0.14	0.08	0.22	2.1e-32	18	5585	1428	61197	1817	epirubicin	breast cancer	40	78	0.62	0.16	1.63	0.53	4	509	123	9638	1817	epirubicin	breast cancer	0	0	Inf	1	0	6	0	110	1817	epirubicin	breast cancer	0.56	0.15	1.49	0.33	4	567	140	11209	1817	epirubicin	breast cancer	-0.58	0.559898366565402	0.51	0.25	0	0.01	0.71	-13.16	367	0.97
1818	bismuth subcitrate potassium	1.7	0.81	3.17	0.097	10	288	177539	8686502	1818	bismuth subcitrate potassium	helicobacter infection	2.24	0.85	5.05	0.08	7	136	57	2485	1818	bismuth subcitrate potassium	helicobacter infection	29	65	0.93	0.1	4.42	1	2	59	11	301	1818	bismuth subcitrate potassium	helicobacter infection	0	0	3.25	0.62	0	29	10	199	1818	bismuth subcitrate potassium	helicobacter infection	1.8	0.18	9.09	0.35	2	45	9	365	1818	bismuth subcitrate potassium	helicobacter infection	-0.2	0.818730753077982	0.76	0.79	0.01	0.01	0.49	0.49	0.44	0.27
1819	mycophenolic acid	0.38	0.29	0.48	6.3e-20	64	8283	177485	8678507	1819	mycophenolic acid	renal transplant	1.09	0.58	1.92	0.77	15	3603	69	18036	1819	mycophenolic acid	renal transplant	34	58.8	1.62	0.26	7.63	0.45	3	395	6	1280	1819	mycophenolic acid	renal transplant	9.64	0.77	505.3	0.044	3	541	1	1740	1819	mycophenolic acid	renal transplant	0	0	2.18	0.22	0	321	8	1185	1819	mycophenolic acid	renal transplant	0.16	1.17351087099181	0.67	0.81	-0.01	0.02	0.47	-1.09	0.61	0.07
1820	azacitidine	0.18	0.13	0.25	4.7e-48	38	10369	177511	8676421	1820	azacitidine	myelodysplastic syndrome	0.94	0.47	1.72	1	13	4236	66	20198	1820	azacitidine	myelodysplastic syndrome	54.7	84.3	0.87	0.2	3.13	1	4	1367	9	2679	1820	azacitidine	myelodysplastic syndrome	0.84	0.08	5.85	1	2	1025	4	1716	1820	azacitidine	myelodysplastic syndrome	1.14	0.11	6.39	1	2	508	6	1734	1820	azacitidine	myelodysplastic syndrome	-0.17	0.843664816596384	0.6	0.77	-0.03	0.02	0.03	-0.5	0.55	0.36
1821	penicillin v	6.11	5.14	7.21	1.9e-66	159	1275	177390	8685515	1821	penicillin v	pain	2.41	1.07	4.81	0.018	9	83	8460	188401	1821	penicillin v	pain	23	79	2.21	0.05	14.37	0.38	1	15	1087	36002	1821	penicillin v	pain	0	0	16.82	1	0	11	364	15306	1821	penicillin v	pain	3.1	0.07	21.87	0.29	1	10	856	26580	1821	penicillin v	pain	0.24	1.2712491503214	1.03	0.82	-0.02	0	0	-0.28	0.06	0
1822	penicillin v potassium	19.28	17.01	21.81	4.4e-289	356	905	177193	8685885	1822	penicillin v potassium	pain	15.82	10.91	22.8	4.7e-38	53	75	8416	188409	1822	penicillin v potassium	pain	23	79	2.55	0.06	16.99	0.34	1	13	1087	36004	1822	penicillin v potassium	pain	0	0	21.4	1	0	9	364	15308	1822	penicillin v potassium	pain	2.82	0.07	19.46	0.32	1	11	856	26579	1822	penicillin v potassium	pain	0.23	1.25860000992948	1.03	0.83	-0.02	0	0	-0.28	0.06	0
1823	streptomycin	0.34	0.11	0.79	0.0076	5	728	177544	8686062	1823	streptomycin	tuberculosis	2.46	0.47	8.14	0.14	3	183	26	3905	1823	streptomycin	tuberculosis	23.8	59	9.46	0.86	61.19	0.032	2	27	5	644	1823	streptomycin	tuberculosis	0	0	22.47	1	0	30	5	594	1823	streptomycin	tuberculosis	28.18	1.94	408.36	0.0075	2	17	2	492	1823	streptomycin	tuberculosis	1.83	6.23388665852472	0.84	0.03	0	0.02	0.79	-0.01	0.68	0.99
1824	erythromycin stearate	0.65	0.08	2.4	0.77	2	150	177547	8686640	1824	erythromycin stearate	rheumatoid arthritis	0	0	147.64	1	0	5	3410	460372	1824	erythromycin stearate	rheumatoid arthritis	33	75	0	0	3934.41	1	0	1	1060	113937	1824	erythromycin stearate	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	1824	erythromycin stearate	rheumatoid arthritis	0	0	3910.38	1	0	1	1011	107963	1824	erythromycin stearate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1825	gramicidin	3.12	2.46	3.92	3.7e-17	79	1238	177470	8685552	1825	gramicidin	pain	5.2	2.68	9.42	2.9e-06	14	60	8455	188424	1825	gramicidin	pain	23	79	2.76	0.06	18.68	0.32	1	12	1087	36005	1825	gramicidin	pain	0	0	102.2	1	0	3	364	15314	1825	gramicidin	pain	3.45	0.08	24.95	0.27	1	9	856	26581	1825	gramicidin	pain	1.08	2.94467955106552	1.05	0.3	-0.02	0	0	-0.28	0.06	0
1826	kanamycin	6.18	4.48	8.36	1.7e-21	48	380	177501	8686410	1826	kanamycin	tuberculosis	4.44	0.5	18.3	0.084	2	67	27	4021	1826	kanamycin	tuberculosis	23.8	59	0	0	21.76	1	0	22	7	649	1826	kanamycin	tuberculosis	0	0	67.49	1	0	11	5	613	1826	kanamycin	tuberculosis	0	0	33.46	1	0	23	4	486	1826	kanamycin	tuberculosis	-13.8	1.01563147100249e-06	1116.88	0.99	-0.01	0.02	0.53	0.05	0.68	0.94
1827	paromomycin	2.39	0.64	6.35	0.095	4	82	177545	8686708	1827	paromomycin	hiv infection	0	0	23.72	1	0	20	500	58371	1827	paromomycin	hiv infection	25	64	0	0	2390.6	1	0	1	120	7640	1827	paromomycin	hiv infection	0	0	2245.39	1	0	1	96	5727	1827	paromomycin	hiv infection	0	0	3186.15	1	0	1	40	3438	1827	paromomycin	hiv infection	-9.28	9.32711234649488e-05	377.97	0.98	0	0.01	0.81	0.38	0.2	0.05
1828	cycloserine	1.05	0.52	1.89	0.88	11	514	177538	8686276	1828	cycloserine	tuberculosis	3.55	1.17	9.06	0.013	6	280	23	3808	1828	cycloserine	tuberculosis	23.8	59	3.12	0.29	19.49	0.19	2	76	5	595	1828	cycloserine	tuberculosis	0	0	8.01	1	0	76	5	548	1828	cycloserine	tuberculosis	11	0.78	155.59	0.039	2	42	2	467	1828	cycloserine	tuberculosis	0.83	2.29331874026418	0.82	0.32	-0.01	0.02	0.65	0.02	0.68	0.97
1829	oxytetracycline calcium	0.8	0.1	2.96	1	2	122	177547	8686668	1829	oxytetracycline calcium	prophylaxis	0	0	32.29	1	0	11	1279	103540	1829	oxytetracycline calcium	prophylaxis	23.9	79.7	0	0	174.45	1	0	4	207	23656	1829	oxytetracycline calcium	prophylaxis	0	0	5924.82	1	0	1	82	13727	1829	oxytetracycline calcium	prophylaxis	0	0	235.52	1	0	3	148	14409	1829	oxytetracycline calcium	prophylaxis	-8.8	0.000150733075095477	267.23	0.97	-0.01	0	0.03	-0.52	0.14	0
1830	methacycline	0	0	118.34	1	0	3	177549	8686787	1830	methacycline	acne	0	0	37	1	0	2	4376	30402	1830	methacycline	acne	14.8	44.4	0	0	Inf	1	0	0	173	2824	1830	methacycline	acne	0	0	Inf	1	0	0	28	1131	1830	methacycline	acne	0	0	Inf	1	0	0	164	2394	1830	methacycline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1831	penicillin g sodium	0	0	2.9	0.64	0	64	177549	8686726	1831	penicillin g sodium	erysipelas	0	0	6921.74	1	0	4	1	795	1831	penicillin g sodium	erysipelas	NA	NA	0	0	Inf	1	0	0	0	0	1831	penicillin g sodium	erysipelas	0	0	Inf	1	0	0	0	81	1831	penicillin g sodium	erysipelas	0	0	Inf	1	0	0	0	100	1831	penicillin g sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1832	viomycin	0	0	260.7	1	0	2	177549	8686788	1832	viomycin	asthma	0	0	1260.69	1	0	1	3044	100373	1832	viomycin	asthma	9	76	0	0	1240.54	1	0	1	540	17515	1832	viomycin	asthma	0	0	1618.33	1	0	1	147	6257	1832	viomycin	asthma	0	0	Inf	1	0	0	458	14562	1832	viomycin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1834	candicidin	0	0	118.34	1	0	3	177549	8686787	1834	candicidin	non-hodgkin s lymphoma	0	0	924.11	1	0	3	32	11833	1834	candicidin	non-hodgkin s lymphoma	50.2	86.8	0	0	Inf	1	0	0	4	1484	1834	candicidin	non-hodgkin s lymphoma	0	0	Inf	1	0	0	3	1065	1834	candicidin	non-hodgkin s lymphoma	0	0	Inf	1	0	0	3	829	1834	candicidin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1835	clindamycin palmitate	8.41	7.44	9.48	1.8e-164	315	1835	177234	8684955	1835	clindamycin palmitate	acne	0.62	0.36	1.01	0.052	18	200	4358	30204	1835	clindamycin palmitate	acne	14.8	44.4	1.49	0.03	10.34	0.51	1	11	172	2813	1835	clindamycin palmitate	acne	0	0	100.33	1	0	3	28	1128	1835	clindamycin palmitate	acne	1.33	0.03	9.25	0.55	1	11	163	2383	1835	clindamycin palmitate	acne	0.19	1.20924959765725	1.04	0.86	0	0.01	0.66	-1.03	0.21	0
1837	griseofulvin, microsize	5.25	3.22	8.17	1.8e-09	22	205	177527	8686585	1837	griseofulvin, microsize	hiv infection	0	0	68.58	1	0	8	500	58383	1837	griseofulvin, microsize	hiv infection	25	64	0	0	97.14	1	0	4	120	7637	1837	griseofulvin, microsize	hiv infection	0	0	145.24	1	0	3	96	5725	1837	griseofulvin, microsize	hiv infection	0	0	3186.15	1	0	1	40	3438	1837	griseofulvin, microsize	hiv infection	-10.42	2.98298794702676e-05	440.69	0.98	0	0.01	0.8	0.38	0.2	0.05
1838	cefuroxime	2.43	2.16	2.72	5e-42	317	6392	177232	8680398	1838	cefuroxime	hypertension	2.91	1.82	4.44	1.3e-05	23	365	6872	317248	1838	cefuroxime	hypertension	38	82.9	0	0	3.44	0.63	0	70	981	62339	1838	cefuroxime	hypertension	0	0	10.36	1	0	35	341	31604	1838	cefuroxime	hypertension	0	0	4.28	1	0	47	762	39883	1838	cefuroxime	hypertension	-11.42	1.09737993897335e-05	158.26	0.94	-0.02	0	0	-0.59	0.07	0
1839	desmethyl piroxicam	2.75	2.35	3.21	9.9e-30	175	3114	177374	8683676	1839	desmethyl piroxicam	rheumatoid arthritis	1.1	0.3	2.84	0.79	4	491	3406	459886	1839	desmethyl piroxicam	rheumatoid arthritis	33	75	3.65	0.43	13.81	0.11	2	59	1058	113879	1839	desmethyl piroxicam	rheumatoid arthritis	0	0	28.82	1	0	20	180	25371	1839	desmethyl piroxicam	rheumatoid arthritis	4.86	0.57	18.68	0.068	2	44	1009	107920	1839	desmethyl piroxicam	rheumatoid arthritis	1.27	3.56085256235552	0.72	0.08	-0.01	0	0	-0.26	0.08	0
1840	sterile water	0.2	0.06	0.52	4.7e-05	4	964	177545	8685826	1840	sterile water	parenteral nutrition	0	0	9.47	1	0	103	4	636	1840	sterile water	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	1840	sterile water	parenteral nutrition	0	0	Inf	1	0	6	0	58	1840	sterile water	parenteral nutrition	0	0	Inf	1	0	19	0	59	1840	sterile water	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1841	testosterone propionate	0.82	0.1	3.01	1	2	120	177547	8686670	1841	testosterone propionate	muscle building therapy	0	0	410.75	1	0	10	1	105	1841	testosterone propionate	muscle building therapy	NA	NA	0	0	Inf	1	0	0	0	0	1841	testosterone propionate	muscle building therapy	0	0	Inf	1	0	4	0	37	1841	testosterone propionate	muscle building therapy	0	0	Inf	1	0	0	0	2	1841	testosterone propionate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1842	sodium succinate	0.51	0.38	0.66	3.1e-08	55	5300	177494	8681490	1842	sodium succinate	prophylaxis	0.83	0.38	1.59	0.76	9	875	1270	102676	1842	sodium succinate	prophylaxis	23.9	79.7	2.75	0.55	8.32	0.1	3	126	204	23534	1842	sodium succinate	prophylaxis	0	0	6.88	1	0	93	82	13635	1842	sodium succinate	prophylaxis	3.29	0.66	10.12	0.069	3	90	145	14322	1842	sodium succinate	prophylaxis	0.61	1.84043139878164	0.59	0.3	-0.01	0	0.03	-0.52	0.14	0
1843	pramoxine	2.17	1.25	3.51	0.0038	17	384	177532	8686406	1843	pramoxine	pain	1.04	0.12	3.97	0.72	2	43	8467	188441	1843	pramoxine	pain	23	79	0	0	9.24	1	0	15	1088	36002	1843	pramoxine	pain	0	0	29.29	1	0	7	364	15310	1843	pramoxine	pain	0	0	13.86	1	0	10	857	26580	1843	pramoxine	pain	-9.95	4.7727633936802e-05	128.97	0.94	-0.02	0	0	-0.28	0.06	0
1844	pentobarbital sodium	0.6	0.07	2.19	0.78	2	164	177547	8686626	1844	pentobarbital sodium	sedation	0	0	2.29	0.41	0	79	114	5366	1844	pentobarbital sodium	sedation	9.5	66	0	0	Inf	1	0	0	18	618	1844	pentobarbital sodium	sedation	0	0	Inf	1	0	0	7	537	1844	pentobarbital sodium	sedation	0	0	Inf	1	0	0	14	432	1844	pentobarbital sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1845	pentobarbital	0.37	0.08	1.08	0.074	3	400	177546	8686390	1845	pentobarbital	status epilepticus	0	0	27.68	1	0	71	5	1772	1845	pentobarbital	status epilepticus	73.8	73.8	0	0	Inf	1	0	0	0	0	1845	pentobarbital	status epilepticus	0	0	Inf	1	0	8	0	197	1845	pentobarbital	status epilepticus	0	0	595.03	1	0	15	1	230	1845	pentobarbital	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1847	gentian violet	6.99	1.33	23.41	0.012	3	21	177546	8686769	1847	gentian violet	ear infection	0	0	47.83	1	0	4	92	2874	1847	gentian violet	ear infection	15	56	0	0	Inf	1	0	0	18	216	1847	gentian violet	ear infection	0	0	Inf	1	0	0	4	235	1847	gentian violet	ear infection	0	0	Inf	1	0	0	17	319	1847	gentian violet	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1848	amphetamine adipate	48.93	0.62	3699.96	0.04	1	1	177548	8686789	1848	amphetamine adipate		0	0	Inf	1	0	0	0	0	1848	amphetamine adipate		NA	NA	0	0	Inf	1	0	0	0	0	1848	amphetamine adipate		0	0	Inf	1	0	0	0	0	1848	amphetamine adipate		0	0	Inf	1	0	0	0	0	1848	amphetamine adipate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1850	digitoxin	0.22	0.11	0.41	7.8e-10	10	2208	177539	8684582	1850	digitoxin	hypertension	0	0	0.24	5.5e-07	0	704	6895	316909	1850	digitoxin	hypertension	38	82.9	0	0	5.32	1	0	46	981	62363	1850	digitoxin	hypertension	0	0	9.5	1	0	38	341	31601	1850	digitoxin	hypertension	0	0	10.63	1	0	20	762	39910	1850	digitoxin	hypertension	-9.95	4.7727633936802e-05	115.18	0.93	-0.02	0	0	-0.59	0.07	0
1851	benoxinate	0	0	2.5	0.41	0	74	177549	8686716	1851	benoxinate	surgery	0	0	2.44	0.4	0	28	225	3865	1851	benoxinate	surgery	28.9	72	0	0	Inf	1	0	0	7	507	1851	benoxinate	surgery	0	0	Inf	1	0	0	3	355	1851	benoxinate	surgery	0	0	Inf	1	0	0	7	357	1851	benoxinate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1852	benzyl benzoate	4.35	1.14	11.93	0.017	4	45	177545	8686745	1852	benzyl benzoate	acarodermatitis	0	0	42.94	1	0	23	4	625	1852	benzyl benzoate	acarodermatitis	46.8	46.8	0	0	Inf	1	0	0	0	0	1852	benzyl benzoate	acarodermatitis	0	0	Inf	1	0	0	0	54	1852	benzyl benzoate	acarodermatitis	0	0	2221.18	1	0	1	1	58	1852	benzyl benzoate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1854	tetrahydrozoline	1.83	0.37	5.56	0.23	3	80	177546	8686710	1854	tetrahydrozoline	colorectal cancer	0	0	199.68	1	0	6	54	12429	1854	tetrahydrozoline	colorectal cancer	40.9	75	0	0	Inf	1	0	0	7	1121	1854	tetrahydrozoline	colorectal cancer	0	0	Inf	1	0	0	5	813	1854	tetrahydrozoline	colorectal cancer	0	0	Inf	1	0	0	4	582	1854	tetrahydrozoline	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1855	dexchlorpheniramine maleate	0.32	0.22	0.45	3.1e-15	34	5122	177515	8681668	1855	dexchlorpheniramine maleate	premedication	0.38	0.17	0.73	0.0015	9	1304	488	27058	1855	dexchlorpheniramine maleate	premedication	13.8	73.2	0.51	0.14	1.36	0.25	4	298	139	5303	1855	dexchlorpheniramine maleate	premedication	0.88	0.17	2.81	1	3	225	39	2582	1855	dexchlorpheniramine maleate	premedication	0.57	0.11	1.74	0.49	3	176	114	3815	1855	dexchlorpheniramine maleate	premedication	-0.34	0.71177032276261	0.42	0.42	0	0	0.38	-0.67	0.18	0
1856	pemetrexed sodium	0.26	0.18	0.36	5e-23	33	6275	177516	8680515	1856	pemetrexed sodium	non-small cell lung cancer	0.82	0.43	1.45	0.59	13	3056	160	30871	1856	pemetrexed sodium	non-small cell lung cancer	43.2	79.8	2.34	0.27	9.56	0.23	2	184	24	5174	1856	pemetrexed sodium	non-small cell lung cancer	4.88	0.53	21.98	0.077	2	103	13	3270	1856	pemetrexed sodium	non-small cell lung cancer	0	0	8.19	1	0	95	15	2745	1856	pemetrexed sodium	non-small cell lung cancer	0.77	2.15976625378492	0.74	0.3	-0.01	0.01	0.35	-0.15	0.37	0.68
1857	asparaginase	0.28	0.19	0.39	3.7e-19	31	5486	177518	8681304	1857	asparaginase	acute lymphocytic leukaemia	0.48	0.21	0.97	0.034	9	2850	61	9233	1857	asparaginase	acute lymphocytic leukaemia	6.4	64.6	0	0	3.04	0.63	0	228	11	1726	1857	asparaginase	acute lymphocytic leukaemia	0	0	2.95	0.38	0	180	11	1322	1857	asparaginase	acute lymphocytic leukaemia	0	0	35.86	1	0	161	2	1080	1857	asparaginase	acute lymphocytic leukaemia	-15.4	2.05052457561193e-07	935.49	0.99	-0.01	0.01	0.53	1.49	0.77	0.05
1858	collagenase	0.7	0.28	1.45	0.42	7	489	177542	8686301	1858	collagenase	dupuytren s contracture	0	0	14.63	1	0	87	3	520	1858	collagenase	dupuytren s contracture	NA	NA	0	0	Inf	1	0	0	0	0	1858	collagenase	dupuytren s contracture	0	0	Inf	1	0	3	0	91	1858	collagenase	dupuytren s contracture	0	0	Inf	1	0	3	0	34	1858	collagenase	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1859	onabotulinumtoxina	0.87	0.79	0.95	0.002	480	27006	177069	8659784	1859	onabotulinumtoxina	skin wrinkling	0.21	0.15	0.29	4.8e-18	224	18030	54	906	1859	onabotulinumtoxina	skin wrinkling	31	58.8	0.58	0.25	1.56	0.2	48	1405	7	119	1859	onabotulinumtoxina	skin wrinkling	0.18	0.01	11.18	0.24	2	116	1	10	1859	onabotulinumtoxina	skin wrinkling	0.47	0.23	1.05	0.036	52	1789	10	160	1859	onabotulinumtoxina	skin wrinkling	-0.9	0.406569659740599	0.34	0.01	-0.02	0.01	0.01	-0.3	0.6	0.61
1860	interferon alfa-2b	1.35	1.12	1.62	0.0016	121	4371	177428	8682419	1860	interferon alfa-2b	hepatitis c	1.05	0.75	1.43	0.75	42	1463	2489	91303	1860	interferon alfa-2b	hepatitis c	32.8	65	0	0	3.33	0.63	0	36	557	17133	1860	interferon alfa-2b	hepatitis c	0	0	5.62	1	0	27	321	12264	1860	interferon alfa-2b	hepatitis c	0	0	9.64	1	0	14	306	9733	1860	interferon alfa-2b	hepatitis c	-12.08	5.67182285902797e-06	226.27	0.96	-0.02	0	0	-0.17	0.08	0.04
1861	interferon alfa-n3	0	0	24.79	1	0	9	177549	8686781	1861	interferon alfa-n3	osteoporosis	0	0	691.14	1	0	1	8802	157685	1861	interferon alfa-n3	osteoporosis	53.1	85	0	0	Inf	1	0	0	808	24568	1861	interferon alfa-n3	osteoporosis	0	0	Inf	1	0	0	31	2935	1861	interferon alfa-n3	osteoporosis	0	0	Inf	1	0	0	868	26887	1861	interferon alfa-n3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1862	alteplase	1.29	1.1	1.51	0.0022	162	6154	177387	8680636	1862	alteplase	ischaemic stroke	0.15	0	1.35	0.091	1	1326	5	1001	1862	alteplase	ischaemic stroke	21	52.3	0	0	Inf	1	0	25	0	38	1862	alteplase	ischaemic stroke	0	0	9.13	0.53	0	115	2	195	1862	alteplase	ischaemic stroke	0	0	Inf	1	0	108	0	161	1862	alteplase	ischaemic stroke	-17.9	1.68317306967376e-08	4382.98	1	-0.09	0.03	0.01	18.21	4019.79	1
1863	epoetin alfa	1.93	1.53	2.41	8.7e-08	82	2078	177467	8684712	1863	epoetin alfa	hypertension	2.07	0.93	4.02	0.047	9	200	6886	317413	1863	epoetin alfa	hypertension	38	82.9	1.45	0.04	8.51	0.5	1	44	980	62365	1863	epoetin alfa	hypertension	0	0	9.24	1	0	39	341	31600	1863	epoetin alfa	hypertension	2.91	0.07	18.5	0.3	1	18	761	39912	1863	epoetin alfa	hypertension	0.05	1.05127109637602	1.01	0.96	-0.02	0	0	-0.59	0.07	0
1864	aldesleukin	0.35	0.14	0.72	0.0019	7	982	177542	8685808	1864	aldesleukin	renal cell carcinoma stage unspecified	0	0	4.14	1	0	172	22	3861	1864	aldesleukin	renal cell carcinoma stage unspecified	NA	NA	0	0	Inf	1	0	0	0	0	1864	aldesleukin	renal cell carcinoma stage unspecified	0	0	Inf	1	0	0	0	0	1864	aldesleukin	renal cell carcinoma stage unspecified	0	0	Inf	1	0	0	0	0	1864	aldesleukin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1865	filgrastim	1.48	1.37	1.61	1.4e-19	611	20156	176938	8666634	1865	filgrastim	diffuse large b-cell lymphoma	1.9	0.35	6.93	0.41	3	1024	13	8430	1865	filgrastim	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	94	0	1120	1865	filgrastim	diffuse large b-cell lymphoma	0	0	51.22	1	0	119	2	1139	1865	filgrastim	diffuse large b-cell lymphoma	0	0	Inf	1	0	72	0	965	1865	filgrastim	diffuse large b-cell lymphoma	-16.6	6.17606133558036e-08	5366.32	1	-0.01	0.04	0.73	17.13	2433.21	0.99
1866	sargramostim	1.44	1.07	1.9	0.014	51	1733	177498	8685057	1866	sargramostim	malignant melanoma	1.9	0.22	7.32	0.29	2	296	48	13514	1866	sargramostim	malignant melanoma	38.5	88	0	0	169.46	1	0	9	14	4227	1866	sargramostim	malignant melanoma	0	0	364.19	1	0	5	9	2650	1866	sargramostim	malignant melanoma	0	0	368.56	1	0	5	7	2007	1866	sargramostim	malignant melanoma	-11.94	6.52414922649937e-06	1249.41	0.99	0.01	0.02	0.56	-0.05	0.51	0.92
1867	pegaspargase	0.72	0.48	1.03	0.071	30	2043	177519	8684747	1867	pegaspargase	acute lymphocytic leukaemia	1.89	0.78	3.97	0.088	8	773	62	11310	1867	pegaspargase	acute lymphocytic leukaemia	6.4	64.6	1.19	0.03	8.43	0.59	1	152	10	1802	1867	pegaspargase	acute lymphocytic leukaemia	2.73	0.28	13.42	0.2	2	113	9	1389	1867	pegaspargase	acute lymphocytic leukaemia	0	0	67.63	1	0	91	2	1150	1867	pegaspargase	acute lymphocytic leukaemia	0.78	2.1814722654982	0.79	0.32	0	0.01	0.88	1.51	0.77	0.05
1868	interferon beta-1b	0.79	0.71	0.87	3e-06	368	22845	177181	8663945	1868	interferon beta-1b	multiple sclerosis	0.98	0.85	1.11	0.77	238	12548	8107	417809	1868	interferon beta-1b	multiple sclerosis	26.5	67	0.84	0.58	1.18	0.34	35	1847	1269	56195	1868	interferon beta-1b	multiple sclerosis	1.2	0.54	2.34	0.57	9	451	226	13598	1868	interferon beta-1b	multiple sclerosis	0.74	0.5	1.07	0.12	30	1701	1188	50148	1868	interferon beta-1b	multiple sclerosis	-0.18	0.835270211411272	0.16	0.26	-0.01	0	0	-0.34	0.07	0
1869	dornase alfa	0.34	0.23	0.5	4.3e-11	27	3857	177522	8682933	1869	dornase alfa	cystic fibrosis	1.44	0.8	2.54	0.19	21	2873	36	7100	1869	dornase alfa	cystic fibrosis	14.3	57.2	0.62	0.15	1.99	0.61	4	1062	14	2317	1869	dornase alfa	cystic fibrosis	0.79	0.07	4.81	1	2	696	5	1366	1869	dornase alfa	cystic fibrosis	0.99	0.22	3.56	1	4	752	9	1673	1869	dornase alfa	cystic fibrosis	0	1	0.49	0.99	0.02	0.01	0.06	-0.45	0.47	0.34
1870	abciximab	0.41	0.27	0.59	5.5e-08	28	3356	177521	8683434	1870	abciximab	acute myocardial infarction	0.41	0.1	1.15	0.11	4	1361	32	4413	1870	abciximab	acute myocardial infarction	39.2	72.8	0	0	26.85	1	0	22	6	657	1870	abciximab	acute myocardial infarction	0	0	28.12	1	0	21	6	655	1870	abciximab	acute myocardial infarction	0	0	330.75	1	0	6	2	342	1870	abciximab	acute myocardial infarction	-15.5	1.85539136261598e-07	1841.81	0.99	-0.07	0.02	0	0.43	0.83	0.6
1871	capromab pendetide	0	0	41.55	1	0	6	177549	8686784	1871	capromab pendetide	prostate cancer	0	0	544.91	1	0	2	444	45749	1871	capromab pendetide	prostate cancer	56.9	87.4	0	0	4547.83	1	0	1	102	12803	1871	capromab pendetide	prostate cancer	0	0	4655.58	1	0	1	114	14675	1871	capromab pendetide	prostate cancer	0	0	Inf	1	0	0	0	51	1871	capromab pendetide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1872	interferon beta-1a	1.2	1.16	1.23	2.4e-31	4656	191146	172893	8495644	1872	interferon beta-1a	multiple sclerosis	1.61	1.54	1.68	6.6e-102	4262	169358	4083	260999	1872	interferon beta-1a	multiple sclerosis	26.5	67	1.6	1.41	1.81	4.5e-13	365	11362	939	46680	1872	interferon beta-1a	multiple sclerosis	1.82	1.35	2.44	8.3e-05	68	2563	167	11486	1872	interferon beta-1a	multiple sclerosis	1.57	1.39	1.79	4.9e-12	359	10876	859	40973	1872	interferon beta-1a	multiple sclerosis	0.51	1.66529119494589	0.06	0	-0.01	0	0	-0.33	0.07	0
1874	becaplermin	0.51	0.26	0.92	0.021	11	1049	177538	8685741	1874	becaplermin	wound	0	0	0.68	0.012	0	439	9	585	1874	becaplermin	wound	36.2	91	0	0	2.51	0.1	0	252	2	117	1874	becaplermin	wound	0	0	Inf	1	0	162	0	73	1874	becaplermin	wound	0	0	1.04	0.028	0	104	4	69	1874	becaplermin	wound	-19.6	3.07487987958661e-09	4351.08	1	0.01	0.03	0.69	-19.22	4526.31	1
1875	rituximab	0.3	0.27	0.33	4.2e-173	345	56862	177204	8629928	1875	rituximab	diffuse large b-cell lymphoma	1.19	0.38	4.35	1	11	6144	5	3310	1875	rituximab	diffuse large b-cell lymphoma	48.5	71.8	0	0	Inf	1	0	554	0	660	1875	rituximab	diffuse large b-cell lymphoma	Inf	0.2	Inf	0.23	2	609	0	649	1875	rituximab	diffuse large b-cell lymphoma	0	0	Inf	1	0	509	0	528	1875	rituximab	diffuse large b-cell lymphoma	18.08	71128595.4304069	3523.73	1	-0.01	0.04	0.75	17.95	3701.9	1
1876	basiliximab	0.06	0.02	0.13	5.1e-34	6	4854	177543	8681936	1876	basiliximab	renal transplant	0.53	0.17	1.3	0.21	5	2295	79	19344	1876	basiliximab	renal transplant	34	58.8	4.49	0.88	21.02	0.036	4	253	5	1422	1876	basiliximab	renal transplant	Inf	3.93	Inf	0.00043	4	326	0	1955	1876	basiliximab	renal transplant	0	0	5.08	1	0	157	8	1349	1876	basiliximab	renal transplant	1.3	3.66929666761924	0.62	0.04	-0.01	0.02	0.62	-1.18	0.62	0.06
1877	denileukin diftitox	0	0	0.62	0.0053	0	291	177549	8686499	1877	denileukin diftitox	peripheral t-cell lymphoma unspecified	0	0	431.89	1	0	67	1	746	1877	denileukin diftitox	peripheral t-cell lymphoma unspecified	60.1	60.1	0	0	Inf	1	0	0	0	0	1877	denileukin diftitox	peripheral t-cell lymphoma unspecified	0	0	Inf	1	0	0	0	86	1877	denileukin diftitox	peripheral t-cell lymphoma unspecified	0	0	Inf	1	0	0	1	64	1877	denileukin diftitox	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1878	palivizumab	0.04	0.01	0.09	1.2e-54	6	7322	177543	8679468	1878	palivizumab	antiviral prophylaxis	0.07	0	0.44	0.00027	1	2345	37	6496	1878	palivizumab	antiviral prophylaxis	13.5	75	0	0	Inf	1	0	0	12	1403	1878	palivizumab	antiviral prophylaxis	0	0	2.82	0.36	0	210	8	1001	1878	palivizumab	antiviral prophylaxis	0	0	2.84	0.36	0	171	8	820	1878	palivizumab	antiviral prophylaxis	-16.47	7.03347394611271e-08	907.85	0.99	-0.01	0.01	0.29	-0.19	0.5	0.7
1879	infliximab	0.37	0.34	0.39	1.3e-292	946	125214	176603	8561576	1879	infliximab	rheumatoid arthritis	0.82	0.71	0.94	0.0032	221	36026	3189	424351	1879	infliximab	rheumatoid arthritis	33	75	1.34	0.9	1.92	0.11	31	2508	1029	111430	1879	infliximab	rheumatoid arthritis	1.6	0.68	3.24	0.18	8	717	172	24674	1879	infliximab	rheumatoid arthritis	1.21	0.79	1.77	0.33	27	2403	984	105561	1879	infliximab	rheumatoid arthritis	0.25	1.28402541668774	0.17	0.15	-0.01	0	0	-0.26	0.08	0
1880	reteplase	0.32	0.13	0.67	0.00061	7	1061	177542	8685729	1880	reteplase	acute myocardial infarction	0.3	0.04	1.19	0.11	2	937	34	4837	1880	reteplase	acute myocardial infarction	39.2	72.8	0	0	4128.84	1	0	1	6	678	1880	reteplase	acute myocardial infarction	0	0	309.26	1	0	3	6	673	1880	reteplase	acute myocardial infarction	0	0	Inf	1	0	0	2	348	1880	reteplase	acute myocardial infarction	-11.74	7.96861385989486e-06	1299.66	0.99	-0.06	0.02	0	0.37	0.83	0.65
1881	trastuzumab	1.37	1.27	1.47	2.3e-15	727	26041	176822	8660749	1881	trastuzumab	breast cancer	0.93	0.81	1.08	0.36	238	11624	1208	55158	1881	trastuzumab	breast cancer	40	78	0.87	0.5	1.43	0.63	19	1707	108	8440	1881	trastuzumab	breast cancer	0	0	Inf	1	0	16	0	100	1881	trastuzumab	breast cancer	0.91	0.56	1.44	0.82	23	2028	121	9748	1881	trastuzumab	breast cancer	-0.1	0.90483741803596	0.23	0.66	0	0.01	0.74	-13.16	367.28	0.97
1882	etanercept	0.3	0.29	0.31	0	2413	385224	175136	8301566	1882	etanercept	rheumatoid arthritis	0.73	0.68	0.79	2.1e-18	1260	204300	2150	256077	1882	etanercept	rheumatoid arthritis	33	75	0.82	0.72	0.92	0.0012	505	60029	555	53909	1882	etanercept	rheumatoid arthritis	0.7	0.51	0.95	0.02	76	12994	104	12397	1882	etanercept	rheumatoid arthritis	0.89	0.79	1.01	0.071	498	56298	513	51666	1882	etanercept	rheumatoid arthritis	-0.17	0.843664816596384	0.06	0	-0.01	0	0	-0.26	0.08	0
1883	interferon gamma-1b	0.62	0.35	1.03	0.077	15	1177	177534	8685613	1883	interferon gamma-1b	chronic granulomatous disease	Inf	0.05	Inf	1	2	398	0	106	1883	interferon gamma-1b	chronic granulomatous disease	18	18	0	0	Inf	1	0	0	0	0	1883	interferon gamma-1b	chronic granulomatous disease	Inf	0.02	Inf	1	2	257	0	24	1883	interferon gamma-1b	chronic granulomatous disease	0	0	Inf	1	0	77	0	3	1883	interferon gamma-1b	chronic granulomatous disease	16.47	14217725.2331003	5521.96	1	0.01	0.06	0.85	16.84	3240.63	1
1884	botulinum toxin type b	0.28	0.01	1.61	0.27	1	172	177548	8686618	1884	botulinum toxin type b	torticollis	0	0	6.74	1	0	31	27	1349	1884	botulinum toxin type b	torticollis	43.9	64.7	0	0	Inf	1	0	0	1	97	1884	botulinum toxin type b	torticollis	0	0	Inf	1	0	0	2	53	1884	botulinum toxin type b	torticollis	0	0	Inf	1	0	0	1	151	1884	botulinum toxin type b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1885	tenecteplase	0.25	0.05	0.73	0.0048	3	589	177546	8686201	1885	tenecteplase	acute myocardial infarction	0.83	0.02	4.97	1	1	193	35	5581	1885	tenecteplase	acute myocardial infarction	39.2	72.8	0	0	149.07	1	0	5	6	674	1885	tenecteplase	acute myocardial infarction	0	0	200.54	1	0	4	6	672	1885	tenecteplase	acute myocardial infarction	0	0	1227.53	1	0	2	2	346	1885	tenecteplase	acute myocardial infarction	-12.86	2.5999976936368e-06	1576.82	0.99	-0.06	0.02	0	0.37	0.83	0.66
1886	rasburicase	0.59	0.26	1.18	0.17	8	659	177541	8686131	1886	rasburicase	prophylaxis	3.25	1.17	7.26	0.013	6	150	1273	103401	1886	rasburicase	prophylaxis	23.9	79.7	0	0	7.69	1	0	57	207	23603	1886	rasburicase	prophylaxis	0	0	14.56	1	0	45	82	13683	1886	rasburicase	prophylaxis	10.37	1.16	43.63	0.019	2	19	146	14393	1886	rasburicase	prophylaxis	1.5	4.48168907033806	0.72	0.04	-0.01	0	0.02	-0.53	0.14	0
1887	alemtuzumab	0.39	0.3	0.49	8.7e-20	68	8551	177481	8678239	1887	alemtuzumab	multiple sclerosis	0.91	0.64	1.25	0.64	39	2214	8306	428143	1887	alemtuzumab	multiple sclerosis	26.5	67	1.32	0.9	1.88	0.13	33	1118	1271	56924	1887	alemtuzumab	multiple sclerosis	0.47	0.09	1.39	0.22	3	380	232	13669	1887	alemtuzumab	multiple sclerosis	1.54	1.03	2.21	0.024	31	865	1187	50984	1887	alemtuzumab	multiple sclerosis	0.17	1.18530485132037	0.18	0.32	-0.01	0	0	-0.35	0.07	0
1888	peginterferon alfa-2b	0.75	0.66	0.85	3.6e-06	245	15978	177304	8670812	1888	peginterferon alfa-2b	hepatitis c	0.9	0.78	1.05	0.18	203	8165	2328	84601	1888	peginterferon alfa-2b	hepatitis c	32.8	65	0.55	0.23	1.1	0.1	8	443	549	16726	1888	peginterferon alfa-2b	hepatitis c	0.57	0.18	1.37	0.29	5	330	316	11961	1888	peginterferon alfa-2b	hepatitis c	0.56	0.15	1.47	0.33	4	225	302	9522	1888	peginterferon alfa-2b	hepatitis c	-0.66	0.516851334491699	0.34	0.05	-0.02	0	0	-0.17	0.08	0.04
1889	anakinra	0.13	0.05	0.26	6.5e-16	7	2725	177542	8684065	1889	anakinra	rheumatoid arthritis	0.49	0.13	1.27	0.21	4	1090	3406	459287	1889	anakinra	rheumatoid arthritis	33	75	0	0	2.54	0.41	0	158	1060	113780	1889	anakinra	rheumatoid arthritis	0	0	22.62	1	0	25	180	25366	1889	anakinra	rheumatoid arthritis	0	0	2.4	0.41	0	166	1011	107798	1889	anakinra	rheumatoid arthritis	-10.87	1.9020370909727e-05	105.09	0.92	-0.01	0	0	-0.26	0.08	0
1890	darbepoetin alfa	1.62	1.53	1.72	9.3e-52	1180	35713	176369	8651077	1890	darbepoetin alfa	nephrogenic anaemia	0.29	0.1	0.76	0.0069	7	5548	15	3442	1890	darbepoetin alfa	nephrogenic anaemia	44.2	82.2	0	0	1.12	0.032	0	1513	3	700	1890	darbepoetin alfa	nephrogenic anaemia	0	0	13.81	0.26	0	1542	1	545	1890	darbepoetin alfa	nephrogenic anaemia	0	0	0.54	0.0048	0	1243	4	442	1890	darbepoetin alfa	nephrogenic anaemia	-18.97	5.7734269918789e-09	2395.37	0.99	-0.02	0.02	0.35	-1.64	1.12	0.14
1891	peginterferon alfa-2a	1.26	1.19	1.32	3.7e-17	1516	59181	176033	8627609	1891	peginterferon alfa-2a	hepatitis c	1.05	0.97	1.14	0.26	1065	37986	1466	54780	1891	peginterferon alfa-2a	hepatitis c	32.8	65	1.38	1.14	1.65	0.00061	182	4475	375	12694	1891	peginterferon alfa-2a	hepatitis c	1.64	1.28	2.1	1e-04	98	2595	223	9696	1891	peginterferon alfa-2a	hepatitis c	1.42	1.11	1.82	0.0054	102	2532	204	7215	1891	peginterferon alfa-2a	hepatitis c	0.3	1.349858807576	0.09	0	-0.02	0	0	-0.16	0.08	0.06
1892	omalizumab	0.86	0.78	0.95	0.0016	441	25052	177108	8661738	1892	omalizumab	asthma	0.63	0.56	0.7	9.3e-19	377	18462	2667	81912	1892	omalizumab	asthma	9	76	1.52	1.26	1.83	1e-05	179	4306	361	13210	1892	omalizumab	asthma	1.43	0.99	2.06	0.053	47	1546	100	4712	1892	omalizumab	asthma	1.62	1.31	2	6.5e-06	136	3007	322	11555	1892	omalizumab	asthma	0.38	1.46228458943422	0.09	0	-0.02	0	0	-0.41	0.1	0
1893	agalsidase beta	0.6	0.47	0.76	7.8e-06	69	5598	177480	8681192	1893	agalsidase beta	fabry s disease	Inf	0.29	Inf	0.63	66	5216	0	89	1893	agalsidase beta	fabry s disease	11.2	56	Inf	0.03	Inf	1	18	944	0	7	1893	agalsidase beta	fabry s disease	Inf	0.02	Inf	1	17	786	0	5	1893	agalsidase beta	fabry s disease	Inf	0.02	Inf	1	9	505	0	6	1893	agalsidase beta	fabry s disease	13.69	882046.451762945	1163.52	0.99	-0.03	0.01	0.01	0.03	0.42	0.95
1894	ibritumomab tiuxetan	0.14	0.05	0.34	1.2e-09	5	1698	177544	8685092	1894	ibritumomab tiuxetan	b-cell lymphoma	0	0	6.32	1	0	325	16	7877	1894	ibritumomab tiuxetan	b-cell lymphoma	45.8	63.5	0	0	43.13	1	0	12	7	667	1894	ibritumomab tiuxetan	b-cell lymphoma	0	0	80.71	1	0	22	4	1122	1894	ibritumomab tiuxetan	b-cell lymphoma	0	0	87.65	1	0	13	5	959	1894	ibritumomab tiuxetan	b-cell lymphoma	-13.06	2.12869806971227e-06	1098.1	0.99	-0.03	0.02	0.15	-0.42	0.67	0.53
1895	pegfilgrastim	1.12	1.02	1.22	0.017	506	22197	177043	8664593	1895	pegfilgrastim	breast cancer	1.56	1.22	1.97	0.00032	78	2352	1368	64430	1895	pegfilgrastim	breast cancer	40	78	1.09	0.35	2.64	0.81	5	368	122	9779	1895	pegfilgrastim	breast cancer	0	0	Inf	1	0	2	0	114	1895	pegfilgrastim	breast cancer	1.01	0.32	2.44	0.82	5	404	139	11372	1895	pegfilgrastim	breast cancer	0.01	1.01005016708417	0.46	0.99	0	0.01	0.79	-13.16	367.31	0.97
1896	adalimumab	0.42	0.41	0.44	0	3277	370359	174272	8316431	1896	adalimumab	rheumatoid arthritis	0.91	0.85	0.99	0.023	896	129087	2514	331290	1896	adalimumab	rheumatoid arthritis	33	75	1.31	1.14	1.5	0.00013	302	26600	758	87338	1896	adalimumab	rheumatoid arthritis	1.43	1.01	1.99	0.037	51	5511	129	19880	1896	adalimumab	rheumatoid arthritis	1.3	1.13	1.49	0.00024	285	25047	726	82917	1896	adalimumab	rheumatoid arthritis	0.26	1.29693008666577	0.06	0	-0.01	0	0	-0.26	0.08	0
1897	laronidase	0.25	0.12	0.49	3.2e-07	9	1727	177540	8685063	1897	laronidase	mucopolysaccharidosis i	Inf	0.01	Inf	1	7	1369	0	15	1897	laronidase	mucopolysaccharidosis i	12.2	16.8	0	0	Inf	1	0	31	0	1	1897	laronidase	mucopolysaccharidosis i	0	0	Inf	1	0	147	0	1	1897	laronidase	mucopolysaccharidosis i	Inf	0	Inf	1	2	161	0	1	1897	laronidase	mucopolysaccharidosis i	17.35	34277509.5904021	30951.55	1	-0.01	0.06	0.8	-18.24	3951.73	1
1898	cetuximab	0.18	0.14	0.22	1.2e-116	93	25494	177456	8661296	1898	cetuximab	non-small cell lung cancer	0.33	0.11	0.79	0.0076	5	2787	168	31140	1898	cetuximab	non-small cell lung cancer	43.2	79.8	0	0	30.83	1	0	28	26	5330	1898	cetuximab	non-small cell lung cancer	0	0	64.56	1	0	16	15	3357	1898	cetuximab	non-small cell lung cancer	0	0	68.57	1	0	13	15	2827	1898	cetuximab	non-small cell lung cancer	-12.24	4.83320862143726e-06	733.54	0.99	-0.01	0.01	0.35	-0.15	0.37	0.67
1899	bevacizumab	0.54	0.5	0.58	3.2e-84	809	73366	176740	8613424	1899	bevacizumab	colorectal cancer metastatic	0.12	0.03	0.33	1.6e-07	4	5414	43	6928	1899	bevacizumab	colorectal cancer metastatic	38.8	74.6	0	0	0.49	0.0021	0	510	21	1304	1899	bevacizumab	colorectal cancer metastatic	0	0	0.83	0.028	0	360	14	983	1899	bevacizumab	colorectal cancer metastatic	0	0	0.91	0.041	0	288	11	653	1899	bevacizumab	colorectal cancer metastatic	-17.34	2.94668480631682e-08	1142.91	0.99	-0.02	0.01	0.12	-0.08	0.41	0.84
1900	palifermin	0.1	0	0.53	0.00072	1	513	177548	8686277	1900	palifermin	mucosal inflammation	0	0	19.55	1	0	231	2	845	1900	palifermin	mucosal inflammation	47.6	47.6	0	0	Inf	1	0	0	0	0	1900	palifermin	mucosal inflammation	0	0	4157.26	1	0	1	1	113	1900	palifermin	mucosal inflammation	0	0	Inf	1	0	0	0	124	1900	palifermin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1901	natalizumab	0.73	0.7	0.76	2.2e-59	2494	166206	175055	8520584	1901	natalizumab	multiple sclerosis	0.71	0.68	0.74	6e-47	2397	155951	5948	274406	1901	natalizumab	multiple sclerosis	26.5	67	0.7	0.59	0.83	2.4e-05	153	9259	1151	48783	1901	natalizumab	multiple sclerosis	0.6	0.38	0.91	0.014	26	2406	209	11643	1901	natalizumab	multiple sclerosis	0.71	0.59	0.85	0.00011	136	7820	1082	44029	1901	natalizumab	multiple sclerosis	-0.41	0.663650250136319	0.08	0	-0.01	0	0	-0.34	0.07	0
1902	galsulfase	0.24	0.11	0.46	9.8e-08	9	1823	177540	8684967	1902	galsulfase	mucopolysaccharidosis vi	Inf	0	Inf	1	3	1566	0	6	1902	galsulfase	mucopolysaccharidosis vi	11.2	11.2	0	0	Inf	1	0	0	0	0	1902	galsulfase	mucopolysaccharidosis vi	Inf	0	Inf	1	1	165	0	2	1902	galsulfase	mucopolysaccharidosis vi	0	0	Inf	1	0	170	0	2	1902	galsulfase	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1903	abatacept	0.26	0.22	0.31	3.8e-96	152	28088	177397	8658702	1903	abatacept	rheumatoid arthritis	0.77	0.63	0.94	0.009	105	18153	3305	442224	1903	abatacept	rheumatoid arthritis	33	75	0.93	0.66	1.27	0.7	41	4743	1019	109195	1903	abatacept	rheumatoid arthritis	0.67	0.21	1.6	0.57	5	1037	175	24354	1903	abatacept	rheumatoid arthritis	0.94	0.68	1.29	0.82	42	4737	969	103227	1903	abatacept	rheumatoid arthritis	-0.07	0.932393819905948	0.15	0.63	-0.01	0	0	-0.26	0.08	0
1904	alglucosidase alfa	0.54	0.37	0.75	0.00012	34	3087	177515	8683703	1904	alglucosidase alfa	glycogen storage disease type ii	Inf	0.05	Inf	1	34	2900	0	19	1904	alglucosidase alfa	glycogen storage disease type ii	5	71	Inf	0	Inf	1	10	384	0	1	1904	alglucosidase alfa	glycogen storage disease type ii	0	0	Inf	1	2	277	0	0	1904	alglucosidase alfa	glycogen storage disease type ii	Inf	0	Inf	1	13	310	0	1	1904	alglucosidase alfa	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1905	panitumumab	0.29	0.22	0.38	3.4e-27	50	8406	177499	8678384	1905	panitumumab	colorectal cancer	0.31	0.11	0.73	0.0036	6	3554	48	8881	1905	panitumumab	colorectal cancer	40.9	75	0	0	3.34	0.61	0	194	7	927	1905	panitumumab	colorectal cancer	1.53	0.03	15.66	0.53	1	114	4	699	1905	panitumumab	colorectal cancer	0	0	6.97	1	0	105	4	477	1905	panitumumab	colorectal cancer	-0.48	0.618783391806141	1.07	0.65	-0.03	0.02	0.21	-0.05	0.68	0.94
1906	idursulfase	0.34	0.18	0.6	1.5e-05	12	1715	177537	8685075	1906	idursulfase	mucopolysaccharidosis ii	Inf	0	Inf	1	9	1555	0	5	1906	idursulfase	mucopolysaccharidosis ii	5.7	26.1	0	0	Inf	1	4	325	0	0	1906	idursulfase	mucopolysaccharidosis ii	0	0	Inf	1	6	444	0	0	1906	idursulfase	mucopolysaccharidosis ii	0	0	Inf	1	0	6	0	0	1906	idursulfase	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1907	ranibizumab	0.19	0.15	0.23	3.1e-94	81	21154	177468	8665636	1907	ranibizumab	age-related macular degeneration	0.65	0.34	1.26	0.18	29	4850	17	1849	1907	ranibizumab	age-related macular degeneration	50.4	78.8	0.52	0.04	7.21	0.61	2	340	2	176	1907	ranibizumab	age-related macular degeneration	0	0	18.19	0.32	0	358	1	166	1907	ranibizumab	age-related macular degeneration	0.39	0.03	3.48	0.37	2	367	3	217	1907	ranibizumab	age-related macular degeneration	-1.54	0.214381101426978	0.93	0.1	-0.07	0.02	0	-1.62	1.11	0.14
1908	certolizumab pegol	0.31	0.27	0.35	1.9e-95	204	32404	177345	8654386	1908	certolizumab pegol	rheumatoid arthritis	0.72	0.56	0.91	0.0051	70	13053	3340	447324	1908	certolizumab pegol	rheumatoid arthritis	33	75	0.73	0.48	1.07	0.11	27	3940	1033	109998	1908	certolizumab pegol	rheumatoid arthritis	0.27	0.03	1.01	0.051	2	999	178	24392	1908	certolizumab pegol	rheumatoid arthritis	0.73	0.48	1.08	0.14	26	3750	985	104214	1908	certolizumab pegol	rheumatoid arthritis	-0.43	0.650509094723317	0.19	0.02	-0.01	0	0	-0.26	0.08	0
1909	methoxy polyethylene glycol-epoetin beta	0.11	0.05	0.19	1.3e-30	11	5097	177538	8681693	1909	methoxy polyethylene glycol-epoetin beta	nephrogenic anaemia	0.28	0.03	1.16	0.087	2	2359	20	6631	1909	methoxy polyethylene glycol-epoetin beta	nephrogenic anaemia	44.2	82.2	0	0	9.38	1	0	455	3	1758	1909	methoxy polyethylene glycol-epoetin beta	nephrogenic anaemia	0	0	195.76	1	0	346	1	1741	1909	methoxy polyethylene glycol-epoetin beta	nephrogenic anaemia	1.6	0.03	19.96	0.53	1	291	3	1394	1909	methoxy polyethylene glycol-epoetin beta	nephrogenic anaemia	-0.13	0.878095430920561	1.13	0.91	-0.04	0.02	0.04	-1.57	1.12	0.16
1910	eculizumab	0.39	0.34	0.44	9.1e-60	214	27016	177335	8659774	1910	eculizumab	paroxysmal nocturnal haemoglobinuria	Inf	0.07	Inf	1	131	15770	0	33	1910	eculizumab	paroxysmal nocturnal haemoglobinuria	27.4	68.4	Inf	0	Inf	1	14	904	0	2	1910	eculizumab	paroxysmal nocturnal haemoglobinuria	Inf	0	Inf	1	1	677	0	2	1910	eculizumab	paroxysmal nocturnal haemoglobinuria	Inf	0	Inf	1	15	767	0	2	1910	eculizumab	paroxysmal nocturnal haemoglobinuria	11.97	157944.660396192	1123.23	0.99	-0.01	0.01	0.56	-2.55	1.04	0.01
1911	rilonacept	0	0	3.16	0.63	0	59	177549	8686731	1911	rilonacept	juvenile idiopathic arthritis	0	0	61.45	1	0	6	107	7670	1911	rilonacept	juvenile idiopathic arthritis	5.9	32.9	0	0	332.33	1	0	2	62	3833	1911	rilonacept	juvenile idiopathic arthritis	0	0	Inf	1	0	0	14	1245	1911	rilonacept	juvenile idiopathic arthritis	0	0	320.52	1	0	2	57	3400	1911	rilonacept	juvenile idiopathic arthritis	-10.48	2.80927225261909e-05	624.19	0.99	0	0.01	0.87	-0.4	0.3	0.18
1912	ustekinumab	0.27	0.22	0.32	8.2e-65	103	18901	177446	8667889	1912	ustekinumab	psoriasis	0.83	0.65	1.03	0.094	84	13611	1106	148080	1912	ustekinumab	psoriasis	25	74.8	0.79	0.52	1.16	0.25	29	4125	350	39400	1912	ustekinumab	psoriasis	0.55	0.26	1.04	0.071	10	2476	139	18868	1912	ustekinumab	psoriasis	0.9	0.54	1.42	0.74	20	2207	254	25136	1912	ustekinumab	psoriasis	-0.3	0.740818220681718	0.19	0.12	0	0	0.69	-0.35	0.1	0
1913	romiplostim	0.15	0.11	0.2	7.8e-73	44	14358	177505	8672432	1913	romiplostim	idiopathic thrombocytopenic purpura	0.54	0.29	1.03	0.047	28	9559	19	3505	1913	romiplostim	idiopathic thrombocytopenic purpura	NA	NA	0	0	Inf	1	0	0	0	0	1913	romiplostim	idiopathic thrombocytopenic purpura	0	0	Inf	1	0	0	0	0	1913	romiplostim	idiopathic thrombocytopenic purpura	0	0	Inf	1	0	0	0	0	1913	romiplostim	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1914	abobotulinumtoxina	2.49	1.84	3.3	1.7e-08	51	1002	177498	8685788	1914	abobotulinumtoxina	skin wrinkling	8.09	5.42	11.79	7e-19	35	331	243	18605	1914	abobotulinumtoxina	skin wrinkling	31	58.8	4.53	1.5	11.47	0.0043	6	40	49	1484	1914	abobotulinumtoxina	skin wrinkling	27.41	0.35	783.99	0.069	1	2	2	124	1914	abobotulinumtoxina	skin wrinkling	6.71	2.75	14.77	3.9e-05	9	48	53	1901	1914	abobotulinumtoxina	skin wrinkling	1.96	7.09932706515663	0.37	0	-0.02	0.01	0.01	-0.27	0.6	0.65
1915	tocilizumab	0.43	0.36	0.49	6.5e-39	176	20209	177373	8666581	1915	tocilizumab	rheumatoid arthritis	1.33	1.12	1.56	0.00083	159	16374	3251	444003	1915	tocilizumab	rheumatoid arthritis	33	75	2.6	2.11	3.19	1.5e-16	107	4714	953	109224	1915	tocilizumab	rheumatoid arthritis	2.41	1.39	3.95	0.0014	18	1120	162	24271	1915	tocilizumab	rheumatoid arthritis	2.49	2	3.08	2e-14	99	4504	912	103460	1915	tocilizumab	rheumatoid arthritis	0.91	2.48432253338482	0.1	0	-0.01	0	0	-0.26	0.08	0
1916	ecallantide	0.91	0.57	1.36	0.76	23	1243	177526	8685547	1916	ecallantide	hereditary angioedema	2.21	1.2	4.04	0.0068	23	1188	26	2962	1916	ecallantide	hereditary angioedema	19.7	61.8	1.05	0.17	4.94	1	3	426	6	894	1916	ecallantide	hereditary angioedema	0	0	Inf	1	0	87	0	242	1916	ecallantide	hereditary angioedema	0.71	0.12	2.99	0.76	3	455	8	864	1916	ecallantide	hereditary angioedema	-0.36	0.697676326071031	0.68	0.6	0.01	0.02	0.71	-16.83	1607.63	0.99
1917	belatacept	0	0	0.12	3.4e-13	0	1457	177549	8685333	1917	belatacept	renal transplant	0	0	1.12	0.079	0	833	84	20806	1917	belatacept	renal transplant	34	58.8	0	0	11.86	1	0	70	9	1605	1917	belatacept	renal transplant	0	0	26.57	1	0	124	4	2157	1917	belatacept	renal transplant	0	0	11.07	1	0	77	8	1429	1917	belatacept	renal transplant	-14.75	3.92786354548104e-07	1226.52	0.99	-0.01	0.02	0.51	-1.09	0.61	0.08
1918	golimumab	0.25	0.2	0.3	1.8e-75	104	20625	177445	8666165	1918	golimumab	rheumatoid arthritis	0.46	0.32	0.64	1.6e-07	37	10669	3373	449708	1918	golimumab	rheumatoid arthritis	33	75	0.53	0.31	0.86	0.0062	17	3392	1043	110546	1918	golimumab	rheumatoid arthritis	0	0	0.82	0.025	0	627	180	24764	1918	golimumab	rheumatoid arthritis	0.53	0.3	0.85	0.0062	17	3401	994	104563	1918	golimumab	rheumatoid arthritis	-0.79	0.453844795282356	0.24	0	-0.01	0	0	-0.26	0.08	0
1919	pegloticase	0.17	0.02	0.61	0.001	2	584	177547	8686206	1919	pegloticase	gout	0.28	0.03	1.03	0.051	2	417	247	14411	1919	pegloticase	gout	41	78.7	0	0	3.76	0.63	0	74	46	3252	1919	pegloticase	gout	0	0	4.58	1	0	77	34	3004	1919	pegloticase	gout	0	0	29.48	1	0	13	17	1393	1919	pegloticase	gout	-14.22	6.67317428126274e-07	685.65	0.98	-0.01	0.01	0.05	-0.14	0.3	0.64
1920	tbo-filgrastim	0	0	1.44	0.19	0	127	177549	8686663	1920	tbo-filgrastim	neutropenia	0	0	27.45	1	0	29	25	4722	1920	tbo-filgrastim	neutropenia	45.2	79.5	0	0	98.58	1	0	14	5	1168	1920	tbo-filgrastim	neutropenia	0	0	330.36	1	0	6	3	719	1920	tbo-filgrastim	neutropenia	0	0	95.86	1	0	14	4	828	1920	tbo-filgrastim	neutropenia	-13.18	1.88798582162818e-06	1457.97	0.99	0	0.02	0.9	-0.15	0.77	0.84
1921	canakinumab	0.31	0.18	0.52	8.4e-08	15	2336	177534	8684454	1921	canakinumab	juvenile idiopathic arthritis	0.18	0	1.06	0.065	1	373	106	7303	1921	canakinumab	juvenile idiopathic arthritis	5.9	32.9	0	0	1.55	0.17	0	148	62	3687	1921	canakinumab	juvenile idiopathic arthritis	0	0	5.35	1	0	68	14	1177	1921	canakinumab	juvenile idiopathic arthritis	0	0	1.92	0.26	0	116	57	3286	1921	canakinumab	juvenile idiopathic arthritis	-14.4	5.5739036926946e-07	479.88	0.98	0	0.01	0.79	-0.38	0.3	0.2
1922	denosumab	0.38	0.35	0.41	2.6e-143	494	63658	177055	8623132	1922	denosumab	osteoporosis postmenopausal	0.57	0.42	0.78	0.00041	175	14857	61	2964	1922	denosumab	osteoporosis postmenopausal	57.3	87.7	0.24	0.11	0.58	0.00093	39	4080	9	228	1922	denosumab	osteoporosis postmenopausal	0	0	Inf	1	0	20	0	1	1922	denosumab	osteoporosis postmenopausal	0.23	0.12	0.5	0.00018	43	4900	11	288	1922	denosumab	osteoporosis postmenopausal	-1.44	0.236927758682122	0.35	0	-0.01	0.01	0.67	-11.94	516.92	0.98
1923	ofatumumab	0.18	0.09	0.33	3.7e-14	11	2926	177538	8683864	1923	ofatumumab	chronic lymphocytic leukaemia	0.54	0.11	1.64	0.37	3	1636	69	20223	1923	ofatumumab	chronic lymphocytic leukaemia	50.7	85	0.38	0.01	2.29	0.51	1	601	30	6841	1923	ofatumumab	chronic lymphocytic leukaemia	0.47	0.01	2.9	0.72	1	438	24	4949	1923	ofatumumab	chronic lymphocytic leukaemia	0	0	5.91	1	0	212	10	2787	1923	ofatumumab	chronic lymphocytic leukaemia	-1.02	0.360594940173078	1.02	0.32	-0.02	0.01	0.21	0.32	0.38	0.4
1924	glucarpidase	0	0	2.43	0.41	0	76	177549	8686714	1924	glucarpidase	toxicity to various agents	0	0	22.18	1	0	44	3	395	1924	glucarpidase	toxicity to various agents	41	41	0	0	Inf	1	0	0	0	0	1924	glucarpidase	toxicity to various agents	0	0	Inf	1	0	8	0	49	1924	glucarpidase	toxicity to various agents	0	0	481.08	1	0	7	1	86	1924	glucarpidase	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1925	collagenase clostridium histolyticum	0.12	0.02	0.34	5.3e-08	3	1259	177546	8685531	1925	collagenase clostridium histolyticum	peyronie s disease	0	0	2.83	0.068	0	635	1	45	1925	collagenase clostridium histolyticum	peyronie s disease	62	62	0	0	Inf	1	0	0	0	0	1925	collagenase clostridium histolyticum	peyronie s disease	0	0	1.1	0.028	0	353	1	9	1925	collagenase clostridium histolyticum	peyronie s disease	0	0	Inf	1	0	0	0	0	1925	collagenase clostridium histolyticum	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1926	raxibacumab	0	0	260.7	1	0	2	177549	8686788	1926	raxibacumab	bacterial infection	0	0	1175.87	1	0	1	126	3869	1926	raxibacumab	bacterial infection	8.7	68	0	0	Inf	1	0	0	17	436	1926	raxibacumab	bacterial infection	0	0	Inf	1	0	0	6	268	1926	raxibacumab	bacterial infection	0	0	Inf	1	0	0	16	389	1926	raxibacumab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1927	asparaginase erwinia chrysanthemi	0.56	0.07	2.05	0.59	2	175	177547	8686615	1927	asparaginase erwinia chrysanthemi	acute lymphocytic leukaemia	0	0	8.75	1	0	76	70	12007	1927	asparaginase erwinia chrysanthemi	acute lymphocytic leukaemia	6.4	64.6	0	0	56.94	1	0	15	11	1939	1927	asparaginase erwinia chrysanthemi	acute lymphocytic leukaemia	0	0	69.24	1	0	10	11	1492	1927	asparaginase erwinia chrysanthemi	acute lymphocytic leukaemia	0	0	680.03	1	0	10	2	1231	1927	asparaginase erwinia chrysanthemi	acute lymphocytic leukaemia	-13.18	1.88798582162818e-06	1420.27	0.99	0	0.01	0.75	1.51	0.77	0.05
1928	incobotulinumtoxina	0.53	0.21	1.1	0.093	7	648	177542	8686142	1928	incobotulinumtoxina	skin wrinkling	0.56	0.01	3.21	1	1	121	277	18815	1928	incobotulinumtoxina	skin wrinkling	31	58.8	0.99	0.02	6.22	1	1	28	54	1496	1928	incobotulinumtoxina	skin wrinkling	0	0	92.32	1	0	4	3	122	1928	incobotulinumtoxina	skin wrinkling	1.09	0.03	6.78	0.61	1	29	61	1920	1928	incobotulinumtoxina	skin wrinkling	0.06	1.06183654654536	1.02	0.95	-0.02	0.01	0.01	-0.31	0.6	0.6
1929	belimumab	1.32	1.1	1.56	0.0026	133	4945	177416	8681845	1929	belimumab	systemic lupus erythematosus	1.56	1.22	1.99	0.00032	120	4060	168	8853	1929	belimumab	systemic lupus erythematosus	31	67	2.41	1.26	4.74	0.0048	27	981	17	1488	1929	belimumab	systemic lupus erythematosus	Inf	0.07	Inf	0.27	1	81	0	221	1929	belimumab	systemic lupus erythematosus	2.11	1.16	3.9	0.012	28	1189	22	1975	1929	belimumab	systemic lupus erythematosus	0.85	2.33964685192599	0.29	0	0.02	0.01	0.11	-1.51	1.01	0.14
1930	ipilimumab	0.12	0.08	0.17	2.1e-63	27	11194	177522	8675596	1930	ipilimumab	malignant melanoma	0.41	0.17	0.89	0.021	8	4349	42	9461	1930	ipilimumab	malignant melanoma	38.5	88	0.4	0.04	1.81	0.38	2	1240	12	2996	1930	ipilimumab	malignant melanoma	0	0	1.14	0.065	0	821	9	1834	1930	ipilimumab	malignant melanoma	1.09	0.1	6.7	1	2	539	5	1473	1930	ipilimumab	malignant melanoma	-1.04	0.35345468195878	0.76	0.17	0.01	0.02	0.63	-0.02	0.51	0.97
1931	aflibercept	0.2	0.13	0.29	1.8e-29	27	6650	177522	8680140	1931	aflibercept	colorectal cancer metastatic	1.03	0.12	3.96	0.72	2	511	45	11831	1931	aflibercept	colorectal cancer metastatic	38.8	74.6	0	0	1.85	0.25	0	172	21	1642	1931	aflibercept	colorectal cancer metastatic	1.53	0.16	6.98	0.64	2	132	12	1211	1931	aflibercept	colorectal cancer metastatic	0	0	4.38	0.61	0	80	11	861	1931	aflibercept	colorectal cancer metastatic	-0.16	0.852143788966211	0.74	0.83	-0.02	0.01	0.08	-0.03	0.41	0.93
1932	brentuximab vedotin	0.18	0.08	0.36	9.5e-11	8	2161	177541	8684629	1932	brentuximab vedotin	hodgkin s disease	1.44	0.5	3.76	0.46	7	1159	15	3576	1932	brentuximab vedotin	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	36	0	89	1932	brentuximab vedotin	hodgkin s disease	0	0	Inf	1	0	113	0	405	1932	brentuximab vedotin	hodgkin s disease	2.69	0.03	211.78	0.47	1	111	1	299	1932	brentuximab vedotin	hodgkin s disease	1.04	2.82921701435156	1.42	0.47	-0.02	0.04	0.66	-18.1	3431.62	1
1933	metreleptin	0	0	0.98	0.058	0	186	177549	8686604	1933	metreleptin	lipodystrophy acquired	0	0	2.65	0.38	0	94	14	811	1933	metreleptin	lipodystrophy acquired	64.4	64.4	0	0	Inf	1	0	0	0	0	1933	metreleptin	lipodystrophy acquired	0	0	233.15	1	0	6	1	35	1933	metreleptin	lipodystrophy acquired	0	0	Inf	1	0	29	0	4	1933	metreleptin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1934	pertuzumab	0.45	0.32	0.61	1.3e-08	40	4344	177509	8682446	1934	pertuzumab	breast cancer	0.35	0.17	0.63	6.3e-05	11	1439	1435	65343	1934	pertuzumab	breast cancer	40	78	0.55	0.15	1.45	0.33	4	568	123	9579	1934	pertuzumab	breast cancer	0	0	Inf	1	0	6	0	110	1934	pertuzumab	breast cancer	0.72	0.26	1.61	0.59	6	673	138	11103	1934	pertuzumab	breast cancer	-0.34	0.71177032276261	0.42	0.41	0	0.01	0.73	-13.16	367.19	0.97
1935	ziv-aflibercept	0.19	0.02	0.68	0.0041	2	519	177547	8686271	1935	ziv-aflibercept	colorectal cancer metastatic	2.95	0.34	11.45	0.16	2	183	45	12159	1935	ziv-aflibercept	colorectal cancer metastatic	38.8	74.6	1.93	0.21	8.17	0.3	2	94	19	1720	1935	ziv-aflibercept	colorectal cancer metastatic	2.78	0.3	12.81	0.19	2	76	12	1267	1935	ziv-aflibercept	colorectal cancer metastatic	0	0	9.59	1	0	39	11	902	1935	ziv-aflibercept	colorectal cancer metastatic	0.59	1.80398841539786	0.75	0.43	-0.03	0.01	0.07	-0.05	0.41	0.91
1936	ocriplasmin	0	0	0.27	2.7e-06	0	674	177549	8686116	1936	ocriplasmin	vitreous adhesions	0	0	Inf	1	0	388	0	6	1936	ocriplasmin	vitreous adhesions	NA	NA	0	0	Inf	1	0	0	0	0	1936	ocriplasmin	vitreous adhesions	0	0	Inf	1	0	40	0	0	1936	ocriplasmin	vitreous adhesions	0	0	Inf	1	0	101	0	0	1936	ocriplasmin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1937	ado-trastuzumab emtansine	0.41	0.22	0.71	0.00038	13	1544	177536	8685246	1937	ado-trastuzumab emtansine	breast cancer metastatic	0.43	0.15	0.94	0.036	6	502	577	20564	1937	ado-trastuzumab emtansine	breast cancer metastatic	42.7	75	2.33	0.6	6.49	0.11	4	129	48	3601	1937	ado-trastuzumab emtansine	breast cancer metastatic	0	0	Inf	1	0	3	0	44	1937	ado-trastuzumab emtansine	breast cancer metastatic	1.95	0.51	5.39	0.16	4	169	55	4542	1937	ado-trastuzumab emtansine	breast cancer metastatic	0.64	1.89648087930495	0.53	0.22	0	0.01	0.68	-13.21	575.55	0.98
1938	albiglutide	0.08	0.04	0.14	5.7e-48	13	7520	177536	8679270	1938	albiglutide	type 2 diabetes mellitus	0.21	0.1	0.4	1.5e-09	9	4798	1213	136300	1938	albiglutide	type 2 diabetes mellitus	43	80.7	0.21	0.06	0.54	9.7e-05	4	2841	210	31053	1938	albiglutide	type 2 diabetes mellitus	0.15	0	0.87	0.021	1	1312	84	16624	1938	albiglutide	type 2 diabetes mellitus	0.37	0.12	0.88	0.018	5	1798	149	19676	1938	albiglutide	type 2 diabetes mellitus	-1.23	0.292292577680859	0.41	0	0	0	0.52	-0.42	0.14	0
1939	elosulfase alfa	0.3	0.12	0.63	0.00026	7	1123	177542	8685667	1939	elosulfase alfa	mucopolysaccharidosis iv	0.2	0.02	10.05	0.22	4	823	1	41	1939	elosulfase alfa	mucopolysaccharidosis iv	13.3	23.7	0	0	Inf	1	0	156	0	1	1939	elosulfase alfa	mucopolysaccharidosis iv	Inf	0	Inf	1	2	238	0	5	1939	elosulfase alfa	mucopolysaccharidosis iv	0	0	Inf	1	0	285	0	5	1939	elosulfase alfa	mucopolysaccharidosis iv	16.74	18624714.6256544	13835.64	1	0.03	0.06	0.6	17.88	2793.66	0.99
1940	dulaglutide	0.28	0.19	0.4	6.1e-19	32	5558	177517	8681232	1940	dulaglutide	type 2 diabetes mellitus	0.51	0.28	0.85	0.0082	14	3155	1208	137943	1940	dulaglutide	type 2 diabetes mellitus	43	80.7	0.26	0.03	0.96	0.037	2	1178	212	32716	1940	dulaglutide	type 2 diabetes mellitus	0	0	1.37	0.12	0	563	85	17373	1940	dulaglutide	type 2 diabetes mellitus	0.71	0.19	1.85	0.67	4	782	150	20692	1940	dulaglutide	type 2 diabetes mellitus	-0.75	0.472366552741015	0.51	0.14	0	0	0.66	-0.42	0.14	0
1941	vedolizumab	0.29	0.2	0.42	5.9e-16	29	4811	177520	8681979	1941	vedolizumab	crohn s disease	0.69	0.37	1.16	0.18	14	2020	1463	145292	1941	vedolizumab	crohn s disease	15.6	67	0.66	0.32	1.24	0.23	10	1198	396	31496	1941	vedolizumab	crohn s disease	0.19	0	1.06	0.067	1	492	147	13506	1941	vedolizumab	crohn s disease	0.83	0.37	1.6	0.75	9	849	296	23048	1941	vedolizumab	crohn s disease	-0.48	0.618783391806141	0.32	0.14	-0.01	0	0	-0.21	0.1	0.03
1942	ramucirumab	0	0	0.16	4.4e-10	0	1103	177549	8685687	1942	ramucirumab	gastric cancer	0	0	6.09	1	0	330	14	6633	1942	ramucirumab	gastric cancer	NA	NA	0	0	Inf	1	0	0	0	0	1942	ramucirumab	gastric cancer	0	0	Inf	1	0	178	0	744	1942	ramucirumab	gastric cancer	0	0	Inf	1	0	63	0	272	1942	ramucirumab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1943	obinutuzumab	0.12	0.04	0.28	4.9e-12	5	2009	177544	8684781	1943	obinutuzumab	prophylaxis	0	0	0.49	0.0012	0	604	1279	102947	1943	obinutuzumab	prophylaxis	23.9	79.7	0	0	0.88	0.038	0	474	207	23186	1943	obinutuzumab	prophylaxis	0	0	2.03	0.27	0	306	82	13422	1943	obinutuzumab	prophylaxis	0	0	1.61	0.18	0	224	148	14188	1943	obinutuzumab	prophylaxis	-13.67	1.15662994617537e-06	282.02	0.96	-0.01	0	0.03	-0.52	0.14	0
1944	siltuximab	1	0.02	5.83	1	1	49	177548	8686741	1944	siltuximab	plasma cell myeloma	0	0	78.4	1	0	11	534	104904	1944	siltuximab	plasma cell myeloma	47.4	82.5	0	0	1278.28	1	0	2	164	39826	1944	siltuximab	plasma cell myeloma	0	0	Inf	1	0	0	93	24562	1944	siltuximab	plasma cell myeloma	0	0	1286.93	1	0	2	91	20956	1944	siltuximab	plasma cell myeloma	-8.69	0.000168260026221911	378.59	0.98	-0.03	0.01	0	-0.15	0.15	0.31
1945	peginterferon beta-1a	0.83	0.63	1.08	0.2	57	3345	177492	8683445	1945	peginterferon beta-1a	multiple sclerosis	0.85	0.63	1.12	0.29	50	3036	8295	427321	1945	peginterferon beta-1a	multiple sclerosis	26.5	67	0.84	0.55	1.25	0.46	26	1365	1278	56677	1945	peginterferon beta-1a	multiple sclerosis	0.34	0.04	1.27	0.13	2	342	233	13707	1945	peginterferon beta-1a	multiple sclerosis	0.89	0.58	1.32	0.7	26	1234	1192	50615	1945	peginterferon beta-1a	multiple sclerosis	-0.21	0.810584245970187	0.19	0.27	-0.01	0	0	-0.34	0.07	0
1946	secukinumab	0.19	0.13	0.26	2.4e-41	35	9122	177514	8677668	1946	secukinumab	psoriasis	0.5	0.29	0.79	0.0015	18	4842	1172	156849	1946	secukinumab	psoriasis	25	74.8	0.46	0.22	0.86	0.012	10	2410	369	41115	1946	secukinumab	psoriasis	0.48	0.13	1.27	0.2	4	1154	145	20190	1946	secukinumab	psoriasis	0.54	0.23	1.08	0.078	8	1452	266	25891	1946	secukinumab	psoriasis	-0.66	0.516851334491699	0.29	0.02	0	0	0.71	-0.36	0.1	0
1948	parathyroid hormone	0.48	0.13	1.23	0.16	4	409	177545	8686381	1948	parathyroid hormone	hypoparathyroidism	0.36	0.06	1.46	0.15	3	312	9	336	1948	parathyroid hormone	hypoparathyroidism	39.5	60.9	0	0	Inf	1	0	111	0	31	1948	parathyroid hormone	hypoparathyroidism	0	0	Inf	1	0	12	0	25	1948	parathyroid hormone	hypoparathyroidism	Inf	0.05	Inf	1	2	185	0	54	1948	parathyroid hormone	hypoparathyroidism	16.56	15556669.322845	3128.93	1	0	0.05	0.99	-15.66	4224.84	1
1949	asfotase alfa	0.3	0.1	0.7	0.0017	5	818	177544	8685972	1949	asfotase alfa	hypophosphatasia	Inf	0.04	Inf	1	4	522	0	29	1949	asfotase alfa	hypophosphatasia	12	12	0	0	Inf	1	0	0	0	0	1949	asfotase alfa	hypophosphatasia	Inf	0	Inf	1	1	48	0	8	1949	asfotase alfa	hypophosphatasia	0	0	Inf	1	0	74	0	16	1949	asfotase alfa	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1950	pembrolizumab	0.23	0.14	0.35	4.6e-18	20	4342	177529	8682448	1950	pembrolizumab	metastatic malignant melanoma	2.23	0.82	5.22	0.082	7	954	29	8806	1950	pembrolizumab	metastatic malignant melanoma	39.5	75.5	5.76	1.57	23.09	0.0035	7	596	5	2453	1950	pembrolizumab	metastatic malignant melanoma	2.47	0.38	12.77	0.19	3	477	5	1968	1950	pembrolizumab	metastatic malignant melanoma	8.83	1.26	98.02	0.013	4	287	2	1269	1950	pembrolizumab	metastatic malignant melanoma	1.45	4.26311451516882	0.54	0.01	-0.01	0.02	0.71	-0.16	0.54	0.76
1951	dinutuximab	0	0	4.49	1	0	42	177549	8686748	1951	dinutuximab	neuroblastoma	0	0	Inf	1	0	30	0	1097	1951	dinutuximab	neuroblastoma	NA	NA	0	0	Inf	1	0	0	0	0	1951	dinutuximab	neuroblastoma	0	0	Inf	1	0	12	0	123	1951	dinutuximab	neuroblastoma	0	0	Inf	1	0	14	0	89	1951	dinutuximab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1952	ixekizumab	0	0	0.47	0.00078	0	386	177549	8686404	1952	ixekizumab	psoriasis	0	0	1.73	0.28	0	291	1190	161400	1952	ixekizumab	psoriasis	25	74.8	0	0	5.17	1	0	84	379	43441	1952	ixekizumab	psoriasis	0	0	15.17	1	0	37	149	21307	1952	ixekizumab	psoriasis	0	0	7.23	1	0	53	274	27290	1952	ixekizumab	psoriasis	-11.83	7.28276470994245e-06	252.48	0.96	0	0	0.7	-0.36	0.1	0
1953	evolocumab	0.39	0.28	0.53	2.7e-12	42	5220	177507	8681570	1953	evolocumab	hypercholesterolaemia	0.54	0.25	1.05	0.073	9	1251	480	36344	1953	evolocumab	hypercholesterolaemia	42.6	78	0.66	0.27	1.38	0.33	8	936	66	5064	1953	evolocumab	hypercholesterolaemia	0.72	0.14	2.31	0.79	3	412	35	3470	1953	evolocumab	hypercholesterolaemia	0.63	0.22	1.5	0.35	6	703	41	3026	1953	evolocumab	hypercholesterolaemia	-0.41	0.663650250136319	0.36	0.25	0	0.01	0.57	-0.28	0.22	0.2
1954	mepolizumab	0.7	0.3	1.38	0.37	8	562	177541	8686228	1954	mepolizumab	asthma	0.52	0.19	1.14	0.13	6	381	3038	99993	1954	mepolizumab	asthma	9	76	0.28	0.03	1.03	0.051	2	229	538	17287	1954	mepolizumab	asthma	0	0	2.09	0.42	0	77	147	6181	1954	mepolizumab	asthma	0.39	0.05	1.45	0.25	2	161	456	14401	1954	mepolizumab	asthma	-1.27	0.28083162177838	0.71	0.07	-0.02	0	0	-0.41	0.1	0
1955	nivolumab	0.1	0.07	0.16	2.1e-63	23	10734	177526	8676056	1955	nivolumab	non-small cell lung cancer	0.68	0.31	1.33	0.31	9	2518	164	31409	1955	nivolumab	non-small cell lung cancer	43.2	79.8	0.77	0.25	2	0.67	6	1498	20	3860	1955	nivolumab	non-small cell lung cancer	1.02	0.27	3.29	1	5	1108	10	2265	1955	nivolumab	non-small cell lung cancer	0.97	0.18	3.62	1	3	581	12	2259	1955	nivolumab	non-small cell lung cancer	0	1	0.42	1	-0.01	0.01	0.35	-0.15	0.37	0.68
1956	infliximab-dyyb	0	0	1.34	0.12	0	137	177549	8686653	1956	infliximab-dyyb	rheumatoid arthritis	0	0	23.51	1	0	23	3410	460354	1956	infliximab-dyyb	rheumatoid arthritis	33	75	0	0	54.6	1	0	9	1060	113929	1956	infliximab-dyyb	rheumatoid arthritis	0	0	5065.99	1	0	1	180	25390	1956	infliximab-dyyb	rheumatoid arthritis	0	0	47.71	1	0	10	1011	107954	1956	infliximab-dyyb	rheumatoid arthritis	-7.96	0.000349153117459826	97.82	0.94	-0.01	0	0	-0.26	0.08	0
1957	necitumumab	0	0	0.44	0.00055	0	411	177549	8686379	1957	necitumumab	non-small cell lung cancer	0	0	2.61	0.41	0	280	173	33647	1957	necitumumab	non-small cell lung cancer	43.2	79.8	0	0	234.09	1	0	5	26	5353	1957	necitumumab	non-small cell lung cancer	0	0	7713.02	1	0	1	15	3372	1957	necitumumab	non-small cell lung cancer	0	0	305.08	1	0	4	15	2836	1957	necitumumab	non-small cell lung cancer	-10.23	3.60717697475854e-05	650.49	0.99	-0.01	0.01	0.35	-0.16	0.37	0.67
1958	filgrastim-sndz	0	0	3.46	0.63	0	54	177549	8686736	1958	filgrastim-sndz	plasma cell myeloma	0	0	115.04	1	0	8	534	104907	1958	filgrastim-sndz	plasma cell myeloma	47.4	82.5	0	0	207.57	1	0	6	164	39822	1958	filgrastim-sndz	plasma cell myeloma	0	0	403.63	1	0	4	93	24558	1958	filgrastim-sndz	plasma cell myeloma	0	0	1286.93	1	0	2	91	20956	1958	filgrastim-sndz	plasma cell myeloma	-9.12	0.000109454677335737	358.99	0.98	-0.03	0.01	0	-0.15	0.15	0.31
1959	blinatumomab	0.18	0.06	0.42	3.5e-07	5	1371	177544	8685419	1959	blinatumomab	acute lymphocytic leukaemia	0.94	0.19	2.89	1	3	548	67	11535	1959	blinatumomab	acute lymphocytic leukaemia	6.4	64.6	1.04	0.11	5.07	1	2	343	9	1611	1959	blinatumomab	acute lymphocytic leukaemia	1.93	0.33	8.12	0.4	3	244	8	1258	1959	blinatumomab	acute lymphocytic leukaemia	0	0	30.32	1	0	186	2	1055	1959	blinatumomab	acute lymphocytic leukaemia	0.51	1.66529119494589	0.68	0.45	-0.01	0.01	0.67	1.5	0.77	0.05
1960	alirocumab	0.3	0.18	0.46	8.9e-11	19	3135	177530	8683655	1960	alirocumab	blood cholesterol increased	0.26	0.05	0.77	0.009	3	478	2253	93750	1960	alirocumab	blood cholesterol increased	39.3	79.8	0.15	0	0.82	0.016	1	390	292	16588	1960	alirocumab	blood cholesterol increased	0.4	0.01	2.34	0.52	1	175	92	6514	1960	alirocumab	blood cholesterol increased	0.41	0.05	1.5	0.25	2	259	232	12235	1960	alirocumab	blood cholesterol increased	-0.77	0.463013068311228	0.58	0.19	-0.03	0	0	-0.27	0.12	0.03
1961	sebelipase alfa	0	0	2.77	0.65	0	67	177549	8686723	1961	sebelipase alfa	lysosomal acid lipase deficiency	0	0	Inf	1	0	60	0	0	1961	sebelipase alfa	lysosomal acid lipase deficiency	NA	NA	0	0	Inf	1	0	0	0	0	1961	sebelipase alfa	lysosomal acid lipase deficiency	0	0	Inf	1	0	5	0	0	1961	sebelipase alfa	lysosomal acid lipase deficiency	0	0	Inf	1	0	11	0	0	1961	sebelipase alfa	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1963	ceftaroline fosamil	0	0	0.59	0.0036	0	306	177549	8686484	1963	ceftaroline fosamil	osteomyelitis	0	0	5.92	1	0	38	47	2628	1963	ceftaroline fosamil	osteomyelitis	38.5	57.5	0	0	74.42	1	0	4	4	148	1963	ceftaroline fosamil	osteomyelitis	0	0	787.27	1	0	16	1	326	1963	ceftaroline fosamil	osteomyelitis	0	0	35.27	1	0	7	5	190	1963	ceftaroline fosamil	osteomyelitis	-14.98	3.12081957293257e-07	2097.67	0.99	-0.01	0.02	0.59	-2.12	1.1	0.05
1964	lurasidone	2.59	2.19	3.05	8.1e-24	154	2907	177395	8683883	1964	lurasidone	bipolar disorder	1.22	0.85	1.71	0.23	37	612	2540	51337	1964	lurasidone	bipolar disorder	19.9	69	1.09	0.66	1.73	0.72	21	311	344	5574	1964	lurasidone	bipolar disorder	1.28	0.45	2.96	0.48	6	107	117	2670	1964	lurasidone	bipolar disorder	1.18	0.68	1.94	0.5	18	244	267	4259	1964	lurasidone	bipolar disorder	0.19	1.20924959765725	0.22	0.39	0	0	0.47	-0.34	0.11	0
1965	sodium glycerophosphate	0	0	0.63	0.0052	0	288	177549	8686502	1965	sodium glycerophosphate	parenteral nutrition	0	0	13.61	1	0	75	4	664	1965	sodium glycerophosphate	parenteral nutrition	NA	NA	0	0	Inf	1	0	0	0	0	1965	sodium glycerophosphate	parenteral nutrition	0	0	Inf	1	0	5	0	59	1965	sodium glycerophosphate	parenteral nutrition	0	0	Inf	1	0	18	0	60	1965	sodium glycerophosphate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1966	pasireotide diaspartate	0.3	0.06	0.89	0.022	3	486	177546	8686304	1966	pasireotide diaspartate	pituitary-dependent cushing s syndrome	2.88	0.33	34.82	0.35	3	178	2	343	1966	pasireotide diaspartate	pituitary-dependent cushing s syndrome	71.5	71.7	0	0	Inf	1	1	0	0	0	1966	pasireotide diaspartate	pituitary-dependent cushing s syndrome	Inf	0.24	Inf	0.19	2	23	0	32	1966	pasireotide diaspartate	pituitary-dependent cushing s syndrome	0	0	Inf	1	0	73	0	106	1966	pasireotide diaspartate	pituitary-dependent cushing s syndrome	22.86	8471725128.33914	9430.35	1	1.13	1.06	0.28	26.69	7569.17	1
1967	cysteamine	0	0	1.21	0.08	0	151	177549	8686639	1967	cysteamine	cystinosis	0	0	26.96	1	0	73	2	366	1967	cysteamine	cystinosis	16.7	65.3	0	0	Inf	1	0	16	0	49	1967	cysteamine	cystinosis	0	0	237.99	1	0	8	1	48	1967	cysteamine	cystinosis	0	0	129.06	1	0	19	1	62	1967	cysteamine	cystinosis	-16.15	9.6859922509254e-08	3259.47	1	0.06	0.04	0.11	1.03	1.72	0.55
1968	azilsartan kamedoxomil	0.82	0.44	1.41	0.61	13	774	177536	8686016	1968	azilsartan kamedoxomil	hypertension	0.38	0.08	1.11	0.1	3	366	6892	317247	1968	azilsartan kamedoxomil	hypertension	38	82.9	0	0	3.04	0.64	0	79	981	62330	1968	azilsartan kamedoxomil	hypertension	0	0	11.78	1	0	31	341	31608	1968	azilsartan kamedoxomil	hypertension	0	0	3.51	0.63	0	57	762	39873	1968	azilsartan kamedoxomil	hypertension	-11.43	1.08646082614024e-05	153.93	0.94	-0.02	0	0	-0.59	0.07	0
1969	cabazitaxel	0.05	0	0.26	4.3e-08	1	1036	177548	8685754	1969	cabazitaxel	prostate cancer metastatic	0	0	0.64	0.0072	0	343	161	9366	1969	cabazitaxel	prostate cancer metastatic	60.4	91.1	0	0	7.28	1	0	51	25	2257	1969	cabazitaxel	prostate cancer metastatic	0	0	6.09	1	0	61	28	2565	1969	cabazitaxel	prostate cancer metastatic	0	0	Inf	1	0	0	0	6	1969	cabazitaxel	prostate cancer metastatic	-13.79	1.02583873698201e-06	832.16	0.99	0.04	0.02	0.08	14.05	2614.62	1
1970	gadobutrol	0.28	0.14	0.49	6.1e-08	12	2104	177537	8684686	1970	gadobutrol	nuclear magnetic resonance imaging	0.03	0.01	0.08	2e-35	3	547	1143	5976	1970	gadobutrol	nuclear magnetic resonance imaging	26.3	65.4	0.3	0.01	2.19	0.3	1	145	9	389	1970	gadobutrol	nuclear magnetic resonance imaging	0	0	6.75	0.57	0	68	3	186	1970	gadobutrol	nuclear magnetic resonance imaging	0.82	0.08	4.36	1	2	143	7	409	1970	gadobutrol	nuclear magnetic resonance imaging	-0.57	0.565525438699537	0.78	0.46	0	0.02	0.94	-0.32	0.67	0.64
1971	linagliptin	0.41	0.31	0.54	7.8e-14	54	6402	177495	8680388	1971	linagliptin	type 2 diabetes mellitus	0.81	0.48	1.28	0.45	18	2564	1204	138534	1971	linagliptin	type 2 diabetes mellitus	43	80.7	0.74	0.2	1.94	0.82	4	845	210	33049	1971	linagliptin	type 2 diabetes mellitus	0.75	0.09	2.81	1	2	558	83	17378	1971	linagliptin	type 2 diabetes mellitus	1.07	0.29	2.81	0.79	4	522	150	20952	1971	linagliptin	type 2 diabetes mellitus	-0.06	0.941764533584249	0.41	0.88	0	0	0.71	-0.41	0.14	0
1972	afatinib dimaleate	0.21	0.1	0.4	1.2e-09	9	2100	177540	8684690	1972	afatinib dimaleate	non-small cell lung cancer	2.04	0.86	4.13	0.068	8	789	165	33138	1972	afatinib dimaleate	non-small cell lung cancer	43.2	79.8	3.39	1.11	8.8	0.017	6	436	20	4922	1972	afatinib dimaleate	non-small cell lung cancer	2.51	0.27	11.19	0.22	2	195	13	3178	1972	afatinib dimaleate	non-small cell lung cancer	2.72	0.63	9.24	0.092	4	335	11	2505	1972	afatinib dimaleate	non-small cell lung cancer	1.01	2.74560101501692	0.46	0.03	-0.01	0.01	0.28	-0.07	0.37	0.85
1973	sodium nitrite	0	0	260.7	1	0	2	177549	8686788	1973	sodium nitrite	ill-defined disorder	0	0	2013.7	1	0	1	568	30279	1973	sodium nitrite	ill-defined disorder	33.1	82	0	0	Inf	1	0	0	21	637	1973	sodium nitrite	ill-defined disorder	0	0	Inf	1	0	0	11	272	1973	sodium nitrite	ill-defined disorder	0	0	Inf	1	0	0	14	470	1973	sodium nitrite	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1974	eribulin mesylate	0.06	0.01	0.21	1.8e-12	2	1691	177547	8685099	1974	eribulin mesylate	breast cancer	0	0	0.37	0.00011	0	457	1446	66325	1974	eribulin mesylate	breast cancer	40	78	0	0	1.66	0.18	0	179	127	9968	1974	eribulin mesylate	breast cancer	0	0	Inf	1	0	0	0	116	1974	eribulin mesylate	breast cancer	0	0	1.54	0.18	0	197	144	11579	1974	eribulin mesylate	breast cancer	-14.18	6.94551169000182e-07	464.71	0.98	0	0.01	0.77	-14.18	605.58	0.98
1975	fidaxomicin	0.19	0.04	0.55	0.00019	3	788	177546	8686002	1975	fidaxomicin	clostridium difficile colitis	0.26	0.01	2.12	0.26	1	312	6	477	1975	fidaxomicin	clostridium difficile colitis	40.9	40.9	0	0	Inf	1	0	0	0	0	1975	fidaxomicin	clostridium difficile colitis	0	0	Inf	1	0	20	0	71	1975	fidaxomicin	clostridium difficile colitis	Inf	0.08	Inf	0.25	1	40	0	122	1975	fidaxomicin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1976	ibuprofen sodium	2.2	2.09	2.31	3.3e-176	1705	38140	175844	8648650	1976	ibuprofen sodium	pain	1.4	1.24	1.59	3.2e-07	272	4351	8197	184133	1976	ibuprofen sodium	pain	23	79	0.94	0.59	1.42	0.84	23	813	1065	35204	1976	ibuprofen sodium	pain	0.15	0	0.83	0.016	1	282	363	15035	1976	ibuprofen sodium	pain	1.17	0.76	1.75	0.44	26	690	831	25900	1976	ibuprofen sodium	pain	-0.12	0.886920436717157	0.2	0.53	-0.02	0	0	-0.28	0.06	0
1977	telaprevir	0.99	0.91	1.07	0.81	642	31743	176907	8655047	1977	telaprevir	hepatitis c	0.73	0.66	0.8	1.1e-10	504	23608	2027	69158	1977	telaprevir	hepatitis c	32.8	65	0.69	0.36	1.2	0.23	13	573	544	16596	1977	telaprevir	hepatitis c	0.55	0.2	1.23	0.2	6	410	315	11881	1977	telaprevir	hepatitis c	0.79	0.31	1.66	0.73	7	282	299	9465	1977	telaprevir	hepatitis c	-0.49	0.612626394184416	0.28	0.09	-0.02	0	0	-0.17	0.08	0.04
1978	varenicline	2.86	2.52	3.23	1.2e-48	276	4729	177273	8682061	1978	varenicline	smoking cessation therapy	0.55	0.47	0.64	1.2e-15	167	2781	6265	57406	1978	varenicline	smoking cessation therapy	26.1	70	0.29	0.01	1.7	0.26	1	76	250	5565	1978	varenicline	smoking cessation therapy	0.92	0.11	3.57	1	2	51	104	2428	1978	varenicline	smoking cessation therapy	0	0	2.74	0.65	0	34	177	4196	1978	varenicline	smoking cessation therapy	-0.72	0.486752255959972	0.72	0.32	-0.02	0	0	-0.02	0.13	0.85
1979	florbetapir f-18	0	0	7.78	1	0	25	177549	8686765	1979	florbetapir f-18	nutritional supplementation	0	0	2938.2	1	0	1	53	4184	1979	florbetapir f-18	nutritional supplementation	13	80.3	0	0	2971.22	1	0	1	28	2236	1979	florbetapir f-18	nutritional supplementation	0	0	2610.07	1	0	1	13	906	1979	florbetapir f-18	nutritional supplementation	0	0	Inf	1	0	0	19	1770	1979	florbetapir f-18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1980	rilpivirine	1.04	0.71	1.45	0.79	34	1606	177515	8685184	1980	rilpivirine	hiv infection	3.54	2.32	5.22	4.5e-08	28	962	472	57429	1980	rilpivirine	hiv infection	25	64	1.75	0.81	3.37	0.092	10	378	110	7263	1980	rilpivirine	hiv infection	1.72	0.75	3.46	0.12	9	325	87	5403	1980	rilpivirine	hiv infection	0.63	0.02	3.8	1	1	134	39	3305	1980	rilpivirine	hiv infection	0.38	1.46228458943422	0.33	0.25	0	0.01	0.81	0.37	0.2	0.06
1981	icosapent ethyl	0.21	0.04	0.62	0.00098	3	696	177546	8686094	1981	icosapent ethyl	blood triglycerides increased	0	0	1.44	0.19	0	180	175	12008	1981	icosapent ethyl	blood triglycerides increased	40.7	74	0	0	8.78	1	0	63	15	1934	1981	icosapent ethyl	blood triglycerides increased	0	0	12.71	1	0	45	4	368	1981	icosapent ethyl	blood triglycerides increased	0	0	15.01	1	0	38	14	1815	1981	icosapent ethyl	blood triglycerides increased	-14.85	3.55407790889063e-07	1177.18	0.99	-0.01	0.02	0.64	0.37	0.57	0.52
1982	clobazam	0.7	0.56	0.86	0.00041	90	6303	177459	8680487	1982	clobazam	epilepsy	1.1	0.75	1.57	0.57	33	2135	607	43291	1982	clobazam	epilepsy	13.6	68.1	2	0.87	4.05	0.057	9	290	78	5024	1982	clobazam	epilepsy	2.19	0.66	5.67	0.098	5	212	36	3340	1982	clobazam	epilepsy	2.38	0.9	5.36	0.04	7	237	49	3947	1982	clobazam	epilepsy	0.89	2.43512965128987	0.32	0.01	0	0	0.34	-0.15	0.21	0.47
1983	darunavir	0.23	0.14	0.36	7.7e-17	20	4168	177529	8682622	1983	darunavir	hiv infection	0.44	0.22	0.77	0.0024	12	3105	488	55286	1983	darunavir	hiv infection	25	64	0.15	0	0.86	0.021	1	405	119	7236	1983	darunavir	hiv infection	0	0	0.73	0.015	0	295	96	5433	1983	darunavir	hiv infection	0.52	0.01	3.11	1	1	162	39	3277	1983	darunavir	hiv infection	-1.96	0.140858420921045	1	0.05	0	0.01	0.84	0.38	0.2	0.05
1984	apixaban	0.26	0.21	0.3	2.5e-91	135	25825	177414	8660965	1984	apixaban	cerebrovascular accident prophylaxis	0.9	0.58	1.35	0.69	28	7876	155	39048	1984	apixaban	cerebrovascular accident prophylaxis	56	85	0.66	0.23	1.54	0.45	6	3508	46	17616	1984	apixaban	cerebrovascular accident prophylaxis	0.46	0.05	1.88	0.41	2	2565	21	12379	1984	apixaban	cerebrovascular accident prophylaxis	1.14	0.45	2.56	0.68	8	2330	30	9984	1984	apixaban	cerebrovascular accident prophylaxis	-0.14	0.869358235398806	0.35	0.69	0	0.01	0.7	-0.69	0.27	0.01
1986	ruxolitinib phosphate	0.35	0.28	0.43	5.7e-32	86	12135	177463	8674655	1986	ruxolitinib phosphate	myelofibrosis	2.01	1.04	4.26	0.03	57	7545	11	2926	1986	ruxolitinib phosphate	myelofibrosis	50.9	85.7	1.18	0.46	3.91	1	32	2994	5	554	1986	ruxolitinib phosphate	myelofibrosis	0.85	0.24	4.66	0.74	14	1745	3	319	1986	ruxolitinib phosphate	myelofibrosis	2.14	0.53	18.77	0.41	25	1586	2	272	1986	ruxolitinib phosphate	myelofibrosis	0.31	1.36342511413218	0.48	0.52	-0.02	0.01	0.1	-0.55	0.31	0.08
1988	boceprevir	1.24	1.09	1.4	0.00079	269	10631	177280	8676159	1988	boceprevir	hepatitis c	1.04	0.9	1.21	0.57	199	7021	2332	85745	1988	boceprevir	hepatitis c	32.8	65	1.09	0.6	1.83	0.68	15	427	542	16742	1988	boceprevir	hepatitis c	0.46	0.12	1.2	0.15	4	329	317	11962	1988	boceprevir	hepatitis c	1.99	0.97	3.71	0.049	11	179	295	9568	1988	boceprevir	hepatitis c	0.03	1.03045453395352	0.27	0.91	-0.02	0	0	-0.17	0.08	0.03
1989	avanafil	0	0	0.47	0.00077	0	383	177549	8686407	1989	avanafil	erectile dysfunction	0	0	1.02	0.055	0	286	326	25511	1989	avanafil	erectile dysfunction	39	73	0	0	2.53	0.4	0	136	56	4978	1989	avanafil	erectile dysfunction	0	0	1.73	0.28	0	200	66	5956	1989	avanafil	erectile dysfunction	0	0	Inf	1	0	0	0	4	1989	avanafil	erectile dysfunction	-13.78	1.03614858769009e-06	437.12	0.97	-0.06	0.01	0	13.95	3153.83	1
1990	crofelemer	0	0	7.78	1	0	25	177549	8686765	1990	crofelemer	diarrhoea	0	0	18.17	1	0	14	288	17263	1990	crofelemer	diarrhoea	16	75.5	0	0	90.17	1	0	6	43	4438	1990	crofelemer	diarrhoea	0	0	118.16	1	0	6	18	2347	1990	crofelemer	diarrhoea	0	0	Inf	1	0	0	32	3934	1990	crofelemer	diarrhoea	-10.71	2.2320612032861e-05	593.44	0.99	-0.03	0.01	0	-0.15	0.3	0.61
1991	dapagliflozin propanediol	0.29	0.18	0.45	1.8e-11	20	3342	177529	8683448	1991	dapagliflozin propanediol	type 2 diabetes mellitus	0.44	0.16	0.97	0.038	6	1556	1216	139542	1991	dapagliflozin propanediol	type 2 diabetes mellitus	43	80.7	0.4	0.05	1.47	0.25	2	782	212	33112	1991	dapagliflozin propanediol	type 2 diabetes mellitus	0.98	0.12	3.68	1	2	430	83	17506	1991	dapagliflozin propanediol	type 2 diabetes mellitus	0.3	0.01	1.69	0.27	1	462	153	21012	1991	dapagliflozin propanediol	type 2 diabetes mellitus	-0.6	0.548811636094027	0.58	0.3	0	0	0.67	-0.41	0.14	0
1992	axitinib	0.24	0.15	0.35	1.6e-21	26	5405	177523	8681385	1992	axitinib	renal cancer	0.17	0.02	0.64	0.0021	2	1561	74	9914	1992	axitinib	renal cancer	41.9	73	0.33	0.04	1.34	0.14	2	485	25	2017	1992	axitinib	renal cancer	0.25	0.01	1.63	0.22	1	467	16	1881	1992	axitinib	renal cancer	0.39	0.01	2.64	0.71	1	180	13	916	1992	axitinib	renal cancer	-1.16	0.313486180882605	0.73	0.11	-0.03	0.01	0.02	-0.56	0.36	0.12
1993	esomeprazole strontium	0	0	33.97	1	0	7	177549	8686783	1993	esomeprazole strontium	prophylaxis of nausea and vomiting	0	0	554.55	1	0	2	80	8347	1993	esomeprazole strontium	prophylaxis of nausea and vomiting	14	75	0	0	1264.5	1	0	2	9	1948	1993	esomeprazole strontium	prophylaxis of nausea and vomiting	0	0	1245.89	1	0	2	5	1020	1993	esomeprazole strontium	prophylaxis of nausea and vomiting	0	0	Inf	1	0	0	8	1317	1993	esomeprazole strontium	prophylaxis of nausea and vomiting	-9.64	6.50730547475429e-05	1029.12	0.99	-0.04	0.01	0	-0.15	0.57	0.79
1994	abiraterone acetate	0.17	0.12	0.24	3.3e-44	32	9216	177517	8677574	1994	abiraterone acetate	prostate cancer	0.35	0.2	0.57	1.5e-06	16	4453	428	41298	1994	abiraterone acetate	prostate cancer	56.9	87.4	0.37	0.13	0.84	0.01	6	1851	96	10953	1994	abiraterone acetate	prostate cancer	0.33	0.12	0.73	0.003	6	2136	108	12540	1994	abiraterone acetate	prostate cancer	0	0	Inf	1	0	7	0	44	1994	abiraterone acetate	prostate cancer	-1.16	0.313486180882605	0.42	0.01	-0.02	0.01	0.03	11.81	332.92	0.97
1995	sitagliptin	0.68	0.52	0.87	0.0016	61	4418	177488	8682372	1995	sitagliptin	type 2 diabetes mellitus	1.74	0.97	2.89	0.039	15	1001	1207	140097	1995	sitagliptin	type 2 diabetes mellitus	43	80.7	1.86	0.38	5.57	0.22	3	257	211	33637	1995	sitagliptin	type 2 diabetes mellitus	2.88	0.34	10.9	0.16	2	149	83	17787	1995	sitagliptin	type 2 diabetes mellitus	0.95	0.02	5.44	1	1	147	153	21327	1995	sitagliptin	type 2 diabetes mellitus	0.54	1.71600686218486	0.58	0.35	0	0	0.7	-0.41	0.14	0
1997	vemurafenib	0.11	0.07	0.17	4.1e-52	21	9032	177528	8677758	1997	vemurafenib	malignant melanoma	0.44	0.14	1.11	0.078	5	2773	45	11037	1997	vemurafenib	malignant melanoma	38.5	88	0	0	1.3	0.087	0	800	14	3436	1997	vemurafenib	malignant melanoma	0	0	2.45	0.37	0	457	9	2198	1997	vemurafenib	malignant melanoma	0	0	2.56	0.36	0	430	7	1582	1997	vemurafenib	malignant melanoma	-16.09	1.02849405615877e-07	980.52	0.99	0.01	0.02	0.61	-0.1	0.51	0.85
1998	aclidinium bromide	1.22	0.94	1.56	0.12	64	2565	177485	8684225	1998	aclidinium bromide	chronic obstructive pulmonary disease	2.13	1.53	2.9	1.2e-05	44	1370	1214	80627	1998	aclidinium bromide	chronic obstructive pulmonary disease	48.4	82.8	3.36	2.19	4.98	1.2e-07	29	643	262	19501	1998	aclidinium bromide	chronic obstructive pulmonary disease	3.04	1.26	6.31	0.0073	8	250	100	9499	1998	aclidinium bromide	chronic obstructive pulmonary disease	3.52	2.18	5.46	7.4e-07	24	461	193	13044	1998	aclidinium bromide	chronic obstructive pulmonary disease	1.22	3.38718773362133	0.19	0	-0.03	0	0	-0.35	0.12	0
1999	tafluprost	0.24	0.07	0.63	6e-04	4	801	177545	8685989	1999	tafluprost	glaucoma	1.06	0.28	2.77	0.79	4	324	215	18411	1999	tafluprost	glaucoma	54.3	87	4.4	0.85	14.45	0.038	3	58	40	3404	1999	tafluprost	glaucoma	0	0	16.13	1	0	28	14	1416	1999	tafluprost	glaucoma	8.59	2.11	25.97	0.0021	4	41	31	2737	1999	tafluprost	glaucoma	1.67	5.31216779718117	0.54	0	-0.01	0.01	0.32	-0.28	0.32	0.38
2000	sodium picosulfate	0.66	0.42	0.98	0.036	24	1788	177525	8685002	2000	sodium picosulfate	constipation	1.35	0.58	2.71	0.4	8	345	720	41944	2000	sodium picosulfate	constipation	2.6	80.7	0	0	2.78	0.65	0	84	169	10340	2000	sodium picosulfate	constipation	0	0	6.27	1	0	51	69	5619	2000	sodium picosulfate	constipation	0	0	5.3	1	0	46	120	7506	2000	sodium picosulfate	constipation	-13.34	1.60883539155672e-06	390.97	0.97	-0.03	0	0	-0.22	0.15	0.15
2001	crizotinib	0.1	0.05	0.16	4.4e-41	13	6667	177536	8680123	2001	crizotinib	lung neoplasm malignant	0.54	0.21	1.15	0.13	7	1997	119	18369	2001	crizotinib	lung neoplasm malignant	42.6	83.8	0.92	0.28	2.42	1	5	688	28	3531	2001	crizotinib	lung neoplasm malignant	1.02	0.11	4.69	1	2	352	11	1970	2001	crizotinib	lung neoplasm malignant	0.66	0.13	2.22	0.79	3	430	21	1985	2001	crizotinib	lung neoplasm malignant	-0.38	0.683861409212356	0.48	0.44	-0.03	0.01	0.01	-0.57	0.35	0.1
2002	mirabegron	0.32	0.25	0.42	2.5e-24	56	8428	177493	8678362	2002	mirabegron	hypertonic bladder	0.55	0.23	1.14	0.11	8	1824	89	11187	2002	mirabegron	hypertonic bladder	55.5	80	0.25	0.01	1.76	0.2	1	425	11	1190	2002	mirabegron	hypertonic bladder	1	0.02	19.31	1	1	236	2	472	2002	mirabegron	hypertonic bladder	0.67	0.07	3.24	1	2	527	9	1582	2002	mirabegron	hypertonic bladder	-0.27	0.763379494336853	0.66	0.68	-0.01	0.02	0.64	-0.16	0.66	0.81
2003	carfilzomib	0.29	0.2	0.4	9e-21	36	6168	177513	8680622	2003	carfilzomib	plasma cell myeloma	1.05	0.67	1.58	0.75	25	4672	509	100243	2003	carfilzomib	plasma cell myeloma	47.4	82.5	1.43	0.81	2.37	0.18	17	2988	147	36840	2003	carfilzomib	plasma cell myeloma	2.1	1.1	3.74	0.018	14	1912	79	22650	2003	carfilzomib	plasma cell myeloma	0.83	0.26	2.02	0.83	5	1370	86	19588	2003	carfilzomib	plasma cell myeloma	0.29	1.33642748802547	0.24	0.23	-0.03	0.01	0	-0.15	0.15	0.3
2004	peginesatide acetate	1.75	0.69	3.67	0.13	7	196	177542	8686594	2004	peginesatide acetate	nephrogenic anaemia	27.46	9.33	72.81	5.8e-08	7	150	15	8840	2004	peginesatide acetate	nephrogenic anaemia	44.2	82.2	133.07	2.08	2872.43	0.012	1	8	2	2205	2004	peginesatide acetate	nephrogenic anaemia	0	0	15422.76	1	0	4	1	2083	2004	peginesatide acetate	nephrogenic anaemia	89.77	1.53	1336.45	0.016	1	6	3	1679	2004	peginesatide acetate	nephrogenic anaemia	4.04	56.826342805469	1.18	0	-0.04	0.02	0.06	-1.6	1.13	0.16
2005	dabrafenib mesylate	0.12	0.04	0.25	3.2e-15	6	2541	177543	8684249	2005	dabrafenib mesylate	malignant melanoma	0.87	0.17	2.7	1	3	946	47	12864	2005	dabrafenib mesylate	malignant melanoma	38.5	88	1.51	0.16	6.84	0.64	2	420	12	3816	2005	dabrafenib mesylate	malignant melanoma	1.13	0.03	8.46	1	1	265	8	2390	2005	dabrafenib mesylate	malignant melanoma	1.48	0.03	12.33	0.53	1	203	6	1809	2005	dabrafenib mesylate	malignant melanoma	0.28	1.32312981233744	0.76	0.71	0.01	0.02	0.54	-0.05	0.51	0.92
2006	linaclotide	0.77	0.62	0.95	0.012	95	6009	177454	8680781	2006	linaclotide	constipation	0.39	0.21	0.64	4e-05	15	2191	713	40098	2006	linaclotide	constipation	2.6	80.7	0.84	0.41	1.56	0.77	11	796	158	9628	2006	linaclotide	constipation	0.89	0.18	2.74	1	3	276	66	5394	2006	linaclotide	constipation	0.75	0.33	1.49	0.53	9	735	111	6817	2006	linaclotide	constipation	-0.13	0.878095430920561	0.3	0.67	-0.03	0	0	-0.23	0.15	0.14
2007	ingenol mebutate	0.05	0.01	0.12	1.2e-30	4	4157	177545	8682633	2007	ingenol mebutate	actinic keratosis	0.09	0.02	0.33	3e-05	3	2717	11	866	2007	ingenol mebutate	actinic keratosis	27.4	78.9	0.59	0.03	34.88	0.54	2	707	1	208	2007	ingenol mebutate	actinic keratosis	0	0	Inf	1	0	284	0	172	2007	ingenol mebutate	actinic keratosis	0.32	0.04	3.86	0.22	3	491	2	104	2007	ingenol mebutate	actinic keratosis	-1.29	0.275270783089752	0.92	0.16	-0.04	0.03	0.28	-17.75	2186.98	0.99
2008	perampanel	1.04	0.63	1.62	0.82	20	940	177529	8685850	2008	perampanel	epilepsy	1.86	0.88	3.47	0.077	10	385	630	45041	2008	perampanel	epilepsy	13.6	68.1	2.16	0.83	4.74	0.085	7	207	80	5107	2008	perampanel	epilepsy	1.43	0.17	5.63	0.65	2	123	39	3429	2008	perampanel	epilepsy	3.56	1.09	9.12	0.018	5	112	51	4072	2008	perampanel	epilepsy	0.92	2.5092903899363	0.4	0.02	0	0	0.55	-0.16	0.21	0.44
2009	teriflunomide	1.3	1.17	1.45	3.4e-06	350	13180	177199	8673610	2009	teriflunomide	multiple sclerosis	1.49	1.32	1.67	1.8e-10	309	10847	8036	419510	2009	teriflunomide	multiple sclerosis	26.5	67	1.63	1.4	1.89	4.7e-10	222	6476	1082	51566	2009	teriflunomide	multiple sclerosis	1.17	0.75	1.74	0.45	28	1460	207	12589	2009	teriflunomide	multiple sclerosis	1.66	1.42	1.93	4.6e-10	209	5752	1009	46097	2009	teriflunomide	multiple sclerosis	0.5	1.64872127070013	0.07	0	-0.01	0	0	-0.34	0.07	0
2010	lapatinib	0.23	0.15	0.33	7.5e-25	29	6174	177520	8680616	2010	lapatinib	breast cancer	0.03	0	0.13	1e-21	2	2575	1444	64207	2010	lapatinib	breast cancer	40	78	0	0	4.06	1	0	75	127	10072	2010	lapatinib	breast cancer	0	0	Inf	1	0	1	0	115	2010	lapatinib	breast cancer	0	0	3.56	0.63	0	87	144	11689	2010	lapatinib	breast cancer	-14.17	7.01531524297137e-07	694.02	0.98	0	0.01	0.76	-14.16	604.74	0.98
2011	regorafenib	0.32	0.2	0.47	8.3e-12	24	3720	177525	8683070	2011	regorafenib	colon cancer	1.51	0.58	3.31	0.34	7	966	67	14005	2011	regorafenib	colon cancer	44.6	81.9	1.56	0.45	4.39	0.38	5	484	18	2721	2011	regorafenib	colon cancer	1.17	0.12	5.52	0.69	2	298	10	1742	2011	regorafenib	colon cancer	2.17	0.5	7.39	0.26	4	242	11	1444	2011	regorafenib	colon cancer	0.5	1.64872127070013	0.47	0.28	0.01	0.01	0.58	-0.42	0.39	0.28
2012	elvitegravir	1.03	0.71	1.44	0.86	35	1663	177514	8685127	2012	elvitegravir	hiv infection	2.39	1.4	3.84	0.0014	18	899	482	57492	2012	elvitegravir	hiv infection	25	64	1.34	0.62	2.58	0.35	10	486	110	7155	2012	elvitegravir	hiv infection	1.54	0.71	3	0.22	10	402	86	5326	2012	elvitegravir	hiv infection	1.6	0.31	5.13	0.44	3	166	37	3273	2012	elvitegravir	hiv infection	0.44	1.55270721851134	0.3	0.14	0	0.01	0.8	0.37	0.2	0.06
2013	cobicistat	1	0.71	1.37	0.94	39	1905	177510	8684885	2013	cobicistat	hiv infection	2.52	1.56	3.89	0.00015	22	1046	478	57345	2013	cobicistat	hiv infection	25	64	1.72	0.9	3.04	0.072	14	545	106	7096	2013	cobicistat	hiv infection	1.33	0.61	2.59	0.35	10	460	86	5268	2013	cobicistat	hiv infection	3.53	1.3	8.24	0.0073	7	195	33	3244	2013	cobicistat	hiv infection	0.59	1.80398841539786	0.26	0.02	0	0.01	0.81	0.36	0.2	0.07
2015	olodaterol	0.49	0.22	0.93	0.024	9	901	177540	8685889	2015	olodaterol	chronic obstructive pulmonary disease	0.59	0.19	1.4	0.29	5	547	1253	81450	2015	olodaterol	chronic obstructive pulmonary disease	48.4	82.8	0.51	0.1	1.51	0.29	3	406	288	19738	2015	olodaterol	chronic obstructive pulmonary disease	0	0	1.36	0.12	0	244	108	9505	2015	olodaterol	chronic obstructive pulmonary disease	1.17	0.31	3.09	0.59	4	213	213	13292	2015	olodaterol	chronic obstructive pulmonary disease	-0.44	0.644036421083141	0.51	0.38	-0.03	0	0	-0.36	0.12	0
2018	ivacaftor	0.33	0.21	0.49	2.8e-11	25	3723	177524	8683067	2018	ivacaftor	cystic fibrosis	1.34	0.76	2.33	0.27	25	3676	32	6297	2018	ivacaftor	cystic fibrosis	14.3	57.2	1.47	0.52	4.29	0.48	10	1555	8	1824	2018	ivacaftor	cystic fibrosis	2.97	0.49	31.26	0.26	5	942	2	1120	2018	ivacaftor	cystic fibrosis	1.49	0.43	5.37	0.58	7	1066	6	1359	2018	ivacaftor	cystic fibrosis	0.69	1.99371553324308	0.46	0.13	0.03	0.01	0.05	-0.46	0.47	0.33
2019	droxidopa	0.4	0.3	0.52	2.9e-15	56	6815	177493	8679975	2019	droxidopa	orthostatic hypotension	0.66	0.25	1.94	0.45	15	1577	7	489	2019	droxidopa	orthostatic hypotension	57.6	87.4	0.48	0.1	4.68	0.29	9	680	2	73	2019	droxidopa	orthostatic hypotension	Inf	0.13	Inf	1	6	528	0	61	2019	droxidopa	orthostatic hypotension	0.21	0.03	1.46	0.06	4	353	3	55	2019	droxidopa	orthostatic hypotension	-0.82	0.440431654505999	0.67	0.22	0.01	0.02	0.51	-0.6	0.58	0.3
2020	tofacitinib citrate	0.39	0.33	0.45	8.2e-45	159	20080	177390	8666710	2020	tofacitinib citrate	rheumatoid arthritis	1.28	1.07	1.53	0.0071	128	13580	3282	446797	2020	tofacitinib citrate	rheumatoid arthritis	33	75	1.2	0.96	1.48	0.085	98	8906	962	105032	2020	tofacitinib citrate	rheumatoid arthritis	1.38	0.77	2.32	0.23	16	1673	164	23718	2020	tofacitinib citrate	rheumatoid arthritis	1.17	0.94	1.45	0.15	94	8670	917	99294	2020	tofacitinib citrate	rheumatoid arthritis	0.21	1.23367805995674	0.1	0.03	-0.01	0	0	-0.26	0.08	0
2021	pasireotide pamoate	0	0	1.13	0.083	0	161	177549	8686629	2021	pasireotide pamoate	acromegaly	0	0	1	0.052	0	113	164	4876	2021	pasireotide pamoate	acromegaly	33.7	68.4	0	0	1.52	0.16	0	45	48	821	2021	pasireotide pamoate	acromegaly	0	0	8.09	1	0	16	15	418	2021	pasireotide pamoate	acromegaly	0	0	1.96	0.25	0	37	42	752	2021	pasireotide pamoate	acromegaly	-14.7	4.12924941587327e-07	538.7	0.98	-0.02	0.01	0.03	-0.45	0.31	0.14
2022	glycerol phenylbutyrate	0.7	0.3	1.39	0.37	8	560	177541	8686230	2022	glycerol phenylbutyrate	urea cycle enzyme deficiency	Inf	0.01	Inf	1	2	258	0	21	2022	glycerol phenylbutyrate	urea cycle enzyme deficiency	17.4	25.6	0	0	Inf	1	0	36	0	4	2022	glycerol phenylbutyrate	urea cycle enzyme deficiency	Inf	0	Inf	1	1	89	0	9	2022	glycerol phenylbutyrate	urea cycle enzyme deficiency	Inf	0	Inf	1	1	160	0	9	2022	glycerol phenylbutyrate	urea cycle enzyme deficiency	14.84	2785672.84997475	2519.36	1	0	0.04	0.93	0.61	1.44	0.67
2023	insulin aspart	0.59	0.43	0.79	0.00017	44	3668	177505	8683122	2023	insulin aspart	diabetes mellitus	1.07	0.39	2.34	0.83	6	586	2321	242312	2023	insulin aspart	diabetes mellitus	39.3	82	0	0	5.65	1	0	93	377	52391	2023	insulin aspart	diabetes mellitus	0	0	12.53	1	0	65	140	29679	2023	insulin aspart	diabetes mellitus	0	0	8.23	1	0	47	281	28155	2023	insulin aspart	diabetes mellitus	-11.57	9.44523666643208e-06	223.97	0.96	-0.01	0	0	-0.75	0.1	0
2024	insulin degludec	0.23	0.1	0.45	1.5e-07	8	1706	177541	8685084	2024	insulin degludec	type 2 diabetes mellitus	0.8	0.22	2.07	1	4	575	1218	140523	2024	insulin degludec	type 2 diabetes mellitus	43	80.7	1.45	0.39	3.81	0.36	4	438	210	33456	2024	insulin degludec	type 2 diabetes mellitus	1.85	0.22	6.96	0.3	2	231	83	17705	2024	insulin degludec	type 2 diabetes mellitus	1.09	0.13	4.03	0.71	2	257	152	21217	2024	insulin degludec	type 2 diabetes mellitus	0.32	1.37712776433596	0.51	0.53	0	0	0.7	-0.41	0.14	0
2025	bosutinib monohydrate	0.29	0.14	0.53	1.7e-06	10	1700	177539	8685090	2025	bosutinib monohydrate	chronic myeloid leukaemia	0.64	0.2	1.5	0.46	5	1014	318	41019	2025	bosutinib monohydrate	chronic myeloid leukaemia	25.8	72.1	0.43	0.09	1.3	0.16	3	500	103	7405	2025	bosutinib monohydrate	chronic myeloid leukaemia	0.79	0.09	3.08	1	2	334	41	5435	2025	bosutinib monohydrate	chronic myeloid leukaemia	0.17	0	0.98	0.042	1	351	74	4393	2025	bosutinib monohydrate	chronic myeloid leukaemia	-0.95	0.386741023454501	0.59	0.11	-0.01	0.01	0.01	-0.75	0.19	0
2026	vismodegib	0.12	0.04	0.28	1.7e-12	5	2060	177544	8684730	2026	vismodegib	basal cell carcinoma	0.21	0.05	0.75	0.0067	5	1235	8	423	2026	vismodegib	basal cell carcinoma	47.6	82.6	Inf	0.08	Inf	1	3	326	0	62	2026	vismodegib	basal cell carcinoma	0	0	5.41	0.12	0	303	1	41	2026	vismodegib	basal cell carcinoma	0.65	0.05	35.08	0.55	3	202	1	44	2026	vismodegib	basal cell carcinoma	-1.1	0.33287108369808	0.93	0.24	-0.02	0.02	0.39	-1.55	1.13	0.17
2027	enzalutamide	0.46	0.4	0.52	1.1e-38	215	22958	177334	8663832	2027	enzalutamide	prostate cancer	0.83	0.67	1.03	0.083	126	14755	318	30996	2027	enzalutamide	prostate cancer	56.9	87.4	2.28	1.48	3.57	8.6e-05	69	6121	33	6683	2027	enzalutamide	prostate cancer	2.22	1.48	3.39	4.5e-05	77	7100	37	7576	2027	enzalutamide	prostate cancer	0	0	Inf	1	0	18	0	33	2027	enzalutamide	prostate cancer	0.82	2.27049983753241	0.2	0	-0.02	0.01	0.03	11.67	332.63	0.97
2029	ponatinib	0.46	0.31	0.64	4.5e-07	33	3534	177516	8683256	2029	ponatinib	chronic myeloid leukaemia	1.59	1.02	2.36	0.027	27	2287	296	39746	2029	ponatinib	chronic myeloid leukaemia	25.8	72.1	1.28	0.59	2.48	0.46	10	594	96	7311	2029	ponatinib	chronic myeloid leukaemia	1.98	0.68	4.78	0.14	6	436	37	5333	2029	ponatinib	chronic myeloid leukaemia	1.27	0.49	2.79	0.51	7	356	68	4388	2029	ponatinib	chronic myeloid leukaemia	0.45	1.56831218549017	0.3	0.13	-0.02	0.01	0	-0.75	0.19	0
2030	treprostinil diolamine	0.53	0.37	0.74	3.2e-05	37	3400	177512	8683390	2030	treprostinil diolamine	pulmonary arterial hypertension	2.51	1.6	3.76	9e-05	25	1856	457	85047	2030	treprostinil diolamine	pulmonary arterial hypertension	28	80	2.11	1.22	3.42	0.0052	18	952	252	28092	2030	treprostinil diolamine	pulmonary arterial hypertension	2.84	0.88	7.15	0.04	5	298	50	8460	2030	treprostinil diolamine	pulmonary arterial hypertension	2.28	1.3	3.75	0.0028	17	820	232	25466	2030	treprostinil diolamine	pulmonary arterial hypertension	0.86	2.36316069370579	0.22	0	0	0	0.15	-0.42	0.15	0.01
2031	ospemifene	0.64	0.4	0.97	0.031	22	1692	177527	8685098	2031	ospemifene	dyspareunia	3.24	0.91	17.57	0.054	15	612	3	397	2031	ospemifene	dyspareunia	50	68.3	Inf	0.29	Inf	0.6	6	227	0	58	2031	ospemifene	dyspareunia	0	0	Inf	1	0	0	0	0	2031	ospemifene	dyspareunia	Inf	0.48	Inf	0.21	8	282	0	82	2031	ospemifene	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2032	raltegravir	0.28	0.18	0.42	5.4e-14	23	3987	177526	8682803	2032	raltegravir	hiv infection	0.32	0.14	0.64	0.00029	8	2798	492	55593	2032	raltegravir	hiv infection	25	64	0	0	0.5	0.0012	0	450	120	7191	2032	raltegravir	hiv infection	0.15	0	0.88	0.031	1	368	95	5360	2032	raltegravir	hiv infection	0	0	1.91	0.26	0	167	40	3272	2032	raltegravir	hiv infection	-2.15	0.116484157773497	1	0.03	0	0.01	0.85	0.39	0.2	0.05
2033	ferric carboxymaltose	0.88	0.38	1.75	0.87	8	444	177541	8686346	2033	ferric carboxymaltose	iron deficiency anaemia	0	0	4.45	1	0	54	55	3353	2033	ferric carboxymaltose	iron deficiency anaemia	22.7	82.4	0	0	8.41	1	0	34	11	685	2033	ferric carboxymaltose	iron deficiency anaemia	0	0	166.88	1	0	3	5	292	2033	ferric carboxymaltose	iron deficiency anaemia	0	0	8.38	1	0	34	9	538	2033	ferric carboxymaltose	iron deficiency anaemia	-14.47	5.19707335581938e-07	1072.11	0.99	0	0.01	0.8	-0.01	0.58	0.99
2034	efinaconazole	0.07	0	0.39	3e-05	1	694	177548	8686096	2034	efinaconazole	onychomycosis	0	0	0.74	0.013	0	320	60	3692	2034	efinaconazole	onychomycosis	33.9	68.2	0	0	1.04	0.047	0	117	14	395	2034	efinaconazole	onychomycosis	0	0	1.6	0.12	0	91	9	280	2034	efinaconazole	onychomycosis	0	0	2.08	0.2	0	119	7	351	2034	efinaconazole	onychomycosis	-16.74	5.36920978441495e-08	1193.38	0.99	-0.03	0.01	0.03	0.51	0.51	0.32
2035	mipomersen sodium	0.24	0.01	1.33	0.14	1	208	177548	8686582	2035	mipomersen sodium	type iia hyperlipidaemia	0.78	0.02	4.75	1	1	150	31	3626	2035	mipomersen sodium	type iia hyperlipidaemia	42.5	80.2	0	0	6.24	1	0	74	14	1497	2035	mipomersen sodium	type iia hyperlipidaemia	0	0	97.69	1	0	33	2	595	2035	mipomersen sodium	type iia hyperlipidaemia	0	0	6.03	1	0	57	14	1107	2035	mipomersen sodium	type iia hyperlipidaemia	-14.87	3.48370245112345e-07	1114.31	0.99	-0.01	0.02	0.66	-1.35	0.76	0.08
2036	omacetaxine mepesuccinate	0.17	0	0.97	0.052	1	284	177548	8686506	2036	omacetaxine mepesuccinate	chronic myeloid leukaemia	0.61	0.02	3.44	1	1	214	322	41819	2036	omacetaxine mepesuccinate	chronic myeloid leukaemia	25.8	72.1	0	0	2.46	0.41	0	114	106	7791	2036	omacetaxine mepesuccinate	chronic myeloid leukaemia	0	0	6.69	1	0	78	43	5691	2036	omacetaxine mepesuccinate	chronic myeloid leukaemia	0	0	3.09	0.63	0	78	75	4666	2036	omacetaxine mepesuccinate	chronic myeloid leukaemia	-14.09	7.5996002783739e-07	515.07	0.98	-0.02	0.01	0	-0.75	0.19	0
2037	neostigmine methylsulfate	6.43	4.17	9.57	1.4e-13	28	213	177521	8686577	2037	neostigmine methylsulfate	anaesthesia	0	0	19.62	1	0	23	60	6581	2037	neostigmine methylsulfate	anaesthesia	23	71.2	0	0	106.28	1	0	4	9	565	2037	neostigmine methylsulfate	anaesthesia	0	0	2854.22	1	0	5	1	382	2037	neostigmine methylsulfate	anaesthesia	0	0	269.73	1	0	2	10	483	2037	neostigmine methylsulfate	anaesthesia	-12.63	3.27235712302789e-06	1412.57	0.99	0	0.01	0.89	-2.08	1.05	0.05
2038	sulfur hexafluoride lipid-type a microspheres	0	0	260.7	1	0	2	177549	8686788	2038	sulfur hexafluoride lipid-type a microspheres	cardiac stress test	0	0	1982.02	1	0	1	18	943	2038	sulfur hexafluoride lipid-type a microspheres	cardiac stress test	61.9	61.9	0	0	Inf	1	0	0	0	0	2038	sulfur hexafluoride lipid-type a microspheres	cardiac stress test	0	0	Inf	1	0	0	0	69	2038	sulfur hexafluoride lipid-type a microspheres	cardiac stress test	0	0	3257.37	1	0	1	1	87	2038	sulfur hexafluoride lipid-type a microspheres	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2039	cabozantinib s-malate	0.57	0.3	0.99	0.042	13	1107	177536	8685683	2039	cabozantinib s-malate	thyroid cancer	0.41	0.05	1.59	0.31	2	418	34	2886	2039	cabozantinib s-malate	thyroid cancer	37.5	77.9	0	0	5.37	1	0	117	6	730	2039	cabozantinib s-malate	thyroid cancer	Inf	0.1	Inf	0.2	1	89	0	354	2039	cabozantinib s-malate	thyroid cancer	0	0	9.45	1	0	42	7	553	2039	cabozantinib s-malate	thyroid cancer	0.29	1.33642748802547	1.1	0.79	-0.03	0.02	0.15	-1.72	1.09	0.11
2040	lomitapide mesylate	0.41	0.26	0.63	2.6e-06	22	2611	177527	8684179	2040	lomitapide mesylate	type iia hyperlipidaemia	1.06	0.49	2.39	1	20	2305	12	1471	2040	lomitapide mesylate	type iia hyperlipidaemia	42.5	80.2	1.28	0.37	5.63	0.78	10	1038	4	533	2040	lomitapide mesylate	type iia hyperlipidaemia	Inf	0.11	Inf	0.53	2	392	0	236	2040	lomitapide mesylate	type iia hyperlipidaemia	0.67	0.2	2.36	0.57	8	775	6	389	2040	lomitapide mesylate	type iia hyperlipidaemia	-0.16	0.852143788966211	0.52	0.75	-0.01	0.02	0.68	-1.37	0.76	0.07
2041	radium ra-223 dichloride	0.17	0.05	0.44	2.4e-06	4	1145	177545	8685645	2041	radium ra-223 dichloride	prostate cancer	0.81	0.1	2.98	1	2	254	442	45497	2041	radium ra-223 dichloride	prostate cancer	56.9	87.4	1.78	0.21	6.73	0.32	2	142	100	12662	2041	radium ra-223 dichloride	prostate cancer	1.76	0.21	6.64	0.32	2	147	112	14529	2041	radium ra-223 dichloride	prostate cancer	0	0	Inf	1	0	0	0	51	2041	radium ra-223 dichloride	prostate cancer	0.55	1.7332530178674	0.72	0.44	-0.01	0.01	0.05	11.79	335.42	0.97
2042	umeclidinium bromide	0.4	0.27	0.57	9.2e-09	30	3657	177519	8683133	2042	umeclidinium bromide	chronic obstructive pulmonary disease	1.05	0.67	1.57	0.83	24	1496	1234	80501	2042	umeclidinium bromide	chronic obstructive pulmonary disease	48.4	82.8	1.22	0.64	2.14	0.43	13	742	278	19402	2042	umeclidinium bromide	chronic obstructive pulmonary disease	0.99	0.26	2.65	1	4	363	104	9386	2042	umeclidinium bromide	chronic obstructive pulmonary disease	1.24	0.58	2.34	0.47	10	508	207	12997	2042	umeclidinium bromide	chronic obstructive pulmonary disease	0.19	1.20924959765725	0.28	0.5	-0.03	0	0	-0.37	0.12	0
2043	vilanterol trifenatate	0.6	0.49	0.72	2e-08	103	8452	177446	8678338	2043	vilanterol trifenatate	chronic obstructive pulmonary disease	1.21	0.91	1.58	0.16	59	3205	1199	78792	2043	vilanterol trifenatate	chronic obstructive pulmonary disease	48.4	82.8	1.13	0.72	1.7	0.51	26	1606	265	18538	2043	vilanterol trifenatate	chronic obstructive pulmonary disease	0.98	0.44	1.96	1	9	824	99	8925	2043	vilanterol trifenatate	chronic obstructive pulmonary disease	1.31	0.79	2.07	0.24	21	1023	196	12482	2043	vilanterol trifenatate	chronic obstructive pulmonary disease	0.22	1.24607673058738	0.19	0.27	-0.03	0	0	-0.37	0.12	0
2044	desvenlafaxine	2.51	1.8	3.41	1.8e-07	43	838	177506	8685952	2044	desvenlafaxine	depression	0.81	0.4	1.49	0.57	11	182	14360	192603	2044	desvenlafaxine	depression	21	73.3	0.46	0.05	1.73	0.44	2	60	2060	28282	2044	desvenlafaxine	depression	0	0	3.15	0.63	0	21	637	10426	2044	desvenlafaxine	depression	0.62	0.07	2.37	0.77	2	47	1669	24337	2044	desvenlafaxine	depression	-0.9	0.406569659740599	0.72	0.21	-0.01	0	0	-0.14	0.05	0
2045	pomalidomide	0.15	0.11	0.19	2.4e-84	49	16435	177500	8670355	2045	pomalidomide	plasma cell myeloma	0.52	0.37	0.71	9.1e-06	44	15447	490	89468	2045	pomalidomide	plasma cell myeloma	47.4	82.5	0.65	0.38	1.05	0.075	19	6710	145	33118	2045	pomalidomide	plasma cell myeloma	0.48	0.2	0.98	0.048	8	4049	85	20513	2045	pomalidomide	plasma cell myeloma	0.91	0.48	1.63	0.89	14	3485	77	17473	2045	pomalidomide	plasma cell myeloma	-0.36	0.697676326071031	0.23	0.11	-0.03	0.01	0	-0.15	0.15	0.31
2046	canagliflozin	0.2	0.15	0.26	4.9e-61	58	14177	177491	8672613	2046	canagliflozin	type 2 diabetes mellitus	0.5	0.33	0.72	5.5e-05	28	6381	1194	134717	2046	canagliflozin	type 2 diabetes mellitus	43	80.7	0.96	0.54	1.6	1	16	2629	198	31265	2046	canagliflozin	type 2 diabetes mellitus	0.49	0.13	1.3	0.19	4	1647	81	16289	2046	canagliflozin	type 2 diabetes mellitus	0.96	0.48	1.74	1	12	1734	142	19740	2046	canagliflozin	type 2 diabetes mellitus	-0.29	0.748263567578565	0.27	0.28	0	0	0.54	-0.41	0.14	0
2047	dimethyl fumarate	0.58	0.54	0.62	3.8e-56	712	59903	176837	8626887	2047	dimethyl fumarate	multiple sclerosis	0.58	0.54	0.64	6.2e-42	600	50393	7745	379964	2047	dimethyl fumarate	multiple sclerosis	26.5	67	0.55	0.47	0.64	2.6e-16	195	14122	1109	43920	2047	dimethyl fumarate	multiple sclerosis	0.67	0.46	0.95	0.024	40	3288	195	10761	2047	dimethyl fumarate	multiple sclerosis	0.52	0.44	0.61	2.2e-17	175	12627	1043	39222	2047	dimethyl fumarate	multiple sclerosis	-0.6	0.548811636094027	0.07	0	-0.01	0	0	-0.35	0.07	0
2048	trametinib dimethyl sulfoxide	0.14	0.05	0.28	2.8e-14	7	2513	177542	8684277	2048	trametinib dimethyl sulfoxide	malignant melanoma	0.94	0.19	2.92	1	3	881	47	12929	2048	trametinib dimethyl sulfoxide	malignant melanoma	38.5	88	1.63	0.18	7.36	0.38	2	393	12	3843	2048	trametinib dimethyl sulfoxide	malignant melanoma	1.2	0.03	8.99	0.59	1	251	8	2404	2048	trametinib dimethyl sulfoxide	malignant melanoma	1.69	0.04	14.01	0.48	1	181	6	1831	2048	trametinib dimethyl sulfoxide	malignant melanoma	0.38	1.46228458943422	0.76	0.62	0.01	0.02	0.54	-0.05	0.51	0.91
2049	luliconazole	0.76	0.02	4.41	1	1	64	177548	8686726	2049	luliconazole	psoriasis	0	0	94.45	1	0	7	1190	161684	2049	luliconazole	psoriasis	25	74.8	0	0	174.92	1	0	4	379	43521	2049	luliconazole	psoriasis	0	0	772.81	1	0	2	149	21342	2049	luliconazole	psoriasis	0	0	527.64	1	0	2	274	27341	2049	luliconazole	psoriasis	-7.78	0.000418012174611013	162.05	0.96	0	0	0.71	-0.36	0.1	0
2050	levomilnacipran	2.24	1.51	3.21	7.2e-05	31	678	177518	8686112	2050	levomilnacipran	depression	0.43	0.17	0.9	0.024	7	218	14364	192567	2050	levomilnacipran	depression	21	73.3	0.69	0.25	1.54	0.48	6	120	2056	28222	2050	levomilnacipran	depression	1.09	0.22	3.42	0.75	3	45	634	10402	2050	levomilnacipran	depression	0.48	0.1	1.45	0.29	3	91	1668	24293	2050	levomilnacipran	depression	-0.43	0.650509094723317	0.42	0.3	-0.01	0	0	-0.14	0.05	0
2051	cariprazine	2.61	1.11	5.28	0.015	8	150	177541	8686640	2051	cariprazine	schizophrenia	0	0	4.51	1	0	34	1515	59490	2051	cariprazine	schizophrenia	20.1	64.1	0	0	3.5	0.63	0	27	294	6987	2051	cariprazine	schizophrenia	0	0	6.61	1	0	18	182	5244	2051	cariprazine	schizophrenia	0	0	10	1	0	10	148	3285	2051	cariprazine	schizophrenia	-12.31	4.50645384894425e-06	274.09	0.96	-0.02	0	0	-0.31	0.11	0.01
2052	bedaquiline fumarate	0	0	3.33	0.63	0	56	177549	8686734	2052	bedaquiline fumarate	tuberculosis	0	0	14.33	1	0	40	29	4048	2052	bedaquiline fumarate	tuberculosis	23.8	59	0	0	28.87	1	0	17	7	654	2052	bedaquiline fumarate	tuberculosis	0	0	61.12	1	0	12	5	612	2052	bedaquiline fumarate	tuberculosis	0	0	107.64	1	0	8	4	501	2052	bedaquiline fumarate	tuberculosis	-13.84	9.75807991409932e-07	1457.59	0.99	-0.01	0.02	0.52	0.09	0.68	0.9
2053	macitentan	0.45	0.37	0.54	4.8e-21	108	11718	177441	8675072	2053	macitentan	pulmonary arterial hypertension	2	1.55	2.55	1.3e-07	81	7974	401	78929	2053	macitentan	pulmonary arterial hypertension	28	80	1.31	0.98	1.74	0.052	70	6109	200	22935	2053	macitentan	pulmonary arterial hypertension	1.28	0.64	2.4	0.41	14	1845	41	6913	2053	macitentan	pulmonary arterial hypertension	1.33	0.98	1.78	0.059	64	5428	185	20858	2053	macitentan	pulmonary arterial hypertension	0.3	1.349858807576	0.13	0.02	-0.01	0	0.1	-0.41	0.15	0.01
2054	tavaborole	0.11	0	0.61	0.0021	1	450	177548	8686340	2054	tavaborole	onychomycosis	0	0	1.15	0.074	0	211	60	3801	2054	tavaborole	onychomycosis	33.9	68.2	0	0	2.13	0.24	0	65	14	447	2054	tavaborole	onychomycosis	0	0	4.78	1	0	37	9	334	2054	tavaborole	onychomycosis	0	0	2.79	0.35	0	95	7	375	2054	tavaborole	onychomycosis	-15.43	1.98992241583405e-07	924.24	0.99	-0.03	0.01	0.03	0.39	0.51	0.45
2055	vortioxetine	2.49	1.96	3.12	2.9e-12	79	1555	177470	8685235	2055	vortioxetine	depression	0.81	0.56	1.14	0.27	36	593	14335	192192	2055	vortioxetine	depression	21	73.3	1.25	0.81	1.87	0.27	27	297	2035	28045	2055	vortioxetine	depression	0.48	0.1	1.46	0.29	3	101	634	10346	2055	vortioxetine	depression	1.4	0.89	2.1	0.12	26	273	1645	24111	2055	vortioxetine	depression	0.06	1.06183654654536	0.19	0.75	-0.01	0	0	-0.14	0.05	0
2056	vasopressin	10.68	9.21	12.36	2.2e-136	224	1027	177325	8685763	2056	vasopressin	hypotension	2.34	0.72	5.96	0.078	5	78	69	2516	2056	vasopressin	hypotension	25	69.3	0	0	50.66	1	0	18	3	360	2056	vasopressin	hypotension	0	0	136.17	1	0	13	2	320	2056	vasopressin	hypotension	0	0	78.27	1	0	12	3	363	2056	vasopressin	hypotension	-14.82	3.66231569524039e-07	2108.74	0.99	-0.03	0.02	0.1	0	0.93	1
2057	olive oil	1.48	0.54	3.29	0.31	6	198	177543	8686592	2057	olive oil	hypertension	0	0	12.84	1	0	15	6895	317598	2057	olive oil	hypertension	38	82.9	0	0	69.49	1	0	5	981	62404	2057	olive oil	hypertension	0	0	Inf	1	0	0	341	31639	2057	olive oil	hypertension	0	0	57.3	1	0	5	762	39925	2057	olive oil	hypertension	-8.26	0.000258658991222064	145.12	0.95	-0.02	0	0	-0.59	0.07	0
2058	suvorexant	1.16	0.95	1.39	0.12	117	4951	177432	8681839	2058	suvorexant	insomnia	0.53	0.42	0.66	7.4e-10	86	3606	2857	63982	2058	suvorexant	insomnia	26.9	78.5	0.81	0.58	1.11	0.22	46	1244	485	10653	2058	suvorexant	insomnia	0.54	0.28	0.96	0.03	13	583	199	4854	2058	suvorexant	insomnia	0.83	0.56	1.18	0.35	35	961	344	7829	2058	suvorexant	insomnia	-0.29	0.748263567578565	0.15	0.06	-0.02	0	0	-0.08	0.09	0.37
2059	diclofenac	0.93	0.86	1.01	0.086	616	32311	176933	8654479	2059	diclofenac	rheumatoid arthritis	0.69	0.47	0.98	0.043	32	6193	3378	454184	2059	diclofenac	rheumatoid arthritis	33	75	1.71	0.95	2.86	0.058	15	946	1045	112992	2059	diclofenac	rheumatoid arthritis	5.8	2.43	11.9	0.00013	8	202	172	25189	2059	diclofenac	rheumatoid arthritis	0.83	0.33	1.73	0.86	7	896	1004	107068	2059	diclofenac	rheumatoid arthritis	0.42	1.52196155561863	0.26	0.11	-0.01	0	0	-0.26	0.08	0
2060	empagliflozin	0.22	0.12	0.36	8.7e-14	14	3161	177535	8683629	2060	empagliflozin	type 2 diabetes mellitus	0.3	0.08	0.78	0.0072	4	1513	1218	139585	2060	empagliflozin	type 2 diabetes mellitus	43	80.7	0.39	0.05	1.43	0.25	2	803	212	33091	2060	empagliflozin	type 2 diabetes mellitus	0.86	0.1	3.23	1	2	488	83	17448	2060	empagliflozin	type 2 diabetes mellitus	0	0	1	0.055	0	509	154	20965	2060	empagliflozin	type 2 diabetes mellitus	-1.13	0.323033256422253	0.71	0.11	0	0	0.6	-0.41	0.14	0
2061	methylene blue	1.24	0.66	2.14	0.43	13	512	177536	8686278	2061	methylene blue	depression	0	0	0.51	0.002	0	98	14371	192687	2061	methylene blue	depression	21	73.3	0	0	2.95	0.64	0	19	2062	28323	2061	methylene blue	depression	0	0	5.39	1	0	13	637	10434	2061	methylene blue	depression	0	0	4.07	0.62	0	15	1671	24369	2061	methylene blue	depression	-10.8	2.03995034111719e-05	100.56	0.91	-0.01	0	0	-0.14	0.05	0
2062	sofosbuvir	1	0.91	1.09	0.97	533	26174	177016	8660616	2062	sofosbuvir	hepatitis c	0.89	0.79	1.01	0.07	317	12803	2214	79963	2062	sofosbuvir	hepatitis c	32.8	65	1.12	0.94	1.33	0.2	237	6830	320	10339	2062	sofosbuvir	hepatitis c	1.02	0.81	1.28	0.91	142	5381	179	6910	2062	sofosbuvir	hepatitis c	1.14	0.9	1.45	0.28	124	3641	182	6106	2062	sofosbuvir	hepatitis c	0.12	1.12749685157938	0.08	0.13	-0.02	0	0	-0.18	0.08	0.03
2063	florbetaben f-18	0	0	1852.91	1	0	1	177549	8686789	2063	florbetaben f-18	imaging procedure	0	0	296.09	1	0	1	59	449	2063	florbetaben f-18	imaging procedure	51.4	59.6	0	0	Inf	1	0	1	0	21	2063	florbetaben f-18	imaging procedure	0	0	Inf	1	0	0	1	40	2063	florbetaben f-18	imaging procedure	0	0	2002.36	1	0	1	1	52	2063	florbetaben f-18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2064	miltefosine	0	0	3.27	0.63	0	57	177549	8686733	2064	miltefosine	balamuthia infection	0	0	Inf	1	0	13	0	0	2064	miltefosine	balamuthia infection	NA	NA	0	0	Inf	1	0	0	0	0	2064	miltefosine	balamuthia infection	0	0	Inf	1	0	3	0	0	2064	miltefosine	balamuthia infection	0	0	Inf	1	0	2	0	0	2064	miltefosine	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2065	naloxegol oxalate	1.91	1.35	2.62	0.00025	40	1026	177509	8685764	2065	naloxegol oxalate	constipation	2.53	1.66	3.72	2.9e-05	28	658	700	41631	2065	naloxegol oxalate	constipation	2.6	80.7	4.61	2.7	7.5	1.3e-07	20	295	149	10129	2065	naloxegol oxalate	constipation	5.22	1.97	11.73	0.00076	7	120	62	5550	2065	naloxegol oxalate	constipation	5.04	2.68	8.89	1.8e-06	15	208	105	7344	2065	naloxegol oxalate	constipation	1.68	5.36555597112197	0.24	0	-0.03	0	0	-0.2	0.15	0.18
2066	gadoterate meglumine	0.57	0.26	1.08	0.096	9	775	177540	8686015	2066	gadoterate meglumine	nuclear magnetic resonance imaging	0.06	0.02	0.15	2.1e-22	4	382	1142	6141	2066	gadoterate meglumine	nuclear magnetic resonance imaging	26.3	65.4	1.06	0.17	4.71	1	3	154	7	380	2066	gadoterate meglumine	nuclear magnetic resonance imaging	0	0	8.17	1	0	59	3	195	2066	gadoterate meglumine	nuclear magnetic resonance imaging	1.75	0.34	8.24	0.47	4	173	5	379	2066	gadoterate meglumine	nuclear magnetic resonance imaging	0.18	1.19721736312181	0.62	0.77	0	0.02	0.96	-0.3	0.67	0.65
2067	dolutegravir sodium	1.08	0.81	1.42	0.56	53	2405	177496	8684385	2067	dolutegravir sodium	hiv infection	3.23	2.28	4.48	6.9e-10	41	1569	459	56822	2067	dolutegravir sodium	hiv infection	25	64	2.4	1.49	3.75	0.00029	27	824	93	6817	2067	dolutegravir sodium	hiv infection	2.13	1.27	3.47	0.0032	23	737	73	4991	2067	dolutegravir sodium	hiv infection	2.63	0.97	6.11	0.029	7	257	33	3182	2067	dolutegravir sodium	hiv infection	0.81	2.24790798667647	0.21	0	0	0.01	0.66	0.33	0.2	0.1
2068	riociguat	0.53	0.4	0.68	1.1e-07	59	5443	177490	8681347	2068	riociguat	pulmonary arterial hypertension	2.55	1.76	3.59	1.8e-06	36	2667	446	84236	2068	riociguat	pulmonary arterial hypertension	28	80	1.62	1.06	2.4	0.021	29	2007	241	27037	2068	riociguat	pulmonary arterial hypertension	1.06	0.28	2.91	0.79	4	601	51	8157	2068	riociguat	pulmonary arterial hypertension	1.88	1.22	2.78	0.0029	29	1724	220	24562	2068	riociguat	pulmonary arterial hypertension	0.55	1.7332530178674	0.19	0	0	0	0.12	-0.41	0.15	0.01
2069	methotrexate	0.49	0.47	0.52	4.5e-277	2047	200639	175502	8486151	2069	methotrexate	rheumatoid arthritis	1.21	1.12	1.3	7.7e-07	990	116418	2420	343959	2069	methotrexate	rheumatoid arthritis	33	75	1.66	1.45	1.9	3.6e-13	316	23185	744	90753	2069	methotrexate	rheumatoid arthritis	1.57	1.12	2.18	0.0076	53	5329	127	20062	2069	methotrexate	rheumatoid arthritis	1.58	1.38	1.82	2.1e-10	289	21780	722	86184	2069	methotrexate	rheumatoid arthritis	0.47	1.59999419321736	0.06	0	-0.01	0	0	-0.26	0.08	0
2070	vorapaxar	0	0	1.64	0.18	0	112	177549	8686678	2070	vorapaxar	peripheral arterial occlusive disease	0	0	70.58	1	0	26	6	2063	2070	vorapaxar	peripheral arterial occlusive disease	55	55	0	0	Inf	1	0	0	0	0	2070	vorapaxar	peripheral arterial occlusive disease	0	0	4848.21	1	0	4	1	537	2070	vorapaxar	peripheral arterial occlusive disease	0	0	Inf	1	0	3	0	307	2070	vorapaxar	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2071	cangrelor	0.56	0.01	3.22	1	1	87	177548	8686703	2071	cangrelor	percutaneous coronary intervention	0	0	52.8	1	0	60	5	2850	2071	cangrelor	percutaneous coronary intervention	40.1	60.4	0	0	Inf	1	0	0	0	146	2071	cangrelor	percutaneous coronary intervention	0	0	2315.52	1	0	5	1	307	2071	cangrelor	percutaneous coronary intervention	0	0	3222.22	1	0	2	1	173	2071	cangrelor	percutaneous coronary intervention	-12.24	4.83320862143726e-06	2383.49	1	-0.06	0.04	0.11	-0.69	1.43	0.63
2073	perindopril arginine	0.58	0.21	1.26	0.21	6	510	177543	8686280	2073	perindopril arginine	hypertension	0.55	0.07	2	0.59	2	169	6893	317444	2073	perindopril arginine	hypertension	38	82.9	0	0	5.44	1	0	45	981	62364	2073	perindopril arginine	hypertension	0	0	14.81	1	0	25	341	31614	2073	perindopril arginine	hypertension	0	0	8.35	1	0	25	762	39905	2073	perindopril arginine	hypertension	-10.42	2.98298794702676e-05	123.45	0.93	-0.02	0	0	-0.59	0.07	0
2074	omega-3-carboxylic acids	0	0	7.78	1	0	25	177549	8686765	2074	omega-3-carboxylic acids	hypertension	0	0	8.01	1	0	23	6895	317590	2074	omega-3-carboxylic acids	hypertension	38	82.9	0	0	11.09	1	0	23	981	62386	2074	omega-3-carboxylic acids	hypertension	0	0	33.52	1	0	12	341	31627	2074	omega-3-carboxylic acids	hypertension	0	0	20.9	1	0	11	762	39919	2074	omega-3-carboxylic acids	hypertension	-9.32	8.96139104029952e-05	110.82	0.93	-0.02	0	0	-0.59	0.07	0
2075	sucroferric oxyhydroxide	0.17	0	0.94	0.035	1	292	177548	8686498	2075	sucroferric oxyhydroxide	hyperphosphataemia	1.74	0.04	11.83	0.46	1	225	12	4690	2075	sucroferric oxyhydroxide	hyperphosphataemia	45.1	65.8	0	0	Inf	1	0	51	0	267	2075	sucroferric oxyhydroxide	hyperphosphataemia	0	0	233.15	1	0	63	1	377	2075	sucroferric oxyhydroxide	hyperphosphataemia	Inf	0.15	Inf	0.14	1	49	0	296	2075	sucroferric oxyhydroxide	hyperphosphataemia	1.76	5.81243739440259	1.42	0.21	-0.02	0.04	0.61	-0.24	1.42	0.87
2076	simeprevir sodium	0.5	0.34	0.72	5.5e-05	29	2820	177520	8683970	2076	simeprevir sodium	hepatitis c	0.69	0.45	1	0.053	28	1488	2503	91278	2076	simeprevir sodium	hepatitis c	32.8	65	1.07	0.65	1.67	0.73	21	604	536	16565	2076	simeprevir sodium	hepatitis c	0.89	0.45	1.58	0.78	12	516	309	11775	2076	simeprevir sodium	hepatitis c	0.91	0.45	1.67	0.88	11	384	295	9363	2076	simeprevir sodium	hepatitis c	-0.09	0.913931185271228	0.22	0.69	-0.02	0	0	-0.17	0.08	0.03
2077	desvenlafaxine fumarate	2.52	1.81	3.43	1.7e-07	43	834	177506	8685956	2077	desvenlafaxine fumarate	depression	0.82	0.4	1.5	0.67	11	180	14360	192605	2077	desvenlafaxine fumarate	depression	21	73.3	0.47	0.06	1.76	0.44	2	59	2060	28283	2077	desvenlafaxine fumarate	depression	0	0	3.15	0.63	0	21	637	10426	2077	desvenlafaxine fumarate	depression	0.63	0.07	2.43	0.77	2	46	1669	24338	2077	desvenlafaxine fumarate	depression	-0.88	0.414782911681581	0.72	0.22	-0.01	0	0	-0.14	0.05	0
2078	sonidegib phosphate	2.64	0.31	10.25	0.18	2	37	177547	8686753	2078	sonidegib phosphate	acute myeloid leukaemia	0	0	238.77	1	0	9	31	14000	2078	sonidegib phosphate	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	1	0	819	2078	sonidegib phosphate	acute myeloid leukaemia	0	0	9168.63	1	0	5	1	1371	2078	sonidegib phosphate	acute myeloid leukaemia	0	0	2400.84	1	0	3	2	1123	2078	sonidegib phosphate	acute myeloid leukaemia	-11.7	8.29381916075737e-06	2279.39	1	0	0.03	0.9	-0.88	1.23	0.47
2079	panobinostat lactate	0.13	0.02	0.49	9.6e-05	2	729	177547	8686061	2079	panobinostat lactate	plasma cell myeloma	0.68	0.08	2.47	1	2	579	532	104336	2079	panobinostat lactate	plasma cell myeloma	47.4	82.5	2.12	0.25	7.86	0.25	2	231	162	39597	2079	panobinostat lactate	plasma cell myeloma	1.84	0.05	10.69	0.42	1	144	92	24418	2079	panobinostat lactate	plasma cell myeloma	2.13	0.05	12.4	0.38	1	109	90	20849	2079	panobinostat lactate	plasma cell myeloma	0.66	1.93479233440203	0.71	0.36	-0.03	0.01	0	-0.15	0.15	0.3
2080	brexpiprazole	2.52	2.07	3.03	8.1e-18	118	2296	177431	8684494	2080	brexpiprazole	major depression	0.75	0.54	1.03	0.077	44	902	853	13142	2080	brexpiprazole	major depression	16.6	66	0.92	0.5	1.57	0.9	16	215	176	2169	2080	brexpiprazole	major depression	1.23	0.37	3.22	0.6	5	76	46	860	2080	brexpiprazole	major depression	0.98	0.51	1.73	1	14	188	150	1968	2080	brexpiprazole	major depression	0.04	1.04081077419239	0.25	0.87	0	0	0.5	-0.34	0.17	0.04
2081	tedizolid phosphate	0	0	2.14	0.42	0	86	177549	8686704	2081	tedizolid phosphate	staphylococcal infection	0	0	43.33	1	0	11	48	5062	2081	tedizolid phosphate	staphylococcal infection	40.8	69.2	0	0	7747.19	1	0	2	1	451	2081	tedizolid phosphate	staphylococcal infection	0	0	7897.44	1	0	2	1	461	2081	tedizolid phosphate	staphylococcal infection	0	0	6906.22	1	0	1	2	396	2081	tedizolid phosphate	staphylococcal infection	-11.79	7.57997997601621e-06	2259.76	1	0	0.03	0.96	-0.85	1.23	0.49
2082	apremilast	0.57	0.51	0.63	2.4e-30	340	29343	177209	8657447	2082	apremilast	psoriasis	1.73	1.47	2.03	2.2e-10	179	14998	1011	146693	2082	apremilast	psoriasis	25	74.8	1.78	1.4	2.26	4.2e-06	96	6964	283	36561	2082	apremilast	psoriasis	3.07	2.12	4.39	5.3e-09	47	2787	102	18557	2082	apremilast	psoriasis	1.32	0.98	1.77	0.068	61	4872	213	22471	2082	apremilast	psoriasis	0.59	1.80398841539786	0.11	0	0	0	0.42	-0.33	0.1	0
2083	eliglustat tartrate	0.95	0.19	2.82	1	3	155	177546	8686635	2083	eliglustat tartrate	gaucher s disease	2.37	0.27	9.37	0.22	2	83	44	4335	2083	eliglustat tartrate	gaucher s disease	39.9	49.4	0	0	8.45	1	0	11	5	75	2083	eliglustat tartrate	gaucher s disease	0	0	393.86	1	0	31	1	314	2083	eliglustat tartrate	gaucher s disease	1.95	0.04	17.97	0.45	1	43	5	419	2083	eliglustat tartrate	gaucher s disease	0.43	1.53725752354828	1.09	0.7	0.01	0.02	0.64	-1.52	1.08	0.16
2084	ibrutinib	0.29	0.22	0.37	2.2e-34	62	10560	177487	8676230	2084	ibrutinib	chronic lymphocytic leukaemia	2.22	1.36	3.63	0.0011	35	6528	37	15331	2084	ibrutinib	chronic lymphocytic leukaemia	50.7	85	3.06	1.32	7.91	0.006	23	3607	8	3835	2084	ibrutinib	chronic lymphocytic leukaemia	3.61	1.38	11.05	0.0042	19	2518	6	2869	2084	ibrutinib	chronic lymphocytic leukaemia	3.34	0.66	32.29	0.12	8	1635	2	1364	2084	ibrutinib	chronic lymphocytic leukaemia	1.28	3.59663972556928	0.4	0	-0.02	0.01	0.15	0.39	0.38	0.3
2085	tasimelteon	0.76	0.43	1.23	0.32	16	1035	177533	8685755	2085	tasimelteon	circadian rhythm sleep disorder	0.25	0.12	0.54	0.00012	14	856	20	311	2085	tasimelteon	circadian rhythm sleep disorder	35.5	68.4	0.35	0.04	16.76	0.34	6	395	1	23	2085	tasimelteon	circadian rhythm sleep disorder	0.04	0	0.84	0.018	1	258	2	21	2085	tasimelteon	circadian rhythm sleep disorder	Inf	0.1	Inf	1	6	276	0	25	2085	tasimelteon	circadian rhythm sleep disorder	-1.19	0.304221264066704	0.87	0.17	0	0.02	0.96	-0.62	0.72	0.38
2086	insulin glargine	0.71	0.57	0.88	0.0013	85	5838	177464	8680952	2086	insulin glargine	diabetes mellitus	1	0.5	1.8	1	11	1148	2316	241750	2086	insulin glargine	diabetes mellitus	39.3	82	2	0.41	5.96	0.2	3	210	374	52274	2086	insulin glargine	diabetes mellitus	1.34	0.03	7.69	0.53	1	159	139	29585	2086	insulin glargine	diabetes mellitus	2.12	0.25	7.95	0.25	2	95	279	28107	2086	insulin glargine	diabetes mellitus	0.58	1.78603843075007	0.58	0.32	-0.01	0	0	-0.75	0.1	0
2087	nitrious oxide	48.93	0.62	3699.96	0.04	1	1	177548	8686789	2087	nitrious oxide	oxygen supplementation	Inf	1.15	Inf	0.022	1	0	2	134	2087	nitrious oxide	oxygen supplementation	69.7	71.9	0	0	Inf	1	0	0	0	1	2087	nitrious oxide	oxygen supplementation	0	0	Inf	1	0	0	1	11	2087	nitrious oxide	oxygen supplementation	0	0	Inf	1	0	0	1	16	2087	nitrious oxide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2088	medical air	0	0	74.11	1	0	4	177549	8686786	2088	medical air	anaesthesia	0	0	4022.84	1	0	1	60	6603	2088	medical air	anaesthesia	23	71.2	0	0	Inf	1	0	0	9	569	2088	medical air	anaesthesia	0	0	Inf	1	0	0	1	387	2088	medical air	anaesthesia	0	0	Inf	1	0	0	10	485	2088	medical air	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2089	oxygen	1.61	1.49	1.74	7.9e-31	698	21216	176851	8665574	2089	oxygen	chronic obstructive pulmonary disease	2.42	1.98	2.94	9.5e-16	117	3333	1141	78664	2089	oxygen	chronic obstructive pulmonary disease	48.4	82.8	3.48	2.33	5.06	8.9e-09	33	714	258	19430	2089	oxygen	chronic obstructive pulmonary disease	2.05	0.8	4.43	0.093	7	319	101	9430	2089	oxygen	chronic obstructive pulmonary disease	3.64	2.32	5.53	9.2e-08	27	507	190	12998	2089	oxygen	chronic obstructive pulmonary disease	1.16	3.18993327611618	0.19	0	-0.03	0	0	-0.36	0.12	0
2090	netupitant	0	0	5.44	1	0	35	177549	8686755	2090	netupitant	prophylaxis of nausea and vomiting	0	0	18.49	1	0	23	80	8326	2090	netupitant	prophylaxis of nausea and vomiting	14	75	0	0	55.47	1	0	19	9	1931	2090	netupitant	prophylaxis of nausea and vomiting	0	0	139.05	1	0	9	5	1013	2090	netupitant	prophylaxis of nausea and vomiting	0	0	71.49	1	0	12	8	1305	2090	netupitant	prophylaxis of nausea and vomiting	-13.03	2.19352657735311e-06	1400.44	0.99	-0.04	0.01	0	-0.16	0.57	0.79
2091	nitrogen	2.27	0.9	4.79	0.041	7	151	177542	8686639	2091	nitrogen	hodgkin s disease	0	0	102.46	1	0	10	22	4725	2091	nitrogen	hodgkin s disease	32.5	40.9	0	0	Inf	1	0	0	0	125	2091	nitrogen	hodgkin s disease	0	0	Inf	1	0	1	0	517	2091	nitrogen	hodgkin s disease	0	0	Inf	1	0	0	2	410	2091	nitrogen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2092	patiromer sorbitex calcium	0.15	0.08	0.26	6.8e-21	12	3938	177537	8682852	2092	patiromer sorbitex calcium	hyperkalaemia	2.24	0.49	20.85	0.37	11	2485	2	1013	2092	patiromer sorbitex calcium	hyperkalaemia	61.2	87.9	Inf	0.05	Inf	1	2	721	0	202	2092	patiromer sorbitex calcium	hyperkalaemia	Inf	0.12	Inf	1	3	606	0	178	2092	patiromer sorbitex calcium	hyperkalaemia	Inf	0.01	Inf	1	1	474	0	132	2092	patiromer sorbitex calcium	hyperkalaemia	15.67	6388435.75109224	1593.18	0.99	0.07	0.05	0.17	0.95	1.16	0.41
2093	cholic acid	0	0	8.51	1	0	23	177549	8686767	2093	cholic acid	inborn error in primary bile acid synthesis	0	0	Inf	1	0	5	0	0	2093	cholic acid	inborn error in primary bile acid synthesis	NA	NA	0	0	Inf	1	0	0	0	0	2093	cholic acid	inborn error in primary bile acid synthesis	0	0	Inf	1	0	3	0	0	2093	cholic acid	inborn error in primary bile acid synthesis	0	0	Inf	1	0	1	0	0	2093	cholic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2094	ceritinib	0.18	0.04	0.53	0.00014	3	812	177546	8685978	2094	ceritinib	non-small cell lung cancer	1.83	0.22	6.81	0.3	2	215	171	33712	2094	ceritinib	non-small cell lung cancer	43.2	79.8	2.67	0.06	16.74	0.32	1	79	25	5279	2094	ceritinib	non-small cell lung cancer	0	0	19.13	1	0	50	15	3323	2094	ceritinib	non-small cell lung cancer	8.39	0.9	38.58	0.03	2	51	13	2789	2094	ceritinib	non-small cell lung cancer	1.35	3.85742553069697	0.75	0.07	-0.01	0.01	0.47	-0.15	0.37	0.69
2095	carbon dioxide	1.51	0.18	5.66	0.39	2	65	177547	8686725	2095	carbon dioxide	laparoscopic surgery	2.19	0.03	180.75	0.54	1	13	1	29	2095	carbon dioxide	laparoscopic surgery	NA	NA	0	0	Inf	1	0	0	0	0	2095	carbon dioxide	laparoscopic surgery	0	0	Inf	1	0	2	0	1	2095	carbon dioxide	laparoscopic surgery	0	0	Inf	1	0	1	0	1	2095	carbon dioxide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2096	medical gas	0	0	1852.91	1	0	1	177549	8686789	2096	medical gas		0	0	Inf	1	0	0	0	0	2096	medical gas		NA	NA	0	0	Inf	1	0	0	0	0	2096	medical gas		0	0	Inf	1	0	0	0	0	2096	medical gas		0	0	Inf	1	0	0	0	0	2096	medical gas	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2097	helium	0	0	5.28	1	0	36	177549	8686754	2097	helium	status asthmaticus	0	0	Inf	1	0	3	0	185	2097	helium	status asthmaticus	NA	NA	0	0	Inf	1	0	0	0	0	2097	helium	status asthmaticus	0	0	Inf	1	0	3	0	14	2097	helium	status asthmaticus	0	0	Inf	1	0	0	0	25	2097	helium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2098	nintedanib esylate	0.49	0.31	0.73	0.00012	24	2410	177525	8684380	2098	nintedanib esylate	idiopathic pulmonary fibrosis	0.8	0.47	1.3	0.42	21	2080	92	7316	2098	nintedanib esylate	idiopathic pulmonary fibrosis	55.7	80.4	0.75	0.37	1.43	0.46	13	1040	46	2777	2098	nintedanib esylate	idiopathic pulmonary fibrosis	0.57	0.23	1.26	0.18	8	889	36	2299	2098	nintedanib esylate	idiopathic pulmonary fibrosis	1.12	0.39	2.9	0.82	7	460	16	1176	2098	nintedanib esylate	idiopathic pulmonary fibrosis	-0.33	0.718923733431926	0.3	0.27	-0.02	0.01	0.02	0	0.26	1
2099	ledipasvir	0.9	0.78	1.03	0.14	219	11887	177330	8674903	2099	ledipasvir	hepatitis c	0.86	0.71	1.03	0.098	132	5579	2399	87187	2099	ledipasvir	hepatitis c	32.8	65	0.96	0.76	1.19	0.74	105	3355	452	13814	2099	ledipasvir	hepatitis c	0.86	0.63	1.14	0.3	60	2599	261	9692	2099	ledipasvir	hepatitis c	1.07	0.79	1.43	0.65	60	1812	246	7935	2099	ledipasvir	hepatitis c	0	1	0.1	0.96	-0.02	0	0	-0.17	0.08	0.03
2100	brivaracetam	2.49	0.89	5.58	0.039	6	118	177543	8686672	2100	brivaracetam	epilepsy	3.62	0.72	11.16	0.055	3	59	637	45367	2100	brivaracetam	epilepsy	13.6	68.1	4.14	0.47	16.78	0.093	2	30	85	5284	2100	brivaracetam	epilepsy	0	0	25	1	0	15	41	3537	2100	brivaracetam	epilepsy	8.11	0.89	34.95	0.031	2	19	54	4165	2100	brivaracetam	epilepsy	1.54	4.66459027098813	0.74	0.04	0	0	0.61	-0.15	0.21	0.48
2101	idelalisib	0.09	0.03	0.2	1.1e-20	6	3231	177543	8683559	2101	idelalisib	chronic lymphocytic leukaemia	0.16	0	0.94	0.045	1	1744	71	20115	2101	idelalisib	chronic lymphocytic leukaemia	50.7	85	0.14	0	0.87	0.02	1	1394	30	6048	2101	idelalisib	chronic lymphocytic leukaemia	0.18	0	1.08	0.07	1	1036	24	4351	2101	idelalisib	chronic lymphocytic leukaemia	0	0	2.25	0.38	0	498	10	2501	2101	idelalisib	chronic lymphocytic leukaemia	-2.03	0.131335521148493	1.01	0.05	-0.02	0.01	0.22	0.34	0.38	0.37
2102	ferric citrate	0	0	0.49	0.0011	0	367	177549	8686423	2102	ferric citrate	blood phosphorus increased	0	0	0.3	3.9e-05	0	123	32	292	2102	ferric citrate	blood phosphorus increased	NA	NA	0	0	Inf	1	0	0	0	0	2102	ferric citrate	blood phosphorus increased	0	0	Inf	1	0	25	0	23	2102	ferric citrate	blood phosphorus increased	0	0	Inf	1	0	23	0	24	2102	ferric citrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2103	nitrous oxide	0.98	0.66	1.39	1	31	1554	177518	8685236	2103	nitrous oxide	anaesthesia	0.48	0.06	1.83	0.44	2	441	58	6163	2103	nitrous oxide	anaesthesia	23	71.2	0	0	24.25	1	0	13	9	556	2103	nitrous oxide	anaesthesia	0	0	674.4	1	0	21	1	366	2103	nitrous oxide	anaesthesia	0	0	14.38	1	0	16	10	469	2103	nitrous oxide	anaesthesia	-14.93	3.28082741402858e-07	1686.03	0.99	0	0.01	0.96	-2.06	1.05	0.05
2104	lumacaftor	0.41	0.24	0.65	2.1e-05	18	2144	177531	8684646	2104	lumacaftor	cystic fibrosis	1.71	0.92	3.07	0.073	18	2120	39	7853	2104	lumacaftor	cystic fibrosis	14.3	57.2	2.06	0.72	5.88	0.13	9	1103	9	2276	2104	lumacaftor	cystic fibrosis	1.69	0.25	10.01	0.45	3	634	4	1428	2104	lumacaftor	cystic fibrosis	2.32	0.64	8.08	0.13	6	655	7	1770	2104	lumacaftor	cystic fibrosis	0.85	2.33964685192599	0.46	0.07	0.03	0.01	0.04	-0.5	0.47	0.29
2105	ethinyl	10.69	10.21	11.18	0	2328	10787	175221	8676003	2105	ethinyl	contraception	3.68	3.36	4.03	2.3e-139	619	3308	7382	145326	2105	ethinyl	contraception	19	43	0.72	0.26	1.62	0.58	6	117	1709	23964	2105	ethinyl	contraception	0	0	Inf	1	0	0	0	22	2105	ethinyl	contraception	0.63	0.25	1.33	0.27	7	165	1932	28740	2105	ethinyl	contraception	-0.46	0.631283645506926	0.39	0.23	0	0	0.92	-10.86	114.15	0.92
2106	asenapine	2.44	1.62	3.54	3e-05	29	582	177520	8686208	2106	asenapine	bipolar disorder	0.45	0.09	1.36	0.22	3	133	2574	51816	2106	asenapine	bipolar disorder	19.9	69	0	0	1.79	0.27	0	35	365	5850	2106	asenapine	bipolar disorder	0	0	4.87	1	0	19	123	2758	2106	asenapine	bipolar disorder	0	0	2.41	0.4	0	26	285	4477	2106	asenapine	bipolar disorder	-12.69	3.08178987968946e-06	216.5	0.95	0	0	0.45	-0.35	0.11	0
2107	ivabradine	0.98	0.65	1.41	1	29	1450	177520	8685340	2107	ivabradine	cardiac failure	2.86	0.34	10.9	0.16	2	134	75	14370	2107	ivabradine	cardiac failure	49.9	87.2	6.13	0.14	44.57	0.17	1	50	10	3069	2107	ivabradine	cardiac failure	0	0	32.24	1	0	42	8	2238	2107	ivabradine	cardiac failure	25.8	0.5	283.09	0.05	1	14	4	1464	2107	ivabradine	cardiac failure	1.65	5.20697982717985	1.05	0.12	-0.01	0.02	0.43	-0.01	0.57	0.99
2108	amphetamine aspartate monohydrate	0	0	21.83	1	0	10	177549	8686780	2108	amphetamine aspartate monohydrate	narcolepsy	0	0	40.3	1	0	3	1854	30873	2108	amphetamine aspartate monohydrate	narcolepsy	18.4	61.1	0	0	Inf	1	0	0	640	8838	2108	amphetamine aspartate monohydrate	narcolepsy	0	0	Inf	1	0	0	162	2920	2108	amphetamine aspartate monohydrate	narcolepsy	0	0	Inf	1	0	0	551	7668	2108	amphetamine aspartate monohydrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2109	olaparib	0.8	0.46	1.31	0.49	16	973	177533	8685817	2109	olaparib	ovarian cancer	2.71	1.42	4.8	0.0016	14	504	101	9849	2109	olaparib	ovarian cancer	45.7	74.2	4.81	2.11	10.51	0.00011	12	192	20	1540	2109	olaparib	ovarian cancer	0	0	Inf	1	0	0	0	3	2109	olaparib	ovarian cancer	5.01	2.3	10.48	3.6e-05	13	222	23	1971	2109	olaparib	ovarian cancer	1.62	5.05309031656387	0.35	0	0.01	0.01	0.55	-11.11	840.27	0.99
2110	cobimetinib fumarate	0	0	0.68	0.0077	0	269	177549	8686521	2110	cobimetinib fumarate	metastatic malignant melanoma	0	0	9.44	1	0	112	36	9648	2110	cobimetinib fumarate	metastatic malignant melanoma	39.5	75.5	0	0	18.71	1	0	59	12	2990	2110	cobimetinib fumarate	metastatic malignant melanoma	0	0	33.8	1	0	43	8	2402	2110	cobimetinib fumarate	metastatic malignant melanoma	0	0	50.25	1	0	27	6	1529	2110	cobimetinib fumarate	metastatic malignant melanoma	-13.94	8.82947583446219e-07	1284.59	0.99	-0.01	0.02	0.74	-0.15	0.54	0.79
2111	piperacillin	0.44	0.35	0.54	2e-17	81	9049	177468	8677741	2111	piperacillin	prophylaxis	0.24	0.03	0.89	0.03	2	658	1277	102893	2111	piperacillin	prophylaxis	23.9	79.7	0	0	2.78	0.65	0	154	207	23506	2111	piperacillin	prophylaxis	0	0	6.07	1	0	105	82	13623	2111	piperacillin	prophylaxis	0	0	4.94	1	0	75	148	14337	2111	piperacillin	prophylaxis	-12.75	2.9023204086504e-06	293.19	0.97	-0.01	0	0.02	-0.52	0.14	0
2112	tazobactam	0.37	0.28	0.47	7.1e-21	62	8293	177487	8678497	2112	tazobactam	pneumonia	0.12	0.01	0.45	3.3e-05	2	700	393	16965	2112	tazobactam	pneumonia	28	83	0.29	0.01	1.71	0.25	1	175	48	2425	2112	tazobactam	pneumonia	0	0	4.48	1	0	97	15	1532	2112	tazobactam	pneumonia	0.32	0.01	1.91	0.36	1	112	45	1611	2112	tazobactam	pneumonia	-1.36	0.256660776953556	1.01	0.18	-0.01	0.01	0.04	-1.07	0.3	0
2113	belinostat	0	0	5.98	1	0	32	177549	8686758	2113	belinostat	neoplasm of thymus	0	0	Inf	1	0	2	0	30	2113	belinostat	neoplasm of thymus	NA	NA	0	0	Inf	1	0	0	0	0	2113	belinostat	neoplasm of thymus	0	0	Inf	1	0	0	0	5	2113	belinostat	neoplasm of thymus	0	0	Inf	1	0	0	0	5	2113	belinostat	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2114	darunavir hydrate	0.5	0.01	2.88	1	1	97	177548	8686693	2114	darunavir hydrate	hiv infection	0	0	5.9	1	0	75	500	58316	2114	darunavir hydrate	hiv infection	25	64	0	0	Inf	1	0	0	120	7641	2114	darunavir hydrate	hiv infection	0	0	Inf	1	0	0	96	5728	2114	darunavir hydrate	hiv infection	0	0	Inf	1	0	0	40	3439	2114	darunavir hydrate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2115	finafloxacin	0	0	1852.91	1	0	1	177549	8686789	2115	finafloxacin	migraine	0	0	866.44	1	0	1	1787	40244	2115	finafloxacin	migraine	20.7	70.1	0	0	Inf	1	0	0	267	7400	2115	finafloxacin	migraine	0	0	Inf	1	0	0	32	1049	2115	finafloxacin	migraine	0	0	Inf	1	0	0	265	7201	2115	finafloxacin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2116	edoxaban tosylate	0.25	0.05	0.73	0.0048	3	588	177546	8686202	2116	edoxaban tosylate	atrial fibrillation	0.63	0.02	3.54	1	1	220	807	111189	2116	edoxaban tosylate	atrial fibrillation	49	86.6	0	0	13.02	1	0	77	132	34549	2116	edoxaban tosylate	atrial fibrillation	0	0	34.65	1	0	45	56	22028	2116	edoxaban tosylate	atrial fibrillation	0	0	16.95	1	0	44	94	17889	2116	edoxaban tosylate	atrial fibrillation	-12.04	5.90329434098699e-06	413.69	0.98	-0.01	0	0	-0.76	0.17	0
2118	deoxycholic acid	0.11	0	0.61	0.0021	1	451	177548	8686339	2118	deoxycholic acid	fat tissue increased	Inf	0	Inf	1	1	269	0	12	2118	deoxycholic acid	fat tissue increased	29.6	29.6	0	0	Inf	1	0	0	0	0	2118	deoxycholic acid	fat tissue increased	0	0	Inf	1	0	24	0	3	2118	deoxycholic acid	fat tissue increased	0	0	Inf	1	1	136	0	0	2118	deoxycholic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2119	oritavancin diphosphate	0.66	0.13	1.94	0.64	3	224	177546	8686566	2119	oritavancin diphosphate	cellulitis	0.95	0.02	5.65	1	1	53	81	4060	2119	oritavancin diphosphate	cellulitis	19	83.5	3.3	0.07	25.79	0.29	1	34	8	899	2119	oritavancin diphosphate	cellulitis	0	0	Inf	1	0	15	0	515	2119	oritavancin diphosphate	cellulitis	2.57	0.06	19.72	0.35	1	20	10	515	2119	oritavancin diphosphate	cellulitis	1.02	2.7731947639643	1.08	0.35	-0.01	0.02	0.37	-17.67	1260.64	0.99
2120	peramivir	0	0	7.78	1	0	25	177549	8686765	2120	peramivir	adverse event	0	0	361.39	1	0	2	16	1049	2120	peramivir	adverse event	48.2	73.4	0	0	3986.29	1	0	2	1	217	2120	peramivir	adverse event	0	0	3934.8	1	0	2	1	214	2120	peramivir	adverse event	0	0	Inf	1	0	0	2	159	2120	peramivir	adverse event	-12.19	5.08101252647241e-06	2797.44	1	0	0.03	0.92	-0.98	1.23	0.43
2121	eteplirsen	0	0	1852.91	1	0	1	177549	8686789	2121	eteplirsen	duchenne muscular dystrophy	0	0	Inf	1	0	1	0	54	2121	eteplirsen	duchenne muscular dystrophy	NA	NA	0	0	Inf	1	0	0	0	0	2121	eteplirsen	duchenne muscular dystrophy	0	0	Inf	1	0	1	0	10	2121	eteplirsen	duchenne muscular dystrophy	0	0	Inf	1	0	0	0	0	2121	eteplirsen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2122	avibactam sodium	0	0	4.85	1	0	39	177549	8686751	2122	avibactam sodium	klebsiella infection	0	0	2725.79	1	0	4	1	291	2122	avibactam sodium	klebsiella infection	NA	NA	0	0	Inf	1	0	0	0	0	2122	avibactam sodium	klebsiella infection	0	0	Inf	1	0	1	0	33	2122	avibactam sodium	klebsiella infection	0	0	Inf	1	0	3	0	41	2122	avibactam sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2123	rolapitant	0.41	0.01	2.36	0.74	1	118	177548	8686672	2123	rolapitant	nausea	0.29	0.01	1.65	0.27	1	86	1223	30322	2123	rolapitant	nausea	17.2	77	0	0	2.95	0.64	0	46	218	7646	2123	rolapitant	nausea	0	0	10.04	1	0	27	50	3314	2123	rolapitant	nausea	0	0	5.26	1	0	22	195	5572	2123	rolapitant	nausea	-12.57	3.47470838657905e-06	336.07	0.97	-0.03	0	0	-0.77	0.16	0
2125	ombitasvir	0.78	0.33	1.54	0.63	8	505	177541	8686285	2125	ombitasvir	hepatitis c	0.67	0.24	1.48	0.49	6	327	2525	92439	2125	ombitasvir	hepatitis c	32.8	65	0.64	0.13	1.92	0.63	3	144	554	17025	2125	ombitasvir	hepatitis c	1.09	0.29	2.87	0.79	4	141	317	12150	2125	ombitasvir	hepatitis c	0.37	0.01	2.12	0.53	1	86	305	9661	2125	ombitasvir	hepatitis c	-0.14	0.869358235398806	0.45	0.76	-0.02	0	0	-0.17	0.08	0.03
2126	paritaprevir	0.91	0.39	1.8	1	8	432	177541	8686358	2126	paritaprevir	hepatitis c	0.76	0.28	1.68	0.71	6	288	2525	92478	2126	paritaprevir	hepatitis c	32.8	65	0.68	0.14	2.05	0.8	3	135	554	17034	2126	paritaprevir	hepatitis c	1.16	0.31	3.08	0.78	4	132	317	12159	2126	paritaprevir	hepatitis c	0.38	0.01	2.2	0.52	1	83	305	9664	2126	paritaprevir	hepatitis c	-0.08	0.923116346386636	0.45	0.86	-0.02	0	0	-0.17	0.08	0.03
2127	eltrombopag	0.08	0.01	0.28	3.4e-09	2	1287	177547	8685503	2127	eltrombopag	thrombocytopenia	0	0	0.82	0.024	0	558	24	2750	2127	eltrombopag	thrombocytopenia	45.5	82.4	0	0	113.59	1	0	146	1	425	2127	eltrombopag	thrombocytopenia	0	0	14.69	1	0	101	2	276	2127	eltrombopag	thrombocytopenia	0	0	190.66	1	0	62	1	303	2127	eltrombopag	thrombocytopenia	-16.43	7.32051546311555e-08	2272.28	0.99	0	0.03	0.88	0.77	1.23	0.53
2128	ceftolozane	0	0	1.37	0.12	0	134	177549	8686656	2128	ceftolozane	pseudomonas infection	0	0	26.08	1	0	23	18	2456	2128	ceftolozane	pseudomonas infection	18.8	83.3	0	0	214.93	1	0	7	4	865	2128	ceftolozane	pseudomonas infection	0	0	796.64	1	0	4	2	527	2128	ceftolozane	pseudomonas infection	0	0	118.8	1	0	7	5	645	2128	ceftolozane	pseudomonas infection	-13.92	9.00784307805218e-07	1918.9	0.99	0.02	0.02	0.18	-0.74	0.84	0.38
2129	daclatasvir	0.6	0.44	0.8	0.00017	48	3912	177501	8682878	2129	daclatasvir	hepatitis c	0.64	0.43	0.91	0.01	32	1823	2499	90943	2129	daclatasvir	hepatitis c	32.8	65	0.72	0.45	1.1	0.16	23	964	534	16205	2129	daclatasvir	hepatitis c	0.58	0.3	1.04	0.077	12	768	309	11523	2129	daclatasvir	hepatitis c	0.75	0.39	1.32	0.37	13	543	293	9204	2129	daclatasvir	hepatitis c	-0.4	0.670320046035639	0.21	0.05	-0.02	0	0	-0.17	0.08	0.04
2130	tirofibran	0	0	74.11	1	0	4	177549	8686786	2130	tirofibran	acute coronary syndrome	0	0	2987.97	1	0	1	104	8357	2130	tirofibran	acute coronary syndrome	51.9	87.2	0	0	Inf	1	0	0	26	1653	2130	tirofibran	acute coronary syndrome	0	0	Inf	1	0	0	9	1273	2130	tirofibran	acute coronary syndrome	0	0	Inf	1	0	0	21	646	2130	tirofibran	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2132	eluxadoline	0.54	0.26	1.01	0.057	10	898	177539	8685892	2132	eluxadoline	irritable bowel syndrome	0.19	0.05	0.5	3.6e-05	4	495	382	9147	2132	eluxadoline	irritable bowel syndrome	21	70.7	0.49	0.13	1.33	0.23	4	197	60	1436	2132	eluxadoline	irritable bowel syndrome	0	0	4.48	0.61	0	60	8	447	2132	eluxadoline	irritable bowel syndrome	0.45	0.12	1.24	0.18	4	229	61	1583	2132	eluxadoline	irritable bowel syndrome	-1.22	0.295230166924014	0.53	0.02	-0.03	0.01	0	-0.88	0.38	0.02
2133	lenvatinib mesylate	0.22	0.06	0.56	0.00012	4	905	177545	8685885	2133	lenvatinib mesylate	thyroid cancer	0.39	0.05	1.53	0.22	2	433	34	2871	2133	lenvatinib mesylate	thyroid cancer	37.5	77.9	0.44	0.01	3.96	0.67	1	265	5	582	2133	lenvatinib mesylate	thyroid cancer	0	0	83.7	1	0	141	1	302	2133	lenvatinib mesylate	thyroid cancer	0.34	0.01	2.83	0.44	1	196	6	399	2133	lenvatinib mesylate	thyroid cancer	-1.03	0.357006960569147	1.09	0.35	-0.03	0.02	0.24	-1.69	1.07	0.12
2134	sorafenib	0.36	0.27	0.46	1.4e-20	59	8016	177490	8678774	2134	sorafenib	hepatic neoplasm malignant	4.48	1.29	16.18	0.0085	7	1800	6	6921	2134	sorafenib	hepatic neoplasm malignant	NA	NA	0	0	Inf	1	0	0	0	0	2134	sorafenib	hepatic neoplasm malignant	0	0	Inf	1	0	0	0	0	2134	sorafenib	hepatic neoplasm malignant	0	0	Inf	1	0	0	0	0	2134	sorafenib	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2135	palbociclib	0.53	0.42	0.64	8.4e-12	94	8735	177455	8678055	2135	palbociclib	breast cancer	0.35	0.21	0.54	8.1e-08	19	2469	1427	64313	2135	palbociclib	breast cancer	40	78	0.61	0.33	1.06	0.08	15	1815	112	8332	2135	palbociclib	breast cancer	0	0	Inf	1	0	27	0	89	2135	palbociclib	breast cancer	0.57	0.32	0.96	0.037	16	2118	128	9658	2135	palbociclib	breast cancer	-0.56	0.571209063848815	0.27	0.04	0	0.01	0.97	-13.13	366.26	0.97
2136	safinamide mesylate	0	0	11.12	1	0	18	177549	8686772	2136	safinamide mesylate	parkinson s disease	0	0	7.29	1	0	18	872	27906	2136	safinamide mesylate	parkinson s disease	50.1	85.7	0	0	14.45	1	0	12	163	6486	2136	safinamide mesylate	parkinson s disease	0	0	19.05	1	0	10	98	4122	2136	safinamide mesylate	parkinson s disease	0	0	188.74	1	0	2	85	2995	2136	safinamide mesylate	parkinson s disease	-11.87	6.99720342114394e-06	419.19	0.98	-0.03	0.01	0	-0.2	0.15	0.18
2137	pimavanserin tartrate	1.13	0.76	1.62	0.49	30	1298	177519	8685492	2137	pimavanserin tartrate	parkinson s disease psychosis	Inf	0.18	Inf	1	22	681	0	24	2137	pimavanserin tartrate	parkinson s disease psychosis	63	83.9	Inf	0.15	Inf	1	18	339	0	13	2137	pimavanserin tartrate	parkinson s disease psychosis	Inf	0.1	Inf	1	15	295	0	10	2137	pimavanserin tartrate	parkinson s disease psychosis	Inf	0.02	Inf	1	5	146	0	5	2137	pimavanserin tartrate	parkinson s disease psychosis	14.38	1758549.71192173	1018.38	0.99	0.02	0.03	0.47	0.44	0.53	0.41
2138	isavuconazonium	0	0	0.57	0.0039	0	321	177549	8686469	2138	isavuconazonium	aspergillus infection	0	0	23.45	1	0	59	4	897	2138	isavuconazonium	aspergillus infection	NA	NA	0	0	Inf	1	0	0	0	0	2138	isavuconazonium	aspergillus infection	0	0	Inf	1	0	15	0	287	2138	isavuconazonium	aspergillus infection	0	0	Inf	1	0	14	0	176	2138	isavuconazonium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2140	aripiprazole lauroxil	1.4	0.6	2.8	0.29	8	279	177541	8686511	2140	aripiprazole lauroxil	schizophrenia	2.07	0.88	4.2	0.065	8	152	1507	59372	2140	aripiprazole lauroxil	schizophrenia	20.1	64.1	2.04	0.85	4.23	0.069	8	95	286	6919	2140	aripiprazole lauroxil	schizophrenia	0.51	0.01	3.02	1	1	56	181	5206	2140	aripiprazole lauroxil	schizophrenia	2.51	0.95	5.6	0.031	7	64	141	3231	2140	aripiprazole lauroxil	schizophrenia	0.45	1.56831218549017	0.37	0.22	-0.02	0	0	-0.3	0.11	0.01
2141	tenofovir alafenamide fumarate	0.59	0.16	1.53	0.43	4	331	177545	8686459	2141	tenofovir alafenamide fumarate	hiv infection	2.53	0.51	7.59	0.12	3	139	497	58252	2141	tenofovir alafenamide fumarate	hiv infection	25	64	1.42	0.17	5.4	0.65	2	90	118	7551	2141	tenofovir alafenamide fumarate	hiv infection	1.43	0.17	5.47	0.65	2	84	94	5644	2141	tenofovir alafenamide fumarate	hiv infection	3.36	0.08	21.57	0.27	1	26	39	3413	2141	tenofovir alafenamide fumarate	hiv infection	0.58	1.78603843075007	0.59	0.33	0	0.01	0.78	0.37	0.2	0.06
2142	sacubitril	0.18	0.12	0.26	8.8e-35	28	7501	177521	8679289	2142	sacubitril	cardiac failure	0.88	0.37	1.84	0.86	8	1683	69	12821	2142	sacubitril	cardiac failure	49.9	87.2	1.16	0.12	5.63	0.69	2	501	9	2618	2142	sacubitril	cardiac failure	1.6	0.16	8.96	0.63	2	394	6	1886	2142	sacubitril	cardiac failure	1.8	0.04	18.34	0.48	1	180	4	1298	2142	sacubitril	cardiac failure	0.48	1.61607440219289	0.66	0.46	-0.01	0.02	0.41	0	0.57	1
2143	fish oil	1.47	1.4	1.55	8.5e-47	1605	53467	175944	8633323	2143	fish oil	hypertension	1.22	1.02	1.45	0.024	137	5182	6758	312431	2143	fish oil	hypertension	38	82.9	1.38	0.91	2	0.097	29	1349	952	61060	2143	fish oil	hypertension	1.45	0.68	2.71	0.25	10	647	331	30992	2143	fish oil	hypertension	1.36	0.84	2.09	0.16	22	854	740	39076	2143	fish oil	hypertension	0.39	1.47698079388264	0.18	0.03	-0.02	0	0	-0.59	0.07	0
2144	medium chain triglycerides	0	0	74.11	1	0	4	177549	8686786	2144	medium chain triglycerides	haemostasis	0	0	16384	1	0	1	1	636	2144	medium chain triglycerides	haemostasis	NA	NA	0	0	Inf	1	0	0	0	0	2144	medium chain triglycerides	haemostasis	0	0	Inf	1	0	0	0	93	2144	medium chain triglycerides	haemostasis	0	0	Inf	1	0	1	0	62	2144	medium chain triglycerides	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2147	selexipag	0.7	0.43	1.08	0.11	21	1458	177528	8685332	2147	selexipag	pulmonary arterial hypertension	2.3	1.13	4.17	0.011	11	875	471	86028	2147	selexipag	pulmonary arterial hypertension	28	80	1.58	0.77	2.89	0.18	11	761	259	28283	2147	selexipag	pulmonary arterial hypertension	0.77	0.02	4.54	1	1	205	54	8553	2147	selexipag	pulmonary arterial hypertension	1.65	0.78	3.1	0.15	10	651	239	25635	2147	selexipag	pulmonary arterial hypertension	0.4	1.49182469764127	0.31	0.19	0	0	0.14	-0.41	0.15	0.01
2148	trabectedin	0.12	0.01	0.43	1.7e-05	2	821	177547	8685969	2148	trabectedin	ovarian cancer	0.73	0.09	2.74	1	2	244	113	10109	2148	trabectedin	ovarian cancer	45.7	74.2	0	0	2.62	0.4	0	79	32	1653	2148	trabectedin	ovarian cancer	0	0	Inf	1	0	0	0	3	2148	trabectedin	ovarian cancer	0	0	2.43	0.4	0	95	36	2098	2148	trabectedin	ovarian cancer	-14.51	4.99329319477119e-07	668.77	0.98	0.01	0.01	0.58	-14.5	3765.82	1
2149	tipiracil	0.11	0.02	0.32	1.3e-08	3	1331	177546	8685459	2149	tipiracil	colon cancer	0	0	1.09	0.081	0	673	74	14298	2149	tipiracil	colon cancer	44.6	81.9	0	0	1.21	0.1	0	406	23	2799	2149	tipiracil	colon cancer	0	0	2.45	0.38	0	263	12	1777	2149	tipiracil	colon cancer	0	0	2.08	0.24	0	201	15	1485	2149	tipiracil	colon cancer	-15.78	1.40227462590254e-07	820.31	0.98	0.01	0.01	0.47	-0.41	0.39	0.3
2150	dabigatran etexilate	0.06	0	0.31	7.9e-07	1	884	177548	8685906	2150	dabigatran etexilate	atrial fibrillation	0	0	2.1	0.43	0	244	808	111165	2150	dabigatran etexilate	atrial fibrillation	49	86.6	0	0	31.41	1	0	33	132	34593	2150	dabigatran etexilate	atrial fibrillation	0	0	98.28	1	0	17	56	22056	2150	dabigatran etexilate	atrial fibrillation	0	0	30.84	1	0	25	94	17908	2150	dabigatran etexilate	atrial fibrillation	-10.98	1.70390975269345e-05	368.31	0.98	-0.01	0	0	-0.76	0.17	0
2151	lesinurad	0	0	28.67	1	0	8	177549	8686782	2151	lesinurad	gout	0	0	41.5	1	0	7	249	14821	2151	lesinurad	gout	41	78.7	0	0	391.76	1	0	2	46	3324	2151	lesinurad	gout	0	0	140.54	1	0	4	34	3077	2151	lesinurad	gout	0	0	Inf	1	0	0	17	1406	2151	lesinurad	gout	-11.34	1.18877749621577e-05	726.32	0.99	-0.01	0.01	0.06	-0.16	0.3	0.61
2152	midostaurin	0	0	2.5	0.41	0	74	177549	8686716	2152	midostaurin	acute myeloid leukaemia	0	0	38.95	1	0	47	31	13962	2152	midostaurin	acute myeloid leukaemia	47	65.9	0	0	Inf	1	0	3	0	817	2152	midostaurin	acute myeloid leukaemia	0	0	5425.54	1	0	9	1	1367	2152	midostaurin	acute myeloid leukaemia	0	0	1083.51	1	0	6	2	1120	2152	midostaurin	acute myeloid leukaemia	-11.76	7.81082473356277e-06	1664.1	0.99	0	0.03	0.9	-0.88	1.23	0.47
2153	obeticholic acid	0	0	0.91	0.038	0	200	177549	8686590	2153	obeticholic acid	biliary cirrhosis primary	0	0	10.85	1	0	162	2	328	2153	obeticholic acid	biliary cirrhosis primary	NA	NA	0	0	Inf	1	0	0	0	0	2153	obeticholic acid	biliary cirrhosis primary	0	0	Inf	1	0	6	0	22	2153	obeticholic acid	biliary cirrhosis primary	0	0	Inf	1	0	43	0	68	2153	obeticholic acid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2154	barium	0.56	0.18	1.31	0.23	5	439	177544	8686351	2154	barium	computerised tomogram abdomen	1.2	0.03	7.52	0.58	1	64	28	2156	2154	barium	computerised tomogram abdomen	53	53	0	0	Inf	1	0	0	0	0	2154	barium	computerised tomogram abdomen	0	0	Inf	1	0	0	0	52	2154	barium	computerised tomogram abdomen	0	0	Inf	1	0	0	2	102	2154	barium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2157	osimertinib mesylate	0.07	0	0.38	2.1e-05	1	713	177548	8686077	2157	osimertinib mesylate	non-small cell lung cancer	0	0	2.54	0.41	0	287	173	33640	2157	osimertinib mesylate	non-small cell lung cancer	43.2	79.8	0	0	4.25	1	0	187	26	5171	2157	osimertinib mesylate	non-small cell lung cancer	0	0	12.35	1	0	76	15	3297	2157	osimertinib mesylate	non-small cell lung cancer	0	0	4.82	1	0	157	15	2683	2157	osimertinib mesylate	non-small cell lung cancer	-14.26	6.41151537506014e-07	703.48	0.98	-0.01	0.01	0.39	-0.19	0.37	0.61
2158	lifitegrast	0.17	0.02	0.62	0.0015	2	569	177547	8686221	2158	lifitegrast	dry eye	0.63	0.07	2.34	0.77	2	361	105	11874	2158	lifitegrast	dry eye	42.4	82.3	1	0.12	3.99	1	2	190	32	3055	2158	lifitegrast	dry eye	0	0	677.76	1	0	39	1	684	2158	lifitegrast	dry eye	0.99	0.11	3.92	1	2	179	35	3114	2158	lifitegrast	dry eye	-0.03	0.970445533548508	0.73	0.97	-0.02	0.01	0.01	-2.15	1.02	0.03
2160	defibrotide sodium	0	0	2.86	0.64	0	65	177549	8686725	2160	defibrotide sodium	venoocclusive disease	0	0	Inf	1	0	23	0	79	2160	defibrotide sodium	venoocclusive disease	NA	NA	0	0	Inf	1	0	0	0	0	2160	defibrotide sodium	venoocclusive disease	0	0	Inf	1	0	8	0	20	2160	defibrotide sodium	venoocclusive disease	0	0	Inf	1	0	6	0	15	2160	defibrotide sodium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2161	uridine triacetate	0	0	9.91	1	0	20	177549	8686770	2161	uridine triacetate	pancreatic carcinoma metastatic	0	0	537.07	1	0	6	6	3011	2161	uridine triacetate	pancreatic carcinoma metastatic	77.6	77.6	0	0	Inf	1	0	0	0	0	2161	uridine triacetate	pancreatic carcinoma metastatic	0	0	10877.09	1	0	2	1	671	2161	uridine triacetate	pancreatic carcinoma metastatic	0	0	Inf	1	0	2	0	463	2161	uridine triacetate	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2162	tenofovir disoproxil	0.09	0.05	0.14	8.1e-53	15	8379	177534	8678411	2162	tenofovir disoproxil	hiv infection	0.19	0.08	0.36	4.5e-11	9	5246	491	53145	2162	tenofovir disoproxil	hiv infection	25	64	0.05	0	0.29	4.2e-07	1	1098	119	6543	2162	tenofovir disoproxil	hiv infection	0.23	0.05	0.68	0.0026	3	715	93	5013	2162	tenofovir disoproxil	hiv infection	0	0	0.51	0.0017	0	546	40	2893	2162	tenofovir disoproxil	hiv infection	-1.94	0.143703949777703	0.58	0	0	0.01	0.79	0.35	0.2	0.08
2163	elbasvir	0.52	0.21	1.07	0.095	7	661	177542	8686129	2163	elbasvir	hepatitis c	0.29	0.06	0.84	0.016	3	384	2528	92382	2163	elbasvir	hepatitis c	32.8	65	0.37	0.04	1.36	0.18	2	166	555	17003	2163	elbasvir	hepatitis c	0.29	0.01	1.67	0.27	1	130	320	12161	2163	elbasvir	hepatitis c	0.36	0.01	2.07	0.53	1	88	305	9659	2163	elbasvir	hepatitis c	-1.08	0.339595525644939	0.71	0.13	-0.02	0	0	-0.17	0.08	0.03
2164	grazoprevir	0.52	0.21	1.07	0.095	7	661	177542	8686129	2164	grazoprevir	hepatitis c	0.29	0.06	0.84	0.016	3	384	2528	92382	2164	grazoprevir	hepatitis c	32.8	65	0.37	0.04	1.36	0.18	2	166	555	17003	2164	grazoprevir	hepatitis c	0.29	0.01	1.67	0.27	1	130	320	12161	2164	grazoprevir	hepatitis c	0.36	0.01	2.07	0.53	1	88	305	9659	2164	grazoprevir	hepatitis c	-1.08	0.339595525644939	0.71	0.13	-0.02	0	0	-0.17	0.08	0.03
2165	ephedrine	5.4	4.59	6.33	1.2e-64	172	1559	177377	8685231	2165	ephedrine	anaesthesia	1.26	0.15	4.83	0.67	2	176	58	6428	2165	ephedrine	anaesthesia	23	71.2	0	0	26.57	1	0	12	9	557	2165	ephedrine	anaesthesia	0	0	791.76	1	0	18	1	369	2165	ephedrine	anaesthesia	0	0	24.67	1	0	10	10	475	2165	ephedrine	anaesthesia	-13.78	1.03614858769009e-06	1171.9	0.99	0	0.01	0.91	-2.06	1.05	0.05
2166	etelcalcetide	0	0	1852.91	1	0	1	177549	8686789	2166	etelcalcetide	anaemia	0	0	1577.65	1	0	1	468	19409	2166	etelcalcetide	anaemia	22.2	83.9	0	0	2656.09	1	0	1	57	4049	2166	etelcalcetide	anaemia	0	0	Inf	1	0	0	6	1866	2166	etelcalcetide	anaemia	0	0	1755.74	1	0	1	59	2730	2166	etelcalcetide	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2167	velpatasvir	0.86	0.37	1.7	0.87	8	457	177541	8686333	2167	velpatasvir	chronic hepatitis c	1.41	0.45	3.38	0.41	5	212	429	25709	2167	velpatasvir	chronic hepatitis c	32.7	72.1	1.1	0.22	3.33	0.76	3	184	155	10462	2167	velpatasvir	chronic hepatitis c	0	0	2.31	0.41	0	117	94	6649	2167	velpatasvir	chronic hepatitis c	4.58	1.41	11.62	0.0067	5	78	77	5508	2167	velpatasvir	chronic hepatitis c	0.56	1.7506725002961	0.46	0.22	-0.02	0.01	0	-0.09	0.15	0.57
2168	dolutegravir	1.04	0.58	1.73	0.79	15	703	177534	8686087	2168	dolutegravir	hiv infection	2.98	1.61	5.09	0.00046	14	559	486	57832	2168	dolutegravir	hiv infection	25	64	2.09	0.87	4.32	0.065	8	253	112	7388	2168	dolutegravir	hiv infection	1.59	0.56	3.64	0.29	6	231	90	5497	2168	dolutegravir	hiv infection	4.08	1.03	11.75	0.022	4	91	36	3348	2168	dolutegravir	hiv infection	0.75	2.11700001661267	0.33	0.02	0	0.01	0.8	0.36	0.2	0.06
2169	calcium gluconate	1.39	1.21	1.6	5.7e-06	212	7451	177337	8679339	2169	calcium gluconate	rheumatoid arthritis	0.58	0.19	1.37	0.3	5	1155	3405	459222	2169	calcium gluconate	rheumatoid arthritis	33	75	0	0	42.88	1	0	11	1060	113927	2169	calcium gluconate	rheumatoid arthritis	0	0	340.53	1	0	3	180	25388	2169	calcium gluconate	rheumatoid arthritis	0	0	47.71	1	0	10	1011	107954	2169	calcium gluconate	rheumatoid arthritis	-8.77	0.00015532358064889	148.25	0.95	-0.01	0	0	-0.26	0.08	0
2170	alectinib	0	0	0.76	0.017	0	238	177549	8686552	2170	alectinib	lung adenocarcinoma	0	0	26.18	1	0	71	12	5056	2170	alectinib	lung adenocarcinoma	62.1	76.9	0	0	892.91	1	0	32	1	742	2170	alectinib	lung adenocarcinoma	0	0	57.33	1	0	31	3	715	2170	alectinib	lung adenocarcinoma	0	0	Inf	1	0	39	0	810	2170	alectinib	lung adenocarcinoma	-17.19	3.42355931050604e-08	8423.7	1	0.04	0.06	0.47	17.97	2665.7	0.99
2172	ixazomib citrate	0.12	0.03	0.32	1.4e-09	4	1569	177545	8685221	2172	ixazomib citrate	plasma cell myeloma	0.46	0.09	1.34	0.23	3	1283	531	103632	2172	ixazomib citrate	plasma cell myeloma	47.4	82.5	0.94	0.11	3.45	1	2	519	162	39309	2172	ixazomib citrate	plasma cell myeloma	0	0	3.26	0.63	0	303	93	24259	2172	ixazomib citrate	plasma cell myeloma	2.39	0.48	7.28	0.14	3	295	88	20663	2172	ixazomib citrate	plasma cell myeloma	0.22	1.24607673058738	0.58	0.7	-0.03	0.01	0	-0.15	0.15	0.31
2173	prasterone	3.89	2.45	5.9	7.2e-08	24	302	177525	8686488	2173	prasterone	hypertension	0	0	7.65	1	0	24	6895	317589	2173	prasterone	hypertension	38	82.9	0	0	2388.53	1	0	1	981	62408	2173	prasterone	hypertension	0	0	3424.95	1	0	1	341	31638	2173	prasterone	hypertension	0	0	Inf	1	0	0	762	39930	2173	prasterone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2174	lixisenatide	0	0	8.51	1	0	23	177549	8686767	2174	lixisenatide	type 2 diabetes mellitus	0	0	58.59	1	0	9	1222	141089	2174	lixisenatide	type 2 diabetes mellitus	43	80.7	0	0	173.8	1	0	5	214	33889	2174	lixisenatide	type 2 diabetes mellitus	0	0	7291.94	1	0	1	85	17935	2174	lixisenatide	type 2 diabetes mellitus	0	0	153.34	1	0	5	154	21469	2174	lixisenatide	type 2 diabetes mellitus	-8.58	0.000187824977406354	218.29	0.97	0	0	0.71	-0.41	0.14	0
2176	venetoclax	0	0	0.26	1.8e-06	0	694	177549	8686096	2176	venetoclax	prophylaxis	0	0	1.24	0.13	0	243	1279	103308	2176	venetoclax	prophylaxis	23.9	79.7	0	0	2.09	0.43	0	204	207	23456	2176	venetoclax	prophylaxis	0	0	4.1	1	0	154	82	13574	2176	venetoclax	prophylaxis	0	0	4.35	1	0	85	148	14327	2176	venetoclax	prophylaxis	-12.6	3.37201523413918e-06	254.87	0.96	-0.01	0	0.03	-0.52	0.14	0
2177	liraglutide	0.17	0.09	0.3	2.1e-17	12	3479	177537	8683311	2177	liraglutide	type 2 diabetes mellitus	0.26	0.09	0.62	0.00036	5	2155	1217	138943	2177	liraglutide	type 2 diabetes mellitus	43	80.7	0	0	2.53	0.41	0	233	214	33661	2177	liraglutide	type 2 diabetes mellitus	0	0	5.18	1	0	154	85	17782	2177	liraglutide	type 2 diabetes mellitus	0	0	5.39	1	0	98	154	21376	2177	liraglutide	type 2 diabetes mellitus	-12.4	4.11858870753571e-06	248.6	0.96	0	0	0.71	-0.41	0.14	0
2179	dasabuvir sodium	0	0	19.5	1	0	11	177549	8686779	2179	dasabuvir sodium	hepatitis c	0	0	31.14	1	0	6	2531	92760	2179	dasabuvir sodium	hepatitis c	32.8	65	0	0	46.77	1	0	4	557	17165	2179	dasabuvir sodium	hepatitis c	0	0	Inf	1	0	0	321	12291	2179	dasabuvir sodium	hepatitis c	0	0	48.39	1	0	4	306	9743	2179	dasabuvir sodium	hepatitis c	-9.02	0.00012096612623881	162.32	0.96	-0.02	0	0	-0.17	0.08	0.03
2180	deflazacort	0.78	0.51	1.14	0.22	26	1636	177523	8685154	2180	deflazacort	rheumatoid arthritis	0.93	0.34	2.03	1	6	871	3404	459506	2180	deflazacort	rheumatoid arthritis	33	75	0.67	0.02	3.78	1	1	161	1059	113777	2180	deflazacort	rheumatoid arthritis	10.12	0.24	67.22	0.1	1	14	179	25377	2180	deflazacort	rheumatoid arthritis	0	0	2.34	0.41	0	170	1011	107794	2180	deflazacort	rheumatoid arthritis	-0.53	0.588604969678355	1	0.6	-0.01	0	0	-0.26	0.08	0
2183	brigatinib	0	0	1852.91	1	0	1	177549	8686789	2183	brigatinib	atrial fibrillation	0	0	4960.68	1	0	1	808	111408	2183	brigatinib	atrial fibrillation	49	86.6	0	0	8820.58	1	0	1	132	34625	2183	brigatinib	atrial fibrillation	0	0	Inf	1	0	0	56	22073	2183	brigatinib	atrial fibrillation	0	0	6665.5	1	0	1	94	17932	2183	brigatinib	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2188	edaravone	0	0	0.57	0.0038	0	318	177549	8686472	2188	edaravone	cerebral infarction	0	0	6.95	1	0	123	21	4394	2188	edaravone	cerebral infarction	49.8	69.9	0	0	250.76	1	0	2	5	213	2188	edaravone	cerebral infarction	0	0	151.32	1	0	16	2	441	2188	edaravone	cerebral infarction	0	0	55.54	1	0	7	5	300	2188	edaravone	cerebral infarction	-14.83	3.62587504520971e-07	2062.04	0.99	-0.04	0.02	0.01	-1.33	0.85	0.12
2192	idarucizumab	0	0	1.44	0.19	0	127	177549	8686663	2192	idarucizumab	atrial fibrillation	0	0	18.74	1	0	29	808	111380	2192	idarucizumab	atrial fibrillation	49	86.6	0	0	56.78	1	0	19	132	34607	2192	idarucizumab	atrial fibrillation	0	0	145.81	1	0	12	56	22061	2192	idarucizumab	atrial fibrillation	0	0	77.08	1	0	11	94	17922	2192	idarucizumab	atrial fibrillation	-9.91	4.96754356281337e-05	301.23	0.97	-0.01	0	0	-0.76	0.17	0
2193	daclizumab	0.25	0.12	0.49	3.2e-07	9	1727	177540	8685063	2193	daclizumab	prophylaxis against transplant rejection	0	0	2.78	0.65	0	190	70	9658	2193	daclizumab	prophylaxis against transplant rejection	14.5	68.6	0	0	1382.92	1	0	2	5	1177	2193	daclizumab	prophylaxis against transplant rejection	0	0	6097.25	1	0	1	5	863	2193	daclizumab	prophylaxis against transplant rejection	0	0	9498.7	1	0	1	2	571	2193	daclizumab	prophylaxis against transplant rejection	-11.3	1.23729242617882e-05	1695.9	0.99	-0.01	0.02	0.5	0.53	0.84	0.53
2194	brodalumab	0	0	24.79	1	0	9	177549	8686781	2194	brodalumab	psoriasis	0	0	148.65	1	0	5	1190	161686	2194	brodalumab	psoriasis	25	74.8	0	0	608.91	1	0	2	379	43523	2194	brodalumab	psoriasis	0	0	772.81	1	0	2	149	21342	2194	brodalumab	psoriasis	0	0	3668.84	1	0	1	274	27342	2194	brodalumab	psoriasis	-7.74	0.000435071575078732	187.16	0.97	0	0	0.71	-0.36	0.1	0
2195	reslizumab	0	0	11.12	1	0	18	177549	8686772	2195	reslizumab	asthma	0	0	13.14	1	0	11	3044	100363	2195	reslizumab	asthma	9	76	0	0	78.62	1	0	3	540	17513	2195	reslizumab	asthma	0	0	1618.33	1	0	1	147	6257	2195	reslizumab	asthma	0	0	169.52	1	0	2	458	14560	2195	reslizumab	asthma	-8.91	0.000135031833988743	186.08	0.96	-0.02	0	0	-0.41	0.1	0
2196	atezolizumab	0.15	0.02	0.56	0.00053	2	632	177547	8686158	2196	atezolizumab	non-small cell lung cancer	0	0	4.95	1	0	149	173	33778	2196	atezolizumab	non-small cell lung cancer	43.2	79.8	0	0	5.67	1	0	142	26	5216	2196	atezolizumab	non-small cell lung cancer	0	0	10.12	1	0	92	15	3281	2196	atezolizumab	non-small cell lung cancer	0	0	14.53	1	0	55	15	2785	2196	atezolizumab	non-small cell lung cancer	-14.22	6.67317428126274e-07	886.14	0.99	-0.01	0.01	0.35	-0.15	0.37	0.69
2197	elotuzumab	0.1	0.01	0.36	1e-06	2	982	177547	8685808	2197	elotuzumab	plasma cell myeloma	0.52	0.06	1.9	0.6	2	751	532	104164	2197	elotuzumab	plasma cell myeloma	47.4	82.5	0	0	2.25	0.42	0	401	164	39427	2197	elotuzumab	plasma cell myeloma	0	0	3.62	0.63	0	273	93	24289	2197	elotuzumab	plasma cell myeloma	0	0	5.27	1	0	165	91	20793	2197	elotuzumab	plasma cell myeloma	-13.03	2.19352657735311e-06	308.96	0.97	-0.03	0.01	0	-0.15	0.15	0.32
2198	daratumumab	0.07	0.01	0.24	1.3e-10	2	1450	177547	8685340	2198	daratumumab	plasma cell myeloma	0.37	0.04	1.35	0.19	2	1053	532	103862	2198	daratumumab	plasma cell myeloma	47.4	82.5	0	0	1.34	0.12	0	668	164	39160	2198	daratumumab	plasma cell myeloma	0	0	2.24	0.42	0	437	93	24125	2198	daratumumab	plasma cell myeloma	0	0	2.73	0.65	0	315	91	20643	2198	daratumumab	plasma cell myeloma	-13.17	1.90696039458808e-06	233.73	0.96	-0.03	0.01	0	-0.15	0.15	0.32
2199	sarilumab	0	0	118.34	1	0	3	177549	8686787	2199	sarilumab	rheumatoid arthritis	0	0	710.39	1	0	2	3410	460375	2199	sarilumab	rheumatoid arthritis	33	75	0	0	3934.41	1	0	1	1060	113937	2199	sarilumab	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	2199	sarilumab	rheumatoid arthritis	0	0	3910.38	1	0	1	1011	107963	2199	sarilumab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2200	olaratumab	0	0	11.85	1	0	17	177549	8686773	2200	olaratumab	liposarcoma	0	0	Inf	1	0	4	0	211	2200	olaratumab	liposarcoma	NA	NA	0	0	Inf	1	0	0	0	0	2200	olaratumab	liposarcoma	0	0	Inf	1	0	1	0	51	2200	olaratumab	liposarcoma	0	0	Inf	1	0	3	0	21	2200	olaratumab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2203	avelumab	0	0	118.34	1	0	3	177549	8686787	2203	avelumab	hypertension	0	0	1747.48	1	0	1	6895	317612	2203	avelumab	hypertension	38	82.9	0	0	Inf	1	0	0	981	62409	2203	avelumab	hypertension	0	0	Inf	1	0	0	341	31639	2203	avelumab	hypertension	0	0	Inf	1	0	0	762	39930	2203	avelumab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2205	ocrelizumab	0.66	0.08	2.43	0.77	2	148	177547	8686642	2205	ocrelizumab	rheumatoid arthritis	0	0	5.29	1	0	96	3410	460281	2205	ocrelizumab	rheumatoid arthritis	33	75	0	0	258.73	1	0	3	1060	113935	2205	ocrelizumab	rheumatoid arthritis	0	0	Inf	1	0	0	180	25391	2205	ocrelizumab	rheumatoid arthritis	0	0	257.06	1	0	3	1011	107961	2205	ocrelizumab	rheumatoid arthritis	-6.96	0.000949096574540873	113.6	0.95	-0.01	0	0	-0.26	0.08	0
2207	dupilumab	0	0	53.4	1	0	5	177549	8686785	2207	dupilumab	dermatitis atopic	0	0	346.5	1	0	3	18	2486	2207	dupilumab	dermatitis atopic	15.7	51.3	0	0	Inf	1	0	0	1	161	2207	dupilumab	dermatitis atopic	0	0	Inf	1	0	0	0	198	2207	dupilumab	dermatitis atopic	0	0	Inf	1	0	0	3	184	2207	dupilumab	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
2208	durvalumab	0	0	11.12	1	0	18	177549	8686772	2208	durvalumab	plasma cell myeloma	0	0	115.04	1	0	8	534	104907	2208	durvalumab	plasma cell myeloma	47.4	82.5	0	0	143.5	1	0	8	164	39820	2208	durvalumab	plasma cell myeloma	0	0	226.88	1	0	6	93	24556	2208	durvalumab	plasma cell myeloma	0	0	1286.93	1	0	2	91	20956	2208	durvalumab	plasma cell myeloma	-8.98	0.00012590284750167	311.08	0.98	-0.03	0.01	0	-0.15	0.15	0.31
